data_2m3t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3t _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 79.0 p . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.844 -0.798 . . . . 109.64 108.844 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 42' ' ' VAL . 42.7 tttt -107.03 147.91 29.36 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.273 0.358 . . . . 84.790000000000006 111.561 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.725 HG21 ' SG ' ' A' ' 83' ' ' CYS . 18.5 tt -140.15 136.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.95 -0.389 . . . . 92.510000000000005 109.95 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.534 HG22 ' CE1' ' A' ' 11' ' ' TYR . 35.4 m -120.32 138.11 53.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 87.530000000000001 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 67.8 m-85 -116.86 116.61 27.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.067 -0.716 . . . . 6.4500000000000002 109.067 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 88.6 m-85 -95.96 140.61 30.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.213 0.53 . . . . 66.760000000000005 111.144 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HB2' ' CB ' ' A' ' 19' ' ' ARG . 4.3 tm-20 -62.06 -51.86 66.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.851 -0.613 . . . . 46.579999999999998 109.841 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.42 -175.95 3.36 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.791 -0.641 . . . . 24.879999999999999 109.92 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.67 -179.38 7.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.75 -0.659 . . . . 261.38 110.455 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 49.77 26.11 1.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 66.739999999999995 110.61 179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.636 ' H ' ' HG ' ' A' ' 39' ' ' SER . 1.3 m-85 57.96 44.57 19.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 24.969999999999999 110.947 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -114.74 161.49 18.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.974 0.416 . . . . 202.34999999999999 110.724 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.26 -146.4 29.06 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.859 -0.61 . . . . 138.46000000000001 112.437 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.557 ' CB ' ' HB2' ' A' ' 12' ' ' GLU . 2.1 ttm-85 -57.05 166.25 1.1 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.709 -0.849 . . . . 828.42999999999995 108.709 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.24 152.12 4.87 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.78 -0.452 . . . . 612.69000000000005 109.78 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 47.4 t80 -130.6 131.9 45.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 83.090000000000003 109.596 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -116.21 128.78 55.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 278.01999999999998 110.649 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.01 139.21 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 488.68000000000001 109.975 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -123.99 22.24 8.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.323 -0.399 . . . . 154.21000000000001 111.147 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 150.29 29.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.069 -0.253 . . . . 222.97999999999999 110.605 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -39.9 156.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.846 -0.616 . . . . 317.22000000000003 111.374 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -157.34 164.21 37.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.625 . . . . 294.14999999999998 110.184 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.04 -56.41 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 98.579999999999998 110.921 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -151.01 108.79 3.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.579 -0.737 . . . . 348.80000000000001 111.295 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.488 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.5 p90 -99.74 5.32 45.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 8.1300000000000008 110.48 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.3 t60 -58.21 -26.89 63.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.186 0.517 . . . . 12.92 109.966 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.9 p -62.04 -20.94 64.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.956 -0.566 . . . . 126.12 110.265 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.16 -17.33 19.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 84.519999999999996 111.266 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -138.91 135.5 34.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.809 0.338 . . . . 88.469999999999999 110.276 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.64 -9.66 26.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.5 -0.318 . . . . 171.22 111.551 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.402 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 30.2 ttm-85 -155.11 142.01 19.12 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 110.025 -0.361 . . . . 533.13999999999999 110.025 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HG ' ' H ' ' A' ' 80' ' ' LEU . 2.3 m -108.59 102.32 11.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.332 0.586 . . . . 199.28 110.847 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 39' ' ' SER . 76.4 m-20 -125.57 154.91 41.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.953 -1.499 . . . . 45.579999999999998 106.953 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.642 ' O ' ' O ' ' A' ' 38' ' ' ASN . 15.6 p 39.04 128.67 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.497 1.142 . . . . 65.219999999999999 112.805 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 13.7 mt -142.02 143.49 26.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.307 -0.86 . . . . 91.5 111.772 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.5 ptpt -154.67 101.79 2.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.722 -0.672 . . . . 106.59 109.571 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 7' ' ' LYS . 1.9 t -65.73 148.03 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 110.033 -0.358 . . . . 284.95999999999998 110.033 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.91 57.8 1.04 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.164 -0.68 . . . . 256.75 109.164 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.96 -100.05 0.13 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.544 -0.753 . . . . 10.26 111.338 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -131.43 -142.32 4.99 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.485 -0.646 . . . . 9.6099999999999994 111.485 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.47 HG21 ' N ' ' A' ' 47' ' ' TRP . 86.6 m -79.98 165.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 101.98 110.601 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.752 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 15.6 m95 -151.79 153.16 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 8.8699999999999992 111.748 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.42 117.69 33.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.274 -1.009 . . . . 89.810000000000002 108.274 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 m -118.03 133.69 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 94.290000000000006 110.662 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.42 117.04 33.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 107.20999999999999 110.182 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.2 -39.59 0.18 Allowed 'General case' 0 C--N 1.333 -0.111 0 O-C-N 123.553 0.533 . . . . 42.520000000000003 110.674 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -116.85 153.32 49.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 999.99000000000001 110.866 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 48.1 Cg_endo -71.06 168.02 24.43 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.103 2.535 . . . . 65.609999999999999 111.108 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.657 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.6 OUTLIER 79.8 -4.29 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.872 0.732 . . . . 371.37 110.885 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 12.0 m-85 . . . . . 0 N--CA 1.464 0.27 0 O-C-N 123.493 0.495 . . . . 36.060000000000002 110.749 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.532 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 13.2 t80 . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 109.587 -0.523 . . . . 999.99000000000001 109.587 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 3.9 mp -102.26 95.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 98.069999999999993 109.811 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -77.56 109.96 11.2 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.241 -0.436 . . . . 90.099999999999994 110.096 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 90.5 Cg_endo -81.98 165.83 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.098 2.532 . . . . 10.27 112.407 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -56.26 112.38 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.182 -0.463 . . . . 16.370000000000001 110.119 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.59 175.74 41.54 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.327 -1.109 . . . . 10.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.614 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.4 mt-10 -100.15 157.75 16.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.096 0.474 . . . . 11.75 110.747 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.614 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.4 m-85 -149.93 80.4 7.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.344 -0.843 . . . . 64.829999999999998 108.955 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 48.2 Cg_exo -48.79 -22.33 4.53 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.008 2.472 . . . . 76.409999999999997 113.284 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.35 163.4 35.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.388 -0.597 . . . . 36.829999999999998 109.388 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 26.5 p90 -61.63 -45.2 95.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 87.280000000000001 110.74 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.582 ' HG2' ' CE2' ' A' ' 70' ' ' TYR . 7.4 mt-30 -46.0 -13.43 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.217 0.451 . . . . 319.02999999999997 112.217 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -75.36 -3.51 34.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.59 -0.277 . . . . 730.28999999999996 111.566 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -118.35 26.33 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.404 -0.221 . . . . 8.2899999999999991 110.404 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.542 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.8 mmt 85.0 23.74 0.09 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.936 0.773 . . . . 168.38 110.955 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.35 50.1 0.25 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.916 -0.473 . . . . 12.4 111.916 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.634 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 16.8 mt -79.89 18.31 0.83 Allowed 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.968 -0.136 . . . . 132.99000000000001 110.917 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.634 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 66.3 t30 106.96 159.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.456 1.097 . . . . 269.25 110.155 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -91.72 57.35 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.666 0.604 . . . . 144.44 110.637 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.16 108.84 9.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.811 -0.631 . . . . 909.05999999999995 110.276 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.03 126.81 19.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.238 -0.585 . . . . 87.329999999999998 110.018 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.526 ' O ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -101.2 -162.54 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.742 -0.663 . . . . 70.950000000000003 109.431 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 12.8 p -50.27 -168.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.403 0.621 . . . . 257.19999999999999 111.262 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.752 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 28.1 p -154.79 161.79 41.36 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.407 -0.517 . . . . 64.189999999999998 110.071 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -122.94 131.84 53.9 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.498 -0.556 . . . . 427.60000000000002 109.498 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 123.6 18.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 92.530000000000001 110.43 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.87 129.92 75.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.401 -0.363 . . . . 110.95999999999999 110.991 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -101.4 157.62 16.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.935 -0.575 . . . . 304.38999999999999 110.265 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.61 150.48 63.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 336.50999999999999 110.651 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 C-N-CA 123.007 2.471 . . . . 12.23 112.284 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.402 ' HG3' ' H ' ' A' ' 94' ' ' TYR . 3.7 pt20 . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.621 0.248 . . . . 53.340000000000003 110.664 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.703 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.8 t80 -162.49 114.39 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.797 -0.446 . . . . 79.170000000000002 109.797 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 110' ' ' GLU . 21.0 tptm -154.83 132.17 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 348.60000000000002 110.828 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.606 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -133.7 143.1 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 89.230000000000004 111.444 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.404 ' CD ' HG23 ' A' ' 132' ' ' VAL . 5.7 mt-30 -120.43 131.15 54.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.043 -0.98 . . . . 141.06 109.255 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 108' ' ' MET . 6.7 mt -120.82 134.13 65.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 116.252 -0.431 . . . . 88.219999999999999 110.677 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.2 m-85 -115.16 132.66 56.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 10.210000000000001 110.976 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.2 -26.7 68.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.637 . . . . 27.190000000000001 110.653 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -122.09 144.77 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 324.81 110.584 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -61.44 174.4 6.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.753 -0.939 . . . . 60.390000000000001 110.753 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.85 33.6 23.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 414.81999999999999 110.536 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 11.7 m-85 53.46 78.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.841 -0.618 . . . . 36.439999999999998 110.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -156.39 163.09 39.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 83.989999999999995 110.699 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.67 -154.91 27.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.436 -0.665 . . . . 44.380000000000003 111.436 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -72.57 132.82 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 35.469999999999999 110.906 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 47.8 ttp -116.7 128.37 55.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.82 -0.627 . . . . 161.99000000000001 110.492 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.67 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 39.1 m-85 -119.25 135.63 54.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 67.670000000000002 110.769 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.465 ' HB2' ' CE ' ' A' ' 95' ' ' LYS . 8.3 pt-20 -121.55 123.31 41.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.397 -0.82 . . . . 48.299999999999997 110.89 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -148.11 125.83 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.138 -0.483 . . . . 103.67 110.976 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.4 OUTLIER -93.22 38.77 1.04 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.534 0.683 . . . . 164.88 110.719 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.78 -176.47 4.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.597 -0.729 . . . . 67.290000000000006 110.352 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -88.1 160.29 17.86 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.891 0.377 . . . . 16.91 110.221 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 121' ' ' GLN . 6.6 t -140.87 122.57 9.29 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.921 -0.582 . . . . 319.91000000000003 110.504 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 172' ' ' SER . 56.1 Cg_endo -75.59 -56.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.785 2.324 . . . . 14.710000000000001 111.609 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -115.28 109.72 18.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.858 -0.61 . . . . 65.400000000000006 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' PHE . 3.2 tt -69.37 -40.94 80.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.247 0.546 . . . . 82.980000000000004 110.025 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.4 ttt -67.79 -31.9 72.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 227.30000000000001 110.855 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.09 -47.2 71.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.207 -0.451 . . . . 342.48000000000002 112.155 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' HG2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -100.87 -29.68 12.1 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.992 0.738 . . . . 251.72999999999999 112.992 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.67 ' CE1' ' HB3' ' A' ' 109' ' ' TYR . 17.4 m-85 -104.02 -1.74 27.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.565 -0.454 . . . . 10.460000000000001 110.948 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.5 m-70 55.25 7.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 18.77 111.737 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.537 ' SD ' ' CG2' ' A' ' 98' ' ' ILE . 41.7 mtt -77.16 132.88 39.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.988 0.423 . . . . 110.93000000000001 110.156 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -102.96 -31.63 10.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.618 -0.719 . . . . 599.49000000000001 110.242 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.476 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 57.4 mt-10 -148.67 110.05 4.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 84.760000000000005 110.372 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.6 mm -74.24 122.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.595 -0.52 . . . . 89.629999999999995 109.595 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.6 m80 -103.17 -32.07 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 9.0999999999999996 110.77 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.476 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 44.3 t -148.18 142.89 26.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.341 -0.39 . . . . 253.59 110.831 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.26 127.21 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 59.619999999999997 110.049 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -109.03 -176.79 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 164.47 110.577 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 95' ' ' LYS . 61.8 t 56.86 98.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.0 -0.545 . . . . 368.60000000000002 110.742 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 133' ' ' LEU . 4.2 mm? -111.72 161.17 16.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.788 -0.642 . . . . 408.81999999999999 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -138.63 111.03 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 385.49000000000001 110.169 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.01 -91.88 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.005 -0.838 . . . . 11.619999999999999 111.005 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 134' ' ' GLU . 42.8 t -122.83 141.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 110.065 -0.346 . . . . 97.030000000000001 110.065 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.703 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 26.6 t-105 -124.51 169.55 11.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 8.7899999999999991 110.66 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.452 HG13 HD13 ' A' ' 176' ' ' ILE . 59.7 mt -145.24 122.21 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.694 -0.684 . . . . 91.980000000000004 111.05 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -108.4 133.91 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.702 -0.481 . . . . 4.8200000000000003 109.702 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.533 ' CE1' ' HG2' ' A' ' 149' ' ' GLN . 25.0 m-85 -111.08 112.14 23.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 62.009999999999998 110.763 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -52.97 -25.27 11.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.159 -0.473 . . . . 28.989999999999998 110.277 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.01 160.61 31.68 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.53 . . . . 106.08 109.99 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD3' ' HG3' ' A' ' 171' ' ' GLN . 58.9 Cg_endo -76.79 169.3 21.98 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.707 2.271 . . . . 14.449999999999999 111.552 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 8.3 m-80 70.9 19.45 5.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 204.59999999999999 111.104 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD1' ' HB3' ' A' ' 174' ' ' ARG . 3.7 m-85 70.92 33.25 2.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.654 -0.248 . . . . 73.569999999999993 111.165 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 140' ' ' TYR . 45.4 mtm180 -121.53 174.0 7.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 999.99000000000001 110.846 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.92 175.36 42.59 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.895 -0.882 . . . . 54.329999999999998 110.895 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -49.03 136.39 14.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 999.99000000000001 110.051 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.533 ' HG2' ' CE1' ' A' ' 140' ' ' TYR . 70.0 mt-30 -99.53 122.1 42.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 397.97000000000003 109.809 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 71.1 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 100.91 109.925 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 162' ' ' ASP . 16.0 m-85 . . . . . 0 N--CA 1.46 0.07 0 N-CA-C 110.274 -0.269 . . . . 111.81 110.274 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.75 -20.52 13.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 999.99000000000001 110.768 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 1.5 pttm -124.77 159.76 56.95 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.107 0.479 . . . . 495.68000000000001 110.773 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.551 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -62.59 -19.84 69.06 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.841 2.361 . . . . 16.219999999999999 112.775 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.25 -6.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.908 0.385 . . . . 122.18000000000001 110.443 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -56.77 -30.32 63.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 33.18 110.975 -178.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.489 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -103.56 23.95 11.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.081 0.467 . . . . 9.2200000000000006 109.929 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.4 28.73 73.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.851 -0.613 . . . . 12.81 112.904 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.489 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.46 137.74 41.87 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.709 0.754 . . . . 89.370000000000005 110.082 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.17 18.73 0.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 101.12 110.647 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 169.39 154.17 0.16 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.695 0.283 . . . . 70.739999999999995 111.171 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 55.6 Cg_endo -74.8 2.98 5.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.172 2.582 . . . . 20.879999999999999 112.037 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.26 75.02 5.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 105.11 110.524 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.602 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.1 t -102.74 -147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.894 -0.78 . . . . 217.69999999999999 108.894 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.602 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 15.7 mm-40 -156.67 -133.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.014 -0.365 . . . . 167.06 110.014 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 115' ' ' CYS . 0.2 OUTLIER -91.95 -153.02 0.32 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.411 0.148 . . . . 307.97000000000003 111.256 -177.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -169.59 -176.14 2.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.064 0.459 . . . . 9.2300000000000004 110.806 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HB3' ' CD1' ' A' ' 145' ' ' TYR . 10.2 ptm180 -160.48 130.88 5.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.599 . . . . 18.09 110.353 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.5 ptt180 -53.01 131.52 36.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 655.46000000000004 110.879 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 138' ' ' ILE . 30.9 mt -62.5 134.68 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.446 -0.797 . . . . 91.299999999999997 109.893 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.452 HG22 HH21 ' A' ' 174' ' ' ARG . 0.1 OUTLIER -135.58 153.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.824 -0.625 . . . . 282.87 110.601 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.026 -0.988 . . . . 408.25 110.757 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 CA--C 1.528 0.098 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.745 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.4 tttt -160.05 151.1 19.23 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.053 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.8 142.14 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.991 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -124.72 138.71 54.27 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 116.16 25.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.453 ' O ' ' O ' ' A' ' 38' ' ' ASN . 87.3 m-85 -96.83 138.24 34.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.271 0.558 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.7 tm-20 -60.88 -49.94 75.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.01 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.7 m-20 -97.82 -176.94 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 110.141 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -82.08 -176.63 6.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.41 24.26 0.28 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.029 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 63.76 41.64 6.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.5 179.15 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 110.451 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.38 -159.06 48.15 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -53.39 175.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.05 150.68 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.4 t80 -127.94 131.34 49.33 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -119.8 124.0 45.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.864 0.364 . . . . 0.0 111.151 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.27 142.59 23.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.316 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -125.39 24.39 7.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASP . 10.6 m -146.22 141.71 27.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 25' ' ' CYS . 55.1 p-10 -36.27 156.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 26' ' ' ASP . 15.5 m -156.48 162.71 39.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -55.96 3.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.05 0.452 . . . . 0.0 110.538 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -153.03 111.35 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 2.2 p90 -101.29 10.56 40.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.963 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.4 t60 -60.85 -26.07 67.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 109.962 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.7 p -63.2 -30.55 71.68 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.229 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.61 -12.41 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.532 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -144.29 138.33 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 109.986 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 m -99.28 -9.22 23.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.652 0.263 . . . . 0.0 111.464 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.2 ttm-85 -156.48 144.89 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.0 m -110.11 103.89 12.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.728 ' O ' ' O ' ' A' ' 39' ' ' SER . 71.5 m-20 -128.7 156.42 43.52 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.728 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.5 p 34.95 129.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.438 1.114 . . . . 0.0 112.399 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -141.76 145.51 24.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.034 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -153.35 102.9 2.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.8 t -66.5 148.96 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.52 0.676 . . . . 0.0 110.568 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -122.21 51.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.732 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.17 -94.64 0.1 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.927 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.31 -140.16 3.9 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 94.9 m -80.56 166.41 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.366 -0.491 . . . . 0.0 110.824 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.745 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.6 m95 -153.78 156.71 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.336 0.589 . . . . 0.0 110.746 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.99 120.36 38.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.83 132.8 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.017 0.437 . . . . 0.0 110.931 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' GLU . 87.8 m-85 -104.45 111.13 23.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.671 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 50' ' ' TYR . 68.8 tt0 -35.74 -35.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.294 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -116.18 148.12 40.86 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.043 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.8 Cg_endo -68.59 158.61 57.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.459 2.106 . . . . 0.0 111.719 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.5 m-80 85.7 -4.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.841 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 10.9 m-85 . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 121.172 0.51 . . . . 0.0 111.1 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 33.4 t80 . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.36 91.29 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.874 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.7 110.38 5.84 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.422 0.451 . . . . 0.0 110.074 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.78 162.14 18.75 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.269 1.979 . . . . 0.0 112.539 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.19 118.17 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.167 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.47 179.36 41.27 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.539 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.5 mt-10 -101.98 152.55 20.81 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.959 0.409 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 21.8 m-85 -145.75 85.23 7.84 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.5 -18.13 24.35 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.142 2.561 . . . . 0.0 113.137 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -150.63 161.73 42.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -63.11 -51.2 67.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.401 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 18.3 mt-30 -43.28 -10.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.1 mmm180 -75.08 -6.5 49.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.724 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -118.02 27.29 9.09 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.853 -0.158 . . . . 0.0 110.646 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.9 mmt 83.56 24.73 0.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.175 0.922 . . . . 0.0 111.102 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.12 50.39 0.48 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.7 mt -74.45 14.21 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.7 t30 110.21 167.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.538 1.149 . . . . 0.0 109.349 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.6 p30 -99.27 60.56 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.034 0.445 . . . . 0.0 110.383 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -137.89 115.72 11.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.057 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -140.74 128.6 21.82 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.3 p -111.81 -162.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 24.3 p -45.25 -179.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.129 0.49 . . . . 0.0 110.504 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -151.09 153.33 34.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -118.69 128.56 54.62 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.71 126.47 27.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.149 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.2 t -126.54 132.6 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.79 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -99.29 161.88 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.85 148.86 82.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.525 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.293 1.996 . . . . 0.0 112.503 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.723 0.297 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 20.5 t80 -155.78 112.4 3.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -149.58 127.91 12.17 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.385 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.2 tt -130.27 136.52 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 53.2 mt-30 -120.04 126.04 49.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 107' ' ' GLN . 5.8 mt -118.37 132.81 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.72 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 46.3 m-85 -117.5 127.75 54.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.05 0.453 . . . . 0.0 111.523 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.52 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 73.6 tt0 -60.27 -28.02 67.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.859 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.462 ' C ' ' H ' ' A' ' 103' ' ' ASP . 51.3 mttm -107.95 141.54 39.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.448 0.642 . . . . 0.0 110.778 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -69.67 37.02 0.37 Allowed Glycine 0 C--N 1.315 -0.597 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.018 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 101' ' ' LYS . 5.6 p-10 -154.27 35.7 0.42 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HA ' ' CG ' ' A' ' 99' ' ' PHE . 28.6 m-85 56.31 56.26 5.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.32 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 3.8 m -161.13 170.68 19.92 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.747 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.63 -43.45 2.89 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.835 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 72.1 tp60 -156.86 119.12 3.91 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.517 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 29.4 ttp -116.6 109.15 16.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.232 0.924 . . . . 0.0 110.159 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.607 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 16.8 m-85 -115.54 133.47 56.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -122.9 122.84 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -152.17 126.24 9.16 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.383 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 t -94.09 44.08 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 111.002 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -141.79 179.52 6.8 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -83.45 155.43 23.42 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.717 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.632 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -131.37 120.71 18.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.939 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.58 -55.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.861 1.707 . . . . 0.0 110.727 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.1 m -118.02 114.36 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.7 tt -69.31 -43.31 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.434 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.5 ttt -67.25 -19.48 65.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.729 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.08 -46.61 41.87 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 4.8 pt20 -99.85 -24.72 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.609 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 28.5 m-85 -114.68 2.48 14.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.6 0.238 . . . . 0.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 50.6 14.02 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.268 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.415 ' N ' ' C ' ' A' ' 122' ' ' PHE . 13.6 mtp -80.24 135.89 36.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -109.32 -25.99 10.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 67.6 mt-10 -150.81 107.06 3.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.014 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.58 123.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.681 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 66.1 m80 -105.4 -31.08 9.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.906 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 14.7 m -150.49 145.79 26.22 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.5 t -150.56 124.88 9.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.19 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -94.39 53.0 1.63 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.488 ' CG1' ' SG ' ' A' ' 130' ' ' CYS . 7.5 p -95.92 125.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.417 ' O ' ' CD ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -147.11 94.95 2.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.325 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 136' ' ' VAL . 14.3 mp0 -144.58 109.78 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.115 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.08 -85.94 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.603 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.7 t -127.12 156.85 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.723 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.4 t-105 -144.82 166.2 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.578 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.3 mt -144.61 123.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.713 0.292 . . . . 0.0 111.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -108.2 129.07 55.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 23.8 m-85 -108.51 110.8 22.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.34 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.528 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 82.2 tt0 -49.85 -23.27 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.77 160.3 37.21 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.331 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.478 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.4 Cg_endo -78.55 165.25 25.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.387 2.058 . . . . 0.0 111.943 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.673 ' ND2' HH21 ' A' ' 146' ' ' ARG . 1.9 m-80 75.1 13.57 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.2 m-85 79.27 24.6 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.673 HH21 ' ND2' ' A' ' 144' ' ' ASN . 87.7 mtm180 -107.03 169.44 8.55 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.35 170.35 36.2 Favored Glycine 0 N--CA 1.463 0.45 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.3 ptt180 -61.75 143.27 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.209 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 70.1 mt-30 -97.97 146.79 25.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.536 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 48.0 m-85 . . . . . 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.72 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 N--CA 1.461 0.125 0 CA-C-O 120.789 0.328 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . 13.4 ptm180 -108.27 -21.62 12.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.546 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 156.2 57.6 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.398 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.8 Cg_endo -61.13 -19.0 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.736 2.291 . . . . 0.0 113.847 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.8 -1.59 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.355 0.598 . . . . 0.0 110.636 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.09 -29.42 70.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.843 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.543 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -105.0 22.91 14.45 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.79 27.55 70.58 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.871 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.481 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.8 138.05 45.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.013 0.906 . . . . 0.0 109.473 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.96 20.63 0.35 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.217 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER 175.42 154.64 0.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.837 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.22 3.14 6.49 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.274 2.649 . . . . 0.0 111.801 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.05 5.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.393 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.599 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -95.95 -150.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.599 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.5 tp60 -157.18 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.786 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.8 -155.57 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 52.0 p90 -169.87 -177.07 2.52 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.082 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.93 131.8 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -54.15 129.91 36.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.021 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.28 135.87 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.288 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.9 152.82 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.261 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.208 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 121.077 0.465 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.728 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.7 tttt -161.25 153.66 20.27 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.277 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.43 142.78 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.714 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 m -126.72 139.96 52.75 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.082 0.468 . . . . 0.0 110.471 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.05 116.73 26.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.297 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.7 m-85 -95.76 138.36 33.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.606 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.46 -49.05 79.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.289 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 82.4 m-20 -100.76 -174.77 2.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.907 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.35 -174.96 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.656 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.8 m120 46.21 22.92 0.17 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.88 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.734 ' H ' ' HG ' ' A' ' 39' ' ' SER . 1.4 m-85 59.17 44.93 15.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.305 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -115.27 161.91 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 110.374 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.36 -151.22 29.47 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.592 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -58.18 173.79 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.46 155.05 5.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -134.61 134.59 41.41 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 30.2 t0 -102.81 154.35 19.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.547 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.43 124.81 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.815 0.34 . . . . 0.0 110.139 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -124.82 11.17 8.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ASP . 8.0 t -150.65 148.25 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.5 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 52.9 p30 -37.54 154.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' C ' ' HG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -155.79 160.69 40.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.03 -56.82 2.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 41.5 p-10 -152.98 113.74 4.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -103.41 8.31 38.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 53.4 t60 -59.61 -29.4 67.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.539 0.685 . . . . 0.0 110.024 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.2 p -60.15 -30.52 69.37 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.383 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -87.34 -13.97 42.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.521 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.0 tp -142.2 137.36 30.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 109.943 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -98.16 -9.42 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.268 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.0 ttm-85 -155.66 144.12 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.2 m -110.18 103.67 12.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 110.671 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.736 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.8 m-20 -128.91 155.16 45.72 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.736 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.9 p 36.11 129.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.558 1.17 . . . . 0.0 112.258 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.5 mt -141.55 146.13 23.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.857 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.307 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.5 ptpt -154.46 104.2 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.248 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.71 149.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.39 0.614 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -120.39 47.69 1.73 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.769 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.08 -94.84 0.1 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.022 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.94 -139.81 3.87 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 93.0 m -79.71 166.66 21.57 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.179 -0.601 . . . . 0.0 110.946 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.728 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -156.0 156.81 35.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.566 0.698 . . . . 0.0 111.039 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.39 119.31 36.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.798 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 m -117.88 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.232 0.539 . . . . 0.0 111.114 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 30.9 m-85 -93.77 175.31 6.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -100.99 -36.69 8.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -118.96 148.14 44.01 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 38.7 Cg_endo -64.16 157.29 54.43 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.006 1.804 . . . . 0.0 111.915 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.2 m120 84.24 -3.9 1.05 Allowed 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.005 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 16.6 m-85 . . . . . 0 N--CA 1.47 0.525 0 O-C-N 123.616 0.572 . . . . 0.0 111.073 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 12.0 t80 . . . . . 0 CA--C 1.52 -0.201 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.22 92.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.438 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -72.22 112.78 15.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.0 162.75 15.71 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.013 1.808 . . . . 0.0 112.456 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.08 115.68 1.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.057 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.11 177.4 41.62 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.8 mt-10 -100.75 153.04 19.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.346 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -144.94 89.41 6.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_endo -63.35 -13.92 38.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.239 1.959 . . . . 0.0 113.419 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 96.7 mt-10 -149.69 161.01 43.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.723 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 34.7 p90 -63.76 -53.69 47.08 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.986 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -43.77 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 70' ' ' TYR . 22.9 mmm180 -75.18 -4.38 38.51 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.723 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.29 24.08 10.93 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.883 -0.144 . . . . 0.0 110.976 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 21.1 mmt 87.69 23.96 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.238 1.015 . . . . 0.0 111.064 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.72 50.27 0.42 Allowed Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.2 mt -74.34 13.36 0.59 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.013 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 46.9 t30 109.81 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.94 1.4 . . . . 0.0 109.157 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -96.29 63.0 2.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.443 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.446 ' CA ' ' HE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.9 116.44 11.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.232 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.31 128.06 20.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 82' ' ' SER . 1.1 p -110.3 -162.92 0.82 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.041 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.7 m -45.47 -179.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.609 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.6 p -150.29 151.51 33.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.634 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.06 128.73 55.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.551 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 128.04 34.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.304 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.8 t -127.34 132.9 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.79 161.64 13.46 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.07 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -87.94 148.17 42.67 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.8 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 120.72 0.295 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.738 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 28.8 t80 -157.29 113.63 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -154.22 133.72 12.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 145.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.131 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.3 mt-30 -123.76 128.17 49.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.563 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.7 mt -118.44 131.93 69.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.16 130.01 56.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.628 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.27 -27.21 65.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.908 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -122.2 149.15 44.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.21 171.34 18.89 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 60.19 29.82 19.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.537 ' H ' ' HG ' ' A' ' 129' ' ' SER . 3.9 m-85 56.01 82.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -158.61 161.6 37.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 0.0 110.26 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.69 -150.95 23.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -74.6 138.87 43.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.5 tmm? -123.55 132.73 53.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.175 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.11 136.37 54.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -123.96 125.67 44.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -151.27 128.56 11.26 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -93.48 44.45 1.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -144.52 -179.25 6.43 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.6 p30 -86.41 159.96 19.19 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.563 ' O ' ' OG ' ' A' ' 172' ' ' SER . 96.5 m -138.71 123.49 11.77 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.73 -55.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.04 1.827 . . . . 0.0 111.665 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 m -116.59 111.89 20.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -41.72 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.406 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 7.7 ttp -67.94 -16.59 64.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.438 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -83.38 -42.73 16.7 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.595 -0.691 . . . . 0.0 111.39 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.584 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -93.85 -30.61 14.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.903 -177.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 26.1 m-85 -114.8 5.9 15.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.8 m-70 50.9 9.35 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.786 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.521 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -76.52 135.36 39.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.868 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -107.35 -27.56 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 49.5 mt-10 -151.03 107.57 3.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.35 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 12.4 mm -75.59 125.4 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 109.779 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.8 m80 -103.75 -31.13 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.283 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.537 ' HG ' ' H ' ' A' ' 104' ' ' PHE . 25.0 p -155.77 151.78 27.69 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.8 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -150.56 131.26 14.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.123 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 51.9 mtmt -112.09 -173.2 2.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.446 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.9 t 55.57 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.679 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.72 167.78 10.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.053 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -139.21 111.38 7.43 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 40.26 -84.82 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.4 t -125.03 154.95 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.745 0.307 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.738 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.8 t-105 -142.12 167.46 22.06 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.594 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.3 mt -145.34 125.72 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.378 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -107.34 112.63 25.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -48.89 -23.15 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.968 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.8 mp -119.26 166.43 14.48 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.2 167.36 12.33 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.093 1.862 . . . . 0.0 111.902 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.81 15.27 1.14 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.078 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.0 m-85 74.02 27.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.635 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 99.5 mtt180 -132.67 126.03 31.67 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.94 174.69 22.87 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -56.08 114.19 1.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -80.93 141.0 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.05 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 179.284 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -109.64 -22.02 12.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.271 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -119.53 156.1 53.7 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 121.005 0.431 . . . . 0.0 110.717 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.562 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -60.48 -16.19 40.66 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.746 2.298 . . . . 0.0 113.531 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.91 -2.22 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.114 0.483 . . . . 0.0 111.02 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -26.05 67.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.638 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.74 21.87 16.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.459 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.18 67.55 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.788 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -108.15 138.9 43.63 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.878 0.839 . . . . 0.0 109.994 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.3 22.28 0.23 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 167.08 155.89 0.11 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.229 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 170' ' ' VAL . 45.7 Cg_endo -70.74 -33.62 12.6 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.596 2.197 . . . . 0.0 111.523 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -47.25 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.31 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.64 ' CG2' ' H ' ' A' ' 171' ' ' GLN . 9.1 p -107.68 -145.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.64 ' H ' ' CG2' ' A' ' 170' ' ' VAL . 69.3 mm-40 -152.9 -132.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.271 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -95.77 -153.29 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -170.69 -177.04 2.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.485 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.55 133.13 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.061 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.5 ptt-85 -52.43 133.66 35.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.384 0.612 . . . . 0.0 110.616 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.6 mt -67.29 135.06 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.35 156.63 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.202 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.494 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 2.7 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.781 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.5 tttt -159.99 151.06 19.29 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.948 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.59 141.31 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.887 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -124.32 138.22 54.4 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.144 0.497 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.6 115.95 25.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 38' ' ' ASN . 85.3 m-85 -96.4 138.28 34.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.301 0.572 . . . . 0.0 111.152 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.4 tm-20 -60.98 -50.0 75.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.856 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.2 m-20 -97.87 -177.79 3.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.295 0.569 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -177.07 6.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.123 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.614 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 46.67 25.36 0.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.876 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' H ' ' CB ' ' A' ' 39' ' ' SER . 1.7 m-85 63.4 40.17 8.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.07 175.11 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.21 -158.33 53.26 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.706 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -53.6 174.91 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -168.46 150.76 5.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -126.5 130.99 51.7 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 42.9 p-10 -119.36 119.96 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.94 142.69 23.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.176 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -125.81 26.32 6.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.7 m -146.75 141.35 26.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -38.01 157.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.713 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.1 t -159.17 166.57 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.586 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.81 -56.12 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.971 0.415 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 43.0 p-10 -152.15 113.6 4.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.441 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -102.4 8.55 40.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.052 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -60.15 -25.68 65.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.485 0.659 . . . . 0.0 110.066 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.9 p -63.62 -30.37 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -87.02 -13.83 43.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.407 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.8 tp -143.51 137.66 28.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 110.068 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -98.74 -9.74 24.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 ttm-85 -155.66 144.08 20.21 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 7.5 p -110.25 104.39 13.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.771 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 59.2 m-20 -128.96 156.56 43.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.26 128.88 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.44 1.114 . . . . 0.0 112.529 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.7 mt -141.71 146.49 22.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.18 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -154.77 103.29 2.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.204 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.0 t -66.73 148.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.713 0.768 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -123.46 54.54 1.28 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.81 -97.34 0.11 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.41 -142.11 4.7 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.23 166.81 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.319 -0.518 . . . . 0.0 110.776 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.781 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -152.98 155.22 36.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.381 0.61 . . . . 0.0 110.783 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.01 120.24 39.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.302 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.59 133.22 67.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.558 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -107.83 115.49 30.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.064 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' ARG . 59.7 tt0 -37.97 -34.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -115.4 146.78 37.27 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.819 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 44.4 Cg_endo -68.18 160.4 48.98 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.422 2.082 . . . . 0.0 111.495 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.1 m120 83.39 -3.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.29 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 7.6 m-85 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.08 0.466 . . . . 0.0 111.308 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 39.5 t80 . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.49 92.24 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.55 110.48 7.05 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.6 163.33 16.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.966 1.777 . . . . 0.0 112.795 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.59 114.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.81 177.52 42.2 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 94.5 mt-10 -101.16 153.03 19.94 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.887 0.375 . . . . 0.0 110.396 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -145.71 90.57 5.89 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.08 -13.72 41.32 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.317 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -149.07 160.92 42.9 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.7 p90 -63.39 -53.21 56.06 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.322 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -44.62 -9.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' TYR . 23.5 mmm180 -75.16 -4.78 40.76 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.834 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.68 24.86 10.8 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.907 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.5 mmt 87.47 23.0 0.05 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 111.085 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.13 52.47 0.52 Allowed Glycine 0 N--CA 1.469 0.865 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.1 mt -77.77 13.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.484 -0.294 . . . . 0.0 111.095 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 53.9 t30 109.79 167.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.612 1.195 . . . . 0.0 109.766 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 52.4 p30 -101.98 66.83 1.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLU . 5.5 tpt180 -143.63 77.28 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.585 0.231 . . . . 0.0 110.983 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -102.98 128.21 49.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.346 0.593 . . . . 0.0 109.605 -178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.3 p -109.38 -163.18 0.85 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.609 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.3 t -44.83 -179.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.174 0.512 . . . . 0.0 110.994 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.592 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.24 155.42 37.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.585 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -121.28 129.89 53.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.96 126.71 28.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.394 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.14 130.19 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.09 162.28 13.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.954 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.583 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -86.51 146.82 42.67 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.688 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 122.427 2.085 . . . . 0.0 112.223 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.666 0.27 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.729 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 15.4 t80 -156.87 113.22 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.2 tptm -153.98 129.29 9.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 111.155 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -133.96 141.57 43.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.9 mt-30 -119.33 128.61 54.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 108' ' ' MET . 12.5 mt -119.38 131.65 71.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.0 m-85 -111.21 131.22 55.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.98 -31.5 71.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -118.73 152.26 36.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.175 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.0 -169.66 2.22 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.0 t0 45.02 29.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 54.19 80.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 m -158.12 162.55 38.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.52 -149.24 19.7 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.58 138.93 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 110.449 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.441 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 45.5 ttp -120.5 127.85 52.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.526 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -119.44 136.63 54.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.204 0.526 . . . . 0.0 110.868 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.81 126.88 46.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.457 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.0 t -147.58 129.21 15.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.42 36.99 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.605 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.96 -177.31 5.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -85.1 158.91 20.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.193 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.449 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.3 t -132.38 123.79 18.82 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.227 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -78.52 -55.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.512 1.474 . . . . 0.0 110.784 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.2 m -119.11 114.44 22.47 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.8 tt -69.13 -45.13 80.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.04 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.0 ttt -65.94 -20.54 66.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.255 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -74.2 -46.84 39.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.15 -24.36 14.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.7 m-85 -110.77 0.92 17.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 52.41 12.13 0.22 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.412 ' H ' ' C ' ' A' ' 122' ' ' PHE . 34.7 mtt -78.97 134.16 36.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -106.22 -27.12 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.222 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.54 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -153.69 109.94 3.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.497 0.665 . . . . 0.0 111.251 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.0 mm -75.85 125.33 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.748 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.3 m80 -106.79 -31.05 8.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.001 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 7.9 m -152.47 147.03 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.5 t -146.66 133.92 20.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.725 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -114.05 -178.18 3.31 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.618 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t 56.46 103.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.663 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.99 163.44 15.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.012 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.7 mp0 -139.21 112.25 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.694 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.95 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 134' ' ' GLU . 41.8 t -126.6 135.88 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.729 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 t-105 -121.84 169.39 10.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 53.1 mt -145.53 124.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.465 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 149' ' ' GLN . 0.7 OUTLIER -110.74 133.73 53.08 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 149' ' ' GLN . 16.9 m-85 -109.73 111.71 23.32 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 123.531 0.519 . . . . 0.0 110.52 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -49.91 -23.38 1.92 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.975 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mp -113.86 166.4 11.46 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.49 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 93.4 Cg_endo -86.47 166.09 9.21 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.216 1.944 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.498 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.5 m-80 69.14 21.26 7.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.454 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.7 m-85 72.19 66.95 0.13 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.703 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -154.63 170.68 20.93 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 122.041 -0.412 . . . . 0.0 110.592 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.38 167.04 29.97 Favored Glycine 0 N--CA 1.464 0.53 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.884 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 149' ' ' GLN . 20.6 ptt180 -68.02 77.57 0.23 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 5.1 pt20 -48.05 175.54 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.443 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.196 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.404 ' O ' ' OG ' ' A' ' 129' ' ' SER . 33.7 ptt180 -107.23 -23.52 12.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.593 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpt -118.18 157.63 48.42 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-O 121.332 0.587 . . . . 0.0 111.044 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.4 Cg_endo -61.24 -19.29 63.14 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.044 1.829 . . . . 0.0 113.451 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.52 -0.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.532 . . . . 0.0 110.834 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -62.79 -25.83 68.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.481 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -108.93 21.14 17.6 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-O 120.931 0.395 . . . . 0.0 110.07 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.4 70.46 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.834 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -104.42 137.63 42.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.524 1.162 . . . . 0.0 109.459 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -72.47 18.37 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.083 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 167.77 157.18 0.14 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.41 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.17 6.17 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.951 2.434 . . . . 0.0 111.617 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.99 69.42 5.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.551 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.634 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.0 t -97.04 -153.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.634 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 79.0 mm-40 -155.13 -130.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.432 0.457 . . . . 0.0 110.228 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 2.6 p -92.72 -155.73 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -169.75 -177.68 2.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.425 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -162.03 134.33 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.124 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 177' ' ' VAL . 15.0 ptt180 -50.83 133.09 26.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.792 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.7 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 175' ' ' ARG . 21.6 t -69.53 140.13 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.072 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.421 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.982 0.42 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.71 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.1 tttt -160.97 149.94 16.58 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.892 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.96 140.47 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.935 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 27.2 m -121.58 137.84 54.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.25 115.49 24.86 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.8 m-85 -95.26 140.0 30.78 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.17 -51.31 69.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.911 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.4 m-20 -98.59 -176.77 3.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HB3' HD21 ' A' ' 15' ' ' ASN . 2.9 mppt? -82.04 -176.78 6.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.719 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.59 26.53 0.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.124 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.575 ' H ' ' HG ' ' A' ' 39' ' ' SER . 0.7 OUTLIER 62.09 41.0 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -106.58 172.0 7.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.16 -157.57 53.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NH1' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -54.56 175.93 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' CD ' ' A' ' 19' ' ' ARG . 2.7 ppt_? -169.21 149.99 4.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -132.92 133.77 43.68 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 45.1 p-10 -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.664 0.268 . . . . 0.0 110.798 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.21 37.73 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -124.64 16.56 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' ASP . 7.7 t -148.54 143.4 26.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' CYS . 52.2 p-10 -37.18 158.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.207 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.3 t -157.6 164.17 37.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -96.35 -49.07 5.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -158.57 105.7 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.254 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 1.7 p90 -97.76 12.58 33.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -64.74 -15.59 61.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 110.214 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.1 p -78.6 2.04 20.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.308 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.3 m-85 -120.2 -13.42 8.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.472 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 20.1 tp -144.76 140.31 28.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 t -100.7 -13.8 18.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.472 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.6 ttm-85 -152.61 141.73 21.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' ' CA ' ' A' ' 79' ' ' ARG . 9.0 p -109.34 104.3 13.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.294 0.569 . . . . 0.0 110.981 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.719 ' O ' ' O ' ' A' ' 39' ' ' SER . 86.4 m-20 -128.77 156.45 43.54 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.719 ' O ' ' O ' ' A' ' 38' ' ' ASN . 9.2 p 36.18 129.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.509 1.147 . . . . 0.0 112.341 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.16 146.39 22.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.828 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.16 102.7 2.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.47 148.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.466 0.65 . . . . 0.0 110.906 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.4 50.74 1.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.38 -97.14 0.11 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.39 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.75 -141.17 4.23 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -80.2 164.43 23.28 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.393 -0.475 . . . . 0.0 110.819 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.71 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 35.4 m95 -153.47 156.27 37.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.72 120.22 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.82 133.02 64.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.175 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 52' ' ' ARG . 82.5 m-85 -104.49 107.22 18.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.876 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' TYR . 44.7 tt0 -34.02 -32.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.441 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 67.9 mtt180 -127.9 151.27 75.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.154 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -58.65 163.59 10.7 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.222 1.948 . . . . 0.0 113.142 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 55' ' ' PHE . 1.4 m120 57.04 66.94 1.06 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.073 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' A' ' 54' ' ' ASN . 1.4 m-85 . . . . . 0 N--CA 1.469 0.509 0 O-C-N 123.437 0.46 . . . . 0.0 111.764 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.4 mp -104.87 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -72.62 110.84 9.1 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.48 162.92 16.98 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.09 1.86 . . . . 0.0 112.877 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -50.47 115.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.827 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.08 178.03 42.04 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.6 mt-10 -101.19 155.28 18.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 41.7 m-85 -149.04 85.2 6.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.33 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.02 -16.37 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.237 2.624 . . . . 0.0 113.228 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -148.7 161.44 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.7 p90 -65.67 -53.18 44.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 16.5 mt-30 -43.27 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -75.61 -6.38 50.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.291 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -116.1 25.86 10.37 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.513 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.0 mmt 85.1 26.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.376 1.048 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.27 52.46 0.41 Allowed Glycine 0 N--CA 1.468 0.778 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 28.3 mt -78.42 13.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.202 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.4 t30 113.16 168.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.681 1.238 . . . . 0.0 109.165 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -102.03 66.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.232 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' CA ' ' SG ' ' A' ' 37' ' ' CYS . 14.3 tpt180 -147.9 122.41 9.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.125 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -143.13 128.96 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' SER . 1.9 p -112.42 -161.29 0.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 2.2 t -44.76 177.79 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.597 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.18 153.6 34.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.563 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -119.45 129.44 54.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.19 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.53 119.95 9.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.971 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.82 121.94 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.82 148.55 22.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.038 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.4 146.55 70.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.51 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 N--CA 1.496 1.643 0 C-N-CA 122.299 2.0 . . . . 0.0 112.052 179.357 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.8 0.334 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.719 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 13.9 t80 -158.15 114.08 2.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.406 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 17.9 tptm -154.7 128.57 8.76 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.357 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 tt -133.9 141.42 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.54 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 14.7 mt-30 -119.22 128.16 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.3 mt -118.79 131.45 71.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.057 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.407 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 59.1 m-85 -111.14 130.68 55.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -60.84 -31.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.614 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -114.97 151.68 33.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.0 171.52 31.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 40.1 t0 59.52 32.9 21.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.556 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 9.2 m-85 54.3 80.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -158.07 163.66 37.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.64 -147.89 20.82 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.24 139.33 41.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.407 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.0 ttp -120.81 126.83 51.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.444 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.469 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 52.9 m-85 -117.87 135.87 53.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.93 125.41 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.422 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 t -152.27 127.97 10.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.16 39.81 1.08 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.41 178.51 7.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.7 p-10 -82.72 156.41 23.78 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -130.85 121.22 18.85 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.7 Cg_endo -78.24 -53.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.865 1.71 . . . . 0.0 110.593 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.0 m -120.43 113.48 20.4 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.58 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.7 tt -69.24 -43.53 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.137 0.494 . . . . 0.0 111.162 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.7 ttt -68.09 -19.2 64.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.017 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -76.04 -45.61 33.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 6.9 pt20 -100.38 -26.18 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m-85 -111.93 1.11 16.31 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.738 0.304 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 52.11 15.3 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.455 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 36.5 mtt -81.97 134.44 35.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -106.91 -28.14 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.659 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.551 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 41.9 mt-10 -151.3 108.79 3.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.852 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.0 mm -74.38 125.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.814 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -106.14 -29.98 9.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.218 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 4.8 m -151.52 146.26 25.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.1 t -153.57 128.82 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.928 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 53.1 mtmt -114.51 -179.44 3.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.854 0.359 . . . . 0.0 110.602 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.5 t 60.79 64.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.575 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 3.8 mm? -96.61 100.83 12.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.213 0.53 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 1.2 mp0 -67.0 121.14 14.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.44 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.48 -110.94 0.09 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 t -98.77 142.35 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 110.14 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 32.7 t-105 -131.84 169.33 16.4 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.1 mt -144.94 123.04 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.729 0.3 . . . . 0.0 111.787 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.93 129.52 55.1 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 20.2 m-85 -109.02 111.46 23.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.26 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -48.41 -23.66 1.01 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.1 160.9 37.31 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 110.277 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.405 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.5 Cg_endo -77.89 167.94 22.96 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.115 1.876 . . . . 0.0 111.83 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 73.07 14.24 4.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.78 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.29 24.54 0.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.636 0.255 . . . . 0.0 111.348 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -108.04 168.96 8.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.26 173.03 38.69 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -52.5 163.87 0.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 11.7 mp0 -129.47 147.12 51.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.152 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.425 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.038 0.447 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.443 ' O ' ' OG ' ' A' ' 129' ' ' SER . 16.6 ptm180 -105.23 -28.29 11.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.719 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -117.59 154.74 50.82 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.539 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.0 Cg_endo -56.78 -18.64 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.38 2.054 . . . . 0.0 113.595 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.52 -2.35 9.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.88 -28.8 70.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.4 OUTLIER -105.06 21.9 16.26 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.43 28.56 71.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.804 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -108.13 137.48 46.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 118.153 0.977 . . . . 0.0 109.051 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -74.22 17.41 0.19 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.29 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 172.13 156.33 0.24 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.983 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.19 5.91 4.25 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.045 2.497 . . . . 0.0 111.733 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.84 70.59 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 0.0 110.746 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.64 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.2 t -98.71 -147.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.64 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.5 tp60 -160.14 -132.31 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.517 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.32 -155.31 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -177.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.613 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 26.9 p90 -170.05 -176.01 2.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -161.59 133.09 5.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.375 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -54.23 130.45 38.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.827 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.6 mt -63.48 138.59 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.632 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.36 159.25 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.299 179.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.755 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.5 tttt -162.29 155.25 20.03 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.106 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.406 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.5 tt -149.05 144.38 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.127 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -128.04 139.59 52.45 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.185 0.517 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.36 117.66 28.33 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.989 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.495 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 62.9 m-85 -96.89 134.15 40.59 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 110.197 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.31 -44.83 92.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.439 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 90.6 m-20 -106.73 -173.45 2.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.972 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -83.64 -177.42 6.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 0.0 111.635 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 48.27 19.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.19 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.591 ' H ' ' HG ' ' A' ' 39' ' ' SER . 6.3 m-85 68.02 40.7 2.2 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.138 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.555 ' C ' ' H ' ' A' ' 19' ' ' ARG . 6.1 pt20 -122.78 -168.03 1.68 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.972 0.415 . . . . 0.0 111.535 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.28 -24.25 0.46 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.481 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.2 ttm180 162.34 -174.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.294 0.637 . . . . 0.0 110.33 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.93 157.99 6.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.416 ' CE1' ' CG ' ' A' ' 33' ' ' TYR . 62.7 t80 -138.84 135.39 34.5 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 91.9 m-20 -100.75 150.44 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -164.05 122.97 1.93 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 178.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -125.38 12.7 8.17 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.614 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.2 m -149.3 145.64 27.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.782 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -38.82 156.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 82' ' ' SER . 2.2 m -157.04 163.26 39.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.279 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.42 -56.74 2.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 39.5 p-10 -153.56 106.76 2.95 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.463 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -96.34 8.84 42.96 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 65.8 t60 -58.46 -27.46 64.42 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.455 0.645 . . . . 0.0 110.003 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.4 p -62.55 -29.12 70.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' CE1' ' A' ' 21' ' ' TYR . 85.1 m-85 -88.44 -14.8 37.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.923 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 31' ' ' HIS . 13.8 tp -141.64 136.89 31.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 t -95.52 -6.54 40.27 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.9 ttm-85 -160.77 152.03 19.1 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.597 ' HG ' ' N ' ' A' ' 80' ' ' LEU . 4.2 p -115.35 103.66 11.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.484 0.659 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.724 ' O ' ' O ' ' A' ' 39' ' ' SER . 80.3 m-20 -129.97 158.66 38.95 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.724 ' O ' ' O ' ' A' ' 38' ' ' ASN . 16.6 p 33.0 125.99 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.319 1.056 . . . . 0.0 112.734 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -139.54 144.68 28.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.355 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -152.21 102.52 2.78 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.939 -0.476 . . . . 0.0 110.211 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.51 150.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.667 0.746 . . . . 0.0 110.547 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -123.61 53.23 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.907 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.29 -93.25 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.582 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.93 -140.35 3.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.452 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 85.6 m -81.72 166.86 19.72 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.426 -0.455 . . . . 0.0 110.786 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.755 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.3 m95 -155.07 156.3 35.63 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.451 0.643 . . . . 0.0 110.782 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.72 122.84 46.71 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.23 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.41 132.01 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -103.1 111.36 23.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -37.57 -36.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.177 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -116.16 137.25 23.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.66 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 16.8 Cg_exo -58.88 159.63 20.66 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.269 1.313 . . . . 0.0 112.351 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 m120 86.1 -3.01 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.011 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.1 m-85 . . . . . 0 N--CA 1.469 0.52 0 O-C-N 123.433 0.458 . . . . 0.0 110.819 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 30.6 t80 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.7 mp -102.02 89.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -68.15 111.43 7.85 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.44 164.26 16.74 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.98 1.786 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -52.86 124.56 14.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.087 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.68 -175.56 40.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.2 mt-10 -107.33 152.89 23.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.217 0.532 . . . . 0.0 110.284 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.549 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.6 m-85 -145.6 84.78 8.17 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.3 Cg_exo -58.07 -17.06 29.73 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.984 2.456 . . . . 0.0 112.77 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -150.91 162.02 41.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.678 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.3 p90 -61.61 -49.46 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.522 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -42.34 -13.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.2 mmt180 -75.25 -5.19 43.31 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.132 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.678 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.02 26.76 9.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 121.522 -0.071 . . . . 0.0 111.16 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 mmt 88.76 17.72 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.481 1.113 . . . . 0.0 110.935 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 34.24 55.85 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.44 -70.29 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -157.18 158.9 37.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.6 p-10 -85.87 55.95 3.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.796 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 10.8 tpt180 -138.1 115.9 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.597 ' N ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.49 128.75 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 82' ' ' SER . 5.8 p -110.25 -161.85 0.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.179 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.628 ' HG ' ' N ' ' A' ' 83' ' ' CYS . 7.0 t -45.45 -178.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.221 0.534 . . . . 0.0 110.708 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.628 ' N ' ' HG ' ' A' ' 82' ' ' SER . 15.4 p -150.01 150.3 31.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.723 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -115.97 126.65 54.13 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -60.61 127.71 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.327 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.3 t -124.53 131.34 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.935 0.398 . . . . 0.0 110.773 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -100.18 162.5 12.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.162 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.93 150.13 74.71 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 C-N-CA 122.233 1.955 . . . . 0.0 112.124 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 t80 -154.29 113.03 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 47.0 tptt -154.59 136.0 14.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.127 0.489 . . . . 0.0 111.034 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.87 145.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.303 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.569 HE21 ' CA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -126.04 132.62 51.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.868 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.426 ' N ' HE21 ' A' ' 97' ' ' GLN . 6.3 mt -120.89 132.34 70.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.894 -177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -112.17 126.84 55.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.988 0.423 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.77 -24.03 61.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.412 ' HZ2' ' HA3' ' A' ' 106' ' ' GLY . 52.0 mttp -125.97 146.76 49.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.214 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -58.81 -168.55 0.2 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 4.5 p-10 42.58 29.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.603 ' H ' ' HG ' ' A' ' 129' ' ' SER . 21.8 m-85 54.38 81.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -158.15 166.42 32.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.058 0.456 . . . . 0.0 110.528 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.412 ' HA3' ' HZ2' ' A' ' 101' ' ' LYS . . . 85.73 -156.11 29.85 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.614 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -65.23 137.01 57.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.443 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 36.2 ttp -120.56 122.09 39.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.554 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 49.8 m-85 -118.13 133.23 56.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 120.07 35.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 t -146.92 127.84 14.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.52 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -95.68 40.96 1.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 111.142 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -141.11 178.38 7.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.526 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.474 ' CG ' HH12 ' A' ' 175' ' ' ARG . 24.6 p-10 -82.76 157.56 23.19 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.533 ' SG ' ' OG ' ' A' ' 172' ' ' SER . 49.7 t -134.4 122.34 15.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 172' ' ' SER . 63.9 Cg_endo -76.43 -57.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.488 1.459 . . . . 0.0 110.862 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.7 m -116.35 115.97 26.86 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.6 tt -70.2 -46.81 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 0.0 110.916 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.464 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.9 ttt -64.59 -20.8 66.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.293 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -72.98 -46.65 51.06 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.897 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.0 pt20 -102.43 -23.39 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.632 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.5 m-85 -111.96 -1.92 15.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.118 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 54.78 11.54 0.47 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.841 0.353 . . . . 0.0 111.018 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.2 mtt -79.77 132.69 36.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.19 -24.89 11.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.722 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 64.9 mt-10 -152.17 108.48 3.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.11 0.481 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.0 mm -75.16 125.44 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.674 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 76.0 m80 -105.16 -33.81 8.14 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.326 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.603 ' HG ' ' H ' ' A' ' 104' ' ' PHE . 16.1 p -155.38 151.09 27.47 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.656 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -144.77 157.13 44.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.818 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.3 mtpt -135.13 -178.98 5.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.48 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 t 54.7 80.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -98.92 165.89 11.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.5 mp0 -139.96 112.37 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.05 -88.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.1 t -120.01 155.07 22.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 109.998 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.4 t-105 -144.07 169.41 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.618 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 86.9 mt -144.84 123.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -109.84 129.69 55.61 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 22.5 m-85 -107.64 111.81 24.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.866 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -50.3 -22.29 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.48 160.09 41.24 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.441 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.1 Cg_endo -77.35 166.4 26.18 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.37 2.047 . . . . 0.0 111.762 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.666 ' ND2' HH21 ' A' ' 146' ' ' ARG . 2.1 m-80 74.13 15.3 3.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.507 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.0 m-85 76.39 25.53 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.608 0.242 . . . . 0.0 111.247 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.666 HH21 ' ND2' ' A' ' 144' ' ' ASN . 88.6 mtm180 -108.55 167.69 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.071 0.462 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.42 168.61 34.24 Favored Glycine 0 N--CA 1.463 0.48 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -59.03 142.28 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 46.2 mt-30 -97.64 147.89 23.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 . . . . . 0 N--CA 1.468 0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.723 0.297 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -105.09 -24.47 12.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -122.53 152.45 61.56 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.57 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.8 Cg_exo -49.9 -35.52 40.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.191 1.928 . . . . 0.0 112.998 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 161' ' ' ILE . 3.7 mp -86.66 -3.4 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.607 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -57.26 -29.89 64.2 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.07 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.57 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.1 p90 -105.23 21.27 17.42 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.43 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.18 61.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.574 -0.57 . . . . 0.0 114.24 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -107.23 137.09 45.95 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.459 1.13 . . . . 0.0 110.572 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.46 21.64 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.684 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 168.99 153.69 0.15 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.684 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.77 5.2 5.03 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.916 2.41 . . . . 0.0 112.044 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.51 71.36 6.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.896 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.5 t -99.55 -147.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.659 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.4 tp60 -159.31 -131.79 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.39 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.3 -156.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -170.21 -178.02 2.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.298 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.86 133.52 8.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.954 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.474 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.0 ptt-85 -51.91 130.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.68 131.66 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.252 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.24 134.68 60.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.438 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 30.9 tp10 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.513 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.023 0.44 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.676 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 45.5 tttt -159.2 153.29 23.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.122 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.407 ' CG2' ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -147.15 147.21 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 92.3 m -133.65 141.65 47.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.27 0.557 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -122.61 116.72 24.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.334 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 63.6 m-85 -95.89 137.02 35.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.267 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -45.08 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.3 m-20 -109.36 -173.35 2.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -82.8 -177.81 6.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.95 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.66 17.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.076 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 5.3 m-85 73.41 38.84 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.781 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.53 ' C ' ' H ' ' A' ' 19' ' ' ARG . 44.1 mt-30 -117.62 -168.45 1.5 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.893 0.378 . . . . 0.0 110.472 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 75.52 -29.01 1.24 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.215 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 19.3 ttt85 158.13 -167.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.729 0.9 . . . . 0.0 109.718 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.527 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -170.25 151.38 3.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.479 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 78.0 t80 -129.88 135.0 47.86 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.2 p-10 -102.21 144.29 30.94 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.076 -0.39 . . . . 0.0 110.989 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' SG ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -166.61 122.74 1.22 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.785 178.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -121.14 20.97 11.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.21 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.35 149.66 29.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -40.9 157.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.471 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.14 160.42 40.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.197 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.99 -55.53 3.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.1 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 43.0 p-10 -155.43 100.62 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.219 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -86.8 9.12 20.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.414 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -59.74 -17.42 34.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.077 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -78.12 -1.15 31.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -117.15 -15.26 10.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 13.2 tp -143.1 139.96 30.67 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -98.28 -7.23 29.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.288 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.0 ttm-85 -159.42 148.27 18.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 80' ' ' LEU . 1.9 m -114.52 103.15 10.75 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.718 ' O ' ' O ' ' A' ' 39' ' ' SER . 97.3 m-20 -129.21 156.54 43.78 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.718 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.7 p 35.89 125.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.909 0.861 . . . . 0.0 112.168 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.592 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.9 mt -138.5 144.11 30.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.088 0 CA-C-O 121.614 0.721 . . . . 0.0 111.806 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -153.48 99.19 2.31 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 18.1 m -70.1 138.61 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.523 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -109.81 52.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.21 -99.33 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.165 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.68 -137.17 3.56 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.3 m -77.23 164.83 25.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 110.884 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.676 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.6 m95 -155.73 157.31 36.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.295 0.569 . . . . 0.0 110.596 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.77 120.37 38.36 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.021 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.66 132.85 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.245 0.545 . . . . 0.0 111.052 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' ARG . 90.5 m-85 -108.07 112.91 25.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 50' ' ' TYR . 42.2 tt0 -35.75 -32.65 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.715 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -121.0 148.3 48.48 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.313 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.662 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 7.7 Cg_exo -67.16 160.19 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.875 1.717 . . . . 0.0 112.123 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 85.46 -4.8 0.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.887 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 6.2 m-85 . . . . . 0 N--CA 1.467 0.414 0 O-C-N 123.427 0.455 . . . . 0.0 111.055 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 23.0 t80 . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.7 mp -102.09 92.4 2.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -68.94 111.15 7.5 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.7 163.92 16.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.025 1.817 . . . . 0.0 112.946 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -50.06 125.53 12.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.138 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.83 -172.51 38.88 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.0 mt-10 -111.65 155.34 23.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.207 0.527 . . . . 0.0 110.126 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.5 m-85 -147.99 81.09 8.45 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 25.5 Cg_endo -61.32 -9.93 14.32 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.294 1.996 . . . . 0.0 112.862 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -149.95 161.18 42.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.749 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.0 p90 -64.98 -50.77 65.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.38 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.9 mt-30 -43.98 -10.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 70' ' ' TYR . 25.1 mmm180 -75.4 0.04 18.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.749 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -124.93 24.07 7.69 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 74' ' ' MET . 11.0 mmm 89.77 17.45 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.952 0.782 . . . . 0.0 111.947 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.72 63.09 0.19 Allowed Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.11 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 19.5 mt -93.69 17.61 11.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.959 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 52.3 t-20 111.99 150.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.206 1.566 . . . . 0.0 109.995 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 51.5 p-10 -83.58 69.93 10.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.23 118.9 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.097 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -147.5 132.18 17.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.144 0.497 . . . . 0.0 110.157 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' SER . 8.9 p -107.68 -163.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.0 p -50.91 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.94 -0.475 . . . . 0.0 110.991 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.6 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 14.7 p -153.51 155.5 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -117.79 128.18 54.61 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.66 131.58 50.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.78 130.84 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -101.39 162.49 12.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.772 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.03 149.17 47.0 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.494 1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 112.083 179.523 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.727 0.299 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 32.3 t80 -152.93 113.87 4.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -154.59 135.27 13.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.104 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 146.08 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.165 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.3 mt-30 -124.82 129.04 49.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.935 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.49 132.43 69.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.368 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 131' ' ' LYS . 39.3 m-85 -112.33 124.74 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.27 -19.9 38.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.778 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -131.09 144.09 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.869 0.366 . . . . 0.0 110.468 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -57.86 -171.08 0.23 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 2.8 p-10 45.25 29.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.72 0.295 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.537 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 14.3 m-85 54.89 81.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.878 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -158.98 163.61 36.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 110.806 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.57 -156.98 28.42 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -66.62 136.48 55.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 41.8 ttp -117.58 122.54 43.91 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.073 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.582 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.9 m-85 -114.97 129.99 56.83 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 110.991 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.99 121.43 37.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.068 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -151.88 130.99 12.67 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.469 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.2 t -97.85 50.79 1.04 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 111.085 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -147.8 -176.44 5.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -89.38 159.7 17.2 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.067 0.461 . . . . 0.0 110.202 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 172' ' ' SER . 45.7 t -137.48 124.81 13.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.754 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.509 ' O ' ' OG ' ' A' ' 172' ' ' SER . 59.4 Cg_endo -78.38 -61.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.662 1.575 . . . . 0.0 110.093 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -112.27 115.01 28.09 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.0 tt -69.16 -45.28 79.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 28.0 ttt -63.78 -23.69 67.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.685 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.7 -50.27 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.483 -0.761 . . . . 0.0 112.245 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.634 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.3 pt20 -97.56 -23.82 15.83 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.634 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 29.5 m-85 -112.3 0.54 15.75 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.55 0.214 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.6 m-70 54.0 2.52 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.088 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -70.53 131.92 44.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -106.83 -25.93 11.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.569 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.9 mt-10 -150.87 109.32 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 8.1 mm -76.26 126.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.67 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.9 m80 -106.41 -36.85 6.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.258 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.537 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 10.0 t -148.63 143.73 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.9 t -144.78 140.12 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 99' ' ' PHE . 35.1 mtmm -124.27 -171.95 2.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 36.3 t 54.34 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.516 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -100.38 166.64 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.199 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -137.35 112.84 9.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 37.79 -89.83 0.01 OUTLIER Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.5 t -117.48 152.19 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.5 t-105 -141.2 166.77 23.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.421 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 78.2 mt -144.02 124.06 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.74 129.47 56.11 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -106.34 113.4 26.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -53.83 -25.79 21.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.64 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.94 159.66 32.74 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-O 120.676 0.274 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 164.66 28.07 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.268 1.979 . . . . 0.0 111.383 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 5.3 m-80 75.57 15.99 2.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.2 m-85 76.6 29.75 0.66 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.098 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -116.41 170.49 8.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.912 0.387 . . . . 0.0 110.733 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.31 167.83 38.59 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.95 152.0 0.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -113.15 127.8 56.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.648 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.109 0.481 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.706 ' HE ' ' HZ3' ' A' ' 159' ' ' LYS . 40.8 ptt180 -108.42 -21.37 12.77 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.0 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.706 ' HZ3' ' HE ' ' A' ' 158' ' ' ARG . 14.3 pttm -123.87 154.54 67.48 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.286 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.502 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.9 Cg_endo -59.1 -19.97 51.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.386 2.057 . . . . 0.0 113.368 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.43 -5.98 9.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.923 0.392 . . . . 0.0 110.591 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.74 -32.89 63.78 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.44 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.502 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.9 OUTLIER -101.71 22.32 13.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.798 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 28.79 67.53 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.914 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.3 138.1 44.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.674 0.737 . . . . 0.0 110.124 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.85 24.3 0.23 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 165.82 154.21 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.496 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 170' ' ' VAL . 56.1 Cg_endo -72.82 -12.01 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.904 2.403 . . . . 0.0 111.398 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.68 69.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.329 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -101.33 -155.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.622 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 64.7 mm-40 -149.98 -130.95 0.05 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.4 p -95.28 -155.08 0.45 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -170.84 -178.75 2.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.282 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -156.1 129.95 8.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.479 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -52.65 129.21 28.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.587 0.708 . . . . 0.0 110.684 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.66 129.05 24.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.28 153.28 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.206 179.716 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.697 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -156.67 148.53 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.1 tt -144.58 140.67 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.608 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -126.73 138.02 53.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.63 115.75 25.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.6 m-85 -96.41 138.53 33.87 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 110.939 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.4 tm-20 -61.43 -49.81 75.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.903 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -98.18 -177.29 3.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -176.74 6.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.164 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.25 25.11 0.33 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.856 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.458 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.1 m-85 60.83 42.72 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.08 166.75 10.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.831 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.27 -153.73 43.45 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.709 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.683 HH21 ' H ' ' A' ' 35' ' ' SER . 15.8 ttp180 -58.75 174.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.03 153.91 5.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.408 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.0 t80 -127.05 130.67 50.39 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 44.8 p-10 -118.68 121.73 40.83 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.9 0.381 . . . . 0.0 111.701 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.9 t -150.21 141.57 23.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.095 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -124.46 26.27 7.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.0 m -148.55 144.75 27.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.502 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -38.54 156.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.846 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 25.0 t -156.76 163.05 39.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.145 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.87 -56.63 2.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.561 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.96 111.57 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -101.85 7.67 41.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 82.6 t60 -58.44 -27.18 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -62.63 -29.81 70.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.426 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.02 -15.36 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.574 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.5 tp -142.83 137.48 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.07 0.462 . . . . 0.0 110.067 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.683 ' H ' HH21 ' A' ' 19' ' ' ARG . 49.9 m -98.9 -9.23 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 56.0 ttm-85 -154.79 143.04 20.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.307 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' HG ' ' N ' ' A' ' 80' ' ' LEU . 5.2 p -109.37 103.62 12.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.732 ' O ' ' O ' ' A' ' 39' ' ' SER . 62.8 m-20 -128.08 156.26 43.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.732 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.9 p 35.05 129.43 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.745 1.259 . . . . 0.0 112.519 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.2 mt -142.55 147.52 20.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.023 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -156.48 100.81 1.98 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.35 139.57 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.292 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -110.13 56.43 0.63 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.268 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.08 -92.84 0.09 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.702 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 -139.11 3.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 43.0 m -80.48 164.9 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.697 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 34.0 m95 -152.94 154.12 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.105 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.18 118.76 35.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.46 132.86 67.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.555 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ARG . 88.2 m-85 -105.59 113.93 27.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 50' ' ' TYR . 79.5 tt0 -30.01 -33.95 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.285 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' TYR . 21.1 mtt180 -127.15 162.67 46.66 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.279 0.362 . . . . 0.0 110.781 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 5.3 Cg_exo -73.9 170.63 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.533 2.155 . . . . 0.0 112.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.7 m120 79.26 -11.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.697 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.1 m-85 . . . . . 0 N--CA 1.465 0.292 0 O-C-N 123.674 0.609 . . . . 0.0 110.43 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.55 94.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -69.2 109.57 4.65 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 123.312 0.383 . . . . 0.0 110.048 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.23 160.83 17.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.15 1.9 . . . . 0.0 113.324 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.81 117.8 1.8 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.291 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.47 -179.29 41.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -106.09 155.82 19.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.085 0.469 . . . . 0.0 110.29 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.9 m-85 -146.7 84.53 7.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 32.0 Cg_exo -57.6 -16.87 25.95 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.174 2.583 . . . . 0.0 112.887 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -149.8 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.706 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.3 p90 -63.59 -51.88 63.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 19.6 mt-30 -43.54 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.1 mmm180 -75.86 -5.58 46.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.706 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.77 23.94 11.37 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.592 -0.067 . . . . 0.0 111.026 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.4 ' O ' ' C ' ' A' ' 75' ' ' GLY . 34.5 mmt 87.41 25.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.45 1.094 . . . . 0.0 110.97 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.11 50.69 0.36 Allowed Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.8 mt -77.45 14.24 1.03 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 118.982 -0.533 . . . . 0.0 111.438 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.9 t30 110.46 164.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.8 1.312 . . . . 0.0 109.252 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.0 p-10 -96.59 64.08 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.493 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 36.5 ttm180 -141.63 117.21 10.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.943 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' N ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.74 129.65 20.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 82' ' ' SER . 53.2 p -112.22 -161.95 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.661 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.9 p -45.99 -178.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.212 0.53 . . . . 0.0 110.642 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 11.8 p -154.3 159.73 41.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.72 131.07 53.49 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.72 127.43 31.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -126.43 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -101.29 157.41 16.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.0 157.18 69.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.522 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.492 1.422 0 C-N-CA 122.661 2.241 . . . . 0.0 112.085 179.429 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.73 0.3 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.749 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.3 t80 -159.14 113.3 2.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.197 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 132' ' ' VAL . 16.7 tptm -152.37 133.75 14.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.3 tt -134.88 142.34 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.749 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.2 mt-30 -120.92 129.08 53.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 108' ' ' MET . 13.8 mt -119.13 130.92 73.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.181 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.0 m-85 -111.52 128.1 55.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.837 0.351 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 84.4 tt0 -60.78 -27.65 68.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.918 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -118.33 146.9 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.929 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.74 172.22 20.01 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.01 31.14 19.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 10.2 m-85 55.14 80.99 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.246 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -160.25 162.61 33.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 -153.01 23.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -70.04 136.16 50.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -121.33 125.51 47.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.4 m-85 -117.11 134.91 54.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.089 0.471 . . . . 0.0 110.657 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -122.16 119.7 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.488 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 111' ' ' THR . 4.5 t -147.0 125.66 12.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -91.06 41.89 1.08 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.019 0.438 . . . . 0.0 111.041 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.07 179.77 6.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 17.1 p-10 -83.95 160.13 21.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.963 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 172' ' ' SER . 40.9 t -134.55 121.31 15.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.194 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.13 -53.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.659 1.573 . . . . 0.0 110.873 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -119.71 111.54 18.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.4 tt -67.36 -44.33 87.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 0.0 110.875 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.8 ttt -66.99 -21.99 65.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -73.01 -48.33 37.28 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.662 -0.649 . . . . 0.0 112.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.2 pt20 -99.16 -24.86 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.631 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 40.2 m-85 -111.58 2.39 17.33 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.992 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.0 m-70 51.41 11.91 0.13 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.132 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.442 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.0 mmt -79.44 135.29 36.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.582 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -110.57 -26.85 9.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.087 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 52.1 mt-10 -150.5 107.11 3.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.033 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.6 mm -77.78 125.11 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.6 m80 -104.81 -30.12 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.135 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 18.6 t -156.54 152.01 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.441 . . . . 0.0 110.957 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -146.58 150.8 36.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.992 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.95 -172.01 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.681 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LYS . 61.5 t 47.49 77.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.381 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.8 mt -101.28 172.29 7.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.183 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.8 mp0 -136.94 114.18 10.78 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.88 -91.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 134' ' ' GLU . 31.7 t -119.18 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -122.15 170.31 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.237 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 62.5 mt -145.8 125.17 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.462 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.88 131.66 55.22 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.81 112.92 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.571 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' VAL . 75.7 tt0 -50.25 -27.24 5.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.723 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.39 166.15 11.57 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.35 164.95 11.03 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.022 1.815 . . . . 0.0 111.37 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.562 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 75.02 16.79 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.47 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.9 m-85 77.0 26.52 0.75 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.091 0.245 . . . . 0.0 111.278 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -107.57 166.32 10.76 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.927 0.394 . . . . 0.0 110.533 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 96.6 170.65 34.41 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -67.3 146.38 54.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 2.5 mp0 -94.23 148.33 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.456 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.953 -179.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.415 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.9 m-85 . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -106.03 -26.13 11.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -120.14 153.82 55.62 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.5 Cg_endo -58.91 -15.19 25.92 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.478 2.119 . . . . 0.0 113.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.05 -3.98 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.037 0.446 . . . . 0.0 110.491 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -28.27 66.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.464 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -106.16 22.79 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.1 70.54 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.523 -0.599 . . . . 0.0 114.014 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.44 140.45 41.73 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.19 0.995 . . . . 0.0 109.723 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.46 21.23 0.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 170.49 154.33 0.19 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.388 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 170' ' ' VAL . 41.1 Cg_endo -68.51 -35.0 18.58 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.489 2.126 . . . . 0.0 111.596 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -51.25 83.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 171' ' ' GLN . 1.4 p -102.54 -97.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.465 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.58 ' N ' ' CG2' ' A' ' 170' ' ' VAL . 0.5 OUTLIER 161.89 -143.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.096 0.872 . . . . 0.0 109.345 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 3.7 p -90.95 -156.0 0.42 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -169.51 -177.96 2.93 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.31 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -159.97 132.27 6.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -51.95 136.09 29.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.749 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.81 135.68 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.825 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.14 158.77 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.484 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.698 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 38.9 tttt -162.05 152.44 17.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -145.66 144.69 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.552 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.8 m -131.61 140.47 49.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 110.387 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -121.07 116.21 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.478 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.473 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 68.0 m-85 -94.15 137.68 33.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -58.51 -48.21 81.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.5 m-20 -107.14 -172.81 2.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.158 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -178.95 7.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.88 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.55 21.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.502 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.502 ' H ' ' HG ' ' A' ' 39' ' ' SER . 4.7 m-85 68.41 39.45 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 19' ' ' ARG . 34.6 mt-30 -117.15 -167.45 1.31 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.04 0.447 . . . . 0.0 110.621 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 73.22 -26.74 0.83 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.058 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.3 ttm-85 158.87 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.457 0.74 . . . . 0.0 109.661 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -172.33 152.17 2.69 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -129.49 133.26 47.18 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 45.8 p-10 -118.0 125.43 50.36 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 t -161.32 139.0 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -126.49 30.72 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 26' ' ' ASP . 3.9 t -147.13 142.29 27.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.775 0.322 . . . . 0.0 110.573 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' CYS . 54.4 p-10 -38.79 157.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.4 m -158.05 163.73 37.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.001 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.63 2.93 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.64 105.19 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.09 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.443 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -94.0 10.63 32.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.969 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.2 t60 -57.35 -25.43 59.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.599 . . . . 0.0 109.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -31.54 72.78 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.505 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.9 -18.33 40.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 12.4 tp -141.0 135.68 31.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 110.411 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -93.85 -10.37 34.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.583 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 23.7 ttm180 -157.53 146.2 19.48 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.7 m -110.78 104.2 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.074 0.464 . . . . 0.0 111.088 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.75 ' O ' ' O ' ' A' ' 39' ' ' SER . 96.7 m-20 -130.38 158.22 40.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.1 p 35.79 128.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.63 0 O-C-N 124.426 1.079 . . . . 0.0 111.825 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.8 mt -140.73 146.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-O 121.785 0.803 . . . . 0.0 112.08 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -156.18 99.73 1.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.447 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.67 141.41 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.311 0.577 . . . . 0.0 110.873 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -111.88 53.78 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.31 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.73 -93.9 0.1 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.29 -137.21 3.26 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 m -77.72 163.04 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.698 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 31.7 m95 -153.97 155.15 35.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.03 119.11 35.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.45 131.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.503 . . . . 0.0 110.85 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -103.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.702 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -37.53 -35.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.915 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -116.81 148.37 41.93 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.9 Cg_endo -67.94 162.61 39.04 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.755 2.303 . . . . 0.0 111.411 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 4.4 m-80 82.58 -5.11 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.287 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 15.4 m-85 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -103.04 91.77 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.36 111.28 8.21 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 123.219 0.325 . . . . 0.0 110.183 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.93 160.61 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.167 1.912 . . . . 0.0 113.089 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.46 122.4 4.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.037 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.07 -174.68 40.21 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.9 mt-10 -111.37 158.53 18.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.186 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 34.0 m-85 -151.81 85.7 4.73 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.934 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 33.9 Cg_exo -57.43 -14.67 16.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.787 2.324 . . . . 0.0 112.598 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.2 mt-10 -151.3 162.25 41.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 23.6 p90 -65.48 -53.12 47.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.5 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.624 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.5 pt20 -40.44 -14.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.102 0.477 . . . . 0.0 112.051 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -74.13 -2.31 24.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.276 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -119.85 23.65 10.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.3 mmt 90.37 24.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.445 1.091 . . . . 0.0 112.059 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.61 54.34 0.24 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.787 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 49.8 mt -87.01 12.8 10.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 49.0 t30 91.15 137.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.932 0.77 . . . . 0.0 110.004 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.674 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.7 p-10 -39.37 -96.08 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.658 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.674 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 8.5 tpp85 29.43 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.431 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.528 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -138.7 128.12 24.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.055 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.6 p -110.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.8 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.4 p -46.31 -178.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.506 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.9 p -152.05 155.81 38.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.459 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -118.82 128.1 54.15 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.84 128.4 36.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.539 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.29 129.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.87 159.24 15.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.825 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mt -78.5 148.95 74.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.531 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.496 1.654 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 179.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 42.1 t80 -155.37 113.44 3.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.195 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 2.9 tppm? -156.2 137.31 13.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.85 145.51 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.003 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mt-30 -121.65 130.94 53.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.146 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' MET . 7.9 mt -120.09 130.09 74.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.387 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 45.4 m-85 -110.92 129.83 55.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.751 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -62.58 -25.57 68.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -123.93 145.02 49.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.613 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.99 179.15 4.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 55.84 30.82 16.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 15.8 m-85 54.21 80.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.033 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.5 m -160.39 161.27 33.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.19 25.41 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -67.65 136.71 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.674 0.274 . . . . 0.0 110.778 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 40.0 ttp -121.63 128.21 51.68 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.622 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 43.4 m-85 -122.84 137.22 54.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.7 127.17 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.602 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.6 t -148.76 129.64 14.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.5 p -93.63 38.18 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.3 179.66 6.95 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -85.02 160.47 20.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.605 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 41.6 t -134.98 125.34 17.12 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' OG ' ' A' ' 172' ' ' SER . 64.7 Cg_endo -80.25 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.938 1.759 . . . . 0.0 111.287 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.609 ' CA ' ' HG ' ' A' ' 172' ' ' SER . 55.6 m -116.5 110.15 18.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.553 ' N ' ' OG ' ' A' ' 172' ' ' SER . 5.1 tt -68.49 -42.44 83.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.079 0.466 . . . . 0.0 111.003 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.7 ttt -67.43 -17.9 64.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.727 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -81.87 -42.54 19.44 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.462 -0.774 . . . . 0.0 111.723 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.652 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -94.24 -30.61 14.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.762 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.64 1.15 13.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.691 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 54.55 13.43 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.791 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.4 mmt -77.53 131.15 37.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -105.14 -29.14 10.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 74.1 mt-10 -151.11 109.08 3.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.187 0.518 . . . . 0.0 110.585 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 7.6 mm -74.6 125.71 34.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.821 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -106.87 -32.9 7.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.803 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.6 t -152.29 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 111.054 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.36 131.8 14.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.75 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -111.33 -169.04 1.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.234 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.4 t 52.61 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.674 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.4 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 4.4 mm? -110.26 164.24 12.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 136' ' ' VAL . 5.9 mp0 -138.34 110.41 7.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.831 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.52 -86.33 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 134' ' ' GLU . 11.6 t -125.74 155.95 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.734 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.4 t-105 -142.67 170.58 15.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 73.5 mt -145.87 125.37 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.401 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.01 131.43 55.05 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.61 110.97 22.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.513 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 70.3 tt0 -49.9 -23.48 1.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.909 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.69 160.57 37.85 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 65.6 Cg_endo -77.79 168.01 22.99 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.54 2.16 . . . . 0.0 111.788 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.601 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 6.7 m-80 70.08 17.61 7.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.5 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.7 m-85 76.23 24.55 1.11 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.653 0.263 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.601 ' NH2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mtm-85 -105.98 162.73 13.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 100.09 164.21 28.77 Favored Glycine 0 N--CA 1.461 0.365 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 18.7 ptt-85 -60.51 138.24 58.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.308 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.555 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 3.7 mp0 -88.12 150.97 23.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.366 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.347 179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.471 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.6 m-85 . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -105.56 -21.36 13.22 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -124.45 153.07 69.24 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.587 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 22.9 Cg_exo -52.89 -30.52 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.514 1.476 . . . . 0.0 113.523 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.4 mp -89.23 -4.72 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 111.033 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -57.04 -27.44 61.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.162 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.587 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -108.66 21.21 17.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.752 0.31 . . . . 0.0 110.451 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.53 60.64 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.645 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -111.42 136.03 51.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.817 0.809 . . . . 0.0 109.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.39 22.12 0.13 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 169.53 155.18 0.18 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.046 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 69.3 Cg_endo -77.39 4.2 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.651 2.234 . . . . 0.0 112.141 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.14 72.71 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.022 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.667 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.4 t -100.83 -147.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.667 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.6 tp60 -159.91 -132.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.796 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.609 ' HG ' ' CA ' ' A' ' 117' ' ' SER . 1.2 m -92.27 -155.01 0.4 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.6 -177.48 2.37 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.033 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.67 132.22 7.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.92 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -51.37 132.2 29.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.429 0.633 . . . . 0.0 110.956 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -66.57 133.89 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.608 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -138.16 159.31 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.967 0.413 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.517 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.477 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 11.2 p . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.662 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.4 tttt -159.67 150.57 19.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 tt -144.88 141.61 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.362 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 m -127.49 139.02 53.07 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.83 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.72 115.7 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -96.28 138.73 33.45 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.079 0.466 . . . . 0.0 110.474 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -61.4 -51.09 70.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.851 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.29 -175.32 3.19 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.253 0.549 . . . . 0.0 110.219 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.97 -175.29 5.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.619 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.7 m120 46.7 23.12 0.22 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.01 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.5 m-85 59.78 44.6 13.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.332 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -116.41 162.05 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.13 0.491 . . . . 0.0 110.495 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.95 -150.87 31.2 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.554 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 170.64 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.18 155.11 6.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.406 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.0 t80 -134.74 134.53 41.09 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 51.8 p-10 -102.08 151.73 21.82 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.524 0.202 . . . . 0.0 110.49 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.8 124.6 2.24 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.673 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.06 12.99 9.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 t -150.54 146.96 26.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.669 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -38.63 157.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.678 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 18.3 t -157.69 164.61 36.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.145 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.34 -56.96 2.75 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -153.3 110.95 3.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.33 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 2.0 p90 -100.55 8.47 43.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.067 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.1 t60 -59.35 -28.76 67.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.527 0.68 . . . . 0.0 110.168 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.0 p -60.69 -28.32 68.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.375 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -89.89 -12.97 37.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.539 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -143.33 138.24 29.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.975 0.417 . . . . 0.0 109.969 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.6 m -100.43 -9.49 22.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 51.3 ttm-85 -153.74 141.11 19.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.469 . . . . 0.0 110.45 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.1 m -111.52 106.15 14.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.76 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' O ' ' C ' ' A' ' 39' ' ' SER . 41.1 m-20 -117.91 -155.68 0.61 Allowed 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' ASN . 12.7 p -19.59 138.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.741 0.65 . . . . 0.0 112.476 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 8.8 mt -142.69 147.19 21.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.963 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.63 101.14 1.98 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.921 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.08 142.17 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -111.22 52.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.47 0.1 OUTLIER Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.753 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.86 -140.07 3.91 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 93.8 m -77.9 165.18 24.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 110.859 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.662 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.0 m95 -154.87 155.76 34.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.956 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.75 121.52 41.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.14 132.53 66.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.516 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' GLU . 52.4 m-85 -103.59 110.8 22.99 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.317 0.386 . . . . 0.0 110.897 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' TYR . 80.1 tt0 -35.37 -37.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.137 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -119.02 150.69 49.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.438 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 52.6 Cg_endo -68.12 161.49 44.19 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.684 2.256 . . . . 0.0 111.567 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.5 m120 83.64 -7.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.991 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.5 m-85 . . . . . 0 N--CA 1.47 0.558 0 O-C-N 123.5 0.5 . . . . 0.0 111.254 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.85 91.19 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -71.56 110.33 7.36 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.95 161.01 21.03 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.099 1.866 . . . . 0.0 113.851 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -47.24 119.78 2.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.912 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.13 -176.26 41.49 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -109.15 157.74 18.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.835 0.35 . . . . 0.0 110.159 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 48.4 m-85 -147.81 91.99 4.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 41.3 Cg_endo -66.69 -11.38 31.66 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.234 1.956 . . . . 0.0 113.269 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.6 mt-10 -151.35 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 36.3 p90 -63.9 -53.05 56.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -44.98 -9.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 70' ' ' TYR . 2.0 tpt180 -75.09 -3.98 35.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.1 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.73 24.07 10.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.7 mmt 86.84 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.438 1.086 . . . . 0.0 111.212 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.24 48.2 0.2 Allowed Glycine 0 N--CA 1.473 1.155 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.16 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 18.3 mt -71.66 13.36 0.27 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 119.073 -0.489 . . . . 0.0 111.078 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.6 t30 107.63 164.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.779 1.299 . . . . 0.0 109.363 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -94.92 62.03 2.58 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.35 115.62 11.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.26 128.66 21.19 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' SER . 2.4 p -110.28 -163.5 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 3.4 t -45.42 -178.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.34 0.591 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.625 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 10.7 p -151.82 155.5 38.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.558 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -121.7 129.97 53.12 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.72 126.87 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.296 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.77 131.08 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -100.13 157.75 16.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -84.27 153.37 62.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 C-N-CA 122.517 2.144 . . . . 0.0 112.146 178.795 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.763 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 26.1 t80 -158.05 114.16 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 110.295 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -153.79 132.56 12.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -135.87 145.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.052 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.1 mt-30 -122.66 131.0 53.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.504 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 108' ' ' MET . 11.8 mt -119.58 130.57 73.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.998 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 46.8 m-85 -112.1 128.88 56.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.883 0.373 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.98 -28.23 68.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -120.37 148.36 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.991 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.47 -169.07 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t0 43.63 30.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 53.97 83.26 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.5 m -160.57 163.72 32.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 0.0 110.753 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.66 -152.09 22.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.709 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -71.76 136.59 47.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 0.0 110.429 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 39.1 ttp -120.5 124.62 45.84 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.781 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 48.8 m-85 -116.0 133.6 55.85 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.13 0.491 . . . . 0.0 110.473 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -122.16 121.61 37.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -147.41 126.94 13.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -93.92 41.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -141.66 -178.46 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.566 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.8 p-10 -84.96 157.69 20.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 70.0 m -134.91 121.06 14.52 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.165 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 60.5 Cg_endo -77.95 -56.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.05 1.833 . . . . 0.0 110.936 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.4 m -116.73 112.8 21.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.3 tt -68.82 -45.05 81.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.403 0.621 . . . . 0.0 110.634 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.465 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -65.71 -21.65 66.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.299 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -73.97 -47.38 37.74 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.275 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.6 pt20 -98.1 -24.8 15.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.1 m-85 -112.53 2.91 16.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.121 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.6 m-70 51.3 10.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.891 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.474 ' H ' ' C ' ' A' ' 122' ' ' PHE . 3.4 mmt -75.72 133.02 40.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -106.27 -30.56 9.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.787 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 29.7 mt-10 -150.58 108.76 3.75 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.089 0.471 . . . . 0.0 111.153 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.37 125.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.586 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.5 m80 -106.31 -32.13 8.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.941 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 17.0 m -154.97 150.28 27.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.116 0.484 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.14 153.63 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.759 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.9 mtpt -131.46 -177.33 4.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.561 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t 54.04 98.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.21 164.44 12.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.566 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -138.92 111.64 7.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.218 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.56 -87.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.3 t -121.95 157.05 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -143.73 168.21 20.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.16 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.9 mt -144.91 122.84 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.186 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 131.72 54.8 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 32.9 m-85 -109.51 112.03 23.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.119 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -50.56 -23.79 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.5 mp -117.38 164.95 17.02 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 94.3 Cg_endo -82.94 167.95 14.06 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.38 2.054 . . . . 0.0 112.194 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.493 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.5 m-80 77.65 15.75 1.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.098 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.493 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.37 29.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.694 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 96.8 mtt180 -135.57 128.43 31.24 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.1 171.98 21.63 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.38 108.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.455 ' CG ' ' CE1' ' A' ' 140' ' ' TYR . 71.6 mt-30 -75.44 147.72 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.963 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.613 0.244 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 129' ' ' SER . 4.2 ptp180 -102.18 -25.58 13.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.077 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.46 50.04 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.03 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.557 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 21.4 Cg_endo -62.8 -17.29 58.59 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.856 2.371 . . . . 0.0 113.235 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.36 -4.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.171 0.51 . . . . 0.0 110.761 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.45 -28.59 67.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.767 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.557 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -104.97 22.94 14.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.189 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.37 28.72 67.34 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.938 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.486 ' HB1' ' HE1' ' A' ' 163' ' ' TRP . . . -110.88 139.58 46.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.024 0.912 . . . . 0.0 109.795 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.08 22.3 0.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 174.01 152.72 0.26 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.728 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.78 5.45 4.36 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.746 2.297 . . . . 0.0 111.542 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.5 70.23 5.92 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.5 t -98.91 -153.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.591 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 78.3 mm-40 -152.74 -132.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.705 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -94.22 -155.1 0.44 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -171.17 -176.01 1.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.21 0.528 . . . . 0.0 111.22 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -158.96 132.32 7.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.936 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -52.99 134.48 37.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.92 133.71 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.466 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.03 156.6 28.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.452 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.7 tp10 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.356 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.748 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.2 tttt -160.26 151.8 19.71 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.008 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -147.23 141.67 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 97.7 m -123.95 138.21 54.5 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.718 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -118.77 115.78 25.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.2 m-85 -94.87 138.31 32.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.231 0.539 . . . . 0.0 110.986 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 7.7 tm-20 -60.44 -49.96 75.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.946 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 45.3 m-20 -99.33 -176.02 3.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.241 0.543 . . . . 0.0 109.773 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -83.19 -176.84 6.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.32 24.3 0.27 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.807 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 62.75 41.53 8.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.176 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.41 173.63 6.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.26 -155.99 53.51 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.682 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -54.65 174.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -169.34 149.92 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 59.4 t80 -132.75 133.15 43.09 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 40.2 p-10 -119.87 132.5 55.58 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.569 0.223 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 140.97 30.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -125.0 15.88 8.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.669 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 26' ' ' ASP . 11.2 m -148.94 145.8 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 43.0 t0 -37.29 155.72 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.542 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 m -155.95 162.03 40.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.98 -56.53 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.802 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -154.18 110.75 3.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.411 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.5 p90 -101.42 9.79 41.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.0 t60 -59.76 -28.57 67.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.694 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.4 p -61.16 -29.12 69.6 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.433 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -88.76 -12.56 41.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.663 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -142.21 136.65 30.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -96.84 -10.73 25.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.702 0.287 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.618 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 59.9 ttp180 -157.05 145.71 19.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.471 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -110.65 104.35 13.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.733 ' O ' ' O ' ' A' ' 39' ' ' SER . 95.3 m-20 -128.57 155.9 44.19 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.733 ' O ' ' O ' ' A' ' 38' ' ' ASN . 24.4 p 35.73 130.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.642 1.21 . . . . 0.0 112.568 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.4 mt -142.15 146.29 22.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.93 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.7 ptpt -154.41 102.55 2.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.008 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.508 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.9 t -66.33 149.08 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.291 0.567 . . . . 0.0 110.552 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.31 50.21 1.41 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.682 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.21 -95.48 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.112 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.56 -140.36 4.04 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 93.2 m -80.93 166.54 20.76 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.433 -0.451 . . . . 0.0 110.89 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.748 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.4 m95 -154.71 156.65 36.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.19 120.97 40.7 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.62 132.28 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -104.35 110.16 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -37.59 -34.49 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -115.91 148.41 41.24 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.883 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.1 Cg_endo -68.54 159.77 52.1 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.465 2.11 . . . . 0.0 111.915 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.3 m-80 85.17 -5.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.835 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 11.7 m-85 . . . . . 0 N--CA 1.471 0.596 0 O-C-N 123.649 0.593 . . . . 0.0 111.001 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 25.9 t80 . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.5 mp -102.91 91.37 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.06 111.72 11.76 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.67 162.29 19.01 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.143 1.895 . . . . 0.0 112.661 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.41 117.36 2.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.024 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.34 41.01 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.5 mt-10 -101.2 153.58 19.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 24.2 m-85 -146.5 86.21 6.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.92 -18.47 16.69 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.857 2.371 . . . . 0.0 112.906 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -152.41 162.47 41.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.654 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 6.1 p90 -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -41.21 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.1 mmt180 -75.77 -5.49 46.04 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -117.61 25.27 10.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 119.698 -0.191 . . . . 0.0 111.362 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.4 mmt 89.79 23.59 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.455 1.097 . . . . 0.0 111.636 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.41 59.11 0.23 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.294 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 38.8 mt -94.69 13.92 22.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 91.91 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.227 0.954 . . . . 0.0 110.599 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.671 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 35.8 p-10 -37.85 -95.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.425 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.671 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.1 tpt180 30.11 93.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.358 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -139.51 128.03 22.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.0 p -111.04 -162.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.135 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.1 p -45.25 -179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.653 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.622 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 18.6 p -149.04 148.76 30.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.26 126.33 55.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.09 124.25 20.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.151 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.21 129.0 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.897 0.379 . . . . 0.0 110.444 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -97.5 160.31 14.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.15 149.95 70.49 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.648 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.32 2.013 . . . . 0.0 112.124 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.665 0.269 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.743 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.1 t80 -157.94 113.31 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -153.56 134.01 13.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.021 0.438 . . . . 0.0 111.354 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.421 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.59 145.74 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.0 mt-30 -124.32 129.76 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.233 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 108' ' ' MET . 10.4 mt -118.7 132.83 67.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.03 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.15 133.89 55.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.258 0.552 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -30.16 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.72 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -119.61 148.65 43.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.225 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.07 174.55 15.67 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.4 t0 57.77 30.76 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.002 0.43 . . . . 0.0 110.441 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 55.87 82.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -160.12 161.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.556 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.03 -150.99 22.55 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.11 136.04 39.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.654 0.264 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.8 tmm? -122.1 133.38 54.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.68 137.71 54.66 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.239 0.542 . . . . 0.0 110.618 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.3 125.28 44.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -147.9 128.25 13.93 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -90.29 41.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -146.65 -178.14 6.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.6 p-10 -86.36 162.16 18.33 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.584 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 84.5 m -138.79 122.81 11.32 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.416 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.01 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.188 1.925 . . . . 0.0 111.678 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -121.09 109.28 14.83 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.1 tt -64.28 -38.09 81.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.625 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 24.0 ttt -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.56 -44.32 17.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.604 -0.685 . . . . 0.0 111.678 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.584 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -90.93 -32.88 15.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.372 -178.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 23.5 m-85 -115.79 8.84 14.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 49.11 11.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.206 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.481 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.5 mtt -79.72 138.05 37.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.465 0.65 . . . . 0.0 110.057 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.518 ' NH2' ' OE2' ' A' ' 126' ' ' GLU . 4.8 ptm180 -109.99 -26.41 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.366 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 75.8 mt-10 -149.84 107.31 3.64 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.321 0.582 . . . . 0.0 111.904 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.6 mm -76.0 122.71 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.7 m80 -102.91 -31.9 10.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.119 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 p -155.93 151.35 26.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.801 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -148.67 131.82 16.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.2 -176.4 3.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t 55.69 98.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.696 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.04 167.02 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.067 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.0 mp0 -142.09 111.73 6.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.974 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.92 -89.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.7 t -119.92 150.99 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.145 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -140.07 170.42 15.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.0 mt -145.14 123.61 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.392 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -112.17 132.84 54.66 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.49 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 40.1 m-85 -110.46 112.24 24.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 78.3 tt0 -51.54 -21.99 2.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.3 mp -118.16 165.32 16.63 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.29 167.45 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.016 1.81 . . . . 0.0 112.186 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.99 14.82 1.1 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.969 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 75.24 28.44 1.01 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.154 0.284 . . . . 0.0 111.371 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 82.0 mtp180 -133.28 126.83 32.33 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.19 174.54 22.17 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.549 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 77.8 mtm180 -53.07 115.99 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.329 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 49.2 mt-30 -85.52 138.16 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.516 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -105.73 -24.1 12.59 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.811 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -121.26 153.3 58.29 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.551 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -58.83 -14.91 24.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.539 2.159 . . . . 0.0 113.453 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.06 -2.9 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.118 0.485 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.36 -26.43 66.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.412 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.551 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -107.39 23.07 15.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.408 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.03 69.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.719 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.476 ' HB2' ' HE1' ' A' ' 163' ' ' TRP . . . -109.02 139.38 43.98 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.257 1.028 . . . . 0.0 109.397 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.4 22.11 0.34 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 170.62 156.27 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.303 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 170' ' ' VAL . 42.1 Cg_endo -68.9 -35.89 14.46 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.674 2.249 . . . . 0.0 111.435 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.65 77.1 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 168' ' ' PRO . 60.6 t -94.11 -102.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.345 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER 162.65 -144.64 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 O-C-N 123.792 0.682 . . . . 0.0 109.718 177.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.9 p -91.02 -157.9 0.52 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.568 0.223 . . . . 0.0 111.225 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -169.78 -177.54 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.218 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -158.21 131.82 7.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.235 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 ptm180 -52.3 133.03 34.7 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.714 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -63.44 134.08 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.589 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.48 137.05 53.74 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.056 0.455 . . . . 0.0 110.577 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.388 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.844 0.354 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.544 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.1 tttt -161.71 153.09 18.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tt -146.71 144.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.808 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 m -135.12 141.28 45.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.431 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -121.05 115.9 24.01 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 81.5 m-85 -95.28 139.52 31.47 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.259 0.552 . . . . 0.0 111.181 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 8.1 tm-20 -63.46 -49.42 73.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.115 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.8 m-20 -98.84 -177.46 3.65 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -81.87 -178.67 7.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 48.57 22.23 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.516 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.5 m-85 60.15 46.41 10.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.196 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.23 167.36 10.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -143.35 31.53 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.499 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -65.58 162.49 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.408 -0.896 . . . . 0.0 109.149 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.57 156.99 8.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.971 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -131.07 133.65 45.88 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 42.6 p-10 -123.79 124.5 42.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.75 143.56 24.57 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.242 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -123.63 28.71 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.388 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.0 t -145.73 142.32 28.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -40.02 157.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.505 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.6 m -159.2 165.05 34.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.87 -54.79 3.6 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.994 0.426 . . . . 0.0 111.01 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -156.51 106.96 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.255 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -94.36 8.14 42.98 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.0 t60 -58.51 -30.93 67.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.3 p -58.02 -29.46 65.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.301 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.72 -16.85 31.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.608 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.559 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -140.02 137.17 34.42 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 109.954 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -100.61 -7.77 23.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.242 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 78' ' ' ASP . 57.6 ttm-85 -153.58 142.76 21.41 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.443 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.63 ' HG ' ' H ' ' A' ' 80' ' ' LEU . 2.0 m -112.44 102.79 10.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.7 m-20 -127.69 153.73 46.14 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 17.1 p 37.38 126.23 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.333 1.064 . . . . 0.0 112.562 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.2 mt -138.93 147.24 25.04 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.463 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.38 100.88 2.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.366 0.603 . . . . 0.0 109.921 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.2 141.45 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.11 47.59 0.95 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.57 -98.65 0.14 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.42 -137.34 3.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 93.2 m -77.87 166.78 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.601 ' CE3' ' SG ' ' A' ' 83' ' ' CYS . 38.6 m95 -156.56 156.8 34.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.546 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.44 118.91 33.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.757 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.38 133.01 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 111.297 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.54 110.57 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.773 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -39.1 -32.77 0.1 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.075 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -116.79 147.72 40.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.733 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -68.71 156.33 65.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.33 2.02 . . . . 0.0 111.585 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 9.2 m-80 86.11 -2.93 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.038 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-85 . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 122.596 0.358 . . . . 0.0 111.785 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.63 99.04 7.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.562 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -71.0 110.63 7.62 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.09 163.82 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.148 1.899 . . . . 0.0 113.255 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.2 123.42 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.914 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.28 -173.64 40.28 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.6 mt-10 -111.46 156.35 21.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.956 0.408 . . . . 0.0 109.904 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.585 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.5 m-85 -147.27 81.12 8.94 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.485 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 36.5 Cg_exo -55.43 -14.0 8.72 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.054 2.503 . . . . 0.0 112.661 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -151.47 163.41 39.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.338 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 10.9 p90 -65.4 -51.01 63.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.405 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.2 mt-30 -43.62 -10.6 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' TYR . 39.2 mmt180 -76.3 -0.55 22.86 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.02 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -123.81 22.6 8.9 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 122.929 0.143 . . . . 0.0 111.019 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 8.7 mmt 91.86 18.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.578 1.151 . . . . 0.0 111.709 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.26 62.16 0.24 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.9 mt -90.91 17.19 8.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.461 0.304 . . . . 0.0 111.27 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 67.0 t30 107.28 155.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.798 1.311 . . . . 0.0 109.639 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 54.0 p-10 -87.54 73.49 9.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.126 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -145.86 118.91 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.63 ' H ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -147.15 130.12 16.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 110.398 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.0 p -108.01 -164.75 0.99 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' SER . 61.5 m -49.44 -174.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.601 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 12.9 p -153.58 156.38 37.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -118.99 129.52 55.19 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.37 133.54 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.629 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.82 134.07 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -101.15 162.13 13.11 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.916 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -91.79 159.45 38.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.662 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.045 179.372 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.641 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.731 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 10.8 t80 -156.88 115.73 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -154.05 131.86 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.26 0.552 . . . . 0.0 110.605 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -138.94 147.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.337 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.8 mt-30 -124.44 129.1 50.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.461 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.3 mt -119.61 131.71 71.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.145 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -111.52 123.76 50.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.115 0.483 . . . . 0.0 110.52 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.51 -19.04 22.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.625 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -131.89 143.58 50.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 110.582 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.85 -178.91 0.78 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.4 t0 52.29 29.44 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.462 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 54.81 80.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.838 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -157.31 164.03 38.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.549 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.46 -157.24 30.03 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -67.7 138.23 56.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.764 0.316 . . . . 0.0 110.636 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 43.4 ttp -118.6 121.33 39.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.488 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.5 m-85 -116.81 132.66 56.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.209 0.528 . . . . 0.0 111.201 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.07 131.33 52.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.826 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -152.84 134.35 14.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -95.54 45.48 1.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -149.24 -177.74 6.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.774 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -86.9 160.28 18.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 64.5 m -137.82 123.34 12.64 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.6 Cg_endo -78.18 -61.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.805 1.67 . . . . 0.0 110.879 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.2 m -111.38 113.16 25.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.598 ' H ' ' HG ' ' A' ' 172' ' ' SER . 4.3 tt -70.04 -35.78 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.116 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 25.3 ttt -71.43 -18.53 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.447 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -82.43 -42.44 18.56 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.079 -1.013 . . . . 0.0 111.397 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.528 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.66 -30.19 15.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -177.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 27.7 m-85 -117.73 4.17 12.29 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.9 m-70 55.06 3.63 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.854 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.574 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -72.15 131.89 43.42 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.943 0.402 . . . . 0.0 109.921 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -108.4 -24.24 11.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.189 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.4 mt-10 -151.0 108.82 3.68 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.001 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.8 mm -76.91 125.79 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.643 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.8 m80 -105.24 -36.88 7.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.119 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.4 p -153.59 149.62 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.868 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -145.92 156.16 43.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.758 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.5 mtpt -134.06 179.13 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.371 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t 57.65 99.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.42 164.02 14.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.372 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -135.91 111.98 9.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.21 -88.0 0.01 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.5 t -125.82 144.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.974 0.416 . . . . 0.0 109.996 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.731 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.2 t-105 -130.09 167.85 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 67.5 mt -144.25 124.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.42 131.88 55.33 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -110.19 114.21 27.52 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.593 0.558 . . . . 0.0 110.784 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 80.8 tt0 -51.86 -23.65 5.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.507 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.05 160.9 37.23 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.449 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.1 Cg_endo -77.77 167.06 24.51 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.205 1.937 . . . . 0.0 111.763 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.514 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.9 m-80 73.2 14.83 4.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.046 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.514 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.2 m-85 77.34 27.84 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.531 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -114.7 170.77 8.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.831 0.348 . . . . 0.0 110.578 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.73 159.57 27.73 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 16.5 ptt180 -64.64 84.7 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.566 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -54.61 -167.5 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.043 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.563 -179.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.546 0.212 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.521 ' CZ ' ' HZ2' ' A' ' 159' ' ' LYS . 48.3 ptt85 -108.34 -22.29 12.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.594 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.521 ' HZ2' ' CZ ' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -121.59 156.41 58.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.84 0.352 . . . . 0.0 110.736 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.503 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -59.42 -23.06 68.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.214 1.943 . . . . 0.0 113.177 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.36 -4.94 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.53 -31.77 62.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.298 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -103.72 20.82 17.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.713 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.64 27.79 64.5 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.087 -0.577 . . . . 0.0 113.769 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -106.6 137.41 44.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.805 0.802 . . . . 0.0 110.301 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.25 26.32 0.16 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 166.0 154.54 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.503 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 170' ' ' VAL . 44.0 Cg_endo -71.49 -13.35 30.23 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.047 2.498 . . . . 0.0 111.337 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.65 69.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.582 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.677 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 4.2 t -101.0 -152.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.677 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.7 tp60 -153.33 -132.04 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.735 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.598 ' HG ' ' H ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -95.15 -152.99 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -170.64 -179.44 2.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.09 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -155.3 130.25 9.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.902 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -52.74 126.39 19.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.943 0.877 . . . . 0.0 110.98 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 mt -59.01 128.22 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.713 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.76 144.05 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.198 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 46' ' ' THR . 42.7 tt0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.081 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.719 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.8 tttt -161.28 152.69 18.94 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.983 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 tt -147.2 141.04 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.098 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.3 m -124.8 138.23 54.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.462 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -118.23 116.3 26.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.441 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 94.0 m-85 -98.59 139.27 34.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.963 0.411 . . . . 0.0 110.96 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.0 tm-20 -62.03 -51.94 65.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.875 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.92 -177.93 4.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.31 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' C ' ' HG ' ' A' ' 39' ' ' SER . 43.2 mtmt -82.36 -177.55 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.42 24.82 0.33 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.177 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.601 ' H ' ' HG ' ' A' ' 39' ' ' SER . 1.8 m-85 62.43 42.71 8.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.257 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.91 172.58 6.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.65 -153.33 51.45 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.845 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -56.89 173.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -169.0 152.53 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.492 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 63.9 t80 -129.23 131.62 47.09 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 37.7 p-10 -120.39 125.36 47.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 0.0 111.24 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.7 t -151.25 142.43 23.21 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.26 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -126.17 24.11 6.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' ASP . 14.3 m -145.99 141.81 28.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.442 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 40.3 t0 -35.73 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 20.8 m -156.85 162.68 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.348 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.75 -55.69 3.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.979 0.419 . . . . 0.0 110.647 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -154.07 110.97 3.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.331 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.3 p90 -100.81 9.27 42.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.963 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.7 t60 -59.07 -28.41 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.515 0.674 . . . . 0.0 110.069 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -60.96 -29.2 69.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.271 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.08 -14.99 37.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -142.34 138.25 31.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -99.98 -8.69 23.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.644 0.259 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 49.2 ttm-85 -154.23 141.5 19.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.824 0.345 . . . . 0.0 110.485 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.4 m -110.92 105.46 14.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.273 0.559 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 45.4 m-20 -117.13 -155.84 0.6 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 16' ' ' PHE . 18.2 p -20.47 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.884 0.74 . . . . 0.0 112.271 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 mt -143.01 146.91 21.14 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.114 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.1 ptpt -154.41 103.97 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.2 t -66.6 148.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.523 0.678 . . . . 0.0 110.555 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.51 50.08 1.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.009 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.77 -95.85 0.1 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.925 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.28 -140.28 4.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 90.0 m -81.05 166.9 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.292 -0.534 . . . . 0.0 110.84 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.3 m95 -154.47 156.9 37.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.286 0.565 . . . . 0.0 110.742 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.43 120.82 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.47 131.9 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 0.0 110.986 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.7 109.65 21.43 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.723 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -37.06 -36.29 0.12 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -113.69 147.98 38.8 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.5 Cg_endo -68.72 157.09 63.25 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.34 2.026 . . . . 0.0 112.05 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 5.5 m-80 86.03 -2.84 0.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.3 m-85 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.146 0.498 . . . . 0.0 111.145 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 26.3 t80 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -104.06 92.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.604 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.3 110.23 5.89 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 162.85 19.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.083 1.855 . . . . 0.0 112.759 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.79 117.41 2.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.087 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.78 179.12 41.3 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.51 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -102.24 153.93 19.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 25.1 m-85 -145.93 83.55 8.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.57 -15.72 9.51 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.26 2.64 . . . . 0.0 113.101 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -152.52 161.43 42.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.734 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 13.2 p90 -65.03 -52.36 56.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.334 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 37.2 mt-30 -42.99 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.609 ' H ' ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.82 -4.97 46.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.059 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.734 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.85 23.24 11.81 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.618 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.6 mmt 87.41 25.35 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.561 1.163 . . . . 0.0 111.158 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 30.83 50.04 0.2 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.078 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 26.5 mt -75.86 14.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.542 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 14.6 t-20 110.95 162.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.368 1.043 . . . . 0.0 109.27 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -94.4 61.23 2.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -137.61 115.78 11.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.246 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.424 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.39 129.16 20.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.6 p -111.58 -162.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.745 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.29 -178.65 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.864 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.59 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.5 p -151.11 153.06 34.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.595 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -118.34 127.86 54.1 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.559 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.49 127.85 33.48 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.63 132.04 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.735 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -100.37 161.56 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.82 150.36 69.12 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.429 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 N--CA 1.496 1.619 0 C-N-CA 122.244 1.963 . . . . 0.0 111.935 179.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.6 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.715 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 21.5 t80 -160.88 114.13 2.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.261 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -157.09 132.28 9.04 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.709 0.29 . . . . 0.0 110.676 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.408 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.5 tt -135.81 145.0 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.221 0.534 . . . . 0.0 111.296 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -122.23 134.02 54.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.36 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 108' ' ' MET . 17.5 mt -121.94 131.52 72.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.216 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -115.98 130.24 56.73 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.211 0.529 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.46 -26.98 65.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.052 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -122.25 147.07 46.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.591 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.46 -168.48 0.41 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 50.7 t0 44.56 29.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.911 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 54.11 79.35 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m -158.56 162.24 37.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.993 0.425 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.99 -171.43 42.69 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -53.89 133.69 42.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.169 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.9 tmm? -121.04 131.98 54.61 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.454 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.7 m-85 -121.46 135.72 55.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.456 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.05 126.24 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.3 t -152.73 128.93 10.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.72 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -95.37 42.68 1.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 111.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.07 -179.46 6.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.508 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.8 p-10 -84.04 156.98 21.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.525 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 65.8 m -134.04 123.02 16.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.907 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' OG ' ' A' ' 172' ' ' SER . 68.3 Cg_endo -77.98 -57.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.8 1.667 . . . . 0.0 110.841 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.8 m -115.89 111.64 20.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 119' ' ' MET . 5.1 tt -67.4 -41.86 86.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 0.0 111.338 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 9.1 ttp -68.17 -17.12 64.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.344 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -82.47 -42.49 18.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.671 -0.643 . . . . 0.0 111.707 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.525 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.9 -29.96 15.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.111 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.523 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 29.3 m-85 -115.99 4.48 13.77 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.5 m-70 52.48 11.64 0.19 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.234 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -76.85 133.01 39.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -106.98 -28.48 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.71 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 30.3 mt-10 -151.45 109.0 3.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.008 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.98 125.17 34.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.901 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.0 m80 -107.44 -33.53 7.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.742 ' HG ' ' H ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.56 -168.12 1.97 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.793 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.742 ' H ' ' HG ' ' A' ' 129' ' ' SER . 0.1 OUTLIER 160.99 137.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.082 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -130.16 -169.54 2.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.052 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.1 t 47.0 87.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 0.0 110.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.28 169.8 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.201 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -141.88 113.65 7.9 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.49 -97.44 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 t -110.54 155.93 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -145.03 168.62 19.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.837 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 70.5 mt -144.63 123.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.974 0.416 . . . . 0.0 111.576 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -109.61 129.82 55.56 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -107.5 110.83 22.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.563 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.2 -22.39 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.27 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.55 164.36 16.66 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 90.7 Cg_endo -84.16 166.9 12.58 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.091 1.86 . . . . 0.0 112.29 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 143' ' ' PRO . 1.8 m-80 68.52 21.96 7.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.6 m-85 71.68 66.83 0.15 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -154.44 169.68 23.17 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.931 0.396 . . . . 0.0 110.698 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.93 172.76 39.12 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.982 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -53.9 138.26 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.554 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 15.5 mp0 -99.56 137.5 37.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.033 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.592 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -109.47 -21.13 12.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.24 155.73 58.22 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 121.124 0.488 . . . . 0.0 110.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.531 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -60.24 -19.03 55.5 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.259 1.973 . . . . 0.0 113.181 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 2.1 mp -97.86 -3.45 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.72 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -27.86 68.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.864 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -107.42 21.25 17.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.28 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.33 70.84 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.331 0.492 . . . . 0.0 114.331 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -105.75 138.58 41.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.973 0.886 . . . . 0.0 110.005 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.57 20.86 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.265 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 169.46 156.73 0.18 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.719 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.7 4.48 6.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.006 2.471 . . . . 0.0 111.585 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.55 71.4 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.798 0.333 . . . . 0.0 111.09 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.603 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.6 t -99.78 -151.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.603 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 79.0 mm-40 -154.61 -130.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.123 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 2.9 p -93.7 -155.48 0.45 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -170.04 -177.27 2.52 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.319 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.72 132.06 6.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.442 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -51.67 134.81 29.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.237 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.2 mt -67.84 135.48 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.658 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.52 156.75 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.152 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.743 0.306 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.738 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.4 tttt -160.03 152.03 20.41 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.004 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.95 142.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.736 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -125.89 138.99 53.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.642 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -119.33 115.8 24.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.373 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.4 m-85 -94.71 138.73 32.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 110.822 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 8.1 tm-20 -61.06 -49.91 75.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.076 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 65.6 m-20 -99.2 -175.96 3.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.182 0.515 . . . . 0.0 109.667 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -82.73 -176.64 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.829 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.53 23.78 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.515 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' H ' ' HG ' ' A' ' 39' ' ' SER . 2.9 m-85 63.18 41.46 7.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.117 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -108.19 177.08 4.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.44 -158.56 50.97 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.508 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -54.64 176.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.25 150.15 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 49.8 t80 -127.23 130.97 50.63 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 38.3 p-10 -119.45 124.0 45.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.096 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -150.03 142.3 24.19 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.241 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -125.25 24.01 7.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.951 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.9 t -146.81 141.81 27.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.8 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 25' ' ' CYS . 74.5 m-20 -36.61 156.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.562 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 23.5 t -157.69 164.27 37.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.301 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.47 -56.57 2.98 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.958 0.409 . . . . 0.0 110.861 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 44.7 p-10 -154.24 110.6 3.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.193 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -99.89 10.83 40.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' LEU . 70.5 t60 -59.79 -26.85 66.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.2 p -63.39 -31.31 72.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -85.85 -12.58 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.15 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -142.93 137.62 29.58 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 p -95.49 -11.74 27.01 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 45.4 ttp180 -158.19 146.07 18.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.217 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HG ' ' H ' ' A' ' 80' ' ' LEU . 2.8 m -110.25 104.15 12.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.37 0.605 . . . . 0.0 111.395 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.727 ' O ' ' O ' ' A' ' 39' ' ' SER . 90.3 m-20 -128.84 155.6 44.95 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.463 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' O ' ' A' ' 38' ' ' ASN . 11.1 p 36.97 128.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.345 1.069 . . . . 0.0 112.192 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.7 mt -141.46 147.12 22.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.403 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -155.94 102.28 2.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.212 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -67.24 149.78 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-O 121.616 0.722 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' N ' HG12 ' A' ' 42' ' ' VAL . 76.1 mm-40 -122.89 50.62 1.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.053 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.53 -96.97 0.11 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.868 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.92 -141.33 4.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 84.9 m -80.84 167.23 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.578 -0.366 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.738 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.8 m95 -154.74 155.65 34.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.611 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 120.79 41.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.48 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.92 131.33 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 110.608 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-85 -102.88 108.23 19.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 50' ' ' TYR . 79.1 tt0 -36.48 -35.32 0.08 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.07 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -115.39 147.3 38.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 49.4 Cg_endo -68.45 160.71 48.04 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.324 2.016 . . . . 0.0 111.446 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 83.37 -3.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.293 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.7 m-85 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.7 m-85 . . . . . 0 C--O 1.231 0.117 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.39 92.14 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 112.98 16.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.67 162.23 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.02 1.813 . . . . 0.0 112.526 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -51.94 115.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.914 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.12 177.52 42.44 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.8 mt-10 -101.06 153.07 19.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.944 0.402 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 30.6 m-85 -146.05 91.11 5.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 37.0 Cg_endo -66.3 -13.62 40.67 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.056 1.837 . . . . 0.0 113.138 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -149.41 161.08 42.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.753 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.6 p90 -63.23 -53.97 44.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.99 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.61 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.9 pt20 -43.46 -10.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 70' ' ' TYR . 24.0 mmm180 -75.04 -5.6 44.93 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.24 24.39 10.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.05 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.0 mmt 87.97 25.48 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.289 0.993 . . . . 0.0 111.286 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.17 51.47 0.26 Allowed Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 10.4 mt -75.88 13.2 0.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.83 -0.185 . . . . 0.0 110.986 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.2 t30 109.06 169.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.578 1.174 . . . . 0.0 108.743 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -98.96 61.46 1.26 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.901 0.382 . . . . 0.0 110.556 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -139.2 116.9 11.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.304 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' H ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.05 129.17 20.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.7 p -111.22 -162.86 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.513 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 81' ' ' SER . 6.3 p -45.51 -179.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.781 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.62 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -150.26 151.89 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.431 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -115.52 127.96 55.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.543 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.18 122.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.479 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.08 130.06 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -102.56 162.87 12.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.6 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -79.91 150.65 72.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 C-N-CA 122.071 1.848 . . . . 0.0 112.329 -179.375 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.63 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.001 0.429 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 31.0 t80 -159.01 114.16 2.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.519 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -156.39 132.66 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.451 . . . . 0.0 111.034 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.41 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -134.53 143.62 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.421 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -123.74 129.58 51.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.418 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.3 mt -119.15 131.18 72.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.588 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -111.58 129.07 56.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.78 -29.88 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 102' ' ' GLY . 81.4 mttt -112.23 146.91 37.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 101' ' ' LYS . . . -54.3 -163.09 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 38.9 t70 51.72 -96.11 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 103' ' ' ASP . 67.1 m-85 -168.95 71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.993 0.808 . . . . 0.0 109.232 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -156.91 161.73 39.65 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.101 0.477 . . . . 0.0 110.986 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.05 -178.93 33.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.633 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.97 133.78 22.19 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.25 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.0 tmm? -122.33 130.32 53.02 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.815 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.488 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 65.0 m-85 -119.77 135.64 54.77 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.43 117.26 26.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.29 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.7 t -140.95 126.37 18.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.7 OUTLIER -92.65 38.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.27 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.12 -177.85 5.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.75 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.7 p30 -85.61 159.12 19.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.058 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.446 ' O ' ' OG ' ' A' ' 172' ' ' SER . 42.1 t -133.3 124.56 18.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.444 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -79.06 -53.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.819 1.679 . . . . 0.0 111.272 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -121.14 113.89 20.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.8 tt -68.25 -46.18 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.187 0.518 . . . . 0.0 110.589 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.459 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -64.65 -20.2 66.15 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -73.49 -47.26 42.58 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.673 -0.642 . . . . 0.0 112.433 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.639 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.67 -23.59 14.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.29 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.1 m-85 -111.49 1.56 16.99 Favored 'General case' 0 C--O 1.228 -0.04 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.2 m-70 50.12 11.17 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.862 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.487 ' H ' ' C ' ' A' ' 122' ' ' PHE . 33.8 mtt -77.38 135.2 38.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -106.36 -28.74 10.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.042 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 72.5 mt-10 -152.36 108.6 3.4 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.99 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.36 125.08 33.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.607 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.8 m80 -106.93 -32.46 7.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.242 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 103' ' ' ASP . 13.6 t -152.21 147.76 26.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 110.987 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.16 156.78 44.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 44.5 mtpt -133.71 -171.14 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.166 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t 47.06 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.414 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 4.3 mm? -110.82 167.48 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -143.17 111.71 6.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.816 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.82 -88.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 134' ' ' GLU . 5.5 t -121.18 155.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.082 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.742 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -143.73 167.81 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.9 mt -144.72 124.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.69 130.77 55.48 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 16.6 m-85 -108.75 111.75 23.67 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.508 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -52.12 -24.7 7.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.7 161.23 27.43 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.342 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.26 164.66 21.7 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.325 2.017 . . . . 0.0 111.489 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.54 15.11 2.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.003 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.7 m-85 78.54 25.91 0.54 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 111.339 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 89.7 mtm180 -109.78 171.26 7.55 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.66 168.56 33.87 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -62.16 134.38 56.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.08 0.467 . . . . 0.0 110.228 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.571 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 54.4 mt-30 -87.27 144.88 26.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.732 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -99.36 -30.36 12.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.47 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -118.12 155.42 51.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.47 -17.17 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.148 1.899 . . . . 0.0 113.432 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.22 -3.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.157 0.504 . . . . 0.0 110.327 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.82 -28.34 69.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.4 OUTLIER -104.68 20.51 18.51 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.09 28.23 66.89 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.134 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.474 ' HB2' ' HE1' ' A' ' 163' ' ' TRP . . . -109.74 137.64 47.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.704 0.752 . . . . 0.0 109.596 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.62 19.68 0.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.563 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 173.12 155.73 0.26 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.481 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.84 4.65 5.5 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.113 2.542 . . . . 0.0 111.709 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.96 69.89 5.2 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.588 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.5 t -97.71 -153.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.588 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 71.8 mm-40 -153.83 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.224 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.584 ' HG ' ' N ' ' A' ' 173' ' ' PHE . 4.0 p -93.17 -155.75 0.45 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.584 ' N ' ' HG ' ' A' ' 172' ' ' SER . 44.4 p90 -170.56 -177.35 2.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.065 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.66 132.04 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.862 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -53.05 135.95 36.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.916 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.6 mt -69.28 135.68 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.836 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.6 160.46 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.603 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 29.1 tp10 . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.432 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.516 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.6 p . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.728 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 31.9 tttt -160.26 151.89 19.83 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -147.49 142.05 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.997 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.5 m -124.9 138.77 54.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -119.11 116.36 26.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.6 m-85 -98.78 139.57 34.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.1 tm-20 -62.19 -51.41 67.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.823 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -94.4 -177.46 4.26 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' HD21 ' A' ' 15' ' ' ASN . 41.8 mtmt -82.8 -176.79 6.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.697 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.41 25.96 0.26 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.321 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CG ' ' C ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 63.61 41.44 7.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.57 177.45 4.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.0 110.493 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.81 -158.75 49.66 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.628 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.11 175.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.43 150.79 5.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.473 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 64.6 t80 -129.65 131.88 46.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -120.14 128.79 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.934 0.397 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.9 t -153.7 142.45 20.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.285 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -124.72 24.09 7.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 m -147.83 143.99 27.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.537 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.402 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 2.2 m-20 -37.77 156.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.778 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' ASP . 12.3 m -156.94 162.81 39.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.22 -56.12 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.941 0.401 . . . . 0.0 110.629 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -154.22 111.89 3.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.317 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.473 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.6 p90 -101.57 10.16 40.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.998 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' LEU . 33.2 t60 -59.58 -28.43 67.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.717 0.77 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.97 -30.99 70.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.456 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -86.8 -13.65 44.5 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.392 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 31' ' ' HIS . 20.0 tp -142.89 137.22 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 109.985 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -97.78 -10.14 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.296 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 59.3 ttm-85 -155.23 142.79 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.63 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.9 m -110.75 105.82 14.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 110.869 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 59.7 m-20 -118.0 -155.7 0.61 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASN . 6.3 p -19.68 137.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.992 0.807 . . . . 0.0 112.468 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.7 mt -142.55 146.54 22.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.046 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.62 104.28 2.34 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.953 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -67.24 148.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.38 0.61 . . . . 0.0 110.083 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.01 50.6 1.43 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.708 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.21 -96.17 0.1 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.071 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.25 -140.56 4.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 91.2 m -80.17 166.34 21.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.466 -0.432 . . . . 0.0 110.954 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.728 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -154.49 155.66 35.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.704 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 120.84 40.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.2 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 m -120.37 133.68 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CD1' ' NH1' ' A' ' 84' ' ' ARG . 11.7 m-85 -106.98 112.88 26.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.602 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -37.65 -32.68 0.06 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.169 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -116.57 147.41 39.68 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 120.596 0.236 . . . . 0.0 110.951 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -69.31 161.78 44.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.268 1.979 . . . . 0.0 111.716 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 3.8 m-80 81.99 -3.66 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.059 0.849 . . . . 0.0 111.075 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 4.4 m-85 . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.235 0.54 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 36.0 t80 . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.33 93.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -71.84 110.9 8.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.43 162.83 17.1 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.137 1.891 . . . . 0.0 112.527 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.66 114.85 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.84 176.75 41.67 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.2 mt-10 -100.02 153.25 19.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.049 0.452 . . . . 0.0 110.566 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 26.4 m-85 -146.14 81.57 9.6 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.19 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.17 -12.52 7.75 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.948 2.432 . . . . 0.0 113.071 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 95.2 mt-10 -152.13 161.35 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.692 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 38.6 p90 -64.21 -54.84 27.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.598 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.7 pt20 -43.84 -9.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' H ' ' C ' ' A' ' 70' ' ' TYR . 31.4 mmt180 -74.83 -4.92 40.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.79 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.99 25.48 10.32 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 119.778 -0.153 . . . . 0.0 110.742 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 23.6 mmt 85.48 24.68 0.08 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.439 1.087 . . . . 0.0 111.191 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.56 51.27 0.43 Allowed Glycine 0 N--CA 1.472 1.1 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.8 mt -76.64 13.82 0.92 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.8 t30 111.55 166.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.063 1.477 . . . . 0.0 109.553 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 50.7 p-10 -98.63 63.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -142.69 119.71 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -143.72 129.66 19.49 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.4 p -110.36 -162.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.555 ' C ' HH21 ' A' ' 84' ' ' ARG . 13.1 p -45.12 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 110.713 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.619 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 19.8 p -147.97 147.91 30.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.799 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 84' ' ' ARG . 0.0 OUTLIER -111.04 124.78 52.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.69 123.31 17.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.002 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.67 130.86 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -98.51 162.35 13.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 178' ' ' GLU . 1.7 mt -80.21 148.14 66.57 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.845 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 C-N-CA 122.17 1.913 . . . . 0.0 112.054 179.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.712 0.291 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.733 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 41.8 t80 -158.29 112.81 2.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -153.56 134.65 14.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.27 0.557 . . . . 0.0 111.111 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -135.9 144.51 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.164 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -122.83 130.17 52.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.55 132.35 69.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -114.44 132.89 56.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.04 -30.54 70.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.974 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -120.6 150.76 40.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.175 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.13 -176.62 4.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 t0 50.44 28.8 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.715 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 7.3 m-85 55.72 82.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.668 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -159.06 161.31 36.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.54 -149.35 20.53 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -77.12 137.43 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.2 tmm? -123.01 133.87 54.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 111.179 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.435 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.9 m-85 -124.71 137.95 54.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.679 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -123.55 123.66 41.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.49 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.408 ' O ' ' CG2' ' A' ' 111' ' ' THR . 5.6 t -151.59 125.55 9.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.581 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -92.39 45.31 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.44 . . . . 0.0 111.334 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.35 -179.24 6.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.538 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 18.6 p-10 -86.48 159.25 19.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.84 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 42.4 t -136.17 124.68 15.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.72 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.4 Cg_endo -77.84 -51.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.623 1.549 . . . . 0.0 111.093 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.0 m -121.97 111.39 17.0 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.982 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.7 tt -68.44 -43.91 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.0 ttt -65.45 -17.66 64.72 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.0 111.032 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -81.87 -43.02 18.77 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.724 -0.61 . . . . 0.0 111.94 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.704 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -95.54 -29.45 14.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.053 -178.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.704 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.03 5.3 14.92 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.678 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.8 m-70 50.78 11.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.919 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 122' ' ' PHE . 36.0 mtt -76.9 135.15 38.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.749 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -107.41 -28.46 9.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.516 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 60.8 mt-10 -151.19 109.04 3.68 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.08 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -74.71 125.14 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.723 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -105.53 -32.19 8.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.8 t -154.04 148.74 26.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.108 0.48 . . . . 0.0 111.267 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -149.8 132.34 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -112.44 -173.08 2.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.243 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t 56.15 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -94.55 168.03 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.136 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.8 mp0 -142.58 112.14 6.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.69 -88.66 0.01 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.5 t -116.59 156.21 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.733 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.2 t-105 -146.21 167.44 23.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 87.4 mt -144.88 123.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.742 0.306 . . . . 0.0 111.119 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.4 131.57 54.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -109.57 111.54 23.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.957 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -51.82 -23.18 4.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.737 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.6 160.4 33.32 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 96.7 Cg_endo -79.47 166.25 22.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.123 1.882 . . . . 0.0 111.46 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.6 m-80 74.84 14.01 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.0 m-85 79.04 25.55 0.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -109.87 171.05 7.68 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.847 0.356 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.23 168.99 36.07 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -56.97 142.39 41.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 109.835 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 69.5 mt-30 -97.6 137.39 36.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.002 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 -179.579 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.457 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.9 m-85 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -107.3 -20.26 13.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.701 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -121.56 154.86 59.96 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 15.5 Cg_endo -60.59 -16.09 40.7 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.4 2.067 . . . . 0.0 113.322 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.2 -1.69 9.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -26.08 67.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.671 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -108.67 21.08 17.75 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.42 26.94 68.8 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.955 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.481 ' HB1' ' HE1' ' A' ' 163' ' ' TRP . . . -106.93 138.28 43.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.38 1.09 . . . . 0.0 109.721 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.76 21.02 0.21 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 170.86 155.41 0.21 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.675 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.24 6.13 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.087 2.525 . . . . 0.0 111.407 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.8 70.64 8.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 111.056 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.648 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.01 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.648 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 73.8 mm-40 -155.04 -130.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.357 0.411 . . . . 0.0 109.893 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.594 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.37 -158.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -170.01 -177.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.405 0.622 . . . . 0.0 111.094 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.87 131.76 7.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -52.89 135.3 36.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.652 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.09 134.49 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.723 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.89 135.58 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.501 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . 11.2 tm-20 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.351 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 73.9 p . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.731 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.8 tttt -158.32 150.71 22.01 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.022 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.3 140.31 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.669 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 42.4 m -122.52 137.95 54.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.33 115.85 25.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.45 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -95.58 138.13 33.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.235 0.54 . . . . 0.0 111.083 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.27 -49.94 75.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.3 m-20 -99.69 -176.2 3.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.188 0.518 . . . . 0.0 110.148 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.43 -177.2 6.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.57 23.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.779 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.575 ' H ' ' HG ' ' A' ' 39' ' ' SER . 3.2 m-85 63.09 41.11 8.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.35 176.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.151 0.5 . . . . 0.0 110.715 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.91 -157.12 52.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.379 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -54.91 174.2 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.137 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.58 151.08 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' THR . 59.6 t80 -135.57 134.14 39.07 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 49.9 p-10 -120.9 140.46 51.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.665 0.269 . . . . 0.0 110.759 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 18.3 t -147.88 141.15 25.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 6' ' ' THR . 7.4 t70 -122.92 14.06 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.8 t -149.66 146.7 27.41 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.812 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 80.3 m-20 -37.54 156.19 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.62 161.22 40.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.35 3.03 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 39.4 p-10 -153.61 111.0 3.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.466 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 2.1 p90 -101.28 9.7 41.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.6 t60 -59.98 -26.47 66.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.986 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -63.28 -29.66 70.95 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.505 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -88.45 -12.87 41.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.469 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 31' ' ' HIS . 17.0 tp -143.5 137.7 28.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -99.46 -9.4 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 14.6 ttm180 -154.75 143.26 20.58 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.3 m -110.65 104.57 13.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.442 0.639 . . . . 0.0 110.887 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.707 ' O ' ' O ' ' A' ' 39' ' ' SER . 70.6 m-20 -129.51 156.78 43.59 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.67 128.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.392 1.091 . . . . 0.0 112.469 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.2 mt -141.44 146.19 23.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.297 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -154.41 103.6 2.51 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.096 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.72 148.23 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.542 0.686 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -120.9 50.42 1.35 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.81 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.45 -95.3 0.1 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.46 -140.0 3.98 Favored Glycine 0 N--CA 1.468 0.767 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.2 167.16 18.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.403 -0.469 . . . . 0.0 110.807 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.731 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.7 m95 -155.07 157.25 37.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.604 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.82 121.59 41.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.64 132.74 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.095 0.474 . . . . 0.0 110.881 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -104.56 110.59 22.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.758 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -38.03 -34.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.136 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -116.14 132.99 22.97 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.414 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.2 Cg_exo -55.92 161.91 7.77 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.371 1.38 . . . . 0.0 112.151 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER 84.69 -4.61 0.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.076 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.9 m-85 . . . . . 0 N--CA 1.468 0.448 0 O-C-N 123.533 0.521 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 36.5 t80 . . . . . 0 C--O 1.232 0.145 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.17 91.81 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 111.15 8.84 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 162.36 16.23 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.085 1.857 . . . . 0.0 112.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -51.03 114.57 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.828 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.06 176.71 41.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.4 mt-10 -100.13 153.13 19.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 110.519 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 36.5 m-85 -146.44 91.83 5.31 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 37.0 Cg_endo -66.11 -13.26 39.08 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.093 1.862 . . . . 0.0 113.246 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -149.82 161.14 42.85 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.732 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 41.6 p90 -63.49 -54.14 41.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.4 pt20 -43.5 -9.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 70' ' ' TYR . 84.5 mmt-85 -75.8 -4.48 40.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.59 25.08 10.67 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.823 -0.171 . . . . 0.0 110.95 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 22.7 mmt 85.39 24.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.465 1.103 . . . . 0.0 111.35 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.54 51.07 0.3 Allowed Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.3 mt -76.19 13.94 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.386 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 10.5 t-20 113.39 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.858 1.349 . . . . 0.0 109.493 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' H ' ' ND2' ' A' ' 77' ' ' ASN . 53.4 p-10 -97.35 62.68 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.052 0.453 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -141.88 118.53 11.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.987 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.15 128.63 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.9 p -110.63 -162.58 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.138 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.9 p -45.64 -179.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.619 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -149.3 149.79 31.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.603 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -115.82 127.85 55.37 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.05 126.49 27.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.277 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.06 131.84 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.649 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.0 159.13 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.598 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -80.89 148.07 63.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.031 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.491 1.344 0 C-N-CA 122.084 1.856 . . . . 0.0 111.803 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.74 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 38.5 t80 -158.06 113.58 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -154.36 132.04 11.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.426 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.5 tt -134.66 143.9 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.194 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.69 131.74 54.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' MET . 14.8 mt -120.33 130.99 73.77 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.97 132.93 55.16 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.048 0.451 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 82.8 tt0 -63.69 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.698 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -117.15 148.32 41.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.12 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 178.27 8.56 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.533 ' N ' ' HG ' ' A' ' 129' ' ' SER . 33.2 t0 54.72 31.25 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.772 0.32 . . . . 0.0 110.5 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 55.4 81.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.279 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -159.82 162.52 34.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.79 20.92 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.658 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.39 136.85 39.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.9 tmm? -122.03 131.62 54.08 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.53 137.15 54.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.516 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.73 127.49 47.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.636 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 t -149.5 128.64 12.77 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.0 OUTLIER -90.48 40.47 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.86 -177.96 5.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.063 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -84.66 159.29 20.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.15 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 45.1 t -132.44 119.59 16.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -79.25 -53.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.495 1.463 . . . . 0.0 111.018 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.9 m -119.08 109.94 16.5 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.7 tt -66.5 -42.58 90.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.355 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 44.1 ttm -66.62 -21.5 66.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.922 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -73.73 -47.48 38.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.241 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.659 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.7 pt20 -101.0 -25.48 14.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 34.9 m-85 -111.47 1.13 16.78 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 51.68 11.38 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.997 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.447 ' H ' ' C ' ' A' ' 122' ' ' PHE . 4.8 mmt -77.58 135.57 38.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -109.36 -28.87 8.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.556 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 35.1 mt-10 -150.36 108.01 3.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.383 0.611 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.39 122.77 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.864 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.8 m80 -104.39 -31.78 9.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.158 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 103' ' ' ASP . 9.4 m -151.71 146.48 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 110.681 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -145.46 132.72 20.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -113.03 -176.25 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.575 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t 53.54 90.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.583 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -105.6 168.09 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.79 111.88 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.91 -86.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.7 t -122.56 149.15 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.74 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -138.11 169.47 17.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.739 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 88.3 mt -145.05 123.51 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -109.39 130.92 55.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -110.5 111.92 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.617 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -52.28 -23.34 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.393 0.433 . . . . 0.0 111.159 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.65 162.09 24.29 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.42 165.28 20.93 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.1 1.867 . . . . 0.0 111.488 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.44 13.87 2.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.965 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.4 m-85 78.78 25.83 0.5 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -109.84 171.5 7.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.739 0.304 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 94.85 170.29 36.94 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.47 148.79 22.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 6.3 mp0 -110.18 148.21 32.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.162 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.571 179.769 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -107.11 -25.67 11.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -119.22 154.04 53.54 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.559 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.527 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -58.81 -15.66 27.69 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.176 1.917 . . . . 0.0 113.729 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.78 -3.29 9.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.313 0.577 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.75 -28.29 68.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.478 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -105.8 23.21 14.28 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 120.826 0.346 . . . . 0.0 110.167 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.1 26.45 72.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.946 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -107.53 139.6 41.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.378 1.089 . . . . 0.0 109.759 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.23 21.25 0.36 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 171.43 154.83 0.22 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.336 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 170' ' ' VAL . 40.1 Cg_endo -68.07 -35.16 20.67 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.641 2.228 . . . . 0.0 111.422 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.92 76.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.801 0.688 . . . . 0.0 110.6 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 168' ' ' PRO . 60.4 t -93.84 -98.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.442 ' HB3' ' H ' ' A' ' 172' ' ' SER . 5.3 mm-40 158.79 -140.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -92.62 -156.12 0.46 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.931 0.332 . . . . 0.0 111.704 -177.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -170.3 -177.11 2.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.53 131.72 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.258 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.7 ptt180 -52.46 135.33 33.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.61 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.9 mt -69.6 135.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.458 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.23 156.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.551 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 31.6 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.451 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.544 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 3.7 p . . . . . 0 C--O 1.215 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 22' ' ' ASP . 31.1 tttt -99.64 159.61 14.91 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.846 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -146.5 140.85 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.823 0.344 . . . . 0.0 111.613 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.6 m -126.61 138.87 53.5 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 110.554 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -118.23 116.55 27.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 92.9 m-85 -97.1 139.77 32.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 110.879 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.5 tm-20 -61.58 -52.61 63.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.764 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 99.0 m-20 -95.27 -178.15 4.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -81.89 -178.15 6.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 47.17 26.04 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.001 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER 62.35 42.48 9.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.414 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -109.79 176.43 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.09 -156.81 52.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.639 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -55.21 174.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.69 148.22 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CE2' ' SG ' ' A' ' 23' ' ' CYS . 51.4 t80 -130.69 132.73 45.55 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 28.6 t0 -118.4 143.42 46.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.775 0.321 . . . . 0.0 110.53 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -160.46 139.57 10.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 35.3 t70 -121.54 21.82 10.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.49 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.37 148.81 28.58 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.048 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 2.8 t70 -38.08 155.77 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 10.7 t -154.71 160.58 41.45 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.44 -56.66 2.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.022 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 41.1 p-10 -152.35 108.6 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.9 9.05 43.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -58.47 -27.48 64.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.039 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.8 p -64.26 -29.73 70.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.953 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.17 -11.63 46.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.6 tp -143.72 137.46 28.16 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -98.32 -12.01 21.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.49 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.4 ttm180 -154.46 143.13 20.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.235 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -114.34 108.06 16.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.648 0.737 . . . . 0.0 110.57 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 39' ' ' SER . 56.9 m-20 -117.61 -156.04 0.62 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.608 -1.178 . . . . 0.0 107.979 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.1 p -18.2 138.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.811 0.694 . . . . 0.0 112.748 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.8 mt -141.98 146.49 22.7 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.709 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -156.57 103.26 2.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.68 146.07 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.517 0.675 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -117.47 50.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.483 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.32 -96.56 0.1 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.796 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.14 -142.14 4.63 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 97.0 m -81.85 166.88 19.57 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.187 0.517 . . . . 0.0 110.956 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.624 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 23.5 m95 -155.2 157.59 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.981 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.89 121.2 40.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.281 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.94 132.06 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 52' ' ' ARG . 57.7 m-85 -104.3 111.12 23.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.527 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 50' ' ' TYR . 45.7 tt0 -32.69 -34.15 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.316 0.385 . . . . 0.0 111.216 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 50' ' ' TYR . 27.3 mtm180 -124.86 158.22 63.51 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 5.8 Cg_exo -71.18 163.47 39.06 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.391 2.06 . . . . 0.0 112.221 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER 86.66 -11.24 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.816 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' N ' HD21 ' A' ' 54' ' ' ASN . 9.8 m-85 . . . . . 0 N--CA 1.465 0.307 0 O-C-N 123.844 0.715 . . . . 0.0 111.595 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 24.0 t80 . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.58 93.07 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 111.92 14.26 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.78 164.01 13.98 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.046 1.83 . . . . 0.0 113.203 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -50.92 111.74 0.6 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.24 171.46 39.27 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.28 155.1 16.9 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.99 0.424 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 56.4 m-85 -149.01 84.23 6.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.702 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -54.09 -14.34 6.03 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.894 2.396 . . . . 0.0 112.814 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -155.45 162.88 40.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 7.9 p90 -64.78 -52.35 57.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.499 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -39.87 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.1 tpm_? -75.79 -5.17 44.54 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.421 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -116.71 25.66 10.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.196 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 mmt 88.78 25.18 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.119 0.967 . . . . 0.0 111.632 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 33.35 55.7 0.58 Allowed Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.318 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.8 mt -88.23 11.12 17.31 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 41.5 t30 87.52 139.3 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.66 0.6 . . . . 0.0 109.912 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 16.0 p-10 -37.88 -95.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.661 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER 27.15 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.55 128.05 20.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 82' ' ' SER . 6.8 p -110.23 -163.15 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.387 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.5 p -45.81 -179.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 110.761 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.624 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 26.5 p -150.8 152.53 33.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.263 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -114.78 127.03 55.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.47 122.08 14.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.55 130.97 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -102.73 162.52 12.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.963 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.32 155.85 69.11 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.494 1.546 0 C-N-CA 122.666 2.244 . . . . 0.0 111.992 179.367 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 35.8 t80 -158.43 113.26 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 36.0 tptt -154.68 133.57 12.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.19 0.519 . . . . 0.0 111.461 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 tt -136.0 145.05 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.253 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.9 mt-30 -123.25 131.42 53.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.526 -1.216 . . . . 0.0 107.942 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 108' ' ' MET . 12.8 mt -119.96 131.9 71.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.036 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -114.1 130.93 56.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 0.0 110.697 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -119.01 147.34 44.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.88 172.02 15.94 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.9 t70 59.75 31.91 21.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.815 0.34 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 54.5 81.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -159.13 163.36 36.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.486 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -151.73 24.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -73.61 135.86 43.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.644 0.259 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 9.3 tmm? -121.83 132.03 54.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.202 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.503 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.0 m-85 -121.52 136.05 54.98 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.74 123.5 41.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.555 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -151.77 126.43 9.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.689 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -92.34 43.44 1.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -142.77 -179.34 6.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 11.4 p-10 -85.2 158.92 20.23 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.536 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.6 m -136.59 121.64 12.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.87 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 172' ' ' SER . 69.0 Cg_endo -77.11 -53.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.768 1.645 . . . . 0.0 111.413 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 m -118.58 109.15 15.83 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.9 tt -66.17 -42.68 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 111.254 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.2 ttt -66.08 -18.45 65.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -82.37 -43.3 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.719 -0.613 . . . . 0.0 111.938 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.84 -31.79 14.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.006 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 28.0 m-85 -115.82 5.8 14.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 51.32 13.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.253 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' C ' ' A' ' 122' ' ' PHE . 2.2 mmt -78.23 133.84 37.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -107.4 -29.55 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.561 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 25.9 mt-10 -150.45 109.14 3.84 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.155 0.502 . . . . 0.0 111.167 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.9 mm -75.03 124.71 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.062 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.3 m80 -104.77 -32.22 8.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.172 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.9 m -154.52 149.28 26.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.05 145.87 32.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.647 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -122.48 -176.91 3.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.668 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t 50.66 92.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.649 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 7.5 mp -107.57 168.57 9.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.121 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.9 mp0 -142.04 112.48 7.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.13 -88.18 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.4 t -119.61 153.72 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.236 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.7 t-105 -141.83 169.32 17.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.767 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.2 mt -144.51 122.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.41 131.87 54.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -110.87 111.72 23.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.92 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -50.38 -21.92 1.64 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.0 mp -119.53 161.62 36.58 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 0.0 110.377 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.8 Cg_endo -77.39 168.25 23.19 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.1 m-80 73.67 11.95 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 78.76 27.92 0.44 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.329 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -112.87 172.3 7.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.75 172.49 42.48 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.598 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.74 156.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 110.239 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.595 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 13.2 mp0 -121.94 126.83 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.384 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.002 0.43 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -104.8 -25.92 12.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.016 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -119.83 154.79 55.3 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.608 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 13.7 Cg_endo -58.68 -19.7 47.05 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.23 1.953 . . . . 0.0 113.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.34 -2.81 9.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.131 0.491 . . . . 0.0 110.704 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.2 -28.16 67.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.547 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -106.87 21.73 17.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.354 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.57 69.9 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 121.134 -0.555 . . . . 0.0 114.283 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -105.92 138.16 42.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.217 1.008 . . . . 0.0 109.765 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.36 20.2 0.16 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 168.99 155.96 0.17 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.845 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.01 7.13 3.0 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.081 2.52 . . . . 0.0 111.502 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.11 70.52 9.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.046 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.646 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.3 t -99.27 -147.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.646 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.6 tp60 -160.47 -131.68 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.696 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.01 -157.59 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -169.81 -177.4 2.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.189 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.94 131.28 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.79 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -52.59 135.46 34.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.149 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.3 mt -69.3 134.42 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.6 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.5 t -137.71 156.55 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.658 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 27.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.882 0.372 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.749 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 39.7 tttt -159.75 151.25 19.95 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.11 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 tt -147.1 141.97 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.4 m -124.63 138.52 54.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.47 116.22 25.67 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.449 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.93 137.75 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.92 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 7.7 tm-20 -60.66 -48.99 79.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.156 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -99.1 -176.07 3.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 109.917 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.56 -176.72 6.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.282 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.8 23.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.883 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.542 ' H ' ' HG ' ' A' ' 39' ' ' SER . 3.4 m-85 63.48 41.76 7.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.235 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.65 174.38 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.604 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.82 -154.97 53.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.66 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -56.26 172.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.94 152.19 5.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -136.22 133.89 37.55 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -121.03 138.2 54.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.698 0.285 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 141.61 25.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.61 16.74 9.58 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.671 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -149.71 146.54 27.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -38.53 156.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.713 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 39.8 t -157.49 163.43 38.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.79 -56.3 3.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.817 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -153.58 112.51 3.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.5 p90 -101.87 8.58 41.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.041 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' LEU . 79.3 t60 -60.33 -27.57 67.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.494 0.664 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.4 p -60.79 -29.37 69.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -89.1 -15.27 34.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.527 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.23 137.65 32.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.954 0.407 . . . . 0.0 110.17 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -99.31 -7.76 25.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 52.5 ttm-85 -156.78 145.75 20.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.865 0.364 . . . . 0.0 110.575 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p -112.26 104.18 12.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.731 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.1 m-20 -129.78 157.55 41.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.731 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 34.24 127.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.581 1.181 . . . . 0.0 112.398 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.6 mt -141.2 146.08 24.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.187 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -154.06 102.96 2.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.25 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.49 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 4.4 t -66.89 149.18 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.478 0.656 . . . . 0.0 110.389 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -122.17 50.94 1.4 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.919 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.13 -95.73 0.1 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.967 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.16 -138.59 3.78 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 56.1 m -82.84 166.99 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.593 -0.357 . . . . 0.0 110.745 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.749 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.5 m95 -153.68 155.57 36.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.577 0.703 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.77 122.16 44.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.026 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 m -118.29 132.07 69.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.189 0.518 . . . . 0.0 110.871 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 52' ' ' ARG . 89.3 m-85 -101.5 108.49 20.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.919 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' TYR . 39.6 tt0 -32.21 -37.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.407 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.0 mtm180 -119.5 148.9 46.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.808 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 39.8 Cg_endo -67.78 163.8 33.93 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.559 2.173 . . . . 0.0 111.901 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 82.56 -3.27 1.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.119 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 N--CA 1.467 0.423 0 O-C-N 123.438 0.461 . . . . 0.0 110.965 179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 N--CA 1.462 0.146 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -101.34 89.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 110.8 7.05 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.95 161.85 18.37 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.181 1.921 . . . . 0.0 112.519 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -52.35 117.31 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.247 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.74 179.32 41.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.06 152.97 20.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 18.8 m-85 -145.67 84.6 8.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.7 Cg_exo -56.65 -17.78 23.87 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.145 2.563 . . . . 0.0 113.028 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -149.88 161.18 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 16.4 p90 -62.68 -49.66 74.24 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.521 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -44.19 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.9 mmt180 -76.38 -5.19 46.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.015 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.673 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -116.66 26.94 9.5 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.469 -0.144 . . . . 0.0 111.249 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 mmt 88.97 19.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.342 1.027 . . . . 0.0 111.316 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 32.51 59.65 0.4 Allowed Glycine 0 N--CA 1.467 0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.336 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mt -79.75 -67.59 0.75 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -159.93 163.86 33.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 54.7 p-10 -91.42 58.58 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 16.8 tpp180 -138.32 115.9 11.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.79 128.26 21.3 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.2 p -111.4 -162.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.605 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 m -44.65 179.85 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.322 0.582 . . . . 0.0 110.664 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 17.7 p -148.57 146.69 28.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.733 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -113.11 126.02 55.01 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.66 126.37 27.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.52 132.05 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.553 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -115.1 121.39 42.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.163 0.506 . . . . 0.0 110.253 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.677 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -46.15 163.21 0.23 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.952 -179.44 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.756 2.304 . . . . 0.0 111.961 179.634 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.714 0.292 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.4 t80 -157.77 113.63 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.237 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 110' ' ' GLU . 25.3 tptp -153.95 131.4 11.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.123 0.487 . . . . 0.0 111.424 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.416 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -133.05 141.24 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.354 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.25 130.16 53.53 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 mt -119.34 130.6 73.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.09 129.91 56.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.821 0.343 . . . . 0.0 110.802 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.04 -31.01 70.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.713 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.21 146.26 39.61 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' PHE . . . -47.98 -93.08 0.01 OUTLIER Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 104' ' ' PHE . 38.7 p-10 -38.28 98.58 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' C ' ' O ' ' A' ' 103' ' ' ASP . 23.7 m-85 -8.99 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.216 0.948 . . . . 0.0 112.046 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' ASP . 38.0 m -153.88 163.28 40.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 -151.53 20.14 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.115 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -73.11 135.55 44.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.481 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 44.3 ttp -120.95 124.52 45.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.614 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.5 m-85 -116.23 134.37 54.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 95' ' ' LYS . 1.9 pt-20 -120.96 119.26 32.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.018 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 111' ' ' THR . 6.1 t -148.98 125.11 10.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.78 44.42 1.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.14 -177.33 5.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.583 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.0 p-10 -87.07 155.96 19.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.127 0.489 . . . . 0.0 110.087 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.6 t -133.16 124.25 18.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.75 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.734 1.622 . . . . 0.0 110.789 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.602 ' CA ' ' HG ' ' A' ' 172' ' ' SER . 57.8 m -115.69 112.83 22.66 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.549 ' N ' ' OG ' ' A' ' 172' ' ' SER . 3.8 tt -68.68 -45.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.523 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.3 ttt -66.06 -19.47 65.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.436 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -76.25 -45.82 31.0 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.004 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.5 pt20 -100.74 -25.81 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 35.0 m-85 -110.25 1.71 18.79 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 52.05 9.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.118 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.47 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -75.91 133.69 40.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -107.52 -30.01 8.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.492 -178.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -149.31 109.28 4.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.87 124.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.792 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.0 m80 -105.79 -30.3 9.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.191 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 102' ' ' GLY . 15.7 t -152.68 147.82 26.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.0 111.196 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -149.22 126.88 11.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.978 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -107.91 -169.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.499 . . . . 0.0 110.468 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t 51.3 89.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.41 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 4.1 mm? -104.37 168.5 9.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.092 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -142.02 111.18 6.37 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 34.19 -91.47 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.016 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.0 t -115.28 138.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.7 t-105 -130.23 168.07 17.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 76.3 mt -144.61 121.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.825 0.345 . . . . 0.0 111.4 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -108.62 130.4 55.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -107.89 111.22 23.23 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.099 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -51.19 -25.67 5.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.99 160.73 28.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 92.2 Cg_endo -79.94 164.87 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.38 2.053 . . . . 0.0 111.583 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.683 ' ND2' HH21 ' A' ' 146' ' ' ARG . 3.2 m-80 74.61 15.97 3.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.32 25.35 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.683 HH21 ' ND2' ' A' ' 144' ' ' ASN . 90.4 mtm180 -108.35 168.32 9.4 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 97.87 168.05 32.11 Favored Glycine 0 N--CA 1.462 0.389 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' H ' HH11 ' A' ' 148' ' ' ARG . 0.1 OUTLIER -64.98 137.27 57.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 147' ' ' GLY . 1.4 mp0 -84.21 145.81 28.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.351 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.448 ' O ' ' OG ' ' A' ' 129' ' ' SER . 3.3 m-85 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -108.92 -19.73 13.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -121.23 156.15 57.75 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.687 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.549 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.5 Cg_endo -61.64 -16.39 48.01 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.652 2.235 . . . . 0.0 113.239 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -100.65 -2.85 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.807 0.337 . . . . 0.0 110.779 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -27.46 68.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.549 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.47 21.85 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.389 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.14 26.91 71.19 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.213 -0.517 . . . . 0.0 114.242 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.467 ' HB2' ' HE1' ' A' ' 163' ' ' TRP . . . -107.88 139.21 42.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.847 0.823 . . . . 0.0 109.812 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.22 20.75 0.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 173.4 153.4 0.25 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.823 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.57 4.38 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 123.023 2.482 . . . . 0.0 111.614 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.33 70.28 4.66 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.616 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.26 -153.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.616 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 70.8 mm-40 -152.7 -131.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.602 ' HG ' ' CA ' ' A' ' 117' ' ' SER . 1.1 m -94.18 -153.67 0.38 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -170.52 -176.25 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -161.08 133.78 6.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.454 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.466 ' CG ' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.95 135.4 42.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.45 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 13.9 mt -67.56 139.16 21.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.986 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.34 155.72 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.61 179.775 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 41.5 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.778 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.2 tttt -160.42 153.24 21.24 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.069 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.39 142.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 122.108 -0.37 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 138.81 53.98 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.964 0.412 . . . . 0.0 110.699 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -119.14 115.01 23.36 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.8 m-85 -94.08 137.96 32.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.14 0.495 . . . . 0.0 110.947 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.22 -49.02 79.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.158 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' OG ' ' A' ' 39' ' ' SER . 83.1 m-20 -100.97 -174.72 2.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.58 -174.97 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 111.633 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.21 23.28 0.19 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.851 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.7 m-85 59.19 44.43 15.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.29 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -115.35 160.67 19.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.355 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.32 -151.4 29.74 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.477 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -56.73 172.36 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -170.56 153.29 4.15 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -135.01 133.81 39.8 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.9 p-10 -120.76 137.63 54.41 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 141.49 25.94 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 8.5 t70 -124.32 15.8 9.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 97.2 m -150.31 147.17 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.35 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 38.1 t0 -37.64 155.55 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.512 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.554 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 43.8 t -155.66 161.91 40.69 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.41 -57.62 2.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.62 112.71 4.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -102.17 8.11 40.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.972 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' O ' ' O ' ' A' ' 34' ' ' LEU . 75.0 t60 -59.0 -29.35 67.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.536 0.684 . . . . 0.0 109.91 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.6 p -60.34 -29.76 69.09 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.01 -15.35 36.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.7 tp -140.87 137.2 33.04 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 t -99.67 -9.02 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.36 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.498 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 14.3 ttm180 -154.18 143.13 21.1 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.238 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 4.6 p -110.47 104.6 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.735 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.0 m-20 -129.32 155.85 44.96 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.735 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 36.47 129.6 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.691 1.244 . . . . 0.0 112.218 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.291 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.0 ptpt -155.87 102.84 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.103 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -65.85 151.05 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.402 0.62 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' N ' HG13 ' A' ' 42' ' ' VAL . 92.3 mt-10 -123.35 51.53 1.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.082 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.27 -96.14 0.1 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.974 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.52 -140.9 4.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 48.8 m -81.43 166.84 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.601 -0.352 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.778 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -154.01 155.39 35.46 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.253 0.549 . . . . 0.0 110.688 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.86 118.33 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m -115.98 131.43 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.052 0.453 . . . . 0.0 110.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.56 111.99 24.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' OE2' ' OD1' ' A' ' 77' ' ' ASN . 76.0 tt0 -38.98 -34.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -113.55 147.19 37.01 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.8 Cg_endo -68.01 157.76 60.35 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.733 2.289 . . . . 0.0 111.309 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.8 m120 86.5 -2.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.329 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.6 m-85 . . . . . 0 N--CA 1.471 0.615 0 O-C-N 123.306 0.379 . . . . 0.0 111.261 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.6 m-85 . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -107.47 98.78 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -76.65 114.26 37.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.25 163.61 17.35 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.298 1.998 . . . . 0.0 112.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.52 115.24 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.87 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.28 176.31 41.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -100.68 154.67 18.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.159 0.504 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 41.6 m-85 -147.34 86.59 6.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.614 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_exo -57.15 -18.32 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.967 2.444 . . . . 0.0 112.761 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -148.45 161.71 41.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.735 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.6 p90 -65.4 -53.18 46.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 28.8 mt-30 -43.18 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.903 0.382 . . . . 0.0 111.894 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.14 -4.17 40.13 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.735 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.81 23.33 11.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.824 -0.171 . . . . 0.0 110.838 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.4 mmt 89.84 23.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.535 1.147 . . . . 0.0 111.661 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 29.85 54.36 0.2 Allowed Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 17.4 mt -82.63 14.87 2.86 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.953 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER 112.73 163.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 125.263 1.602 . . . . 0.0 109.771 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 53.4 p30 -94.73 64.99 3.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.675 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 35.9 ttm180 -142.07 118.75 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.5 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.76 129.34 20.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 109.784 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' SER . 2.8 p -110.07 -163.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.0 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.5 m -45.33 -179.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.499 . . . . 0.0 110.879 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.613 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 14.4 p -150.46 152.22 33.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -116.99 128.66 55.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.89 123.24 17.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.118 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.23 133.06 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -103.68 161.42 13.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.061 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -76.84 159.57 78.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.477 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.311 -1.398 0 C-N-CA 122.536 2.157 . . . . 0.0 112.209 179.342 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 34.4 t80 -156.15 114.17 3.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.343 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.4 tptm -155.62 133.01 10.96 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.148 0.499 . . . . 0.0 111.034 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.9 tt -135.03 145.64 31.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.95 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -123.57 130.77 53.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.748 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.5 mt -119.98 131.04 73.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.167 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.7 m-85 -111.83 130.01 55.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.964 0.411 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.27 -28.11 68.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.65 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -122.55 148.54 45.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.206 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.24 -171.48 1.25 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.43 ' N ' ' HG ' ' A' ' 129' ' ' SER . 34.3 t0 46.33 29.22 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.404 . . . . 0.0 110.464 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 54.67 82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 m -160.32 161.04 33.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.838 0.351 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.85 -153.11 22.21 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -72.58 137.58 46.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 110.641 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.452 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 53.0 ttp -122.13 127.11 49.71 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.827 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.421 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -118.07 134.97 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 110.65 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.68 116.74 25.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.052 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.22 126.48 24.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.978 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -93.24 36.38 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.35 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.04 -177.65 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.732 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p30 -85.68 160.13 19.64 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.32 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.2 t -136.03 124.86 15.63 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.669 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 57.4 Cg_endo -78.61 -53.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.208 1.939 . . . . 0.0 110.855 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.3 m -120.26 113.11 19.92 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.8 tt -67.91 -46.18 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.653 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.48 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 26.9 ttt -64.73 -20.6 66.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.101 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.38 -49.18 35.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 3.9 pt20 -100.16 -23.04 14.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.167 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 33.9 m-85 -111.09 -0.1 16.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.855 0.359 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.1 m-70 52.14 10.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.281 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.457 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.2 mtt -78.58 134.5 37.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -107.3 -27.5 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 48.4 mt-10 -151.19 107.5 3.46 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.075 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -73.67 124.98 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.757 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.3 m80 -105.48 -33.43 8.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.035 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 103' ' ' ASP . 13.5 m -152.31 147.46 26.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.986 0.422 . . . . 0.0 110.73 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -145.36 137.46 25.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.776 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -116.07 -173.24 2.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.374 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t 49.21 94.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.41 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 27.1 mt -111.93 168.49 9.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' VAL . 4.3 mp0 -140.62 112.5 7.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.5 -90.77 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 134' ' ' GLU . 10.6 t -117.26 156.29 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.6 t-105 -144.63 169.18 18.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.456 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.7 mt -144.23 123.05 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.47 131.41 55.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -109.17 111.29 22.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -50.11 -21.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.247 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.4 mp -119.37 165.69 16.63 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 86.6 Cg_endo -83.46 167.79 13.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.334 2.023 . . . . 0.0 111.961 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER 79.78 14.57 0.94 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.956 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.4 m-85 76.01 28.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.143 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 80.5 mtp180 -136.81 130.21 31.53 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.92 169.14 20.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -51.96 98.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.213 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.616 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 75.5 mt-30 -60.72 133.8 56.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.711 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 120.977 0.418 . . . . 0.0 110.822 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -105.87 -23.21 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.96 157.3 50.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 121.271 0.558 . . . . 0.0 110.784 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.526 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.1 Cg_endo -61.65 -19.38 64.82 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.164 1.909 . . . . 0.0 113.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -98.81 -2.27 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.107 0.479 . . . . 0.0 110.756 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.66 -24.87 64.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.153 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.8 OUTLIER -110.36 21.95 16.08 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.54 66.49 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.591 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -108.27 137.01 46.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.988 0.894 . . . . 0.0 109.437 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.79 21.33 0.16 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 168.1 156.64 0.14 Allowed Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 6.69 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.061 2.507 . . . . 0.0 111.461 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.99 70.87 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.694 0.283 . . . . 0.0 111.35 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.632 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.1 t -99.03 -150.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.632 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 16.6 mm-40 -155.99 -132.97 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.356 0 O-C-N 123.14 0.275 . . . . 0.0 110.426 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 3.3 p -93.4 -155.81 0.46 Allowed 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 122.081 -0.387 . . . . 0.0 111.992 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -171.5 -176.04 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.033 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.31 133.1 8.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.157 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' N ' ' HH ' ' A' ' 94' ' ' TYR . 34.2 ptt180 -51.9 134.37 31.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.235 0.541 . . . . 0.0 110.649 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.5 mt -68.58 134.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.902 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.15 157.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 46' ' ' THR . 17.6 tp10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.92 0.39 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.759 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -159.22 152.3 22.17 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.096 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -147.49 142.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.816 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 m -125.98 138.97 53.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -119.12 115.75 24.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 84.1 m-85 -95.24 138.23 33.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.49 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.1 tm-20 -61.24 -49.36 77.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.067 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 99.6 m-20 -98.03 -177.51 3.77 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.103 0.477 . . . . 0.0 109.842 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.7 -176.54 6.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.876 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.58 24.43 0.32 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.778 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.708 ' H ' ' HG ' ' A' ' 39' ' ' SER . 2.5 m-85 62.07 41.61 10.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.157 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -109.11 172.99 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.114 0.483 . . . . 0.0 110.535 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.77 -155.3 52.82 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.439 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -55.77 175.08 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.8 154.58 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 55.9 t80 -130.76 131.58 44.8 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 45.7 p-10 -119.66 125.99 50.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.964 0.412 . . . . 0.0 111.197 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -152.79 143.17 22.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.372 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -126.53 24.58 6.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.809 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ASP . 4.4 t -146.79 141.95 27.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.602 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' CYS . 51.7 p-10 -37.16 156.02 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 m -157.95 163.22 38.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.27 -56.63 2.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 38.8 p-10 -152.43 112.26 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -102.19 9.2 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.985 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' O ' ' O ' ' A' ' 34' ' ' LEU . 81.6 t60 -59.66 -28.27 67.11 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.458 0.647 . . . . 0.0 109.964 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -61.27 -30.48 70.5 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.425 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -86.63 -14.06 43.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.97 136.35 30.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.136 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 m -94.86 -10.12 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.495 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.607 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 58.7 ttp180 -158.7 146.86 18.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.474 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.2 m -110.67 104.61 13.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.416 0.627 . . . . 0.0 111.391 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.741 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.8 m-20 -129.33 156.8 43.45 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.348 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.741 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.3 p 35.52 128.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.42 1.105 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.4 mt -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.385 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.2 ptpt -154.67 102.92 2.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.57 150.17 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.448 0.642 . . . . 0.0 110.226 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 42' ' ' VAL . 93.1 mt-10 -123.1 51.68 1.43 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.964 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.06 -96.2 0.1 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.218 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.25 -141.89 4.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 83.8 m -79.86 166.34 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.759 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.7 m95 -154.65 155.48 34.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.496 0.665 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.36 121.62 42.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.382 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.8 133.54 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.014 0.435 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 52' ' ' ARG . 77.9 m-85 -104.41 109.82 21.83 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 50' ' ' TYR . 74.0 tt0 -33.55 -33.29 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.644 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 29.9 mtp85 -121.71 151.48 57.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 56.0 Cg_endo -69.92 164.2 35.58 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.764 2.309 . . . . 0.0 112.158 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 4.6 m-80 78.99 -8.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.884 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.9 m-85 . . . . . 0 N--CA 1.463 0.213 0 O-C-N 123.5 0.5 . . . . 0.0 110.742 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.2 t80 . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.65 91.02 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -70.32 111.86 10.81 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.82 163.51 16.02 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.111 1.874 . . . . 0.0 112.739 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -52.7 116.87 2.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.151 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.64 178.77 42.23 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.528 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.1 mt-10 -101.55 152.4 20.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.002 0.43 . . . . 0.0 110.336 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 22.6 m-85 -144.29 89.52 6.96 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.36 -14.73 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.223 1.948 . . . . 0.0 113.331 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -150.26 161.06 43.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.685 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 15.0 p90 -63.26 -50.06 71.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.759 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 30.2 mt-30 -45.0 -9.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' H ' ' C ' ' A' ' 70' ' ' TYR . 22.8 mmm180 -75.18 -5.41 44.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.685 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.11 25.98 9.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 75' ' ' GLY . 21.8 mmm 84.93 24.55 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.131 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.4 54.02 0.31 Allowed Glycine 0 N--CA 1.474 1.196 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 30.8 mt -78.98 14.44 1.39 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.148 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 60.0 t30 112.61 164.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.039 1.462 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 52.7 p30 -96.45 65.93 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.57 120.23 10.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.121 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.77 129.73 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' SER . 1.7 p -111.19 -162.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.578 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.99 -178.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 110.793 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.614 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.8 p -149.75 150.49 32.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -115.99 127.42 54.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.545 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 126.39 27.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.309 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.4 t -123.84 131.19 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.704 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -101.66 161.78 13.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.019 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.06 157.52 71.1 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 C-N-CA 122.31 2.007 . . . . 0.0 112.023 179.189 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.8 t80 -157.21 113.45 2.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.111 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HZ1' ' CB ' ' A' ' 110' ' ' GLU . 27.1 tptp -154.68 130.99 10.41 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.434 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.3 tt -134.26 142.58 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.0 mt-30 -123.11 130.59 52.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.49 131.84 70.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.208 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -112.77 131.61 55.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.36 -29.99 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 150.26 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.3 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.5 176.24 14.6 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 55.75 30.58 15.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 6.1 m-85 56.0 83.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -160.58 161.18 32.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.955 0.407 . . . . 0.0 110.569 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.6 -149.36 21.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -77.22 138.59 39.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.671 0.272 . . . . 0.0 110.483 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.3 tmm? -122.23 132.96 54.69 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.055 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 58.1 m-85 -122.1 135.86 54.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CB ' ' HZ1' ' A' ' 95' ' ' LYS . 3.6 pt-20 -123.11 124.2 42.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.445 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -147.75 128.57 14.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 p -92.92 38.78 1.03 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.62 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 -177.62 5.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.761 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.4 p-10 -85.51 158.51 20.15 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.7 t -132.8 124.23 18.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.372 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.5 Cg_endo -79.57 -56.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.606 1.537 . . . . 0.0 110.958 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.639 ' CA ' ' HG ' ' A' ' 172' ' ' SER . 19.7 m -116.05 113.03 22.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.533 ' N ' ' OG ' ' A' ' 172' ' ' SER . 3.8 tt -69.76 -46.59 74.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-O 121.168 0.509 . . . . 0.0 110.787 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.471 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.1 ttt -65.48 -18.87 65.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.243 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.36 -46.36 33.61 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 121.606 -0.684 . . . . 0.0 111.992 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.45 -24.74 14.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.254 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.3 m-85 -111.28 -0.55 16.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.022 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 52.76 12.13 0.24 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.982 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -79.28 133.12 36.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -107.55 -26.94 10.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.545 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.9 mt-10 -150.83 108.27 3.63 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.08 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.7 mm -74.7 125.97 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.794 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -107.37 -32.27 7.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.332 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 130' ' ' CYS . 13.5 t -153.59 147.21 25.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.29 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.528 ' N ' ' HG ' ' A' ' 129' ' ' SER . 0.7 OUTLIER -146.72 129.18 15.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.735 179.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 132' ' ' VAL . 43.9 mtmt -99.83 -157.88 0.63 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.016 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.578 ' O ' ' O ' ' A' ' 131' ' ' LYS . 1.1 m 32.39 110.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.906 0.86 . . . . 0.0 112.058 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.98 166.87 11.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.766 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.2 mp0 -142.75 111.07 6.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.781 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . 35.03 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.603 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 t -117.25 156.31 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 110.165 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 25.9 t-105 -145.36 168.2 21.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.379 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 91.0 mt -145.39 123.79 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.759 0.314 . . . . 0.0 111.377 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.77 130.22 55.38 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.03 110.81 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.83 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -49.46 -22.51 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -118.47 161.01 37.6 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.42 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 74.1 Cg_endo -77.97 167.44 23.6 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.324 2.016 . . . . 0.0 111.68 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.534 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 73.14 14.12 4.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.921 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.2 24.52 0.66 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.636 0.255 . . . . 0.0 111.306 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -108.49 168.96 8.95 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.07 170.43 36.63 Favored Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -55.52 150.32 12.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.148 0.499 . . . . 0.0 109.771 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 7.1 mp0 -108.8 146.7 33.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.665 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 179.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 121.009 0.433 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.659 ' HE ' ' HZ1' ' A' ' 159' ' ' LYS . 40.2 ptt180 -107.59 -24.69 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.659 ' HZ1' ' HE ' ' A' ' 158' ' ' ARG . 14.2 pttm -119.82 154.06 54.98 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 120.84 0.353 . . . . 0.0 110.492 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.537 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.3 Cg_endo -58.42 -16.63 29.97 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.31 2.006 . . . . 0.0 113.5 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 2.3 mp -100.93 -3.68 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.15 -27.16 68.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.481 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.537 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -107.7 20.69 18.49 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.642 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.43 28.41 67.8 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.626 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.25 137.67 45.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.792 0.796 . . . . 0.0 109.72 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.11 20.81 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.314 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 171.48 155.47 0.22 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.477 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.64 5.0 5.11 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.952 2.435 . . . . 0.0 111.596 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.59 70.92 6.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.612 0.244 . . . . 0.0 111.153 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.65 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.3 t -100.93 -147.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.65 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.6 tp60 -157.73 -132.25 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.611 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.639 ' HG ' ' CA ' ' A' ' 117' ' ' SER . 1.1 m -92.21 -154.09 0.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -170.37 -177.07 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.136 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.48 132.45 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.924 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -53.92 129.34 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 16.7 mt -59.77 135.41 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.383 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.2 t -133.97 138.74 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.517 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.0 tp10 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.436 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.959 0.409 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.686 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.8 tttt -161.45 155.85 22.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.321 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -148.58 146.99 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.035 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 m -132.97 141.43 48.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -121.71 117.26 26.21 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.5 m-85 -99.68 141.13 32.88 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.047 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.9 tm-20 -64.07 -51.66 63.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.23 -176.39 4.13 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 109.616 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.54 ' C ' ' HG ' ' A' ' 39' ' ' SER . 42.1 mtmt -84.28 -178.17 6.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.805 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.692 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.5 OUTLIER 46.25 24.55 0.28 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.128 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.537 ' H ' ' HG ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 61.81 44.24 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.214 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -111.21 166.1 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -144.09 31.96 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.608 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -60.97 166.47 3.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.151 -1.025 . . . . 0.0 109.024 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.7 155.94 7.49 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.003 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -135.62 135.42 40.21 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 p-10 -104.25 150.12 24.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.615 0.245 . . . . 0.0 110.563 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -162.55 124.94 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.527 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.08 14.35 9.81 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.657 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' OD1' ' A' ' 26' ' ' ASP . 35.8 t -150.66 148.46 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.713 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' OD1' ' SG ' ' A' ' 25' ' ' CYS . 49.0 p30 -39.28 156.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.7 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 48.3 t -158.29 164.29 36.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.65 -56.07 3.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -156.31 109.19 2.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.343 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -92.67 7.53 43.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' TYR . 71.7 t60 -58.76 -30.36 67.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.103 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.8 p -64.52 -1.1 1.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.699 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' HIS . 67.8 m-85 -119.39 -14.84 9.15 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.768 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 15.8 tp -141.33 139.61 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -102.21 -8.38 21.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.852 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.7 ttm180 -153.32 141.87 20.83 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.685 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.9 m -113.02 104.23 12.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.772 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 52.6 m-20 -115.17 -153.76 0.53 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.54 ' HG ' ' C ' ' A' ' 14' ' ' LYS . 19.1 p -24.94 137.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.61 0.719 . . . . 0.0 112.587 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.0 mt -140.54 147.85 22.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.742 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.8 ptpt -155.89 103.12 2.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.239 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.542 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.0 t -66.49 144.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.93 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -115.1 46.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.48 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.15 -100.28 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.811 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.29 -140.15 4.24 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 91.6 m -78.7 167.27 21.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.437 -0.449 . . . . 0.0 110.851 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.686 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 39.3 m95 -157.11 158.82 37.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.376 0.608 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.98 122.57 43.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.791 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -119.41 133.02 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.891 0.377 . . . . 0.0 110.671 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 51' ' ' GLU . 92.9 m-85 -106.17 110.57 22.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.928 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' TYR . 71.4 tt0 -34.87 -36.06 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.37 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.7 mtt-85 -116.61 147.42 39.74 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 45.3 Cg_endo -68.01 156.36 66.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.37 2.047 . . . . 0.0 111.88 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 7.8 m-80 86.23 0.41 0.63 Allowed 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.931 0.769 . . . . 0.0 111.216 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 8.9 m-85 . . . . . 0 N--CA 1.468 0.447 0 O-C-N 123.464 0.478 . . . . 0.0 111.216 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.6 t80 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -101.37 94.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -72.46 111.22 10.2 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.15 164.84 19.48 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.078 1.852 . . . . 0.0 112.418 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -55.06 118.83 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.08 179.458 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.48 -180.0 41.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.74 153.24 20.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.004 0.43 . . . . 0.0 110.176 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 4.4 m-85 -142.54 69.79 20.8 Favored Pre-proline 0 C--O 1.221 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 69.1 Cg_exo -44.29 -13.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.845 2.363 . . . . 0.0 113.079 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 67' ' ' TYR . 71.2 mt-10 -155.46 163.99 39.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.689 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.1 p90 -65.18 -49.58 69.24 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.063 -179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -42.44 -10.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -80.23 0.78 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.488 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.73 20.9 10.92 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.36 0.124 . . . . 0.0 111.124 178.595 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.8 mmt 92.22 20.33 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.781 1.233 . . . . 0.0 111.716 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.19 59.6 0.27 Allowed Glycine 0 CA--C 1.536 1.358 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.4 mt -89.23 17.14 6.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.423 0.289 . . . . 0.0 111.543 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.6 t30 103.78 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.744 1.278 . . . . 0.0 109.578 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.24 63.74 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -131.54 112.77 12.93 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 130.34 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.123 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.7 p -108.78 -164.17 0.93 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.034 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' SER . 2.9 m -48.37 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.399 0.619 . . . . 0.0 111.553 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.619 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 13.5 p -151.41 151.65 32.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.698 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.28 128.28 56.02 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.57 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.87 132.4 53.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.79 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.1 t -129.03 132.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.706 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -98.9 162.8 12.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.74 149.92 61.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.494 1.551 0 C-N-CA 122.126 1.884 . . . . 0.0 112.14 179.836 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.725 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 36.7 t80 -153.54 113.1 3.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.2 tptm -153.64 137.29 16.03 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.102 0.477 . . . . 0.0 111.138 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -137.82 145.66 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.087 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.4 mt-30 -123.9 129.49 51.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.746 177.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.83 131.42 72.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -111.15 123.38 50.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.011 0.434 . . . . 0.0 110.786 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.01 -19.74 20.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HZ3' ' CA ' ' A' ' 106' ' ' GLY . 57.0 mttp -131.2 144.75 51.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.455 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.49 -170.46 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 44.62 29.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.741 0.305 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.511 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 17.4 m-85 54.64 82.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -159.64 164.13 34.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.498 ' CA ' ' HZ3' ' A' ' 101' ' ' LYS . . . 87.37 -158.49 30.04 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.863 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -64.66 135.74 56.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.361 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 45.2 ttp -118.23 122.21 42.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.186 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.58 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 44.9 m-85 -115.85 130.57 56.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.46 120.69 36.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.097 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -149.54 129.75 13.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.412 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -97.09 49.91 1.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.48 -176.63 5.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.351 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.3 p-10 -89.65 160.51 16.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 58.2 m -138.41 123.02 11.83 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.492 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 58.0 Cg_endo -76.15 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.878 1.719 . . . . 0.0 110.53 178.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.9 m -110.34 114.09 27.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.2 tt -70.05 -37.19 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.958 0.409 . . . . 0.0 110.947 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.5 ttt -70.51 -19.01 62.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.728 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -81.81 -42.3 19.88 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.14 -0.975 . . . . 0.0 111.513 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.15 -30.53 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.769 -177.531 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.592 ' C ' ' H ' ' A' ' 124' ' ' MET . 32.1 m-85 -116.86 4.23 12.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.813 -178.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.7 m-70 54.19 3.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.0 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.592 ' H ' ' C ' ' A' ' 122' ' ' PHE . 35.8 mtt -72.12 133.09 44.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.112 0.482 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -109.02 -24.65 11.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.192 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.557 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.8 mt-10 -151.78 107.78 3.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 13.8 mm -76.71 126.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.587 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.4 m80 -104.55 -36.5 7.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.169 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.511 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 7.4 t -148.27 143.47 26.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.129 0.49 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.3 t -143.44 134.09 25.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -114.38 -175.99 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.571 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.0 t 54.7 93.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.92 165.56 11.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.106 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.4 mp0 -139.4 111.83 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.55 -88.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.6 t -119.13 156.48 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.096 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.725 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.2 t-105 -144.47 166.72 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.643 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.8 mt -144.23 124.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.375 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 30.8 m-85 -107.4 113.8 27.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.802 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.1 -22.76 1.77 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.647 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.9 mp -121.74 165.36 20.31 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.0 Cg_endo -81.93 169.91 14.35 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.241 1.961 . . . . 0.0 112.3 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.496 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 77.0 13.67 2.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.783 179.759 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.496 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 74.25 30.12 1.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.11 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 93.0 mtt180 -134.68 126.23 28.68 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.4 173.62 20.77 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -52.45 113.66 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.896 0.379 . . . . 0.0 110.499 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -82.18 149.48 27.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.857 179.404 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.965 0.412 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -108.58 -21.48 12.69 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -123.64 154.88 66.8 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.362 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.492 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.0 Cg_endo -58.98 -20.53 53.71 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.481 2.121 . . . . 0.0 113.611 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.24 -5.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 110.654 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.81 -33.18 64.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.331 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.502 ' HE1' ' HB2' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.02 21.97 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.459 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.96 27.64 66.24 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.629 176.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -106.83 138.2 43.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.802 0.801 . . . . 0.0 110.678 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.31 24.2 0.19 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.1 m 165.19 153.79 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.447 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 170' ' ' VAL . 50.9 Cg_endo -71.18 -18.07 30.85 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.797 2.332 . . . . 0.0 111.509 178.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.41 70.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.302 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.648 ' CG2' ' H ' ' A' ' 171' ' ' GLN . 8.8 p -104.99 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.648 ' H ' ' CG2' ' A' ' 170' ' ' VAL . 2.0 tp60 -152.82 -130.86 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.501 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.6 p -94.85 -154.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -171.53 -178.17 2.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.295 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -157.7 132.97 8.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.96 178.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -52.74 126.11 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 110.347 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.9 mt -56.59 129.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.823 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.35 135.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.502 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.049 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.53 -1.428 . . . . 999.99000000000001 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 4' ' ' THR . 47.3 p -95.17 -118.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.075 -0.343 . . . . 999.99000000000001 110.075 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 34.05 29.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.787 0.679 . . . . 999.99000000000001 112.797 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 3' ' ' LYS . 2.9 t 161.39 -20.3 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.055 0.761 . . . . 999.99000000000001 113.055 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 107.5 2.31 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.36 -0.924 . . . . 251.37 111.212 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 79.0 p -95.28 115.26 27.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.844 -0.798 . . . . 109.64 108.844 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.591 ' O ' HG13 ' A' ' 42' ' ' VAL . 42.7 tttt -107.03 147.91 29.36 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.273 0.358 . . . . 84.790000000000006 111.561 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.725 HG21 ' SG ' ' A' ' 83' ' ' CYS . 18.5 tt -140.15 136.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.95 -0.389 . . . . 92.510000000000005 109.95 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.534 HG22 ' CE1' ' A' ' 11' ' ' TYR . 35.4 m -120.32 138.11 53.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 87.530000000000001 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 67.8 m-85 -116.86 116.61 27.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.067 -0.716 . . . . 6.4500000000000002 109.067 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 88.6 m-85 -95.96 140.61 30.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.213 0.53 . . . . 66.760000000000005 111.144 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HB2' ' CB ' ' A' ' 19' ' ' ARG . 4.3 tm-20 -62.06 -51.86 66.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.851 -0.613 . . . . 46.579999999999998 109.841 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.42 -175.95 3.36 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.791 -0.641 . . . . 24.879999999999999 109.92 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.67 -179.38 7.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.75 -0.659 . . . . 261.38 110.455 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 49.77 26.11 1.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 66.739999999999995 110.61 179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.636 ' H ' ' HG ' ' A' ' 39' ' ' SER . 1.3 m-85 57.96 44.57 19.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 24.969999999999999 110.947 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -114.74 161.49 18.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.974 0.416 . . . . 202.34999999999999 110.724 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.26 -146.4 29.06 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.859 -0.61 . . . . 138.46000000000001 112.437 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.557 ' CB ' ' HB2' ' A' ' 12' ' ' GLU . 2.1 ttm-85 -57.05 166.25 1.1 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.709 -0.849 . . . . 828.42999999999995 108.709 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.24 152.12 4.87 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.78 -0.452 . . . . 612.69000000000005 109.78 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 47.4 t80 -130.6 131.9 45.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 83.090000000000003 109.596 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -116.21 128.78 55.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 278.01999999999998 110.649 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.01 139.21 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 488.68000000000001 109.975 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -123.99 22.24 8.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.323 -0.399 . . . . 154.21000000000001 111.147 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 150.29 29.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.069 -0.253 . . . . 222.97999999999999 110.605 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -39.9 156.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.846 -0.616 . . . . 317.22000000000003 111.374 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HB3' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -157.34 164.21 37.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.625 . . . . 294.14999999999998 110.184 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.04 -56.41 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 98.579999999999998 110.921 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -151.01 108.79 3.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.579 -0.737 . . . . 348.80000000000001 111.295 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.488 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.5 p90 -99.74 5.32 45.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 8.1300000000000008 110.48 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.3 t60 -58.21 -26.89 63.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.186 0.517 . . . . 12.92 109.966 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.9 p -62.04 -20.94 64.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.956 -0.566 . . . . 126.12 110.265 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.16 -17.33 19.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 84.519999999999996 111.266 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -138.91 135.5 34.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.809 0.338 . . . . 88.469999999999999 110.276 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.64 -9.66 26.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.5 -0.318 . . . . 171.22 111.551 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.402 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 30.2 ttm-85 -155.11 142.01 19.12 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 110.025 -0.361 . . . . 533.13999999999999 110.025 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HG ' ' H ' ' A' ' 80' ' ' LEU . 2.3 m -108.59 102.32 11.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.332 0.586 . . . . 199.28 110.847 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 39' ' ' SER . 76.4 m-20 -125.57 154.91 41.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.953 -1.499 . . . . 45.579999999999998 106.953 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.642 ' O ' ' O ' ' A' ' 38' ' ' ASN . 15.6 p 39.04 128.67 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.497 1.142 . . . . 65.219999999999999 112.805 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 13.7 mt -142.02 143.49 26.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.307 -0.86 . . . . 91.5 111.772 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.5 ptpt -154.67 101.79 2.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.722 -0.672 . . . . 106.59 109.571 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 7' ' ' LYS . 1.9 t -65.73 148.03 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 110.033 -0.358 . . . . 284.95999999999998 110.033 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.91 57.8 1.04 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.164 -0.68 . . . . 256.75 109.164 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.96 -100.05 0.13 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.544 -0.753 . . . . 10.26 111.338 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -131.43 -142.32 4.99 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.485 -0.646 . . . . 9.6099999999999994 111.485 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.47 HG21 ' N ' ' A' ' 47' ' ' TRP . 86.6 m -79.98 165.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 101.98 110.601 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.752 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 15.6 m95 -151.79 153.16 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 8.8699999999999992 111.748 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -112.42 117.69 33.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.274 -1.009 . . . . 89.810000000000002 108.274 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 m -118.03 133.69 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 94.290000000000006 110.662 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.42 117.04 33.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 107.20999999999999 110.182 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.2 -39.59 0.18 Allowed 'General case' 0 C--N 1.333 -0.111 0 O-C-N 123.553 0.533 . . . . 42.520000000000003 110.674 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HE ' ' CA ' ' A' ' 57' ' ' GLY . 25.5 mtm180 -116.85 153.32 49.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 999.99000000000001 110.866 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 48.1 Cg_endo -71.06 168.02 24.43 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.103 2.535 . . . . 65.609999999999999 111.108 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.657 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.6 OUTLIER 79.8 -4.29 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.872 0.732 . . . . 371.37 110.885 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 12.0 m-85 84.61 51.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.493 0.495 . . . . 36.060000000000002 110.749 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.33 22.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.326 -0.397 . . . . 121.0 110.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' CA ' ' HE ' ' A' ' 52' ' ' ARG . . . 89.61 -158.44 27.4 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.132 -0.787 . . . . 118.16 111.132 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.402 ' HH ' ' NH2' ' A' ' 148' ' ' ARG . 24.0 m-85 -66.94 138.07 57.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 600.87 110.299 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 149' ' ' GLN . 62.6 mtt -104.08 109.16 20.84 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.974 -0.557 . . . . 927.44000000000005 109.818 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.532 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 13.2 t80 -115.15 133.07 56.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.587 -0.523 . . . . 999.99000000000001 109.587 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.478 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 3.9 mp -102.26 95.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 98.069999999999993 109.811 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -77.56 109.96 11.2 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.241 -0.436 . . . . 90.099999999999994 110.096 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 90.5 Cg_endo -81.98 165.83 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.098 2.532 . . . . 10.27 112.407 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -56.26 112.38 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.182 -0.463 . . . . 16.370000000000001 110.119 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.59 175.74 41.54 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.327 -1.109 . . . . 10.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.614 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.4 mt-10 -100.15 157.75 16.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.096 0.474 . . . . 11.75 110.747 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.614 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.4 m-85 -149.93 80.4 7.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.344 -0.843 . . . . 64.829999999999998 108.955 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 48.2 Cg_exo -48.79 -22.33 4.53 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.008 2.472 . . . . 76.409999999999997 113.284 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.35 163.4 35.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.388 -0.597 . . . . 36.829999999999998 109.388 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 26.5 p90 -61.63 -45.2 95.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 87.280000000000001 110.74 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.582 ' HG2' ' CE2' ' A' ' 70' ' ' TYR . 7.4 mt-30 -46.0 -13.43 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.217 0.451 . . . . 319.02999999999997 112.217 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -75.36 -3.51 34.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.59 -0.277 . . . . 730.28999999999996 111.566 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -118.35 26.33 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.404 -0.221 . . . . 8.2899999999999991 110.404 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.542 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.8 mmt 85.0 23.74 0.09 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.936 0.773 . . . . 168.38 110.955 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.35 50.1 0.25 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.916 -0.473 . . . . 12.4 111.916 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.634 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 16.8 mt -79.89 18.31 0.83 Allowed 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.968 -0.136 . . . . 132.99000000000001 110.917 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.634 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 66.3 t30 106.96 159.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.456 1.097 . . . . 269.25 110.155 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -91.72 57.35 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.666 0.604 . . . . 144.44 110.637 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.16 108.84 9.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.811 -0.631 . . . . 909.05999999999995 110.276 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.03 126.81 19.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.238 -0.585 . . . . 87.329999999999998 110.018 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.526 ' O ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -101.2 -162.54 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.742 -0.663 . . . . 70.950000000000003 109.431 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 12.8 p -50.27 -168.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.403 0.621 . . . . 257.19999999999999 111.262 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.752 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 28.1 p -154.79 161.79 41.36 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.407 -0.517 . . . . 64.189999999999998 110.071 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -122.94 131.84 53.9 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.498 -0.556 . . . . 427.60000000000002 109.498 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 123.6 18.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 92.530000000000001 110.43 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -121.87 129.92 75.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.401 -0.363 . . . . 110.95999999999999 110.991 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -101.4 157.62 16.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.935 -0.575 . . . . 304.38999999999999 110.265 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.61 150.48 63.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 336.50999999999999 110.651 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.14 156.23 55.8 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 123.007 2.471 . . . . 12.23 112.284 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.8 p -170.85 -15.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 329.32999999999998 111.592 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.69 93.89 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.99 -0.624 . . . . 216.49000000000001 111.552 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -122.49 54.46 0.7 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.949 -0.86 . . . . 176.66 110.949 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 92' ' ' GLY . 3.7 pt20 34.43 -102.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.621 0.248 . . . . 53.340000000000003 110.664 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.703 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.8 t80 -162.49 114.39 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.797 -0.446 . . . . 79.170000000000002 109.797 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.465 ' CE ' ' HB2' ' A' ' 110' ' ' GLU . 21.0 tptm -154.83 132.17 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 348.60000000000002 110.828 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.606 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -133.7 143.1 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 89.230000000000004 111.444 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.404 ' CD ' HG23 ' A' ' 132' ' ' VAL . 5.7 mt-30 -120.43 131.15 54.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.043 -0.98 . . . . 141.06 109.255 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 108' ' ' MET . 6.7 mt -120.82 134.13 65.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 116.252 -0.431 . . . . 88.219999999999999 110.677 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.2 m-85 -115.16 132.66 56.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 10.210000000000001 110.976 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.2 -26.7 68.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.637 . . . . 27.190000000000001 110.653 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -122.09 144.77 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 324.81 110.584 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -61.44 174.4 6.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.753 -0.939 . . . . 60.390000000000001 110.753 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.85 33.6 23.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 414.81999999999999 110.536 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 11.7 m-85 53.46 78.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.841 -0.618 . . . . 36.439999999999998 110.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -156.39 163.09 39.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 83.989999999999995 110.699 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.67 -154.91 27.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.436 -0.665 . . . . 44.380000000000003 111.436 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -72.57 132.82 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 35.469999999999999 110.906 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.585 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 47.8 ttp -116.7 128.37 55.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.82 -0.627 . . . . 161.99000000000001 110.492 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.67 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 39.1 m-85 -119.25 135.63 54.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 67.670000000000002 110.769 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.465 ' HB2' ' CE ' ' A' ' 95' ' ' LYS . 8.3 pt-20 -121.55 123.31 41.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.397 -0.82 . . . . 48.299999999999997 110.89 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.8 t -148.11 125.83 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.138 -0.483 . . . . 103.67 110.976 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.4 OUTLIER -93.22 38.77 1.04 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.534 0.683 . . . . 164.88 110.719 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.78 -176.47 4.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.597 -0.729 . . . . 67.290000000000006 110.352 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -88.1 160.29 17.86 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.891 0.377 . . . . 16.91 110.221 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 121' ' ' GLN . 6.6 t -140.87 122.57 9.29 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.921 -0.582 . . . . 319.91000000000003 110.504 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 172' ' ' SER . 56.1 Cg_endo -75.59 -56.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.785 2.324 . . . . 14.710000000000001 111.609 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -115.28 109.72 18.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.858 -0.61 . . . . 65.400000000000006 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 122' ' ' PHE . 3.2 tt -69.37 -40.94 80.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.247 0.546 . . . . 82.980000000000004 110.025 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.518 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.4 ttt -67.79 -31.9 72.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 227.30000000000001 110.855 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.09 -47.2 71.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.207 -0.451 . . . . 342.48000000000002 112.155 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' HG2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -100.87 -29.68 12.1 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.992 0.738 . . . . 251.72999999999999 112.992 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.67 ' CE1' ' HB3' ' A' ' 109' ' ' TYR . 17.4 m-85 -104.02 -1.74 27.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.565 -0.454 . . . . 10.460000000000001 110.948 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.518 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.5 m-70 55.25 7.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 18.77 111.737 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.537 ' SD ' ' CG2' ' A' ' 98' ' ' ILE . 41.7 mtt -77.16 132.88 39.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.988 0.423 . . . . 110.93000000000001 110.156 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -102.96 -31.63 10.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.618 -0.719 . . . . 599.49000000000001 110.242 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.476 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 57.4 mt-10 -148.67 110.05 4.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 84.760000000000005 110.372 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 11.6 mm -74.24 122.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.595 -0.52 . . . . 89.629999999999995 109.595 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.6 m80 -103.17 -32.07 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 9.0999999999999996 110.77 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.476 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 44.3 t -148.18 142.89 26.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.341 -0.39 . . . . 253.59 110.831 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.26 127.21 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 59.619999999999997 110.049 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -109.03 -176.79 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 164.47 110.577 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 95' ' ' LYS . 61.8 t 56.86 98.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.0 -0.545 . . . . 368.60000000000002 110.742 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 133' ' ' LEU . 4.2 mm? -111.72 161.17 16.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.788 -0.642 . . . . 408.81999999999999 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -138.63 111.03 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 385.49000000000001 110.169 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.01 -91.88 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.005 -0.838 . . . . 11.619999999999999 111.005 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 134' ' ' GLU . 42.8 t -122.83 141.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 110.065 -0.346 . . . . 97.030000000000001 110.065 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.703 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 26.6 t-105 -124.51 169.55 11.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 8.7899999999999991 110.66 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.452 HG13 HD13 ' A' ' 176' ' ' ILE . 59.7 mt -145.24 122.21 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.694 -0.684 . . . . 91.980000000000004 111.05 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.434 ' HB2' ' HB2' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -108.4 133.91 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.702 -0.481 . . . . 4.8200000000000003 109.702 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.533 ' CE1' ' HG2' ' A' ' 149' ' ' GLN . 25.0 m-85 -111.08 112.14 23.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 62.009999999999998 110.763 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -52.97 -25.27 11.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.159 -0.473 . . . . 28.989999999999998 110.277 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.01 160.61 31.68 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.53 . . . . 106.08 109.99 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD3' ' HG3' ' A' ' 171' ' ' GLN . 58.9 Cg_endo -76.79 169.3 21.98 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.707 2.271 . . . . 14.449999999999999 111.552 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 8.3 m-80 70.9 19.45 5.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 204.59999999999999 111.104 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.497 ' CD1' ' HB3' ' A' ' 174' ' ' ARG . 3.7 m-85 70.92 33.25 2.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.654 -0.248 . . . . 73.569999999999993 111.165 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 140' ' ' TYR . 45.4 mtm180 -121.53 174.0 7.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 999.99000000000001 110.846 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.92 175.36 42.59 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.895 -0.882 . . . . 54.329999999999998 110.895 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.402 ' NH2' ' HH ' ' A' ' 58' ' ' TYR . 97.0 mtt180 -49.03 136.39 14.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 999.99000000000001 110.051 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 59' ' ' MET . 70.0 mt-30 -99.53 122.1 42.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 397.97000000000003 109.809 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 71.1 m-85 -98.34 129.99 45.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 100.91 109.925 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.41 96.86 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 515.16999999999996 109.641 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.2 tp -121.71 140.72 51.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 999.99000000000001 110.057 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -83.44 109.82 17.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 999.99000000000001 110.568 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -167.44 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 999.99000000000001 110.263 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -126.05 0.75 7.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 999.99000000000001 111.373 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 177.97 159.3 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.771 -0.372 . . . . 235.22 110.96 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.411 ' HA ' ' CG ' ' A' ' 162' ' ' ASP . 16.0 m-85 -128.54 112.17 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.05 -0.523 . . . . 111.81 110.274 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.75 -20.52 13.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 999.99000000000001 110.768 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 1.5 pttm -124.77 159.76 56.95 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.107 0.479 . . . . 495.68000000000001 110.773 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.551 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -62.59 -19.84 69.06 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.841 2.361 . . . . 16.219999999999999 112.775 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.3 mp -96.25 -6.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.908 0.385 . . . . 122.18000000000001 110.443 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -56.77 -30.32 63.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 33.18 110.975 -178.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.489 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -103.56 23.95 11.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.081 0.467 . . . . 9.2200000000000006 109.929 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.4 28.73 73.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.851 -0.613 . . . . 12.81 112.904 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.489 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.46 137.74 41.87 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.709 0.754 . . . . 89.370000000000005 110.082 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.17 18.73 0.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 101.12 110.647 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 169.39 154.17 0.16 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.695 0.283 . . . . 70.739999999999995 111.171 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 55.6 Cg_endo -74.8 2.98 5.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.172 2.582 . . . . 20.879999999999999 112.037 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.26 75.02 5.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 105.11 110.524 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.602 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.1 t -102.74 -147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.894 -0.78 . . . . 217.69999999999999 108.894 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.602 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 15.7 mm-40 -156.67 -133.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.014 -0.365 . . . . 167.06 110.014 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 115' ' ' CYS . 0.2 OUTLIER -91.95 -153.02 0.32 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.411 0.148 . . . . 307.97000000000003 111.256 -177.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -169.59 -176.14 2.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.064 0.459 . . . . 9.2300000000000004 110.806 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HB3' ' CD1' ' A' ' 145' ' ' TYR . 10.2 ptm180 -160.48 130.88 5.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.599 . . . . 18.09 110.353 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.5 ptt180 -53.01 131.52 36.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 655.46000000000004 110.879 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 138' ' ' ILE . 30.9 mt -62.5 134.68 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.446 -0.797 . . . . 91.299999999999997 109.893 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.452 HG22 HH21 ' A' ' 174' ' ' ARG . 0.1 OUTLIER -135.58 153.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.824 -0.625 . . . . 282.87 110.601 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.026 -0.988 . . . . 408.25 110.757 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -88.02 172.34 9.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.733 0.301 . . . . 0.0 110.595 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -129.91 41.79 3.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.6 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -142.58 -59.88 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.541 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.65 117.68 5.87 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.8 p -83.0 158.61 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.745 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.4 tttt -160.05 151.1 19.23 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.053 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.8 142.14 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.991 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -124.72 138.71 54.27 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 116.16 25.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.453 ' O ' ' O ' ' A' ' 38' ' ' ASN . 87.3 m-85 -96.83 138.24 34.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.271 0.558 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.7 tm-20 -60.88 -49.94 75.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.01 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.7 m-20 -97.82 -176.94 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 110.141 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -82.08 -176.63 6.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.41 24.26 0.28 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.029 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.3 m-85 63.76 41.64 6.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.5 179.15 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 110.451 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.38 -159.06 48.15 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -53.39 175.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.05 150.68 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.4 t80 -127.94 131.34 49.33 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -119.8 124.0 45.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.864 0.364 . . . . 0.0 111.151 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.27 142.59 23.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.316 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -125.39 24.39 7.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASP . 10.6 m -146.22 141.71 27.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 25' ' ' CYS . 55.1 p-10 -36.27 156.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 26' ' ' ASP . 15.5 m -156.48 162.71 39.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.354 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -55.96 3.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.05 0.452 . . . . 0.0 110.538 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -153.03 111.35 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 2.2 p90 -101.29 10.56 40.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.963 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.4 t60 -60.85 -26.07 67.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 109.962 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.7 p -63.2 -30.55 71.68 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.229 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.61 -12.41 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.532 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -144.29 138.33 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 109.986 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 m -99.28 -9.22 23.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.652 0.263 . . . . 0.0 111.464 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.2 ttm-85 -156.48 144.89 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.0 m -110.11 103.89 12.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.728 ' O ' ' O ' ' A' ' 39' ' ' SER . 71.5 m-20 -128.7 156.42 43.52 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.728 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.5 p 34.95 129.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.438 1.114 . . . . 0.0 112.399 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -141.76 145.51 24.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.034 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -153.35 102.9 2.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.8 t -66.5 148.96 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.52 0.676 . . . . 0.0 110.568 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -122.21 51.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.732 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.17 -94.64 0.1 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.927 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.31 -140.16 3.9 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 94.9 m -80.56 166.41 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.366 -0.491 . . . . 0.0 110.824 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.745 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.6 m95 -153.78 156.71 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.336 0.589 . . . . 0.0 110.746 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.99 120.36 38.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.83 132.8 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.017 0.437 . . . . 0.0 110.931 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' GLU . 87.8 m-85 -104.45 111.13 23.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.671 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 68.8 tt0 -35.74 -35.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.294 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.473 HH21 ' CB ' ' A' ' 56' ' ' ALA . 10.3 mtm180 -116.18 148.12 40.86 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.043 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.8 Cg_endo -68.59 158.61 57.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.459 2.106 . . . . 0.0 111.719 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.5 m-80 85.7 -4.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.841 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 10.9 m-85 85.64 62.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.172 0.51 . . . . 0.0 111.1 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' HH21 ' A' ' 52' ' ' ARG . . . -145.32 168.3 20.79 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.46 -157.11 28.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 21.1 m-85 -70.8 141.71 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.097 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 61.9 mtt -106.86 87.55 2.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.549 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 33.4 t80 -92.56 136.17 33.45 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.36 91.29 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.874 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.7 110.38 5.84 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.422 0.451 . . . . 0.0 110.074 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.78 162.14 18.75 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.269 1.979 . . . . 0.0 112.539 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.19 118.17 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.167 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.47 179.36 41.27 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.539 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.5 mt-10 -101.98 152.55 20.81 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.959 0.409 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 21.8 m-85 -145.75 85.23 7.84 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.5 -18.13 24.35 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.142 2.561 . . . . 0.0 113.137 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -150.63 161.73 42.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -63.11 -51.2 67.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.401 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 18.3 mt-30 -43.28 -10.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.1 mmm180 -75.08 -6.5 49.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.724 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -118.02 27.29 9.09 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.853 -0.158 . . . . 0.0 110.646 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.9 mmt 83.56 24.73 0.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.175 0.922 . . . . 0.0 111.102 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.12 50.39 0.48 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.7 mt -74.45 14.21 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.7 t30 110.21 167.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.538 1.149 . . . . 0.0 109.349 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 54.6 p30 -99.27 60.56 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.034 0.445 . . . . 0.0 110.383 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -137.89 115.72 11.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.057 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -140.74 128.6 21.82 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.3 p -111.81 -162.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 24.3 p -45.25 -179.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.129 0.49 . . . . 0.0 110.504 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -151.09 153.33 34.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -118.69 128.56 54.62 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.71 126.47 27.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.149 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.2 t -126.54 132.6 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.79 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -99.29 161.88 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.85 148.86 82.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.525 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.78 153.26 73.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.293 1.996 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -173.27 -13.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.249 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.71 95.5 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -130.33 53.03 0.81 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.3 pt20 35.46 -107.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.723 0.297 . . . . 0.0 110.628 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 20.5 t80 -155.78 112.4 3.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -149.58 127.91 12.17 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.385 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.438 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.2 tt -130.27 136.52 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 53.2 mt-30 -120.04 126.04 49.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 107' ' ' GLN . 5.8 mt -118.37 132.81 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.72 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.657 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 46.3 m-85 -117.5 127.75 54.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.05 0.453 . . . . 0.0 111.523 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.52 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 73.6 tt0 -60.27 -28.02 67.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.859 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.462 ' C ' ' H ' ' A' ' 103' ' ' ASP . 51.3 mttm -107.95 141.54 39.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.448 0.642 . . . . 0.0 110.778 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -69.67 37.02 0.37 Allowed Glycine 0 C--N 1.315 -0.597 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.018 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 101' ' ' LYS . 5.6 p-10 -154.27 35.7 0.42 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.452 ' HA ' ' CG ' ' A' ' 99' ' ' PHE . 28.6 m-85 56.31 56.26 5.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.32 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 3.8 m -161.13 170.68 19.92 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.747 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.63 -43.45 2.89 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.835 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 72.1 tp60 -156.86 119.12 3.91 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.517 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 29.4 ttp -116.6 109.15 16.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.232 0.924 . . . . 0.0 110.159 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.607 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 16.8 m-85 -115.54 133.47 56.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -122.9 122.84 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -152.17 126.24 9.16 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.383 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 t -94.09 44.08 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 111.002 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -141.79 179.52 6.8 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -83.45 155.43 23.42 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.717 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.632 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -131.37 120.71 18.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.939 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.58 -55.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.861 1.707 . . . . 0.0 110.727 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.1 m -118.02 114.36 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.7 tt -69.31 -43.31 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.434 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.5 ttt -67.25 -19.48 65.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.729 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.08 -46.61 41.87 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 4.8 pt20 -99.85 -24.72 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.609 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 28.5 m-85 -114.68 2.48 14.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.6 0.238 . . . . 0.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 50.6 14.02 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.268 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.415 ' N ' ' C ' ' A' ' 122' ' ' PHE . 13.6 mtp -80.24 135.89 36.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -109.32 -25.99 10.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 67.6 mt-10 -150.81 107.06 3.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.014 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.58 123.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.681 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 66.1 m80 -105.4 -31.08 9.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.906 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 14.7 m -150.49 145.79 26.22 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.5 t -150.56 124.88 9.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.19 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -94.39 53.0 1.63 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.488 ' CG1' ' SG ' ' A' ' 130' ' ' CYS . 7.5 p -95.92 125.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.417 ' O ' ' CD ' ' A' ' 134' ' ' GLU . 0.3 OUTLIER -147.11 94.95 2.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.325 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 136' ' ' VAL . 14.3 mp0 -144.58 109.78 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.115 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.08 -85.94 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.603 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.7 t -127.12 156.85 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.723 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.4 t-105 -144.82 166.2 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.578 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.3 mt -144.61 123.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.713 0.292 . . . . 0.0 111.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -108.2 129.07 55.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 23.8 m-85 -108.51 110.8 22.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.34 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.528 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 82.2 tt0 -49.85 -23.27 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.77 160.3 37.21 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.331 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.478 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.4 Cg_endo -78.55 165.25 25.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.387 2.058 . . . . 0.0 111.943 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.673 ' ND2' HH21 ' A' ' 146' ' ' ARG . 1.9 m-80 75.1 13.57 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.2 m-85 79.27 24.6 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.673 HH21 ' ND2' ' A' ' 144' ' ' ASN . 87.7 mtm180 -107.03 169.44 8.55 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.35 170.35 36.2 Favored Glycine 0 N--CA 1.463 0.45 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.3 ptt180 -61.75 143.27 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.209 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 70.1 mt-30 -97.97 146.79 25.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.536 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 48.0 m-85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.72 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' O ' ' SD ' ' A' ' 59' ' ' MET . 3.3 tt -149.14 100.81 3.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.204 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.02 132.46 26.85 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.901 0.382 . . . . 0.0 110.061 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.543 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 21.7 t0 -83.47 -143.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 1.7 ttpm? 67.49 103.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 154' ' ' LYS . 68.2 mttm 42.87 -166.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.552 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 156' ' ' GLU . 2.5 pm0 -86.59 -138.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 15.1 m-85 -137.93 109.28 6.9 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.789 0.328 . . . . 0.0 110.291 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . 13.4 ptm180 -108.27 -21.62 12.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.546 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 156.2 57.6 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.398 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.8 Cg_endo -61.13 -19.0 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.736 2.291 . . . . 0.0 113.847 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.8 -1.59 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.355 0.598 . . . . 0.0 110.636 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.09 -29.42 70.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.843 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.543 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -105.0 22.91 14.45 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.79 27.55 70.58 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.871 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.481 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.8 138.05 45.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.013 0.906 . . . . 0.0 109.473 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.96 20.63 0.35 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.217 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER 175.42 154.64 0.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.837 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.22 3.14 6.49 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.274 2.649 . . . . 0.0 111.801 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.05 5.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.393 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.599 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -95.95 -150.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.599 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.5 tp60 -157.18 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.786 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.8 -155.57 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.617 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 52.0 p90 -169.87 -177.07 2.52 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.082 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.93 131.8 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -54.15 129.91 36.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.021 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.5 mt -61.28 135.87 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.288 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.9 152.82 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.261 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.208 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 2.2 m 160.4 -100.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.53 175.67 0.08 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.723 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 74.98 161.87 0.25 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.444 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.68 -36.62 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p -81.47 156.63 25.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 110.695 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.728 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.7 tttt -161.25 153.66 20.27 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.277 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.43 142.78 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.714 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 m -126.72 139.96 52.75 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.082 0.468 . . . . 0.0 110.471 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.05 116.73 26.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.297 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.7 m-85 -95.76 138.36 33.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.606 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.46 -49.05 79.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.289 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 82.4 m-20 -100.76 -174.77 2.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.907 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.35 -174.96 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.656 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.8 m120 46.21 22.92 0.17 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.88 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.734 ' H ' ' HG ' ' A' ' 39' ' ' SER . 1.4 m-85 59.17 44.93 15.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.305 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -115.27 161.91 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 110.374 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.36 -151.22 29.47 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.592 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -58.18 173.79 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.46 155.05 5.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -134.61 134.59 41.41 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 30.2 t0 -102.81 154.35 19.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.547 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.43 124.81 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.815 0.34 . . . . 0.0 110.139 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -124.82 11.17 8.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ASP . 8.0 t -150.65 148.25 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.5 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 52.9 p30 -37.54 154.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' C ' ' HG ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -155.79 160.69 40.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.03 -56.82 2.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 41.5 p-10 -152.98 113.74 4.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -103.41 8.31 38.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 53.4 t60 -59.61 -29.4 67.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.539 0.685 . . . . 0.0 110.024 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.2 p -60.15 -30.52 69.37 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.383 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -87.34 -13.97 42.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.521 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.0 tp -142.2 137.36 30.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 109.943 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -98.16 -9.42 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.268 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.0 ttm-85 -155.66 144.12 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.2 m -110.18 103.67 12.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 110.671 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.736 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.8 m-20 -128.91 155.16 45.72 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.736 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.9 p 36.11 129.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.558 1.17 . . . . 0.0 112.258 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.5 mt -141.55 146.13 23.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.857 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.307 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.5 ptpt -154.46 104.2 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.248 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.71 149.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.39 0.614 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -120.39 47.69 1.73 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.769 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.08 -94.84 0.1 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.022 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.94 -139.81 3.87 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 93.0 m -79.71 166.66 21.57 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.179 -0.601 . . . . 0.0 110.946 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.728 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -156.0 156.81 35.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.566 0.698 . . . . 0.0 111.039 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.39 119.31 36.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.798 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 m -117.88 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.232 0.539 . . . . 0.0 111.114 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 30.9 m-85 -93.77 175.31 6.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -100.99 -36.69 8.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -118.96 148.14 44.01 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 38.7 Cg_endo -64.16 157.29 54.43 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.006 1.804 . . . . 0.0 111.915 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.2 m120 84.24 -3.9 1.05 Allowed 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.005 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 16.6 m-85 85.76 62.87 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.616 0.572 . . . . 0.0 111.073 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.63 168.49 21.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.672 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.49 -159.56 33.6 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.712 ' HH ' HH21 ' A' ' 148' ' ' ARG . 6.7 m-85 -65.19 155.5 34.79 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.2 mtp -130.7 140.13 50.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.177 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 12.0 t80 -146.18 145.04 30.31 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.22 92.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.438 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -72.22 112.78 15.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.0 162.75 15.71 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.013 1.808 . . . . 0.0 112.456 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.08 115.68 1.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.057 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.11 177.4 41.62 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.8 mt-10 -100.75 153.04 19.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.346 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -144.94 89.41 6.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_endo -63.35 -13.92 38.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.239 1.959 . . . . 0.0 113.419 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 96.7 mt-10 -149.69 161.01 43.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.723 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 34.7 p90 -63.76 -53.69 47.08 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.986 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -43.77 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 70' ' ' TYR . 22.9 mmm180 -75.18 -4.38 38.51 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.723 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.29 24.08 10.93 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.883 -0.144 . . . . 0.0 110.976 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 21.1 mmt 87.69 23.96 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.238 1.015 . . . . 0.0 111.064 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.72 50.27 0.42 Allowed Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.2 mt -74.34 13.36 0.59 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.013 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 46.9 t30 109.81 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.94 1.4 . . . . 0.0 109.157 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -96.29 63.0 2.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.443 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.446 ' CA ' ' HE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.9 116.44 11.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.232 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.31 128.06 20.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 82' ' ' SER . 1.1 p -110.3 -162.92 0.82 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.041 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.7 m -45.47 -179.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.609 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.6 p -150.29 151.51 33.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.634 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.06 128.73 55.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.551 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 128.04 34.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.304 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.8 t -127.34 132.9 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.79 161.64 13.46 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.07 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -87.94 148.17 42.67 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.57 156.72 64.93 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.9 t -170.74 -17.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.16 -49.83 50.23 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.416 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -113.33 53.51 0.59 Allowed Glycine 0 N--CA 1.467 0.75 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.7 pt20 33.45 -106.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.72 0.295 . . . . 0.0 110.916 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.738 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 28.8 t80 -157.29 113.63 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -154.22 133.72 12.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 145.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.131 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.532 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.3 mt-30 -123.76 128.17 49.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.563 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.7 mt -118.44 131.93 69.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.16 130.01 56.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.628 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.27 -27.21 65.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.908 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -122.2 149.15 44.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.21 171.34 18.89 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 60.19 29.82 19.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.537 ' H ' ' HG ' ' A' ' 129' ' ' SER . 3.9 m-85 56.01 82.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -158.61 161.6 37.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 0.0 110.26 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.69 -150.95 23.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -74.6 138.87 43.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.5 tmm? -123.55 132.73 53.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.175 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.11 136.37 54.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -123.96 125.67 44.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -151.27 128.56 11.26 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -93.48 44.45 1.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -144.52 -179.25 6.43 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.6 p30 -86.41 159.96 19.19 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.563 ' O ' ' OG ' ' A' ' 172' ' ' SER . 96.5 m -138.71 123.49 11.77 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.73 -55.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.04 1.827 . . . . 0.0 111.665 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 m -116.59 111.89 20.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -41.72 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.406 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 7.7 ttp -67.94 -16.59 64.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.438 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -83.38 -42.73 16.7 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.595 -0.691 . . . . 0.0 111.39 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.584 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -93.85 -30.61 14.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.903 -177.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 26.1 m-85 -114.8 5.9 15.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.8 m-70 50.9 9.35 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.786 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.521 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -76.52 135.36 39.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.868 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -107.35 -27.56 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 49.5 mt-10 -151.03 107.57 3.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.35 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 12.4 mm -75.59 125.4 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 109.779 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.8 m80 -103.75 -31.13 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.283 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.537 ' HG ' ' H ' ' A' ' 104' ' ' PHE . 25.0 p -155.77 151.78 27.69 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.8 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -150.56 131.26 14.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.123 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 51.9 mtmt -112.09 -173.2 2.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.446 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.9 t 55.57 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.679 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.72 167.78 10.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.053 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -139.21 111.38 7.43 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 40.26 -84.82 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.4 t -125.03 154.95 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.745 0.307 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.738 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.8 t-105 -142.12 167.46 22.06 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.594 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.3 mt -145.34 125.72 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.378 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -107.34 112.63 25.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -48.89 -23.15 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.968 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.8 mp -119.26 166.43 14.48 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.2 167.36 12.33 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.093 1.862 . . . . 0.0 111.902 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.81 15.27 1.14 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.078 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.0 m-85 74.02 27.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.635 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 99.5 mtt180 -132.67 126.03 31.67 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.94 174.69 22.87 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.712 HH21 ' HH ' ' A' ' 58' ' ' TYR . 35.0 ttm180 -56.08 114.19 1.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -80.93 141.0 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.05 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -112.69 129.93 56.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.18 101.49 3.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 153' ' ' ASP . 49.1 tp -130.43 152.76 49.47 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 152' ' ' LEU . 57.8 t0 -35.68 104.17 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.789 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 139.82 58.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.944 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -174.51 -56.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.432 . . . . 0.0 110.268 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -172.49 137.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -123.73 108.22 12.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.936 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -109.64 -22.02 12.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.271 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -119.53 156.1 53.7 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 121.005 0.431 . . . . 0.0 110.717 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.562 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -60.48 -16.19 40.66 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.746 2.298 . . . . 0.0 113.531 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.91 -2.22 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.114 0.483 . . . . 0.0 111.02 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -26.05 67.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.638 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.74 21.87 16.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.459 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.18 67.55 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.788 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -108.15 138.9 43.63 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.878 0.839 . . . . 0.0 109.994 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.3 22.28 0.23 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 167.08 155.89 0.11 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.229 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 170' ' ' VAL . 45.7 Cg_endo -70.74 -33.62 12.6 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.596 2.197 . . . . 0.0 111.523 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -47.25 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.31 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.64 ' CG2' ' H ' ' A' ' 171' ' ' GLN . 9.1 p -107.68 -145.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.64 ' H ' ' CG2' ' A' ' 170' ' ' VAL . 69.3 mm-40 -152.9 -132.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.271 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -95.77 -153.29 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -170.69 -177.04 2.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.485 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -157.55 133.13 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.061 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.5 ptt-85 -52.43 133.66 35.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.384 0.612 . . . . 0.0 110.616 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.6 mt -67.29 135.06 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.863 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.35 156.63 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.202 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 4' ' ' THR . 73.6 m -156.04 161.42 40.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt 63.61 -25.7 0.07 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.233 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.635 ' H ' ' C ' ' A' ' 2' ' ' SER . 28.0 p 40.2 87.71 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.817 0.342 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.56 -153.03 7.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.494 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 2.7 p -83.16 156.77 23.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.781 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.5 tttt -159.99 151.06 19.29 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.948 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.59 141.31 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.887 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -124.32 138.22 54.4 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.144 0.497 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.6 115.95 25.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 38' ' ' ASN . 85.3 m-85 -96.4 138.28 34.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.301 0.572 . . . . 0.0 111.152 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.4 tm-20 -60.98 -50.0 75.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.856 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.2 m-20 -97.87 -177.79 3.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.295 0.569 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -177.07 6.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.123 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.614 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.8 OUTLIER 46.67 25.36 0.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.876 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' H ' ' CB ' ' A' ' 39' ' ' SER . 1.7 m-85 63.4 40.17 8.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.07 175.11 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.21 -158.33 53.26 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.706 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -53.6 174.91 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -168.46 150.76 5.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -126.5 130.99 51.7 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 42.9 p-10 -119.36 119.96 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.94 142.69 23.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.176 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -125.81 26.32 6.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.7 m -146.75 141.35 26.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -38.01 157.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.713 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.1 t -159.17 166.57 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.586 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.81 -56.12 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.971 0.415 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 43.0 p-10 -152.15 113.6 4.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.441 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -102.4 8.55 40.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.052 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -60.15 -25.68 65.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.485 0.659 . . . . 0.0 110.066 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.9 p -63.62 -30.37 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -87.02 -13.83 43.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.407 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.8 tp -143.51 137.66 28.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 110.068 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -98.74 -9.74 24.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 ttm-85 -155.66 144.08 20.21 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 7.5 p -110.25 104.39 13.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.771 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 59.2 m-20 -128.96 156.56 43.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.26 128.88 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.44 1.114 . . . . 0.0 112.529 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.7 mt -141.71 146.49 22.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.18 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -154.77 103.29 2.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.204 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.0 t -66.73 148.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.713 0.768 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -123.46 54.54 1.28 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.81 -97.34 0.11 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.41 -142.11 4.7 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.23 166.81 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.319 -0.518 . . . . 0.0 110.776 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.781 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -152.98 155.22 36.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.381 0.61 . . . . 0.0 110.783 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.01 120.24 39.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.302 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 m -119.59 133.22 67.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.558 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -107.83 115.49 30.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.064 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 59.7 tt0 -37.97 -34.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -115.4 146.78 37.27 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.819 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 44.4 Cg_endo -68.18 160.4 48.98 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.422 2.082 . . . . 0.0 111.495 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.1 m120 83.39 -3.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.29 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 7.6 m-85 85.66 60.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.08 0.466 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.05 171.52 14.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.51 -161.9 34.24 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 15.3 m-85 -68.77 138.01 54.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 tpt -102.45 124.27 47.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 39.5 t80 -131.5 136.87 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.49 92.24 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.55 110.48 7.05 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.6 163.33 16.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.966 1.777 . . . . 0.0 112.795 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.59 114.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.81 177.52 42.2 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 94.5 mt-10 -101.16 153.03 19.94 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.887 0.375 . . . . 0.0 110.396 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -145.71 90.57 5.89 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.08 -13.72 41.32 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.317 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -149.07 160.92 42.9 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.7 p90 -63.39 -53.21 56.06 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.322 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -44.62 -9.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' A' ' 70' ' ' TYR . 23.5 mmm180 -75.16 -4.78 40.76 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.834 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.68 24.86 10.8 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.907 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.5 mmt 87.47 23.0 0.05 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 111.085 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.13 52.47 0.52 Allowed Glycine 0 N--CA 1.469 0.865 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.1 mt -77.77 13.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.484 -0.294 . . . . 0.0 111.095 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 53.9 t30 109.79 167.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.612 1.195 . . . . 0.0 109.766 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 52.4 p30 -101.98 66.83 1.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLU . 5.5 tpt180 -143.63 77.28 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.585 0.231 . . . . 0.0 110.983 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -102.98 128.21 49.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.346 0.593 . . . . 0.0 109.605 -178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.3 p -109.38 -163.18 0.85 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.609 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.3 t -44.83 -179.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.174 0.512 . . . . 0.0 110.994 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.592 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.24 155.42 37.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.585 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -121.28 129.89 53.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.96 126.71 28.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.394 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.8 t -123.14 130.19 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.09 162.28 13.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.954 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.583 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -86.51 146.82 42.67 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.688 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.27 159.37 53.52 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.427 2.085 . . . . 0.0 112.223 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.9 p -171.2 -18.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.009 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.68 60.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.531 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -113.03 51.49 0.7 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.3 pt20 33.96 -105.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.666 0.27 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.729 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 15.4 t80 -156.87 113.22 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.2 tptm -153.98 129.29 9.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 111.155 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -133.96 141.57 43.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.9 mt-30 -119.33 128.61 54.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 108' ' ' MET . 12.5 mt -119.38 131.65 71.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.0 m-85 -111.21 131.22 55.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.98 -31.5 71.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -118.73 152.26 36.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.175 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.0 -169.66 2.22 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.0 t0 45.02 29.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 17.0 m-85 54.19 80.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 m -158.12 162.55 38.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.52 -149.24 19.7 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.58 138.93 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 110.449 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.441 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 45.5 ttp -120.5 127.85 52.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.526 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -119.44 136.63 54.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.204 0.526 . . . . 0.0 110.868 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.81 126.88 46.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.457 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.0 t -147.58 129.21 15.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.42 36.99 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.605 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.96 -177.31 5.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -85.1 158.91 20.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.193 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.449 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.3 t -132.38 123.79 18.82 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.227 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -78.52 -55.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.512 1.474 . . . . 0.0 110.784 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.2 m -119.11 114.44 22.47 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.8 tt -69.13 -45.13 80.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.04 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.0 ttt -65.94 -20.54 66.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.255 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -74.2 -46.84 39.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.15 -24.36 14.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.7 m-85 -110.77 0.92 17.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 52.41 12.13 0.22 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.412 ' H ' ' C ' ' A' ' 122' ' ' PHE . 34.7 mtt -78.97 134.16 36.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -106.22 -27.12 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.222 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.54 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -153.69 109.94 3.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.497 0.665 . . . . 0.0 111.251 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.0 mm -75.85 125.33 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.748 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.3 m80 -106.79 -31.05 8.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.001 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 7.9 m -152.47 147.03 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.5 t -146.66 133.92 20.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.725 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -114.05 -178.18 3.31 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.618 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t 56.46 103.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.663 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.99 163.44 15.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.012 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.7 mp0 -139.21 112.25 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.694 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.95 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 134' ' ' GLU . 41.8 t -126.6 135.88 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.729 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 t-105 -121.84 169.39 10.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 53.1 mt -145.53 124.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.465 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 149' ' ' GLN . 0.7 OUTLIER -110.74 133.73 53.08 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 149' ' ' GLN . 16.9 m-85 -109.73 111.71 23.32 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 123.531 0.519 . . . . 0.0 110.52 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -49.91 -23.38 1.92 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.975 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mp -113.86 166.4 11.46 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.49 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 93.4 Cg_endo -86.47 166.09 9.21 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.216 1.944 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.498 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.5 m-80 69.14 21.26 7.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.454 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.7 m-85 72.19 66.95 0.13 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.703 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -154.63 170.68 20.93 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 122.041 -0.412 . . . . 0.0 110.592 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.38 167.04 29.97 Favored Glycine 0 N--CA 1.464 0.53 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.884 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 149' ' ' GLN . 20.6 ptt180 -68.02 77.57 0.23 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 5.1 pt20 -48.05 175.54 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.443 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -138.83 146.33 41.13 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.196 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.4 tt -147.76 93.67 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.092 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -112.24 150.77 30.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.825 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -128.84 56.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.654 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.503 ' CE ' ' OD1' ' A' ' 162' ' ' ASP . 36.5 ttpt -91.85 -91.89 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -172.06 94.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.072 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 56.8 tt0 63.61 163.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.075 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.39 107.73 10.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.404 ' O ' ' OG ' ' A' ' 129' ' ' SER . 33.7 ptt180 -107.23 -23.52 12.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.593 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpt -118.18 157.63 48.42 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-O 121.332 0.587 . . . . 0.0 111.044 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.4 Cg_endo -61.24 -19.29 63.14 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.044 1.829 . . . . 0.0 113.451 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 mp -99.52 -0.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.532 . . . . 0.0 110.834 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.503 ' OD1' ' CE ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -62.79 -25.83 68.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.481 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -108.93 21.14 17.6 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-O 120.931 0.395 . . . . 0.0 110.07 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.4 70.46 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.834 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -104.42 137.63 42.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.524 1.162 . . . . 0.0 109.459 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -72.47 18.37 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.083 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 167.77 157.18 0.14 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.41 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.17 6.17 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.951 2.434 . . . . 0.0 111.617 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.99 69.42 5.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.551 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.634 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.0 t -97.04 -153.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.634 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 79.0 mm-40 -155.13 -130.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.432 0.457 . . . . 0.0 110.228 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 2.6 p -92.72 -155.73 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -169.75 -177.68 2.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.425 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -162.03 134.33 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.124 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 177' ' ' VAL . 15.0 ptt180 -50.83 133.09 26.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.792 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.8 mt -59.7 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 175' ' ' ARG . 21.6 t -69.53 140.13 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.072 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.421 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -165.02 165.61 19.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.85 0.357 . . . . 0.0 110.51 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -137.89 -23.83 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.635 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.4 t -88.7 -36.44 16.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.48 137.23 9.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.3 p -142.42 132.82 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.409 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.71 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.1 tttt -160.97 149.94 16.58 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.892 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.96 140.47 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.935 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 27.2 m -121.58 137.84 54.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.25 115.49 24.86 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.8 m-85 -95.26 140.0 30.78 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.17 -51.31 69.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.911 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.4 m-20 -98.59 -176.77 3.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' HB3' HD21 ' A' ' 15' ' ' ASN . 2.9 mppt? -82.04 -176.78 6.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.719 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.59 26.53 0.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.124 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.575 ' H ' ' HG ' ' A' ' 39' ' ' SER . 0.7 OUTLIER 62.09 41.0 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -106.58 172.0 7.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.16 -157.57 53.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NH1' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -54.56 175.93 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' CD ' ' A' ' 19' ' ' ARG . 2.7 ppt_? -169.21 149.99 4.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -132.92 133.77 43.68 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 45.1 p-10 -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.664 0.268 . . . . 0.0 110.798 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.21 37.73 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -124.64 16.56 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' ASP . 7.7 t -148.54 143.4 26.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' CYS . 52.2 p-10 -37.18 158.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.207 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.3 t -157.6 164.17 37.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -96.35 -49.07 5.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -158.57 105.7 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.254 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 1.7 p90 -97.76 12.58 33.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -64.74 -15.59 61.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 110.214 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.1 p -78.6 2.04 20.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.308 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.3 m-85 -120.2 -13.42 8.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.472 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 20.1 tp -144.76 140.31 28.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 t -100.7 -13.8 18.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.472 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.6 ttm-85 -152.61 141.73 21.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' ' CA ' ' A' ' 79' ' ' ARG . 9.0 p -109.34 104.3 13.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.294 0.569 . . . . 0.0 110.981 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.719 ' O ' ' O ' ' A' ' 39' ' ' SER . 86.4 m-20 -128.77 156.45 43.54 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.719 ' O ' ' O ' ' A' ' 38' ' ' ASN . 9.2 p 36.18 129.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.509 1.147 . . . . 0.0 112.341 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.16 146.39 22.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.828 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.16 102.7 2.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.47 148.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.466 0.65 . . . . 0.0 110.906 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.4 50.74 1.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.38 -97.14 0.11 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.39 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.75 -141.17 4.23 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.6 m -80.2 164.43 23.28 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.393 -0.475 . . . . 0.0 110.819 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.71 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 35.4 m95 -153.47 156.27 37.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.72 120.22 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.82 133.02 64.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.175 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 52' ' ' ARG . 82.5 m-85 -104.49 107.22 18.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.876 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' TYR . 44.7 tt0 -34.02 -32.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.441 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 67.9 mtt180 -127.9 151.27 75.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.154 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -58.65 163.59 10.7 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.222 1.948 . . . . 0.0 113.142 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 55' ' ' PHE . 1.4 m120 57.04 66.94 1.06 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.073 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' A' ' 54' ' ' ASN . 1.4 m-85 22.54 66.27 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.437 0.46 . . . . 0.0 111.764 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.45 161.32 39.99 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.717 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.63 -164.27 43.1 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.542 ' CE2' ' NE ' ' A' ' 148' ' ' ARG . 18.0 m-85 -66.5 138.01 57.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.1 mtm -127.25 131.71 50.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.667 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -138.22 159.48 41.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.4 mp -104.87 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -72.62 110.84 9.1 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.48 162.92 16.98 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.09 1.86 . . . . 0.0 112.877 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -50.47 115.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.827 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.08 178.03 42.04 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.6 mt-10 -101.19 155.28 18.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 41.7 m-85 -149.04 85.2 6.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.33 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.02 -16.37 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.237 2.624 . . . . 0.0 113.228 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -148.7 161.44 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.7 p90 -65.67 -53.18 44.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 16.5 mt-30 -43.27 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -75.61 -6.38 50.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.291 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -116.1 25.86 10.37 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.513 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.0 mmt 85.1 26.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.376 1.048 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.27 52.46 0.41 Allowed Glycine 0 N--CA 1.468 0.778 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 28.3 mt -78.42 13.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.202 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.4 t30 113.16 168.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.681 1.238 . . . . 0.0 109.165 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -102.03 66.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.232 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' CA ' ' SG ' ' A' ' 37' ' ' CYS . 14.3 tpt180 -147.9 122.41 9.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.125 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -143.13 128.96 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 82' ' ' SER . 1.9 p -112.42 -161.29 0.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 2.2 t -44.76 177.79 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.597 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.18 153.6 34.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.563 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -119.45 129.44 54.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.19 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.53 119.95 9.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.971 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -103.82 121.94 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.82 148.55 22.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.038 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.4 146.55 70.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.51 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.47 151.8 70.77 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.299 2.0 . . . . 0.0 112.052 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.8 t -169.94 -18.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.998 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.79 87.4 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -137.76 56.16 0.67 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' GLY . 4.3 pt20 34.28 -101.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.8 0.334 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.719 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 13.9 t80 -158.15 114.08 2.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.406 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 17.9 tptm -154.7 128.57 8.76 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.357 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 tt -133.9 141.42 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.54 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 14.7 mt-30 -119.22 128.16 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.3 mt -118.79 131.45 71.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.057 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.407 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 59.1 m-85 -111.14 130.68 55.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -60.84 -31.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.614 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -114.97 151.68 33.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.0 171.52 31.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 40.1 t0 59.52 32.9 21.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.556 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 9.2 m-85 54.3 80.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -158.07 163.66 37.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.64 -147.89 20.82 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.24 139.33 41.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.407 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 46.0 ttp -120.81 126.83 51.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.444 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.469 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 52.9 m-85 -117.87 135.87 53.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.93 125.41 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.422 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 t -152.27 127.97 10.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.71 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.16 39.81 1.08 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.41 178.51 7.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.7 p-10 -82.72 156.41 23.78 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -130.85 121.22 18.85 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.7 Cg_endo -78.24 -53.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.865 1.71 . . . . 0.0 110.593 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.0 m -120.43 113.48 20.4 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.58 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.7 tt -69.24 -43.53 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.137 0.494 . . . . 0.0 111.162 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.7 ttt -68.09 -19.2 64.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.017 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -76.04 -45.61 33.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 6.9 pt20 -100.38 -26.18 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m-85 -111.93 1.11 16.31 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.738 0.304 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 52.11 15.3 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.455 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 36.5 mtt -81.97 134.44 35.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -106.91 -28.14 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.659 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.551 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 41.9 mt-10 -151.3 108.79 3.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.852 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.0 mm -74.38 125.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.814 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -106.14 -29.98 9.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.218 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 4.8 m -151.52 146.26 25.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.1 t -153.57 128.82 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.928 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 53.1 mtmt -114.51 -179.44 3.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.854 0.359 . . . . 0.0 110.602 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.5 t 60.79 64.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.575 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 3.8 mm? -96.61 100.83 12.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.213 0.53 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 1.2 mp0 -67.0 121.14 14.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.44 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.48 -110.94 0.09 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 t -98.77 142.35 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 110.14 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 32.7 t-105 -131.84 169.33 16.4 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.1 mt -144.94 123.04 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.729 0.3 . . . . 0.0 111.787 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.93 129.52 55.1 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 20.2 m-85 -109.02 111.46 23.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.26 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -48.41 -23.66 1.01 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.1 160.9 37.31 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 110.277 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.405 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.5 Cg_endo -77.89 167.94 22.96 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.115 1.876 . . . . 0.0 111.83 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 73.07 14.24 4.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.78 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.29 24.54 0.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.636 0.255 . . . . 0.0 111.348 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -108.04 168.96 8.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.26 173.03 38.69 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.542 ' NE ' ' CE2' ' A' ' 58' ' ' TYR . 81.4 mtt85 -52.5 163.87 0.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 11.7 mp0 -129.47 147.12 51.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.152 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -121.22 132.66 54.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.425 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.41 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 3.8 tt -145.16 101.58 3.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 27.0 mt -136.8 151.19 48.89 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 28.7 t0 -67.08 -143.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.534 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 71.1 tttt 74.33 -33.46 0.25 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.942 0.401 . . . . 0.0 110.565 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 153' ' ' ASP . 52.0 mtmt 53.53 18.81 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 157' ' ' TYR . 80.6 tt0 -148.61 135.97 20.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 22.4 m-85 -135.67 112.48 10.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.038 0.447 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.443 ' O ' ' OG ' ' A' ' 129' ' ' SER . 16.6 ptm180 -105.23 -28.29 11.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.719 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -117.59 154.74 50.82 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.539 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.0 Cg_endo -56.78 -18.64 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.38 2.054 . . . . 0.0 113.595 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.52 -2.35 9.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.88 -28.8 70.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.539 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.4 OUTLIER -105.06 21.9 16.26 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.43 28.56 71.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.804 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.484 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -108.13 137.48 46.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 118.153 0.977 . . . . 0.0 109.051 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -74.22 17.41 0.19 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.29 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 172.13 156.33 0.24 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.983 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.19 5.91 4.25 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.045 2.497 . . . . 0.0 111.733 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.84 70.59 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 0.0 110.746 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.64 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.2 t -98.71 -147.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.64 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.5 tp60 -160.14 -132.31 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.517 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.32 -155.31 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -177.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.613 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 26.9 p90 -170.05 -176.01 2.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -161.59 133.09 5.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.375 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -54.23 130.45 38.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.827 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.6 mt -63.48 138.59 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.632 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.36 159.25 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.299 179.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 5.1 p 45.21 69.7 0.42 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.687 0.28 . . . . 0.0 110.529 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt 66.19 -57.25 0.36 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 3.9 t -97.75 -132.8 0.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.526 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . 177.88 -91.38 0.08 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.8 p -82.11 161.09 22.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.755 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.5 tttt -162.29 155.25 20.03 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.106 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.5 tt -149.05 144.38 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.127 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -128.04 139.59 52.45 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.185 0.517 . . . . 0.0 110.508 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.36 117.66 28.33 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.989 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 62.9 m-85 -96.89 134.15 40.59 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 110.197 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.31 -44.83 92.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.439 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' O ' ' OG ' ' A' ' 39' ' ' SER . 90.6 m-20 -106.73 -173.45 2.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.972 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -83.64 -177.42 6.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 0.0 111.635 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 48.27 19.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.19 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.591 ' H ' ' HG ' ' A' ' 39' ' ' SER . 6.3 m-85 68.02 40.7 2.2 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.138 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.555 ' C ' ' H ' ' A' ' 19' ' ' ARG . 6.1 pt20 -122.78 -168.03 1.68 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.972 0.415 . . . . 0.0 111.535 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.28 -24.25 0.46 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.481 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.2 ttm180 162.34 -174.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.294 0.637 . . . . 0.0 110.33 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.93 157.99 6.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.416 ' CE1' ' CG ' ' A' ' 33' ' ' TYR . 62.7 t80 -138.84 135.39 34.5 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 91.9 m-20 -100.75 150.44 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -164.05 122.97 1.93 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 178.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -125.38 12.7 8.17 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.614 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.2 m -149.3 145.64 27.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.782 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -38.82 156.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 82' ' ' SER . 2.2 m -157.04 163.26 39.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.279 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.42 -56.74 2.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 39.5 p-10 -153.56 106.76 2.95 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.463 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -96.34 8.84 42.96 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 65.8 t60 -58.46 -27.46 64.42 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.455 0.645 . . . . 0.0 110.003 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.4 p -62.55 -29.12 70.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' CE1' ' A' ' 21' ' ' TYR . 85.1 m-85 -88.44 -14.8 37.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.923 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 31' ' ' HIS . 13.8 tp -141.64 136.89 31.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 t -95.52 -6.54 40.27 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.9 ttm-85 -160.77 152.03 19.1 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.597 ' HG ' ' N ' ' A' ' 80' ' ' LEU . 4.2 p -115.35 103.66 11.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.484 0.659 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.724 ' O ' ' O ' ' A' ' 39' ' ' SER . 80.3 m-20 -129.97 158.66 38.95 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.724 ' O ' ' O ' ' A' ' 38' ' ' ASN . 16.6 p 33.0 125.99 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.319 1.056 . . . . 0.0 112.734 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -139.54 144.68 28.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.355 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -152.21 102.52 2.78 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.939 -0.476 . . . . 0.0 110.211 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.51 150.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.667 0.746 . . . . 0.0 110.547 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -123.61 53.23 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.907 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.29 -93.25 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.582 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.93 -140.35 3.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.452 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 85.6 m -81.72 166.86 19.72 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.426 -0.455 . . . . 0.0 110.786 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.755 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.3 m95 -155.07 156.3 35.63 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.451 0.643 . . . . 0.0 110.782 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.72 122.84 46.71 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.23 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.41 132.01 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 0.0 110.712 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -103.1 111.36 23.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 42.6 tt0 -37.57 -36.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.177 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.484 HH21 ' H ' ' A' ' 57' ' ' GLY . 73.3 mtm180 -116.16 137.25 23.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.66 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 16.8 Cg_exo -58.88 159.63 20.66 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.269 1.313 . . . . 0.0 112.351 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 m120 86.1 -3.01 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.011 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.1 m-85 84.0 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.433 0.458 . . . . 0.0 110.819 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.45 24.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' H ' HH21 ' A' ' 52' ' ' ARG . . . 87.55 -156.77 28.24 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 6.7 m-85 -71.14 144.0 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.856 0.36 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.2 mtt -111.42 88.21 2.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.599 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 30.6 t80 -92.43 136.5 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.7 mp -102.02 89.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -68.15 111.43 7.85 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.44 164.26 16.74 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.98 1.786 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -52.86 124.56 14.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.087 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.68 -175.56 40.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.2 mt-10 -107.33 152.89 23.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.217 0.532 . . . . 0.0 110.284 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.549 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.6 m-85 -145.6 84.78 8.17 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.3 Cg_exo -58.07 -17.06 29.73 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.984 2.456 . . . . 0.0 112.77 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -150.91 162.02 41.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.678 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.3 p90 -61.61 -49.46 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.522 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -42.34 -13.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.2 mmt180 -75.25 -5.19 43.31 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.132 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.678 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.02 26.76 9.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 121.522 -0.071 . . . . 0.0 111.16 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 mmt 88.76 17.72 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.481 1.113 . . . . 0.0 110.935 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 34.24 55.85 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.44 -70.29 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -157.18 158.9 37.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.6 p-10 -85.87 55.95 3.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.796 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 10.8 tpt180 -138.1 115.9 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.597 ' N ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.49 128.75 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 82' ' ' SER . 5.8 p -110.25 -161.85 0.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.179 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.628 ' HG ' ' N ' ' A' ' 83' ' ' CYS . 7.0 t -45.45 -178.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.221 0.534 . . . . 0.0 110.708 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.628 ' N ' ' HG ' ' A' ' 82' ' ' SER . 15.4 p -150.01 150.3 31.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.723 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -115.97 126.65 54.13 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -60.61 127.71 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.327 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.3 t -124.53 131.34 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.935 0.398 . . . . 0.0 110.773 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -100.18 162.5 12.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.162 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.93 150.13 74.71 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.18 151.89 80.56 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.233 1.955 . . . . 0.0 112.124 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.9 t -157.24 172.46 18.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.431 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.23 -72.07 1.69 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.03 34.14 1.27 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.6 pt20 34.73 -109.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 t80 -154.29 113.03 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 47.0 tptt -154.59 136.0 14.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.127 0.489 . . . . 0.0 111.034 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.87 145.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.303 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.569 HE21 ' CA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -126.04 132.62 51.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.868 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.426 ' N ' HE21 ' A' ' 97' ' ' GLN . 6.3 mt -120.89 132.34 70.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.894 -177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -112.17 126.84 55.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.988 0.423 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.77 -24.03 61.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.412 ' HZ2' ' HA3' ' A' ' 106' ' ' GLY . 52.0 mttp -125.97 146.76 49.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.214 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -58.81 -168.55 0.2 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 4.5 p-10 42.58 29.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.603 ' H ' ' HG ' ' A' ' 129' ' ' SER . 21.8 m-85 54.38 81.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -158.15 166.42 32.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.058 0.456 . . . . 0.0 110.528 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.412 ' HA3' ' HZ2' ' A' ' 101' ' ' LYS . . . 85.73 -156.11 29.85 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.614 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -65.23 137.01 57.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.443 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 36.2 ttp -120.56 122.09 39.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.554 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 49.8 m-85 -118.13 133.23 56.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 120.07 35.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.4 t -146.92 127.84 14.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.52 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.459 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -95.68 40.96 1.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 111.142 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -141.11 178.38 7.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.526 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.474 ' CG ' HH12 ' A' ' 175' ' ' ARG . 24.6 p-10 -82.76 157.56 23.19 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.533 ' SG ' ' OG ' ' A' ' 172' ' ' SER . 49.7 t -134.4 122.34 15.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 172' ' ' SER . 63.9 Cg_endo -76.43 -57.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.488 1.459 . . . . 0.0 110.862 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.7 m -116.35 115.97 26.86 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.6 tt -70.2 -46.81 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 0.0 110.916 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.464 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.9 ttt -64.59 -20.8 66.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.293 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -72.98 -46.65 51.06 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.897 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.0 pt20 -102.43 -23.39 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.632 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.5 m-85 -111.96 -1.92 15.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.118 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 54.78 11.54 0.47 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.841 0.353 . . . . 0.0 111.018 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.2 mtt -79.77 132.69 36.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.19 -24.89 11.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.722 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 64.9 mt-10 -152.17 108.48 3.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.11 0.481 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.0 mm -75.16 125.44 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.674 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 76.0 m80 -105.16 -33.81 8.14 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.326 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.603 ' HG ' ' H ' ' A' ' 104' ' ' PHE . 16.1 p -155.38 151.09 27.47 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.656 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -144.77 157.13 44.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.818 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.3 mtpt -135.13 -178.98 5.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.48 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 t 54.7 80.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.602 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -98.92 165.89 11.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.5 mp0 -139.96 112.37 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.05 -88.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.1 t -120.01 155.07 22.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 109.998 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.4 t-105 -144.07 169.41 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.618 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 86.9 mt -144.84 123.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -109.84 129.69 55.61 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 22.5 m-85 -107.64 111.81 24.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.866 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -50.3 -22.29 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.48 160.09 41.24 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.441 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.1 Cg_endo -77.35 166.4 26.18 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.37 2.047 . . . . 0.0 111.762 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.666 ' ND2' HH21 ' A' ' 146' ' ' ARG . 2.1 m-80 74.13 15.3 3.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.507 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.0 m-85 76.39 25.53 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.608 0.242 . . . . 0.0 111.247 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.666 HH21 ' ND2' ' A' ' 144' ' ' ASN . 88.6 mtm180 -108.55 167.69 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.071 0.462 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.42 168.61 34.24 Favored Glycine 0 N--CA 1.463 0.48 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -59.03 142.28 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 46.2 mt-30 -97.64 147.89 23.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -118.62 137.46 53.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -153.54 105.46 2.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.456 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -151.05 116.53 5.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 152' ' ' LEU . 91.2 m-20 54.33 164.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -137.95 8.65 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.9 -53.12 43.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.068 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.401 ' CD ' ' CZ ' ' A' ' 104' ' ' PHE . 16.0 tt0 -177.94 166.28 2.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.234 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -133.79 107.3 7.81 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.697 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -105.09 -24.47 12.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -122.53 152.45 61.56 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.57 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.8 Cg_exo -49.9 -35.52 40.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.191 1.928 . . . . 0.0 112.998 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 161' ' ' ILE . 3.7 mp -86.66 -3.4 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.607 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -57.26 -29.89 64.2 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.07 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.57 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.1 p90 -105.23 21.27 17.42 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.43 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.18 61.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.574 -0.57 . . . . 0.0 114.24 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -107.23 137.09 45.95 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.459 1.13 . . . . 0.0 110.572 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.46 21.64 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.684 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 168.99 153.69 0.15 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.684 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.77 5.2 5.03 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.916 2.41 . . . . 0.0 112.044 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.51 71.36 6.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.896 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.5 t -99.55 -147.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.659 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.4 tp60 -159.31 -131.79 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.39 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.3 -156.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -170.21 -178.02 2.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.298 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.86 133.52 8.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.954 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.474 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.0 ptt-85 -51.91 130.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.68 131.66 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.252 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.24 134.68 60.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.438 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 30.9 tp10 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.513 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.0 p -75.21 166.09 24.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HG3' ' H ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -74.9 -57.12 4.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.453 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 81.5 p -147.47 144.1 28.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.487 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.12 121.15 18.04 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.7 p -80.81 164.3 22.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 110.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.676 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 45.5 tttt -159.2 153.29 23.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.122 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.407 ' CG2' ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -147.15 147.21 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 92.3 m -133.65 141.65 47.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.27 0.557 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -122.61 116.72 24.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.334 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 63.6 m-85 -95.89 137.02 35.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.267 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -45.08 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.3 m-20 -109.36 -173.35 2.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -82.8 -177.81 6.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.95 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.66 17.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.076 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 5.3 m-85 73.41 38.84 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.781 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.53 ' C ' ' H ' ' A' ' 19' ' ' ARG . 44.1 mt-30 -117.62 -168.45 1.5 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.893 0.378 . . . . 0.0 110.472 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 75.52 -29.01 1.24 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.215 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 19.3 ttt85 158.13 -167.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.729 0.9 . . . . 0.0 109.718 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.527 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -170.25 151.38 3.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.479 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 78.0 t80 -129.88 135.0 47.86 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.2 p-10 -102.21 144.29 30.94 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.076 -0.39 . . . . 0.0 110.989 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.479 ' SG ' ' CD2' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -166.61 122.74 1.22 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.785 178.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -121.14 20.97 11.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.21 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.35 149.66 29.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -40.9 157.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.471 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.14 160.42 40.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.197 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.99 -55.53 3.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.1 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 43.0 p-10 -155.43 100.62 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.219 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -86.8 9.12 20.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.414 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -59.74 -17.42 34.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.077 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -78.12 -1.15 31.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -117.15 -15.26 10.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 13.2 tp -143.1 139.96 30.67 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -98.28 -7.23 29.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.288 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.0 ttm-85 -159.42 148.27 18.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 80' ' ' LEU . 1.9 m -114.52 103.15 10.75 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.718 ' O ' ' O ' ' A' ' 39' ' ' SER . 97.3 m-20 -129.21 156.54 43.78 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.718 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.7 p 35.89 125.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.909 0.861 . . . . 0.0 112.168 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.592 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.9 mt -138.5 144.11 30.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.088 0 CA-C-O 121.614 0.721 . . . . 0.0 111.806 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -153.48 99.19 2.31 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 18.1 m -70.1 138.61 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.523 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -109.81 52.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.21 -99.33 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.165 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.68 -137.17 3.56 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.3 m -77.23 164.83 25.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 110.884 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.676 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.6 m95 -155.73 157.31 36.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.295 0.569 . . . . 0.0 110.596 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.77 120.37 38.36 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.021 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.66 132.85 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.245 0.545 . . . . 0.0 111.052 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' ARG . 90.5 m-85 -108.07 112.91 25.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 50' ' ' TYR . 42.2 tt0 -35.75 -32.65 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.715 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -121.0 148.3 48.48 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.313 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.662 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 7.7 Cg_exo -67.16 160.19 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.875 1.717 . . . . 0.0 112.123 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 85.46 -4.8 0.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.887 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 6.2 m-85 84.6 58.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.427 0.455 . . . . 0.0 111.055 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.85 168.55 19.95 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.518 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 148' ' ' ARG . . . 85.04 -163.73 38.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -64.17 131.11 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -105.74 127.75 53.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.467 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 23.0 t80 -134.75 140.1 45.67 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.7 mp -102.09 92.4 2.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -68.94 111.15 7.5 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.7 163.92 16.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.025 1.817 . . . . 0.0 112.946 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -50.06 125.53 12.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.138 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.83 -172.51 38.88 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.0 mt-10 -111.65 155.34 23.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.207 0.527 . . . . 0.0 110.126 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.5 m-85 -147.99 81.09 8.45 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 25.5 Cg_endo -61.32 -9.93 14.32 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.294 1.996 . . . . 0.0 112.862 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -149.95 161.18 42.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.749 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.0 p90 -64.98 -50.77 65.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.38 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.9 mt-30 -43.98 -10.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 70' ' ' TYR . 25.1 mmm180 -75.4 0.04 18.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.749 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -124.93 24.07 7.69 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 74' ' ' MET . 11.0 mmm 89.77 17.45 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.952 0.782 . . . . 0.0 111.947 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.72 63.09 0.19 Allowed Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.11 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 19.5 mt -93.69 17.61 11.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.959 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 52.3 t-20 111.99 150.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.206 1.566 . . . . 0.0 109.995 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 51.5 p-10 -83.58 69.93 10.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.23 118.9 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.097 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 0.3 OUTLIER -147.5 132.18 17.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.144 0.497 . . . . 0.0 110.157 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 82' ' ' SER . 8.9 p -107.68 -163.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.0 p -50.91 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.94 -0.475 . . . . 0.0 110.991 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.6 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 14.7 p -153.51 155.5 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -117.79 128.18 54.61 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.66 131.58 50.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.78 130.84 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -101.39 162.49 12.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.772 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.03 149.17 47.0 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.654 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.48 155.13 71.54 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 112.083 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -170.05 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.988 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.16 -56.38 5.26 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -115.92 59.24 0.44 Allowed Glycine 0 N--CA 1.464 0.567 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 33.73 -109.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.727 0.299 . . . . 0.0 111.247 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 32.3 t80 -152.93 113.87 4.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -154.59 135.27 13.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.104 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 146.08 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.165 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.3 mt-30 -124.82 129.04 49.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.935 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.5 mt -119.49 132.43 69.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.368 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 131' ' ' LYS . 39.3 m-85 -112.33 124.74 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.27 -19.9 38.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.778 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -131.09 144.09 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.869 0.366 . . . . 0.0 110.468 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -57.86 -171.08 0.23 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 2.8 p-10 45.25 29.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.72 0.295 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.537 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 14.3 m-85 54.89 81.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.878 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -158.98 163.61 36.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 110.806 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.57 -156.98 28.42 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -66.62 136.48 55.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 41.8 ttp -117.58 122.54 43.91 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.073 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.582 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.9 m-85 -114.97 129.99 56.83 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 110.991 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.99 121.43 37.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.068 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -151.88 130.99 12.67 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.469 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.2 t -97.85 50.79 1.04 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 111.085 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -147.8 -176.44 5.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -89.38 159.7 17.2 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.067 0.461 . . . . 0.0 110.202 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 172' ' ' SER . 45.7 t -137.48 124.81 13.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.754 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.509 ' O ' ' OG ' ' A' ' 172' ' ' SER . 59.4 Cg_endo -78.38 -61.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.662 1.575 . . . . 0.0 110.093 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -112.27 115.01 28.09 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.0 tt -69.16 -45.28 79.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 28.0 ttt -63.78 -23.69 67.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.685 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.7 -50.27 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.483 -0.761 . . . . 0.0 112.245 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.634 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.3 pt20 -97.56 -23.82 15.83 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.634 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 29.5 m-85 -112.3 0.54 15.75 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.55 0.214 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.6 m-70 54.0 2.52 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.088 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -70.53 131.92 44.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -106.83 -25.93 11.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.569 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.9 mt-10 -150.87 109.32 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 8.1 mm -76.26 126.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.67 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.9 m80 -106.41 -36.85 6.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.258 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.537 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 10.0 t -148.63 143.73 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.9 t -144.78 140.12 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 99' ' ' PHE . 35.1 mtmm -124.27 -171.95 2.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 36.3 t 54.34 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.516 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -100.38 166.64 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.199 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -137.35 112.84 9.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 37.79 -89.83 0.01 OUTLIER Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.5 t -117.48 152.19 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.5 t-105 -141.2 166.77 23.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.421 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 78.2 mt -144.02 124.06 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.74 129.47 56.11 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -106.34 113.4 26.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -53.83 -25.79 21.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.64 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.94 159.66 32.74 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-O 120.676 0.274 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 164.66 28.07 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.268 1.979 . . . . 0.0 111.383 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 5.3 m-80 75.57 15.99 2.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.2 m-85 76.6 29.75 0.66 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.098 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -116.41 170.49 8.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.912 0.387 . . . . 0.0 110.733 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.31 167.83 38.59 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' NH2' ' O ' ' A' ' 57' ' ' GLY . 80.2 ttt180 -47.95 152.0 0.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -113.15 127.8 56.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.648 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.2 144.69 26.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 3.0 tt -163.95 105.21 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 42.9 tp -126.71 134.56 50.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.843 0.354 . . . . 0.0 110.327 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.74 88.76 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.462 ' CG ' ' H ' ' A' ' 155' ' ' LYS . 14.0 tptp -124.8 -145.91 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.462 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 99.1 mttt -142.82 -9.1 0.81 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.481 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -175.26 162.36 2.94 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.676 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -129.11 109.31 11.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.109 0.481 . . . . 0.0 110.656 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.706 ' HE ' ' HZ3' ' A' ' 159' ' ' LYS . 40.8 ptt180 -108.42 -21.37 12.77 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.0 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.706 ' HZ3' ' HE ' ' A' ' 158' ' ' ARG . 14.3 pttm -123.87 154.54 67.48 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.286 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.502 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.9 Cg_endo -59.1 -19.97 51.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.386 2.057 . . . . 0.0 113.368 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.43 -5.98 9.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.923 0.392 . . . . 0.0 110.591 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.74 -32.89 63.78 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.44 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.502 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.9 OUTLIER -101.71 22.32 13.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.798 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 28.79 67.53 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.914 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.3 138.1 44.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.674 0.737 . . . . 0.0 110.124 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.85 24.3 0.23 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 165.82 154.21 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.496 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 170' ' ' VAL . 56.1 Cg_endo -72.82 -12.01 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.904 2.403 . . . . 0.0 111.398 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.68 69.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.329 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -101.33 -155.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.622 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 64.7 mm-40 -149.98 -130.95 0.05 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.4 p -95.28 -155.08 0.45 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -170.84 -178.75 2.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.282 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -156.1 129.95 8.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.479 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -52.65 129.21 28.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.587 0.708 . . . . 0.0 110.684 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.0 mt -61.66 129.05 24.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.289 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.28 153.28 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.206 179.716 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -142.76 -74.3 0.28 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.913 0.387 . . . . 0.0 110.468 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.78 50.93 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.865 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.433 ' HG1' ' H ' ' A' ' 5' ' ' GLY . 26.4 p -138.3 -49.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.46 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.433 ' H ' ' HG1' ' A' ' 4' ' ' THR . . . -119.74 132.31 9.4 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.8 p -83.63 158.62 21.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 110.273 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.697 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -156.67 148.53 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.1 tt -144.58 140.67 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.608 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -126.73 138.02 53.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.63 115.75 25.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.6 m-85 -96.41 138.53 33.87 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 110.939 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.4 tm-20 -61.43 -49.81 75.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.903 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -98.18 -177.29 3.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -176.74 6.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.164 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.25 25.11 0.33 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.856 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.458 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.1 m-85 60.83 42.72 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.08 166.75 10.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.831 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.27 -153.73 43.45 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.709 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.683 HH21 ' H ' ' A' ' 35' ' ' SER . 15.8 ttp180 -58.75 174.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.03 153.91 5.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.408 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.0 t80 -127.05 130.67 50.39 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 44.8 p-10 -118.68 121.73 40.83 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.9 0.381 . . . . 0.0 111.701 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.9 t -150.21 141.57 23.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.095 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -124.46 26.27 7.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.0 m -148.55 144.75 27.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.502 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -38.54 156.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.846 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 25.0 t -156.76 163.05 39.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.145 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.87 -56.63 2.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.561 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.96 111.57 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -101.85 7.67 41.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 82.6 t60 -58.44 -27.18 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -62.63 -29.81 70.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.426 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.02 -15.36 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.574 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.5 tp -142.83 137.48 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.07 0.462 . . . . 0.0 110.067 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.683 ' H ' HH21 ' A' ' 19' ' ' ARG . 49.9 m -98.9 -9.23 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 56.0 ttm-85 -154.79 143.04 20.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.307 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' HG ' ' N ' ' A' ' 80' ' ' LEU . 5.2 p -109.37 103.62 12.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.732 ' O ' ' O ' ' A' ' 39' ' ' SER . 62.8 m-20 -128.08 156.26 43.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.732 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.9 p 35.05 129.43 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.745 1.259 . . . . 0.0 112.519 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.2 mt -142.55 147.52 20.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.023 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -156.48 100.81 1.98 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.35 139.57 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.292 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -110.13 56.43 0.63 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.268 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.08 -92.84 0.09 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.702 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 -139.11 3.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 43.0 m -80.48 164.9 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.697 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 34.0 m95 -152.94 154.12 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.105 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.18 118.76 35.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.46 132.86 67.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.555 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ARG . 88.2 m-85 -105.59 113.93 27.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 79.5 tt0 -30.01 -33.95 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.285 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' TYR . 21.1 mtt180 -127.15 162.67 46.66 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.279 0.362 . . . . 0.0 110.781 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 5.3 Cg_exo -73.9 170.63 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.533 2.155 . . . . 0.0 112.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.7 m120 79.26 -11.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.697 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.1 m-85 83.43 51.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.674 0.609 . . . . 0.0 110.43 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.84 114.94 5.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.614 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 133.08 113.23 1.41 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.572 ' O ' ' O ' ' A' ' 57' ' ' GLY . 28.2 m-85 41.52 -178.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.133 0.492 . . . . 0.0 110.69 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 3.7 mtm -154.28 113.15 3.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -130.1 131.41 45.71 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.55 94.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -69.2 109.57 4.65 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 123.312 0.383 . . . . 0.0 110.048 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.23 160.83 17.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.15 1.9 . . . . 0.0 113.324 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.81 117.8 1.8 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.291 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.47 -179.29 41.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -106.09 155.82 19.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.085 0.469 . . . . 0.0 110.29 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.9 m-85 -146.7 84.53 7.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 32.0 Cg_exo -57.6 -16.87 25.95 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.174 2.583 . . . . 0.0 112.887 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -149.8 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.706 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.3 p90 -63.59 -51.88 63.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 19.6 mt-30 -43.54 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.1 mmm180 -75.86 -5.58 46.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.706 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.77 23.94 11.37 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.592 -0.067 . . . . 0.0 111.026 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.4 ' O ' ' C ' ' A' ' 75' ' ' GLY . 34.5 mmt 87.41 25.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.45 1.094 . . . . 0.0 110.97 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.11 50.69 0.36 Allowed Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.8 mt -77.45 14.24 1.03 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 118.982 -0.533 . . . . 0.0 111.438 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.9 t30 110.46 164.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.8 1.312 . . . . 0.0 109.252 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.0 p-10 -96.59 64.08 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 36.5 ttm180 -141.63 117.21 10.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.943 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' N ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.74 129.65 20.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 82' ' ' SER . 53.2 p -112.22 -161.95 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.661 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.9 p -45.99 -178.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.212 0.53 . . . . 0.0 110.642 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 11.8 p -154.3 159.73 41.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.72 131.07 53.49 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.72 127.43 31.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.9 t -126.43 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -101.29 157.41 16.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.0 157.18 69.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.522 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.46 156.04 40.89 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.661 2.241 . . . . 0.0 112.085 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 p -173.14 -18.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.21 -34.11 89.07 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -130.58 58.14 0.71 Allowed Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.6 pt20 33.42 -107.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.73 0.3 . . . . 0.0 110.835 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.749 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.3 t80 -159.14 113.3 2.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.197 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 132' ' ' VAL . 16.7 tptm -152.37 133.75 14.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.3 tt -134.88 142.34 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.749 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.2 mt-30 -120.92 129.08 53.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 108' ' ' MET . 13.8 mt -119.13 130.92 73.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.181 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.0 m-85 -111.52 128.1 55.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.837 0.351 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 84.4 tt0 -60.78 -27.65 68.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.918 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -118.33 146.9 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.929 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.74 172.22 20.01 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.01 31.14 19.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 10.2 m-85 55.14 80.99 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.246 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -160.25 162.61 33.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 -153.01 23.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -70.04 136.16 50.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -121.33 125.51 47.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.4 m-85 -117.11 134.91 54.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.089 0.471 . . . . 0.0 110.657 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -122.16 119.7 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.488 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 111' ' ' THR . 4.5 t -147.0 125.66 12.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -91.06 41.89 1.08 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.019 0.438 . . . . 0.0 111.041 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.07 179.77 6.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 17.1 p-10 -83.95 160.13 21.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.963 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 172' ' ' SER . 40.9 t -134.55 121.31 15.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.194 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.13 -53.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.659 1.573 . . . . 0.0 110.873 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -119.71 111.54 18.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.4 tt -67.36 -44.33 87.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 0.0 110.875 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.8 ttt -66.99 -21.99 65.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -73.01 -48.33 37.28 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.662 -0.649 . . . . 0.0 112.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.2 pt20 -99.16 -24.86 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.631 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 40.2 m-85 -111.58 2.39 17.33 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.992 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.0 m-70 51.41 11.91 0.13 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.132 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.442 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.0 mmt -79.44 135.29 36.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.582 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -110.57 -26.85 9.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.087 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 52.1 mt-10 -150.5 107.11 3.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.033 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.6 mm -77.78 125.11 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.6 m80 -104.81 -30.12 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.135 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 18.6 t -156.54 152.01 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.441 . . . . 0.0 110.957 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -146.58 150.8 36.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.992 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.95 -172.01 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.681 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LYS . 61.5 t 47.49 77.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.381 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.8 mt -101.28 172.29 7.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.183 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.8 mp0 -136.94 114.18 10.78 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.88 -91.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 134' ' ' GLU . 31.7 t -119.18 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -122.15 170.31 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.237 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.437 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 62.5 mt -145.8 125.17 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.462 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.88 131.66 55.22 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.81 112.92 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.571 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' VAL . 75.7 tt0 -50.25 -27.24 5.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.723 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.39 166.15 11.57 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.35 164.95 11.03 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.022 1.815 . . . . 0.0 111.37 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.562 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 75.02 16.79 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.47 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.9 m-85 77.0 26.52 0.75 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.091 0.245 . . . . 0.0 111.278 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -107.57 166.32 10.76 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.927 0.394 . . . . 0.0 110.533 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 96.6 170.65 34.41 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -67.3 146.38 54.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 2.5 mp0 -94.23 148.33 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.456 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -112.61 131.21 55.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.953 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' O ' ' SD ' ' A' ' 59' ' ' MET . 58.1 tp -149.01 99.23 2.94 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.048 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.9 153.22 33.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.634 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.1 t70 76.63 164.15 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.405 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.54 -77.81 0.05 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -161.85 67.77 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.208 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -172.79 132.96 0.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.158 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.415 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.9 m-85 -133.85 109.37 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.434 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -106.03 -26.13 11.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -120.14 153.82 55.62 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.5 Cg_endo -58.91 -15.19 25.92 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.478 2.119 . . . . 0.0 113.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.05 -3.98 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.037 0.446 . . . . 0.0 110.491 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -28.27 66.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.464 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -106.16 22.79 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.1 70.54 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.523 -0.599 . . . . 0.0 114.014 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.44 140.45 41.73 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.19 0.995 . . . . 0.0 109.723 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.46 21.23 0.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 170.49 154.33 0.19 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.388 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 170' ' ' VAL . 41.1 Cg_endo -68.51 -35.0 18.58 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.489 2.126 . . . . 0.0 111.596 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -51.25 83.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 171' ' ' GLN . 1.4 p -102.54 -97.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.465 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.58 ' N ' ' CG2' ' A' ' 170' ' ' VAL . 0.5 OUTLIER 161.89 -143.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.096 0.872 . . . . 0.0 109.345 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 3.7 p -90.95 -156.0 0.42 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -169.51 -177.96 2.93 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.31 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -159.97 132.27 6.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -51.95 136.09 29.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.749 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.81 135.68 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.825 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.14 158.77 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.484 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m 45.96 -166.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 110.349 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' THR . 5.5 mtpm? -108.64 -48.01 3.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 3' ' ' LYS . 80.9 p 50.04 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.984 0.421 . . . . 0.0 110.502 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.3 -40.55 2.57 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.4 p -138.59 127.93 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.698 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 38.9 tttt -162.05 152.44 17.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -145.66 144.69 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.552 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 17.8 m -131.61 140.47 49.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 110.387 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -121.07 116.21 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.478 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.473 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 68.0 m-85 -94.15 137.68 33.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -58.51 -48.21 81.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.5 m-20 -107.14 -172.81 2.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.158 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -178.95 7.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.88 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.55 21.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.502 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.502 ' H ' ' HG ' ' A' ' 39' ' ' SER . 4.7 m-85 68.41 39.45 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.553 ' C ' ' H ' ' A' ' 19' ' ' ARG . 34.6 mt-30 -117.15 -167.45 1.31 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.04 0.447 . . . . 0.0 110.621 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 73.22 -26.74 0.83 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.058 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 17' ' ' GLN . 23.3 ttm-85 158.87 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.457 0.74 . . . . 0.0 109.661 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -172.33 152.17 2.69 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -129.49 133.26 47.18 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 45.8 p-10 -118.0 125.43 50.36 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 t -161.32 139.0 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -126.49 30.72 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 26' ' ' ASP . 3.9 t -147.13 142.29 27.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.775 0.322 . . . . 0.0 110.573 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' CYS . 54.4 p-10 -38.79 157.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.4 m -158.05 163.73 37.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.001 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.63 2.93 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.64 105.19 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.09 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.443 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -94.0 10.63 32.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.969 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.2 t60 -57.35 -25.43 59.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.599 . . . . 0.0 109.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -31.54 72.78 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.505 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.9 -18.33 40.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 12.4 tp -141.0 135.68 31.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 110.411 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -93.85 -10.37 34.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.583 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 23.7 ttm180 -157.53 146.2 19.48 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.7 m -110.78 104.2 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.074 0.464 . . . . 0.0 111.088 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.75 ' O ' ' O ' ' A' ' 39' ' ' SER . 96.7 m-20 -130.38 158.22 40.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.1 p 35.79 128.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.63 0 O-C-N 124.426 1.079 . . . . 0.0 111.825 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.8 mt -140.73 146.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-O 121.785 0.803 . . . . 0.0 112.08 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -156.18 99.73 1.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.447 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.67 141.41 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.311 0.577 . . . . 0.0 110.873 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -111.88 53.78 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.31 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.73 -93.9 0.1 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.29 -137.21 3.26 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 m -77.72 163.04 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.698 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 31.7 m95 -153.97 155.15 35.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.03 119.11 35.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.45 131.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.503 . . . . 0.0 110.85 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CZ ' ' CE ' ' A' ' 59' ' ' MET . 87.4 m-85 -103.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.702 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -37.53 -35.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.915 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -116.81 148.37 41.93 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.9 Cg_endo -67.94 162.61 39.04 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.755 2.303 . . . . 0.0 111.411 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 4.4 m-80 82.58 -5.11 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.287 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 15.4 m-85 85.59 57.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 176.67 9.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.24 -162.6 44.25 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -63.44 137.32 58.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.458 ' CE ' ' CZ ' ' A' ' 50' ' ' TYR . 1.8 tpt -112.24 130.01 56.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.128 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -136.15 139.73 43.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.701 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -103.04 91.77 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.36 111.28 8.21 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 123.219 0.325 . . . . 0.0 110.183 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.93 160.61 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.167 1.912 . . . . 0.0 113.089 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.46 122.4 4.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.037 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.07 -174.68 40.21 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.9 mt-10 -111.37 158.53 18.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.186 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 34.0 m-85 -151.81 85.7 4.73 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.934 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 33.9 Cg_exo -57.43 -14.67 16.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.787 2.324 . . . . 0.0 112.598 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.2 mt-10 -151.3 162.25 41.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 23.6 p90 -65.48 -53.12 47.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.5 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.624 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.5 pt20 -40.44 -14.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.102 0.477 . . . . 0.0 112.051 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -74.13 -2.31 24.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.276 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -119.85 23.65 10.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.3 mmt 90.37 24.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.445 1.091 . . . . 0.0 112.059 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.61 54.34 0.24 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.787 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 49.8 mt -87.01 12.8 10.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 49.0 t30 91.15 137.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.932 0.77 . . . . 0.0 110.004 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.674 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.7 p-10 -39.37 -96.08 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.658 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.674 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 8.5 tpp85 29.43 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.431 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.528 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -138.7 128.12 24.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.055 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.6 p -110.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.8 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.4 p -46.31 -178.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.506 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.9 p -152.05 155.81 38.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.459 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -118.82 128.1 54.15 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.84 128.4 36.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.539 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.29 129.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.87 159.24 15.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.825 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mt -78.5 148.95 74.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.531 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.03 153.22 75.6 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 p -157.0 171.77 19.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.516 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.41 -72.28 1.72 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -75.91 34.29 1.24 Allowed Glycine 0 C--O 1.225 -0.424 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.488 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.2 pt20 34.22 -109.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 42.1 t80 -155.37 113.44 3.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.195 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 2.9 tppm? -156.2 137.31 13.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.85 145.51 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.003 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mt-30 -121.65 130.94 53.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.146 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 108' ' ' MET . 7.9 mt -120.09 130.09 74.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.387 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 45.4 m-85 -110.92 129.83 55.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.751 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -62.58 -25.57 68.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -123.93 145.02 49.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.613 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.99 179.15 4.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 55.84 30.82 16.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 15.8 m-85 54.21 80.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.033 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.5 m -160.39 161.27 33.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.19 25.41 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -67.65 136.71 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.674 0.274 . . . . 0.0 110.778 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.411 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 40.0 ttp -121.63 128.21 51.68 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.622 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 43.4 m-85 -122.84 137.22 54.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.7 127.17 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.602 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.6 t -148.76 129.64 14.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.5 p -93.63 38.18 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.3 179.66 6.95 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -85.02 160.47 20.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.605 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 41.6 t -134.98 125.34 17.12 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' OG ' ' A' ' 172' ' ' SER . 64.7 Cg_endo -80.25 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.938 1.759 . . . . 0.0 111.287 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.609 ' CA ' ' HG ' ' A' ' 172' ' ' SER . 55.6 m -116.5 110.15 18.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.553 ' N ' ' OG ' ' A' ' 172' ' ' SER . 5.1 tt -68.49 -42.44 83.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.079 0.466 . . . . 0.0 111.003 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.7 ttt -67.43 -17.9 64.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.727 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -81.87 -42.54 19.44 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.462 -0.774 . . . . 0.0 111.723 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.652 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -94.24 -30.61 14.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.762 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.64 1.15 13.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.691 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 54.55 13.43 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.791 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.4 mmt -77.53 131.15 37.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -105.14 -29.14 10.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 74.1 mt-10 -151.11 109.08 3.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.187 0.518 . . . . 0.0 110.585 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 7.6 mm -74.6 125.71 34.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.821 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -106.87 -32.9 7.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.803 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.6 t -152.29 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 111.054 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.36 131.8 14.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.75 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -111.33 -169.04 1.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.234 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.4 t 52.61 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.674 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.4 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 4.4 mm? -110.26 164.24 12.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 136' ' ' VAL . 5.9 mp0 -138.34 110.41 7.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.831 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.52 -86.33 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 134' ' ' GLU . 11.6 t -125.74 155.95 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.734 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.4 t-105 -142.67 170.58 15.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 73.5 mt -145.87 125.37 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.401 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -111.01 131.43 55.05 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.61 110.97 22.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.513 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 70.3 tt0 -49.9 -23.48 1.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.909 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.69 160.57 37.85 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 65.6 Cg_endo -77.79 168.01 22.99 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.54 2.16 . . . . 0.0 111.788 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.601 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 6.7 m-80 70.08 17.61 7.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.5 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.7 m-85 76.23 24.55 1.11 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.653 0.263 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.601 ' NH2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mtm-85 -105.98 162.73 13.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 100.09 164.21 28.77 Favored Glycine 0 N--CA 1.461 0.365 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 18.7 ptt-85 -60.51 138.24 58.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.308 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.555 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 3.7 mp0 -88.12 150.97 23.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.366 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -117.94 134.92 54.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.347 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.404 ' CD2' ' C ' ' A' ' 151' ' ' LEU . 3.2 tt -152.17 107.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.096 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 50.1 tp -131.22 139.78 49.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.263 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -65.93 115.32 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -169.46 179.31 3.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.193 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -134.39 4.67 3.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.378 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.51 150.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.271 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.471 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.6 m-85 -125.89 106.74 9.87 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -105.56 -21.36 13.22 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -124.45 153.07 69.24 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.587 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 22.9 Cg_exo -52.89 -30.52 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.514 1.476 . . . . 0.0 113.523 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.4 mp -89.23 -4.72 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 111.033 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -57.04 -27.44 61.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.162 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.587 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -108.66 21.21 17.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.752 0.31 . . . . 0.0 110.451 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.53 60.64 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.645 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -111.42 136.03 51.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.817 0.809 . . . . 0.0 109.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.39 22.12 0.13 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 169.53 155.18 0.18 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.046 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 69.3 Cg_endo -77.39 4.2 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.651 2.234 . . . . 0.0 112.141 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.14 72.71 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.022 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.667 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.4 t -100.83 -147.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.667 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.6 tp60 -159.91 -132.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.796 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.609 ' HG ' ' CA ' ' A' ' 117' ' ' SER . 1.2 m -92.27 -155.01 0.4 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.6 -177.48 2.37 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.033 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.67 132.22 7.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.92 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -51.37 132.2 29.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.429 0.633 . . . . 0.0 110.956 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -66.57 133.89 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.608 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -138.16 159.31 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.967 0.413 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.517 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 4' ' ' THR . 4.3 m 59.43 128.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 70.34 -30.16 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.55 ' H ' ' C ' ' A' ' 2' ' ' SER . 22.5 p -110.35 113.66 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.931 0.396 . . . . 0.0 110.518 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 4' ' ' THR . . . 57.12 158.06 0.01 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.477 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 11.2 p -81.65 157.6 24.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.381 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.662 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.4 tttt -159.67 150.57 19.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.9 tt -144.88 141.61 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.362 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 m -127.49 139.02 53.07 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.83 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.72 115.7 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -96.28 138.73 33.45 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.079 0.466 . . . . 0.0 110.474 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -61.4 -51.09 70.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.851 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.29 -175.32 3.19 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.253 0.549 . . . . 0.0 110.219 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.97 -175.29 5.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.619 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.7 m120 46.7 23.12 0.22 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.01 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.5 m-85 59.78 44.6 13.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.332 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -116.41 162.05 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.13 0.491 . . . . 0.0 110.495 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.95 -150.87 31.2 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.554 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 170.64 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.18 155.11 6.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.406 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.0 t80 -134.74 134.53 41.09 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 51.8 p-10 -102.08 151.73 21.82 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.524 0.202 . . . . 0.0 110.49 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.8 124.6 2.24 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.673 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.06 12.99 9.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 t -150.54 146.96 26.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.669 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -38.63 157.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.678 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 18.3 t -157.69 164.61 36.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.145 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.34 -56.96 2.75 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -153.3 110.95 3.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.33 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 2.0 p90 -100.55 8.47 43.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.067 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.1 t60 -59.35 -28.76 67.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.527 0.68 . . . . 0.0 110.168 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.0 p -60.69 -28.32 68.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.375 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -89.89 -12.97 37.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.539 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -143.33 138.24 29.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.975 0.417 . . . . 0.0 109.969 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.6 m -100.43 -9.49 22.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 51.3 ttm-85 -153.74 141.11 19.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.469 . . . . 0.0 110.45 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.1 m -111.52 106.15 14.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.76 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' O ' ' C ' ' A' ' 39' ' ' SER . 41.1 m-20 -117.91 -155.68 0.61 Allowed 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' ASN . 12.7 p -19.59 138.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.741 0.65 . . . . 0.0 112.476 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 8.8 mt -142.69 147.19 21.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.963 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.63 101.14 1.98 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.921 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.08 142.17 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 2' ' ' SER . 94.8 mt-10 -111.22 52.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.47 0.1 OUTLIER Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.753 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.86 -140.07 3.91 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 93.8 m -77.9 165.18 24.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 110.859 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.662 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.0 m95 -154.87 155.76 34.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.956 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.75 121.52 41.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 59' ' ' MET . 6.0 m -117.14 132.53 66.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.516 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' GLU . 52.4 m-85 -103.59 110.8 22.99 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.317 0.386 . . . . 0.0 110.897 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' TYR . 80.1 tt0 -35.37 -37.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.137 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -119.02 150.69 49.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.438 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 52.6 Cg_endo -68.12 161.49 44.19 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.684 2.256 . . . . 0.0 111.567 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.5 m120 83.64 -7.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.991 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.5 m-85 85.53 58.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.5 0.5 . . . . 0.0 111.254 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.25 179.76 7.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.135 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.07 -69.77 1.57 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.371 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 58' ' ' TYR . 0.6 OUTLIER 169.2 121.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -110.93 136.99 49.12 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.331 0.586 . . . . 0.0 111.929 -178.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -116.43 159.62 21.74 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.85 91.19 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -71.56 110.33 7.36 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.95 161.01 21.03 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.099 1.866 . . . . 0.0 113.851 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -47.24 119.78 2.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.912 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.13 -176.26 41.49 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -109.15 157.74 18.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.835 0.35 . . . . 0.0 110.159 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 48.4 m-85 -147.81 91.99 4.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 41.3 Cg_endo -66.69 -11.38 31.66 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.234 1.956 . . . . 0.0 113.269 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.6 mt-10 -151.35 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 36.3 p90 -63.9 -53.05 56.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -44.98 -9.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 70' ' ' TYR . 2.0 tpt180 -75.09 -3.98 35.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.1 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.73 24.07 10.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.7 mmt 86.84 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.438 1.086 . . . . 0.0 111.212 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.24 48.2 0.2 Allowed Glycine 0 N--CA 1.473 1.155 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.16 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 18.3 mt -71.66 13.36 0.27 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 119.073 -0.489 . . . . 0.0 111.078 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.6 t30 107.63 164.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.779 1.299 . . . . 0.0 109.363 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -94.92 62.03 2.58 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.35 115.62 11.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.41 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.26 128.66 21.19 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' SER . 2.4 p -110.28 -163.5 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 3.4 t -45.42 -178.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.34 0.591 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.625 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 10.7 p -151.82 155.5 38.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.558 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -121.7 129.97 53.12 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.72 126.87 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.296 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.77 131.08 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -100.13 157.75 16.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -84.27 153.37 62.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.417 ' O ' ' OG ' ' A' ' 90' ' ' SER . 73.1 Cg_endo -74.03 157.84 46.44 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.517 2.144 . . . . 0.0 112.146 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 89' ' ' PRO . 4.9 m -175.58 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.958 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.19 51.15 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.639 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -111.24 54.49 0.54 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLY . 6.5 pt20 33.67 -109.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.763 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 26.1 t80 -158.05 114.16 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 110.295 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -153.79 132.56 12.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -135.87 145.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.052 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.1 mt-30 -122.66 131.0 53.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.504 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 108' ' ' MET . 11.8 mt -119.58 130.57 73.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.998 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 46.8 m-85 -112.1 128.88 56.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.883 0.373 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.98 -28.23 68.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -120.37 148.36 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.991 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.47 -169.07 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t0 43.63 30.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 53.97 83.26 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.5 m -160.57 163.72 32.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 0.0 110.753 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.66 -152.09 22.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.709 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -71.76 136.59 47.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 0.0 110.429 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 39.1 ttp -120.5 124.62 45.84 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.781 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 48.8 m-85 -116.0 133.6 55.85 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.13 0.491 . . . . 0.0 110.473 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -122.16 121.61 37.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.9 t -147.41 126.94 13.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -93.92 41.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -141.66 -178.46 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.566 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.8 p-10 -84.96 157.69 20.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 70.0 m -134.91 121.06 14.52 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.165 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 60.5 Cg_endo -77.95 -56.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.05 1.833 . . . . 0.0 110.936 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.4 m -116.73 112.8 21.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.3 tt -68.82 -45.05 81.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.403 0.621 . . . . 0.0 110.634 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.465 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -65.71 -21.65 66.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.299 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -73.97 -47.38 37.74 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.275 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.6 pt20 -98.1 -24.8 15.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.1 m-85 -112.53 2.91 16.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.121 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.6 m-70 51.3 10.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.891 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.474 ' H ' ' C ' ' A' ' 122' ' ' PHE . 3.4 mmt -75.72 133.02 40.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -106.27 -30.56 9.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.787 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 29.7 mt-10 -150.58 108.76 3.75 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.089 0.471 . . . . 0.0 111.153 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.37 125.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.586 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.5 m80 -106.31 -32.13 8.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.941 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 17.0 m -154.97 150.28 27.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.116 0.484 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.14 153.63 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.759 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.9 mtpt -131.46 -177.33 4.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.561 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 t 54.04 98.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.21 164.44 12.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.566 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -138.92 111.64 7.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.218 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.56 -87.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.3 t -121.95 157.05 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -143.73 168.21 20.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.16 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.9 mt -144.91 122.84 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.186 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.62 131.72 54.8 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 32.9 m-85 -109.51 112.03 23.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.119 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -50.56 -23.79 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.5 mp -117.38 164.95 17.02 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 94.3 Cg_endo -82.94 167.95 14.06 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.38 2.054 . . . . 0.0 112.194 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.493 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.5 m-80 77.65 15.75 1.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.098 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.493 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.37 29.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.694 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 96.8 mtt180 -135.57 128.43 31.24 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.1 171.98 21.63 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.38 108.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.455 ' CG ' ' CE1' ' A' ' 140' ' ' TYR . 71.6 mt-30 -75.44 147.72 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.963 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.59 164.54 12.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.38 146.78 41.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 152' ' ' LEU . 3.4 mm? -64.3 151.49 43.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.467 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -127.18 -145.7 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.016 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -73.6 -107.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.737 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -56.95 -161.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 157' ' ' TYR . 9.9 pm0 -78.84 -118.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.741 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 5.2 m-85 -150.42 107.15 3.53 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.013 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 129' ' ' SER . 4.2 ptp180 -102.18 -25.58 13.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.077 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.46 50.04 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.03 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.557 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 21.4 Cg_endo -62.8 -17.29 58.59 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.856 2.371 . . . . 0.0 113.235 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.2 mp -101.36 -4.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.171 0.51 . . . . 0.0 110.761 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.45 -28.59 67.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.767 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.557 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -104.97 22.94 14.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.189 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.37 28.72 67.34 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.938 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.486 ' HB1' ' HE1' ' A' ' 163' ' ' TRP . . . -110.88 139.58 46.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.024 0.912 . . . . 0.0 109.795 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.08 22.3 0.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 174.01 152.72 0.26 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.728 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.78 5.45 4.36 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.746 2.297 . . . . 0.0 111.542 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.5 70.23 5.92 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.591 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.5 t -98.91 -153.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.591 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 78.3 mm-40 -152.74 -132.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.705 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -94.22 -155.1 0.44 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -171.17 -176.01 1.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.21 0.528 . . . . 0.0 111.22 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -158.96 132.32 7.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.936 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -52.99 134.48 37.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.5 mt -67.92 133.71 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.466 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.03 156.6 28.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.452 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.7 tp10 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.356 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 3' ' ' LYS . 6.6 p -79.48 176.58 9.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 2' ' ' SER . 17.3 ptmt -34.54 -45.84 0.25 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 t -62.09 -173.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.422 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.22 80.18 0.05 OUTLIER Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.1 p -84.39 159.35 20.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.748 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.2 tttt -160.26 151.8 19.71 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.008 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -147.23 141.67 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 97.7 m -123.95 138.21 54.5 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.718 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -118.77 115.78 25.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.2 m-85 -94.87 138.31 32.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.231 0.539 . . . . 0.0 110.986 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 7.7 tm-20 -60.44 -49.96 75.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.946 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 45.3 m-20 -99.33 -176.02 3.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.241 0.543 . . . . 0.0 109.773 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -83.19 -176.84 6.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.32 24.3 0.27 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.807 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 62.75 41.53 8.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.176 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.41 173.63 6.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.26 -155.99 53.51 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.682 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -54.65 174.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -169.34 149.92 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 59.4 t80 -132.75 133.15 43.09 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 40.2 p-10 -119.87 132.5 55.58 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.569 0.223 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 140.97 30.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -125.0 15.88 8.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.669 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 26' ' ' ASP . 11.2 m -148.94 145.8 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 43.0 t0 -37.29 155.72 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.542 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 m -155.95 162.03 40.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.98 -56.53 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.802 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -154.18 110.75 3.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.411 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.5 p90 -101.42 9.79 41.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.0 t60 -59.76 -28.57 67.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.694 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.4 p -61.16 -29.12 69.6 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.433 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -88.76 -12.56 41.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.663 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -142.21 136.65 30.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -96.84 -10.73 25.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.702 0.287 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.618 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 59.9 ttp180 -157.05 145.71 19.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.471 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -110.65 104.35 13.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.733 ' O ' ' O ' ' A' ' 39' ' ' SER . 95.3 m-20 -128.57 155.9 44.19 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.733 ' O ' ' O ' ' A' ' 38' ' ' ASN . 24.4 p 35.73 130.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.642 1.21 . . . . 0.0 112.568 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.4 mt -142.15 146.29 22.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.93 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.7 ptpt -154.41 102.55 2.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.008 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.508 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.9 t -66.33 149.08 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.291 0.567 . . . . 0.0 110.552 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.31 50.21 1.41 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.682 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.21 -95.48 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.112 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.56 -140.36 4.04 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 93.2 m -80.93 166.54 20.76 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.433 -0.451 . . . . 0.0 110.89 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.748 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.4 m95 -154.71 156.65 36.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.19 120.97 40.7 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.62 132.28 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -104.35 110.16 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -37.59 -34.49 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -115.91 148.41 41.24 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.883 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.1 Cg_endo -68.54 159.77 52.1 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.465 2.11 . . . . 0.0 111.915 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.3 m-80 85.17 -5.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.835 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 11.7 m-85 85.99 60.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.649 0.593 . . . . 0.0 111.001 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.63 177.72 9.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 81.62 -163.31 44.16 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.88 122.2 17.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.4 mpt? -98.3 136.69 38.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.249 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 25.9 t80 -139.74 142.49 36.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.5 mp -102.91 91.37 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.06 111.72 11.76 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.67 162.29 19.01 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.143 1.895 . . . . 0.0 112.661 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.41 117.36 2.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.024 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.34 41.01 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.5 mt-10 -101.2 153.58 19.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 24.2 m-85 -146.5 86.21 6.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.92 -18.47 16.69 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.857 2.371 . . . . 0.0 112.906 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -152.41 162.47 41.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.654 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 6.1 p90 -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -41.21 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.1 mmt180 -75.77 -5.49 46.04 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -117.61 25.27 10.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 119.698 -0.191 . . . . 0.0 111.362 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.4 mmt 89.79 23.59 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.455 1.097 . . . . 0.0 111.636 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.41 59.11 0.23 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.294 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 38.8 mt -94.69 13.92 22.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 91.91 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.227 0.954 . . . . 0.0 110.599 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.671 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 35.8 p-10 -37.85 -95.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.425 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.671 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.1 tpt180 30.11 93.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.358 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -139.51 128.03 22.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.0 p -111.04 -162.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.135 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.1 p -45.25 -179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.653 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.622 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 18.6 p -149.04 148.76 30.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.26 126.33 55.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.09 124.25 20.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.151 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.9 t -120.21 129.0 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.897 0.379 . . . . 0.0 110.444 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -97.5 160.31 14.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.16 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.15 149.95 70.49 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.648 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.23 150.93 77.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.32 2.013 . . . . 0.0 112.124 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -155.27 169.65 23.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.15 -70.28 1.85 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -74.39 30.71 0.99 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' A' ' 91' ' ' GLY . 4.7 pt20 34.82 -106.19 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.665 0.269 . . . . 0.0 111.169 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.743 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.1 t80 -157.94 113.31 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -153.56 134.01 13.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.021 0.438 . . . . 0.0 111.354 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.421 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.59 145.74 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.0 mt-30 -124.32 129.76 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.233 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 108' ' ' MET . 10.4 mt -118.7 132.83 67.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.03 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.15 133.89 55.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.258 0.552 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -30.16 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.72 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -119.61 148.65 43.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.225 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.07 174.55 15.67 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.4 t0 57.77 30.76 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.002 0.43 . . . . 0.0 110.441 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 156' ' ' GLU . 5.4 m-85 55.87 82.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -160.12 161.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.556 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.03 -150.99 22.55 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.11 136.04 39.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.654 0.264 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.8 tmm? -122.1 133.38 54.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -123.68 137.71 54.66 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.239 0.542 . . . . 0.0 110.618 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.3 125.28 44.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.1 t -147.9 128.25 13.93 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.705 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -90.29 41.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -146.65 -178.14 6.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.6 p-10 -86.36 162.16 18.33 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.584 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 84.5 m -138.79 122.81 11.32 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.01 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.188 1.925 . . . . 0.0 111.678 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -121.09 109.28 14.83 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.1 tt -64.28 -38.09 81.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.625 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 24.0 ttt -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.56 -44.32 17.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.604 -0.685 . . . . 0.0 111.678 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.584 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -90.93 -32.88 15.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.372 -178.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 23.5 m-85 -115.79 8.84 14.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 49.11 11.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.206 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.481 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.5 mtt -79.72 138.05 37.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.465 0.65 . . . . 0.0 110.057 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.518 ' NH2' ' OE2' ' A' ' 126' ' ' GLU . 4.8 ptm180 -109.99 -26.41 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.366 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 75.8 mt-10 -149.84 107.31 3.64 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.321 0.582 . . . . 0.0 111.904 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.6 mm -76.0 122.71 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.442 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.7 m80 -102.91 -31.9 10.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.119 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 p -155.93 151.35 26.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.801 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -148.67 131.82 16.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.2 -176.4 3.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 t 55.69 98.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.696 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.04 167.02 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.067 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.0 mp0 -142.09 111.73 6.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.974 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.92 -89.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.7 t -119.92 150.99 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.145 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -140.07 170.42 15.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.0 mt -145.14 123.61 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.392 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -112.17 132.84 54.66 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 40.1 m-85 -110.46 112.24 24.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 78.3 tt0 -51.54 -21.99 2.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.3 mp -118.16 165.32 16.63 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.29 167.45 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.016 1.81 . . . . 0.0 112.186 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.99 14.82 1.1 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.969 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 75.24 28.44 1.01 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.154 0.284 . . . . 0.0 111.371 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 82.0 mtp180 -133.28 126.83 32.33 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.19 174.54 22.17 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.549 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 77.8 mtm180 -53.07 115.99 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.329 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 49.2 mt-30 -85.52 138.16 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -114.0 128.89 56.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -140.63 87.66 2.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.681 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.0 mt -132.32 116.6 17.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.988 -0.445 . . . . 0.0 110.244 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.64 87.6 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.103 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -114.27 -160.52 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.939 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.62 93.09 4.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 104' ' ' PHE . 33.7 tt0 58.76 161.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.295 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -118.76 107.99 14.33 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -105.73 -24.1 12.59 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.811 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -121.26 153.3 58.29 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.551 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -58.83 -14.91 24.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.539 2.159 . . . . 0.0 113.453 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.06 -2.9 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.118 0.485 . . . . 0.0 110.477 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.36 -26.43 66.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.412 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.551 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -107.39 23.07 15.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.408 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.03 69.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.719 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.476 ' HB2' ' HE1' ' A' ' 163' ' ' TRP . . . -109.02 139.38 43.98 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.257 1.028 . . . . 0.0 109.397 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.4 22.11 0.34 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 170.62 156.27 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.303 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 170' ' ' VAL . 42.1 Cg_endo -68.9 -35.89 14.46 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.674 2.249 . . . . 0.0 111.435 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.65 77.1 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' A' ' 168' ' ' PRO . 60.6 t -94.11 -102.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.345 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER 162.65 -144.64 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 O-C-N 123.792 0.682 . . . . 0.0 109.718 177.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 1.9 p -91.02 -157.9 0.52 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.568 0.223 . . . . 0.0 111.225 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -169.78 -177.54 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.218 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -158.21 131.82 7.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.235 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 ptm180 -52.3 133.03 34.7 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.714 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.8 mt -63.44 134.08 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.589 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.48 137.05 53.74 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.056 0.455 . . . . 0.0 110.577 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.388 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.5 p 40.44 -152.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.767 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -149.06 7.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.353 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 p -62.42 168.18 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.02 35.11 1.72 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 p -132.2 120.01 21.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.844 0.354 . . . . 0.0 110.614 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.1 tttt -161.71 153.09 18.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' CG2' ' SG ' ' A' ' 83' ' ' CYS . 15.6 tt -146.71 144.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.808 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 m -135.12 141.28 45.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.431 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -121.05 115.9 24.01 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 81.5 m-85 -95.28 139.52 31.47 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.259 0.552 . . . . 0.0 111.181 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 8.1 tm-20 -63.46 -49.42 73.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.115 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.8 m-20 -98.84 -177.46 3.65 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -81.87 -178.67 7.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 48.57 22.23 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.516 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.5 m-85 60.15 46.41 10.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.196 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.23 167.36 10.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -143.35 31.53 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.499 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -65.58 162.49 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.408 -0.896 . . . . 0.0 109.149 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.57 156.99 8.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.971 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -131.07 133.65 45.88 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 42.6 p-10 -123.79 124.5 42.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.75 143.56 24.57 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.242 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -123.63 28.71 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.388 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.0 t -145.73 142.32 28.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -40.02 157.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.505 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.6 m -159.2 165.05 34.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.87 -54.79 3.6 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.994 0.426 . . . . 0.0 111.01 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -156.51 106.96 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.255 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -94.36 8.14 42.98 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.0 t60 -58.51 -30.93 67.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.3 p -58.02 -29.46 65.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.301 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.72 -16.85 31.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.608 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.559 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -140.02 137.17 34.42 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 109.954 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -100.61 -7.77 23.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.242 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 78' ' ' ASP . 57.6 ttm-85 -153.58 142.76 21.41 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.443 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.63 ' HG ' ' H ' ' A' ' 80' ' ' LEU . 2.0 m -112.44 102.79 10.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.7 m-20 -127.69 153.73 46.14 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 17.1 p 37.38 126.23 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.333 1.064 . . . . 0.0 112.562 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.2 mt -138.93 147.24 25.04 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.463 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.38 100.88 2.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.366 0.603 . . . . 0.0 109.921 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -70.2 141.45 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.11 47.59 0.95 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.57 -98.65 0.14 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.42 -137.34 3.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 93.2 m -77.87 166.78 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.601 ' CE3' ' SG ' ' A' ' 83' ' ' CYS . 38.6 m95 -156.56 156.8 34.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.546 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.44 118.91 33.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.757 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.38 133.01 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 111.297 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.608 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 31.4 m-85 -107.54 110.57 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.773 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -39.1 -32.77 0.1 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.075 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -116.79 147.72 40.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.733 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -68.71 156.33 65.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.33 2.02 . . . . 0.0 111.585 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 9.2 m-80 86.11 -2.93 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.038 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-85 85.07 59.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.596 0.358 . . . . 0.0 111.785 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.49 176.85 9.5 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.42 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.23 -164.39 47.73 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -59.49 137.39 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.608 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 10.7 tpt -123.78 126.08 45.86 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -140.91 152.79 45.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.63 99.04 7.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.562 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -71.0 110.63 7.62 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.09 163.82 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.148 1.899 . . . . 0.0 113.255 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.2 123.42 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.914 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.28 -173.64 40.28 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.6 mt-10 -111.46 156.35 21.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.956 0.408 . . . . 0.0 109.904 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.585 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.5 m-85 -147.27 81.12 8.94 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.485 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 36.5 Cg_exo -55.43 -14.0 8.72 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.054 2.503 . . . . 0.0 112.661 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -151.47 163.41 39.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.338 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 10.9 p90 -65.4 -51.01 63.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.405 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.2 mt-30 -43.62 -10.6 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' TYR . 39.2 mmt180 -76.3 -0.55 22.86 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.02 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -123.81 22.6 8.9 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 122.929 0.143 . . . . 0.0 111.019 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 8.7 mmt 91.86 18.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.578 1.151 . . . . 0.0 111.709 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.26 62.16 0.24 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.9 mt -90.91 17.19 8.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.461 0.304 . . . . 0.0 111.27 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 67.0 t30 107.28 155.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.798 1.311 . . . . 0.0 109.639 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 54.0 p-10 -87.54 73.49 9.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.126 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -145.86 118.91 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.63 ' H ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -147.15 130.12 16.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 110.398 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.0 p -108.01 -164.75 0.99 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' SER . 61.5 m -49.44 -174.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.601 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 12.9 p -153.58 156.38 37.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -118.99 129.52 55.19 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.37 133.54 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.629 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.82 134.07 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -101.15 162.13 13.11 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.916 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -91.79 159.45 38.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.662 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.55 149.77 62.38 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.045 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 92' ' ' GLY . 17.8 p -172.53 -9.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.149 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.33 7.27 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.526 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 90' ' ' SER . . . -174.49 -69.06 0.05 OUTLIER Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.641 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 170.36 -103.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.262 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.731 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 10.8 t80 -156.88 115.73 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -154.05 131.86 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.26 0.552 . . . . 0.0 110.605 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -138.94 147.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.337 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.8 mt-30 -124.44 129.1 50.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.461 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.3 mt -119.61 131.71 71.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.145 -178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -111.52 123.76 50.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.115 0.483 . . . . 0.0 110.52 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.51 -19.04 22.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.625 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -131.89 143.58 50.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 110.582 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.85 -178.91 0.78 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.4 t0 52.29 29.44 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.462 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 54.81 80.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.838 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -157.31 164.03 38.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.549 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.46 -157.24 30.03 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -67.7 138.23 56.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.764 0.316 . . . . 0.0 110.636 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 43.4 ttp -118.6 121.33 39.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.488 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.5 m-85 -116.81 132.66 56.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.209 0.528 . . . . 0.0 111.201 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.07 131.33 52.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.826 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -152.84 134.35 14.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -95.54 45.48 1.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -149.24 -177.74 6.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.774 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -86.9 160.28 18.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 64.5 m -137.82 123.34 12.64 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.519 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.6 Cg_endo -78.18 -61.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.805 1.67 . . . . 0.0 110.879 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.2 m -111.38 113.16 25.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.598 ' H ' ' HG ' ' A' ' 172' ' ' SER . 4.3 tt -70.04 -35.78 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.116 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 25.3 ttt -71.43 -18.53 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.447 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -82.43 -42.44 18.56 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.079 -1.013 . . . . 0.0 111.397 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.528 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.66 -30.19 15.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -177.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 27.7 m-85 -117.73 4.17 12.29 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.9 m-70 55.06 3.63 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.854 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.574 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -72.15 131.89 43.42 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.943 0.402 . . . . 0.0 109.921 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -108.4 -24.24 11.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.189 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.4 mt-10 -151.0 108.82 3.68 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.001 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.8 mm -76.91 125.79 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.643 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.8 m80 -105.24 -36.88 7.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.119 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.4 p -153.59 149.62 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.868 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -145.92 156.16 43.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.758 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.5 mtpt -134.06 179.13 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.371 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 t 57.65 99.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.42 164.02 14.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.372 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -135.91 111.98 9.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.21 -88.0 0.01 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.5 t -125.82 144.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.974 0.416 . . . . 0.0 109.996 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.731 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.2 t-105 -130.09 167.85 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 67.5 mt -144.25 124.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -112.42 131.88 55.33 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -110.19 114.21 27.52 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.593 0.558 . . . . 0.0 110.784 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 80.8 tt0 -51.86 -23.65 5.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.507 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.05 160.9 37.23 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.449 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.1 Cg_endo -77.77 167.06 24.51 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.205 1.937 . . . . 0.0 111.763 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.514 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.9 m-80 73.2 14.83 4.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.046 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.514 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.2 m-85 77.34 27.84 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.531 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -114.7 170.77 8.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.831 0.348 . . . . 0.0 110.578 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.73 159.57 27.73 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 16.5 ptt180 -64.64 84.7 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.566 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -54.61 -167.5 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.043 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -144.1 162.3 36.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.563 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.0 148.44 24.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 110.194 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD2' ' OH ' ' A' ' 157' ' ' TYR . 1.9 tt -72.78 117.59 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.707 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -146.32 164.23 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.982 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.3 tptp 61.34 149.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.455 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.52 120.55 26.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.779 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 64.42 161.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.427 ' OH ' ' CD2' ' A' ' 152' ' ' LEU . 5.2 m-85 -127.32 108.56 10.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.521 ' CZ ' ' HZ2' ' A' ' 159' ' ' LYS . 48.3 ptt85 -108.34 -22.29 12.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.594 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.521 ' HZ2' ' CZ ' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -121.59 156.41 58.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.84 0.352 . . . . 0.0 110.736 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.503 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -59.42 -23.06 68.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.214 1.943 . . . . 0.0 113.177 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.36 -4.94 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.53 -31.77 62.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.298 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -103.72 20.82 17.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.713 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.64 27.79 64.5 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.087 -0.577 . . . . 0.0 113.769 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -106.6 137.41 44.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.805 0.802 . . . . 0.0 110.301 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.25 26.32 0.16 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 166.0 154.54 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.503 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 170' ' ' VAL . 44.0 Cg_endo -71.49 -13.35 30.23 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.047 2.498 . . . . 0.0 111.337 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.65 69.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.582 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.677 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 4.2 t -101.0 -152.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.677 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.7 tp60 -153.33 -132.04 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.735 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.598 ' HG ' ' H ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -95.15 -152.99 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -170.64 -179.44 2.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.09 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -155.3 130.25 9.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.902 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -52.74 126.39 19.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.943 0.877 . . . . 0.0 110.98 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.3 mt -59.01 128.22 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.713 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -135.76 144.05 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.198 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 46' ' ' THR . 42.7 tt0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.081 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.1 166.5 25.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.651 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -74.81 119.92 19.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.972 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.6 p -71.21 162.74 28.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.281 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 21.18 31.98 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -134.06 122.02 22.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.719 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.8 tttt -161.28 152.69 18.94 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.983 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 tt -147.2 141.04 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.098 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.3 m -124.8 138.23 54.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.462 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -118.23 116.3 26.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.441 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 94.0 m-85 -98.59 139.27 34.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.963 0.411 . . . . 0.0 110.96 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.0 tm-20 -62.03 -51.94 65.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.875 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.92 -177.93 4.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.31 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' C ' ' HG ' ' A' ' 39' ' ' SER . 43.2 mtmt -82.36 -177.55 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.42 24.82 0.33 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.177 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.601 ' H ' ' HG ' ' A' ' 39' ' ' SER . 1.8 m-85 62.43 42.71 8.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.257 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.91 172.58 6.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.65 -153.33 51.45 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.845 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -56.89 173.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -169.0 152.53 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.492 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 63.9 t80 -129.23 131.62 47.09 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 37.7 p-10 -120.39 125.36 47.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 0.0 111.24 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.7 t -151.25 142.43 23.21 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.26 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -126.17 24.11 6.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' ASP . 14.3 m -145.99 141.81 28.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.442 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 40.3 t0 -35.73 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 20.8 m -156.85 162.68 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.348 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.75 -55.69 3.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.979 0.419 . . . . 0.0 110.647 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -154.07 110.97 3.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.331 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.3 p90 -100.81 9.27 42.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.963 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.7 t60 -59.07 -28.41 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.515 0.674 . . . . 0.0 110.069 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -60.96 -29.2 69.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.271 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.08 -14.99 37.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -142.34 138.25 31.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -99.98 -8.69 23.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.644 0.259 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 49.2 ttm-85 -154.23 141.5 19.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.824 0.345 . . . . 0.0 110.485 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.4 m -110.92 105.46 14.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.273 0.559 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 45.4 m-20 -117.13 -155.84 0.6 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' A' ' 16' ' ' PHE . 18.2 p -20.47 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.884 0.74 . . . . 0.0 112.271 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 mt -143.01 146.91 21.14 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.114 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.1 ptpt -154.41 103.97 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.2 t -66.6 148.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.523 0.678 . . . . 0.0 110.555 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.51 50.08 1.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.009 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.77 -95.85 0.1 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.925 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.28 -140.28 4.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 90.0 m -81.05 166.9 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.292 -0.534 . . . . 0.0 110.84 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.719 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.3 m95 -154.47 156.9 37.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.286 0.565 . . . . 0.0 110.742 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.43 120.82 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.1 m -117.47 131.9 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 0.0 110.986 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.7 109.65 21.43 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.723 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 60.2 tt0 -37.06 -36.29 0.12 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -113.69 147.98 38.8 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.5 Cg_endo -68.72 157.09 63.25 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.34 2.026 . . . . 0.0 112.05 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 5.5 m-80 86.03 -2.84 0.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.3 m-85 85.21 61.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.146 0.498 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.57 171.5 14.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.132 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.05 -158.47 34.79 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 4.2 m-85 -69.04 137.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.25 90.14 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 26.3 t80 -98.22 144.64 27.45 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -104.06 92.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.604 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.3 110.23 5.89 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 162.85 19.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.083 1.855 . . . . 0.0 112.759 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.79 117.41 2.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.087 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.78 179.12 41.3 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.51 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -102.24 153.93 19.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 25.1 m-85 -145.93 83.55 8.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.57 -15.72 9.51 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.26 2.64 . . . . 0.0 113.101 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -152.52 161.43 42.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.734 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 13.2 p90 -65.03 -52.36 56.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.334 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 37.2 mt-30 -42.99 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.609 ' H ' ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.82 -4.97 46.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.059 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.734 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.85 23.24 11.81 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.618 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.6 mmt 87.41 25.35 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.561 1.163 . . . . 0.0 111.158 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 30.83 50.04 0.2 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.078 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 26.5 mt -75.86 14.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.542 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 14.6 t-20 110.95 162.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.368 1.043 . . . . 0.0 109.27 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -94.4 61.23 2.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -137.61 115.78 11.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.246 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.424 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.39 129.16 20.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.6 p -111.58 -162.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.745 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.29 -178.65 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.864 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.59 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.5 p -151.11 153.06 34.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.595 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -118.34 127.86 54.1 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.559 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.49 127.85 33.48 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.63 132.04 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.735 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -100.37 161.56 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.82 150.36 69.12 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.429 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.01 151.23 82.36 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.244 1.963 . . . . 0.0 111.935 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 92' ' ' GLY . 25.7 p -169.3 -17.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.079 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.84 -5.61 0.61 Allowed Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.548 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 90' ' ' SER . . . -158.09 -73.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.6 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 171.54 -100.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.981 0.419 . . . . 0.0 109.919 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.715 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 21.5 t80 -160.88 114.13 2.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.261 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -157.09 132.28 9.04 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.709 0.29 . . . . 0.0 110.676 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.408 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.5 tt -135.81 145.0 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.221 0.534 . . . . 0.0 111.296 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -122.23 134.02 54.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.36 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 108' ' ' MET . 17.5 mt -121.94 131.52 72.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.216 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -115.98 130.24 56.73 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.211 0.529 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.46 -26.98 65.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.052 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -122.25 147.07 46.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.591 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.46 -168.48 0.41 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 50.7 t0 44.56 29.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.911 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.482 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 12.9 m-85 54.11 79.35 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m -158.56 162.24 37.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.993 0.425 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.99 -171.43 42.69 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -53.89 133.69 42.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.169 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.9 tmm? -121.04 131.98 54.61 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.454 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.7 m-85 -121.46 135.72 55.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.456 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.05 126.24 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.3 t -152.73 128.93 10.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.72 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -95.37 42.68 1.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 111.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.07 -179.46 6.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.508 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.8 p-10 -84.04 156.98 21.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.525 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 65.8 m -134.04 123.02 16.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.907 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' O ' ' OG ' ' A' ' 172' ' ' SER . 68.3 Cg_endo -77.98 -57.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.8 1.667 . . . . 0.0 110.841 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.8 m -115.89 111.64 20.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 119' ' ' MET . 5.1 tt -67.4 -41.86 86.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 0.0 111.338 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 9.1 ttp -68.17 -17.12 64.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.344 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -82.47 -42.49 18.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.671 -0.643 . . . . 0.0 111.707 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.525 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.9 -29.96 15.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.111 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.523 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 29.3 m-85 -115.99 4.48 13.77 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.5 m-70 52.48 11.64 0.19 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.234 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -76.85 133.01 39.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -106.98 -28.48 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.71 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 30.3 mt-10 -151.45 109.0 3.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.008 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.9 mm -74.98 125.17 34.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.901 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.0 m80 -107.44 -33.53 7.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.742 ' HG ' ' H ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.56 -168.12 1.97 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.793 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.742 ' H ' ' HG ' ' A' ' 129' ' ' SER . 0.1 OUTLIER 160.99 137.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.082 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -130.16 -169.54 2.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.052 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.1 t 47.0 87.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 0.0 110.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.28 169.8 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.201 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -141.88 113.65 7.9 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.49 -97.44 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 t -110.54 155.93 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -145.03 168.62 19.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.837 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 70.5 mt -144.63 123.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.974 0.416 . . . . 0.0 111.576 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -109.61 129.82 55.56 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -107.5 110.83 22.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.563 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.2 -22.39 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.27 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.55 164.36 16.66 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 90.7 Cg_endo -84.16 166.9 12.58 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.091 1.86 . . . . 0.0 112.29 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 143' ' ' PRO . 1.8 m-80 68.52 21.96 7.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.6 m-85 71.68 66.83 0.15 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -154.44 169.68 23.17 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.931 0.396 . . . . 0.0 110.698 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.93 172.76 39.12 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.982 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.426 ' NE ' ' CD1' ' A' ' 58' ' ' TYR . 79.1 mtp180 -53.9 138.26 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.554 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 15.5 mp0 -99.56 137.5 37.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.033 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -106.83 129.2 54.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.592 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 53.5 tp -76.36 144.32 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.367 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.7 mp -128.32 145.98 50.9 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.168 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -136.78 70.99 1.41 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.993 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? 38.29 -126.16 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt 59.2 -105.14 0.23 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.665 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.482 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 18.4 tt0 -178.07 159.49 1.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -129.68 108.21 10.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.405 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -109.47 -21.13 12.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.24 155.73 58.22 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 121.124 0.488 . . . . 0.0 110.965 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.531 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -60.24 -19.03 55.5 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.259 1.973 . . . . 0.0 113.181 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 2.1 mp -97.86 -3.45 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.72 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -27.86 68.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.864 -178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -107.42 21.25 17.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.28 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.33 70.84 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.331 0.492 . . . . 0.0 114.331 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -105.75 138.58 41.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.973 0.886 . . . . 0.0 110.005 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.57 20.86 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.265 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 169.46 156.73 0.18 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.719 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.7 4.48 6.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.006 2.471 . . . . 0.0 111.585 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.55 71.4 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.798 0.333 . . . . 0.0 111.09 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.603 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.6 t -99.78 -151.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.603 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 79.0 mm-40 -154.61 -130.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.123 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 2.9 p -93.7 -155.48 0.45 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -170.04 -177.27 2.52 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.319 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.72 132.06 6.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.442 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -51.67 134.81 29.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.237 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.2 mt -67.84 135.48 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.658 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.52 156.75 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.152 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.711 ' HG ' ' H ' ' A' ' 3' ' ' LYS . 18.4 p -139.5 -63.08 0.52 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 110.648 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.711 ' H ' ' HG ' ' A' ' 2' ' ' SER . 99.3 mttt -62.56 -45.85 91.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.383 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.8 p -41.54 128.8 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.26 -169.33 42.05 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.0 p -139.14 128.09 23.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 110.393 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.738 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.4 tttt -160.03 152.03 20.41 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.004 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.95 142.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.736 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -125.89 138.99 53.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.642 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -119.33 115.8 24.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.373 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.4 m-85 -94.71 138.73 32.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 110.822 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 8.1 tm-20 -61.06 -49.91 75.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.076 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 65.6 m-20 -99.2 -175.96 3.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.182 0.515 . . . . 0.0 109.667 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -82.73 -176.64 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.829 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.53 23.78 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.515 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' H ' ' HG ' ' A' ' 39' ' ' SER . 2.9 m-85 63.18 41.46 7.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.117 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -108.19 177.08 4.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.44 -158.56 50.97 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.508 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -54.64 176.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.25 150.15 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 49.8 t80 -127.23 130.97 50.63 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 38.3 p-10 -119.45 124.0 45.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.096 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -150.03 142.3 24.19 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.241 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -125.25 24.01 7.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.951 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.9 t -146.81 141.81 27.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.8 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 25' ' ' CYS . 74.5 m-20 -36.61 156.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.562 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 23.5 t -157.69 164.27 37.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.301 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.47 -56.57 2.98 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.958 0.409 . . . . 0.0 110.861 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 44.7 p-10 -154.24 110.6 3.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.193 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -99.89 10.83 40.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' LEU . 70.5 t60 -59.79 -26.85 66.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.2 p -63.39 -31.31 72.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -85.85 -12.58 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.15 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -142.93 137.62 29.58 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 p -95.49 -11.74 27.01 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 45.4 ttp180 -158.19 146.07 18.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.217 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' HG ' ' H ' ' A' ' 80' ' ' LEU . 2.8 m -110.25 104.15 12.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.37 0.605 . . . . 0.0 111.395 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.727 ' O ' ' O ' ' A' ' 39' ' ' SER . 90.3 m-20 -128.84 155.6 44.95 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.463 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' O ' ' A' ' 38' ' ' ASN . 11.1 p 36.97 128.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.345 1.069 . . . . 0.0 112.192 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.7 mt -141.46 147.12 22.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.403 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -155.94 102.28 2.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.212 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -67.24 149.78 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-O 121.616 0.722 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' N ' HG12 ' A' ' 42' ' ' VAL . 76.1 mm-40 -122.89 50.62 1.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.053 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -168.53 -96.97 0.11 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.868 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.92 -141.33 4.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 84.9 m -80.84 167.23 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.578 -0.366 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.738 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.8 m95 -154.74 155.65 34.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.611 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 120.79 41.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.48 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.92 131.33 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 110.608 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-85 -102.88 108.23 19.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 79.1 tt0 -36.48 -35.32 0.08 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.07 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.534 HH21 ' CB ' ' A' ' 56' ' ' ALA . 10.5 mtm180 -115.39 147.3 38.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 49.4 Cg_endo -68.45 160.71 48.04 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.324 2.016 . . . . 0.0 111.446 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 83.37 -3.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.293 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.7 m-85 85.42 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' CB ' HH21 ' A' ' 52' ' ' ARG . . . -145.22 168.38 20.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.548 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.34 -156.69 28.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 3.8 m-85 -82.8 114.63 21.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -87.94 98.26 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.332 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.7 m-85 -92.84 146.6 23.51 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.39 92.14 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.419 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 112.98 16.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.67 162.23 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.02 1.813 . . . . 0.0 112.526 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -51.94 115.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.914 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.12 177.52 42.44 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.8 mt-10 -101.06 153.07 19.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.944 0.402 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 30.6 m-85 -146.05 91.11 5.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 37.0 Cg_endo -66.3 -13.62 40.67 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.056 1.837 . . . . 0.0 113.138 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -149.41 161.08 42.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.753 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.6 p90 -63.23 -53.97 44.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.99 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.61 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.9 pt20 -43.46 -10.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 70' ' ' TYR . 24.0 mmm180 -75.04 -5.6 44.93 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.24 24.39 10.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.05 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.0 mmt 87.97 25.48 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.289 0.993 . . . . 0.0 111.286 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.17 51.47 0.26 Allowed Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 10.4 mt -75.88 13.2 0.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.83 -0.185 . . . . 0.0 110.986 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.2 t30 109.06 169.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.578 1.174 . . . . 0.0 108.743 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -98.96 61.46 1.26 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.901 0.382 . . . . 0.0 110.556 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -139.2 116.9 11.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.304 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' H ' ' HG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.05 129.17 20.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.7 p -111.22 -162.86 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.513 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 81' ' ' SER . 6.3 p -45.51 -179.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.781 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.62 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -150.26 151.89 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.431 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -115.52 127.96 55.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.543 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.18 122.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.479 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.08 130.06 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -102.56 162.87 12.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.6 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -79.91 150.65 72.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.83 147.11 95.05 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.071 1.848 . . . . 0.0 112.329 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -159.91 174.61 14.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.238 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.75 -44.69 2.54 Favored Glycine 0 CA--C 1.518 0.255 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.89 -80.74 1.33 Allowed Glycine 0 N--CA 1.458 0.131 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.63 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 164.97 -104.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 110.046 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 31.0 t80 -159.01 114.16 2.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.519 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -156.39 132.66 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.451 . . . . 0.0 111.034 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.41 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -134.53 143.62 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.421 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -123.74 129.58 51.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.418 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.3 mt -119.15 131.18 72.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.588 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -111.58 129.07 56.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.78 -29.88 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 102' ' ' GLY . 81.4 mttt -112.23 146.91 37.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 101' ' ' LYS . . . -54.3 -163.09 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 38.9 t70 51.72 -96.11 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 103' ' ' ASP . 67.1 m-85 -168.95 71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.993 0.808 . . . . 0.0 109.232 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -156.91 161.73 39.65 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.101 0.477 . . . . 0.0 110.986 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.05 -178.93 33.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.633 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.97 133.78 22.19 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.25 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.0 tmm? -122.33 130.32 53.02 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.815 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.488 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 65.0 m-85 -119.77 135.64 54.77 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.43 117.26 26.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.29 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.7 t -140.95 126.37 18.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.7 OUTLIER -92.65 38.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.27 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.12 -177.85 5.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.75 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.7 p30 -85.61 159.12 19.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.058 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.446 ' O ' ' OG ' ' A' ' 172' ' ' SER . 42.1 t -133.3 124.56 18.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.444 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -79.06 -53.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.819 1.679 . . . . 0.0 111.272 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -121.14 113.89 20.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.8 tt -68.25 -46.18 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.187 0.518 . . . . 0.0 110.589 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.459 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -64.65 -20.2 66.15 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -73.49 -47.26 42.58 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.673 -0.642 . . . . 0.0 112.433 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.639 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.67 -23.59 14.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.29 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.1 m-85 -111.49 1.56 16.99 Favored 'General case' 0 C--O 1.228 -0.04 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.2 m-70 50.12 11.17 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.862 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.487 ' H ' ' C ' ' A' ' 122' ' ' PHE . 33.8 mtt -77.38 135.2 38.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -106.36 -28.74 10.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.042 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 72.5 mt-10 -152.36 108.6 3.4 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.99 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.36 125.08 33.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.607 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.8 m80 -106.93 -32.46 7.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.242 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 103' ' ' ASP . 13.6 t -152.21 147.76 26.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 110.987 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.16 156.78 44.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 44.5 mtpt -133.71 -171.14 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.166 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 t 47.06 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.414 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 4.3 mm? -110.82 167.48 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -143.17 111.71 6.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.816 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.82 -88.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 134' ' ' GLU . 5.5 t -121.18 155.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.082 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.742 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -143.73 167.81 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.9 mt -144.72 124.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.69 130.77 55.48 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 16.6 m-85 -108.75 111.75 23.67 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.508 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -52.12 -24.7 7.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.7 161.23 27.43 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.342 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.26 164.66 21.7 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.325 2.017 . . . . 0.0 111.489 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.54 15.11 2.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.003 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.7 m-85 78.54 25.91 0.54 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 111.339 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 89.7 mtm180 -109.78 171.26 7.55 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.66 168.56 33.87 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -62.16 134.38 56.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.08 0.467 . . . . 0.0 110.228 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.571 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 54.4 mt-30 -87.27 144.88 26.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -110.79 127.25 55.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.732 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.5 tp -143.39 93.65 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 153' ' ' ASP . 30.9 tp -151.61 142.34 22.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.499 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 7.2 p-10 40.21 95.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.246 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -91.52 91.28 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.235 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -165.16 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 34.9 tt0 -174.01 168.6 4.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.488 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 21.4 m-85 -142.03 108.57 5.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.893 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -99.36 -30.36 12.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.47 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -118.12 155.42 51.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.47 -17.17 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.148 1.899 . . . . 0.0 113.432 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.22 -3.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.157 0.504 . . . . 0.0 110.327 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 1.0 OUTLIER -61.82 -28.34 69.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.4 OUTLIER -104.68 20.51 18.51 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.09 28.23 66.89 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.134 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.474 ' HB2' ' HE1' ' A' ' 163' ' ' TRP . . . -109.74 137.64 47.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.704 0.752 . . . . 0.0 109.596 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.62 19.68 0.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.563 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 173.12 155.73 0.26 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.481 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.84 4.65 5.5 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.113 2.542 . . . . 0.0 111.709 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.96 69.89 5.2 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.588 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.5 t -97.71 -153.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.588 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 71.8 mm-40 -153.83 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.224 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.584 ' HG ' ' N ' ' A' ' 173' ' ' PHE . 4.0 p -93.17 -155.75 0.45 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.584 ' N ' ' HG ' ' A' ' 172' ' ' SER . 44.4 p90 -170.56 -177.35 2.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.065 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.66 132.04 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.862 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -53.05 135.95 36.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.916 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.6 mt -69.28 135.68 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.836 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.6 160.46 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.603 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 29.1 tp10 . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.432 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 44' ' ' GLY . 60.4 p -86.04 165.65 16.49 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -142.12 -1.73 1.2 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.56 ' HG1' ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -90.73 -92.86 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.56 ' H ' ' HG1' ' A' ' 4' ' ' THR . . . -80.46 111.36 3.26 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.516 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.6 p -84.93 160.86 20.02 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.728 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 31.9 tttt -160.26 151.89 19.83 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -147.49 142.05 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.997 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.5 m -124.9 138.77 54.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -119.11 116.36 26.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.6 m-85 -98.78 139.57 34.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.1 tm-20 -62.19 -51.41 67.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.823 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -94.4 -177.46 4.26 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' HD21 ' A' ' 15' ' ' ASN . 41.8 mtmt -82.8 -176.79 6.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.697 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.41 25.96 0.26 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.321 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.465 ' CG ' ' C ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 63.61 41.44 7.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.57 177.45 4.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.0 110.493 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.81 -158.75 49.66 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.628 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.11 175.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.43 150.79 5.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.473 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 64.6 t80 -129.65 131.88 46.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -120.14 128.79 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.934 0.397 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.9 t -153.7 142.45 20.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.285 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -124.72 24.09 7.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 m -147.83 143.99 27.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.537 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' O ' ' SG ' ' A' ' 27' ' ' CYS . 2.2 m-20 -37.77 156.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.778 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 26' ' ' ASP . 12.3 m -156.94 162.81 39.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.22 -56.12 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.941 0.401 . . . . 0.0 110.629 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -154.22 111.89 3.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.317 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.473 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.6 p90 -101.57 10.16 40.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.998 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' LEU . 33.2 t60 -59.58 -28.43 67.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.717 0.77 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.97 -30.99 70.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.456 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -86.8 -13.65 44.5 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.392 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 31' ' ' HIS . 20.0 tp -142.89 137.22 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 109.985 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -97.78 -10.14 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.296 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 59.3 ttm-85 -155.23 142.79 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.63 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.9 m -110.75 105.82 14.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 110.869 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 59.7 m-20 -118.0 -155.7 0.61 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 38' ' ' ASN . 6.3 p -19.68 137.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.992 0.807 . . . . 0.0 112.468 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.7 mt -142.55 146.54 22.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.046 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.62 104.28 2.34 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.953 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -67.24 148.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.38 0.61 . . . . 0.0 110.083 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.01 50.6 1.43 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.708 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . -168.21 -96.17 0.1 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.071 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.25 -140.56 4.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 91.2 m -80.17 166.34 21.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.466 -0.432 . . . . 0.0 110.954 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.728 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -154.49 155.66 35.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.704 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 120.84 40.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.2 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.0 m -120.37 133.68 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CD1' ' NH1' ' A' ' 84' ' ' ARG . 11.7 m-85 -106.98 112.88 26.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.602 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 44.3 tt0 -37.65 -32.68 0.06 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.169 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -116.57 147.41 39.68 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 120.596 0.236 . . . . 0.0 110.951 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -69.31 161.78 44.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.268 1.979 . . . . 0.0 111.716 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 3.8 m-80 81.99 -3.66 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.059 0.849 . . . . 0.0 111.075 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 4.4 m-85 86.02 62.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.235 0.54 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.07 170.2 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.233 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.96 -159.94 34.76 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 6.5 m-85 -69.17 139.53 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -106.37 87.95 2.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.599 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 36.0 t80 -92.75 136.0 33.62 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.33 93.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -71.84 110.9 8.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.43 162.83 17.1 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.137 1.891 . . . . 0.0 112.527 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.66 114.85 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.84 176.75 41.67 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.2 mt-10 -100.02 153.25 19.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.049 0.452 . . . . 0.0 110.566 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 26.4 m-85 -146.14 81.57 9.6 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.19 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.17 -12.52 7.75 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.948 2.432 . . . . 0.0 113.071 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 95.2 mt-10 -152.13 161.35 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.692 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 38.6 p90 -64.21 -54.84 27.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.598 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.7 pt20 -43.84 -9.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' H ' ' C ' ' A' ' 70' ' ' TYR . 31.4 mmt180 -74.83 -4.92 40.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.79 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.99 25.48 10.32 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 119.778 -0.153 . . . . 0.0 110.742 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 23.6 mmt 85.48 24.68 0.08 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.439 1.087 . . . . 0.0 111.191 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.56 51.27 0.43 Allowed Glycine 0 N--CA 1.472 1.1 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.8 mt -76.64 13.82 0.92 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.8 t30 111.55 166.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.063 1.477 . . . . 0.0 109.553 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 50.7 p-10 -98.63 63.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -142.69 119.71 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -143.72 129.66 19.49 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.4 p -110.36 -162.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.555 ' C ' HH21 ' A' ' 84' ' ' ARG . 13.1 p -45.12 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 110.713 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.619 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 19.8 p -147.97 147.91 30.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.799 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 84' ' ' ARG . 0.0 OUTLIER -111.04 124.78 52.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.69 123.31 17.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.002 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.67 130.86 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -98.51 162.35 13.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 178' ' ' GLU . 1.7 mt -80.21 148.14 66.57 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.845 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' O ' ' OG ' ' A' ' 90' ' ' SER . 60.4 Cg_endo -70.51 155.4 63.53 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.17 1.913 . . . . 0.0 112.054 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 89' ' ' PRO . 19.2 m -171.99 -13.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.078 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.73 -33.41 86.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -139.05 57.36 0.62 Allowed Glycine 0 N--CA 1.464 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 35.2 -105.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.712 0.291 . . . . 0.0 111.301 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.733 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 41.8 t80 -158.29 112.81 2.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -153.56 134.65 14.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.27 0.557 . . . . 0.0 111.111 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -135.9 144.51 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.164 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -122.83 130.17 52.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.55 132.35 69.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -114.44 132.89 56.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.04 -30.54 70.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.974 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -120.6 150.76 40.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.175 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.13 -176.62 4.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 t0 50.44 28.8 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.715 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 7.3 m-85 55.72 82.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.668 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -159.06 161.31 36.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.54 -149.35 20.53 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -77.12 137.43 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.2 tmm? -123.01 133.87 54.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 111.179 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.435 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.9 m-85 -124.71 137.95 54.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.679 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -123.55 123.66 41.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.49 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.408 ' O ' ' CG2' ' A' ' 111' ' ' THR . 5.6 t -151.59 125.55 9.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.581 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -92.39 45.31 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.44 . . . . 0.0 111.334 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.35 -179.24 6.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.538 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 18.6 p-10 -86.48 159.25 19.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.84 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 42.4 t -136.17 124.68 15.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.72 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.4 Cg_endo -77.84 -51.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.623 1.549 . . . . 0.0 111.093 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.0 m -121.97 111.39 17.0 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.982 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.7 tt -68.44 -43.91 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.0 ttt -65.45 -17.66 64.72 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.0 111.032 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -81.87 -43.02 18.77 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.724 -0.61 . . . . 0.0 111.94 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.704 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -95.54 -29.45 14.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.053 -178.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.704 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.03 5.3 14.92 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.678 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.8 m-70 50.78 11.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.919 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 122' ' ' PHE . 36.0 mtt -76.9 135.15 38.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.749 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -107.41 -28.46 9.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.516 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 60.8 mt-10 -151.19 109.04 3.68 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.08 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -74.71 125.14 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.723 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -105.53 -32.19 8.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.8 t -154.04 148.74 26.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.108 0.48 . . . . 0.0 111.267 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -149.8 132.34 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -112.44 -173.08 2.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.243 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t 56.15 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -94.55 168.03 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.136 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.8 mp0 -142.58 112.14 6.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.69 -88.66 0.01 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.5 t -116.59 156.21 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.733 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.2 t-105 -146.21 167.44 23.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 87.4 mt -144.88 123.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.742 0.306 . . . . 0.0 111.119 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.4 131.57 54.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -109.57 111.54 23.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.957 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -51.82 -23.18 4.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.737 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.6 160.4 33.32 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 96.7 Cg_endo -79.47 166.25 22.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.123 1.882 . . . . 0.0 111.46 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.6 m-80 74.84 14.01 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.0 m-85 79.04 25.55 0.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -109.87 171.05 7.68 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.847 0.356 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.23 168.99 36.07 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' NE ' ' CD1' ' A' ' 58' ' ' TYR . 71.2 mtp180 -56.97 142.39 41.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 109.835 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 69.5 mt-30 -97.6 137.39 36.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.002 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -104.83 126.22 51.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.4 tp -81.11 153.14 27.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.542 0.687 . . . . 0.0 110.218 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.636 ' H ' ' CD1' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -120.21 154.92 34.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.34 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -175.33 -25.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.601 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -72.36 146.91 46.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.82 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 156' ' ' GLU . 68.0 mttm -76.67 99.35 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 13.6 tt0 75.05 148.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.077 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.457 ' O ' ' OG ' ' A' ' 129' ' ' SER . 1.9 m-85 -118.08 111.43 18.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.473 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -107.3 -20.26 13.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.701 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -121.56 154.86 59.96 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 15.5 Cg_endo -60.59 -16.09 40.7 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.4 2.067 . . . . 0.0 113.322 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.2 -1.69 9.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -26.08 67.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.671 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -108.67 21.08 17.75 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.42 26.94 68.8 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.955 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.481 ' HB1' ' HE1' ' A' ' 163' ' ' TRP . . . -106.93 138.28 43.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.38 1.09 . . . . 0.0 109.721 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.76 21.02 0.21 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 170.86 155.41 0.21 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.675 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.24 6.13 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.087 2.525 . . . . 0.0 111.407 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.8 70.64 8.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 111.056 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.648 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.01 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.648 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 73.8 mm-40 -155.04 -130.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.357 0.411 . . . . 0.0 109.893 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.594 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.37 -158.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -170.01 -177.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.405 0.622 . . . . 0.0 111.094 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.87 131.76 7.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -52.89 135.3 36.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.652 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.4 mt -64.09 134.49 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.723 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.89 135.58 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.501 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . 11.2 tm-20 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.351 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.58 -167.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.523 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.17 -47.57 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.046 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 5' ' ' GLY . 11.1 t -65.86 -44.2 86.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.731 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 4' ' ' THR . . . -92.11 113.58 4.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 73.9 p -84.64 158.17 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.731 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.8 tttt -158.32 150.71 22.01 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.022 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.3 140.31 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.669 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 42.4 m -122.52 137.95 54.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.33 115.85 25.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.45 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -95.58 138.13 33.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.235 0.54 . . . . 0.0 111.083 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.27 -49.94 75.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.3 m-20 -99.69 -176.2 3.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.188 0.518 . . . . 0.0 110.148 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.43 -177.2 6.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.57 23.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.779 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.575 ' H ' ' HG ' ' A' ' 39' ' ' SER . 3.2 m-85 63.09 41.11 8.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.35 176.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.151 0.5 . . . . 0.0 110.715 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.91 -157.12 52.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.379 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -54.91 174.2 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.137 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.58 151.08 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' THR . 59.6 t80 -135.57 134.14 39.07 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 49.9 p-10 -120.9 140.46 51.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.665 0.269 . . . . 0.0 110.759 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 18.3 t -147.88 141.15 25.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 6' ' ' THR . 7.4 t70 -122.92 14.06 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.8 t -149.66 146.7 27.41 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.812 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 80.3 m-20 -37.54 156.19 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.62 161.22 40.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.35 3.03 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 39.4 p-10 -153.61 111.0 3.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.466 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 2.1 p90 -101.28 9.7 41.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.6 t60 -59.98 -26.47 66.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.986 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -63.28 -29.66 70.95 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.505 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -88.45 -12.87 41.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.469 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 31' ' ' HIS . 17.0 tp -143.5 137.7 28.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -99.46 -9.4 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 14.6 ttm180 -154.75 143.26 20.58 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.3 m -110.65 104.57 13.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.442 0.639 . . . . 0.0 110.887 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.707 ' O ' ' O ' ' A' ' 39' ' ' SER . 70.6 m-20 -129.51 156.78 43.59 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.67 128.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.392 1.091 . . . . 0.0 112.469 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.2 mt -141.44 146.19 23.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.297 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -154.41 103.6 2.51 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.096 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.72 148.23 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.542 0.686 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -120.9 50.42 1.35 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.81 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.45 -95.3 0.1 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.46 -140.0 3.98 Favored Glycine 0 N--CA 1.468 0.767 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.472 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.2 167.16 18.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.403 -0.469 . . . . 0.0 110.807 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.731 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.7 m95 -155.07 157.25 37.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.604 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.82 121.59 41.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.64 132.74 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.095 0.474 . . . . 0.0 110.881 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -104.56 110.59 22.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.758 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -38.03 -34.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.136 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -116.14 132.99 22.97 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.414 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.2 Cg_exo -55.92 161.91 7.77 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.371 1.38 . . . . 0.0 112.151 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER 84.69 -4.61 0.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.076 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.9 m-85 84.88 59.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.533 0.521 . . . . 0.0 110.9 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.04 13.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.021 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 -158.33 35.2 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' HH ' ' NE ' ' A' ' 148' ' ' ARG . 4.2 m-30 -66.52 140.7 58.0 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.501 ' N ' ' SD ' ' A' ' 59' ' ' MET . 2.3 mpt? -110.11 87.02 2.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.013 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 36.5 t80 -94.42 135.79 35.44 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.17 91.81 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 111.15 8.84 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 162.36 16.23 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.085 1.857 . . . . 0.0 112.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -51.03 114.57 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.828 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.06 176.71 41.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.4 mt-10 -100.13 153.13 19.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 110.519 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 36.5 m-85 -146.44 91.83 5.31 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 37.0 Cg_endo -66.11 -13.26 39.08 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.093 1.862 . . . . 0.0 113.246 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -149.82 161.14 42.85 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.732 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 41.6 p90 -63.49 -54.14 41.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.4 pt20 -43.5 -9.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 70' ' ' TYR . 84.5 mmt-85 -75.8 -4.48 40.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.59 25.08 10.67 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.823 -0.171 . . . . 0.0 110.95 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 22.7 mmt 85.39 24.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.465 1.103 . . . . 0.0 111.35 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.54 51.07 0.3 Allowed Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.3 mt -76.19 13.94 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.386 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 10.5 t-20 113.39 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.858 1.349 . . . . 0.0 109.493 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' H ' ' ND2' ' A' ' 77' ' ' ASN . 53.4 p-10 -97.35 62.68 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.052 0.453 . . . . 0.0 110.182 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -141.88 118.53 11.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.987 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.15 128.63 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.9 p -110.63 -162.58 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.138 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.9 p -45.64 -179.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.619 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -149.3 149.79 31.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.603 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -115.82 127.85 55.37 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.05 126.49 27.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.277 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.1 t -125.06 131.84 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.649 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.0 159.13 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.598 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -80.89 148.07 63.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.031 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.8 155.23 69.36 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.084 1.856 . . . . 0.0 111.803 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -173.39 -16.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.78 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.5 -36.81 93.63 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.59 55.32 0.77 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 33.8 -106.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.74 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 38.5 t80 -158.06 113.58 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -154.36 132.04 11.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.426 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.5 tt -134.66 143.9 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.194 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.69 131.74 54.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' MET . 14.8 mt -120.33 130.99 73.77 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.97 132.93 55.16 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.048 0.451 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 82.8 tt0 -63.69 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.698 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -117.15 148.32 41.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.12 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 178.27 8.56 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.533 ' N ' ' HG ' ' A' ' 129' ' ' SER . 33.2 t0 54.72 31.25 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.772 0.32 . . . . 0.0 110.5 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 9.7 m-85 55.4 81.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.279 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -159.82 162.52 34.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.79 20.92 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.658 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.39 136.85 39.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.9 tmm? -122.03 131.62 54.08 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.53 137.15 54.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.516 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.73 127.49 47.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.636 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 t -149.5 128.64 12.77 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.0 OUTLIER -90.48 40.47 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 -179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.86 -177.96 5.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.063 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -84.66 159.29 20.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.15 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 45.1 t -132.44 119.59 16.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -79.25 -53.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.495 1.463 . . . . 0.0 111.018 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.9 m -119.08 109.94 16.5 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.7 tt -66.5 -42.58 90.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.355 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 44.1 ttm -66.62 -21.5 66.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.922 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -73.73 -47.48 38.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.241 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.659 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.7 pt20 -101.0 -25.48 14.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 34.9 m-85 -111.47 1.13 16.78 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 51.68 11.38 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.997 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.447 ' H ' ' C ' ' A' ' 122' ' ' PHE . 4.8 mmt -77.58 135.57 38.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -109.36 -28.87 8.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.556 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 35.1 mt-10 -150.36 108.01 3.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.383 0.611 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.39 122.77 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.864 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.8 m80 -104.39 -31.78 9.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.158 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 103' ' ' ASP . 9.4 m -151.71 146.48 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 110.681 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -145.46 132.72 20.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -113.03 -176.25 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.575 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t 53.54 90.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.583 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.601 ' N ' ' CD2' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -105.6 168.09 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.79 111.88 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.91 -86.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.7 t -122.56 149.15 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.74 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -138.11 169.47 17.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.739 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 88.3 mt -145.05 123.51 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -109.39 130.92 55.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -110.5 111.92 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.617 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -52.28 -23.34 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.393 0.433 . . . . 0.0 111.159 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.65 162.09 24.29 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.42 165.28 20.93 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.1 1.867 . . . . 0.0 111.488 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.44 13.87 2.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.965 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.4 m-85 78.78 25.83 0.5 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -109.84 171.5 7.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.739 0.304 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 94.85 170.29 36.94 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.548 ' NE ' ' HH ' ' A' ' 58' ' ' TYR . 94.3 mtt180 -57.47 148.79 22.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 6.3 mp0 -110.18 148.21 32.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.162 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -116.58 130.44 56.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.571 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -144.3 98.24 3.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.268 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 153' ' ' ASP . 93.0 mt -142.93 109.28 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 30.1 t0 35.28 -150.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.937 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.567 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 59.8 pttt -163.18 33.41 0.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -73.3 35.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.766 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 44.4 tt0 71.81 156.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -125.89 111.61 15.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -107.11 -25.67 11.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -119.22 154.04 53.54 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.559 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.527 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -58.81 -15.66 27.69 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.176 1.917 . . . . 0.0 113.729 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.78 -3.29 9.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.313 0.577 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.75 -28.29 68.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.478 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -105.8 23.21 14.28 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 120.826 0.346 . . . . 0.0 110.167 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.1 26.45 72.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.946 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -107.53 139.6 41.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.378 1.089 . . . . 0.0 109.759 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.23 21.25 0.36 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 171.43 154.83 0.22 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.336 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 170' ' ' VAL . 40.1 Cg_endo -68.07 -35.16 20.67 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.641 2.228 . . . . 0.0 111.422 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.92 76.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.801 0.688 . . . . 0.0 110.6 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' A' ' 168' ' ' PRO . 60.4 t -93.84 -98.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.442 ' HB3' ' H ' ' A' ' 172' ' ' SER . 5.3 mm-40 158.79 -140.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -92.62 -156.12 0.46 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.931 0.332 . . . . 0.0 111.704 -177.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -170.3 -177.11 2.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.53 131.72 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.258 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.7 ptt180 -52.46 135.33 33.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.61 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.9 mt -69.6 135.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.458 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.23 156.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.551 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 31.6 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.451 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 p -100.97 -30.7 11.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.634 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -97.56 -3.97 38.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.632 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.0 p -80.0 42.37 0.55 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.577 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.36 161.04 21.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.544 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 3.7 p -116.26 118.58 33.17 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 22' ' ' ASP . 31.1 tttt -99.64 159.61 14.91 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.846 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -146.5 140.85 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.823 0.344 . . . . 0.0 111.613 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 90.6 m -126.61 138.87 53.5 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 110.554 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -118.23 116.55 27.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 92.9 m-85 -97.1 139.77 32.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 110.879 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.5 tm-20 -61.58 -52.61 63.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.764 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 99.0 m-20 -95.27 -178.15 4.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -81.89 -178.15 6.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 47.17 26.04 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.001 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER 62.35 42.48 9.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.414 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -109.79 176.43 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.09 -156.81 52.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.639 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -55.21 174.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.69 148.22 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' CE2' ' SG ' ' A' ' 23' ' ' CYS . 51.4 t80 -130.69 132.73 45.55 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 28.6 t0 -118.4 143.42 46.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.775 0.321 . . . . 0.0 110.53 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -160.46 139.57 10.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 35.3 t70 -121.54 21.82 10.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.49 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.37 148.81 28.58 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.048 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 2.8 t70 -38.08 155.77 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 10.7 t -154.71 160.58 41.45 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.44 -56.66 2.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.022 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 41.1 p-10 -152.35 108.6 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.9 9.05 43.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -58.47 -27.48 64.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.039 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.8 p -64.26 -29.73 70.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.953 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.17 -11.63 46.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.6 tp -143.72 137.46 28.16 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -98.32 -12.01 21.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.49 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.4 ttm180 -154.46 143.13 20.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.235 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -114.34 108.06 16.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.648 0.737 . . . . 0.0 110.57 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 39' ' ' SER . 56.9 m-20 -117.61 -156.04 0.62 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.608 -1.178 . . . . 0.0 107.979 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.1 p -18.2 138.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.811 0.694 . . . . 0.0 112.748 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.8 mt -141.98 146.49 22.7 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.709 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -156.57 103.26 2.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.68 146.07 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.517 0.675 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -117.47 50.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.483 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.32 -96.56 0.1 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.796 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.14 -142.14 4.63 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 97.0 m -81.85 166.88 19.57 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.187 0.517 . . . . 0.0 110.956 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.624 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 23.5 m95 -155.2 157.59 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.981 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.89 121.2 40.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.281 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.94 132.06 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 52' ' ' ARG . 57.7 m-85 -104.3 111.12 23.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.527 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 50' ' ' TYR . 45.7 tt0 -32.69 -34.15 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.316 0.385 . . . . 0.0 111.216 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 50' ' ' TYR . 27.3 mtm180 -124.86 158.22 63.51 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 5.8 Cg_exo -71.18 163.47 39.06 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.391 2.06 . . . . 0.0 112.221 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.653 HD22 ' CB ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 86.66 -11.24 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.816 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' N ' HD21 ' A' ' 54' ' ' ASN . 9.8 m-85 85.56 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.844 0.715 . . . . 0.0 111.595 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.653 ' CB ' HD22 ' A' ' 54' ' ' ASN . . . -149.82 118.85 6.71 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.243 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' HE ' ' A' ' 52' ' ' ARG . . . 122.72 127.42 3.29 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 22.24 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.703 0.401 . . . . 0.0 111.402 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.8 mtt -92.04 86.26 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 24.0 t80 -91.18 141.69 28.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.58 93.07 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 111.92 14.26 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.78 164.01 13.98 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.046 1.83 . . . . 0.0 113.203 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -50.92 111.74 0.6 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.24 171.46 39.27 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.28 155.1 16.9 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.99 0.424 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 56.4 m-85 -149.01 84.23 6.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.702 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -54.09 -14.34 6.03 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.894 2.396 . . . . 0.0 112.814 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -155.45 162.88 40.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 7.9 p90 -64.78 -52.35 57.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.499 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -39.87 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.1 tpm_? -75.79 -5.17 44.54 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.421 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -116.71 25.66 10.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.196 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 mmt 88.78 25.18 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.119 0.967 . . . . 0.0 111.632 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 33.35 55.7 0.58 Allowed Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.318 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.8 mt -88.23 11.12 17.31 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 41.5 t30 87.52 139.3 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.66 0.6 . . . . 0.0 109.912 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 16.0 p-10 -37.88 -95.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.661 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER 27.15 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.55 128.05 20.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 82' ' ' SER . 6.8 p -110.23 -163.15 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.387 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.5 p -45.81 -179.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 110.761 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.624 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 26.5 p -150.8 152.53 33.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.263 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -114.78 127.03 55.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.47 122.08 14.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.55 130.97 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -102.73 162.52 12.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.963 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.32 155.85 69.11 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.88 154.14 53.34 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.666 2.244 . . . . 0.0 111.992 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 p -163.11 -19.17 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.785 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.47 49.24 3.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . 155.78 39.85 0.02 OUTLIER Glycine 0 C--O 1.222 -0.595 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.9 pt20 34.59 -106.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 35.8 t80 -158.43 113.26 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 36.0 tptt -154.68 133.57 12.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.19 0.519 . . . . 0.0 111.461 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.7 tt -136.0 145.05 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.253 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.9 mt-30 -123.25 131.42 53.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.526 -1.216 . . . . 0.0 107.942 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 108' ' ' MET . 12.8 mt -119.96 131.9 71.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.036 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -114.1 130.93 56.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 0.0 110.697 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -119.01 147.34 44.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.88 172.02 15.94 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.9 t70 59.75 31.91 21.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.815 0.34 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 54.5 81.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -159.13 163.36 36.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.486 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -151.73 24.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -73.61 135.86 43.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.644 0.259 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 9.3 tmm? -121.83 132.03 54.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.202 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.503 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.0 m-85 -121.52 136.05 54.98 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.74 123.5 41.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.555 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -151.77 126.43 9.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.689 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -92.34 43.44 1.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -142.77 -179.34 6.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 11.4 p-10 -85.2 158.92 20.23 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.536 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.6 m -136.59 121.64 12.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.87 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 172' ' ' SER . 69.0 Cg_endo -77.11 -53.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.768 1.645 . . . . 0.0 111.413 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 m -118.58 109.15 15.83 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 119' ' ' MET . 4.9 tt -66.17 -42.68 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 111.254 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.2 ttt -66.08 -18.45 65.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -82.37 -43.3 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.719 -0.613 . . . . 0.0 111.938 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.84 -31.79 14.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.006 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 28.0 m-85 -115.82 5.8 14.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 51.32 13.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.253 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' C ' ' A' ' 122' ' ' PHE . 2.2 mmt -78.23 133.84 37.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -107.4 -29.55 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.561 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 25.9 mt-10 -150.45 109.14 3.84 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.155 0.502 . . . . 0.0 111.167 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.9 mm -75.03 124.71 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.062 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.3 m80 -104.77 -32.22 8.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.172 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.9 m -154.52 149.28 26.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.05 145.87 32.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.647 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -122.48 -176.91 3.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.668 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.1 t 50.66 92.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.649 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 7.5 mp -107.57 168.57 9.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.121 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.9 mp0 -142.04 112.48 7.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.13 -88.18 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.4 t -119.61 153.72 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.236 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.7 t-105 -141.83 169.32 17.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.767 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.2 mt -144.51 122.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.41 131.87 54.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -110.87 111.72 23.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.92 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -50.38 -21.92 1.64 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.0 mp -119.53 161.62 36.58 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 0.0 110.377 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.8 Cg_endo -77.39 168.25 23.19 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.1 m-80 73.67 11.95 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 78.76 27.92 0.44 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.329 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -112.87 172.3 7.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.75 172.49 42.48 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.598 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.74 156.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 110.239 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.595 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 13.2 mp0 -121.94 126.83 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -107.57 130.78 54.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.1 tt -147.34 95.13 2.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.13 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.59 116.61 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.915 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.49 138.15 50.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.169 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -158.68 -44.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.404 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -174.74 72.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.558 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.74 -174.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -130.65 108.63 10.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.002 0.43 . . . . 0.0 110.851 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -104.8 -25.92 12.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.016 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -119.83 154.79 55.3 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.608 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 13.7 Cg_endo -58.68 -19.7 47.05 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.23 1.953 . . . . 0.0 113.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.6 mp -99.34 -2.81 9.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.131 0.491 . . . . 0.0 110.704 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.2 -28.16 67.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.547 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -106.87 21.73 17.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.354 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.57 69.9 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 121.134 -0.555 . . . . 0.0 114.283 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.492 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -105.92 138.16 42.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.217 1.008 . . . . 0.0 109.765 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.36 20.2 0.16 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 168.99 155.96 0.17 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.845 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.01 7.13 3.0 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.081 2.52 . . . . 0.0 111.502 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.11 70.52 9.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.046 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.646 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.3 t -99.27 -147.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.646 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.6 tp60 -160.47 -131.68 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.696 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.01 -157.59 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -169.81 -177.4 2.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.189 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.94 131.28 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.79 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -52.59 135.46 34.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.149 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.3 mt -69.3 134.42 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.6 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 43.5 t -137.71 156.55 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.658 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 27.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.616 ' C ' ' H ' ' A' ' 4' ' ' THR . 1.5 m -100.49 78.62 2.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.105 0.478 . . . . 0.0 110.563 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 60.73 -4.97 0.11 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.616 ' H ' ' C ' ' A' ' 2' ' ' SER . 3.7 m 39.39 72.64 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.927 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.18 161.61 28.5 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p -84.72 161.08 20.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.242 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.749 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 39.7 tttt -159.75 151.25 19.95 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.11 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 tt -147.1 141.97 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.4 m -124.63 138.52 54.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.47 116.22 25.67 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.449 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.93 137.75 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.92 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 7.7 tm-20 -60.66 -48.99 79.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.156 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -99.1 -176.07 3.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 109.917 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.56 -176.72 6.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.282 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.8 23.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.883 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.542 ' H ' ' HG ' ' A' ' 39' ' ' SER . 3.4 m-85 63.48 41.76 7.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.235 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.65 174.38 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.604 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.82 -154.97 53.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.66 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -56.26 172.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.94 152.19 5.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -136.22 133.89 37.55 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -121.03 138.2 54.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.698 0.285 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 141.61 25.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.61 16.74 9.58 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.671 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -149.71 146.54 27.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -38.53 156.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.713 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 39.8 t -157.49 163.43 38.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.79 -56.3 3.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.817 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -153.58 112.51 3.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.5 p90 -101.87 8.58 41.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.041 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' LEU . 79.3 t60 -60.33 -27.57 67.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.494 0.664 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.4 p -60.79 -29.37 69.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -89.1 -15.27 34.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.527 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.23 137.65 32.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.954 0.407 . . . . 0.0 110.17 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -99.31 -7.76 25.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 52.5 ttm-85 -156.78 145.75 20.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.865 0.364 . . . . 0.0 110.575 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p -112.26 104.18 12.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.731 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.1 m-20 -129.78 157.55 41.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.731 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 34.24 127.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.581 1.181 . . . . 0.0 112.398 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.6 mt -141.2 146.08 24.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.187 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -154.06 102.96 2.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.25 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 4.4 t -66.89 149.18 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.478 0.656 . . . . 0.0 110.389 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -122.17 50.94 1.4 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.919 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.13 -95.73 0.1 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.967 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.16 -138.59 3.78 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 56.1 m -82.84 166.99 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.593 -0.357 . . . . 0.0 110.745 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.749 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.5 m95 -153.68 155.57 36.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.577 0.703 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.77 122.16 44.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.026 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 m -118.29 132.07 69.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.189 0.518 . . . . 0.0 110.871 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 52' ' ' ARG . 89.3 m-85 -101.5 108.49 20.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.919 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' TYR . 39.6 tt0 -32.21 -37.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.407 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.59 HH21 ' N ' ' A' ' 57' ' ' GLY . 62.0 mtm180 -119.5 148.9 46.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.808 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 39.8 Cg_endo -67.78 163.8 33.93 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.559 2.173 . . . . 0.0 111.901 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 82.56 -3.27 1.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.119 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 81.79 56.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.438 0.461 . . . . 0.0 110.965 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.68 171.24 14.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.785 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.59 ' N ' HH21 ' A' ' 52' ' ' ARG . . . 87.44 -161.65 32.69 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -63.97 -179.18 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -146.44 126.39 13.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -132.14 135.09 46.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.564 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -101.34 89.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 110.8 7.05 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.95 161.85 18.37 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.181 1.921 . . . . 0.0 112.519 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -52.35 117.31 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.247 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.74 179.32 41.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.06 152.97 20.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 18.8 m-85 -145.67 84.6 8.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.7 Cg_exo -56.65 -17.78 23.87 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.145 2.563 . . . . 0.0 113.028 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -149.88 161.18 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 16.4 p90 -62.68 -49.66 74.24 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.521 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -44.19 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.9 mmt180 -76.38 -5.19 46.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.015 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.673 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -116.66 26.94 9.5 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.469 -0.144 . . . . 0.0 111.249 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.0 mmt 88.97 19.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.342 1.027 . . . . 0.0 111.316 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 32.51 59.65 0.4 Allowed Glycine 0 N--CA 1.467 0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.336 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 mt -79.75 -67.59 0.75 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -159.93 163.86 33.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 54.7 p-10 -91.42 58.58 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 16.8 tpp180 -138.32 115.9 11.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.79 128.26 21.3 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 82' ' ' SER . 3.2 p -111.4 -162.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.605 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 m -44.65 179.85 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.322 0.582 . . . . 0.0 110.664 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.606 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 17.7 p -148.57 146.69 28.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.733 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -113.11 126.02 55.01 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.66 126.37 27.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.5 t -126.52 132.05 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.553 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -115.1 121.39 42.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.163 0.506 . . . . 0.0 110.253 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.677 ' H ' ' CD1' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -46.15 163.21 0.23 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.952 -179.44 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.07 163.35 30.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.756 2.304 . . . . 0.0 111.961 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 t -163.97 -25.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.631 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.36 -63.33 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.593 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -84.73 43.96 3.3 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.6 pt20 34.36 -108.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.714 0.292 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.4 t80 -157.77 113.63 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.237 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 110' ' ' GLU . 25.3 tptp -153.95 131.4 11.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.123 0.487 . . . . 0.0 111.424 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.416 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -133.05 141.24 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.354 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.25 130.16 53.53 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.3 mt -119.34 130.6 73.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 -178.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.09 129.91 56.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.821 0.343 . . . . 0.0 110.802 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.04 -31.01 70.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.713 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.21 146.26 39.61 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' PHE . . . -47.98 -93.08 0.01 OUTLIER Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 104' ' ' PHE . 38.7 p-10 -38.28 98.58 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' C ' ' O ' ' A' ' 103' ' ' ASP . 23.7 m-85 -8.99 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.216 0.948 . . . . 0.0 112.046 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' ASP . 38.0 m -153.88 163.28 40.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 -151.53 20.14 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.115 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -73.11 135.55 44.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.481 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 44.3 ttp -120.95 124.52 45.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.614 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.5 m-85 -116.23 134.37 54.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 95' ' ' LYS . 1.9 pt-20 -120.96 119.26 32.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.018 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 111' ' ' THR . 6.1 t -148.98 125.11 10.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.78 44.42 1.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.14 -177.33 5.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.583 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.0 p-10 -87.07 155.96 19.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.127 0.489 . . . . 0.0 110.087 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 172' ' ' SER . 53.6 t -133.16 124.25 18.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.75 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.734 1.622 . . . . 0.0 110.789 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.602 ' CA ' ' HG ' ' A' ' 172' ' ' SER . 57.8 m -115.69 112.83 22.66 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.549 ' N ' ' OG ' ' A' ' 172' ' ' SER . 3.8 tt -68.68 -45.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.523 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.3 ttt -66.06 -19.47 65.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.436 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -76.25 -45.82 31.0 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.004 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.5 pt20 -100.74 -25.81 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 35.0 m-85 -110.25 1.71 18.79 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 52.05 9.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.118 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.47 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -75.91 133.69 40.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -107.52 -30.01 8.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.492 -178.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -149.31 109.28 4.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.87 124.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.792 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.0 m80 -105.79 -30.3 9.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.191 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 102' ' ' GLY . 15.7 t -152.68 147.82 26.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.0 111.196 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -149.22 126.88 11.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.978 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -107.91 -169.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.499 . . . . 0.0 110.468 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t 51.3 89.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.41 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 4.1 mm? -104.37 168.5 9.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.092 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -142.02 111.18 6.37 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 34.19 -91.47 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.016 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.0 t -115.28 138.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.7 t-105 -130.23 168.07 17.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 76.3 mt -144.61 121.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.825 0.345 . . . . 0.0 111.4 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -108.62 130.4 55.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -107.89 111.22 23.23 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.099 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -51.19 -25.67 5.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.99 160.73 28.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 92.2 Cg_endo -79.94 164.87 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.38 2.053 . . . . 0.0 111.583 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.683 ' ND2' HH21 ' A' ' 146' ' ' ARG . 3.2 m-80 74.61 15.97 3.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.32 25.35 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.683 HH21 ' ND2' ' A' ' 144' ' ' ASN . 90.4 mtm180 -108.35 168.32 9.4 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 97.87 168.05 32.11 Favored Glycine 0 N--CA 1.462 0.389 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' H ' HH11 ' A' ' 148' ' ' ARG . 0.1 OUTLIER -64.98 137.27 57.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 147' ' ' GLY . 1.4 mp0 -84.21 145.81 28.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -111.54 129.91 55.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.351 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.0 tp -146.32 93.97 2.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.845 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 153' ' ' ASP . 6.0 tp -149.9 145.08 26.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.088 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 152' ' ' LEU . 99.6 m-20 55.88 159.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -156.18 58.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.32 -45.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.346 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -178.85 150.01 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.199 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.448 ' O ' ' OG ' ' A' ' 129' ' ' SER . 3.3 m-85 -122.09 108.33 13.23 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.536 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -108.92 -19.73 13.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -121.23 156.15 57.75 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.687 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.549 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.5 Cg_endo -61.64 -16.39 48.01 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.652 2.235 . . . . 0.0 113.239 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.9 mp -100.65 -2.85 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.807 0.337 . . . . 0.0 110.779 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -27.46 68.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.549 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.47 21.85 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.389 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.14 26.91 71.19 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.213 -0.517 . . . . 0.0 114.242 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.467 ' HB2' ' HE1' ' A' ' 163' ' ' TRP . . . -107.88 139.21 42.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.847 0.823 . . . . 0.0 109.812 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.22 20.75 0.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 173.4 153.4 0.25 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.823 -179.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.57 4.38 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 123.023 2.482 . . . . 0.0 111.614 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.33 70.28 4.66 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.616 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.26 -153.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.616 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 70.8 mm-40 -152.7 -131.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.602 ' HG ' ' CA ' ' A' ' 117' ' ' SER . 1.1 m -94.18 -153.67 0.38 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -170.52 -176.25 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -161.08 133.78 6.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.454 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.466 ' CG ' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.95 135.4 42.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.45 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 13.9 mt -67.56 139.16 21.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.986 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.34 155.72 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.61 179.775 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 4' ' ' THR . 30.3 p -147.76 149.33 32.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.73 0.3 . . . . 0.0 110.271 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 56.94 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.6 p 43.0 26.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.16 43.22 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 4' ' ' THR . 41.5 p -143.38 134.44 25.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.501 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.778 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.2 tttt -160.42 153.24 21.24 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.069 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.39 142.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 122.108 -0.37 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 138.81 53.98 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.964 0.412 . . . . 0.0 110.699 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -119.14 115.01 23.36 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.8 m-85 -94.08 137.96 32.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.14 0.495 . . . . 0.0 110.947 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.22 -49.02 79.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.158 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' OG ' ' A' ' 39' ' ' SER . 83.1 m-20 -100.97 -174.72 2.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.58 -174.97 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 111.633 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.21 23.28 0.19 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.851 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.7 m-85 59.19 44.43 15.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.29 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -115.35 160.67 19.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.355 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.32 -151.4 29.74 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.477 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -56.73 172.36 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -170.56 153.29 4.15 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -135.01 133.81 39.8 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.9 p-10 -120.76 137.63 54.41 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 141.49 25.94 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 8.5 t70 -124.32 15.8 9.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 97.2 m -150.31 147.17 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.35 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 38.1 t0 -37.64 155.55 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.512 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.554 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 43.8 t -155.66 161.91 40.69 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.41 -57.62 2.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.62 112.71 4.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -102.17 8.11 40.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.972 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' O ' ' O ' ' A' ' 34' ' ' LEU . 75.0 t60 -59.0 -29.35 67.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.536 0.684 . . . . 0.0 109.91 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.6 p -60.34 -29.76 69.09 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.01 -15.35 36.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.7 tp -140.87 137.2 33.04 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 t -99.67 -9.02 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.36 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.498 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 14.3 ttm180 -154.18 143.13 21.1 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.238 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 4.6 p -110.47 104.6 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.735 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.0 m-20 -129.32 155.85 44.96 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.735 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 36.47 129.6 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.691 1.244 . . . . 0.0 112.218 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.291 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.0 ptpt -155.87 102.84 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.103 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -65.85 151.05 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.402 0.62 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' N ' HG13 ' A' ' 42' ' ' VAL . 92.3 mt-10 -123.35 51.53 1.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.082 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.27 -96.14 0.1 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.974 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.52 -140.9 4.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 48.8 m -81.43 166.84 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.601 -0.352 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.778 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -154.01 155.39 35.46 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.253 0.549 . . . . 0.0 110.688 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.86 118.33 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m -115.98 131.43 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.052 0.453 . . . . 0.0 110.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.56 111.99 24.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 76.0 tt0 -38.98 -34.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -113.55 147.19 37.01 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.8 Cg_endo -68.01 157.76 60.35 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.733 2.289 . . . . 0.0 111.309 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.8 m120 86.5 -2.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.329 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.6 m-85 85.61 59.14 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.306 0.379 . . . . 0.0 111.261 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . -149.99 178.77 8.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.022 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 60.56 124.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 6.0 m-85 16.34 104.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.074 0.55 . . . . 0.0 112.26 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.7 OUTLIER -99.57 101.86 13.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.341 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.6 m-85 -103.52 149.76 24.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.098 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -107.47 98.78 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -76.65 114.26 37.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.25 163.61 17.35 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.298 1.998 . . . . 0.0 112.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.52 115.24 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.87 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.28 176.31 41.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -100.68 154.67 18.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.159 0.504 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 41.6 m-85 -147.34 86.59 6.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.614 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_exo -57.15 -18.32 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.967 2.444 . . . . 0.0 112.761 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -148.45 161.71 41.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.735 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.6 p90 -65.4 -53.18 46.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 28.8 mt-30 -43.18 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.903 0.382 . . . . 0.0 111.894 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.14 -4.17 40.13 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.735 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.81 23.33 11.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.824 -0.171 . . . . 0.0 110.838 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.4 mmt 89.84 23.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.535 1.147 . . . . 0.0 111.661 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 29.85 54.36 0.2 Allowed Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 17.4 mt -82.63 14.87 2.86 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.953 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER 112.73 163.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 125.263 1.602 . . . . 0.0 109.771 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 53.4 p30 -94.73 64.99 3.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.675 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 35.9 ttm180 -142.07 118.75 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.5 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.76 129.34 20.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 109.784 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 82' ' ' SER . 2.8 p -110.07 -163.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.0 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.5 m -45.33 -179.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.499 . . . . 0.0 110.879 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.613 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 14.4 p -150.46 152.22 33.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -116.99 128.66 55.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.89 123.24 17.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.118 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.23 133.06 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -103.68 161.42 13.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.061 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -76.84 159.57 78.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.477 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.2 150.73 53.96 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.536 2.157 . . . . 0.0 112.209 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.7 p -155.52 169.34 24.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.467 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 76.28 -71.57 2.01 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -74.98 32.3 1.07 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 91' ' ' GLY . 4.9 pt20 34.16 -106.44 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.27 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 34.4 t80 -156.15 114.17 3.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.343 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.4 tptm -155.62 133.01 10.96 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.148 0.499 . . . . 0.0 111.034 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.9 tt -135.03 145.64 31.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.95 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -123.57 130.77 53.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.748 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.5 mt -119.98 131.04 73.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.167 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.7 m-85 -111.83 130.01 55.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.964 0.411 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.27 -28.11 68.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.65 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -122.55 148.54 45.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.206 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.24 -171.48 1.25 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.43 ' N ' ' HG ' ' A' ' 129' ' ' SER . 34.3 t0 46.33 29.22 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.404 . . . . 0.0 110.464 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 54.67 82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 m -160.32 161.04 33.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.838 0.351 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.85 -153.11 22.21 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -72.58 137.58 46.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 110.641 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.452 ' SD ' ' CZ ' ' A' ' 99' ' ' PHE . 53.0 ttp -122.13 127.11 49.71 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.827 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.421 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -118.07 134.97 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 110.65 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.68 116.74 25.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.052 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.22 126.48 24.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.978 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.6 OUTLIER -93.24 36.38 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.35 -179.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.04 -177.65 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.732 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p30 -85.68 160.13 19.64 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.32 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.498 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.2 t -136.03 124.86 15.63 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.669 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 57.4 Cg_endo -78.61 -53.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.208 1.939 . . . . 0.0 110.855 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.3 m -120.26 113.11 19.92 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 119' ' ' MET . 3.8 tt -67.91 -46.18 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.653 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.48 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 26.9 ttt -64.73 -20.6 66.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.101 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.38 -49.18 35.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 3.9 pt20 -100.16 -23.04 14.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.167 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 33.9 m-85 -111.09 -0.1 16.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.855 0.359 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.1 m-70 52.14 10.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.281 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.457 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.2 mtt -78.58 134.5 37.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -107.3 -27.5 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 48.4 mt-10 -151.19 107.5 3.46 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.075 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -73.67 124.98 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.757 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.3 m80 -105.48 -33.43 8.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.035 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' A' ' 103' ' ' ASP . 13.5 m -152.31 147.46 26.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.986 0.422 . . . . 0.0 110.73 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -145.36 137.46 25.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.776 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -116.07 -173.24 2.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.374 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t 49.21 94.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.41 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 27.1 mt -111.93 168.49 9.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' VAL . 4.3 mp0 -140.62 112.5 7.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.5 -90.77 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 134' ' ' GLU . 10.6 t -117.26 156.29 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.6 t-105 -144.63 169.18 18.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.456 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.7 mt -144.23 123.05 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -111.47 131.41 55.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -109.17 111.29 22.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -50.11 -21.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.247 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.4 mp -119.37 165.69 16.63 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 86.6 Cg_endo -83.46 167.79 13.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.334 2.023 . . . . 0.0 111.961 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER 79.78 14.57 0.94 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.956 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.4 m-85 76.01 28.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.143 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 80.5 mtp180 -136.81 130.21 31.53 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.92 169.14 20.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -51.96 98.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.213 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.616 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 75.5 mt-30 -60.72 133.8 56.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.711 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.4 130.06 56.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.977 0.418 . . . . 0.0 110.822 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 37.3 tp -69.83 134.5 48.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.219 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.31 148.08 45.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.881 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 155' ' ' LYS . 55.1 t0 -121.5 131.56 54.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.125 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -56.84 78.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.465 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 153' ' ' ASP . 49.4 mtpt -145.59 -91.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -174.39 150.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.85 109.6 12.15 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -105.87 -23.21 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' CB ' ' NZ ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.96 157.3 50.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 121.271 0.558 . . . . 0.0 110.784 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.526 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.1 Cg_endo -61.65 -19.38 64.82 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.164 1.909 . . . . 0.0 113.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -98.81 -2.27 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.107 0.479 . . . . 0.0 110.756 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.66 -24.87 64.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.153 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.8 OUTLIER -110.36 21.95 16.08 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.54 66.49 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.591 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -108.27 137.01 46.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.988 0.894 . . . . 0.0 109.437 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.79 21.33 0.16 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 168.1 156.64 0.14 Allowed Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 6.69 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.061 2.507 . . . . 0.0 111.461 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.99 70.87 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.694 0.283 . . . . 0.0 111.35 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.632 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.1 t -99.03 -150.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.632 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 16.6 mm-40 -155.99 -132.97 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.356 0 O-C-N 123.14 0.275 . . . . 0.0 110.426 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 3.3 p -93.4 -155.81 0.46 Allowed 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 122.081 -0.387 . . . . 0.0 111.992 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -171.5 -176.04 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.033 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -158.31 133.1 8.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.157 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' N ' ' HH ' ' A' ' 94' ' ' TYR . 34.2 ptt180 -51.9 134.37 31.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.235 0.541 . . . . 0.0 110.649 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 11.5 mt -68.58 134.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.902 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.15 157.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.255 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 46' ' ' THR . 17.6 tp10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -179.03 -168.34 0.13 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.73 -43.08 97.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.577 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p -113.46 10.65 18.27 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.489 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.9 100.45 2.09 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.2 p -143.03 133.2 24.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.92 0.39 . . . . 0.0 110.534 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.759 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -159.22 152.3 22.17 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.096 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -147.49 142.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.816 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 m -125.98 138.97 53.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -119.12 115.75 24.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 84.1 m-85 -95.24 138.23 33.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.49 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.1 tm-20 -61.24 -49.36 77.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.067 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 99.6 m-20 -98.03 -177.51 3.77 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.103 0.477 . . . . 0.0 109.842 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.7 -176.54 6.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.876 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.58 24.43 0.32 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.778 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.708 ' H ' ' HG ' ' A' ' 39' ' ' SER . 2.5 m-85 62.07 41.61 10.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.157 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -109.11 172.99 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.114 0.483 . . . . 0.0 110.535 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.77 -155.3 52.82 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.439 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -55.77 175.08 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.8 154.58 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 55.9 t80 -130.76 131.58 44.8 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 45.7 p-10 -119.66 125.99 50.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.964 0.412 . . . . 0.0 111.197 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -152.79 143.17 22.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.372 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -126.53 24.58 6.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.809 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ASP . 4.4 t -146.79 141.95 27.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.602 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' CYS . 51.7 p-10 -37.16 156.02 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 m -157.95 163.22 38.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.27 -56.63 2.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 38.8 p-10 -152.43 112.26 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -102.19 9.2 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.985 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' O ' ' O ' ' A' ' 34' ' ' LEU . 81.6 t60 -59.66 -28.27 67.11 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.458 0.647 . . . . 0.0 109.964 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -61.27 -30.48 70.5 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.425 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -86.63 -14.06 43.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.97 136.35 30.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.136 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 m -94.86 -10.12 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.495 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.607 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 58.7 ttp180 -158.7 146.86 18.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.474 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.2 m -110.67 104.61 13.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.416 0.627 . . . . 0.0 111.391 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.741 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.8 m-20 -129.33 156.8 43.45 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.348 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.741 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.3 p 35.52 128.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.42 1.105 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.4 mt -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.385 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.2 ptpt -154.67 102.92 2.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.57 150.17 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.448 0.642 . . . . 0.0 110.226 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 42' ' ' VAL . 93.1 mt-10 -123.1 51.68 1.43 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.964 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.06 -96.2 0.1 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.218 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.25 -141.89 4.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 83.8 m -79.86 166.34 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.759 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.7 m95 -154.65 155.48 34.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.496 0.665 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.36 121.62 42.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.382 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.8 133.54 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.014 0.435 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 52' ' ' ARG . 77.9 m-85 -104.41 109.82 21.83 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 74.0 tt0 -33.55 -33.29 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.644 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 29.9 mtp85 -121.71 151.48 57.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 56.0 Cg_endo -69.92 164.2 35.58 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.764 2.309 . . . . 0.0 112.158 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 4.6 m-80 78.99 -8.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.884 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.9 m-85 81.5 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.5 0.5 . . . . 0.0 110.742 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 52' ' ' ARG . . . -150.01 111.14 4.38 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.874 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 162.45 -66.54 0.24 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' CD1' ' OE1' ' A' ' 51' ' ' GLU . 54.0 m-85 -152.04 178.07 9.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 66.3 mtt -142.09 87.71 2.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.2 t80 -108.96 135.89 49.4 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.65 91.02 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -70.32 111.86 10.81 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.82 163.51 16.02 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.111 1.874 . . . . 0.0 112.739 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -52.7 116.87 2.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.151 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.64 178.77 42.23 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.528 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.1 mt-10 -101.55 152.4 20.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.002 0.43 . . . . 0.0 110.336 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 22.6 m-85 -144.29 89.52 6.96 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.36 -14.73 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.223 1.948 . . . . 0.0 113.331 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -150.26 161.06 43.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.685 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 15.0 p90 -63.26 -50.06 71.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.759 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 30.2 mt-30 -45.0 -9.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' H ' ' C ' ' A' ' 70' ' ' TYR . 22.8 mmm180 -75.18 -5.41 44.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.685 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.11 25.98 9.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 75' ' ' GLY . 21.8 mmm 84.93 24.55 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.131 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.4 54.02 0.31 Allowed Glycine 0 N--CA 1.474 1.196 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 30.8 mt -78.98 14.44 1.39 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.148 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 60.0 t30 112.61 164.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.039 1.462 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 52.7 p30 -96.45 65.93 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.57 120.23 10.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.121 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -142.77 129.73 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 82' ' ' SER . 1.7 p -111.19 -162.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.578 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.99 -178.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 110.793 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.614 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.8 p -149.75 150.49 32.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -115.99 127.42 54.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 126.39 27.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.309 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.4 t -123.84 131.19 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.704 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -101.66 161.78 13.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.019 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.06 157.52 71.1 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.24 150.8 53.8 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.31 2.007 . . . . 0.0 112.023 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.4 p -161.9 -19.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.806 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.02 51.72 2.85 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . 153.26 37.61 0.03 OUTLIER Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 35.04 -106.76 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 111.131 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.8 t80 -157.21 113.45 2.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.111 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HZ1' ' CB ' ' A' ' 110' ' ' GLU . 27.1 tptp -154.68 130.99 10.41 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.3 tt -134.26 142.58 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.0 mt-30 -123.11 130.59 52.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.49 131.84 70.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.208 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -112.77 131.61 55.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.36 -29.99 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 150.26 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.3 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.5 176.24 14.6 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 55.75 30.58 15.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 6.1 m-85 56.0 83.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -160.58 161.18 32.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.955 0.407 . . . . 0.0 110.569 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.6 -149.36 21.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -77.22 138.59 39.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.671 0.272 . . . . 0.0 110.483 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.3 tmm? -122.23 132.96 54.69 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.055 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 58.1 m-85 -122.1 135.86 54.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.441 ' CB ' ' HZ1' ' A' ' 95' ' ' LYS . 3.6 pt-20 -123.11 124.2 42.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.445 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -147.75 128.57 14.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 p -92.92 38.78 1.03 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.62 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 -177.62 5.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.761 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.4 p-10 -85.51 158.51 20.15 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.7 t -132.8 124.23 18.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.372 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.5 Cg_endo -79.57 -56.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.606 1.537 . . . . 0.0 110.958 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.639 ' CA ' ' HG ' ' A' ' 172' ' ' SER . 19.7 m -116.05 113.03 22.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.533 ' N ' ' OG ' ' A' ' 172' ' ' SER . 3.8 tt -69.76 -46.59 74.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-O 121.168 0.509 . . . . 0.0 110.787 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.471 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.1 ttt -65.48 -18.87 65.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.243 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.36 -46.36 33.61 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 121.606 -0.684 . . . . 0.0 111.992 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.45 -24.74 14.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.254 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.3 m-85 -111.28 -0.55 16.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.022 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 52.76 12.13 0.24 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.982 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -79.28 133.12 36.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -107.55 -26.94 10.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.545 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.9 mt-10 -150.83 108.27 3.63 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.08 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.7 mm -74.7 125.97 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.794 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -107.37 -32.27 7.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.332 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 130' ' ' CYS . 13.5 t -153.59 147.21 25.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.29 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.528 ' N ' ' HG ' ' A' ' 129' ' ' SER . 0.7 OUTLIER -146.72 129.18 15.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.735 179.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 132' ' ' VAL . 43.9 mtmt -99.83 -157.88 0.63 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.016 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.578 ' O ' ' O ' ' A' ' 131' ' ' LYS . 1.1 m 32.39 110.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.906 0.86 . . . . 0.0 112.058 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.98 166.87 11.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.766 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.2 mp0 -142.75 111.07 6.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.781 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . 35.03 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.603 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.9 t -117.25 156.31 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 110.165 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 25.9 t-105 -145.36 168.2 21.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.379 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 91.0 mt -145.39 123.79 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.759 0.314 . . . . 0.0 111.377 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -108.77 130.22 55.38 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.03 110.81 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.83 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -49.46 -22.51 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.7 mp -118.47 161.01 37.6 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.42 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 74.1 Cg_endo -77.97 167.44 23.6 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.324 2.016 . . . . 0.0 111.68 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' ND2' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 73.14 14.12 4.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.921 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.2 24.52 0.66 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.636 0.255 . . . . 0.0 111.306 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -108.49 168.96 8.95 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.07 170.43 36.63 Favored Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -55.52 150.32 12.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.148 0.499 . . . . 0.0 109.771 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 7.1 mp0 -108.8 146.7 33.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.665 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -115.46 130.01 56.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 59' ' ' MET . 4.0 tt -150.76 113.42 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.5 tp -150.25 135.71 18.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.232 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 25.2 p30 -86.85 107.86 18.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.543 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -138.38 -116.36 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.565 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -169.3 95.83 0.32 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.48 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 63.61 155.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.467 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.14 108.6 14.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.009 0.433 . . . . 0.0 111.381 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.659 ' HE ' ' HZ1' ' A' ' 159' ' ' LYS . 40.2 ptt180 -107.59 -24.69 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.659 ' HZ1' ' HE ' ' A' ' 158' ' ' ARG . 14.2 pttm -119.82 154.06 54.98 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 120.84 0.353 . . . . 0.0 110.492 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.537 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.3 Cg_endo -58.42 -16.63 29.97 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.31 2.006 . . . . 0.0 113.5 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 161' ' ' ILE . 2.3 mp -100.93 -3.68 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.15 -27.16 68.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.481 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.537 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -107.7 20.69 18.49 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.642 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.43 28.41 67.8 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.626 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.479 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.25 137.67 45.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.792 0.796 . . . . 0.0 109.72 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.11 20.81 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.314 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 171.48 155.47 0.22 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.477 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.64 5.0 5.11 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.952 2.435 . . . . 0.0 111.596 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.59 70.92 6.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.612 0.244 . . . . 0.0 111.153 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.65 ' CG1' ' H ' ' A' ' 171' ' ' GLN . 3.3 t -100.93 -147.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.65 ' H ' ' CG1' ' A' ' 170' ' ' VAL . 1.6 tp60 -157.73 -132.25 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.611 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.639 ' HG ' ' CA ' ' A' ' 117' ' ' SER . 1.1 m -92.21 -154.09 0.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -170.37 -177.07 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.136 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.48 132.45 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.924 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -53.92 129.34 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 16.7 mt -59.77 135.41 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.383 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.2 t -133.97 138.74 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.517 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.0 tp10 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.436 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.608 ' H3 ' ' CA ' ' A' ' 5' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 m -58.96 -43.58 91.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.512 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -144.59 -41.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 43.2 p -60.37 -75.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.608 ' CA ' ' H3 ' ' A' ' 1' ' ' GLY . . . 154.09 -50.54 0.48 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p -81.58 163.86 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 110.338 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.686 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.8 tttt -161.45 155.85 22.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.321 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.41 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -148.58 146.99 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.035 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 m -132.97 141.43 48.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -121.71 117.26 26.21 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.5 m-85 -99.68 141.13 32.88 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.047 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.9 tm-20 -64.07 -51.66 63.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.23 -176.39 4.13 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 109.616 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.54 ' C ' ' HG ' ' A' ' 39' ' ' SER . 42.1 mtmt -84.28 -178.17 6.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.805 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.692 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.5 OUTLIER 46.25 24.55 0.28 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.128 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.537 ' H ' ' HG ' ' A' ' 39' ' ' SER . 0.2 OUTLIER 61.81 44.24 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.214 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -111.21 166.1 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -144.09 31.96 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.608 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -60.97 166.47 3.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.151 -1.025 . . . . 0.0 109.024 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' O ' ' NH1' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.7 155.94 7.49 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.003 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -135.62 135.42 40.21 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 p-10 -104.25 150.12 24.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.615 0.245 . . . . 0.0 110.563 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -162.55 124.94 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.527 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.08 14.35 9.81 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.657 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' SG ' ' OD1' ' A' ' 26' ' ' ASP . 35.8 t -150.66 148.46 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.713 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' OD1' ' SG ' ' A' ' 25' ' ' CYS . 49.0 p30 -39.28 156.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.7 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 48.3 t -158.29 164.29 36.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.65 -56.07 3.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -156.31 109.19 2.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.343 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -92.67 7.53 43.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' TYR . 71.7 t60 -58.76 -30.36 67.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.103 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.8 p -64.52 -1.1 1.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.699 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' HIS . 67.8 m-85 -119.39 -14.84 9.15 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.768 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 15.8 tp -141.33 139.61 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -102.21 -8.38 21.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.852 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.7 ttm180 -153.32 141.87 20.83 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.685 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.9 m -113.02 104.23 12.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.772 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 52.6 m-20 -115.17 -153.76 0.53 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.54 ' HG ' ' C ' ' A' ' 14' ' ' LYS . 19.1 p -24.94 137.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.61 0.719 . . . . 0.0 112.587 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.0 mt -140.54 147.85 22.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.742 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.8 ptpt -155.89 103.12 2.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.239 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.542 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 3.0 t -66.49 144.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.93 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -115.1 46.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.48 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.15 -100.28 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.811 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.29 -140.15 4.24 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' A' ' 47' ' ' TRP . 91.6 m -78.7 167.27 21.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.437 -0.449 . . . . 0.0 110.851 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.686 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 39.3 m95 -157.11 158.82 37.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.376 0.608 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.98 122.57 43.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.791 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -119.41 133.02 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.891 0.377 . . . . 0.0 110.671 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 51' ' ' GLU . 92.9 m-85 -106.17 110.57 22.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.928 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 71.4 tt0 -34.87 -36.06 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.37 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.7 mtt-85 -116.61 147.42 39.74 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 45.3 Cg_endo -68.01 156.36 66.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.37 2.047 . . . . 0.0 111.88 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 7.8 m-80 86.23 0.41 0.63 Allowed 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.931 0.769 . . . . 0.0 111.216 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 8.9 m-85 82.23 56.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.464 0.478 . . . . 0.0 111.216 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.83 38.31 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.388 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -155.68 22.67 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 17.0 m-85 -74.72 139.11 43.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -103.69 88.98 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.443 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.6 t80 -92.42 135.42 34.06 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -101.37 94.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -72.46 111.22 10.2 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.15 164.84 19.48 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.078 1.852 . . . . 0.0 112.418 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -55.06 118.83 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.08 179.458 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.48 -180.0 41.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.74 153.24 20.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.004 0.43 . . . . 0.0 110.176 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 4.4 m-85 -142.54 69.79 20.8 Favored Pre-proline 0 C--O 1.221 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 69.1 Cg_exo -44.29 -13.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.845 2.363 . . . . 0.0 113.079 -179.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 67' ' ' TYR . 71.2 mt-10 -155.46 163.99 39.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.689 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.1 p90 -65.18 -49.58 69.24 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.063 -179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -42.44 -10.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -80.23 0.78 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.488 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.73 20.9 10.92 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.36 0.124 . . . . 0.0 111.124 178.595 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.8 mmt 92.22 20.33 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.781 1.233 . . . . 0.0 111.716 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.19 59.6 0.27 Allowed Glycine 0 CA--C 1.536 1.358 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.4 mt -89.23 17.14 6.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.423 0.289 . . . . 0.0 111.543 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.6 t30 103.78 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.744 1.278 . . . . 0.0 109.578 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.24 63.74 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -131.54 112.77 12.93 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.15 130.34 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.123 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 82' ' ' SER . 4.7 p -108.78 -164.17 0.93 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.034 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' SER . 2.9 m -48.37 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.399 0.619 . . . . 0.0 111.553 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.619 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 13.5 p -151.41 151.65 32.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.698 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.28 128.28 56.02 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.57 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.87 132.4 53.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.79 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.1 t -129.03 132.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.706 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -98.9 162.8 12.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.74 149.92 61.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.08 149.91 82.36 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.126 1.884 . . . . 0.0 112.14 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -156.55 169.45 24.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.284 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 78.72 -73.27 2.29 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -75.93 34.2 1.25 Allowed Glycine 0 C--O 1.226 -0.378 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.5 pt20 33.66 -109.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 111.228 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.725 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 36.7 t80 -153.54 113.1 3.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.2 tptm -153.64 137.29 16.03 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.102 0.477 . . . . 0.0 111.138 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -137.82 145.66 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.087 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.4 mt-30 -123.9 129.49 51.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.746 177.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.83 131.42 72.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -111.15 123.38 50.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.011 0.434 . . . . 0.0 110.786 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.01 -19.74 20.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HZ3' ' CA ' ' A' ' 106' ' ' GLY . 57.0 mttp -131.2 144.75 51.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.455 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.49 -170.46 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 44.62 29.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.741 0.305 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.511 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 17.4 m-85 54.64 82.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -159.64 164.13 34.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.498 ' CA ' ' HZ3' ' A' ' 101' ' ' LYS . . . 87.37 -158.49 30.04 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.863 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -64.66 135.74 56.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.361 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 45.2 ttp -118.23 122.21 42.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.186 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.58 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 44.9 m-85 -115.85 130.57 56.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.46 120.69 36.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.097 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -149.54 129.75 13.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.412 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -97.09 49.91 1.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.48 -176.63 5.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.351 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.3 p-10 -89.65 160.51 16.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 58.2 m -138.41 123.02 11.83 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.492 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 58.0 Cg_endo -76.15 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.878 1.719 . . . . 0.0 110.53 178.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.9 m -110.34 114.09 27.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.2 tt -70.05 -37.19 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.958 0.409 . . . . 0.0 110.947 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.5 ttt -70.51 -19.01 62.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.728 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -81.81 -42.3 19.88 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.14 -0.975 . . . . 0.0 111.513 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.15 -30.53 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.769 -177.531 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.592 ' C ' ' H ' ' A' ' 124' ' ' MET . 32.1 m-85 -116.86 4.23 12.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.813 -178.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.7 m-70 54.19 3.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.0 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.592 ' H ' ' C ' ' A' ' 122' ' ' PHE . 35.8 mtt -72.12 133.09 44.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.112 0.482 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -109.02 -24.65 11.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.192 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.557 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.8 mt-10 -151.78 107.78 3.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 13.8 mm -76.71 126.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.587 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.4 m80 -104.55 -36.5 7.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.169 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.511 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 7.4 t -148.27 143.47 26.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.129 0.49 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.3 t -143.44 134.09 25.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -114.38 -175.99 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.571 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.0 t 54.7 93.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.92 165.56 11.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.106 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.4 mp0 -139.4 111.83 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.55 -88.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.6 t -119.13 156.48 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.096 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.725 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.2 t-105 -144.47 166.72 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.643 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.8 mt -144.23 124.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.375 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 30.8 m-85 -107.4 113.8 27.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.802 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.1 -22.76 1.77 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.647 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.9 mp -121.74 165.36 20.31 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.0 Cg_endo -81.93 169.91 14.35 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.241 1.961 . . . . 0.0 112.3 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.496 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 77.0 13.67 2.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.783 179.759 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.496 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 74.25 30.12 1.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.11 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 93.0 mtt180 -134.68 126.23 28.68 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.4 173.62 20.77 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -52.45 113.66 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.896 0.379 . . . . 0.0 110.499 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -82.18 149.48 27.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.53 152.33 39.31 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.857 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tp -110.58 154.42 23.77 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.83 133.73 51.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -121.41 -110.99 0.33 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.428 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.42 153.07 43.76 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.663 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -62.75 129.44 40.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 64.66 158.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.57 111.49 14.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.965 0.412 . . . . 0.0 111.146 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -108.58 -21.48 12.69 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -123.64 154.88 66.8 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.362 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.492 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.0 Cg_endo -58.98 -20.53 53.71 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.481 2.121 . . . . 0.0 113.611 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.24 -5.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 110.654 -179.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.81 -33.18 64.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.331 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.502 ' HE1' ' HB2' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.02 21.97 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.459 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.96 27.64 66.24 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.629 176.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 167' ' ' SER . . . -106.83 138.2 43.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.802 0.801 . . . . 0.0 110.678 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.31 24.2 0.19 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.1 m 165.19 153.79 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.447 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 170' ' ' VAL . 50.9 Cg_endo -71.18 -18.07 30.85 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.797 2.332 . . . . 0.0 111.509 178.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.41 70.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.302 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.648 ' CG2' ' H ' ' A' ' 171' ' ' GLN . 8.8 p -104.99 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.648 ' H ' ' CG2' ' A' ' 170' ' ' VAL . 2.0 tp60 -152.82 -130.86 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.501 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.6 p -94.85 -154.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -171.53 -178.17 2.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.295 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -157.7 132.97 8.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.96 178.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -52.74 126.11 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 110.347 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.9 mt -56.59 129.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.823 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.35 135.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.502 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.049 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 79.0 p . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.844 -0.798 . . . . 75.04 108.844 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.663 ' O ' HG13 ' A' ' 42' ' ' VAL . 42.7 tttt -107.03 147.91 29.36 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.273 0.358 . . . . 8.2 111.561 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 83' ' ' CYS . 18.5 tt -140.15 136.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.95 -0.389 . . . . 6.76 109.95 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 35.4 m -120.32 138.11 53.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 8.47 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 67.8 m-85 -116.86 116.61 27.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.067 -0.716 . . . . 4.74 109.067 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.602 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 88.6 m-85 -95.96 140.61 30.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.213 0.53 . . . . 9.67 111.144 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HB2' ' CB ' ' A' ' 19' ' ' ARG . 4.3 tm-20 -62.06 -51.86 66.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.851 -0.613 . . . . 46.58 109.841 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.42 -175.95 3.36 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.791 -0.641 . . . . 24.88 109.92 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.67 -179.38 7.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.75 -0.659 . . . . 104.03 110.455 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 49.77 26.11 1.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 66.74 110.61 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m-85 57.96 44.57 19.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 19.33 110.947 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -114.74 161.49 18.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.974 0.416 . . . . 111.5 110.724 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.26 -146.4 29.06 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.859 -0.61 . . . . 138.46 112.437 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.728 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.1 ttm-85 -57.05 166.25 1.1 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.709 -0.849 . . . . 613.65 108.709 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.24 152.12 4.87 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.78 -0.452 . . . . 325.16 109.78 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 47.4 t80 -130.6 131.9 45.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 18.95 109.596 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -116.21 128.78 55.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 278.02 110.649 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.01 139.21 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 342.02 109.975 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -123.99 22.24 8.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.323 -0.399 . . . . 154.21 111.147 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 150.29 29.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.069 -0.253 . . . . 117.53 110.605 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -39.9 156.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.846 -0.616 . . . . 317.22 111.374 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -157.34 164.21 37.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.625 . . . . 167.98 110.184 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.04 -56.41 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 11.81 110.921 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -151.01 108.79 3.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.579 -0.737 . . . . 348.8 111.295 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.488 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.5 p90 -99.74 5.32 45.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 6.94 110.48 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.3 t60 -58.21 -26.89 63.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.186 0.517 . . . . 9.31 109.966 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.9 p -62.04 -20.94 64.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.956 -0.566 . . . . 32.68 110.265 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.16 -17.33 19.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 13.98 111.266 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.728 HD12 ' HD2' ' A' ' 19' ' ' ARG . 15.7 tp -138.91 135.5 34.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.809 0.338 . . . . 5.79 110.276 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.64 -9.66 26.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.5 -0.318 . . . . 80.89 111.551 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 30.2 ttm-85 -155.11 142.01 19.12 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 110.025 -0.361 . . . . 332.73 110.025 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -108.59 102.32 11.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.332 0.586 . . . . 99.41 110.847 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 39' ' ' SER . 76.4 m-20 -125.57 154.91 41.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.953 -1.499 . . . . 45.58 106.953 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.642 ' O ' ' O ' ' A' ' 38' ' ' ASN . 15.6 p 39.04 128.67 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.497 1.142 . . . . 8.21 112.805 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 13.7 mt -142.02 143.49 26.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.307 -0.86 . . . . 5.81 111.772 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.5 ptpt -154.67 101.79 2.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.722 -0.672 . . . . 8.95 109.571 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 7' ' ' LYS . 1.9 t -65.73 148.03 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 110.033 -0.358 . . . . 131.71 110.033 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.91 57.8 1.04 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.164 -0.68 . . . . 256.75 109.164 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.96 -100.05 0.13 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.544 -0.753 . . . . 10.26 111.338 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -131.43 -142.32 4.99 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.485 -0.646 . . . . 8.86 111.485 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 47' ' ' TRP . 86.6 m -79.98 165.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 8.71 110.601 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.751 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 15.6 m95 -151.79 153.16 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 7.86 111.748 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.42 117.69 33.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.274 -1.009 . . . . 6.12 108.274 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 80' ' ' LEU . 15.4 m -118.03 133.69 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 6.2 110.662 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.42 117.04 33.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 43.74 110.182 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.2 -39.59 0.18 Allowed 'General case' 0 C--N 1.333 -0.111 0 O-C-N 123.553 0.533 . . . . 42.52 110.674 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -116.85 153.32 49.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 698.05 110.866 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 48.1 Cg_endo -71.06 168.02 24.43 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.103 2.535 . . . . 26.34 111.108 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 2.0 m-20 79.8 -4.29 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.872 0.732 . . . . 216.76 110.885 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 12.0 m-85 . . . . . 0 N--CA 1.464 0.27 0 O-C-N 123.493 0.495 . . . . 25.54 110.749 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.532 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 13.2 t80 . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 109.587 -0.523 . . . . 999.99 109.587 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -102.26 95.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 11.1 109.811 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD13 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -77.56 109.96 11.2 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.241 -0.436 . . . . 6.8 110.096 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 90.5 Cg_endo -81.98 165.83 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.098 2.532 . . . . 9.35 112.407 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.26 112.38 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.182 -0.463 . . . . 16.37 110.119 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.59 175.74 41.54 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.327 -1.109 . . . . 9.23 110.327 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.614 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.4 mt-10 -100.15 157.75 16.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.096 0.474 . . . . 11.75 110.747 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.614 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.4 m-85 -149.93 80.4 7.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.344 -0.843 . . . . 12.89 108.955 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 48.2 Cg_exo -48.79 -22.33 4.53 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.008 2.472 . . . . 28.55 113.284 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.35 163.4 35.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.388 -0.597 . . . . 36.83 109.388 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 26.5 p90 -61.63 -45.2 95.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 22.71 110.74 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG2' ' CE2' ' A' ' 70' ' ' TYR . 7.4 mt-30 -46.0 -13.43 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.217 0.451 . . . . 319.03 112.217 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -75.36 -3.51 34.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.59 -0.277 . . . . 516.27 111.566 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -118.35 26.33 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.404 -0.221 . . . . 7.41 110.404 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.546 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.8 mmt 85.0 23.74 0.09 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.936 0.773 . . . . 49.56 110.955 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.35 50.1 0.25 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.916 -0.473 . . . . 12.4 111.916 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.634 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 16.8 mt -79.89 18.31 0.83 Allowed 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.968 -0.136 . . . . 54.39 110.917 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.634 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 66.3 t30 106.96 159.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.456 1.097 . . . . 154.95 110.155 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -91.72 57.35 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.666 0.604 . . . . 144.44 110.637 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.16 108.84 9.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.811 -0.631 . . . . 657.17 110.276 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -141.03 126.81 19.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.238 -0.585 . . . . 5.23 110.018 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -101.2 -162.54 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.742 -0.663 . . . . 5.2 109.431 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 12.8 p -50.27 -168.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.403 0.621 . . . . 140.35 111.262 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.751 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 28.1 p -154.79 161.79 41.36 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.407 -0.517 . . . . 8.04 110.071 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -122.94 131.84 53.9 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.498 -0.556 . . . . 332.31 109.498 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 123.6 18.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 9.1 110.43 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 48' ' ' ALA . 48.2 t -121.87 129.92 75.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.401 -0.363 . . . . 16.84 110.991 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -101.4 157.62 16.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.935 -0.575 . . . . 126.92 110.265 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.61 150.48 63.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 176.97 110.651 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 C-N-CA 123.007 2.471 . . . . 11.34 112.284 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.621 0.248 . . . . 44.38 110.664 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.703 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.8 t80 -162.49 114.39 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.797 -0.446 . . . . 11.73 109.797 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.486 ' CE ' ' HB2' ' A' ' 110' ' ' GLU . 21.0 tptm -154.83 132.17 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 179.04 110.828 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -133.7 143.1 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 4.92 111.444 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.43 131.15 54.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.043 -0.98 . . . . 81.94 109.255 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 108' ' ' MET . 6.7 mt -120.82 134.13 65.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 116.252 -0.431 . . . . 4.03 110.677 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.2 m-85 -115.16 132.66 56.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 7.67 110.976 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.2 -26.7 68.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.637 . . . . 27.19 110.653 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -122.09 144.77 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 146.97 110.584 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -61.44 174.4 6.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.753 -0.939 . . . . 60.39 110.753 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.85 33.6 23.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 414.82 110.536 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 11.7 m-85 53.46 78.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.841 -0.618 . . . . 19.09 110.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -156.39 163.09 39.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 19.13 110.699 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.67 -154.91 27.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.436 -0.665 . . . . 44.38 111.436 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -72.57 132.82 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 35.47 110.906 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 47.8 ttp -116.7 128.37 55.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.82 -0.627 . . . . 161.99 110.492 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 39.1 m-85 -119.25 135.63 54.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 16.12 110.769 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' HB2' ' CE ' ' A' ' 95' ' ' LYS . 8.3 pt-20 -121.55 123.31 41.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.397 -0.82 . . . . 48.3 110.89 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 111' ' ' THR . 11.8 t -148.11 125.83 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.138 -0.483 . . . . 13.7 110.976 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.4 OUTLIER -93.22 38.77 1.04 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.534 0.683 . . . . 113.42 110.719 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.78 -176.47 4.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.597 -0.729 . . . . 67.29 110.352 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -88.1 160.29 17.86 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.891 0.377 . . . . 16.91 110.221 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.59 ' SG ' ' HG2' ' A' ' 121' ' ' GLN . 6.6 t -140.87 122.57 9.29 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.921 -0.582 . . . . 162.84 110.504 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 172' ' ' SER . 56.1 Cg_endo -75.59 -56.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.785 2.324 . . . . 12.34 111.609 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -115.28 109.72 18.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.858 -0.61 . . . . 13.14 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.2 tt -69.37 -40.94 80.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.247 0.546 . . . . 6.62 110.025 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.4 ttt -67.79 -31.9 72.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 78.86 110.855 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.09 -47.2 71.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.207 -0.451 . . . . 342.48 112.155 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.59 ' HG2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -100.87 -29.68 12.1 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.992 0.738 . . . . 251.73 112.992 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 109' ' ' TYR . 17.4 m-85 -104.02 -1.74 27.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.565 -0.454 . . . . 7.65 110.948 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.5 m-70 55.25 7.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 14.8 111.737 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.537 ' SD ' ' CG2' ' A' ' 98' ' ' ILE . 41.7 mtt -77.16 132.88 39.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.988 0.423 . . . . 85.03 110.156 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -102.96 -31.63 10.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.618 -0.719 . . . . 337.58 110.242 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.476 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 57.4 mt-10 -148.67 110.05 4.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 84.76 110.372 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 11.6 mm -74.24 122.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.595 -0.52 . . . . 4.4 109.595 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.6 m80 -103.17 -32.07 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 7.83 110.77 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.476 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 44.3 t -148.18 142.89 26.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.341 -0.39 . . . . 136.38 110.831 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.26 127.21 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 18.11 110.049 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -109.03 -176.79 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.577 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.638 ' C ' HD22 ' A' ' 133' ' ' LEU . 61.8 t 56.86 98.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.0 -0.545 . . . . 239.63 110.742 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.72 161.17 16.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.788 -0.642 . . . . 238.81 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -138.63 111.03 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 385.49 110.169 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.01 -91.88 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.005 -0.838 . . . . 11.62 111.005 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 134' ' ' GLU . 42.8 t -122.83 141.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 110.065 -0.346 . . . . 8.41 110.065 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.703 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 26.6 t-105 -124.51 169.55 11.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 5.14 110.66 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HG12 ' A' ' 176' ' ' ILE . 59.7 mt -145.24 122.21 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.694 -0.684 . . . . 4.68 111.05 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.4 133.91 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.702 -0.481 . . . . 4.24 109.702 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 149' ' ' GLN . 25.0 m-85 -111.08 112.14 23.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 7.07 110.763 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -52.97 -25.27 11.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.159 -0.473 . . . . 28.99 110.277 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.01 160.61 31.68 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.53 . . . . 18.0 109.99 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HG3' ' A' ' 171' ' ' GLN . 58.9 Cg_endo -76.79 169.3 21.98 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.707 2.271 . . . . 11.59 111.552 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.407 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 9.5 m120 70.9 19.45 5.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 119.59 111.104 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 174' ' ' ARG . 3.7 m-85 70.92 33.25 2.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.654 -0.248 . . . . 18.4 111.165 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 140' ' ' TYR . 45.4 mtm180 -121.53 174.0 7.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 999.99 110.846 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.92 175.36 42.59 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.895 -0.882 . . . . 20.69 110.895 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -49.03 136.39 14.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 949.07 110.051 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.556 ' HG2' ' CE1' ' A' ' 140' ' ' TYR . 70.0 mt-30 -99.53 122.1 42.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 397.97 109.809 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 71.1 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 40.01 109.925 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.554 ' HE2' HD11 ' A' ' 133' ' ' LEU . 16.0 m-85 . . . . . 0 N--CA 1.46 0.07 0 N-CA-C 110.274 -0.269 . . . . 31.64 110.274 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' HG2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -104.75 -20.52 13.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 708.49 110.768 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 1.5 pttm -124.77 159.76 56.95 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.107 0.479 . . . . 310.53 110.773 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -62.59 -19.84 69.06 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.841 2.361 . . . . 12.19 112.775 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.3 mp -96.25 -6.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.908 0.385 . . . . 26.61 110.443 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -56.77 -30.32 63.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 33.18 110.975 -178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -103.56 23.95 11.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.081 0.467 . . . . 9.22 109.929 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.4 28.73 73.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.851 -0.613 . . . . 11.66 112.904 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.46 137.74 41.87 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.709 0.754 . . . . 10.16 110.082 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.17 18.73 0.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 15.02 110.647 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 169.39 154.17 0.16 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.695 0.283 . . . . 17.04 111.171 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 55.6 Cg_endo -74.8 2.98 5.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.172 2.582 . . . . 20.88 112.037 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.26 75.02 5.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 15.0 110.524 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.863 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -102.74 -147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.894 -0.78 . . . . 80.6 108.894 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.863 ' H ' HG12 ' A' ' 170' ' ' VAL . 15.7 mm-40 -156.67 -133.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.014 -0.365 . . . . 126.0 110.014 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -91.95 -153.02 0.32 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.411 0.148 . . . . 152.78 111.256 -177.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -169.59 -176.14 2.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.064 0.459 . . . . 6.31 110.806 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.55 HH21 HG23 ' A' ' 177' ' ' VAL . 10.2 ptm180 -160.48 130.88 5.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.599 . . . . 13.69 110.353 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.5 ptt180 -53.01 131.52 36.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 467.95 110.879 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 138' ' ' ILE . 30.9 mt -62.5 134.68 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.446 -0.797 . . . . 15.16 109.893 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.55 HG23 HH21 ' A' ' 174' ' ' ARG . 0.1 OUTLIER -135.58 153.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.824 -0.625 . . . . 132.74 110.601 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.026 -0.988 . . . . 408.25 110.757 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 CA--C 1.528 0.098 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.782 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.4 tttt -160.05 151.1 19.23 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.053 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.8 142.14 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.991 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -124.72 138.71 54.27 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 116.16 25.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.83 138.24 34.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.271 0.558 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.416 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 6.7 tm-20 -60.88 -49.94 75.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.01 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 99.7 m-20 -97.82 -176.94 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 110.141 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -82.08 -176.63 6.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 46.41 24.26 0.28 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.029 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' H ' ' CB ' ' A' ' 39' ' ' SER . 3.3 m-85 63.76 41.64 6.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -108.5 179.15 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 110.451 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.38 -159.06 48.15 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -53.39 175.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.05 150.68 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.4 t80 -127.94 131.34 49.33 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -119.8 124.0 45.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.864 0.364 . . . . 0.0 111.151 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.27 142.59 23.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.316 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -125.39 24.39 7.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASP . 10.6 m -146.22 141.71 27.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 25' ' ' CYS . 55.1 p-10 -36.27 156.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.5 m -156.48 162.71 39.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.354 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -55.96 3.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.05 0.452 . . . . 0.0 110.538 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -153.03 111.35 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.2 p90 -101.29 10.56 40.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.963 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.4 t60 -60.85 -26.07 67.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 109.962 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.7 p -63.2 -30.55 71.68 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.229 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.61 -12.41 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.532 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -144.29 138.33 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 109.986 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 m -99.28 -9.22 23.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.652 0.263 . . . . 0.0 111.464 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 53.2 ttm-85 -156.48 144.89 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' C ' HD21 ' A' ' 38' ' ' ASN . 3.0 m -110.11 103.89 12.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.728 ' O ' ' O ' ' A' ' 39' ' ' SER . 5.7 m120 -128.7 156.42 43.52 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.728 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.5 p 34.95 129.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.438 1.114 . . . . 0.0 112.399 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -141.76 145.51 24.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.034 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -153.35 102.9 2.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -66.5 148.96 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.52 0.676 . . . . 0.0 110.568 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -122.21 51.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.732 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.548 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.17 -94.64 0.1 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.927 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -139.31 -140.16 3.9 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 47' ' ' TRP . 94.9 m -80.56 166.41 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.366 -0.491 . . . . 0.0 110.824 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.782 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.6 m95 -153.78 156.71 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.336 0.589 . . . . 0.0 110.746 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.99 120.36 38.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.83 132.8 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.017 0.437 . . . . 0.0 110.931 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' GLU . 87.8 m-85 -104.45 111.13 23.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.671 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 50' ' ' TYR . 68.8 tt0 -35.74 -35.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.294 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -116.18 148.12 40.86 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.043 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 47.8 Cg_endo -68.59 158.61 57.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.459 2.106 . . . . 0.0 111.719 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 3.8 m120 85.7 -4.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.841 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 10.9 m-85 . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 121.172 0.51 . . . . 0.0 111.1 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' CE2' ' OE1' ' A' ' 149' ' ' GLN . 33.4 t80 . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.36 91.29 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.874 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.7 110.38 5.84 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.422 0.451 . . . . 0.0 110.074 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.78 162.14 18.75 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.269 1.979 . . . . 0.0 112.539 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.19 118.17 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.167 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.47 179.36 41.27 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.539 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.5 mt-10 -101.98 152.55 20.81 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.959 0.409 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 21.8 m-85 -145.75 85.23 7.84 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.5 -18.13 24.35 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.142 2.561 . . . . 0.0 113.137 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.7 mt-10 -150.63 161.73 42.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -63.11 -51.2 67.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.401 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 66.3 mt-30 -43.28 -10.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.1 mmm180 -75.08 -6.5 49.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.724 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -118.02 27.29 9.09 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.853 -0.158 . . . . 0.0 110.646 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.9 mmt 83.56 24.73 0.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.175 0.922 . . . . 0.0 111.102 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.12 50.39 0.48 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.7 mt -74.45 14.21 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.7 t30 110.21 167.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.538 1.149 . . . . 0.0 109.349 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 54.6 p30 -99.27 60.56 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.034 0.445 . . . . 0.0 110.383 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -137.89 115.72 11.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.057 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.74 128.6 21.82 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -111.81 -162.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 24.3 p -45.25 -179.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.129 0.49 . . . . 0.0 110.504 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.54 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -151.09 153.33 34.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -118.69 128.56 54.62 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.71 126.47 27.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.149 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.2 t -126.54 132.6 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.79 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -99.29 161.88 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.85 148.86 82.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.525 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.293 1.996 . . . . 0.0 112.503 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.723 0.297 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 20.5 t80 -155.78 112.4 3.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -149.58 127.91 12.17 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.385 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.2 tt -130.27 136.52 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 53.2 mt-30 -120.04 126.04 49.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 107' ' ' GLN . 5.8 mt -118.37 132.81 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.72 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.691 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 46.3 m-85 -117.5 127.75 54.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.05 0.453 . . . . 0.0 111.523 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.52 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 73.6 tt0 -60.27 -28.02 67.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.859 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 103' ' ' ASP . 51.3 mttm -107.95 141.54 39.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.448 0.642 . . . . 0.0 110.778 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -69.67 37.02 0.37 Allowed Glycine 0 C--N 1.315 -0.597 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.018 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 101' ' ' LYS . 5.6 p-10 -154.27 35.7 0.42 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.479 ' HA ' ' CG ' ' A' ' 99' ' ' PHE . 28.6 m-85 56.31 56.26 5.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.32 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 3.8 m -161.13 170.68 19.92 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.747 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.63 -43.45 2.89 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.835 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 11.7 tp-100 -156.86 119.12 3.91 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.517 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 29.4 ttp -116.6 109.15 16.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.232 0.924 . . . . 0.0 110.159 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.607 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 16.8 m-85 -115.54 133.47 56.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -122.9 122.84 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 111' ' ' THR . 5.8 t -152.17 126.24 9.16 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.383 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 t -94.09 44.08 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 111.002 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -141.79 179.52 6.8 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -83.45 155.43 23.42 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.717 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.632 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -131.37 120.71 18.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.939 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.58 -55.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.861 1.707 . . . . 0.0 110.727 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.1 m -118.02 114.36 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -69.31 -43.31 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.5 ttt -67.25 -19.48 65.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.729 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.08 -46.61 41.87 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 4.8 pt20 -99.85 -24.72 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.609 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 28.5 m-85 -114.68 2.48 14.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.6 0.238 . . . . 0.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 50.6 14.02 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.268 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.415 ' N ' ' C ' ' A' ' 122' ' ' PHE . 13.6 mtp -80.24 135.89 36.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -109.32 -25.99 10.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 67.6 mt-10 -150.81 107.06 3.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.014 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 118' ' ' ILE . 8.4 mm -74.58 123.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.681 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 66.1 m80 -105.4 -31.08 9.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.906 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 14.7 m -150.49 145.79 26.22 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.623 ' SG ' HG12 ' A' ' 132' ' ' VAL . 6.5 t -150.56 124.88 9.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.19 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -94.39 53.0 1.63 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.623 HG12 ' SG ' ' A' ' 130' ' ' CYS . 7.5 p -95.92 125.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -147.11 94.95 2.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.325 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 136' ' ' VAL . 14.3 mp0 -144.58 109.78 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.115 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.08 -85.94 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.603 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.7 t -127.12 156.85 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.723 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.4 t-105 -144.82 166.2 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.578 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.3 mt -144.61 123.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.713 0.292 . . . . 0.0 111.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.616 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -108.2 129.07 55.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 23.8 m-85 -108.51 110.8 22.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.34 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.528 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 82.2 tt0 -49.85 -23.27 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.77 160.3 37.21 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.331 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.426 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.4 Cg_endo -78.55 165.25 25.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.387 2.058 . . . . 0.0 111.943 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.1 m120 75.1 13.57 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.2 m-85 79.27 24.6 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -107.03 169.44 8.55 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.35 170.35 36.2 Favored Glycine 0 N--CA 1.463 0.45 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.3 ptt180 -61.75 143.27 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.209 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.479 ' OE1' ' CE2' ' A' ' 60' ' ' TYR . 36.3 mt-30 -97.97 146.79 25.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.536 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 48.0 m-85 . . . . . 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.72 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 N--CA 1.461 0.125 0 CA-C-O 120.789 0.328 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . 13.4 ptm180 -108.27 -21.62 12.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.546 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.44 ' H ' ' HG3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -121.19 156.2 57.6 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.398 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.8 Cg_endo -61.13 -19.0 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.736 2.291 . . . . 0.0 113.847 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -100.8 -1.59 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.355 0.598 . . . . 0.0 110.636 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.09 -29.42 70.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.843 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.571 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -105.0 22.91 14.45 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.79 27.55 70.58 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.871 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.8 138.05 45.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.013 0.906 . . . . 0.0 109.473 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.96 20.63 0.35 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.217 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER 175.42 154.64 0.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.837 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.22 3.14 6.49 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.274 2.649 . . . . 0.0 111.801 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.05 5.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.393 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -95.95 -150.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.9 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -157.18 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.786 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.8 -155.57 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.61 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 52.0 p90 -169.87 -177.07 2.52 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.082 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.93 131.8 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -54.15 129.91 36.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.021 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.557 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.5 mt -61.28 135.87 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.9 152.82 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.261 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.208 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 121.077 0.465 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.77 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.7 tttt -161.25 153.66 20.27 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.277 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.43 142.78 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.714 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 m -126.72 139.96 52.75 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.082 0.468 . . . . 0.0 110.471 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.05 116.73 26.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.297 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.7 m-85 -95.76 138.36 33.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.606 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.46 -49.05 79.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.289 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 82.4 m-20 -100.76 -174.77 2.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.907 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' A' ' 39' ' ' SER . 2.8 mppt? -84.35 -174.96 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.656 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 46.21 22.92 0.17 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.88 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.4 m-85 59.17 44.93 15.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.305 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -115.27 161.91 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 110.374 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.36 -151.22 29.47 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.592 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -58.18 173.79 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.46 155.05 5.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -134.61 134.59 41.41 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 30.2 t0 -102.81 154.35 19.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.547 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.43 124.81 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.815 0.34 . . . . 0.0 110.139 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -124.82 11.17 8.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ASP . 8.0 t -150.65 148.25 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.5 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 52.9 p30 -37.54 154.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.79 160.69 40.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.03 -56.82 2.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.5 p-10 -152.98 113.74 4.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -103.41 8.31 38.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 53.4 t60 -59.61 -29.4 67.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.539 0.685 . . . . 0.0 110.024 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.2 p -60.15 -30.52 69.37 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.383 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -87.34 -13.97 42.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.521 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.0 tp -142.2 137.36 30.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 109.943 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -98.16 -9.42 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.268 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.0 ttm-85 -155.66 144.12 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.2 m -110.18 103.67 12.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 110.671 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.736 ' O ' ' O ' ' A' ' 39' ' ' SER . 5.4 m120 -128.91 155.16 45.72 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.736 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.9 p 36.11 129.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.558 1.17 . . . . 0.0 112.258 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.5 mt -141.55 146.13 23.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.857 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.307 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.5 ptpt -154.46 104.2 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.248 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.71 149.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.39 0.614 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -120.39 47.69 1.73 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.769 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -167.08 -94.84 0.1 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.022 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.536 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.94 -139.81 3.87 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.0 m -79.71 166.66 21.57 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.179 -0.601 . . . . 0.0 110.946 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.77 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -156.0 156.81 35.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.566 0.698 . . . . 0.0 111.039 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.39 119.31 36.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.798 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 5.5 m -117.88 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.232 0.539 . . . . 0.0 111.114 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 30.9 m-85 -93.77 175.31 6.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -100.99 -36.69 8.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -118.96 148.14 44.01 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 38.7 Cg_endo -64.16 157.29 54.43 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.006 1.804 . . . . 0.0 111.915 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.2 m120 84.24 -3.9 1.05 Allowed 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.005 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 16.6 m-85 . . . . . 0 N--CA 1.47 0.525 0 O-C-N 123.616 0.572 . . . . 0.0 111.073 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.475 ' C ' HD12 ' A' ' 61' ' ' ILE . 12.0 t80 . . . . . 0 CA--C 1.52 -0.201 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.22 92.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.438 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -72.22 112.78 15.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.0 162.75 15.71 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.013 1.808 . . . . 0.0 112.456 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.08 115.68 1.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.057 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.11 177.4 41.62 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.8 mt-10 -100.75 153.04 19.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.346 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -144.94 89.41 6.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_endo -63.35 -13.92 38.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.239 1.959 . . . . 0.0 113.419 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 96.7 mt-10 -149.69 161.01 43.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.723 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 34.7 p90 -63.76 -53.69 47.08 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.986 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -43.77 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.9 mmm180 -75.18 -4.38 38.51 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.723 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.29 24.08 10.93 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.883 -0.144 . . . . 0.0 110.976 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 21.1 mmt 87.69 23.96 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.238 1.015 . . . . 0.0 111.064 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.72 50.27 0.42 Allowed Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.2 mt -74.34 13.36 0.59 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.013 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 13.2 t-20 109.81 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.94 1.4 . . . . 0.0 109.157 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -96.29 63.0 2.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.443 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' CA ' ' HE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.9 116.44 11.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.232 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.31 128.06 20.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.1 p -110.3 -162.92 0.82 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.041 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.7 m -45.47 -179.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.6 p -150.29 151.51 33.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.634 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.06 128.73 55.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.551 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 128.04 34.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.304 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.8 t -127.34 132.9 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.79 161.64 13.46 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.07 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -87.94 148.17 42.67 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.8 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 120.72 0.295 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.738 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 28.8 t80 -157.29 113.63 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -154.22 133.72 12.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 145.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.131 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 38.6 mt-30 -123.76 128.17 49.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.563 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.7 mt -118.44 131.93 69.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.16 130.01 56.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.628 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.27 -27.21 65.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.908 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -122.2 149.15 44.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.21 171.34 18.89 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 60.19 29.82 19.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 3.9 m-85 56.01 82.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -158.61 161.6 37.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 0.0 110.26 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.69 -150.95 23.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -74.6 138.87 43.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.5 tmm? -123.55 132.73 53.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.175 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.402 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.3 m-85 -124.11 136.37 54.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -123.96 125.67 44.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -151.27 128.56 11.26 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -93.48 44.45 1.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -144.52 -179.25 6.43 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.6 p30 -86.41 159.96 19.19 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.612 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 96.5 m -138.71 123.49 11.77 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.73 -55.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.04 1.827 . . . . 0.0 111.665 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 m -116.59 111.89 20.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -41.72 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.7 ttp -67.94 -16.59 64.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.438 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -83.38 -42.73 16.7 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.595 -0.691 . . . . 0.0 111.39 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -93.85 -30.61 14.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.903 -177.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.734 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 26.1 m-85 -114.8 5.9 15.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.8 m-70 50.9 9.35 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.786 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -76.52 135.36 39.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.868 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -107.35 -27.56 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 49.5 mt-10 -151.03 107.57 3.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.35 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 12.4 mm -75.59 125.4 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 109.779 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.8 m80 -103.75 -31.13 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.283 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.0 p -155.77 151.78 27.69 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.8 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -150.56 131.26 14.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.123 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 51.9 mtmt -112.09 -173.2 2.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.446 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.9 t 55.57 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.679 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.72 167.78 10.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.053 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -139.21 111.38 7.43 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 40.26 -84.82 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.4 t -125.03 154.95 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.745 0.307 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.738 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.8 t-105 -142.12 167.46 22.06 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.594 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.3 mt -145.34 125.72 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.378 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -107.34 112.63 25.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -48.89 -23.15 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.968 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.8 mp -119.26 166.43 14.48 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.2 167.36 12.33 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.093 1.862 . . . . 0.0 111.902 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.3 m-20 78.81 15.27 1.14 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.078 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.0 m-85 74.02 27.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.635 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 99.5 mtt180 -132.67 126.03 31.67 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.94 174.69 22.87 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -56.08 114.19 1.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -80.93 141.0 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.05 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 179.284 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -109.64 -22.02 12.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.271 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -119.53 156.1 53.7 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 121.005 0.431 . . . . 0.0 110.717 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.562 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -60.48 -16.19 40.66 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.746 2.298 . . . . 0.0 113.531 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -101.91 -2.22 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.114 0.483 . . . . 0.0 111.02 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -26.05 67.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.638 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.74 21.87 16.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.459 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.18 67.55 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.788 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.15 138.9 43.63 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.878 0.839 . . . . 0.0 109.994 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.3 22.28 0.23 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 167.08 155.89 0.11 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.229 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 170' ' ' VAL . 45.7 Cg_endo -70.74 -33.62 12.6 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.596 2.197 . . . . 0.0 111.523 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -47.25 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.31 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.892 HG22 ' H ' ' A' ' 171' ' ' GLN . 9.1 p -107.68 -145.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG22 ' A' ' 170' ' ' VAL . 69.3 mm-40 -152.9 -132.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.271 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -95.77 -153.29 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -170.69 -177.04 2.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.485 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.486 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -157.55 133.13 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.061 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.5 ptt-85 -52.43 133.66 35.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.384 0.612 . . . . 0.0 110.616 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 138' ' ' ILE . 18.6 mt -67.29 135.06 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.863 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.486 HG22 HH21 ' A' ' 174' ' ' ARG . 34.2 m -137.35 156.63 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.202 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.486 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 2.7 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.829 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.5 tttt -159.99 151.06 19.29 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.948 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.59 141.31 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.887 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -124.32 138.22 54.4 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.144 0.497 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.6 115.95 25.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.3 m-85 -96.4 138.28 34.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.301 0.572 . . . . 0.0 111.152 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.4 tm-20 -60.98 -50.0 75.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.856 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.2 m-20 -97.87 -177.79 3.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.295 0.569 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -81.7 -177.07 6.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.123 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 46.67 25.36 0.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.876 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 39' ' ' SER . 1.7 m-85 63.4 40.17 8.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -107.07 175.11 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.21 -158.33 53.26 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.706 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -53.6 174.91 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -168.46 150.76 5.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -126.5 130.99 51.7 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.9 p-10 -119.36 119.96 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.94 142.69 23.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.176 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -125.81 26.32 6.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.7 m -146.75 141.35 26.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -38.01 157.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.713 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.1 t -159.17 166.57 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.586 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.81 -56.12 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.971 0.415 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -152.15 113.6 4.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.441 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -102.4 8.55 40.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.052 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -60.15 -25.68 65.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.485 0.659 . . . . 0.0 110.066 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.9 p -63.62 -30.37 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -87.02 -13.83 43.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.407 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.8 tp -143.51 137.66 28.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 110.068 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -98.74 -9.74 24.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 ttm-85 -155.66 144.08 20.21 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 7.5 p -110.25 104.39 13.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.771 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 59.2 m-20 -128.96 156.56 43.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.26 128.88 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.44 1.114 . . . . 0.0 112.529 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.7 mt -141.71 146.49 22.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.18 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -154.77 103.29 2.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.204 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.0 t -66.73 148.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.713 0.768 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -123.46 54.54 1.28 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.81 -97.34 0.11 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -133.41 -142.11 4.7 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.23 166.81 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.319 -0.518 . . . . 0.0 110.776 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.829 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -152.98 155.22 36.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.381 0.61 . . . . 0.0 110.783 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.01 120.24 39.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.302 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 80' ' ' LEU . 9.7 m -119.59 133.22 67.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.558 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -107.83 115.49 30.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.064 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' ARG . 59.7 tt0 -37.97 -34.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -115.4 146.78 37.27 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.819 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 44.4 Cg_endo -68.18 160.4 48.98 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.422 2.082 . . . . 0.0 111.495 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.1 m-20 83.39 -3.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.29 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 7.6 m-85 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.08 0.466 . . . . 0.0 111.308 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 39.5 t80 . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.49 92.24 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.55 110.48 7.05 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.6 163.33 16.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.966 1.777 . . . . 0.0 112.795 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.59 114.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.81 177.52 42.2 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 94.5 mt-10 -101.16 153.03 19.94 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.887 0.375 . . . . 0.0 110.396 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -145.71 90.57 5.89 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.08 -13.72 41.32 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.317 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 93.8 mt-10 -149.07 160.92 42.9 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.7 p90 -63.39 -53.21 56.06 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.322 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -44.62 -9.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.5 mmm180 -75.16 -4.78 40.76 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.834 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.68 24.86 10.8 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.907 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.5 mmt 87.47 23.0 0.05 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 111.085 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 33.13 52.47 0.52 Allowed Glycine 0 N--CA 1.469 0.865 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.1 mt -77.77 13.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.484 -0.294 . . . . 0.0 111.095 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 53.9 t30 109.79 167.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.612 1.195 . . . . 0.0 109.766 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 52.4 p30 -101.98 66.83 1.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLU . 5.5 tpt180 -143.63 77.28 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.585 0.231 . . . . 0.0 110.983 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -102.98 128.21 49.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.346 0.593 . . . . 0.0 109.605 -178.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.678 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -109.38 -163.18 0.85 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.609 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.3 t -44.83 -179.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.174 0.512 . . . . 0.0 110.994 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.536 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.24 155.42 37.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.585 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -121.28 129.89 53.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.96 126.71 28.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.394 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.8 t -123.14 130.19 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.09 162.28 13.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.954 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.897 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -86.51 146.82 42.67 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.688 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 122.427 2.085 . . . . 0.0 112.223 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.666 0.27 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.729 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 15.4 t80 -156.87 113.22 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.2 tptm -153.98 129.29 9.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 111.155 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -133.96 141.57 43.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 39.7 mt-30 -119.33 128.61 54.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 118' ' ' ILE . 12.5 mt -119.38 131.65 71.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.0 m-85 -111.21 131.22 55.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.98 -31.5 71.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -118.73 152.26 36.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.175 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.0 -169.66 2.22 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.0 t0 45.02 29.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 54.19 80.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 m -158.12 162.55 38.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.52 -149.24 19.7 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.58 138.93 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 110.449 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -120.5 127.85 52.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.526 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -119.44 136.63 54.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.204 0.526 . . . . 0.0 110.868 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.81 126.88 46.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.457 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -147.58 129.21 15.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.42 36.99 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.605 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.96 -177.31 5.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -85.1 158.91 20.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.193 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -132.38 123.79 18.82 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.227 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -78.52 -55.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.512 1.474 . . . . 0.0 110.784 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.2 m -119.11 114.44 22.47 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.13 -45.13 80.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.04 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.0 ttt -65.94 -20.54 66.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.255 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -74.2 -46.84 39.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.15 -24.36 14.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.7 m-85 -110.77 0.92 17.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.4 m-70 52.41 12.13 0.22 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.234 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 122' ' ' PHE . 34.7 mtt -78.97 134.16 36.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -106.22 -27.12 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.222 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.54 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -153.69 109.94 3.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.497 0.665 . . . . 0.0 111.251 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -75.85 125.33 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.748 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.3 m80 -106.79 -31.05 8.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.001 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 7.9 m -152.47 147.03 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.5 t -146.66 133.92 20.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.725 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -114.05 -178.18 3.31 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.618 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 21.5 t 56.46 103.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.99 163.44 15.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.7 mp0 -139.21 112.25 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.694 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.95 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 134' ' ' GLU . 41.8 t -126.6 135.88 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.729 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 t-105 -121.84 169.39 10.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 53.1 mt -145.53 124.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.465 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -110.74 133.73 53.08 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 149' ' ' GLN . 16.9 m-85 -109.73 111.71 23.32 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 123.531 0.519 . . . . 0.0 110.52 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -49.91 -23.38 1.92 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.975 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mp -113.86 166.4 11.46 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -86.47 166.09 9.21 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.216 1.944 . . . . 0.0 112.044 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.498 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.7 m120 69.14 21.26 7.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.454 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.7 m-85 72.19 66.95 0.13 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.703 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -154.63 170.68 20.93 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 122.041 -0.412 . . . . 0.0 110.592 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.38 167.04 29.97 Favored Glycine 0 N--CA 1.464 0.53 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.884 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 149' ' ' GLN . 20.6 ptt180 -68.02 77.57 0.23 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 5.1 pt20 -48.05 175.54 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.443 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.196 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.404 ' O ' ' OG ' ' A' ' 129' ' ' SER . 33.7 ptt180 -107.23 -23.52 12.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.593 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpt -118.18 157.63 48.42 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-O 121.332 0.587 . . . . 0.0 111.044 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.4 Cg_endo -61.24 -19.29 63.14 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.044 1.829 . . . . 0.0 113.451 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -99.52 -0.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.532 . . . . 0.0 110.834 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -62.79 -25.83 68.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.481 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -108.93 21.14 17.6 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-O 120.931 0.395 . . . . 0.0 110.07 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.4 70.46 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.834 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.42 137.63 42.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.524 1.162 . . . . 0.0 109.459 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -72.47 18.37 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.083 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 167.77 157.18 0.14 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.41 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.17 6.17 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.951 2.434 . . . . 0.0 111.617 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.99 69.42 5.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.551 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.0 t -97.04 -153.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.914 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -155.13 -130.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.432 0.457 . . . . 0.0 110.228 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 2.6 p -92.72 -155.73 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -169.75 -177.68 2.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.425 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -162.03 134.33 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.124 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.692 ' O ' HG23 ' A' ' 177' ' ' VAL . 15.0 ptt180 -50.83 133.09 26.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.792 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 136' ' ' VAL . 5.8 mt -59.7 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 175' ' ' ARG . 21.6 t -69.53 140.13 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.072 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.421 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.982 0.42 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.752 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.1 tttt -160.97 149.94 16.58 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.892 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.96 140.47 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.935 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 27.2 m -121.58 137.84 54.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.25 115.49 24.86 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.8 m-85 -95.26 140.0 30.78 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.17 -51.31 69.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.911 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.4 m-20 -98.59 -176.77 3.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 2.9 mppt? -82.04 -176.78 6.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m120 45.59 26.53 0.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.124 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.7 OUTLIER 62.09 41.0 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -106.58 172.0 7.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.16 -157.57 53.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NH1' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -54.56 175.93 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' CD ' ' A' ' 19' ' ' ARG . 2.7 ppt_? -169.21 149.99 4.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -132.92 133.77 43.68 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.1 p-10 -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.664 0.268 . . . . 0.0 110.798 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.21 37.73 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -124.64 16.56 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' ASP . 7.7 t -148.54 143.4 26.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' CYS . 52.2 p-10 -37.18 158.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.207 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.3 t -157.6 164.17 37.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -96.35 -49.07 5.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -158.57 105.7 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.254 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 1.7 p90 -97.76 12.58 33.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -64.74 -15.59 61.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 110.214 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.1 p -78.6 2.04 20.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.308 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.3 m-85 -120.2 -13.42 8.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 36' ' ' ARG . 20.1 tp -144.76 140.31 28.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 t -100.7 -13.8 18.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' O ' HD21 ' A' ' 34' ' ' LEU . 55.6 ttm-85 -152.61 141.73 21.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' ' CA ' ' A' ' 79' ' ' ARG . 9.0 p -109.34 104.3 13.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.294 0.569 . . . . 0.0 110.981 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.719 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.4 m120 -128.77 156.45 43.54 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.719 ' O ' ' O ' ' A' ' 38' ' ' ASN . 9.2 p 36.18 129.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.509 1.147 . . . . 0.0 112.341 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.16 146.39 22.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.828 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.16 102.7 2.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.47 148.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.466 0.65 . . . . 0.0 110.906 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.4 50.74 1.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.38 -97.14 0.11 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.39 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.488 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.75 -141.17 4.23 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 47' ' ' TRP . 25.6 m -80.2 164.43 23.28 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.393 -0.475 . . . . 0.0 110.819 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.752 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 35.4 m95 -153.47 156.27 37.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -115.72 120.22 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.552 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -116.82 133.02 64.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.175 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 52' ' ' ARG . 82.5 m-85 -104.49 107.22 18.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.876 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' TYR . 44.7 tt0 -34.02 -32.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.441 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 67.9 mtt180 -127.9 151.27 75.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.154 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -58.65 163.59 10.7 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.222 1.948 . . . . 0.0 113.142 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 55' ' ' PHE . 3.1 m-20 57.04 66.94 1.06 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.073 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' A' ' 54' ' ' ASN . 1.4 m-85 . . . . . 0 N--CA 1.469 0.509 0 O-C-N 123.437 0.46 . . . . 0.0 111.764 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.4 mp -104.87 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -72.62 110.84 9.1 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.48 162.92 16.98 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.09 1.86 . . . . 0.0 112.877 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.47 115.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.827 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.08 178.03 42.04 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.6 mt-10 -101.19 155.28 18.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 41.7 m-85 -149.04 85.2 6.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.33 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.02 -16.37 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.237 2.624 . . . . 0.0 113.228 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -148.7 161.44 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.7 p90 -65.67 -53.18 44.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 63.5 mt-30 -43.27 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -75.61 -6.38 50.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.291 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -116.1 25.86 10.37 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.513 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.0 mmt 85.1 26.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.376 1.048 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.27 52.46 0.41 Allowed Glycine 0 N--CA 1.468 0.778 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 28.3 mt -78.42 13.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.202 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.4 t30 113.16 168.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.681 1.238 . . . . 0.0 109.165 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -102.03 66.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.232 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' CA ' ' SG ' ' A' ' 37' ' ' CYS . 14.3 tpt180 -147.9 122.41 9.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.125 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -143.13 128.96 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.689 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.9 p -112.42 -161.29 0.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 2.2 t -44.76 177.79 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.55 ' N ' ' OG ' ' A' ' 82' ' ' SER . 13.8 p -152.18 153.6 34.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.563 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -119.45 129.44 54.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.19 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.53 119.95 9.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.971 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.568 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.5 t -103.82 121.94 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.82 148.55 22.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.038 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.4 146.55 70.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.51 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 N--CA 1.496 1.643 0 C-N-CA 122.299 2.0 . . . . 0.0 112.052 179.357 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.8 0.334 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.719 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 13.9 t80 -158.15 114.08 2.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.406 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 17.9 tptm -154.7 128.57 8.76 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.357 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 tt -133.9 141.42 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.54 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.464 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 60.4 mt-30 -119.22 128.16 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 118' ' ' ILE . 9.3 mt -118.79 131.45 71.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.057 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.407 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 59.1 m-85 -111.14 130.68 55.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -60.84 -31.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.614 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -114.97 151.68 33.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.0 171.52 31.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 40.1 t0 59.52 32.9 21.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.556 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 9.2 m-85 54.3 80.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -158.07 163.66 37.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.64 -147.89 20.82 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.24 139.33 41.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 46.0 ttp -120.81 126.83 51.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.444 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.469 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 52.9 m-85 -117.87 135.87 53.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.93 125.41 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.422 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 6.0 t -152.27 127.97 10.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.71 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.16 39.81 1.08 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.41 178.51 7.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.7 p-10 -82.72 156.41 23.78 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -130.85 121.22 18.85 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.7 Cg_endo -78.24 -53.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.865 1.71 . . . . 0.0 110.593 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.0 m -120.43 113.48 20.4 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.58 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -69.24 -43.53 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.137 0.494 . . . . 0.0 111.162 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.7 ttt -68.09 -19.2 64.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.017 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -76.04 -45.61 33.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 6.9 pt20 -100.38 -26.18 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m-85 -111.93 1.11 16.31 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.738 0.304 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.6 m-70 52.11 15.3 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.455 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 36.5 mtt -81.97 134.44 35.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -106.91 -28.14 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.659 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.551 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 41.9 mt-10 -151.3 108.79 3.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.852 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -74.38 125.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.814 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -106.14 -29.98 9.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.218 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 4.8 m -151.52 146.26 25.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.1 t -153.57 128.82 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.928 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 53.1 mtmt -114.51 -179.44 3.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.854 0.359 . . . . 0.0 110.602 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.447 ' C ' HD22 ' A' ' 133' ' ' LEU . 5.5 t 60.79 64.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 133' ' ' LEU . 3.8 mm? -96.61 100.83 12.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.213 0.53 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 1.2 mp0 -67.0 121.14 14.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.44 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.48 -110.94 0.09 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 176' ' ' ILE . 11.3 t -98.77 142.35 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 110.14 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 32.7 t-105 -131.84 169.33 16.4 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.1 mt -144.94 123.04 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.729 0.3 . . . . 0.0 111.787 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.628 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -107.93 129.52 55.1 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 20.2 m-85 -109.02 111.46 23.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.26 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 142' ' ' LEU . 77.0 tt0 -48.41 -23.66 1.01 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -118.1 160.9 37.31 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 110.277 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.416 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.5 Cg_endo -77.89 167.94 22.96 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.115 1.876 . . . . 0.0 111.83 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.5 m-20 73.07 14.24 4.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.78 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.29 24.54 0.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.636 0.255 . . . . 0.0 111.348 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -108.04 168.96 8.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.26 173.03 38.69 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -52.5 163.87 0.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 11.7 mp0 -129.47 147.12 51.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.152 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.425 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.038 0.447 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.443 ' O ' ' OG ' ' A' ' 129' ' ' SER . 16.6 ptm180 -105.23 -28.29 11.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.719 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -117.59 154.74 50.82 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.539 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.0 Cg_endo -56.78 -18.64 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.38 2.054 . . . . 0.0 113.595 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -102.52 -2.35 9.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.88 -28.8 70.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -105.06 21.9 16.26 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.43 28.56 71.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.804 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.13 137.48 46.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 118.153 0.977 . . . . 0.0 109.051 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -74.22 17.41 0.19 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.29 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 172.13 156.33 0.24 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.983 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.19 5.91 4.25 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.045 2.497 . . . . 0.0 111.733 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.84 70.59 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 0.0 110.746 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.892 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.2 t -98.71 -147.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -160.14 -132.31 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.517 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.32 -155.31 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -177.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.613 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 26.9 p90 -170.05 -176.01 2.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.448 HH21 HG22 ' A' ' 177' ' ' VAL . 10.1 ptm180 -161.59 133.09 5.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.375 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -54.23 130.45 38.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.827 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 136' ' ' VAL . 12.6 mt -63.48 138.59 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.632 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.448 HG22 HH21 ' A' ' 174' ' ' ARG . 31.0 m -139.36 159.25 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.299 179.66 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.5 tttt -162.29 155.25 20.03 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.106 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.5 tt -149.05 144.38 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.127 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 21' ' ' TYR . 19.0 m -128.04 139.59 52.45 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.185 0.517 . . . . 0.0 110.508 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.36 117.66 28.33 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.989 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 62.9 m-85 -96.89 134.15 40.59 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 110.197 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' A' ' 34' ' ' LEU . 3.1 tm-20 -59.31 -44.83 92.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.439 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 90.6 m-20 -106.73 -173.45 2.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.972 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -83.64 -177.42 6.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 0.0 111.635 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 48.27 19.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.19 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 6.3 m-85 68.02 40.7 2.2 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.138 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 19' ' ' ARG . 10.6 pt20 -122.78 -168.03 1.68 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.972 0.415 . . . . 0.0 111.535 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.28 -24.25 0.46 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.481 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.2 ttm180 162.34 -174.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.294 0.637 . . . . 0.0 110.33 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.93 157.99 6.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 9' ' ' THR . 62.7 t80 -138.84 135.39 34.5 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 91.9 m-20 -100.75 150.44 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -164.05 122.97 1.93 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 178.675 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -125.38 12.7 8.17 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.614 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.2 m -149.3 145.64 27.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.782 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -38.82 156.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 82' ' ' SER . 2.2 m -157.04 163.26 39.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.279 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.42 -56.74 2.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.5 p-10 -153.56 106.76 2.95 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.463 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -96.34 8.84 42.96 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 65.8 t60 -58.46 -27.46 64.42 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.455 0.645 . . . . 0.0 110.003 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.4 p -62.55 -29.12 70.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' CE1' ' A' ' 21' ' ' TYR . 85.1 m-85 -88.44 -14.8 37.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.923 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 31' ' ' HIS . 13.8 tp -141.64 136.89 31.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 t -95.52 -6.54 40.27 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.9 ttm-85 -160.77 152.03 19.1 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 4.2 p -115.35 103.66 11.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.484 0.659 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.724 ' O ' ' O ' ' A' ' 39' ' ' SER . 80.3 m-20 -129.97 158.66 38.95 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.724 ' O ' ' O ' ' A' ' 38' ' ' ASN . 16.6 p 33.0 125.99 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.319 1.056 . . . . 0.0 112.734 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -139.54 144.68 28.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.355 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -152.21 102.52 2.78 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.939 -0.476 . . . . 0.0 110.211 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.51 150.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.667 0.746 . . . . 0.0 110.547 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -123.61 53.23 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.907 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.29 -93.25 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.582 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.473 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.93 -140.35 3.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 47' ' ' TRP . 85.6 m -81.72 166.86 19.72 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.426 -0.455 . . . . 0.0 110.786 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.3 m95 -155.07 156.3 35.63 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.451 0.643 . . . . 0.0 110.782 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.72 122.84 46.71 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.23 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.5 m -119.41 132.01 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 0.0 110.712 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -103.1 111.36 23.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -37.57 -36.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.177 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -116.16 137.25 23.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.66 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 16.8 Cg_exo -58.88 159.63 20.66 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.269 1.313 . . . . 0.0 112.351 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 m120 86.1 -3.01 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.011 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.1 m-85 . . . . . 0 N--CA 1.469 0.52 0 O-C-N 123.433 0.458 . . . . 0.0 110.819 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 30.6 t80 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.753 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.7 mp -102.02 89.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -68.15 111.43 7.85 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.44 164.26 16.74 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.98 1.786 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -52.86 124.56 14.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.087 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.68 -175.56 40.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.2 mt-10 -107.33 152.89 23.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.217 0.532 . . . . 0.0 110.284 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.6 m-85 -145.6 84.78 8.17 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.3 Cg_exo -58.07 -17.06 29.73 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.984 2.456 . . . . 0.0 112.77 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.8 mt-10 -150.91 162.02 41.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.678 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.3 p90 -61.61 -49.46 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.522 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -42.34 -13.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.2 mmt180 -75.25 -5.19 43.31 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.132 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.678 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.02 26.76 9.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 121.522 -0.071 . . . . 0.0 111.16 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 mmt 88.76 17.72 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.481 1.113 . . . . 0.0 110.935 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 34.24 55.85 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.44 -70.29 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -157.18 158.9 37.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.6 p-10 -85.87 55.95 3.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.796 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 10.8 tpt180 -138.1 115.9 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.49 128.75 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.8 p -110.25 -161.85 0.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.179 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 7.0 t -45.45 -178.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.221 0.534 . . . . 0.0 110.708 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.61 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.4 p -150.01 150.3 31.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.723 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -115.97 126.65 54.13 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -60.61 127.71 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.327 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.3 t -124.53 131.34 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.935 0.398 . . . . 0.0 110.773 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.414 ' O ' HG21 ' A' ' 136' ' ' VAL . 99.4 m-70 -100.18 162.5 12.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.93 150.13 74.71 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 C-N-CA 122.233 1.955 . . . . 0.0 112.124 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 t80 -154.29 113.03 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 47.0 tptt -154.59 136.0 14.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.127 0.489 . . . . 0.0 111.034 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.87 145.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.303 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.484 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 4.9 mm-40 -126.04 132.62 51.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.868 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.529 HD13 HD11 ' A' ' 118' ' ' ILE . 6.3 mt -120.89 132.34 70.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.894 -177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -112.17 126.84 55.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.988 0.423 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.77 -24.03 61.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -125.97 146.76 49.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.214 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -58.81 -168.55 0.2 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 4.5 p-10 42.58 29.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 54.38 81.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -158.15 166.42 32.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.058 0.456 . . . . 0.0 110.528 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 -156.11 29.85 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.614 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -65.23 137.01 57.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.429 ' HG2' ' NE2' ' A' ' 97' ' ' GLN . 36.2 ttp -120.56 122.09 39.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.484 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 49.8 m-85 -118.13 133.23 56.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 120.07 35.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 111' ' ' THR . 7.4 t -146.92 127.84 14.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.52 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -95.68 40.96 1.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 111.142 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -141.11 178.38 7.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.526 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.482 ' CG ' HH12 ' A' ' 175' ' ' ARG . 24.6 p-10 -82.76 157.56 23.19 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.533 ' SG ' ' OG ' ' A' ' 172' ' ' SER . 49.7 t -134.4 122.34 15.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 172' ' ' SER . 63.9 Cg_endo -76.43 -57.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.488 1.459 . . . . 0.0 110.862 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.7 m -116.35 115.97 26.86 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.6 tt -70.2 -46.81 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 0.0 110.916 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.464 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.9 ttt -64.59 -20.8 66.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.293 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -72.98 -46.65 51.06 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.897 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.0 pt20 -102.43 -23.39 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.632 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.5 m-85 -111.96 -1.92 15.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.118 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 54.78 11.54 0.47 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.841 0.353 . . . . 0.0 111.018 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.2 mtt -79.77 132.69 36.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.19 -24.89 11.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.722 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 64.9 mt-10 -152.17 108.48 3.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.11 0.481 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 118' ' ' ILE . 8.0 mm -75.16 125.44 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.674 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 76.0 m80 -105.16 -33.81 8.14 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.326 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.1 p -155.38 151.09 27.47 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.656 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -144.77 157.13 44.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.818 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.3 mtpt -135.13 -178.98 5.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.48 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 t 54.7 80.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -98.92 165.89 11.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.5 mp0 -139.96 112.37 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.05 -88.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.1 t -120.01 155.07 22.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 109.998 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.4 t-105 -144.07 169.41 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.618 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 86.9 mt -144.84 123.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.633 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.84 129.69 55.61 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 22.5 m-85 -107.64 111.81 24.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.866 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' O ' HD12 ' A' ' 142' ' ' LEU . 73.8 tt0 -50.3 -22.29 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.1 mp -118.48 160.09 41.24 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.402 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.1 Cg_endo -77.35 166.4 26.18 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.37 2.047 . . . . 0.0 111.762 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.507 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.3 m120 74.13 15.3 3.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.507 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.0 m-85 76.39 25.53 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.608 0.242 . . . . 0.0 111.247 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -108.55 167.69 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.071 0.462 . . . . 0.0 110.582 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.42 168.61 34.24 Favored Glycine 0 N--CA 1.463 0.48 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -59.03 142.28 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 46.2 mt-30 -97.64 147.89 23.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 . . . . . 0 N--CA 1.468 0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.723 0.297 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -105.09 -24.47 12.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -122.53 152.45 61.56 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.57 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.8 Cg_exo -49.9 -35.52 40.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.191 1.928 . . . . 0.0 112.998 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.7 mp -86.66 -3.4 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.607 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -57.26 -29.89 64.2 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.07 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.57 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.1 p90 -105.23 21.27 17.42 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.43 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.18 61.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.574 -0.57 . . . . 0.0 114.24 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.23 137.09 45.95 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.459 1.13 . . . . 0.0 110.572 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.46 21.64 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.684 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 168.99 153.69 0.15 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.684 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.77 5.2 5.03 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.916 2.41 . . . . 0.0 112.044 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.51 71.36 6.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.896 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.912 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.5 t -99.55 -147.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.912 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.4 tp60 -159.31 -131.79 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.39 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.3 -156.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -170.21 -178.02 2.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.298 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.86 133.52 8.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.954 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.482 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.0 ptt-85 -51.91 130.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.68 131.66 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.252 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.24 134.68 60.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.438 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 30.9 tp10 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.513 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.023 0.44 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.711 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 45.5 tttt -159.2 153.29 23.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.122 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -147.15 147.21 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 92.3 m -133.65 141.65 47.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.27 0.557 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -122.61 116.72 24.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.334 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 63.6 m-85 -95.89 137.02 35.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.267 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -45.08 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.3 m-20 -109.36 -173.35 2.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -82.8 -177.81 6.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.95 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 1.3 m-20 50.66 17.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.076 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.476 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 5.3 m-85 73.41 38.84 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.781 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 19' ' ' ARG . 55.3 mt-30 -117.62 -168.45 1.5 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.893 0.378 . . . . 0.0 110.472 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 75.52 -29.01 1.24 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.215 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 19.3 ttt85 158.13 -167.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.729 0.9 . . . . 0.0 109.718 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -170.25 151.38 3.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' THR . 78.0 t80 -129.88 135.0 47.86 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.2 p-10 -102.21 144.29 30.94 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.076 -0.39 . . . . 0.0 110.989 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -166.61 122.74 1.22 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.785 178.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -121.14 20.97 11.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.21 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.35 149.66 29.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -40.9 157.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.471 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.14 160.42 40.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.197 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.99 -55.53 3.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.1 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -155.43 100.62 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.219 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -86.8 9.12 20.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.414 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -59.74 -17.42 34.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.077 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -78.12 -1.15 31.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -117.15 -15.26 10.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 13.2 tp -143.1 139.96 30.67 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -98.28 -7.23 29.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.288 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.0 ttm-85 -159.42 148.27 18.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.9 m -114.52 103.15 10.75 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.718 ' O ' ' O ' ' A' ' 39' ' ' SER . 97.3 m-20 -129.21 156.54 43.78 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.718 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.7 p 35.89 125.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.909 0.861 . . . . 0.0 112.168 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.9 mt -138.5 144.11 30.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.088 0 CA-C-O 121.614 0.721 . . . . 0.0 111.806 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -153.48 99.19 2.31 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 8' ' ' ILE . 18.1 m -70.1 138.61 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.523 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -109.81 52.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.21 -99.33 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.165 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.68 -137.17 3.56 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 47' ' ' TRP . 41.3 m -77.23 164.83 25.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 110.884 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.711 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.6 m95 -155.73 157.31 36.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.295 0.569 . . . . 0.0 110.596 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.77 120.37 38.36 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.021 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.45 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.7 m -118.66 132.85 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.245 0.545 . . . . 0.0 111.052 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' ARG . 90.5 m-85 -108.07 112.91 25.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 50' ' ' TYR . 42.2 tt0 -35.75 -32.65 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.715 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -121.0 148.3 48.48 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.313 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.662 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 7.7 Cg_exo -67.16 160.19 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.875 1.717 . . . . 0.0 112.123 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 85.46 -4.8 0.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.887 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 6.2 m-85 . . . . . 0 N--CA 1.467 0.414 0 O-C-N 123.427 0.455 . . . . 0.0 111.055 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 23.0 t80 . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.7 mp -102.09 92.4 2.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -68.94 111.15 7.5 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.7 163.92 16.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.025 1.817 . . . . 0.0 112.946 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.06 125.53 12.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.138 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.83 -172.51 38.88 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.0 mt-10 -111.65 155.34 23.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.207 0.527 . . . . 0.0 110.126 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.5 m-85 -147.99 81.09 8.45 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.32 -9.93 14.32 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.294 1.996 . . . . 0.0 112.862 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.3 mt-10 -149.95 161.18 42.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.749 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.0 p90 -64.98 -50.77 65.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.38 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.9 mt-30 -43.98 -10.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 70' ' ' TYR . 25.1 mmm180 -75.4 0.04 18.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.749 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -124.93 24.07 7.69 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 74' ' ' MET . 11.0 mmm 89.77 17.45 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.952 0.782 . . . . 0.0 111.947 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.72 63.09 0.19 Allowed Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.11 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 19.5 mt -93.69 17.61 11.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.959 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 52.3 t-20 111.99 150.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.206 1.566 . . . . 0.0 109.995 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 51.5 p-10 -83.58 69.93 10.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.23 118.9 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.097 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -147.5 132.18 17.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.144 0.497 . . . . 0.0 110.157 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.717 ' N ' HD13 ' A' ' 80' ' ' LEU . 8.9 p -107.68 -163.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.0 p -50.91 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.94 -0.475 . . . . 0.0 110.991 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 8' ' ' ILE . 14.7 p -153.51 155.5 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -117.79 128.18 54.61 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.66 131.58 50.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.78 130.84 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -101.39 162.49 12.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.772 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 88' ' ' LEU . 1.3 mt -87.03 149.17 47.0 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.654 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.494 1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 112.083 179.523 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.727 0.299 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 32.3 t80 -152.93 113.87 4.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -154.59 135.27 13.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.104 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 146.08 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.165 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 37.1 mt-30 -124.82 129.04 49.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.935 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 118' ' ' ILE . 6.5 mt -119.49 132.43 69.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.368 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 131' ' ' LYS . 39.3 m-85 -112.33 124.74 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.27 -19.9 38.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.778 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -131.09 144.09 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.869 0.366 . . . . 0.0 110.468 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.86 -171.08 0.23 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 2.8 p-10 45.25 29.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.72 0.295 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.537 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 14.3 m-85 54.89 81.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.878 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -158.98 163.61 36.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 110.806 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.57 -156.98 28.42 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -66.62 136.48 55.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 41.8 ttp -117.58 122.54 43.91 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.073 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.582 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.9 m-85 -114.97 129.99 56.83 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 110.991 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.99 121.43 37.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.068 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -151.88 130.99 12.67 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.469 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -97.85 50.79 1.04 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -147.8 -176.44 5.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -89.38 159.7 17.2 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.067 0.461 . . . . 0.0 110.202 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 172' ' ' SER . 45.7 t -137.48 124.81 13.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.754 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.509 ' O ' ' OG ' ' A' ' 172' ' ' SER . 59.4 Cg_endo -78.38 -61.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.662 1.575 . . . . 0.0 110.093 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -112.27 115.01 28.09 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -69.16 -45.28 79.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 28.0 ttt -63.78 -23.69 67.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.685 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.7 -50.27 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.483 -0.761 . . . . 0.0 112.245 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.634 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.3 pt20 -97.56 -23.82 15.83 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.634 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 29.5 m-85 -112.3 0.54 15.75 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.55 0.214 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.6 m-70 54.0 2.52 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.088 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.557 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -70.53 131.92 44.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -106.83 -25.93 11.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.569 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.9 mt-10 -150.87 109.32 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 8.1 mm -76.26 126.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.67 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.9 m80 -106.41 -36.85 6.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.258 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.537 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 10.0 t -148.63 143.73 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.9 t -144.78 140.12 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 99' ' ' PHE . 35.1 mtmm -124.27 -171.95 2.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 36.3 t 54.34 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.516 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -100.38 166.64 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.199 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -137.35 112.84 9.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 37.79 -89.83 0.01 OUTLIER Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.5 t -117.48 152.19 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.5 t-105 -141.2 166.77 23.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 176' ' ' ILE . 78.2 mt -144.02 124.06 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -111.74 129.47 56.11 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -106.34 113.4 26.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -53.83 -25.79 21.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.64 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.94 159.66 32.74 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-O 120.676 0.274 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 164.66 28.07 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.268 1.979 . . . . 0.0 111.383 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m120 75.57 15.99 2.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.2 m-85 76.6 29.75 0.66 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.098 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -116.41 170.49 8.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.912 0.387 . . . . 0.0 110.733 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.31 167.83 38.59 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.95 152.0 0.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -113.15 127.8 56.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.648 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.329 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.109 0.481 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.673 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.8 ptt180 -108.42 -21.37 12.77 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.0 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.673 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.3 pttm -123.87 154.54 67.48 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.286 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.502 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.9 Cg_endo -59.1 -19.97 51.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.386 2.057 . . . . 0.0 113.368 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.43 -5.98 9.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.923 0.392 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.74 -32.89 63.78 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.44 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.549 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.71 22.32 13.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.798 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 28.79 67.53 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.914 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.3 138.1 44.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.674 0.737 . . . . 0.0 110.124 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.85 24.3 0.23 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER 165.82 154.21 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.496 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 170' ' ' VAL . 56.1 Cg_endo -72.82 -12.01 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.904 2.403 . . . . 0.0 111.398 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.68 69.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.329 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.928 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -101.33 -155.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.928 ' H ' HG12 ' A' ' 170' ' ' VAL . 64.7 mm-40 -149.98 -130.95 0.05 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.4 p -95.28 -155.08 0.45 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -170.84 -178.75 2.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.282 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -156.1 129.95 8.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.479 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -52.65 129.21 28.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.587 0.708 . . . . 0.0 110.684 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -61.66 129.05 24.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.289 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.28 153.28 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.206 179.716 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.732 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -156.67 148.53 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.1 tt -144.58 140.67 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.608 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -126.73 138.02 53.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.63 115.75 25.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.6 m-85 -96.41 138.53 33.87 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 110.939 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.4 tm-20 -61.43 -49.81 75.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.903 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -98.18 -177.29 3.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -176.74 6.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.164 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 46.25 25.11 0.33 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.856 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.1 m-85 60.83 42.72 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.08 166.75 10.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.831 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.27 -153.73 43.45 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.709 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.694 ' NH2' ' H ' ' A' ' 35' ' ' SER . 15.8 ttp180 -58.75 174.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.03 153.91 5.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.408 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.0 t80 -127.05 130.67 50.39 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 44.8 p-10 -118.68 121.73 40.83 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.9 0.381 . . . . 0.0 111.701 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.9 t -150.21 141.57 23.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.095 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -124.46 26.27 7.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.0 m -148.55 144.75 27.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.502 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -38.54 156.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.846 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 25.0 t -156.76 163.05 39.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.145 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.87 -56.63 2.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.561 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.96 111.57 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -101.85 7.67 41.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 82.6 t60 -58.44 -27.18 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -62.63 -29.81 70.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.426 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.02 -15.36 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.574 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.632 HD12 ' HE ' ' A' ' 19' ' ' ARG . 16.5 tp -142.83 137.48 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.07 0.462 . . . . 0.0 110.067 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.694 ' H ' ' NH2' ' A' ' 19' ' ' ARG . 49.9 m -98.9 -9.23 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 56.0 ttm-85 -154.79 143.04 20.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.307 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 5.2 p -109.37 103.62 12.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.732 ' O ' ' O ' ' A' ' 39' ' ' SER . 62.8 m-20 -128.08 156.26 43.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.732 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.9 p 35.05 129.43 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.745 1.259 . . . . 0.0 112.519 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.2 mt -142.55 147.52 20.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.023 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -156.48 100.81 1.98 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.35 139.57 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.292 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -110.13 56.43 0.63 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.268 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.08 -92.84 0.09 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.702 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 -139.11 3.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 47' ' ' TRP . 43.0 m -80.48 164.9 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.732 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 34.0 m95 -152.94 154.12 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.105 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.18 118.76 35.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' HB ' HD21 ' A' ' 80' ' ' LEU . 4.7 m -118.46 132.86 67.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.555 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ARG . 88.2 m-85 -105.59 113.93 27.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 50' ' ' TYR . 79.5 tt0 -30.01 -33.95 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.285 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' TYR . 21.1 mtt180 -127.15 162.67 46.66 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.279 0.362 . . . . 0.0 110.781 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 5.3 Cg_exo -73.9 170.63 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.533 2.155 . . . . 0.0 112.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.7 m120 79.26 -11.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.697 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.1 m-85 . . . . . 0 N--CA 1.465 0.292 0 O-C-N 123.674 0.609 . . . . 0.0 110.43 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.504 ' C ' HD12 ' A' ' 61' ' ' ILE . 29.3 t80 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.55 94.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -69.2 109.57 4.65 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 123.312 0.383 . . . . 0.0 110.048 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.23 160.83 17.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.15 1.9 . . . . 0.0 113.324 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 117.8 1.8 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.291 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.47 -179.29 41.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -106.09 155.82 19.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.085 0.469 . . . . 0.0 110.29 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.9 m-85 -146.7 84.53 7.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 32.0 Cg_exo -57.6 -16.87 25.95 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.174 2.583 . . . . 0.0 112.887 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 47.8 mt-10 -149.8 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.706 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.3 p90 -63.59 -51.88 63.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 19.6 mt-30 -43.54 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.1 mmm180 -75.86 -5.58 46.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.706 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.77 23.94 11.37 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.592 -0.067 . . . . 0.0 111.026 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 34.5 mmt 87.41 25.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.45 1.094 . . . . 0.0 110.97 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.11 50.69 0.36 Allowed Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.8 mt -77.45 14.24 1.03 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 118.982 -0.533 . . . . 0.0 111.438 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.9 t30 110.46 164.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.8 1.312 . . . . 0.0 109.252 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.0 p-10 -96.59 64.08 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.493 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 36.5 ttm180 -141.63 117.21 10.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.943 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.74 129.65 20.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.683 ' N ' HD13 ' A' ' 80' ' ' LEU . 53.2 p -112.22 -161.95 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.661 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.9 p -45.99 -178.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.212 0.53 . . . . 0.0 110.642 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 11.8 p -154.3 159.73 41.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.72 131.07 53.49 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.72 127.43 31.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 48' ' ' ALA . 68.9 t -126.43 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -101.29 157.41 16.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.0 157.18 69.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.522 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.492 1.422 0 C-N-CA 122.661 2.241 . . . . 0.0 112.085 179.429 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.73 0.3 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.749 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.3 t80 -159.14 113.3 2.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.197 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 132' ' ' VAL . 16.7 tptm -152.37 133.75 14.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.3 tt -134.88 142.34 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.749 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 36.4 mt-30 -120.92 129.08 53.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 108' ' ' MET . 13.8 mt -119.13 130.92 73.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.181 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.0 m-85 -111.52 128.1 55.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.837 0.351 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 84.4 tt0 -60.78 -27.65 68.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.918 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -118.33 146.9 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.929 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.74 172.22 20.01 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.01 31.14 19.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.538 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 10.2 m-85 55.14 80.99 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.246 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -160.25 162.61 33.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 -153.01 23.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -70.04 136.16 50.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -121.33 125.51 47.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.4 m-85 -117.11 134.91 54.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.089 0.471 . . . . 0.0 110.657 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -122.16 119.7 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.488 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 111' ' ' THR . 4.5 t -147.0 125.66 12.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -91.06 41.89 1.08 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.019 0.438 . . . . 0.0 111.041 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.07 179.77 6.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 17.1 p-10 -83.95 160.13 21.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.963 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -134.55 121.31 15.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.194 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.13 -53.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.659 1.573 . . . . 0.0 110.873 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -119.71 111.54 18.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -44.33 87.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 0.0 110.875 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.8 ttt -66.99 -21.99 65.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -73.01 -48.33 37.28 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.662 -0.649 . . . . 0.0 112.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.2 pt20 -99.16 -24.86 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.631 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 40.2 m-85 -111.58 2.39 17.33 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.992 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.0 m-70 51.41 11.91 0.13 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.132 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.0 mmt -79.44 135.29 36.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.582 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -110.57 -26.85 9.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.087 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 52.1 mt-10 -150.5 107.11 3.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.033 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.6 mm -77.78 125.11 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.6 m80 -104.81 -30.12 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.135 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.538 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 18.6 t -156.54 152.01 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.441 . . . . 0.0 110.957 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -146.58 150.8 36.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.992 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.95 -172.01 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.681 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LYS . 61.5 t 47.49 77.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.381 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 157' ' ' TYR . 67.8 mt -101.28 172.29 7.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.183 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.8 mp0 -136.94 114.18 10.78 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.88 -91.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 134' ' ' GLU . 31.7 t -119.18 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -122.15 170.31 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.237 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 176' ' ' ILE . 62.5 mt -145.8 125.17 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.462 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.88 131.66 55.22 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.81 112.92 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.571 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' VAL . 75.7 tt0 -50.25 -27.24 5.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.723 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.39 166.15 11.57 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.35 164.95 11.03 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.022 1.815 . . . . 0.0 111.37 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.562 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 75.02 16.79 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.47 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.9 m-85 77.0 26.52 0.75 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.091 0.245 . . . . 0.0 111.278 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -107.57 166.32 10.76 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.927 0.394 . . . . 0.0 110.533 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 96.6 170.65 34.41 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -67.3 146.38 54.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 2.5 mp0 -94.23 148.33 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.456 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.953 -179.771 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.415 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.9 m-85 . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -106.03 -26.13 11.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -120.14 153.82 55.62 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.5 Cg_endo -58.91 -15.19 25.92 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.478 2.119 . . . . 0.0 113.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -103.05 -3.98 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.037 0.446 . . . . 0.0 110.491 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -28.27 66.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.464 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -106.16 22.79 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.1 70.54 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.523 -0.599 . . . . 0.0 114.014 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.44 140.45 41.73 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.19 0.995 . . . . 0.0 109.723 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.46 21.23 0.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 170.49 154.33 0.19 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.388 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.548 ' O ' HG12 ' A' ' 170' ' ' VAL . 41.1 Cg_endo -68.51 -35.0 18.58 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.489 2.126 . . . . 0.0 111.596 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -51.25 83.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.814 HG22 ' N ' ' A' ' 171' ' ' GLN . 1.4 p -102.54 -97.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.465 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.814 ' N ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 161.89 -143.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.096 0.872 . . . . 0.0 109.345 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 3.7 p -90.95 -156.0 0.42 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -169.51 -177.96 2.93 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.31 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -159.97 132.27 6.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 2.8 ptm180 -51.95 136.09 29.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.519 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -68.81 135.68 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.825 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.14 158.77 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.484 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.737 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 38.9 tttt -162.05 152.44 17.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.519 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -145.66 144.69 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.552 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.8 m -131.61 140.47 49.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 110.387 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -121.07 116.21 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.478 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 68.0 m-85 -94.15 137.68 33.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -58.51 -48.21 81.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.5 m-20 -107.14 -172.81 2.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.158 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -178.95 7.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.88 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 50.55 21.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.502 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.7 m-85 68.41 39.45 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' ARG . 80.8 mt-30 -117.15 -167.45 1.31 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.04 0.447 . . . . 0.0 110.621 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 73.22 -26.74 0.83 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.058 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.3 ttm-85 158.87 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.457 0.74 . . . . 0.0 109.661 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -172.33 152.17 2.69 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.783 ' O ' HG23 ' A' ' 9' ' ' THR . 68.2 t80 -129.49 133.26 47.18 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.8 p-10 -118.0 125.43 50.36 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 t -161.32 139.0 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -126.49 30.72 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 26' ' ' ASP . 3.9 t -147.13 142.29 27.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.775 0.322 . . . . 0.0 110.573 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' CYS . 54.4 p-10 -38.79 157.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.4 m -158.05 163.73 37.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.001 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.63 2.93 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.64 105.19 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.09 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.443 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -94.0 10.63 32.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.969 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.2 t60 -57.35 -25.43 59.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.599 . . . . 0.0 109.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -31.54 72.78 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.505 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.9 -18.33 40.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 12.4 tp -141.0 135.68 31.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 110.411 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -93.85 -10.37 34.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.583 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 23.7 ttm180 -157.53 146.2 19.48 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.7 m -110.78 104.2 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.074 0.464 . . . . 0.0 111.088 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.75 ' O ' ' O ' ' A' ' 39' ' ' SER . 8.1 m120 -130.38 158.22 40.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.1 p 35.79 128.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.63 0 O-C-N 124.426 1.079 . . . . 0.0 111.825 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.8 mt -140.73 146.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-O 121.785 0.803 . . . . 0.0 112.08 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -156.18 99.73 1.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.447 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.67 141.41 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.311 0.577 . . . . 0.0 110.873 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -111.88 53.78 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.31 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.73 -93.9 0.1 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.29 -137.21 3.26 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.7 m -77.72 163.04 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.737 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 31.7 m95 -153.97 155.15 35.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.03 119.11 35.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.2 m -116.45 131.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.503 . . . . 0.0 110.85 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -103.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.702 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -37.53 -35.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.915 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -116.81 148.37 41.93 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.9 Cg_endo -67.94 162.61 39.04 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.755 2.303 . . . . 0.0 111.411 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 4.4 m-80 82.58 -5.11 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.287 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 15.4 m-85 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 61' ' ' ILE . 21.0 t80 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -103.04 91.77 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.36 111.28 8.21 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 123.219 0.325 . . . . 0.0 110.183 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.93 160.61 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.167 1.912 . . . . 0.0 113.089 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.46 122.4 4.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.037 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.07 -174.68 40.21 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.9 mt-10 -111.37 158.53 18.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.186 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 34.0 m-85 -151.81 85.7 4.73 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.934 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 33.9 Cg_exo -57.43 -14.67 16.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.787 2.324 . . . . 0.0 112.598 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.2 mt-10 -151.3 162.25 41.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 23.6 p90 -65.48 -53.12 47.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.5 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.624 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.5 pt20 -40.44 -14.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.102 0.477 . . . . 0.0 112.051 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -74.13 -2.31 24.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.276 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -119.85 23.65 10.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.3 mmt 90.37 24.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.445 1.091 . . . . 0.0 112.059 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.61 54.34 0.24 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.787 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 49.8 mt -87.01 12.8 10.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 49.0 t30 91.15 137.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.932 0.77 . . . . 0.0 110.004 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.7 p-10 -39.37 -96.08 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.658 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.645 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 8.5 tpp85 29.43 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.431 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -138.7 128.12 24.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.055 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.6 p -110.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.8 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.4 p -46.31 -178.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.506 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.9 p -152.05 155.81 38.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.459 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -118.82 128.1 54.15 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.84 128.4 36.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.539 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.29 129.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.87 159.24 15.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.825 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mt -78.5 148.95 74.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.531 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.496 1.654 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 179.776 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 42.1 t80 -155.37 113.44 3.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.195 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 2.9 tppm? -156.2 137.31 13.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.85 145.51 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.003 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 45.4 mt-30 -121.65 130.94 53.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.146 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.719 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.09 130.09 74.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.387 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 45.4 m-85 -110.92 129.83 55.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.751 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -62.58 -25.57 68.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -123.93 145.02 49.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.613 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.99 179.15 4.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 55.84 30.82 16.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 15.8 m-85 54.21 80.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.033 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.5 m -160.39 161.27 33.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.19 25.41 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -67.65 136.71 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.674 0.274 . . . . 0.0 110.778 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.0 ttp -121.63 128.21 51.68 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.622 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 43.4 m-85 -122.84 137.22 54.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.7 127.17 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.602 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' THR . 11.6 t -148.76 129.64 14.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.5 p -93.63 38.18 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.3 179.66 6.95 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -85.02 160.47 20.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 41.6 t -134.98 125.34 17.12 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' OG ' ' A' ' 172' ' ' SER . 64.7 Cg_endo -80.25 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.938 1.759 . . . . 0.0 111.287 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.6 m -116.5 110.15 18.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -68.49 -42.44 83.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.079 0.466 . . . . 0.0 111.003 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.7 ttt -67.43 -17.9 64.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.727 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -81.87 -42.54 19.44 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.462 -0.774 . . . . 0.0 111.723 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.652 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -94.24 -30.61 14.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.762 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.64 1.15 13.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.691 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 54.55 13.43 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.791 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.4 mmt -77.53 131.15 37.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -105.14 -29.14 10.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 74.1 mt-10 -151.11 109.08 3.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.187 0.518 . . . . 0.0 110.585 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.6 mm -74.6 125.71 34.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.821 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -106.87 -32.9 7.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.803 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.6 t -152.29 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 111.054 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.36 131.8 14.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.75 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -111.33 -169.04 1.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.234 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.492 ' C ' HD22 ' A' ' 133' ' ' LEU . 44.4 t 52.61 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.674 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.492 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -110.26 164.24 12.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 136' ' ' VAL . 5.9 mp0 -138.34 110.41 7.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.831 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.52 -86.33 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 134' ' ' GLU . 11.6 t -125.74 155.95 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.734 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.4 t-105 -142.67 170.58 15.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 73.5 mt -145.87 125.37 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.401 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -111.01 131.43 55.05 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.61 110.97 22.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.513 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 70.3 tt0 -49.9 -23.48 1.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.909 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.69 160.57 37.85 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.438 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 65.6 Cg_endo -77.79 168.01 22.99 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.54 2.16 . . . . 0.0 111.788 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.5 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.7 m120 70.08 17.61 7.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.5 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.7 m-85 76.23 24.55 1.11 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.653 0.263 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 96.0 mtm-85 -105.98 162.73 13.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 100.09 164.21 28.77 Favored Glycine 0 N--CA 1.461 0.365 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 18.7 ptt-85 -60.51 138.24 58.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.308 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.555 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 3.7 mp0 -88.12 150.97 23.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.366 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.347 179.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.466 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.6 m-85 . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -105.56 -21.36 13.22 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -124.45 153.07 69.24 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.587 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 22.9 Cg_exo -52.89 -30.52 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.514 1.476 . . . . 0.0 113.523 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.4 mp -89.23 -4.72 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 111.033 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -57.04 -27.44 61.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.162 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.587 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -108.66 21.21 17.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.752 0.31 . . . . 0.0 110.451 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.53 60.64 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.645 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -111.42 136.03 51.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.817 0.809 . . . . 0.0 109.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.39 22.12 0.13 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 169.53 155.18 0.18 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.046 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 69.3 Cg_endo -77.39 4.2 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.651 2.234 . . . . 0.0 112.141 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.14 72.71 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.022 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.4 t -100.83 -147.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.922 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -159.91 -132.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.796 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 m -92.27 -155.01 0.4 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.6 -177.48 2.37 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.033 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.67 132.22 7.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.92 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -51.37 132.2 29.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.429 0.633 . . . . 0.0 110.956 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.1 mt -66.57 133.89 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -138.16 159.31 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.967 0.413 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.517 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 11.2 p . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.691 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.4 tttt -159.67 150.57 19.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.9 tt -144.88 141.61 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.362 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 m -127.49 139.02 53.07 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.83 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.72 115.7 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -96.28 138.73 33.45 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.079 0.466 . . . . 0.0 110.474 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -61.4 -51.09 70.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.851 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HA ' HD22 ' A' ' 38' ' ' ASN . 83.3 m-20 -97.29 -175.32 3.19 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.253 0.549 . . . . 0.0 110.219 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.97 -175.29 5.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.619 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 46.7 23.12 0.22 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.01 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.5 m-85 59.78 44.6 13.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.332 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -116.41 162.05 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.13 0.491 . . . . 0.0 110.495 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.95 -150.87 31.2 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.554 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 170.64 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.18 155.11 6.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.406 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.0 t80 -134.74 134.53 41.09 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 51.8 p-10 -102.08 151.73 21.82 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.524 0.202 . . . . 0.0 110.49 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.8 124.6 2.24 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.673 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.06 12.99 9.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 t -150.54 146.96 26.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.669 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -38.63 157.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.678 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 18.3 t -157.69 164.61 36.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.145 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.34 -56.96 2.75 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -153.3 110.95 3.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.33 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.0 p90 -100.55 8.47 43.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.067 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.1 t60 -59.35 -28.76 67.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.527 0.68 . . . . 0.0 110.168 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.0 p -60.69 -28.32 68.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.375 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -89.89 -12.97 37.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.539 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -143.33 138.24 29.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.975 0.417 . . . . 0.0 109.969 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.6 m -100.43 -9.49 22.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 34' ' ' LEU . 51.3 ttm-85 -153.74 141.11 19.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.469 . . . . 0.0 110.45 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.1 m -111.52 106.15 14.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.76 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' O ' ' C ' ' A' ' 39' ' ' SER . 41.1 m-20 -117.91 -155.68 0.61 Allowed 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' ASN . 12.7 p -19.59 138.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.741 0.65 . . . . 0.0 112.476 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 8.8 mt -142.69 147.19 21.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.963 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.63 101.14 1.98 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.921 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.08 142.17 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -111.22 52.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.47 0.1 OUTLIER Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.753 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.86 -140.07 3.91 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.8 m -77.9 165.18 24.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 110.859 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.691 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.0 m95 -154.87 155.76 34.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.956 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.75 121.52 41.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.533 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -117.14 132.53 66.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.516 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' GLU . 52.4 m-85 -103.59 110.8 22.99 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.317 0.386 . . . . 0.0 110.897 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' TYR . 80.1 tt0 -35.37 -37.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.137 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 52' ' ' ARG . 19.0 mtp180 -119.02 150.69 49.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.438 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 52.6 Cg_endo -68.12 161.49 44.19 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.684 2.256 . . . . 0.0 111.567 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.5 m120 83.64 -7.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.991 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.5 m-85 . . . . . 0 N--CA 1.47 0.558 0 O-C-N 123.5 0.5 . . . . 0.0 111.254 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.85 91.19 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -71.56 110.33 7.36 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.95 161.01 21.03 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.099 1.866 . . . . 0.0 113.851 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -47.24 119.78 2.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.912 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.13 -176.26 41.49 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -109.15 157.74 18.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.835 0.35 . . . . 0.0 110.159 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 48.4 m-85 -147.81 91.99 4.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 41.3 Cg_endo -66.69 -11.38 31.66 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.234 1.956 . . . . 0.0 113.269 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.6 mt-10 -151.35 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 36.3 p90 -63.9 -53.05 56.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -44.98 -9.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.0 tpt180 -75.09 -3.98 35.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.1 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.73 24.07 10.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.7 mmt 86.84 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.438 1.086 . . . . 0.0 111.212 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.24 48.2 0.2 Allowed Glycine 0 N--CA 1.473 1.155 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.16 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 18.3 mt -71.66 13.36 0.27 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 119.073 -0.489 . . . . 0.0 111.078 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.6 t30 107.63 164.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.779 1.299 . . . . 0.0 109.363 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -94.92 62.03 2.58 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.35 115.62 11.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.26 128.66 21.19 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.4 p -110.28 -163.5 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 3.4 t -45.42 -178.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.34 0.591 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.595 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 10.7 p -151.82 155.5 38.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.558 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -121.7 129.97 53.12 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.72 126.87 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.296 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.6 t -122.77 131.08 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.52 ' O ' HG21 ' A' ' 136' ' ' VAL . 38.0 m80 -100.13 157.75 16.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.768 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -84.27 153.37 62.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 C-N-CA 122.517 2.144 . . . . 0.0 112.146 178.795 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.763 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 26.1 t80 -158.05 114.16 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 110.295 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -153.79 132.56 12.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -135.87 145.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 37.4 mt-30 -122.66 131.0 53.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.504 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 118' ' ' ILE . 11.8 mt -119.58 130.57 73.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.998 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 46.8 m-85 -112.1 128.88 56.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.883 0.373 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.98 -28.23 68.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -120.37 148.36 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.991 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.47 -169.07 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t0 43.63 30.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 53.97 83.26 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.5 m -160.57 163.72 32.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 0.0 110.753 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.66 -152.09 22.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.709 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -71.76 136.59 47.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 0.0 110.429 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 39.1 ttp -120.5 124.62 45.84 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.781 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 48.8 m-85 -116.0 133.6 55.85 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.13 0.491 . . . . 0.0 110.473 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -122.16 121.61 37.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 111' ' ' THR . 6.9 t -147.41 126.94 13.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -93.92 41.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -141.66 -178.46 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.566 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.8 p-10 -84.96 157.69 20.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.513 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.0 m -134.91 121.06 14.52 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.165 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 60.5 Cg_endo -77.95 -56.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.05 1.833 . . . . 0.0 110.936 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.4 m -116.73 112.8 21.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -68.82 -45.05 81.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.403 0.621 . . . . 0.0 110.634 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.465 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -65.71 -21.65 66.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.299 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -73.97 -47.38 37.74 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.275 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.479 ' CD ' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -98.1 -24.8 15.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE2' ' CD ' ' A' ' 121' ' ' GLN . 37.1 m-85 -112.53 2.91 16.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.121 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.6 m-70 51.3 10.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.891 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 122' ' ' PHE . 3.4 mmt -75.72 133.02 40.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -106.27 -30.56 9.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.787 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 29.7 mt-10 -150.58 108.76 3.75 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.089 0.471 . . . . 0.0 111.153 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.37 125.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.586 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.5 m80 -106.31 -32.13 8.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.941 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 17.0 m -154.97 150.28 27.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.116 0.484 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.14 153.63 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.759 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.9 mtpt -131.46 -177.33 4.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.561 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.552 ' C ' HD22 ' A' ' 133' ' ' LEU . 13.8 t 54.04 98.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.552 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.5 mm? -111.21 164.44 12.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.566 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -138.92 111.64 7.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.218 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.56 -87.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.3 t -121.95 157.05 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -143.73 168.21 20.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.16 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.9 mt -144.91 122.84 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.186 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.534 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -109.62 131.72 54.8 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 32.9 m-85 -109.51 112.03 23.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.119 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -50.56 -23.79 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.5 mp -117.38 164.95 17.02 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 94.3 Cg_endo -82.94 167.95 14.06 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.38 2.054 . . . . 0.0 112.194 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.493 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.5 m-80 77.65 15.75 1.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.098 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.493 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.37 29.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.694 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 96.8 mtt180 -135.57 128.43 31.24 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.1 171.98 21.63 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.38 108.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.455 ' CG ' ' CE1' ' A' ' 140' ' ' TYR . 71.6 mt-30 -75.44 147.72 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.963 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.613 0.244 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 129' ' ' SER . 4.2 ptp180 -102.18 -25.58 13.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.077 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.46 50.04 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.03 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.557 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 21.4 Cg_endo -62.8 -17.29 58.59 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.856 2.371 . . . . 0.0 113.235 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.2 mp -101.36 -4.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.171 0.51 . . . . 0.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.45 -28.59 67.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.767 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -104.97 22.94 14.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.189 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.37 28.72 67.34 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.938 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.596 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -110.88 139.58 46.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.024 0.912 . . . . 0.0 109.795 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.08 22.3 0.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.01 152.72 0.26 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.728 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.78 5.45 4.36 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.746 2.297 . . . . 0.0 111.542 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.5 70.23 5.92 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -98.91 -153.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.868 ' H ' HG12 ' A' ' 170' ' ' VAL . 78.3 mm-40 -152.74 -132.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.705 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -94.22 -155.1 0.44 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -171.17 -176.01 1.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.21 0.528 . . . . 0.0 111.22 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.443 HH21 HG22 ' A' ' 177' ' ' VAL . 9.7 ptm180 -158.96 132.32 7.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.936 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 ptt-85 -52.99 134.48 37.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 138' ' ' ILE . 15.5 mt -67.92 133.71 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.466 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.443 HG22 HH21 ' A' ' 174' ' ' ARG . 34.5 m -139.03 156.6 28.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.452 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.7 tp10 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.356 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.417 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.786 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.2 tttt -160.26 151.8 19.71 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.008 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -147.23 141.67 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 97.7 m -123.95 138.21 54.5 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.718 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -118.77 115.78 25.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.2 m-85 -94.87 138.31 32.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.231 0.539 . . . . 0.0 110.986 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 7.7 tm-20 -60.44 -49.96 75.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.946 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 45.3 m-20 -99.33 -176.02 3.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.241 0.543 . . . . 0.0 109.773 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -83.19 -176.84 6.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.32 24.3 0.27 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.807 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.483 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 62.75 41.53 8.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.176 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.41 173.63 6.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.26 -155.99 53.51 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.682 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -54.65 174.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -169.34 149.92 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 59.4 t80 -132.75 133.15 43.09 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 40.2 p-10 -119.87 132.5 55.58 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.569 0.223 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 140.97 30.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -125.0 15.88 8.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.669 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 26' ' ' ASP . 11.2 m -148.94 145.8 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 43.0 t0 -37.29 155.72 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.542 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 m -155.95 162.03 40.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.98 -56.53 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.802 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -154.18 110.75 3.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.411 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.5 p90 -101.42 9.79 41.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.0 t60 -59.76 -28.57 67.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.694 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.4 p -61.16 -29.12 69.6 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.433 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -88.76 -12.56 41.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.663 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -142.21 136.65 30.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -96.84 -10.73 25.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.702 0.287 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.539 ' NH2' ' OD1' ' A' ' 13' ' ' ASP . 59.9 ttp180 -157.05 145.71 19.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.471 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -110.65 104.35 13.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.733 ' O ' ' O ' ' A' ' 39' ' ' SER . 8.4 m120 -128.57 155.9 44.19 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.733 ' O ' ' O ' ' A' ' 38' ' ' ASN . 24.4 p 35.73 130.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.642 1.21 . . . . 0.0 112.568 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.4 mt -142.15 146.29 22.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.93 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.7 ptpt -154.41 102.55 2.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.008 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.33 149.08 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.291 0.567 . . . . 0.0 110.552 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.31 50.21 1.41 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.682 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.21 -95.48 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.112 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.56 -140.36 4.04 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -80.93 166.54 20.76 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.433 -0.451 . . . . 0.0 110.89 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.786 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.4 m95 -154.71 156.65 36.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.19 120.97 40.7 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.62 132.28 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -104.35 110.16 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -37.59 -34.49 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -115.91 148.41 41.24 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.883 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.1 Cg_endo -68.54 159.77 52.1 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.465 2.11 . . . . 0.0 111.915 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.3 m-80 85.17 -5.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.835 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 11.7 m-85 . . . . . 0 N--CA 1.471 0.596 0 O-C-N 123.649 0.593 . . . . 0.0 111.001 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 25.9 t80 . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.786 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.5 mp -102.91 91.37 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.06 111.72 11.76 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.67 162.29 19.01 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.143 1.895 . . . . 0.0 112.661 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.41 117.36 2.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.024 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.34 41.01 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.5 mt-10 -101.2 153.58 19.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 24.2 m-85 -146.5 86.21 6.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.92 -18.47 16.69 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.857 2.371 . . . . 0.0 112.906 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -152.41 162.47 41.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.654 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 6.1 p90 -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -41.21 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.1 mmt180 -75.77 -5.49 46.04 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -117.61 25.27 10.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 119.698 -0.191 . . . . 0.0 111.362 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.4 mmt 89.79 23.59 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.455 1.097 . . . . 0.0 111.636 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.41 59.11 0.23 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.294 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 38.8 mt -94.69 13.92 22.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 33.8 t-20 91.91 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.227 0.954 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.64 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 35.8 p-10 -37.85 -95.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.425 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.64 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.1 tpt180 30.11 93.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.358 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -139.51 128.03 22.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.64 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.0 p -111.04 -162.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.135 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.1 p -45.25 -179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.653 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.521 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 18.6 p -149.04 148.76 30.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.26 126.33 55.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.09 124.25 20.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.151 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 48' ' ' ALA . 67.9 t -120.21 129.0 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.897 0.379 . . . . 0.0 110.444 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 136' ' ' VAL . 93.4 m-70 -97.5 160.31 14.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.16 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.15 149.95 70.49 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.648 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.32 2.013 . . . . 0.0 112.124 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.665 0.269 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.743 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.1 t80 -157.94 113.31 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -153.56 134.01 13.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.021 0.438 . . . . 0.0 111.354 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.59 145.74 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 28.0 mt-30 -124.32 129.76 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.233 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 108' ' ' MET . 10.4 mt -118.7 132.83 67.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.03 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.15 133.89 55.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.258 0.552 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -30.16 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.72 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -119.61 148.65 43.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.225 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.07 174.55 15.67 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.4 t0 57.77 30.76 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.002 0.43 . . . . 0.0 110.441 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 55.87 82.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -160.12 161.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.556 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.03 -150.99 22.55 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.11 136.04 39.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.654 0.264 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.8 tmm? -122.1 133.38 54.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 59.0 m-85 -123.68 137.71 54.66 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.239 0.542 . . . . 0.0 110.618 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.3 125.28 44.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 111' ' ' THR . 5.1 t -147.9 128.25 13.93 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.705 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -90.29 41.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -146.65 -178.14 6.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.6 p-10 -86.36 162.16 18.33 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.651 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 84.5 m -138.79 122.81 11.32 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.416 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.01 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.188 1.925 . . . . 0.0 111.678 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -121.09 109.28 14.83 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.1 tt -64.28 -38.09 81.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.625 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 24.0 ttt -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.56 -44.32 17.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.604 -0.685 . . . . 0.0 111.678 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 1.7 pt20 -90.93 -32.88 15.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.372 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.734 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 23.5 m-85 -115.79 8.84 14.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 49.11 11.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.206 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.5 mtt -79.72 138.05 37.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.465 0.65 . . . . 0.0 110.057 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.518 ' NH2' ' OE2' ' A' ' 126' ' ' GLU . 4.8 ptm180 -109.99 -26.41 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.366 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 75.8 mt-10 -149.84 107.31 3.64 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.321 0.582 . . . . 0.0 111.904 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 118' ' ' ILE . 9.6 mm -76.0 122.71 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.442 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.7 m80 -102.91 -31.9 10.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.119 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 p -155.93 151.35 26.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.801 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -148.67 131.82 16.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.2 -176.4 3.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 133' ' ' LEU . 27.8 t 55.69 98.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.04 167.02 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.067 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.0 mp0 -142.09 111.73 6.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.974 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.92 -89.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.7 t -119.92 150.99 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.145 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -140.07 170.42 15.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.0 mt -145.14 123.61 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.392 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -112.17 132.84 54.66 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.49 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 40.1 m-85 -110.46 112.24 24.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 78.3 tt0 -51.54 -21.99 2.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.3 mp -118.16 165.32 16.63 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.29 167.45 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.016 1.81 . . . . 0.0 112.186 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.2 m-20 78.99 14.82 1.1 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.969 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 75.24 28.44 1.01 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.154 0.284 . . . . 0.0 111.371 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 82.0 mtp180 -133.28 126.83 32.33 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.19 174.54 22.17 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.549 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 77.8 mtm180 -53.07 115.99 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.329 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 49.2 mt-30 -85.52 138.16 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.516 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -105.73 -24.1 12.59 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.811 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -121.26 153.3 58.29 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.551 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -58.83 -14.91 24.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.539 2.159 . . . . 0.0 113.453 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -103.06 -2.9 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.118 0.485 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.36 -26.43 66.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.412 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.39 23.07 15.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.408 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.03 69.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.719 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.02 139.38 43.98 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.257 1.028 . . . . 0.0 109.397 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.4 22.11 0.34 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 170.62 156.27 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.303 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.831 ' O ' HG23 ' A' ' 170' ' ' VAL . 42.1 Cg_endo -68.9 -35.89 14.46 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.674 2.249 . . . . 0.0 111.435 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.65 77.1 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.6 t -94.11 -102.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.345 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.711 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER 162.65 -144.64 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 O-C-N 123.792 0.682 . . . . 0.0 109.718 177.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 1.9 p -91.02 -157.9 0.52 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.568 0.223 . . . . 0.0 111.225 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -169.78 -177.54 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.218 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -158.21 131.82 7.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.235 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 ptm180 -52.3 133.03 34.7 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.714 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.457 HG12 HD12 ' A' ' 138' ' ' ILE . 12.8 mt -63.44 134.08 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.48 137.05 53.74 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.056 0.455 . . . . 0.0 110.577 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.388 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.844 0.354 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.57 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.1 tttt -161.71 153.09 18.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.862 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.6 tt -146.71 144.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.808 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.7 m -135.12 141.28 45.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -121.05 115.9 24.01 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 81.5 m-85 -95.28 139.52 31.47 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.259 0.552 . . . . 0.0 111.181 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 8.1 tm-20 -63.46 -49.42 73.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.115 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.8 m-20 -98.84 -177.46 3.65 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -81.87 -178.67 7.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 48.57 22.23 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.516 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.5 m-85 60.15 46.41 10.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.196 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -114.23 167.36 10.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -143.35 31.53 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.499 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -65.58 162.49 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.408 -0.896 . . . . 0.0 109.149 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.57 156.99 8.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.971 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.512 ' O ' HG23 ' A' ' 9' ' ' THR . 27.6 t80 -131.07 133.65 45.88 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.6 p-10 -123.79 124.5 42.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.75 143.56 24.57 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.242 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -123.63 28.71 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.388 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.0 t -145.73 142.32 28.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -40.02 157.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.505 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.6 m -159.2 165.05 34.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.87 -54.79 3.6 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.994 0.426 . . . . 0.0 111.01 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -156.51 106.96 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.255 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -94.36 8.14 42.98 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.0 t60 -58.51 -30.93 67.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.3 p -58.02 -29.46 65.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.301 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.72 -16.85 31.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.608 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.559 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -140.02 137.17 34.42 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 109.954 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -100.61 -7.77 23.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.242 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 78' ' ' ASP . 57.6 ttm-85 -153.58 142.76 21.41 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.443 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.0 m -112.44 102.79 10.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.0 m120 -127.69 153.73 46.14 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 17.1 p 37.38 126.23 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.333 1.064 . . . . 0.0 112.562 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.2 mt -138.93 147.24 25.04 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.463 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.38 100.88 2.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.366 0.603 . . . . 0.0 109.921 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 42' ' ' VAL . 6.7 m -70.2 141.45 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.11 47.59 0.95 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.57 -98.65 0.14 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.42 -137.34 3.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -77.87 166.78 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.62 ' N ' HG22 ' A' ' 46' ' ' THR . 38.6 m95 -156.56 156.8 34.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.546 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.44 118.91 33.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.757 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.38 133.01 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 111.297 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.54 110.57 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.773 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -39.1 -32.77 0.1 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.075 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -116.79 147.72 40.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.733 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -68.71 156.33 65.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.33 2.02 . . . . 0.0 111.585 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.4 m120 86.11 -2.93 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.038 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-85 . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 122.596 0.358 . . . . 0.0 111.785 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.737 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.63 99.04 7.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.562 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -71.0 110.63 7.62 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.09 163.82 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.148 1.899 . . . . 0.0 113.255 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.2 123.42 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.914 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.28 -173.64 40.28 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.6 mt-10 -111.46 156.35 21.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.956 0.408 . . . . 0.0 109.904 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.585 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.5 m-85 -147.27 81.12 8.94 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.485 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 36.5 Cg_exo -55.43 -14.0 8.72 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.054 2.503 . . . . 0.0 112.661 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -151.47 163.41 39.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.338 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 10.9 p90 -65.4 -51.01 63.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.405 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.2 mt-30 -43.62 -10.6 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' TYR . 39.2 mmt180 -76.3 -0.55 22.86 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.02 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -123.81 22.6 8.9 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 122.929 0.143 . . . . 0.0 111.019 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 8.7 mmt 91.86 18.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.578 1.151 . . . . 0.0 111.709 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.26 62.16 0.24 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.9 mt -90.91 17.19 8.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.461 0.304 . . . . 0.0 111.27 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 67.0 t30 107.28 155.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.798 1.311 . . . . 0.0 109.639 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 54.0 p-10 -87.54 73.49 9.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.126 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -145.86 118.91 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -147.15 130.12 16.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 110.398 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.0 p -108.01 -164.75 0.99 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' SER . 61.5 m -49.44 -174.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.862 ' SG ' HG21 ' A' ' 8' ' ' ILE . 12.9 p -153.58 156.38 37.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -118.99 129.52 55.19 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.37 133.54 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.629 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.82 134.07 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.582 ' O ' HG21 ' A' ' 136' ' ' VAL . 37.4 m80 -101.15 162.13 13.11 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.916 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -91.79 159.45 38.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.662 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.045 179.372 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.412 ' CG ' ' H ' ' A' ' 94' ' ' TYR . 1.2 pt20 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.731 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 10.8 t80 -156.88 115.73 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -154.05 131.86 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.26 0.552 . . . . 0.0 110.605 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -138.94 147.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.337 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 38.0 mt-30 -124.44 129.1 50.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.461 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 7.3 mt -119.61 131.71 71.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -111.52 123.76 50.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.115 0.483 . . . . 0.0 110.52 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.51 -19.04 22.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.625 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -131.89 143.58 50.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 110.582 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.85 -178.91 0.78 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.4 t0 52.29 29.44 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.462 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 54.81 80.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.838 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -157.31 164.03 38.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.549 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.46 -157.24 30.03 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -67.7 138.23 56.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.764 0.316 . . . . 0.0 110.636 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 43.4 ttp -118.6 121.33 39.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.488 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.5 m-85 -116.81 132.66 56.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.209 0.528 . . . . 0.0 111.201 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.07 131.33 52.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.826 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -152.84 134.35 14.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -95.54 45.48 1.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -149.24 -177.74 6.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.774 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -86.9 160.28 18.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 64.5 m -137.82 123.34 12.64 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.6 Cg_endo -78.18 -61.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.805 1.67 . . . . 0.0 110.879 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.2 m -111.38 113.16 25.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -70.04 -35.78 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.116 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 25.3 ttt -71.43 -18.53 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.447 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -82.43 -42.44 18.56 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.079 -1.013 . . . . 0.0 111.397 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.528 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.66 -30.19 15.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -177.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 27.7 m-85 -117.73 4.17 12.29 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.9 m-70 55.06 3.63 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.854 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -72.15 131.89 43.42 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.943 0.402 . . . . 0.0 109.921 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -108.4 -24.24 11.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.189 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.4 mt-10 -151.0 108.82 3.68 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.001 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 118' ' ' ILE . 7.8 mm -76.91 125.79 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.8 m80 -105.24 -36.88 7.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.119 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.4 p -153.59 149.62 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.868 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -145.92 156.16 43.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.758 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.5 mtpt -134.06 179.13 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.371 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.553 ' C ' HD22 ' A' ' 133' ' ' LEU . 12.8 t 57.65 99.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -114.42 164.02 14.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.372 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -135.91 111.98 9.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.21 -88.0 0.01 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 87' ' ' HIS . 17.5 t -125.82 144.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.974 0.416 . . . . 0.0 109.996 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.731 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.2 t-105 -130.09 167.85 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 67.5 mt -144.25 124.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -112.42 131.88 55.33 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -110.19 114.21 27.52 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.593 0.558 . . . . 0.0 110.784 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 80.8 tt0 -51.86 -23.65 5.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.507 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.8 mp -118.05 160.9 37.23 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.1 Cg_endo -77.77 167.06 24.51 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.205 1.937 . . . . 0.0 111.763 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.514 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.9 m120 73.2 14.83 4.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.046 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.514 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.2 m-85 77.34 27.84 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.531 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -114.7 170.77 8.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.831 0.348 . . . . 0.0 110.578 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.73 159.57 27.73 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 16.5 ptt180 -64.64 84.7 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.648 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -54.61 -167.5 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.043 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.563 -179.878 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.546 0.212 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.539 ' CZ ' ' HZ3' ' A' ' 159' ' ' LYS . 48.3 ptt85 -108.34 -22.29 12.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.594 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HZ3' ' CZ ' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -121.59 156.41 58.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.84 0.352 . . . . 0.0 110.736 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.503 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -59.42 -23.06 68.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.214 1.943 . . . . 0.0 113.177 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -94.36 -4.94 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -55.53 -31.77 62.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.298 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 1.0 OUTLIER -103.72 20.82 17.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.713 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.64 27.79 64.5 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.087 -0.577 . . . . 0.0 113.769 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.6 137.41 44.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.805 0.802 . . . . 0.0 110.301 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.25 26.32 0.16 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 166.0 154.54 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.503 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 170' ' ' VAL . 44.0 Cg_endo -71.49 -13.35 30.23 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.047 2.498 . . . . 0.0 111.337 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.65 69.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.582 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.953 HG12 ' H ' ' A' ' 171' ' ' GLN . 4.2 t -101.0 -152.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.953 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.7 tp60 -153.33 -132.04 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.735 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -95.15 -152.99 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.179 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -170.64 -179.44 2.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.09 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.474 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -155.3 130.25 9.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.902 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -52.74 126.39 19.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.943 0.877 . . . . 0.0 110.98 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.445 HG12 HD12 ' A' ' 138' ' ' ILE . 9.3 mt -59.01 128.22 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 174' ' ' ARG . 2.9 m -135.76 144.05 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.198 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 46' ' ' THR . 42.7 tt0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.081 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.745 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.8 tttt -161.28 152.69 18.94 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.983 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 tt -147.2 141.04 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.098 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.3 m -124.8 138.23 54.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.462 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -118.23 116.3 26.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 94.0 m-85 -98.59 139.27 34.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.963 0.411 . . . . 0.0 110.96 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.0 tm-20 -62.03 -51.94 65.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.875 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.92 -177.93 4.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.31 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -82.36 -177.55 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.853 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 46.42 24.82 0.33 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.177 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.8 m-85 62.43 42.71 8.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.257 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.91 172.58 6.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.65 -153.33 51.45 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.845 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -56.89 173.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -169.0 152.53 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.492 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 63.9 t80 -129.23 131.62 47.09 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 37.7 p-10 -120.39 125.36 47.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 0.0 111.24 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.7 t -151.25 142.43 23.21 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.26 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -126.17 24.11 6.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' ASP . 14.3 m -145.99 141.81 28.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.442 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 40.3 t0 -35.73 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 20.8 m -156.85 162.68 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.348 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.75 -55.69 3.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.979 0.419 . . . . 0.0 110.647 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -154.07 110.97 3.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.331 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.3 p90 -100.81 9.27 42.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.963 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.7 t60 -59.07 -28.41 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.515 0.674 . . . . 0.0 110.069 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -60.96 -29.2 69.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.271 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.08 -14.99 37.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -142.34 138.25 31.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -99.98 -8.69 23.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.644 0.259 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 49.2 ttm-85 -154.23 141.5 19.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.824 0.345 . . . . 0.0 110.485 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.4 m -110.92 105.46 14.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.273 0.559 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 45.4 m-20 -117.13 -155.84 0.6 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' ASN . 18.2 p -20.47 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.884 0.74 . . . . 0.0 112.271 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 mt -143.01 146.91 21.14 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.114 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.1 ptpt -154.41 103.97 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.2 t -66.6 148.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.523 0.678 . . . . 0.0 110.555 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.51 50.08 1.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.009 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.77 -95.85 0.1 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.925 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.28 -140.28 4.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 90.0 m -81.05 166.9 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.292 -0.534 . . . . 0.0 110.84 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.745 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.3 m95 -154.47 156.9 37.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.286 0.565 . . . . 0.0 110.742 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.43 120.82 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.1 m -117.47 131.9 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 0.0 110.986 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.7 109.65 21.43 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.723 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -37.06 -36.29 0.12 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -113.69 147.98 38.8 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.5 Cg_endo -68.72 157.09 63.25 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.34 2.026 . . . . 0.0 112.05 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 5.5 m-80 86.03 -2.84 0.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.3 m-85 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.146 0.498 . . . . 0.0 111.145 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 26.3 t80 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -104.06 92.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.604 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.3 110.23 5.89 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 162.85 19.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.083 1.855 . . . . 0.0 112.759 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 117.41 2.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.087 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.78 179.12 41.3 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.51 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -102.24 153.93 19.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 25.1 m-85 -145.93 83.55 8.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.57 -15.72 9.51 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.26 2.64 . . . . 0.0 113.101 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -152.52 161.43 42.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.734 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 13.2 p90 -65.03 -52.36 56.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.334 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 37.2 mt-30 -42.99 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.82 -4.97 46.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.059 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.734 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.85 23.24 11.81 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.618 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.6 mmt 87.41 25.35 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.561 1.163 . . . . 0.0 111.158 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 30.83 50.04 0.2 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.078 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 26.5 mt -75.86 14.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.542 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 14.6 t-20 110.95 162.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.368 1.043 . . . . 0.0 109.27 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -94.4 61.23 2.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -137.61 115.78 11.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.246 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.39 129.16 20.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.6 p -111.58 -162.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.745 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.29 -178.65 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.864 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.588 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.5 p -151.11 153.06 34.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.595 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -118.34 127.86 54.1 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.559 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.49 127.85 33.48 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 48' ' ' ALA . 70.7 t -125.63 132.04 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.735 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.437 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.7 m-70 -100.37 161.56 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 1.2 mt -80.82 150.36 69.12 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.429 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 N--CA 1.496 1.619 0 C-N-CA 122.244 1.963 . . . . 0.0 111.935 179.708 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' CG ' ' H ' ' A' ' 94' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.715 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 21.5 t80 -160.88 114.13 2.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.261 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -157.09 132.28 9.04 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.709 0.29 . . . . 0.0 110.676 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.5 tt -135.81 145.0 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.221 0.534 . . . . 0.0 111.296 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 132' ' ' VAL . 11.8 mt-30 -122.23 134.02 54.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.36 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.641 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 mt -121.94 131.52 72.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.216 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -115.98 130.24 56.73 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.211 0.529 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.46 -26.98 65.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.052 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -122.25 147.07 46.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.591 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.46 -168.48 0.41 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 50.7 t0 44.56 29.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.911 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 54.11 79.35 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m -158.56 162.24 37.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.993 0.425 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.99 -171.43 42.69 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -53.89 133.69 42.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.169 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.9 tmm? -121.04 131.98 54.61 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.454 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.7 m-85 -121.46 135.72 55.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.456 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.05 126.24 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 111' ' ' THR . 7.3 t -152.73 128.93 10.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.72 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -95.37 42.68 1.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 111.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.07 -179.46 6.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.508 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.8 p-10 -84.04 156.98 21.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.525 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 65.8 m -134.04 123.02 16.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.907 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' OG ' ' A' ' 172' ' ' SER . 68.3 Cg_endo -77.98 -57.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.8 1.667 . . . . 0.0 110.841 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.8 m -115.89 111.64 20.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -67.4 -41.86 86.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 0.0 111.338 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 9.1 ttp -68.17 -17.12 64.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.344 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -82.47 -42.49 18.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.671 -0.643 . . . . 0.0 111.707 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.525 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.9 -29.96 15.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.111 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.523 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 29.3 m-85 -115.99 4.48 13.77 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.5 m-70 52.48 11.64 0.19 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.234 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -76.85 133.01 39.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -106.98 -28.48 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.71 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 30.3 mt-10 -151.45 109.0 3.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.008 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.9 mm -74.98 125.17 34.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.901 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.0 m80 -107.44 -33.53 7.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.56 -168.12 1.97 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.793 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.609 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.1 OUTLIER 160.99 137.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.082 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -130.16 -169.54 2.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.052 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 97' ' ' GLN . 49.1 t 47.0 87.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 0.0 110.3 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.28 169.8 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.201 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -141.88 113.65 7.9 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.49 -97.44 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -110.54 155.93 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -145.03 168.62 19.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.837 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.47 HD12 HG12 ' A' ' 176' ' ' ILE . 70.5 mt -144.63 123.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.974 0.416 . . . . 0.0 111.576 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.61 129.82 55.56 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -107.5 110.83 22.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.563 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.2 -22.39 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.27 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.55 164.36 16.66 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.16 166.9 12.58 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.091 1.86 . . . . 0.0 112.29 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.492 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.1 m120 68.52 21.96 7.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.6 m-85 71.68 66.83 0.15 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -154.44 169.68 23.17 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.931 0.396 . . . . 0.0 110.698 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.93 172.76 39.12 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.982 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -53.9 138.26 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.554 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 15.5 mp0 -99.56 137.5 37.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.033 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.592 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -109.47 -21.13 12.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -121.24 155.73 58.22 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 121.124 0.488 . . . . 0.0 110.965 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.531 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -60.24 -19.03 55.5 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.259 1.973 . . . . 0.0 113.181 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.686 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.1 mp -97.86 -3.45 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.72 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.5 OUTLIER -60.62 -27.86 68.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.864 -178.384 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.563 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -107.42 21.25 17.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.28 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.33 70.84 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.331 0.492 . . . . 0.0 114.331 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.563 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.75 138.58 41.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.973 0.886 . . . . 0.0 110.005 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.57 20.86 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.265 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 169.46 156.73 0.18 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.719 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.7 4.48 6.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.006 2.471 . . . . 0.0 111.585 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.55 71.4 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.798 0.333 . . . . 0.0 111.09 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.6 t -99.78 -151.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.888 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -154.61 -130.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.123 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 2.9 p -93.7 -155.48 0.45 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -170.04 -177.27 2.52 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.319 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.72 132.06 6.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.442 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -51.67 134.81 29.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.237 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.2 mt -67.84 135.48 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.658 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.52 156.75 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.152 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.743 0.306 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.777 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.4 tttt -160.03 152.03 20.41 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.004 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.95 142.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.736 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -125.89 138.99 53.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.642 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -119.33 115.8 24.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.373 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.4 m-85 -94.71 138.73 32.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 110.822 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 8.1 tm-20 -61.06 -49.91 75.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.076 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 65.6 m-20 -99.2 -175.96 3.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.182 0.515 . . . . 0.0 109.667 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -82.73 -176.64 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.829 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 47.53 23.78 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.515 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.9 m-85 63.18 41.46 7.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.117 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -108.19 177.08 4.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.44 -158.56 50.97 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.508 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -54.64 176.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.25 150.15 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 49.8 t80 -127.23 130.97 50.63 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -119.45 124.0 45.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.096 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -150.03 142.3 24.19 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.241 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -125.25 24.01 7.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.951 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.9 t -146.81 141.81 27.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.8 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 25' ' ' CYS . 74.5 m-20 -36.61 156.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.562 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 23.5 t -157.69 164.27 37.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.301 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.47 -56.57 2.98 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.958 0.409 . . . . 0.0 110.861 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 44.7 p-10 -154.24 110.6 3.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.193 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -99.89 10.83 40.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' LEU . 70.5 t60 -59.79 -26.85 66.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.2 p -63.39 -31.31 72.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -85.85 -12.58 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.15 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -142.93 137.62 29.58 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 p -95.49 -11.74 27.01 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.53 ' NH2' ' OD1' ' A' ' 13' ' ' ASP . 45.4 ttp180 -158.19 146.07 18.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.217 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.8 m -110.25 104.15 12.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.37 0.605 . . . . 0.0 111.395 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.727 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.7 m120 -128.84 155.6 44.95 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.463 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' O ' ' A' ' 38' ' ' ASN . 11.1 p 36.97 128.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.345 1.069 . . . . 0.0 112.192 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.7 mt -141.46 147.12 22.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.403 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -155.94 102.28 2.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.212 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -67.24 149.78 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-O 121.616 0.722 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -122.89 50.62 1.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.053 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.582 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.53 -96.97 0.11 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.868 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.509 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.92 -141.33 4.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 47' ' ' TRP . 84.9 m -80.84 167.23 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.578 -0.366 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.777 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.8 m95 -154.74 155.65 34.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.611 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 120.79 41.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.48 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.92 131.33 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 110.608 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-85 -102.88 108.23 19.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 50' ' ' TYR . 79.1 tt0 -36.48 -35.32 0.08 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.07 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -115.39 147.3 38.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 49.4 Cg_endo -68.45 160.71 48.04 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.324 2.016 . . . . 0.0 111.446 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 83.37 -3.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.293 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.7 m-85 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.7 m-85 . . . . . 0 C--O 1.231 0.117 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -104.39 92.14 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 112.98 16.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.67 162.23 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.02 1.813 . . . . 0.0 112.526 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -51.94 115.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.914 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.12 177.52 42.44 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.8 mt-10 -101.06 153.07 19.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.944 0.402 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 30.6 m-85 -146.05 91.11 5.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 -13.62 40.67 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.056 1.837 . . . . 0.0 113.138 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 91.7 mt-10 -149.41 161.08 42.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.753 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.6 p90 -63.23 -53.97 44.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.99 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.61 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 8.3 pt20 -43.46 -10.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 70' ' ' TYR . 24.0 mmm180 -75.04 -5.6 44.93 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.24 24.39 10.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.05 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.0 mmt 87.97 25.48 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.289 0.993 . . . . 0.0 111.286 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.17 51.47 0.26 Allowed Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 10.4 mt -75.88 13.2 0.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.83 -0.185 . . . . 0.0 110.986 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.2 t30 109.06 169.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.578 1.174 . . . . 0.0 108.743 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -98.96 61.46 1.26 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.901 0.382 . . . . 0.0 110.556 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -139.2 116.9 11.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.304 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.05 129.17 20.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.7 p -111.22 -162.86 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.513 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 81' ' ' SER . 6.3 p -45.51 -179.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.781 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -150.26 151.89 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.431 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -115.52 127.96 55.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.543 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.18 122.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.479 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.08 130.06 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -102.56 162.87 12.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -79.91 150.65 72.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 C-N-CA 122.071 1.848 . . . . 0.0 112.329 -179.375 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.454 ' CG ' ' H ' ' A' ' 94' ' ' TYR . 1.7 pt20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.001 0.429 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 31.0 t80 -159.01 114.16 2.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.519 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.413 ' CG ' HG11 ' A' ' 132' ' ' VAL . 17.9 tptm -156.39 132.66 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.451 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -134.53 143.62 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.421 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 34.3 mt-30 -123.74 129.58 51.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.418 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.3 mt -119.15 131.18 72.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.588 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -111.58 129.07 56.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.78 -29.88 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 102' ' ' GLY . 81.4 mttt -112.23 146.91 37.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 101' ' ' LYS . . . -54.3 -163.09 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 38.9 t70 51.72 -96.11 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 103' ' ' ASP . 67.1 m-85 -168.95 71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.993 0.808 . . . . 0.0 109.232 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -156.91 161.73 39.65 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.101 0.477 . . . . 0.0 110.986 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.05 -178.93 33.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.633 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.97 133.78 22.19 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.25 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.0 tmm? -122.33 130.32 53.02 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.815 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.488 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 65.0 m-85 -119.77 135.64 54.77 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.43 117.26 26.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.29 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 111' ' ' THR . 11.7 t -140.95 126.37 18.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.65 38.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.27 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.12 -177.85 5.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.75 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.7 p30 -85.61 159.12 19.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.058 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.1 t -133.3 124.56 18.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -79.06 -53.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.819 1.679 . . . . 0.0 111.272 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -121.14 113.89 20.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.757 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.25 -46.18 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.187 0.518 . . . . 0.0 110.589 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.459 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -64.65 -20.2 66.15 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -73.49 -47.26 42.58 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.673 -0.642 . . . . 0.0 112.433 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.639 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.67 -23.59 14.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.29 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.1 m-85 -111.49 1.56 16.99 Favored 'General case' 0 C--O 1.228 -0.04 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.2 m-70 50.12 11.17 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.862 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.482 ' H ' ' C ' ' A' ' 122' ' ' PHE . 33.8 mtt -77.38 135.2 38.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -106.36 -28.74 10.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.042 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 72.5 mt-10 -152.36 108.6 3.4 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.99 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.36 125.08 33.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.607 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.8 m80 -106.93 -32.46 7.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.242 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 t -152.21 147.76 26.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.16 156.78 44.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 44.5 mtpt -133.71 -171.14 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.166 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.456 ' C ' HD22 ' A' ' 133' ' ' LEU . 25.5 t 47.06 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.3 mm? -110.82 167.48 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -143.17 111.71 6.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.816 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.82 -88.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 134' ' ' GLU . 5.5 t -121.18 155.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.082 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.742 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -143.73 167.81 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.9 mt -144.72 124.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.69 130.77 55.48 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 16.6 m-85 -108.75 111.75 23.67 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.508 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -52.12 -24.7 7.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.7 161.23 27.43 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.342 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.26 164.66 21.7 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.325 2.017 . . . . 0.0 111.489 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.54 15.11 2.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.003 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.7 m-85 78.54 25.91 0.54 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 111.339 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 89.7 mtm180 -109.78 171.26 7.55 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.66 168.56 33.87 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -62.16 134.38 56.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.08 0.467 . . . . 0.0 110.228 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.571 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 54.4 mt-30 -87.27 144.88 26.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.732 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -99.36 -30.36 12.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.47 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 162' ' ' ASP . 15.4 pttm -118.12 155.42 51.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.47 -17.17 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.148 1.899 . . . . 0.0 113.432 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.22 -3.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.157 0.504 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 159' ' ' LYS . 1.0 OUTLIER -61.82 -28.34 69.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.582 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -104.68 20.51 18.51 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.09 28.23 66.89 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.134 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.74 137.64 47.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.704 0.752 . . . . 0.0 109.596 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.62 19.68 0.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.563 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 173.12 155.73 0.26 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.481 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.84 4.65 5.5 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.113 2.542 . . . . 0.0 111.709 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.96 69.89 5.2 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -97.71 -153.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.879 ' H ' HG12 ' A' ' 170' ' ' VAL . 71.8 mm-40 -153.83 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.224 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.0 p -93.17 -155.75 0.45 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -170.56 -177.35 2.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.66 132.04 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.862 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 ptt180 -53.05 135.95 36.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 138' ' ' ILE . 14.6 mt -69.28 135.68 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.836 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.6 160.46 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.603 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 29.1 tp10 . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.432 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.6 p . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.767 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 31.9 tttt -160.26 151.89 19.83 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -147.49 142.05 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.997 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.5 m -124.9 138.77 54.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -119.11 116.36 26.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.448 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.6 m-85 -98.78 139.57 34.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.1 tm-20 -62.19 -51.41 67.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.823 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -94.4 -177.46 4.26 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -82.8 -176.79 6.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 1.6 m120 45.41 25.96 0.26 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.321 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.493 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 63.61 41.44 7.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.57 177.45 4.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.0 110.493 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.81 -158.75 49.66 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.628 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.11 175.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.43 150.79 5.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.473 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 64.6 t80 -129.65 131.88 46.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -120.14 128.79 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.934 0.397 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.9 t -153.7 142.45 20.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.285 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -124.72 24.09 7.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 m -147.83 143.99 27.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.537 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -37.77 156.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -156.94 162.81 39.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.22 -56.12 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.941 0.401 . . . . 0.0 110.629 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -154.22 111.89 3.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.317 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.473 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.6 p90 -101.57 10.16 40.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.998 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' LEU . 42.3 t-80 -59.58 -28.43 67.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.717 0.77 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -60.97 -30.99 70.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.456 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -86.8 -13.65 44.5 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.392 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 31' ' ' HIS . 20.0 tp -142.89 137.22 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 109.985 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -97.78 -10.14 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.296 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HD21 ' A' ' 34' ' ' LEU . 59.3 ttm-85 -155.23 142.79 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.63 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.9 m -110.75 105.82 14.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 110.869 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 59.7 m-20 -118.0 -155.7 0.61 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.493 ' CB ' ' H ' ' A' ' 16' ' ' PHE . 6.3 p -19.68 137.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.992 0.807 . . . . 0.0 112.468 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.7 mt -142.55 146.54 22.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.046 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.62 104.28 2.34 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.953 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -67.24 148.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.38 0.61 . . . . 0.0 110.083 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.01 50.6 1.43 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.708 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.21 -96.17 0.1 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.071 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.25 -140.56 4.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.2 m -80.17 166.34 21.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.466 -0.432 . . . . 0.0 110.954 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.767 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -154.49 155.66 35.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.704 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 120.84 40.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.2 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' A' ' 80' ' ' LEU . 10.0 m -120.37 133.68 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 111.072 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CD1' ' NH1' ' A' ' 84' ' ' ARG . 11.7 m-85 -106.98 112.88 26.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.602 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -37.65 -32.68 0.06 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.169 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -116.57 147.41 39.68 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 120.596 0.236 . . . . 0.0 110.951 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -69.31 161.78 44.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.268 1.979 . . . . 0.0 111.716 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' C ' ' CG ' ' A' ' 55' ' ' PHE . 2.9 m120 81.99 -3.66 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.059 0.849 . . . . 0.0 111.075 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 4.4 m-85 . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.235 0.54 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.507 ' C ' HD12 ' A' ' 61' ' ' ILE . 36.0 t80 . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.33 93.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -71.84 110.9 8.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.43 162.83 17.1 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.137 1.891 . . . . 0.0 112.527 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.66 114.85 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.84 176.75 41.67 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.2 mt-10 -100.02 153.25 19.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.049 0.452 . . . . 0.0 110.566 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 26.4 m-85 -146.14 81.57 9.6 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.19 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.17 -12.52 7.75 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.948 2.432 . . . . 0.0 113.071 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 95.2 mt-10 -152.13 161.35 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.692 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 38.6 p90 -64.21 -54.84 27.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.598 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 11.7 pt20 -43.84 -9.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.4 mmt180 -74.83 -4.92 40.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.79 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.99 25.48 10.32 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 119.778 -0.153 . . . . 0.0 110.742 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.6 mmt 85.48 24.68 0.08 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.439 1.087 . . . . 0.0 111.191 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.56 51.27 0.43 Allowed Glycine 0 N--CA 1.472 1.1 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.8 mt -76.64 13.82 0.92 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.8 t30 111.55 166.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.063 1.477 . . . . 0.0 109.553 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 50.7 p-10 -98.63 63.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -142.69 119.71 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -143.72 129.66 19.49 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.682 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.4 p -110.36 -162.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 84' ' ' ARG . 13.1 p -45.12 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 110.713 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.614 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 19.8 p -147.97 147.91 30.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.799 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.629 ' CG ' HH11 ' A' ' 84' ' ' ARG . 0.0 OUTLIER -111.04 124.78 52.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.69 123.31 17.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.002 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.67 130.86 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -98.51 162.35 13.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 178' ' ' GLU . 1.7 mt -80.21 148.14 66.57 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.845 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 C-N-CA 122.17 1.913 . . . . 0.0 112.054 179.597 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.712 0.291 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.733 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 41.8 t80 -158.29 112.81 2.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -153.56 134.65 14.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.27 0.557 . . . . 0.0 111.111 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -135.9 144.51 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.164 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 30.6 mt-30 -122.83 130.17 52.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.55 132.35 69.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -114.44 132.89 56.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.04 -30.54 70.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.974 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -120.6 150.76 40.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.175 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.13 -176.62 4.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 t0 50.44 28.8 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.715 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 7.3 m-85 55.72 82.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.668 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -159.06 161.31 36.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.54 -149.35 20.53 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -77.12 137.43 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.2 tmm? -123.01 133.87 54.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 111.179 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.9 m-85 -124.71 137.95 54.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.679 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -123.55 123.66 41.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.49 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 111' ' ' THR . 5.6 t -151.59 125.55 9.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.581 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 112' ' ' THR . 1.7 t -92.39 45.31 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.44 . . . . 0.0 111.334 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.35 -179.24 6.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.538 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 18.6 p-10 -86.48 159.25 19.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.84 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 42.4 t -136.17 124.68 15.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.72 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.4 Cg_endo -77.84 -51.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.623 1.549 . . . . 0.0 111.093 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.0 m -121.97 111.39 17.0 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.982 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -68.44 -43.91 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.0 ttt -65.45 -17.66 64.72 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.0 111.032 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -81.87 -43.02 18.77 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.724 -0.61 . . . . 0.0 111.94 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.704 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -95.54 -29.45 14.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.053 -178.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.704 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.03 5.3 14.92 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.678 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.8 m-70 50.78 11.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.919 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 122' ' ' PHE . 36.0 mtt -76.9 135.15 38.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.749 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -107.41 -28.46 9.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.516 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 60.8 mt-10 -151.19 109.04 3.68 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.08 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -74.71 125.14 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.723 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -105.53 -32.19 8.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.8 t -154.04 148.74 26.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.108 0.48 . . . . 0.0 111.267 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -149.8 132.34 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -112.44 -173.08 2.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.243 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t 56.15 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.822 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -94.55 168.03 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.136 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.8 mp0 -142.58 112.14 6.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.69 -88.66 0.01 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.5 t -116.59 156.21 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.733 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.2 t-105 -146.21 167.44 23.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 87.4 mt -144.88 123.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.742 0.306 . . . . 0.0 111.119 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -110.4 131.57 54.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -109.57 111.54 23.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.957 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -51.82 -23.18 4.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.737 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.6 160.4 33.32 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 96.7 Cg_endo -79.47 166.25 22.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.123 1.882 . . . . 0.0 111.46 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.6 m-80 74.84 14.01 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.0 m-85 79.04 25.55 0.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -109.87 171.05 7.68 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.847 0.356 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.23 168.99 36.07 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -56.97 142.39 41.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 109.835 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.483 ' OE1' ' CE2' ' A' ' 60' ' ' TYR . 35.1 mt-30 -97.6 137.39 36.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.002 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 -179.579 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -107.3 -20.26 13.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.701 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -121.56 154.86 59.96 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 15.5 Cg_endo -60.59 -16.09 40.7 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.4 2.067 . . . . 0.0 113.322 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 4.1 mp -100.2 -1.69 9.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -26.08 67.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.671 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.566 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -108.67 21.08 17.75 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.42 26.94 68.8 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.955 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.566 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.93 138.28 43.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.38 1.09 . . . . 0.0 109.721 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.76 21.02 0.21 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 170.86 155.41 0.21 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.675 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.24 6.13 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.087 2.525 . . . . 0.0 111.407 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.8 70.64 8.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 111.056 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.941 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.01 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.941 ' H ' HG12 ' A' ' 170' ' ' VAL . 73.8 mm-40 -155.04 -130.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.357 0.411 . . . . 0.0 109.893 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.594 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.37 -158.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -170.01 -177.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.405 0.622 . . . . 0.0 111.094 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.87 131.76 7.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -52.89 135.3 36.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.652 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.4 mt -64.09 134.49 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.89 135.58 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.501 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . 11.2 tm-20 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.351 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 73.9 p . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.768 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.8 tttt -158.32 150.71 22.01 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.022 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.3 140.31 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.669 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 42.4 m -122.52 137.95 54.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.33 115.85 25.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -95.58 138.13 33.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.235 0.54 . . . . 0.0 111.083 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.27 -49.94 75.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.3 m-20 -99.69 -176.2 3.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.188 0.518 . . . . 0.0 110.148 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.43 -177.2 6.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 47.57 23.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.779 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.2 m-85 63.09 41.11 8.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -108.35 176.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.151 0.5 . . . . 0.0 110.715 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.91 -157.12 52.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.379 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -54.91 174.2 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.137 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.58 151.08 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' THR . 59.6 t80 -135.57 134.14 39.07 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 49.9 p-10 -120.9 140.46 51.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.665 0.269 . . . . 0.0 110.759 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 18.3 t -147.88 141.15 25.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 6' ' ' THR . 7.4 t70 -122.92 14.06 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.8 t -149.66 146.7 27.41 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.812 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 80.3 m-20 -37.54 156.19 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.62 161.22 40.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.35 3.03 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.4 p-10 -153.61 111.0 3.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.466 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.1 p90 -101.28 9.7 41.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.6 t60 -59.98 -26.47 66.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.986 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -63.28 -29.66 70.95 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.505 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -88.45 -12.87 41.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.469 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 31' ' ' HIS . 17.0 tp -143.5 137.7 28.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -99.46 -9.4 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.6 ttm180 -154.75 143.26 20.58 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.3 m -110.65 104.57 13.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.442 0.639 . . . . 0.0 110.887 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.707 ' O ' ' O ' ' A' ' 39' ' ' SER . 70.6 m-20 -129.51 156.78 43.59 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.67 128.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.392 1.091 . . . . 0.0 112.469 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.2 mt -141.44 146.19 23.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.297 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.4 ptpt -154.41 103.6 2.51 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.096 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.72 148.23 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.542 0.686 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -120.9 50.42 1.35 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.81 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.45 -95.3 0.1 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.537 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.46 -140.0 3.98 Favored Glycine 0 N--CA 1.468 0.767 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.2 167.16 18.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.403 -0.469 . . . . 0.0 110.807 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.768 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.7 m95 -155.07 157.25 37.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.604 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.82 121.59 41.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.64 132.74 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.095 0.474 . . . . 0.0 110.881 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -104.56 110.59 22.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.758 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -38.03 -34.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.136 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -116.14 132.99 22.97 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.414 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.2 Cg_exo -55.92 161.91 7.77 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.371 1.38 . . . . 0.0 112.151 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.4 m-20 84.69 -4.61 0.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.076 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.9 m-85 . . . . . 0 N--CA 1.468 0.448 0 O-C-N 123.533 0.521 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 36.5 t80 . . . . . 0 C--O 1.232 0.145 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.17 91.81 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 111.15 8.84 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 162.36 16.23 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.085 1.857 . . . . 0.0 112.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -51.03 114.57 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.828 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.06 176.71 41.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.4 mt-10 -100.13 153.13 19.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 110.519 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 36.5 m-85 -146.44 91.83 5.31 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.11 -13.26 39.08 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.093 1.862 . . . . 0.0 113.246 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -149.82 161.14 42.85 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.732 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 41.6 p90 -63.49 -54.14 41.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 12.3 pt20 -43.5 -9.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 70' ' ' TYR . 84.5 mmt-85 -75.8 -4.48 40.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.59 25.08 10.67 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.823 -0.171 . . . . 0.0 110.95 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 22.7 mmt 85.39 24.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.465 1.103 . . . . 0.0 111.35 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.54 51.07 0.3 Allowed Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.3 mt -76.19 13.94 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.386 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 55.5 t30 113.39 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.858 1.349 . . . . 0.0 109.493 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -97.35 62.68 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.052 0.453 . . . . 0.0 110.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -141.88 118.53 11.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.987 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.15 128.63 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.9 p -110.63 -162.58 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.138 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.9 p -45.64 -179.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.619 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.495 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.1 p -149.3 149.79 31.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.603 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -115.82 127.85 55.37 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.05 126.49 27.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.277 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 48' ' ' ALA . 73.1 t -125.06 131.84 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.649 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.0 159.13 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.908 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -80.89 148.07 63.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.031 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.491 1.344 0 C-N-CA 122.084 1.856 . . . . 0.0 111.803 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.74 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 38.5 t80 -158.06 113.58 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -154.36 132.04 11.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.5 tt -134.66 143.9 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.194 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 31.9 mt-30 -121.69 131.74 54.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 118' ' ' ILE . 14.8 mt -120.33 130.99 73.77 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.97 132.93 55.16 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.048 0.451 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 82.8 tt0 -63.69 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.698 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -117.15 148.32 41.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.12 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 178.27 8.56 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.2 t0 54.72 31.25 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.772 0.32 . . . . 0.0 110.5 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 55.4 81.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.279 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -159.82 162.52 34.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.79 20.92 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.658 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.39 136.85 39.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.9 tmm? -122.03 131.62 54.08 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.53 137.15 54.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.516 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.73 127.49 47.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.636 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 111' ' ' THR . 5.6 t -149.5 128.64 12.77 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.48 40.47 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.86 -177.96 5.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.063 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -84.66 159.29 20.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.15 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 45.1 t -132.44 119.59 16.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -79.25 -53.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.495 1.463 . . . . 0.0 111.018 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.9 m -119.08 109.94 16.5 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -66.5 -42.58 90.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.355 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 44.1 ttm -66.62 -21.5 66.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.922 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -73.73 -47.48 38.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.241 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.659 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.7 pt20 -101.0 -25.48 14.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 34.9 m-85 -111.47 1.13 16.78 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 51.68 11.38 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.997 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 122' ' ' PHE . 4.8 mmt -77.58 135.57 38.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -109.36 -28.87 8.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.556 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 35.1 mt-10 -150.36 108.01 3.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.383 0.611 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 118' ' ' ILE . 8.7 mm -76.39 122.77 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.864 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.8 m80 -104.39 -31.78 9.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.158 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -151.71 146.48 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 110.681 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -145.46 132.72 20.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -113.03 -176.25 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.575 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' C ' HD22 ' A' ' 133' ' ' LEU . 15.1 t 53.54 90.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -105.6 168.09 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.79 111.88 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.91 -86.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.7 t -122.56 149.15 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.74 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -138.11 169.47 17.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.739 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.446 HD12 HG12 ' A' ' 176' ' ' ILE . 88.3 mt -145.05 123.51 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.679 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.39 130.92 55.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.001 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -110.5 111.92 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.617 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -52.28 -23.34 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.393 0.433 . . . . 0.0 111.159 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.65 162.09 24.29 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.42 165.28 20.93 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.1 1.867 . . . . 0.0 111.488 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.2 m-20 75.44 13.87 2.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.965 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.4 m-85 78.78 25.83 0.5 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -109.84 171.5 7.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.739 0.304 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 94.85 170.29 36.94 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.47 148.79 22.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 6.3 mp0 -110.18 148.21 32.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.162 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.571 179.769 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -107.11 -25.67 11.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -119.22 154.04 53.54 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.559 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.527 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -58.81 -15.66 27.69 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.176 1.917 . . . . 0.0 113.729 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.78 -3.29 9.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.313 0.577 . . . . 0.0 110.477 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.75 -28.29 68.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.478 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -105.8 23.21 14.28 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 120.826 0.346 . . . . 0.0 110.167 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.1 26.45 72.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.946 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.53 139.6 41.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.378 1.089 . . . . 0.0 109.759 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.23 21.25 0.36 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 171.43 154.83 0.22 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.336 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.847 ' O ' HG23 ' A' ' 170' ' ' VAL . 40.1 Cg_endo -68.07 -35.16 20.67 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.641 2.228 . . . . 0.0 111.422 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.92 76.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.801 0.688 . . . . 0.0 110.6 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.4 t -93.84 -98.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.741 ' O ' HD12 ' A' ' 118' ' ' ILE . 5.3 mm-40 158.79 -140.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -92.62 -156.12 0.46 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.931 0.332 . . . . 0.0 111.704 -177.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -170.3 -177.11 2.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.53 131.72 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.258 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.7 ptt180 -52.46 135.33 33.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.61 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 138' ' ' ILE . 15.9 mt -69.6 135.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 178' ' ' GLU . 39.7 t -136.23 156.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.388 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.551 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 31.6 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.451 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.544 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 3.7 p . . . . . 0 C--O 1.215 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.801 ' O ' HG13 ' A' ' 42' ' ' VAL . 31.1 tttt -99.64 159.61 14.91 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.846 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -146.5 140.85 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.823 0.344 . . . . 0.0 111.613 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 90.6 m -126.61 138.87 53.5 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 110.554 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -118.23 116.55 27.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 92.9 m-85 -97.1 139.77 32.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 110.879 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.5 tm-20 -61.58 -52.61 63.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.764 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HA ' HD22 ' A' ' 38' ' ' ASN . 99.0 m-20 -95.27 -178.15 4.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -81.89 -178.15 6.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.4 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 2.4 m-20 47.17 26.04 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.001 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 62.35 42.48 9.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.414 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -109.79 176.43 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.09 -156.81 52.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.639 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -55.21 174.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.69 148.22 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' THR . 51.4 t80 -130.69 132.73 45.55 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 28.6 t0 -118.4 143.42 46.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.775 0.321 . . . . 0.0 110.53 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -160.46 139.57 10.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 35.3 t70 -121.54 21.82 10.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.49 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.37 148.81 28.58 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.048 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 2.8 t70 -38.08 155.77 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 10.7 t -154.71 160.58 41.45 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.44 -56.66 2.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.022 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.1 p-10 -152.35 108.6 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.9 9.05 43.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -58.47 -27.48 64.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.039 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.8 p -64.26 -29.73 70.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.953 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.17 -11.63 46.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.6 tp -143.72 137.46 28.16 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -98.32 -12.01 21.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.498 ' O ' HD21 ' A' ' 34' ' ' LEU . 17.4 ttm180 -154.46 143.13 20.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.235 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -114.34 108.06 16.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.648 0.737 . . . . 0.0 110.57 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 39' ' ' SER . 56.9 m-20 -117.61 -156.04 0.62 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.608 -1.178 . . . . 0.0 107.979 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.1 p -18.2 138.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.811 0.694 . . . . 0.0 112.748 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.8 mt -141.98 146.49 22.7 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.709 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -156.57 103.26 2.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.68 146.07 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.517 0.675 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -117.47 50.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.483 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.32 -96.56 0.1 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.582 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.14 -142.14 4.63 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 97.0 m -81.85 166.88 19.57 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.187 0.517 . . . . 0.0 110.956 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.632 ' N ' HG22 ' A' ' 46' ' ' THR . 23.5 m95 -155.2 157.59 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.981 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.89 121.2 40.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.281 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.94 132.06 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 52' ' ' ARG . 57.7 m-85 -104.3 111.12 23.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.527 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 50' ' ' TYR . 45.7 tt0 -32.69 -34.15 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.316 0.385 . . . . 0.0 111.216 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 50' ' ' TYR . 27.3 mtm180 -124.86 158.22 63.51 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' OD1' ' A' ' 54' ' ' ASN . 5.8 Cg_exo -71.18 163.47 39.06 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.391 2.06 . . . . 0.0 112.221 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 0.7 OUTLIER 86.66 -11.24 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.816 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.8 m-85 . . . . . 0 N--CA 1.465 0.307 0 O-C-N 123.844 0.715 . . . . 0.0 111.595 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 24.0 t80 . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.58 93.07 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 111.92 14.26 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.78 164.01 13.98 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.046 1.83 . . . . 0.0 113.203 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -50.92 111.74 0.6 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.24 171.46 39.27 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.28 155.1 16.9 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.99 0.424 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 56.4 m-85 -149.01 84.23 6.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.702 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -54.09 -14.34 6.03 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.894 2.396 . . . . 0.0 112.814 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -155.45 162.88 40.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 7.9 p90 -64.78 -52.35 57.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.499 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 26.4 mt-30 -39.87 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.1 tpm_? -75.79 -5.17 44.54 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.421 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -116.71 25.66 10.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.196 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.7 mmt 88.78 25.18 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.119 0.967 . . . . 0.0 111.632 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 33.35 55.7 0.58 Allowed Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.318 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.8 mt -88.23 11.12 17.31 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 41.5 t30 87.52 139.3 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.66 0.6 . . . . 0.0 109.912 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.641 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 16.0 p-10 -37.88 -95.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.641 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER 27.15 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.55 128.05 20.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.649 ' N ' HD13 ' A' ' 80' ' ' LEU . 6.8 p -110.23 -163.15 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.387 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.5 p -45.81 -179.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 110.761 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 26.5 p -150.8 152.53 33.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.263 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -114.78 127.03 55.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.47 122.08 14.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 48' ' ' ALA . 46.1 t -123.55 130.97 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 136' ' ' VAL . 29.5 m80 -102.73 162.52 12.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.963 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.32 155.85 69.11 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.494 1.546 0 C-N-CA 122.666 2.244 . . . . 0.0 111.992 179.367 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 35.8 t80 -158.43 113.26 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 36.0 tptt -154.68 133.57 12.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.19 0.519 . . . . 0.0 111.461 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.0 145.05 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 41.5 mt-30 -123.25 131.42 53.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.526 -1.216 . . . . 0.0 107.942 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.57 HD13 HD11 ' A' ' 118' ' ' ILE . 12.8 mt -119.96 131.9 71.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.036 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -114.1 130.93 56.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 0.0 110.697 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -119.01 147.34 44.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.88 172.02 15.94 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.9 t70 59.75 31.91 21.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.815 0.34 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 54.5 81.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -159.13 163.36 36.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.486 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -151.73 24.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -73.61 135.86 43.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.644 0.259 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 9.3 tmm? -121.83 132.03 54.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.202 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.503 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.0 m-85 -121.52 136.05 54.98 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.74 123.5 41.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.555 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 4.9 t -151.77 126.43 9.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.689 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 t -92.34 43.44 1.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -142.77 -179.34 6.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 11.4 p-10 -85.2 158.92 20.23 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.536 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.6 m -136.59 121.64 12.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.87 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 172' ' ' SER . 69.0 Cg_endo -77.11 -53.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.768 1.645 . . . . 0.0 111.413 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 m -118.58 109.15 15.83 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -66.17 -42.68 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 111.254 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.2 ttt -66.08 -18.45 65.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -82.37 -43.3 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.719 -0.613 . . . . 0.0 111.938 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.84 -31.79 14.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.006 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 28.0 m-85 -115.82 5.8 14.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 51.32 13.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.253 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' C ' ' A' ' 122' ' ' PHE . 2.2 mmt -78.23 133.84 37.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -107.4 -29.55 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.561 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 25.9 mt-10 -150.45 109.14 3.84 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.155 0.502 . . . . 0.0 111.167 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.9 mm -75.03 124.71 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.062 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.3 m80 -104.77 -32.22 8.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.172 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.9 m -154.52 149.28 26.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.05 145.87 32.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.647 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -122.48 -176.91 3.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.668 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' C ' HD12 ' A' ' 133' ' ' LEU . 25.1 t 50.66 92.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.649 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.519 HD21 ' CE2' ' A' ' 157' ' ' TYR . 7.5 mp -107.57 168.57 9.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.121 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.9 mp0 -142.04 112.48 7.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.13 -88.18 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.4 t -119.61 153.72 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.236 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.7 t-105 -141.83 169.32 17.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.767 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.2 mt -144.51 122.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.41 131.87 54.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.026 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -110.87 111.72 23.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.92 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 142' ' ' LEU . 74.8 tt0 -50.38 -21.92 1.64 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -119.53 161.62 36.58 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 0.0 110.377 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.414 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.8 Cg_endo -77.39 168.25 23.19 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.3 m120 73.67 11.95 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 78.76 27.92 0.44 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.329 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -112.87 172.3 7.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.75 172.49 42.48 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.598 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.74 156.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 110.239 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.595 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 13.2 mp0 -121.94 126.83 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.384 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.519 ' CE2' HD21 ' A' ' 133' ' ' LEU . 10.9 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.002 0.43 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -104.8 -25.92 12.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.016 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -119.83 154.79 55.3 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.608 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 13.7 Cg_endo -58.68 -19.7 47.05 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.23 1.953 . . . . 0.0 113.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -99.34 -2.81 9.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.131 0.491 . . . . 0.0 110.704 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.2 -28.16 67.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.547 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.573 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -106.87 21.73 17.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.354 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.57 69.9 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 121.134 -0.555 . . . . 0.0 114.283 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.573 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.92 138.16 42.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.217 1.008 . . . . 0.0 109.765 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.36 20.2 0.16 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 168.99 155.96 0.17 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.845 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.01 7.13 3.0 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.081 2.52 . . . . 0.0 111.502 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.11 70.52 9.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.046 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -99.27 -147.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -160.47 -131.68 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.696 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.01 -157.59 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.456 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -169.81 -177.4 2.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.189 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.94 131.28 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.79 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -52.59 135.46 34.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.149 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.465 HG12 HD12 ' A' ' 138' ' ' ILE . 14.3 mt -69.3 134.42 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.6 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 178' ' ' GLU . 43.5 t -137.71 156.55 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.658 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 27.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.882 0.372 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.792 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 39.7 tttt -159.75 151.25 19.95 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.11 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 tt -147.1 141.97 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.4 m -124.63 138.52 54.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.47 116.22 25.67 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.93 137.75 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.92 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 7.7 tm-20 -60.66 -48.99 79.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.156 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -99.1 -176.07 3.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 109.917 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.56 -176.72 6.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.282 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 46.8 23.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.883 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 63.48 41.76 7.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.235 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -108.65 174.38 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.604 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.82 -154.97 53.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.66 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -56.26 172.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.94 152.19 5.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -136.22 133.89 37.55 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -121.03 138.2 54.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.698 0.285 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 141.61 25.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.61 16.74 9.58 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.671 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -149.71 146.54 27.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -38.53 156.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.713 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 39.8 t -157.49 163.43 38.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.79 -56.3 3.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.817 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -153.58 112.51 3.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.5 p90 -101.87 8.58 41.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.041 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' LEU . 79.3 t60 -60.33 -27.57 67.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.494 0.664 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.4 p -60.79 -29.37 69.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -89.1 -15.27 34.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.527 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.23 137.65 32.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.954 0.407 . . . . 0.0 110.17 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -99.31 -7.76 25.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 52.5 ttm-85 -156.78 145.75 20.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.865 0.364 . . . . 0.0 110.575 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p -112.26 104.18 12.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.731 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.1 m-20 -129.78 157.55 41.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.731 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 34.24 127.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.581 1.181 . . . . 0.0 112.398 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.6 mt -141.2 146.08 24.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.187 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -154.06 102.96 2.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.25 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -66.89 149.18 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.478 0.656 . . . . 0.0 110.389 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -122.17 50.94 1.4 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.919 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.13 -95.73 0.1 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.967 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.16 -138.59 3.78 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 56.1 m -82.84 166.99 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.593 -0.357 . . . . 0.0 110.745 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.792 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.5 m95 -153.68 155.57 36.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.577 0.703 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.77 122.16 44.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.026 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 60' ' ' TYR . 8.1 m -118.29 132.07 69.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.189 0.518 . . . . 0.0 110.871 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 52' ' ' ARG . 89.3 m-85 -101.5 108.49 20.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.919 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' TYR . 39.6 tt0 -32.21 -37.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.407 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.0 mtm180 -119.5 148.9 46.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.808 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 39.8 Cg_endo -67.78 163.8 33.93 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.559 2.173 . . . . 0.0 111.901 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 82.56 -3.27 1.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.119 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 N--CA 1.467 0.423 0 O-C-N 123.438 0.461 . . . . 0.0 110.965 179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.495 ' CE1' HD13 ' A' ' 76' ' ' LEU . 5.6 m-85 . . . . . 0 N--CA 1.462 0.146 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -101.34 89.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 110.8 7.05 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.95 161.85 18.37 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.181 1.921 . . . . 0.0 112.519 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.35 117.31 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.247 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.74 179.32 41.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.06 152.97 20.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 18.8 m-85 -145.67 84.6 8.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.65 -17.78 23.87 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.145 2.563 . . . . 0.0 113.028 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -149.88 161.18 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 16.4 p90 -62.68 -49.66 74.24 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.521 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -44.19 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.9 mmt180 -76.38 -5.19 46.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.015 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.673 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -116.66 26.94 9.5 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.469 -0.144 . . . . 0.0 111.249 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 22.0 mmt 88.97 19.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.342 1.027 . . . . 0.0 111.316 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 32.51 59.65 0.4 Allowed Glycine 0 N--CA 1.467 0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.336 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.4 mt -79.75 -67.59 0.75 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -159.93 163.86 33.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 54.7 p-10 -91.42 58.58 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 16.8 tpp180 -138.32 115.9 11.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.79 128.26 21.3 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.644 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.2 p -111.4 -162.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.605 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 m -44.65 179.85 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.322 0.582 . . . . 0.0 110.664 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 17.7 p -148.57 146.69 28.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.733 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -113.11 126.02 55.01 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.66 126.37 27.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.5 t -126.52 132.05 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.553 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -115.1 121.39 42.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.163 0.506 . . . . 0.0 110.253 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.817 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -46.15 163.21 0.23 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.952 -179.44 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.756 2.304 . . . . 0.0 111.961 179.634 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.714 0.292 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.4 t80 -157.77 113.63 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.237 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 110' ' ' GLU . 25.3 tptp -153.95 131.4 11.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.123 0.487 . . . . 0.0 111.424 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.425 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -133.05 141.24 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.354 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 33.8 mt-30 -121.25 130.16 53.53 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' ILE . 8.3 mt -119.34 130.6 73.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.09 129.91 56.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.821 0.343 . . . . 0.0 110.802 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.04 -31.01 70.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.713 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.21 146.26 39.61 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' PHE . . . -47.98 -93.08 0.01 OUTLIER Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 104' ' ' PHE . 38.7 p-10 -38.28 98.58 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' C ' ' O ' ' A' ' 103' ' ' ASP . 23.7 m-85 -8.99 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.216 0.948 . . . . 0.0 112.046 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' ASP . 38.0 m -153.88 163.28 40.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 -151.53 20.14 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.115 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -73.11 135.55 44.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.481 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 44.3 ttp -120.95 124.52 45.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.614 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.5 m-85 -116.23 134.37 54.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 95' ' ' LYS . 1.9 pt-20 -120.96 119.26 32.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.018 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 111' ' ' THR . 6.1 t -148.98 125.11 10.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.78 44.42 1.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.14 -177.33 5.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.583 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.0 p-10 -87.07 155.96 19.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.127 0.489 . . . . 0.0 110.087 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 172' ' ' SER . 53.6 t -133.16 124.25 18.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.75 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.734 1.622 . . . . 0.0 110.789 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.8 m -115.69 112.83 22.66 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.68 -45.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.523 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.3 ttt -66.06 -19.47 65.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.436 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -76.25 -45.82 31.0 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.004 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.5 pt20 -100.74 -25.81 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 35.0 m-85 -110.25 1.71 18.79 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.4 m-70 52.05 9.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.118 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -75.91 133.69 40.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -107.52 -30.01 8.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.492 -178.429 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -149.31 109.28 4.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.87 124.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.792 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.0 m80 -105.79 -30.3 9.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.191 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 102' ' ' GLY . 15.7 t -152.68 147.82 26.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.0 111.196 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -149.22 126.88 11.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.978 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -107.91 -169.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.499 . . . . 0.0 110.468 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t 51.3 89.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.5 HD11 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mm? -104.37 168.5 9.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.092 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -142.02 111.18 6.37 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 34.19 -91.47 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.016 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.0 t -115.28 138.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.7 t-105 -130.23 168.07 17.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 HG12 ' A' ' 176' ' ' ILE . 76.3 mt -144.61 121.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.825 0.345 . . . . 0.0 111.4 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.62 130.4 55.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -107.89 111.22 23.23 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.099 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -51.19 -25.67 5.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.99 160.73 28.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.94 164.87 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.38 2.053 . . . . 0.0 111.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m120 74.61 15.97 3.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.32 25.35 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -108.35 168.32 9.4 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 97.87 168.05 32.11 Favored Glycine 0 N--CA 1.462 0.389 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.504 HH11 ' H ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -64.98 137.27 57.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 147' ' ' GLY . 1.4 mp0 -84.21 145.81 28.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.351 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.5 ' HE2' HD11 ' A' ' 133' ' ' LEU . 3.3 m-85 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -108.92 -19.73 13.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -121.23 156.15 57.75 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.687 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.549 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.5 Cg_endo -61.64 -16.39 48.01 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.652 2.235 . . . . 0.0 113.239 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -100.65 -2.85 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.807 0.337 . . . . 0.0 110.779 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -27.46 68.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.549 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.47 21.85 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.389 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.14 26.91 71.19 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.213 -0.517 . . . . 0.0 114.242 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.88 139.21 42.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.847 0.823 . . . . 0.0 109.812 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.22 20.75 0.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.4 153.4 0.25 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.823 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.57 4.38 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 123.023 2.482 . . . . 0.0 111.614 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.33 70.28 4.66 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.929 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.26 -153.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.929 ' H ' HG12 ' A' ' 170' ' ' VAL . 70.8 mm-40 -152.7 -131.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -94.18 -153.67 0.38 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -170.52 -176.25 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -161.08 133.78 6.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.454 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.466 ' CG ' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.95 135.4 42.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.45 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.495 HG12 HD12 ' A' ' 138' ' ' ILE . 13.9 mt -67.56 139.16 21.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.986 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.34 155.72 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.61 179.775 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 41.5 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.822 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.2 tttt -160.42 153.24 21.24 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.069 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.39 142.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 122.108 -0.37 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 138.81 53.98 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.964 0.412 . . . . 0.0 110.699 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -119.14 115.01 23.36 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.8 m-85 -94.08 137.96 32.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.14 0.495 . . . . 0.0 110.947 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.22 -49.02 79.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.158 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 39' ' ' SER . 83.1 m-20 -100.97 -174.72 2.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.58 -174.97 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 111.633 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 46.21 23.28 0.19 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.851 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.7 m-85 59.19 44.43 15.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.29 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -115.35 160.67 19.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.355 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.32 -151.4 29.74 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.477 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -56.73 172.36 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -170.56 153.29 4.15 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -135.01 133.81 39.8 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.9 p-10 -120.76 137.63 54.41 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 141.49 25.94 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 8.5 t70 -124.32 15.8 9.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 97.2 m -150.31 147.17 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.35 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 38.1 t0 -37.64 155.55 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.512 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.564 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 43.8 t -155.66 161.91 40.69 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.41 -57.62 2.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.62 112.71 4.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -102.17 8.11 40.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.972 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' O ' ' O ' ' A' ' 34' ' ' LEU . 75.0 t60 -59.0 -29.35 67.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.536 0.684 . . . . 0.0 109.91 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.6 p -60.34 -29.76 69.09 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.01 -15.35 36.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.7 tp -140.87 137.2 33.04 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 t -99.67 -9.02 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.36 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.3 ttm180 -154.18 143.13 21.1 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.238 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 4.6 p -110.47 104.6 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.735 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.0 m-20 -129.32 155.85 44.96 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.735 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 36.47 129.6 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.691 1.244 . . . . 0.0 112.218 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.291 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.0 ptpt -155.87 102.84 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.103 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -65.85 151.05 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.402 0.62 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -123.35 51.53 1.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.082 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.27 -96.14 0.1 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.974 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.52 -140.9 4.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 48.8 m -81.43 166.84 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.601 -0.352 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.822 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -154.01 155.39 35.46 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.253 0.549 . . . . 0.0 110.688 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.86 118.33 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 m -115.98 131.43 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.052 0.453 . . . . 0.0 110.73 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.56 111.99 24.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' OE2' ' OD1' ' A' ' 77' ' ' ASN . 76.0 tt0 -38.98 -34.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -113.55 147.19 37.01 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.8 Cg_endo -68.01 157.76 60.35 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.733 2.289 . . . . 0.0 111.309 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.8 m120 86.5 -2.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.329 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.6 m-85 . . . . . 0 N--CA 1.471 0.615 0 O-C-N 123.306 0.379 . . . . 0.0 111.261 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.6 m-85 . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -107.47 98.78 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -76.65 114.26 37.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.25 163.61 17.35 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.298 1.998 . . . . 0.0 112.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.52 115.24 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.87 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.28 176.31 41.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -100.68 154.67 18.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.159 0.504 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 41.6 m-85 -147.34 86.59 6.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.614 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_exo -57.15 -18.32 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.967 2.444 . . . . 0.0 112.761 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -148.45 161.71 41.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.735 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.6 p90 -65.4 -53.18 46.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 28.8 mt-30 -43.18 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.903 0.382 . . . . 0.0 111.894 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.14 -4.17 40.13 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.735 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.81 23.33 11.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.824 -0.171 . . . . 0.0 110.838 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.4 mmt 89.84 23.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.535 1.147 . . . . 0.0 111.661 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 29.85 54.36 0.2 Allowed Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 17.4 mt -82.63 14.87 2.86 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.953 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER 112.73 163.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 125.263 1.602 . . . . 0.0 109.771 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.4 p30 -94.73 64.99 3.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.675 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 35.9 ttm180 -142.07 118.75 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.76 129.34 20.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 109.784 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.691 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.8 p -110.07 -163.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.0 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.5 m -45.33 -179.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.499 . . . . 0.0 110.879 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.535 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 14.4 p -150.46 152.22 33.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -116.99 128.66 55.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.89 123.24 17.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.118 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.2 t -125.23 133.06 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.495 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.6 m-70 -103.68 161.42 13.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.061 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.784 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -76.84 159.57 78.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.477 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.311 -1.398 0 C-N-CA 122.536 2.157 . . . . 0.0 112.209 179.342 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 34.4 t80 -156.15 114.17 3.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.343 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.4 tptm -155.62 133.01 10.96 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.148 0.499 . . . . 0.0 111.034 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.9 tt -135.03 145.64 31.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.95 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 28.2 mt-30 -123.57 130.77 53.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.748 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.596 HD13 HD11 ' A' ' 118' ' ' ILE . 8.5 mt -119.98 131.04 73.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.167 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.7 m-85 -111.83 130.01 55.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.964 0.411 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.27 -28.11 68.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.65 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -122.55 148.54 45.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.206 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.24 -171.48 1.25 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 46.33 29.22 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.404 . . . . 0.0 110.464 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 54.67 82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 m -160.32 161.04 33.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.838 0.351 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.85 -153.11 22.21 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -72.58 137.58 46.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 110.641 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 53.0 ttp -122.13 127.11 49.71 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.827 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 54.1 m-85 -118.07 134.97 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 110.65 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.68 116.74 25.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.052 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.22 126.48 24.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.978 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.24 36.38 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.35 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.04 -177.65 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.732 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p30 -85.68 160.13 19.64 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.32 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.2 t -136.03 124.86 15.63 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.669 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 57.4 Cg_endo -78.61 -53.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.208 1.939 . . . . 0.0 110.855 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.3 m -120.26 113.11 19.92 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -67.91 -46.18 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.653 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.48 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 26.9 ttt -64.73 -20.6 66.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.101 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.38 -49.18 35.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 3.9 pt20 -100.16 -23.04 14.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.167 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 33.9 m-85 -111.09 -0.1 16.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.855 0.359 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.1 m-70 52.14 10.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.281 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.438 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.2 mtt -78.58 134.5 37.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -107.3 -27.5 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 48.4 mt-10 -151.19 107.5 3.46 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.075 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 118' ' ' ILE . 8.5 mm -73.67 124.98 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.3 m80 -105.48 -33.43 8.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.035 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 m -152.31 147.46 26.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.986 0.422 . . . . 0.0 110.73 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -145.36 137.46 25.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.776 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -116.07 -173.24 2.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.374 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t 49.21 94.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.41 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 27.1 mt -111.93 168.49 9.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' VAL . 4.3 mp0 -140.62 112.5 7.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.5 -90.77 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 134' ' ' GLU . 10.6 t -117.26 156.29 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.6 t-105 -144.63 169.18 18.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.456 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.7 mt -144.23 123.05 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.47 131.41 55.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -109.17 111.29 22.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -50.11 -21.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.247 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.4 mp -119.37 165.69 16.63 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 86.6 Cg_endo -83.46 167.79 13.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.334 2.023 . . . . 0.0 111.961 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.3 m-20 79.78 14.57 0.94 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.956 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.4 m-85 76.01 28.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.143 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 80.5 mtp180 -136.81 130.21 31.53 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.92 169.14 20.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -51.96 98.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.213 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.616 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 75.5 mt-30 -60.72 133.8 56.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.711 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 120.977 0.418 . . . . 0.0 110.822 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -105.87 -23.21 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.96 157.3 50.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 121.271 0.558 . . . . 0.0 110.784 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.526 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.1 Cg_endo -61.65 -19.38 64.82 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.164 1.909 . . . . 0.0 113.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -98.81 -2.27 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.107 0.479 . . . . 0.0 110.756 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -59.66 -24.87 64.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.153 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.8 OUTLIER -110.36 21.95 16.08 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.54 66.49 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.591 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.27 137.01 46.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.988 0.894 . . . . 0.0 109.437 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.79 21.33 0.16 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 168.1 156.64 0.14 Allowed Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 6.69 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.061 2.507 . . . . 0.0 111.461 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.99 70.87 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.694 0.283 . . . . 0.0 111.35 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -99.03 -150.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.935 ' H ' HG12 ' A' ' 170' ' ' VAL . 16.6 mm-40 -155.99 -132.97 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.356 0 O-C-N 123.14 0.275 . . . . 0.0 110.426 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.3 p -93.4 -155.81 0.46 Allowed 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 122.081 -0.387 . . . . 0.0 111.992 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -171.5 -176.04 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.033 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.433 HH21 HG22 ' A' ' 177' ' ' VAL . 9.1 ptm180 -158.31 133.1 8.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.157 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -51.9 134.37 31.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.235 0.541 . . . . 0.0 110.649 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 138' ' ' ILE . 11.5 mt -68.58 134.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.902 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.433 HG22 HH21 ' A' ' 174' ' ' ARG . 34.7 m -136.15 157.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.255 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 46' ' ' THR . 17.6 tp10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.92 0.39 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -159.22 152.3 22.17 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.096 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -147.49 142.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.816 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 m -125.98 138.97 53.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -119.12 115.75 24.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 84.1 m-85 -95.24 138.23 33.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.432 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 6.1 tm-20 -61.24 -49.36 77.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.067 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 99.6 m-20 -98.03 -177.51 3.77 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.103 0.477 . . . . 0.0 109.842 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.7 -176.54 6.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.876 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 46.58 24.43 0.32 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.778 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.481 ' H ' ' CB ' ' A' ' 39' ' ' SER . 2.5 m-85 62.07 41.61 10.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.157 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -109.11 172.99 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.114 0.483 . . . . 0.0 110.535 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.77 -155.3 52.82 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.439 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -55.77 175.08 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.8 154.58 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 55.9 t80 -130.76 131.58 44.8 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.7 p-10 -119.66 125.99 50.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.964 0.412 . . . . 0.0 111.197 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -152.79 143.17 22.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.372 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -126.53 24.58 6.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.809 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ASP . 4.4 t -146.79 141.95 27.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.602 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' CYS . 51.7 p-10 -37.16 156.02 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 m -157.95 163.22 38.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.27 -56.63 2.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 38.8 p-10 -152.43 112.26 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -102.19 9.2 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.985 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' O ' ' O ' ' A' ' 34' ' ' LEU . 81.6 t60 -59.66 -28.27 67.11 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.458 0.647 . . . . 0.0 109.964 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -61.27 -30.48 70.5 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.425 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -86.63 -14.06 43.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.97 136.35 30.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.136 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 m -94.86 -10.12 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.495 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 13' ' ' ASP . 58.7 ttp180 -158.7 146.86 18.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.474 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.2 m -110.67 104.61 13.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.416 0.627 . . . . 0.0 111.391 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.741 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.4 m120 -129.33 156.8 43.45 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.348 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.741 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.3 p 35.52 128.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.42 1.105 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.4 mt -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.385 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.2 ptpt -154.67 102.92 2.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.57 150.17 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.448 0.642 . . . . 0.0 110.226 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -123.1 51.68 1.43 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.964 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.06 -96.2 0.1 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.218 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.25 -141.89 4.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 47' ' ' TRP . 83.8 m -79.86 166.34 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.7 m95 -154.65 155.48 34.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.496 0.665 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.36 121.62 42.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.382 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.8 133.54 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.014 0.435 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 52' ' ' ARG . 77.9 m-85 -104.41 109.82 21.83 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 50' ' ' TYR . 74.0 tt0 -33.55 -33.29 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.644 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 29.9 mtp85 -121.71 151.48 57.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 56.0 Cg_endo -69.92 164.2 35.58 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.764 2.309 . . . . 0.0 112.158 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.6 m120 78.99 -8.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.884 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.9 m-85 . . . . . 0 N--CA 1.463 0.213 0 O-C-N 123.5 0.5 . . . . 0.0 110.742 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.2 t80 . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.782 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.65 91.02 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -70.32 111.86 10.81 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.82 163.51 16.02 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.111 1.874 . . . . 0.0 112.739 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -52.7 116.87 2.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.151 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.64 178.77 42.23 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.528 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.1 mt-10 -101.55 152.4 20.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.002 0.43 . . . . 0.0 110.336 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 22.6 m-85 -144.29 89.52 6.96 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.36 -14.73 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.223 1.948 . . . . 0.0 113.331 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.1 mt-10 -150.26 161.06 43.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.685 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 15.0 p90 -63.26 -50.06 71.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.759 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 30.2 mt-30 -45.0 -9.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.8 mmm180 -75.18 -5.41 44.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.685 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.11 25.98 9.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 75' ' ' GLY . 21.8 mmm 84.93 24.55 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.131 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.4 54.02 0.31 Allowed Glycine 0 N--CA 1.474 1.196 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 30.8 mt -78.98 14.44 1.39 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.148 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 60.0 t30 112.61 164.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.039 1.462 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 52.7 p30 -96.45 65.93 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.57 120.23 10.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.121 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.77 129.73 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.675 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.7 p -111.19 -162.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.578 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.99 -178.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 110.793 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.481 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.8 p -149.75 150.49 32.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -115.99 127.42 54.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.545 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 126.39 27.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.309 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.4 t -123.84 131.19 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.704 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.502 ' O ' HG21 ' A' ' 136' ' ' VAL . 25.7 m80 -101.66 161.78 13.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.751 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.06 157.52 71.1 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 C-N-CA 122.31 2.007 . . . . 0.0 112.023 179.189 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.8 t80 -157.21 113.45 2.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.111 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -154.68 130.99 10.41 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.3 tt -134.26 142.58 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 38.6 mt-30 -123.11 130.59 52.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 8.1 mt -119.49 131.84 70.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.208 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -112.77 131.61 55.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.36 -29.99 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 150.26 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.3 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.5 176.24 14.6 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 55.75 30.58 15.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 6.1 m-85 56.0 83.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -160.58 161.18 32.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.955 0.407 . . . . 0.0 110.569 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.6 -149.36 21.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -77.22 138.59 39.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.671 0.272 . . . . 0.0 110.483 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.3 tmm? -122.23 132.96 54.69 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.055 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 58.1 m-85 -122.1 135.86 54.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -123.11 124.2 42.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.445 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 111' ' ' THR . 11.9 t -147.75 128.57 14.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 p -92.92 38.78 1.03 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.62 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 -177.62 5.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.761 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.4 p-10 -85.51 158.51 20.15 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 172' ' ' SER . 42.7 t -132.8 124.23 18.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.372 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.5 Cg_endo -79.57 -56.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.606 1.537 . . . . 0.0 110.958 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -116.05 113.03 22.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.76 -46.59 74.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-O 121.168 0.509 . . . . 0.0 110.787 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.471 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.1 ttt -65.48 -18.87 65.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.243 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.36 -46.36 33.61 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 121.606 -0.684 . . . . 0.0 111.992 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.45 -24.74 14.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.254 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.3 m-85 -111.28 -0.55 16.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.022 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 52.76 12.13 0.24 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.982 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.414 ' N ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -79.28 133.12 36.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -107.55 -26.94 10.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.545 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.9 mt-10 -150.83 108.27 3.63 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.08 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 118' ' ' ILE . 7.7 mm -74.7 125.97 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.794 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -107.37 -32.27 7.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.332 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.523 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 13.5 t -153.59 147.21 25.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.29 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -146.72 129.18 15.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.735 179.17 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 132' ' ' VAL . 43.9 mtmt -99.83 -157.88 0.63 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.016 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.578 ' O ' ' O ' ' A' ' 131' ' ' LYS . 1.1 m 32.39 110.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.906 0.86 . . . . 0.0 112.058 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 132' ' ' VAL . 3.6 mm? -117.98 166.87 11.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.766 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.2 mp0 -142.75 111.07 6.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.781 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . 35.03 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.603 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -117.25 156.31 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 110.165 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 25.9 t-105 -145.36 168.2 21.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.379 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 91.0 mt -145.39 123.79 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.759 0.314 . . . . 0.0 111.377 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -108.77 130.22 55.38 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.03 110.81 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.83 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 142' ' ' LEU . 76.4 tt0 -49.46 -22.51 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.7 mp -118.47 161.01 37.6 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.432 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 74.1 Cg_endo -77.97 167.44 23.6 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.324 2.016 . . . . 0.0 111.68 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.3 m-20 73.14 14.12 4.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.921 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.2 24.52 0.66 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.636 0.255 . . . . 0.0 111.306 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -108.49 168.96 8.95 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.07 170.43 36.63 Favored Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -55.52 150.32 12.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.148 0.499 . . . . 0.0 109.771 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 7.1 mp0 -108.8 146.7 33.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.665 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 179.967 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 121.009 0.433 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.607 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.2 ptt180 -107.59 -24.69 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.607 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.2 pttm -119.82 154.06 54.98 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 120.84 0.353 . . . . 0.0 110.492 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.537 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.3 Cg_endo -58.42 -16.63 29.97 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.31 2.006 . . . . 0.0 113.5 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.3 mp -100.93 -3.68 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.15 -27.16 68.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.481 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.555 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.7 20.69 18.49 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.642 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.43 28.41 67.8 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.626 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.25 137.67 45.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.792 0.796 . . . . 0.0 109.72 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.11 20.81 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.314 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 171.48 155.47 0.22 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.477 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.64 5.0 5.11 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.952 2.435 . . . . 0.0 111.596 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.59 70.92 6.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.612 0.244 . . . . 0.0 111.153 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -100.93 -147.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -157.73 -132.25 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.611 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -92.21 -154.09 0.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -170.37 -177.07 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.136 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.48 132.45 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.924 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.9 ptm180 -53.92 129.34 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.686 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 138' ' ' ILE . 16.7 mt -59.77 135.41 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.383 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.2 t -133.97 138.74 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.517 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.0 tp10 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.436 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.959 0.409 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.722 ' O ' HG13 ' A' ' 42' ' ' VAL . 40.8 tttt -161.45 155.85 22.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.321 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.4 tt -148.58 146.99 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.035 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.6 m -132.97 141.43 48.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -121.71 117.26 26.21 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.5 m-85 -99.68 141.13 32.88 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.047 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.9 tm-20 -64.07 -51.66 63.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.23 -176.39 4.13 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 109.616 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -84.28 -178.17 6.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.466 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 1.6 m120 46.25 24.55 0.28 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER 61.81 44.24 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.214 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -111.21 166.1 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -144.09 31.96 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.608 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -60.97 166.47 3.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.151 -1.025 . . . . 0.0 109.024 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.7 155.94 7.49 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.003 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 58.2 t80 -135.62 135.42 40.21 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 p-10 -104.25 150.12 24.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.615 0.245 . . . . 0.0 110.563 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -162.55 124.94 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.527 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.08 14.35 9.81 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.657 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.8 t -150.66 148.46 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 p30 -39.28 156.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.7 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 48.3 t -158.29 164.29 36.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.65 -56.07 3.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -156.31 109.19 2.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.343 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -92.67 7.53 43.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -58.76 -30.36 67.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.103 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.8 p -64.52 -1.1 1.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.699 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -119.39 -14.84 9.15 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.768 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 15.8 tp -141.33 139.61 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -102.21 -8.38 21.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.852 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.7 ttm180 -153.32 141.87 20.83 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.685 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.9 m -113.02 104.23 12.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.772 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 52.6 m-20 -115.17 -153.76 0.53 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' ASN . 19.1 p -24.94 137.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.61 0.719 . . . . 0.0 112.587 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.0 mt -140.54 147.85 22.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.742 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.8 ptpt -155.89 103.12 2.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.239 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.0 t -66.49 144.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.93 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -115.1 46.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.48 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -164.15 -100.28 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.811 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.544 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.29 -140.15 4.24 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.6 m -78.7 167.27 21.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.437 -0.449 . . . . 0.0 110.851 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.714 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 39.3 m95 -157.11 158.82 37.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.376 0.608 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.98 122.57 43.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.791 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.8 m -119.41 133.02 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.891 0.377 . . . . 0.0 110.671 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 51' ' ' GLU . 92.9 m-85 -106.17 110.57 22.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.928 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' TYR . 71.4 tt0 -34.87 -36.06 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.37 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.7 mtt-85 -116.61 147.42 39.74 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 45.3 Cg_endo -68.01 156.36 66.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.37 2.047 . . . . 0.0 111.88 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 m120 86.23 0.41 0.63 Allowed 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.931 0.769 . . . . 0.0 111.216 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 8.9 m-85 . . . . . 0 N--CA 1.468 0.447 0 O-C-N 123.464 0.478 . . . . 0.0 111.216 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.495 ' C ' HD12 ' A' ' 61' ' ' ILE . 20.6 t80 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -101.37 94.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -72.46 111.22 10.2 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.15 164.84 19.48 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.078 1.852 . . . . 0.0 112.418 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.06 118.83 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.08 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.48 -180.0 41.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.74 153.24 20.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.004 0.43 . . . . 0.0 110.176 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 4.4 m-85 -142.54 69.79 20.8 Favored Pre-proline 0 C--O 1.221 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.29 -13.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.845 2.363 . . . . 0.0 113.079 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 67' ' ' TYR . 71.2 mt-10 -155.46 163.99 39.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.689 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.1 p90 -65.18 -49.58 69.24 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.063 -179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -42.44 -10.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -80.23 0.78 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.488 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.73 20.9 10.92 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.36 0.124 . . . . 0.0 111.124 178.595 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.8 mmt 92.22 20.33 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.781 1.233 . . . . 0.0 111.716 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.19 59.6 0.27 Allowed Glycine 0 CA--C 1.536 1.358 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.4 mt -89.23 17.14 6.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.423 0.289 . . . . 0.0 111.543 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.6 t30 103.78 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.744 1.278 . . . . 0.0 109.578 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.24 63.74 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -131.54 112.77 12.93 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -146.15 130.34 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.123 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.673 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -108.78 -164.17 0.93 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.034 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' SER . 2.9 m -48.37 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.399 0.619 . . . . 0.0 111.553 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 8' ' ' ILE . 13.5 p -151.41 151.65 32.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.698 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.28 128.28 56.02 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.57 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.87 132.4 53.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.79 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.1 t -129.03 132.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.706 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.44 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.9 m-70 -98.9 162.8 12.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.74 149.92 61.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.494 1.551 0 C-N-CA 122.126 1.884 . . . . 0.0 112.14 179.836 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.725 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 36.7 t80 -153.54 113.1 3.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.2 tptm -153.64 137.29 16.03 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.102 0.477 . . . . 0.0 111.138 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -137.82 145.66 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.087 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 37.2 mt-30 -123.9 129.49 51.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.746 177.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.83 131.42 72.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -111.15 123.38 50.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.011 0.434 . . . . 0.0 110.786 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.01 -19.74 20.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -131.2 144.75 51.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.455 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.49 -170.46 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 44.62 29.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.741 0.305 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 17.4 m-85 54.64 82.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -159.64 164.13 34.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 -158.49 30.04 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.863 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -64.66 135.74 56.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.361 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 45.2 ttp -118.23 122.21 42.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.186 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.58 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 44.9 m-85 -115.85 130.57 56.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.46 120.69 36.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.097 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -149.54 129.75 13.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.412 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -97.09 49.91 1.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.48 -176.63 5.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.351 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.3 p-10 -89.65 160.51 16.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.652 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 58.2 m -138.41 123.02 11.83 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.492 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 58.0 Cg_endo -76.15 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.878 1.719 . . . . 0.0 110.53 178.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.9 m -110.34 114.09 27.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.2 tt -70.05 -37.19 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.958 0.409 . . . . 0.0 110.947 -178.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.5 ttt -70.51 -19.01 62.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.728 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -81.81 -42.3 19.88 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.14 -0.975 . . . . 0.0 111.513 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.669 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 1.0 OUTLIER -93.15 -30.53 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.769 -177.531 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.1 m-85 -116.86 4.23 12.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.813 -178.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.7 m-70 54.19 3.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.0 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.548 ' H ' ' C ' ' A' ' 122' ' ' PHE . 35.8 mtt -72.12 133.09 44.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.112 0.482 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -109.02 -24.65 11.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.192 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.557 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.8 mt-10 -151.78 107.78 3.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 13.8 mm -76.71 126.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.587 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.4 m80 -104.55 -36.5 7.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.169 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.509 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 7.4 t -148.27 143.47 26.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.129 0.49 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.3 t -143.44 134.09 25.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -114.38 -175.99 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.571 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 28.0 t 54.7 93.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.92 165.56 11.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.106 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.4 mp0 -139.4 111.83 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.55 -88.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.6 t -119.13 156.48 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.096 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.725 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.2 t-105 -144.47 166.72 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.643 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.8 mt -144.23 124.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.375 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.888 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 30.8 m-85 -107.4 113.8 27.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.802 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.1 -22.76 1.77 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.647 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.9 mp -121.74 165.36 20.31 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.462 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.0 Cg_endo -81.93 169.91 14.35 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.241 1.961 . . . . 0.0 112.3 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.496 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.3 m-20 77.0 13.67 2.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.783 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.496 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 74.25 30.12 1.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.11 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 93.0 mtt180 -134.68 126.23 28.68 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.4 173.62 20.77 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -52.45 113.66 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.896 0.379 . . . . 0.0 110.499 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' CE2' ' A' ' 60' ' ' TYR . 33.9 mt-30 -82.18 149.48 27.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.857 179.404 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.965 0.412 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -108.58 -21.48 12.69 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -123.64 154.88 66.8 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.362 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.492 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.0 Cg_endo -58.98 -20.53 53.71 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.481 2.121 . . . . 0.0 113.611 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.24 -5.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 110.654 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.81 -33.18 64.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.331 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.547 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.02 21.97 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.459 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.96 27.64 66.24 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.629 176.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.83 138.2 43.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.802 0.801 . . . . 0.0 110.678 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.31 24.2 0.19 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.1 m 165.19 153.79 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.447 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 170' ' ' VAL . 50.9 Cg_endo -71.18 -18.07 30.85 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.797 2.332 . . . . 0.0 111.509 178.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.41 70.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.302 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.963 HG22 ' H ' ' A' ' 171' ' ' GLN . 8.8 p -104.99 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.963 ' H ' HG22 ' A' ' 170' ' ' VAL . 2.0 tp60 -152.82 -130.86 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.501 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.6 p -94.85 -154.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -171.53 -178.17 2.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.295 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -157.7 132.97 8.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.96 178.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -52.74 126.11 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 110.347 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.491 HD12 ' HB ' ' A' ' 136' ' ' VAL . 10.9 mt -56.59 129.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.823 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.35 135.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.502 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.049 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.53 -1.428 . . . . 999.99 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.616 ' O ' HG22 ' A' ' 4' ' ' THR . 47.3 p -95.17 -118.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.075 -0.343 . . . . 999.99 110.075 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 34.05 29.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.787 0.679 . . . . 999.99 112.797 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 2' ' ' SER . 2.9 t 161.39 -20.3 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.055 0.761 . . . . 999.99 113.055 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 107.5 2.31 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.36 -0.924 . . . . 127.44 111.212 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 79.0 p -95.28 115.26 27.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.844 -0.798 . . . . 75.04 108.844 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.663 ' O ' HG13 ' A' ' 42' ' ' VAL . 42.7 tttt -107.03 147.91 29.36 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.273 0.358 . . . . 8.2 111.561 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 83' ' ' CYS . 18.5 tt -140.15 136.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.95 -0.389 . . . . 6.76 109.95 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 35.4 m -120.32 138.11 53.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 8.47 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 67.8 m-85 -116.86 116.61 27.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.067 -0.716 . . . . 4.74 109.067 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.602 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 88.6 m-85 -95.96 140.61 30.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.213 0.53 . . . . 9.67 111.144 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HB2' ' CB ' ' A' ' 19' ' ' ARG . 4.3 tm-20 -62.06 -51.86 66.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.851 -0.613 . . . . 46.58 109.841 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.42 -175.95 3.36 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.791 -0.641 . . . . 24.88 109.92 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.67 -179.38 7.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.75 -0.659 . . . . 104.03 110.455 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 49.77 26.11 1.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 66.74 110.61 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m-85 57.96 44.57 19.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 19.33 110.947 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -114.74 161.49 18.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.974 0.416 . . . . 111.5 110.724 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.26 -146.4 29.06 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.859 -0.61 . . . . 138.46 112.437 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.728 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.1 ttm-85 -57.05 166.25 1.1 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.709 -0.849 . . . . 613.65 108.709 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.24 152.12 4.87 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.78 -0.452 . . . . 325.16 109.78 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 47.4 t80 -130.6 131.9 45.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 18.95 109.596 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -116.21 128.78 55.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 278.02 110.649 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.01 139.21 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 342.02 109.975 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -123.99 22.24 8.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.323 -0.399 . . . . 154.21 111.147 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 150.29 29.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.069 -0.253 . . . . 117.53 110.605 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -39.9 156.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.846 -0.616 . . . . 317.22 111.374 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -157.34 164.21 37.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.625 . . . . 167.98 110.184 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.04 -56.41 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 11.81 110.921 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -151.01 108.79 3.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.579 -0.737 . . . . 348.8 111.295 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.488 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.5 p90 -99.74 5.32 45.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 6.94 110.48 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.3 t60 -58.21 -26.89 63.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.186 0.517 . . . . 9.31 109.966 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.9 p -62.04 -20.94 64.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.956 -0.566 . . . . 32.68 110.265 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.16 -17.33 19.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 13.98 111.266 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.728 HD12 ' HD2' ' A' ' 19' ' ' ARG . 15.7 tp -138.91 135.5 34.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.809 0.338 . . . . 5.79 110.276 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.64 -9.66 26.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.5 -0.318 . . . . 80.89 111.551 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 30.2 ttm-85 -155.11 142.01 19.12 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 110.025 -0.361 . . . . 332.73 110.025 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -108.59 102.32 11.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.332 0.586 . . . . 99.41 110.847 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 39' ' ' SER . 76.4 m-20 -125.57 154.91 41.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.953 -1.499 . . . . 45.58 106.953 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.642 ' O ' ' O ' ' A' ' 38' ' ' ASN . 15.6 p 39.04 128.67 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.497 1.142 . . . . 8.21 112.805 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 13.7 mt -142.02 143.49 26.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.307 -0.86 . . . . 5.81 111.772 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.5 ptpt -154.67 101.79 2.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.722 -0.672 . . . . 8.95 109.571 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 7' ' ' LYS . 1.9 t -65.73 148.03 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 110.033 -0.358 . . . . 131.71 110.033 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.91 57.8 1.04 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.164 -0.68 . . . . 256.75 109.164 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.96 -100.05 0.13 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.544 -0.753 . . . . 10.26 111.338 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -131.43 -142.32 4.99 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.485 -0.646 . . . . 8.86 111.485 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 47' ' ' TRP . 86.6 m -79.98 165.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 8.71 110.601 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.751 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 15.6 m95 -151.79 153.16 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 7.86 111.748 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.42 117.69 33.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.274 -1.009 . . . . 6.12 108.274 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 80' ' ' LEU . 15.4 m -118.03 133.69 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 6.2 110.662 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.42 117.04 33.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 43.74 110.182 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.2 -39.59 0.18 Allowed 'General case' 0 C--N 1.333 -0.111 0 O-C-N 123.553 0.533 . . . . 42.52 110.674 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HE ' ' CA ' ' A' ' 57' ' ' GLY . 25.5 mtm180 -116.85 153.32 49.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 698.05 110.866 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 48.1 Cg_endo -71.06 168.02 24.43 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.103 2.535 . . . . 26.34 111.108 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 2.0 m-20 79.8 -4.29 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.872 0.732 . . . . 216.76 110.885 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 12.0 m-85 84.61 51.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.493 0.495 . . . . 25.54 110.749 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.33 22.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.326 -0.397 . . . . 61.34 110.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' CA ' ' HE ' ' A' ' 52' ' ' ARG . . . 89.61 -158.44 27.4 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.132 -0.787 . . . . 118.16 111.132 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -66.94 138.07 57.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 436.64 110.299 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.565 ' O ' ' HB2' ' A' ' 149' ' ' GLN . 62.6 mtt -104.08 109.16 20.84 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.974 -0.557 . . . . 614.82 109.818 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.532 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 13.2 t80 -115.15 133.07 56.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.587 -0.523 . . . . 999.99 109.587 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -102.26 95.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 11.1 109.811 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD13 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -77.56 109.96 11.2 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.241 -0.436 . . . . 6.8 110.096 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 90.5 Cg_endo -81.98 165.83 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.098 2.532 . . . . 9.35 112.407 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.26 112.38 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.182 -0.463 . . . . 16.37 110.119 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.59 175.74 41.54 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.327 -1.109 . . . . 9.23 110.327 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.614 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.4 mt-10 -100.15 157.75 16.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.096 0.474 . . . . 11.75 110.747 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.614 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.4 m-85 -149.93 80.4 7.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.344 -0.843 . . . . 12.89 108.955 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 48.2 Cg_exo -48.79 -22.33 4.53 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.008 2.472 . . . . 28.55 113.284 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.35 163.4 35.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.388 -0.597 . . . . 36.83 109.388 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 26.5 p90 -61.63 -45.2 95.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 22.71 110.74 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG2' ' CE2' ' A' ' 70' ' ' TYR . 7.4 mt-30 -46.0 -13.43 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.217 0.451 . . . . 319.03 112.217 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -75.36 -3.51 34.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.59 -0.277 . . . . 516.27 111.566 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -118.35 26.33 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.404 -0.221 . . . . 7.41 110.404 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.546 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.8 mmt 85.0 23.74 0.09 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.936 0.773 . . . . 49.56 110.955 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.35 50.1 0.25 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.916 -0.473 . . . . 12.4 111.916 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.634 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 16.8 mt -79.89 18.31 0.83 Allowed 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.968 -0.136 . . . . 54.39 110.917 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.634 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 66.3 t30 106.96 159.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.456 1.097 . . . . 154.95 110.155 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -91.72 57.35 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.666 0.604 . . . . 144.44 110.637 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.16 108.84 9.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.811 -0.631 . . . . 657.17 110.276 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -141.03 126.81 19.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.238 -0.585 . . . . 5.23 110.018 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -101.2 -162.54 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.742 -0.663 . . . . 5.2 109.431 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 12.8 p -50.27 -168.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.403 0.621 . . . . 140.35 111.262 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.751 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 28.1 p -154.79 161.79 41.36 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.407 -0.517 . . . . 8.04 110.071 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -122.94 131.84 53.9 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.498 -0.556 . . . . 332.31 109.498 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 123.6 18.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 9.1 110.43 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 48' ' ' ALA . 48.2 t -121.87 129.92 75.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.401 -0.363 . . . . 16.84 110.991 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -101.4 157.62 16.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.935 -0.575 . . . . 126.92 110.265 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.61 150.48 63.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 176.97 110.651 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.14 156.23 55.8 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 123.007 2.471 . . . . 11.34 112.284 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.8 p -170.85 -15.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 193.91 111.592 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.69 93.89 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.99 -0.624 . . . . 192.01 111.552 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -122.49 54.46 0.7 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.949 -0.86 . . . . 176.66 110.949 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 92' ' ' GLY . 3.7 pt20 34.43 -102.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.621 0.248 . . . . 44.38 110.664 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.703 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.8 t80 -162.49 114.39 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.797 -0.446 . . . . 11.73 109.797 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' CE ' ' HB2' ' A' ' 110' ' ' GLU . 21.0 tptm -154.83 132.17 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 179.04 110.828 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -133.7 143.1 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 4.92 111.444 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -120.43 131.15 54.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.043 -0.98 . . . . 81.94 109.255 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 108' ' ' MET . 6.7 mt -120.82 134.13 65.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 116.252 -0.431 . . . . 4.03 110.677 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.2 m-85 -115.16 132.66 56.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 7.67 110.976 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.2 -26.7 68.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.637 . . . . 27.19 110.653 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -122.09 144.77 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 146.97 110.584 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -61.44 174.4 6.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.753 -0.939 . . . . 60.39 110.753 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.85 33.6 23.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 414.82 110.536 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 11.7 m-85 53.46 78.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.841 -0.618 . . . . 19.09 110.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -156.39 163.09 39.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 19.13 110.699 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.67 -154.91 27.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.436 -0.665 . . . . 44.38 111.436 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -72.57 132.82 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 35.47 110.906 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 47.8 ttp -116.7 128.37 55.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.82 -0.627 . . . . 161.99 110.492 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 39.1 m-85 -119.25 135.63 54.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 16.12 110.769 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' HB2' ' CE ' ' A' ' 95' ' ' LYS . 8.3 pt-20 -121.55 123.31 41.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.397 -0.82 . . . . 48.3 110.89 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 111' ' ' THR . 11.8 t -148.11 125.83 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.138 -0.483 . . . . 13.7 110.976 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.4 OUTLIER -93.22 38.77 1.04 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.534 0.683 . . . . 113.42 110.719 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.78 -176.47 4.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.597 -0.729 . . . . 67.29 110.352 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -88.1 160.29 17.86 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.891 0.377 . . . . 16.91 110.221 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.59 ' SG ' ' HG2' ' A' ' 121' ' ' GLN . 6.6 t -140.87 122.57 9.29 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.921 -0.582 . . . . 162.84 110.504 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 172' ' ' SER . 56.1 Cg_endo -75.59 -56.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.785 2.324 . . . . 12.34 111.609 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -115.28 109.72 18.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.858 -0.61 . . . . 13.14 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.2 tt -69.37 -40.94 80.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.247 0.546 . . . . 6.62 110.025 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.4 ttt -67.79 -31.9 72.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 78.86 110.855 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.09 -47.2 71.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.207 -0.451 . . . . 342.48 112.155 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.59 ' HG2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -100.87 -29.68 12.1 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.992 0.738 . . . . 251.73 112.992 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 109' ' ' TYR . 17.4 m-85 -104.02 -1.74 27.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.565 -0.454 . . . . 7.65 110.948 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.5 m-70 55.25 7.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 14.8 111.737 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.537 ' SD ' ' CG2' ' A' ' 98' ' ' ILE . 41.7 mtt -77.16 132.88 39.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.988 0.423 . . . . 85.03 110.156 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -102.96 -31.63 10.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.618 -0.719 . . . . 337.58 110.242 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.476 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 57.4 mt-10 -148.67 110.05 4.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 84.76 110.372 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 11.6 mm -74.24 122.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.595 -0.52 . . . . 4.4 109.595 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.6 m80 -103.17 -32.07 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 7.83 110.77 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.476 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 44.3 t -148.18 142.89 26.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.341 -0.39 . . . . 136.38 110.831 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.26 127.21 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 18.11 110.049 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -109.03 -176.79 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.577 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.638 ' C ' HD22 ' A' ' 133' ' ' LEU . 61.8 t 56.86 98.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.0 -0.545 . . . . 239.63 110.742 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.72 161.17 16.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.788 -0.642 . . . . 238.81 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -138.63 111.03 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 385.49 110.169 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.01 -91.88 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.005 -0.838 . . . . 11.62 111.005 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 134' ' ' GLU . 42.8 t -122.83 141.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 110.065 -0.346 . . . . 8.41 110.065 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.703 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 26.6 t-105 -124.51 169.55 11.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 5.14 110.66 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HG12 ' A' ' 176' ' ' ILE . 59.7 mt -145.24 122.21 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.694 -0.684 . . . . 4.68 111.05 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.4 133.91 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.702 -0.481 . . . . 4.24 109.702 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 149' ' ' GLN . 25.0 m-85 -111.08 112.14 23.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 7.07 110.763 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -52.97 -25.27 11.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.159 -0.473 . . . . 28.99 110.277 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.01 160.61 31.68 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.53 . . . . 18.0 109.99 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HG3' ' A' ' 171' ' ' GLN . 58.9 Cg_endo -76.79 169.3 21.98 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.707 2.271 . . . . 11.59 111.552 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.407 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 9.5 m120 70.9 19.45 5.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 119.59 111.104 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 174' ' ' ARG . 3.7 m-85 70.92 33.25 2.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.654 -0.248 . . . . 18.4 111.165 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 140' ' ' TYR . 45.4 mtm180 -121.53 174.0 7.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 999.99 110.846 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.92 175.36 42.59 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.895 -0.882 . . . . 20.69 110.895 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -49.03 136.39 14.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 949.07 110.051 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' A' ' 59' ' ' MET . 70.0 mt-30 -99.53 122.1 42.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 397.97 109.809 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 71.1 m-85 -98.34 129.99 45.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 40.01 109.925 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -149.41 96.86 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 291.8 109.641 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 162' ' ' ASP . 29.2 tp -121.71 140.72 51.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 999.99 110.057 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -83.44 109.82 17.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 999.99 110.568 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -167.44 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 999.99 110.263 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -126.05 0.75 7.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 999.99 111.373 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 177.97 159.3 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.771 -0.372 . . . . 235.22 110.96 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.554 ' HE2' HD11 ' A' ' 133' ' ' LEU . 16.0 m-85 -128.54 112.17 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.05 -0.523 . . . . 31.64 110.274 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' HG2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -104.75 -20.52 13.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 708.49 110.768 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 1.5 pttm -124.77 159.76 56.95 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.107 0.479 . . . . 310.53 110.773 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -62.59 -19.84 69.06 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.841 2.361 . . . . 12.19 112.775 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.3 mp -96.25 -6.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.908 0.385 . . . . 26.61 110.443 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.48 ' O ' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -56.77 -30.32 63.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 33.18 110.975 -178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -103.56 23.95 11.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.081 0.467 . . . . 9.22 109.929 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.4 28.73 73.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.851 -0.613 . . . . 11.66 112.904 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.46 137.74 41.87 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.709 0.754 . . . . 10.16 110.082 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.17 18.73 0.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 15.02 110.647 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 169.39 154.17 0.16 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.695 0.283 . . . . 17.04 111.171 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 55.6 Cg_endo -74.8 2.98 5.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.172 2.582 . . . . 20.88 112.037 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.26 75.02 5.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 15.0 110.524 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.863 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -102.74 -147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.894 -0.78 . . . . 80.6 108.894 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.863 ' H ' HG12 ' A' ' 170' ' ' VAL . 15.7 mm-40 -156.67 -133.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.014 -0.365 . . . . 126.0 110.014 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -91.95 -153.02 0.32 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.411 0.148 . . . . 152.78 111.256 -177.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -169.59 -176.14 2.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.064 0.459 . . . . 6.31 110.806 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.55 HH21 HG23 ' A' ' 177' ' ' VAL . 10.2 ptm180 -160.48 130.88 5.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.599 . . . . 13.69 110.353 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.5 ptt180 -53.01 131.52 36.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 467.95 110.879 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 138' ' ' ILE . 30.9 mt -62.5 134.68 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.446 -0.797 . . . . 15.16 109.893 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.55 HG23 HH21 ' A' ' 174' ' ' ARG . 0.1 OUTLIER -135.58 153.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.824 -0.625 . . . . 132.74 110.601 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.026 -0.988 . . . . 408.25 110.757 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -88.02 172.34 9.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.733 0.301 . . . . 0.0 110.595 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -129.91 41.79 3.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.6 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -142.58 -59.88 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.541 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.65 117.68 5.87 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.8 p -83.0 158.61 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.782 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.4 tttt -160.05 151.1 19.23 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.053 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.8 142.14 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.991 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -124.72 138.71 54.27 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 116.16 25.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.83 138.24 34.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.271 0.558 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.416 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 6.7 tm-20 -60.88 -49.94 75.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.01 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 99.7 m-20 -97.82 -176.94 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 110.141 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -82.08 -176.63 6.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 46.41 24.26 0.28 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.029 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' H ' ' CB ' ' A' ' 39' ' ' SER . 3.3 m-85 63.76 41.64 6.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -108.5 179.15 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 110.451 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.38 -159.06 48.15 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -53.39 175.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.05 150.68 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.4 t80 -127.94 131.34 49.33 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -119.8 124.0 45.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.864 0.364 . . . . 0.0 111.151 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.27 142.59 23.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.316 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -125.39 24.39 7.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASP . 10.6 m -146.22 141.71 27.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 25' ' ' CYS . 55.1 p-10 -36.27 156.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.5 m -156.48 162.71 39.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.354 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -55.96 3.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.05 0.452 . . . . 0.0 110.538 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -153.03 111.35 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.2 p90 -101.29 10.56 40.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.963 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.4 t60 -60.85 -26.07 67.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 109.962 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.7 p -63.2 -30.55 71.68 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.229 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.61 -12.41 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.532 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -144.29 138.33 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 109.986 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 m -99.28 -9.22 23.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.652 0.263 . . . . 0.0 111.464 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 53.2 ttm-85 -156.48 144.89 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' C ' HD21 ' A' ' 38' ' ' ASN . 3.0 m -110.11 103.89 12.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.728 ' O ' ' O ' ' A' ' 39' ' ' SER . 5.7 m120 -128.7 156.42 43.52 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.728 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.5 p 34.95 129.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.438 1.114 . . . . 0.0 112.399 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -141.76 145.51 24.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.034 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -153.35 102.9 2.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -66.5 148.96 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.52 0.676 . . . . 0.0 110.568 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -122.21 51.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.732 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.548 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.17 -94.64 0.1 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.927 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -139.31 -140.16 3.9 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 47' ' ' TRP . 94.9 m -80.56 166.41 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.366 -0.491 . . . . 0.0 110.824 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.782 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.6 m95 -153.78 156.71 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.336 0.589 . . . . 0.0 110.746 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.99 120.36 38.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.83 132.8 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.017 0.437 . . . . 0.0 110.931 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' GLU . 87.8 m-85 -104.45 111.13 23.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.671 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 68.8 tt0 -35.74 -35.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.294 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 56' ' ' ALA . 10.3 mtm180 -116.18 148.12 40.86 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.043 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 47.8 Cg_endo -68.59 158.61 57.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.459 2.106 . . . . 0.0 111.719 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 3.8 m120 85.7 -4.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.841 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 10.9 m-85 85.64 62.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.172 0.51 . . . . 0.0 111.1 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' CB ' HH21 ' A' ' 52' ' ' ARG . . . -145.32 168.3 20.79 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.46 -157.11 28.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 21.1 m-85 -70.8 141.71 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.097 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 61.9 mtt -106.86 87.55 2.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.549 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' CE2' ' OE1' ' A' ' 149' ' ' GLN . 33.4 t80 -92.56 136.17 33.45 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.36 91.29 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.874 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.7 110.38 5.84 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.422 0.451 . . . . 0.0 110.074 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.78 162.14 18.75 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.269 1.979 . . . . 0.0 112.539 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.19 118.17 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.167 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.47 179.36 41.27 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.539 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.5 mt-10 -101.98 152.55 20.81 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.959 0.409 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 21.8 m-85 -145.75 85.23 7.84 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.5 -18.13 24.35 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.142 2.561 . . . . 0.0 113.137 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.7 mt-10 -150.63 161.73 42.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -63.11 -51.2 67.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.401 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 66.3 mt-30 -43.28 -10.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.1 mmm180 -75.08 -6.5 49.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.724 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -118.02 27.29 9.09 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.853 -0.158 . . . . 0.0 110.646 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.9 mmt 83.56 24.73 0.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.175 0.922 . . . . 0.0 111.102 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.12 50.39 0.48 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.7 mt -74.45 14.21 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.7 t30 110.21 167.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.538 1.149 . . . . 0.0 109.349 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 54.6 p30 -99.27 60.56 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.034 0.445 . . . . 0.0 110.383 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -137.89 115.72 11.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.057 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.74 128.6 21.82 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -111.81 -162.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 24.3 p -45.25 -179.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.129 0.49 . . . . 0.0 110.504 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.54 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -151.09 153.33 34.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -118.69 128.56 54.62 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.71 126.47 27.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.149 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.2 t -126.54 132.6 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.79 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -99.29 161.88 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.85 148.86 82.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.525 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.78 153.26 73.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.293 1.996 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -173.27 -13.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.249 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.71 95.5 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -130.33 53.03 0.81 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.3 pt20 35.46 -107.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.723 0.297 . . . . 0.0 110.628 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 20.5 t80 -155.78 112.4 3.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -149.58 127.91 12.17 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.385 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.2 tt -130.27 136.52 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 53.2 mt-30 -120.04 126.04 49.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 107' ' ' GLN . 5.8 mt -118.37 132.81 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.72 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.691 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 46.3 m-85 -117.5 127.75 54.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.05 0.453 . . . . 0.0 111.523 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.52 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 73.6 tt0 -60.27 -28.02 67.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.859 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 103' ' ' ASP . 51.3 mttm -107.95 141.54 39.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.448 0.642 . . . . 0.0 110.778 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -69.67 37.02 0.37 Allowed Glycine 0 C--N 1.315 -0.597 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.018 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 101' ' ' LYS . 5.6 p-10 -154.27 35.7 0.42 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.479 ' HA ' ' CG ' ' A' ' 99' ' ' PHE . 28.6 m-85 56.31 56.26 5.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.32 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 3.8 m -161.13 170.68 19.92 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.747 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.63 -43.45 2.89 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.835 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 11.7 tp-100 -156.86 119.12 3.91 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.517 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 29.4 ttp -116.6 109.15 16.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.232 0.924 . . . . 0.0 110.159 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.607 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 16.8 m-85 -115.54 133.47 56.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -122.9 122.84 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 111' ' ' THR . 5.8 t -152.17 126.24 9.16 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.383 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 t -94.09 44.08 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 111.002 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -141.79 179.52 6.8 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -83.45 155.43 23.42 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.717 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.632 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -131.37 120.71 18.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.939 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.58 -55.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.861 1.707 . . . . 0.0 110.727 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.1 m -118.02 114.36 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -69.31 -43.31 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.5 ttt -67.25 -19.48 65.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.729 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.08 -46.61 41.87 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 4.8 pt20 -99.85 -24.72 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.609 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 28.5 m-85 -114.68 2.48 14.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.6 0.238 . . . . 0.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 50.6 14.02 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.268 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.415 ' N ' ' C ' ' A' ' 122' ' ' PHE . 13.6 mtp -80.24 135.89 36.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -109.32 -25.99 10.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 67.6 mt-10 -150.81 107.06 3.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.014 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 118' ' ' ILE . 8.4 mm -74.58 123.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.681 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 66.1 m80 -105.4 -31.08 9.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.906 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 14.7 m -150.49 145.79 26.22 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.623 ' SG ' HG12 ' A' ' 132' ' ' VAL . 6.5 t -150.56 124.88 9.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.19 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -94.39 53.0 1.63 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.623 HG12 ' SG ' ' A' ' 130' ' ' CYS . 7.5 p -95.92 125.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -147.11 94.95 2.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.325 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 136' ' ' VAL . 14.3 mp0 -144.58 109.78 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.115 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.08 -85.94 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.603 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.7 t -127.12 156.85 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.723 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.4 t-105 -144.82 166.2 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.578 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.3 mt -144.61 123.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.713 0.292 . . . . 0.0 111.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.616 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -108.2 129.07 55.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 23.8 m-85 -108.51 110.8 22.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.34 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.528 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 82.2 tt0 -49.85 -23.27 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.77 160.3 37.21 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.331 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.426 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.4 Cg_endo -78.55 165.25 25.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.387 2.058 . . . . 0.0 111.943 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.1 m120 75.1 13.57 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.2 m-85 79.27 24.6 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -107.03 169.44 8.55 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.35 170.35 36.2 Favored Glycine 0 N--CA 1.463 0.45 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.3 ptt180 -61.75 143.27 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.209 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.479 ' OE1' ' CE2' ' A' ' 60' ' ' TYR . 36.3 mt-30 -97.97 146.79 25.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.536 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 48.0 m-85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.72 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.3 tt -149.14 100.81 3.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.204 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.02 132.46 26.85 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.901 0.382 . . . . 0.0 110.061 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 21.7 t0 -83.47 -143.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 1.7 ttpm? 67.49 103.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 154' ' ' LYS . 68.2 mttm 42.87 -166.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.552 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 2.5 pm0 -86.59 -138.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 15.1 m-85 -137.93 109.28 6.9 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.789 0.328 . . . . 0.0 110.291 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . 13.4 ptm180 -108.27 -21.62 12.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.546 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.44 ' H ' ' HG3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -121.19 156.2 57.6 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.398 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.8 Cg_endo -61.13 -19.0 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.736 2.291 . . . . 0.0 113.847 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -100.8 -1.59 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.355 0.598 . . . . 0.0 110.636 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.09 -29.42 70.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.843 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.571 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -105.0 22.91 14.45 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.79 27.55 70.58 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.871 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.8 138.05 45.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.013 0.906 . . . . 0.0 109.473 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.96 20.63 0.35 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.217 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER 175.42 154.64 0.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.837 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.22 3.14 6.49 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.274 2.649 . . . . 0.0 111.801 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.05 5.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.393 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -95.95 -150.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.9 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -157.18 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.786 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.8 -155.57 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.61 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 52.0 p90 -169.87 -177.07 2.52 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.082 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.93 131.8 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -54.15 129.91 36.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.021 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.557 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.5 mt -61.28 135.87 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.9 152.82 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.261 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.208 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 2.2 m 160.4 -100.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.53 175.67 0.08 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.723 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 74.98 161.87 0.25 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.444 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.68 -36.62 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p -81.47 156.63 25.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 110.695 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.77 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.7 tttt -161.25 153.66 20.27 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.277 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.43 142.78 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.714 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 m -126.72 139.96 52.75 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.082 0.468 . . . . 0.0 110.471 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.05 116.73 26.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.297 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.7 m-85 -95.76 138.36 33.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.606 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.46 -49.05 79.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.289 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 82.4 m-20 -100.76 -174.77 2.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.907 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' A' ' 39' ' ' SER . 2.8 mppt? -84.35 -174.96 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.656 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 46.21 22.92 0.17 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.88 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.4 m-85 59.17 44.93 15.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.305 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -115.27 161.91 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 110.374 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.36 -151.22 29.47 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.592 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -58.18 173.79 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.46 155.05 5.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -134.61 134.59 41.41 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 30.2 t0 -102.81 154.35 19.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.547 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.43 124.81 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.815 0.34 . . . . 0.0 110.139 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -124.82 11.17 8.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ASP . 8.0 t -150.65 148.25 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.5 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 52.9 p30 -37.54 154.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.79 160.69 40.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.03 -56.82 2.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.5 p-10 -152.98 113.74 4.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -103.41 8.31 38.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 53.4 t60 -59.61 -29.4 67.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.539 0.685 . . . . 0.0 110.024 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.2 p -60.15 -30.52 69.37 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.383 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -87.34 -13.97 42.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.521 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.0 tp -142.2 137.36 30.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 109.943 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -98.16 -9.42 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.268 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.0 ttm-85 -155.66 144.12 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.2 m -110.18 103.67 12.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 110.671 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.736 ' O ' ' O ' ' A' ' 39' ' ' SER . 5.4 m120 -128.91 155.16 45.72 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.736 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.9 p 36.11 129.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.558 1.17 . . . . 0.0 112.258 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.5 mt -141.55 146.13 23.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.857 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.307 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.5 ptpt -154.46 104.2 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.248 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.71 149.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.39 0.614 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -120.39 47.69 1.73 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.769 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -167.08 -94.84 0.1 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.022 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.536 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.94 -139.81 3.87 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.0 m -79.71 166.66 21.57 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.179 -0.601 . . . . 0.0 110.946 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.77 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -156.0 156.81 35.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.566 0.698 . . . . 0.0 111.039 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.39 119.31 36.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.798 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 5.5 m -117.88 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.232 0.539 . . . . 0.0 111.114 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 30.9 m-85 -93.77 175.31 6.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -100.99 -36.69 8.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -118.96 148.14 44.01 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 38.7 Cg_endo -64.16 157.29 54.43 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.006 1.804 . . . . 0.0 111.915 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.2 m120 84.24 -3.9 1.05 Allowed 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.005 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 16.6 m-85 85.76 62.87 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.616 0.572 . . . . 0.0 111.073 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.63 168.49 21.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.672 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.49 -159.56 33.6 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -65.19 155.5 34.79 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.2 mtp -130.7 140.13 50.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.177 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.475 ' C ' HD12 ' A' ' 61' ' ' ILE . 12.0 t80 -146.18 145.04 30.31 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.22 92.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.438 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -72.22 112.78 15.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.0 162.75 15.71 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.013 1.808 . . . . 0.0 112.456 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.08 115.68 1.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.057 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.11 177.4 41.62 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.8 mt-10 -100.75 153.04 19.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.346 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -144.94 89.41 6.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_endo -63.35 -13.92 38.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.239 1.959 . . . . 0.0 113.419 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 96.7 mt-10 -149.69 161.01 43.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.723 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 34.7 p90 -63.76 -53.69 47.08 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.986 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -43.77 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.9 mmm180 -75.18 -4.38 38.51 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.723 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.29 24.08 10.93 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.883 -0.144 . . . . 0.0 110.976 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 21.1 mmt 87.69 23.96 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.238 1.015 . . . . 0.0 111.064 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.72 50.27 0.42 Allowed Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.2 mt -74.34 13.36 0.59 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.013 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 13.2 t-20 109.81 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.94 1.4 . . . . 0.0 109.157 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -96.29 63.0 2.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.443 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' CA ' ' HE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.9 116.44 11.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.232 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.31 128.06 20.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.1 p -110.3 -162.92 0.82 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.041 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.7 m -45.47 -179.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.6 p -150.29 151.51 33.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.634 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.06 128.73 55.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.551 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 128.04 34.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.304 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.8 t -127.34 132.9 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.79 161.64 13.46 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.07 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -87.94 148.17 42.67 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.57 156.72 64.93 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.9 t -170.74 -17.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.16 -49.83 50.23 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.416 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -113.33 53.51 0.59 Allowed Glycine 0 N--CA 1.467 0.75 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.7 pt20 33.45 -106.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.72 0.295 . . . . 0.0 110.916 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.738 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 28.8 t80 -157.29 113.63 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -154.22 133.72 12.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 145.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.131 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 38.6 mt-30 -123.76 128.17 49.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.563 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.7 mt -118.44 131.93 69.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.16 130.01 56.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.628 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.27 -27.21 65.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.908 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -122.2 149.15 44.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.21 171.34 18.89 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 60.19 29.82 19.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 3.9 m-85 56.01 82.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -158.61 161.6 37.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 0.0 110.26 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.69 -150.95 23.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -74.6 138.87 43.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.5 tmm? -123.55 132.73 53.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.175 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.402 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.3 m-85 -124.11 136.37 54.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -123.96 125.67 44.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -151.27 128.56 11.26 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -93.48 44.45 1.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -144.52 -179.25 6.43 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.6 p30 -86.41 159.96 19.19 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.612 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 96.5 m -138.71 123.49 11.77 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.73 -55.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.04 1.827 . . . . 0.0 111.665 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 m -116.59 111.89 20.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -41.72 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.7 ttp -67.94 -16.59 64.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.438 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -83.38 -42.73 16.7 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.595 -0.691 . . . . 0.0 111.39 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 0.9 OUTLIER -93.85 -30.61 14.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.903 -177.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.734 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 26.1 m-85 -114.8 5.9 15.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.8 m-70 50.9 9.35 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.786 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -76.52 135.36 39.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.868 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -107.35 -27.56 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 49.5 mt-10 -151.03 107.57 3.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.35 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 12.4 mm -75.59 125.4 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 109.779 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.8 m80 -103.75 -31.13 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.283 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.0 p -155.77 151.78 27.69 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.8 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -150.56 131.26 14.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.123 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 51.9 mtmt -112.09 -173.2 2.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.446 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.9 t 55.57 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.679 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.72 167.78 10.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.053 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -139.21 111.38 7.43 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 40.26 -84.82 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.4 t -125.03 154.95 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.745 0.307 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.738 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.8 t-105 -142.12 167.46 22.06 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.594 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.3 mt -145.34 125.72 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.378 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -107.34 112.63 25.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -48.89 -23.15 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.968 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.8 mp -119.26 166.43 14.48 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.2 167.36 12.33 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.093 1.862 . . . . 0.0 111.902 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.3 m-20 78.81 15.27 1.14 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.078 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.0 m-85 74.02 27.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.635 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 99.5 mtt180 -132.67 126.03 31.67 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.94 174.69 22.87 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -56.08 114.19 1.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -80.93 141.0 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.05 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -112.69 129.93 56.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.18 101.49 3.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 153' ' ' ASP . 49.1 tp -130.43 152.76 49.47 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 152' ' ' LEU . 57.8 t0 -35.68 104.17 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.789 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 139.82 58.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.944 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -174.51 -56.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.432 . . . . 0.0 110.268 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -172.49 137.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -123.73 108.22 12.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.936 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -109.64 -22.02 12.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.271 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -119.53 156.1 53.7 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 121.005 0.431 . . . . 0.0 110.717 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.562 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -60.48 -16.19 40.66 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.746 2.298 . . . . 0.0 113.531 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -101.91 -2.22 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.114 0.483 . . . . 0.0 111.02 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -26.05 67.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.638 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.74 21.87 16.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.459 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.18 67.55 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.788 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.15 138.9 43.63 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.878 0.839 . . . . 0.0 109.994 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.3 22.28 0.23 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 167.08 155.89 0.11 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.229 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 170' ' ' VAL . 45.7 Cg_endo -70.74 -33.62 12.6 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.596 2.197 . . . . 0.0 111.523 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -47.25 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.31 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.892 HG22 ' H ' ' A' ' 171' ' ' GLN . 9.1 p -107.68 -145.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG22 ' A' ' 170' ' ' VAL . 69.3 mm-40 -152.9 -132.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.271 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -95.77 -153.29 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -170.69 -177.04 2.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.485 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.486 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -157.55 133.13 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.061 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.5 ptt-85 -52.43 133.66 35.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.384 0.612 . . . . 0.0 110.616 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 138' ' ' ILE . 18.6 mt -67.29 135.06 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.863 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.486 HG22 HH21 ' A' ' 174' ' ' ARG . 34.2 m -137.35 156.63 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.202 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 4' ' ' THR . 73.6 m -156.04 161.42 40.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt 63.61 -25.7 0.07 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.233 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 2' ' ' SER . 28.0 p 40.2 87.71 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.817 0.342 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.56 -153.03 7.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.486 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 2.7 p -83.16 156.77 23.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.829 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.5 tttt -159.99 151.06 19.29 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.948 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.59 141.31 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.887 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -124.32 138.22 54.4 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.144 0.497 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.6 115.95 25.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.3 m-85 -96.4 138.28 34.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.301 0.572 . . . . 0.0 111.152 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.4 tm-20 -60.98 -50.0 75.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.856 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.2 m-20 -97.87 -177.79 3.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.295 0.569 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -81.7 -177.07 6.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.123 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 46.67 25.36 0.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.876 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 39' ' ' SER . 1.7 m-85 63.4 40.17 8.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -107.07 175.11 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.21 -158.33 53.26 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.706 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -53.6 174.91 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -168.46 150.76 5.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -126.5 130.99 51.7 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.9 p-10 -119.36 119.96 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.94 142.69 23.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.176 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -125.81 26.32 6.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.7 m -146.75 141.35 26.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -38.01 157.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.713 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.1 t -159.17 166.57 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.586 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.81 -56.12 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.971 0.415 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -152.15 113.6 4.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.441 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -102.4 8.55 40.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.052 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -60.15 -25.68 65.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.485 0.659 . . . . 0.0 110.066 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.9 p -63.62 -30.37 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -87.02 -13.83 43.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.407 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.8 tp -143.51 137.66 28.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 110.068 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -98.74 -9.74 24.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 ttm-85 -155.66 144.08 20.21 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 7.5 p -110.25 104.39 13.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.771 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 59.2 m-20 -128.96 156.56 43.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.26 128.88 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.44 1.114 . . . . 0.0 112.529 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.7 mt -141.71 146.49 22.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.18 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -154.77 103.29 2.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.204 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.0 t -66.73 148.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.713 0.768 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -123.46 54.54 1.28 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.81 -97.34 0.11 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -133.41 -142.11 4.7 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.23 166.81 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.319 -0.518 . . . . 0.0 110.776 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.829 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -152.98 155.22 36.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.381 0.61 . . . . 0.0 110.783 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.01 120.24 39.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.302 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 80' ' ' LEU . 9.7 m -119.59 133.22 67.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.558 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -107.83 115.49 30.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.064 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 59.7 tt0 -37.97 -34.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -115.4 146.78 37.27 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.819 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 44.4 Cg_endo -68.18 160.4 48.98 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.422 2.082 . . . . 0.0 111.495 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.1 m-20 83.39 -3.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.29 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 7.6 m-85 85.66 60.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.08 0.466 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.05 171.52 14.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.51 -161.9 34.24 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 15.3 m-85 -68.77 138.01 54.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.411 ' CE ' ' HB1' ' A' ' 48' ' ' ALA . 3.9 tpt -102.45 124.27 47.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 39.5 t80 -131.5 136.87 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.49 92.24 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.55 110.48 7.05 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.6 163.33 16.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.966 1.777 . . . . 0.0 112.795 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.59 114.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.81 177.52 42.2 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 94.5 mt-10 -101.16 153.03 19.94 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.887 0.375 . . . . 0.0 110.396 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -145.71 90.57 5.89 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.08 -13.72 41.32 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.317 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 93.8 mt-10 -149.07 160.92 42.9 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.7 p90 -63.39 -53.21 56.06 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.322 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -44.62 -9.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.5 mmm180 -75.16 -4.78 40.76 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.834 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.68 24.86 10.8 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.907 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.5 mmt 87.47 23.0 0.05 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 111.085 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 33.13 52.47 0.52 Allowed Glycine 0 N--CA 1.469 0.865 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.1 mt -77.77 13.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.484 -0.294 . . . . 0.0 111.095 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 53.9 t30 109.79 167.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.612 1.195 . . . . 0.0 109.766 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 52.4 p30 -101.98 66.83 1.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLU . 5.5 tpt180 -143.63 77.28 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.585 0.231 . . . . 0.0 110.983 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -102.98 128.21 49.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.346 0.593 . . . . 0.0 109.605 -178.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.678 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -109.38 -163.18 0.85 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.609 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.3 t -44.83 -179.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.174 0.512 . . . . 0.0 110.994 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.536 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.24 155.42 37.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.585 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -121.28 129.89 53.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.96 126.71 28.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.394 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.8 t -123.14 130.19 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.09 162.28 13.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.954 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.897 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -86.51 146.82 42.67 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.688 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.27 159.37 53.52 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.427 2.085 . . . . 0.0 112.223 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.9 p -171.2 -18.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.009 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.68 60.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.531 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -113.03 51.49 0.7 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.3 pt20 33.96 -105.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.666 0.27 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.729 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 15.4 t80 -156.87 113.22 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.2 tptm -153.98 129.29 9.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 111.155 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -133.96 141.57 43.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 39.7 mt-30 -119.33 128.61 54.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 118' ' ' ILE . 12.5 mt -119.38 131.65 71.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.0 m-85 -111.21 131.22 55.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.98 -31.5 71.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -118.73 152.26 36.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.175 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.0 -169.66 2.22 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.0 t0 45.02 29.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 17.0 m-85 54.19 80.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 m -158.12 162.55 38.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.52 -149.24 19.7 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.58 138.93 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 110.449 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -120.5 127.85 52.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.526 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -119.44 136.63 54.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.204 0.526 . . . . 0.0 110.868 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.81 126.88 46.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.457 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -147.58 129.21 15.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.42 36.99 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.605 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.96 -177.31 5.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -85.1 158.91 20.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.193 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -132.38 123.79 18.82 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.227 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -78.52 -55.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.512 1.474 . . . . 0.0 110.784 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.2 m -119.11 114.44 22.47 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.13 -45.13 80.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.04 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.0 ttt -65.94 -20.54 66.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.255 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -74.2 -46.84 39.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.15 -24.36 14.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.7 m-85 -110.77 0.92 17.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.4 m-70 52.41 12.13 0.22 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.234 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 122' ' ' PHE . 34.7 mtt -78.97 134.16 36.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -106.22 -27.12 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.222 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.54 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -153.69 109.94 3.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.497 0.665 . . . . 0.0 111.251 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -75.85 125.33 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.748 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.3 m80 -106.79 -31.05 8.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.001 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 7.9 m -152.47 147.03 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.5 t -146.66 133.92 20.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.725 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -114.05 -178.18 3.31 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.618 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 21.5 t 56.46 103.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.99 163.44 15.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.7 mp0 -139.21 112.25 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.694 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.95 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 134' ' ' GLU . 41.8 t -126.6 135.88 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.729 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 t-105 -121.84 169.39 10.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 53.1 mt -145.53 124.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.465 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -110.74 133.73 53.08 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 149' ' ' GLN . 16.9 m-85 -109.73 111.71 23.32 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 123.531 0.519 . . . . 0.0 110.52 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -49.91 -23.38 1.92 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.975 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mp -113.86 166.4 11.46 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -86.47 166.09 9.21 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.216 1.944 . . . . 0.0 112.044 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.498 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.7 m120 69.14 21.26 7.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.454 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.7 m-85 72.19 66.95 0.13 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.703 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -154.63 170.68 20.93 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 122.041 -0.412 . . . . 0.0 110.592 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.38 167.04 29.97 Favored Glycine 0 N--CA 1.464 0.53 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.884 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 149' ' ' GLN . 20.6 ptt180 -68.02 77.57 0.23 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 5.1 pt20 -48.05 175.54 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.443 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -138.83 146.33 41.13 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.196 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' C ' HD22 ' A' ' 152' ' ' LEU . 2.4 tt -147.76 93.67 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.092 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 151' ' ' LEU . 4.3 mm? -112.24 150.77 30.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.825 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -128.84 56.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.654 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.503 ' CE ' ' OD1' ' A' ' 162' ' ' ASP . 36.5 ttpt -91.85 -91.89 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -172.06 94.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.072 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 56.8 tt0 63.61 163.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.075 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.39 107.73 10.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.404 ' O ' ' OG ' ' A' ' 129' ' ' SER . 33.7 ptt180 -107.23 -23.52 12.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.593 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpt -118.18 157.63 48.42 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-O 121.332 0.587 . . . . 0.0 111.044 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.4 Cg_endo -61.24 -19.29 63.14 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.044 1.829 . . . . 0.0 113.451 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -99.52 -0.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.532 . . . . 0.0 110.834 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.503 ' OD1' ' CE ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -62.79 -25.83 68.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.481 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -108.93 21.14 17.6 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-O 120.931 0.395 . . . . 0.0 110.07 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.4 70.46 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.834 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.42 137.63 42.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.524 1.162 . . . . 0.0 109.459 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -72.47 18.37 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.083 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 167.77 157.18 0.14 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.41 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.17 6.17 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.951 2.434 . . . . 0.0 111.617 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.99 69.42 5.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.551 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.0 t -97.04 -153.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.914 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -155.13 -130.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.432 0.457 . . . . 0.0 110.228 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 2.6 p -92.72 -155.73 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -169.75 -177.68 2.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.425 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -162.03 134.33 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.124 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.692 ' O ' HG23 ' A' ' 177' ' ' VAL . 15.0 ptt180 -50.83 133.09 26.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.792 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 136' ' ' VAL . 5.8 mt -59.7 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 175' ' ' ARG . 21.6 t -69.53 140.13 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.072 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.421 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.43 ' HG ' ' C ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -165.02 165.61 19.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.85 0.357 . . . . 0.0 110.51 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -137.89 -23.83 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.635 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 5' ' ' GLY . 15.4 t -88.7 -36.44 16.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.619 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' N ' HG23 ' A' ' 4' ' ' THR . . . 99.48 137.23 9.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.3 p -142.42 132.82 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.409 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.752 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.1 tttt -160.97 149.94 16.58 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.892 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.96 140.47 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.935 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 27.2 m -121.58 137.84 54.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.25 115.49 24.86 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.8 m-85 -95.26 140.0 30.78 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.17 -51.31 69.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.911 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.4 m-20 -98.59 -176.77 3.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 2.9 mppt? -82.04 -176.78 6.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 m120 45.59 26.53 0.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.124 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.7 OUTLIER 62.09 41.0 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -106.58 172.0 7.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.16 -157.57 53.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NH1' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -54.56 175.93 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' CD ' ' A' ' 19' ' ' ARG . 2.7 ppt_? -169.21 149.99 4.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -132.92 133.77 43.68 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.1 p-10 -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.664 0.268 . . . . 0.0 110.798 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.21 37.73 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -124.64 16.56 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' ASP . 7.7 t -148.54 143.4 26.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' CYS . 52.2 p-10 -37.18 158.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.207 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.3 t -157.6 164.17 37.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -96.35 -49.07 5.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -158.57 105.7 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.254 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 1.7 p90 -97.76 12.58 33.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -64.74 -15.59 61.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 110.214 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.1 p -78.6 2.04 20.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.308 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.3 m-85 -120.2 -13.42 8.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 36' ' ' ARG . 20.1 tp -144.76 140.31 28.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 t -100.7 -13.8 18.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' O ' HD21 ' A' ' 34' ' ' LEU . 55.6 ttm-85 -152.61 141.73 21.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' ' CA ' ' A' ' 79' ' ' ARG . 9.0 p -109.34 104.3 13.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.294 0.569 . . . . 0.0 110.981 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.719 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.4 m120 -128.77 156.45 43.54 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.719 ' O ' ' O ' ' A' ' 38' ' ' ASN . 9.2 p 36.18 129.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.509 1.147 . . . . 0.0 112.341 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.16 146.39 22.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.828 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.16 102.7 2.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.47 148.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.466 0.65 . . . . 0.0 110.906 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.4 50.74 1.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.38 -97.14 0.11 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.39 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.488 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.75 -141.17 4.23 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 47' ' ' TRP . 25.6 m -80.2 164.43 23.28 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.393 -0.475 . . . . 0.0 110.819 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.752 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 35.4 m95 -153.47 156.27 37.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -115.72 120.22 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.552 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -116.82 133.02 64.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.175 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 52' ' ' ARG . 82.5 m-85 -104.49 107.22 18.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.876 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' TYR . 44.7 tt0 -34.02 -32.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.441 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 67.9 mtt180 -127.9 151.27 75.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.154 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -58.65 163.59 10.7 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.222 1.948 . . . . 0.0 113.142 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 55' ' ' PHE . 3.1 m-20 57.04 66.94 1.06 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.073 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' A' ' 54' ' ' ASN . 1.4 m-85 22.54 66.27 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.437 0.46 . . . . 0.0 111.764 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.45 161.32 39.99 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.717 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.63 -164.27 43.1 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.542 ' CE2' ' NE ' ' A' ' 148' ' ' ARG . 18.0 m-85 -66.5 138.01 57.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.1 mtm -127.25 131.71 50.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.667 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -138.22 159.48 41.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.4 mp -104.87 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -72.62 110.84 9.1 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.48 162.92 16.98 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.09 1.86 . . . . 0.0 112.877 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.47 115.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.827 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.08 178.03 42.04 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.6 mt-10 -101.19 155.28 18.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 41.7 m-85 -149.04 85.2 6.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.33 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.02 -16.37 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.237 2.624 . . . . 0.0 113.228 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -148.7 161.44 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.7 p90 -65.67 -53.18 44.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 63.5 mt-30 -43.27 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -75.61 -6.38 50.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.291 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -116.1 25.86 10.37 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.513 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.0 mmt 85.1 26.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.376 1.048 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.27 52.46 0.41 Allowed Glycine 0 N--CA 1.468 0.778 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 28.3 mt -78.42 13.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.202 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.4 t30 113.16 168.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.681 1.238 . . . . 0.0 109.165 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -102.03 66.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.232 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' CA ' ' SG ' ' A' ' 37' ' ' CYS . 14.3 tpt180 -147.9 122.41 9.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.125 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -143.13 128.96 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.689 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.9 p -112.42 -161.29 0.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 2.2 t -44.76 177.79 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.55 ' N ' ' OG ' ' A' ' 82' ' ' SER . 13.8 p -152.18 153.6 34.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.563 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -119.45 129.44 54.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.19 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.53 119.95 9.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.971 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.568 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.5 t -103.82 121.94 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.82 148.55 22.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.038 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.4 146.55 70.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.51 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.47 151.8 70.77 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.299 2.0 . . . . 0.0 112.052 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.8 t -169.94 -18.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.998 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.79 87.4 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -137.76 56.16 0.67 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' GLY . 4.3 pt20 34.28 -101.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.8 0.334 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.719 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 13.9 t80 -158.15 114.08 2.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.406 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 17.9 tptm -154.7 128.57 8.76 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.357 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 tt -133.9 141.42 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.54 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.464 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 60.4 mt-30 -119.22 128.16 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 118' ' ' ILE . 9.3 mt -118.79 131.45 71.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.057 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.407 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 59.1 m-85 -111.14 130.68 55.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -60.84 -31.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.614 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -114.97 151.68 33.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.0 171.52 31.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 40.1 t0 59.52 32.9 21.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.556 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 9.2 m-85 54.3 80.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -158.07 163.66 37.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.64 -147.89 20.82 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.24 139.33 41.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 46.0 ttp -120.81 126.83 51.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.444 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.469 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 52.9 m-85 -117.87 135.87 53.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.93 125.41 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.422 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 6.0 t -152.27 127.97 10.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.71 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.16 39.81 1.08 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.41 178.51 7.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.7 p-10 -82.72 156.41 23.78 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -130.85 121.22 18.85 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.7 Cg_endo -78.24 -53.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.865 1.71 . . . . 0.0 110.593 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.0 m -120.43 113.48 20.4 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.58 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -69.24 -43.53 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.137 0.494 . . . . 0.0 111.162 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.7 ttt -68.09 -19.2 64.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.017 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -76.04 -45.61 33.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 6.9 pt20 -100.38 -26.18 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m-85 -111.93 1.11 16.31 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.738 0.304 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.6 m-70 52.11 15.3 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.455 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 36.5 mtt -81.97 134.44 35.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -106.91 -28.14 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.659 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.551 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 41.9 mt-10 -151.3 108.79 3.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.852 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -74.38 125.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.814 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -106.14 -29.98 9.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.218 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 4.8 m -151.52 146.26 25.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.1 t -153.57 128.82 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.928 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 53.1 mtmt -114.51 -179.44 3.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.854 0.359 . . . . 0.0 110.602 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.447 ' C ' HD22 ' A' ' 133' ' ' LEU . 5.5 t 60.79 64.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 133' ' ' LEU . 3.8 mm? -96.61 100.83 12.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.213 0.53 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 1.2 mp0 -67.0 121.14 14.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.44 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.48 -110.94 0.09 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 176' ' ' ILE . 11.3 t -98.77 142.35 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 110.14 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 32.7 t-105 -131.84 169.33 16.4 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.1 mt -144.94 123.04 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.729 0.3 . . . . 0.0 111.787 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.628 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -107.93 129.52 55.1 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 20.2 m-85 -109.02 111.46 23.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.26 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 142' ' ' LEU . 77.0 tt0 -48.41 -23.66 1.01 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -118.1 160.9 37.31 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 110.277 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.416 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.5 Cg_endo -77.89 167.94 22.96 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.115 1.876 . . . . 0.0 111.83 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.5 m-20 73.07 14.24 4.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.78 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.29 24.54 0.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.636 0.255 . . . . 0.0 111.348 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -108.04 168.96 8.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.26 173.03 38.69 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.542 ' NE ' ' CE2' ' A' ' 58' ' ' TYR . 81.4 mtt85 -52.5 163.87 0.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 11.7 mp0 -129.47 147.12 51.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.152 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -121.22 132.66 54.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.425 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.8 tt -145.16 101.58 3.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 27.0 mt -136.8 151.19 48.89 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 28.7 t0 -67.08 -143.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 71.1 tttt 74.33 -33.46 0.25 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.942 0.401 . . . . 0.0 110.565 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 153' ' ' ASP . 52.0 mtmt 53.53 18.81 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 157' ' ' TYR . 80.6 tt0 -148.61 135.97 20.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 22.4 m-85 -135.67 112.48 10.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.038 0.447 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.443 ' O ' ' OG ' ' A' ' 129' ' ' SER . 16.6 ptm180 -105.23 -28.29 11.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.719 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -117.59 154.74 50.82 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.539 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.0 Cg_endo -56.78 -18.64 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.38 2.054 . . . . 0.0 113.595 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -102.52 -2.35 9.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.88 -28.8 70.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -105.06 21.9 16.26 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.43 28.56 71.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.804 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.13 137.48 46.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 118.153 0.977 . . . . 0.0 109.051 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -74.22 17.41 0.19 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.29 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 172.13 156.33 0.24 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.983 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.19 5.91 4.25 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.045 2.497 . . . . 0.0 111.733 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.84 70.59 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 0.0 110.746 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.892 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.2 t -98.71 -147.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -160.14 -132.31 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.517 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.32 -155.31 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -177.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.613 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 26.9 p90 -170.05 -176.01 2.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.448 HH21 HG22 ' A' ' 177' ' ' VAL . 10.1 ptm180 -161.59 133.09 5.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.375 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -54.23 130.45 38.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.827 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 136' ' ' VAL . 12.6 mt -63.48 138.59 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.632 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.448 HG22 HH21 ' A' ' 174' ' ' ARG . 31.0 m -139.36 159.25 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.299 179.66 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 5.1 p 45.21 69.7 0.42 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.687 0.28 . . . . 0.0 110.529 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt 66.19 -57.25 0.36 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 3.9 t -97.75 -132.8 0.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.526 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . 177.88 -91.38 0.08 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.8 p -82.11 161.09 22.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.5 tttt -162.29 155.25 20.03 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.106 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.5 tt -149.05 144.38 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.127 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 21' ' ' TYR . 19.0 m -128.04 139.59 52.45 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.185 0.517 . . . . 0.0 110.508 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.36 117.66 28.33 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.989 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 62.9 m-85 -96.89 134.15 40.59 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 110.197 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' A' ' 34' ' ' LEU . 3.1 tm-20 -59.31 -44.83 92.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.439 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 90.6 m-20 -106.73 -173.45 2.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.972 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -83.64 -177.42 6.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 0.0 111.635 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 48.27 19.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.19 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 6.3 m-85 68.02 40.7 2.2 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.138 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 19' ' ' ARG . 10.6 pt20 -122.78 -168.03 1.68 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.972 0.415 . . . . 0.0 111.535 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.28 -24.25 0.46 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.481 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.2 ttm180 162.34 -174.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.294 0.637 . . . . 0.0 110.33 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.93 157.99 6.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 9' ' ' THR . 62.7 t80 -138.84 135.39 34.5 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 91.9 m-20 -100.75 150.44 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -164.05 122.97 1.93 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 178.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -125.38 12.7 8.17 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.614 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.2 m -149.3 145.64 27.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.782 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -38.82 156.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 82' ' ' SER . 2.2 m -157.04 163.26 39.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.279 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.42 -56.74 2.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.5 p-10 -153.56 106.76 2.95 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.463 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -96.34 8.84 42.96 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 65.8 t60 -58.46 -27.46 64.42 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.455 0.645 . . . . 0.0 110.003 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.4 p -62.55 -29.12 70.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' CE1' ' A' ' 21' ' ' TYR . 85.1 m-85 -88.44 -14.8 37.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.923 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 31' ' ' HIS . 13.8 tp -141.64 136.89 31.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 t -95.52 -6.54 40.27 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.9 ttm-85 -160.77 152.03 19.1 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 4.2 p -115.35 103.66 11.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.484 0.659 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.724 ' O ' ' O ' ' A' ' 39' ' ' SER . 80.3 m-20 -129.97 158.66 38.95 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.724 ' O ' ' O ' ' A' ' 38' ' ' ASN . 16.6 p 33.0 125.99 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.319 1.056 . . . . 0.0 112.734 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -139.54 144.68 28.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.355 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -152.21 102.52 2.78 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.939 -0.476 . . . . 0.0 110.211 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.51 150.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.667 0.746 . . . . 0.0 110.547 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -123.61 53.23 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.907 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.29 -93.25 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.582 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.93 -140.35 3.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 47' ' ' TRP . 85.6 m -81.72 166.86 19.72 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.426 -0.455 . . . . 0.0 110.786 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.3 m95 -155.07 156.3 35.63 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.451 0.643 . . . . 0.0 110.782 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.72 122.84 46.71 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.23 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.5 m -119.41 132.01 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 0.0 110.712 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -103.1 111.36 23.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 42.6 tt0 -37.57 -36.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.177 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.54 HH21 ' H ' ' A' ' 57' ' ' GLY . 73.3 mtm180 -116.16 137.25 23.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.66 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 16.8 Cg_exo -58.88 159.63 20.66 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.269 1.313 . . . . 0.0 112.351 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 m120 86.1 -3.01 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.011 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.1 m-85 84.0 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.433 0.458 . . . . 0.0 110.819 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.45 24.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.54 ' H ' HH21 ' A' ' 52' ' ' ARG . . . 87.55 -156.77 28.24 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 6.7 m-85 -71.14 144.0 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.856 0.36 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.2 mtt -111.42 88.21 2.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.599 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 30.6 t80 -92.43 136.5 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.753 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.7 mp -102.02 89.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -68.15 111.43 7.85 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.44 164.26 16.74 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.98 1.786 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -52.86 124.56 14.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.087 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.68 -175.56 40.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.2 mt-10 -107.33 152.89 23.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.217 0.532 . . . . 0.0 110.284 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.6 m-85 -145.6 84.78 8.17 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.3 Cg_exo -58.07 -17.06 29.73 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.984 2.456 . . . . 0.0 112.77 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.8 mt-10 -150.91 162.02 41.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.678 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.3 p90 -61.61 -49.46 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.522 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -42.34 -13.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.2 mmt180 -75.25 -5.19 43.31 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.132 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.678 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.02 26.76 9.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 121.522 -0.071 . . . . 0.0 111.16 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 mmt 88.76 17.72 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.481 1.113 . . . . 0.0 110.935 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 34.24 55.85 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.44 -70.29 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -157.18 158.9 37.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.6 p-10 -85.87 55.95 3.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.796 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 10.8 tpt180 -138.1 115.9 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.49 128.75 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.8 p -110.25 -161.85 0.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.179 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 7.0 t -45.45 -178.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.221 0.534 . . . . 0.0 110.708 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.61 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.4 p -150.01 150.3 31.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.723 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -115.97 126.65 54.13 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -60.61 127.71 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.327 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.3 t -124.53 131.34 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.935 0.398 . . . . 0.0 110.773 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.414 ' O ' HG21 ' A' ' 136' ' ' VAL . 99.4 m-70 -100.18 162.5 12.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.93 150.13 74.71 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.18 151.89 80.56 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.233 1.955 . . . . 0.0 112.124 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.9 t -157.24 172.46 18.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.431 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.23 -72.07 1.69 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.03 34.14 1.27 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.6 pt20 34.73 -109.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 t80 -154.29 113.03 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 47.0 tptt -154.59 136.0 14.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.127 0.489 . . . . 0.0 111.034 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.87 145.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.303 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.484 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 4.9 mm-40 -126.04 132.62 51.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.868 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.529 HD13 HD11 ' A' ' 118' ' ' ILE . 6.3 mt -120.89 132.34 70.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.894 -177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -112.17 126.84 55.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.988 0.423 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.77 -24.03 61.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -125.97 146.76 49.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.214 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -58.81 -168.55 0.2 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 4.5 p-10 42.58 29.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.401 ' CZ ' ' CD ' ' A' ' 156' ' ' GLU . 21.8 m-85 54.38 81.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -158.15 166.42 32.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.058 0.456 . . . . 0.0 110.528 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 -156.11 29.85 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.614 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -65.23 137.01 57.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.429 ' HG2' ' NE2' ' A' ' 97' ' ' GLN . 36.2 ttp -120.56 122.09 39.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.484 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 49.8 m-85 -118.13 133.23 56.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 120.07 35.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 111' ' ' THR . 7.4 t -146.92 127.84 14.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.52 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -95.68 40.96 1.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 111.142 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -141.11 178.38 7.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.526 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.482 ' CG ' HH12 ' A' ' 175' ' ' ARG . 24.6 p-10 -82.76 157.56 23.19 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.533 ' SG ' ' OG ' ' A' ' 172' ' ' SER . 49.7 t -134.4 122.34 15.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 172' ' ' SER . 63.9 Cg_endo -76.43 -57.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.488 1.459 . . . . 0.0 110.862 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.7 m -116.35 115.97 26.86 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.6 tt -70.2 -46.81 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 0.0 110.916 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.464 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.9 ttt -64.59 -20.8 66.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.293 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -72.98 -46.65 51.06 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.897 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.0 pt20 -102.43 -23.39 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.632 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.5 m-85 -111.96 -1.92 15.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.118 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 54.78 11.54 0.47 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.841 0.353 . . . . 0.0 111.018 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.2 mtt -79.77 132.69 36.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.19 -24.89 11.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.722 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 64.9 mt-10 -152.17 108.48 3.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.11 0.481 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 118' ' ' ILE . 8.0 mm -75.16 125.44 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.674 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 76.0 m80 -105.16 -33.81 8.14 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.326 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.1 p -155.38 151.09 27.47 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.656 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -144.77 157.13 44.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.818 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.3 mtpt -135.13 -178.98 5.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.48 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 t 54.7 80.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -98.92 165.89 11.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.5 mp0 -139.96 112.37 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.05 -88.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.1 t -120.01 155.07 22.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 109.998 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.4 t-105 -144.07 169.41 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.618 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 86.9 mt -144.84 123.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.633 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.84 129.69 55.61 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 22.5 m-85 -107.64 111.81 24.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.866 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' O ' HD12 ' A' ' 142' ' ' LEU . 73.8 tt0 -50.3 -22.29 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.1 mp -118.48 160.09 41.24 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.402 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.1 Cg_endo -77.35 166.4 26.18 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.37 2.047 . . . . 0.0 111.762 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.507 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.3 m120 74.13 15.3 3.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.507 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.0 m-85 76.39 25.53 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.608 0.242 . . . . 0.0 111.247 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -108.55 167.69 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.071 0.462 . . . . 0.0 110.582 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.42 168.61 34.24 Favored Glycine 0 N--CA 1.463 0.48 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -59.03 142.28 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 46.2 mt-30 -97.64 147.89 23.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -118.62 137.46 53.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -153.54 105.46 2.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.456 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -151.05 116.53 5.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.561 ' N ' HD13 ' A' ' 152' ' ' LEU . 91.2 m-20 54.33 164.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -137.95 8.65 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.9 -53.12 43.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.068 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.401 ' CD ' ' CZ ' ' A' ' 104' ' ' PHE . 16.0 tt0 -177.94 166.28 2.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.234 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -133.79 107.3 7.81 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.697 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -105.09 -24.47 12.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -122.53 152.45 61.56 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.57 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.8 Cg_exo -49.9 -35.52 40.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.191 1.928 . . . . 0.0 112.998 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.7 mp -86.66 -3.4 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.607 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -57.26 -29.89 64.2 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.07 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.57 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.1 p90 -105.23 21.27 17.42 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.43 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.18 61.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.574 -0.57 . . . . 0.0 114.24 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.23 137.09 45.95 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.459 1.13 . . . . 0.0 110.572 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.46 21.64 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.684 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 168.99 153.69 0.15 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.684 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.77 5.2 5.03 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.916 2.41 . . . . 0.0 112.044 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.51 71.36 6.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.896 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.912 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.5 t -99.55 -147.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.912 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.4 tp60 -159.31 -131.79 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.39 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.3 -156.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -170.21 -178.02 2.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.298 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.86 133.52 8.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.954 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.482 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.0 ptt-85 -51.91 130.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.68 131.66 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.252 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.24 134.68 60.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.438 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 30.9 tp10 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.513 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.0 p -75.21 166.09 24.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -74.9 -57.12 4.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.438 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 81.5 p -147.47 144.1 28.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.487 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.12 121.15 18.04 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.7 p -80.81 164.3 22.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 110.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.711 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 45.5 tttt -159.2 153.29 23.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.122 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -147.15 147.21 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 92.3 m -133.65 141.65 47.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.27 0.557 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -122.61 116.72 24.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.334 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 63.6 m-85 -95.89 137.02 35.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.267 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -45.08 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.3 m-20 -109.36 -173.35 2.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -82.8 -177.81 6.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.95 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 1.3 m-20 50.66 17.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.076 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.476 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 5.3 m-85 73.41 38.84 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.781 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 19' ' ' ARG . 55.3 mt-30 -117.62 -168.45 1.5 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.893 0.378 . . . . 0.0 110.472 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 75.52 -29.01 1.24 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.215 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 19.3 ttt85 158.13 -167.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.729 0.9 . . . . 0.0 109.718 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -170.25 151.38 3.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' THR . 78.0 t80 -129.88 135.0 47.86 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.2 p-10 -102.21 144.29 30.94 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.076 -0.39 . . . . 0.0 110.989 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -166.61 122.74 1.22 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.785 178.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -121.14 20.97 11.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.21 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.35 149.66 29.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -40.9 157.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.471 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.14 160.42 40.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.197 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.99 -55.53 3.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.1 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -155.43 100.62 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.219 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -86.8 9.12 20.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.414 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -59.74 -17.42 34.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.077 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -78.12 -1.15 31.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -117.15 -15.26 10.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 13.2 tp -143.1 139.96 30.67 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -98.28 -7.23 29.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.288 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.0 ttm-85 -159.42 148.27 18.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.9 m -114.52 103.15 10.75 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.718 ' O ' ' O ' ' A' ' 39' ' ' SER . 97.3 m-20 -129.21 156.54 43.78 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.718 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.7 p 35.89 125.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.909 0.861 . . . . 0.0 112.168 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.9 mt -138.5 144.11 30.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.088 0 CA-C-O 121.614 0.721 . . . . 0.0 111.806 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -153.48 99.19 2.31 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 8' ' ' ILE . 18.1 m -70.1 138.61 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.523 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -109.81 52.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.21 -99.33 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.165 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.68 -137.17 3.56 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 47' ' ' TRP . 41.3 m -77.23 164.83 25.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 110.884 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.711 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.6 m95 -155.73 157.31 36.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.295 0.569 . . . . 0.0 110.596 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -116.77 120.37 38.36 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.7 m -118.66 132.85 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.245 0.545 . . . . 0.0 111.052 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' ARG . 90.5 m-85 -108.07 112.91 25.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 50' ' ' TYR . 42.2 tt0 -35.75 -32.65 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.715 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -121.0 148.3 48.48 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.313 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.662 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 7.7 Cg_exo -67.16 160.19 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.875 1.717 . . . . 0.0 112.123 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 85.46 -4.8 0.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.887 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 6.2 m-85 84.6 58.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.427 0.455 . . . . 0.0 111.055 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.85 168.55 19.95 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.518 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 148' ' ' ARG . . . 85.04 -163.73 38.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -64.17 131.11 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.6 ' CE ' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -105.74 127.75 53.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.467 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 23.0 t80 -134.75 140.1 45.67 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.7 mp -102.09 92.4 2.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -68.94 111.15 7.5 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.7 163.92 16.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.025 1.817 . . . . 0.0 112.946 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.06 125.53 12.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.138 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.83 -172.51 38.88 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.0 mt-10 -111.65 155.34 23.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.207 0.527 . . . . 0.0 110.126 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.5 m-85 -147.99 81.09 8.45 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.32 -9.93 14.32 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.294 1.996 . . . . 0.0 112.862 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.3 mt-10 -149.95 161.18 42.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.749 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.0 p90 -64.98 -50.77 65.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.38 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.9 mt-30 -43.98 -10.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 70' ' ' TYR . 25.1 mmm180 -75.4 0.04 18.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.749 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -124.93 24.07 7.69 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 74' ' ' MET . 11.0 mmm 89.77 17.45 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.952 0.782 . . . . 0.0 111.947 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.72 63.09 0.19 Allowed Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.11 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 19.5 mt -93.69 17.61 11.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.959 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 52.3 t-20 111.99 150.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.206 1.566 . . . . 0.0 109.995 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 51.5 p-10 -83.58 69.93 10.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.23 118.9 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.097 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -147.5 132.18 17.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.144 0.497 . . . . 0.0 110.157 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.717 ' N ' HD13 ' A' ' 80' ' ' LEU . 8.9 p -107.68 -163.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.0 p -50.91 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.94 -0.475 . . . . 0.0 110.991 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 8' ' ' ILE . 14.7 p -153.51 155.5 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -117.79 128.18 54.61 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.66 131.58 50.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.78 130.84 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -101.39 162.49 12.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.772 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 88' ' ' LEU . 1.3 mt -87.03 149.17 47.0 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.654 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.48 155.13 71.54 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 112.083 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.427 ' H ' ' H ' ' A' ' 91' ' ' GLY . 3.2 p -170.05 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.988 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -74.16 -56.38 5.26 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -115.92 59.24 0.44 Allowed Glycine 0 N--CA 1.464 0.567 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 33.73 -109.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.727 0.299 . . . . 0.0 111.247 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 32.3 t80 -152.93 113.87 4.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -154.59 135.27 13.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.104 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 146.08 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.165 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 37.1 mt-30 -124.82 129.04 49.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.935 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 118' ' ' ILE . 6.5 mt -119.49 132.43 69.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.368 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 131' ' ' LYS . 39.3 m-85 -112.33 124.74 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.27 -19.9 38.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.778 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -131.09 144.09 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.869 0.366 . . . . 0.0 110.468 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.86 -171.08 0.23 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 2.8 p-10 45.25 29.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.72 0.295 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.537 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 14.3 m-85 54.89 81.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.878 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -158.98 163.61 36.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 110.806 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.57 -156.98 28.42 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -66.62 136.48 55.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 41.8 ttp -117.58 122.54 43.91 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.073 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.582 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.9 m-85 -114.97 129.99 56.83 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 110.991 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.99 121.43 37.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.068 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -151.88 130.99 12.67 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.469 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -97.85 50.79 1.04 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -147.8 -176.44 5.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -89.38 159.7 17.2 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.067 0.461 . . . . 0.0 110.202 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 172' ' ' SER . 45.7 t -137.48 124.81 13.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.754 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.509 ' O ' ' OG ' ' A' ' 172' ' ' SER . 59.4 Cg_endo -78.38 -61.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.662 1.575 . . . . 0.0 110.093 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -112.27 115.01 28.09 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -69.16 -45.28 79.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 28.0 ttt -63.78 -23.69 67.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.685 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.7 -50.27 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.483 -0.761 . . . . 0.0 112.245 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.634 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.3 pt20 -97.56 -23.82 15.83 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.634 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 29.5 m-85 -112.3 0.54 15.75 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.55 0.214 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.6 m-70 54.0 2.52 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.088 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.557 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -70.53 131.92 44.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -106.83 -25.93 11.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.569 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.9 mt-10 -150.87 109.32 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 8.1 mm -76.26 126.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.67 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.9 m80 -106.41 -36.85 6.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.258 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.537 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 10.0 t -148.63 143.73 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.9 t -144.78 140.12 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 99' ' ' PHE . 35.1 mtmm -124.27 -171.95 2.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 36.3 t 54.34 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.516 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -100.38 166.64 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.199 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -137.35 112.84 9.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 37.79 -89.83 0.01 OUTLIER Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.5 t -117.48 152.19 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.5 t-105 -141.2 166.77 23.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 176' ' ' ILE . 78.2 mt -144.02 124.06 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -111.74 129.47 56.11 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -106.34 113.4 26.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -53.83 -25.79 21.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.64 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.94 159.66 32.74 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-O 120.676 0.274 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 164.66 28.07 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.268 1.979 . . . . 0.0 111.383 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 4.8 m120 75.57 15.99 2.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.2 m-85 76.6 29.75 0.66 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.098 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -116.41 170.49 8.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.912 0.387 . . . . 0.0 110.733 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.31 167.83 38.59 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' NH2' ' O ' ' A' ' 57' ' ' GLY . 80.2 ttt180 -47.95 152.0 0.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -113.15 127.8 56.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.648 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.2 144.69 26.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.0 tt -163.95 105.21 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 151' ' ' LEU . 42.9 tp -126.71 134.56 50.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.843 0.354 . . . . 0.0 110.327 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.74 88.76 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 155' ' ' LYS . 14.0 tptp -124.8 -145.91 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 99.1 mttt -142.82 -9.1 0.81 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.481 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -175.26 162.36 2.94 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.676 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -129.11 109.31 11.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.109 0.481 . . . . 0.0 110.656 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.673 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.8 ptt180 -108.42 -21.37 12.77 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.0 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.673 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.3 pttm -123.87 154.54 67.48 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.286 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.502 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.9 Cg_endo -59.1 -19.97 51.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.386 2.057 . . . . 0.0 113.368 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.43 -5.98 9.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.923 0.392 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.74 -32.89 63.78 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.44 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.549 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.71 22.32 13.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.798 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 28.79 67.53 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.914 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.3 138.1 44.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.674 0.737 . . . . 0.0 110.124 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.85 24.3 0.23 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER 165.82 154.21 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.496 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 170' ' ' VAL . 56.1 Cg_endo -72.82 -12.01 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.904 2.403 . . . . 0.0 111.398 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.68 69.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.329 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.928 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -101.33 -155.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.928 ' H ' HG12 ' A' ' 170' ' ' VAL . 64.7 mm-40 -149.98 -130.95 0.05 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.4 p -95.28 -155.08 0.45 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -170.84 -178.75 2.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.282 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -156.1 129.95 8.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.479 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -52.65 129.21 28.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.587 0.708 . . . . 0.0 110.684 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -61.66 129.05 24.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.289 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.28 153.28 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.206 179.716 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -142.76 -74.3 0.28 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.913 0.387 . . . . 0.0 110.468 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 20.6 ptmt -84.78 50.93 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.4 p -138.3 -49.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.46 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.31 9.4 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.8 p -83.63 158.62 21.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 110.273 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.732 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -156.67 148.53 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.1 tt -144.58 140.67 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.608 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -126.73 138.02 53.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.63 115.75 25.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.6 m-85 -96.41 138.53 33.87 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 110.939 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.4 tm-20 -61.43 -49.81 75.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.903 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -98.18 -177.29 3.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -176.74 6.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.164 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 46.25 25.11 0.33 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.856 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.1 m-85 60.83 42.72 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.08 166.75 10.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.831 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.27 -153.73 43.45 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.709 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.694 ' NH2' ' H ' ' A' ' 35' ' ' SER . 15.8 ttp180 -58.75 174.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.03 153.91 5.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.408 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.0 t80 -127.05 130.67 50.39 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 44.8 p-10 -118.68 121.73 40.83 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.9 0.381 . . . . 0.0 111.701 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.9 t -150.21 141.57 23.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.095 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -124.46 26.27 7.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.0 m -148.55 144.75 27.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.502 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -38.54 156.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.846 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 25.0 t -156.76 163.05 39.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.145 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.87 -56.63 2.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.561 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.96 111.57 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -101.85 7.67 41.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 82.6 t60 -58.44 -27.18 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -62.63 -29.81 70.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.426 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.02 -15.36 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.574 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.632 HD12 ' HE ' ' A' ' 19' ' ' ARG . 16.5 tp -142.83 137.48 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.07 0.462 . . . . 0.0 110.067 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.694 ' H ' ' NH2' ' A' ' 19' ' ' ARG . 49.9 m -98.9 -9.23 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 56.0 ttm-85 -154.79 143.04 20.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.307 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 5.2 p -109.37 103.62 12.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.732 ' O ' ' O ' ' A' ' 39' ' ' SER . 62.8 m-20 -128.08 156.26 43.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.732 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.9 p 35.05 129.43 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.745 1.259 . . . . 0.0 112.519 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.2 mt -142.55 147.52 20.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.023 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -156.48 100.81 1.98 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.35 139.57 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.292 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -110.13 56.43 0.63 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.268 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.08 -92.84 0.09 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.702 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 -139.11 3.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 47' ' ' TRP . 43.0 m -80.48 164.9 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.732 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 34.0 m95 -152.94 154.12 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.105 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.18 118.76 35.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' HB ' HD21 ' A' ' 80' ' ' LEU . 4.7 m -118.46 132.86 67.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.555 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ARG . 88.2 m-85 -105.59 113.93 27.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 79.5 tt0 -30.01 -33.95 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.285 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' TYR . 21.1 mtt180 -127.15 162.67 46.66 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.279 0.362 . . . . 0.0 110.781 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 5.3 Cg_exo -73.9 170.63 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.533 2.155 . . . . 0.0 112.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.7 m120 79.26 -11.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.697 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.1 m-85 83.43 51.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.674 0.609 . . . . 0.0 110.43 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.84 114.94 5.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.614 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 133.08 113.23 1.41 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.572 ' O ' ' O ' ' A' ' 57' ' ' GLY . 28.2 m-85 41.52 -178.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.133 0.492 . . . . 0.0 110.69 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 3.7 mtm -154.28 113.15 3.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.504 ' C ' HD12 ' A' ' 61' ' ' ILE . 29.3 t80 -130.1 131.41 45.71 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.55 94.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -69.2 109.57 4.65 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 123.312 0.383 . . . . 0.0 110.048 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.23 160.83 17.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.15 1.9 . . . . 0.0 113.324 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.81 117.8 1.8 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.291 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.47 -179.29 41.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -106.09 155.82 19.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.085 0.469 . . . . 0.0 110.29 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.9 m-85 -146.7 84.53 7.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 32.0 Cg_exo -57.6 -16.87 25.95 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.174 2.583 . . . . 0.0 112.887 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 47.8 mt-10 -149.8 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.706 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.3 p90 -63.59 -51.88 63.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 19.6 mt-30 -43.54 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.1 mmm180 -75.86 -5.58 46.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.706 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.77 23.94 11.37 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.592 -0.067 . . . . 0.0 111.026 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 34.5 mmt 87.41 25.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.45 1.094 . . . . 0.0 110.97 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.11 50.69 0.36 Allowed Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.8 mt -77.45 14.24 1.03 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 118.982 -0.533 . . . . 0.0 111.438 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.9 t30 110.46 164.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.8 1.312 . . . . 0.0 109.252 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.0 p-10 -96.59 64.08 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 36.5 ttm180 -141.63 117.21 10.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.943 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.74 129.65 20.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.683 ' N ' HD13 ' A' ' 80' ' ' LEU . 53.2 p -112.22 -161.95 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.661 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.9 p -45.99 -178.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.212 0.53 . . . . 0.0 110.642 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 11.8 p -154.3 159.73 41.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.72 131.07 53.49 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.72 127.43 31.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 48' ' ' ALA . 68.9 t -126.43 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -101.29 157.41 16.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.0 157.18 69.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.522 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.46 156.04 40.89 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.661 2.241 . . . . 0.0 112.085 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 91' ' ' GLY . 4.7 p -173.14 -18.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -63.21 -34.11 89.07 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -130.58 58.14 0.71 Allowed Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.6 pt20 33.42 -107.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.73 0.3 . . . . 0.0 110.835 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.749 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.3 t80 -159.14 113.3 2.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.197 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 132' ' ' VAL . 16.7 tptm -152.37 133.75 14.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.3 tt -134.88 142.34 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.749 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 36.4 mt-30 -120.92 129.08 53.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 108' ' ' MET . 13.8 mt -119.13 130.92 73.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.181 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.0 m-85 -111.52 128.1 55.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.837 0.351 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 84.4 tt0 -60.78 -27.65 68.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.918 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -118.33 146.9 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.929 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.74 172.22 20.01 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.01 31.14 19.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.538 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 10.2 m-85 55.14 80.99 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.246 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -160.25 162.61 33.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 -153.01 23.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -70.04 136.16 50.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -121.33 125.51 47.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.4 m-85 -117.11 134.91 54.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.089 0.471 . . . . 0.0 110.657 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -122.16 119.7 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.488 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 111' ' ' THR . 4.5 t -147.0 125.66 12.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -91.06 41.89 1.08 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.019 0.438 . . . . 0.0 111.041 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.07 179.77 6.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 17.1 p-10 -83.95 160.13 21.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.963 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -134.55 121.31 15.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.194 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.13 -53.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.659 1.573 . . . . 0.0 110.873 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -119.71 111.54 18.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -44.33 87.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 0.0 110.875 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.8 ttt -66.99 -21.99 65.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -73.01 -48.33 37.28 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.662 -0.649 . . . . 0.0 112.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.2 pt20 -99.16 -24.86 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.631 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 40.2 m-85 -111.58 2.39 17.33 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.992 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.0 m-70 51.41 11.91 0.13 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.132 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.0 mmt -79.44 135.29 36.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.582 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -110.57 -26.85 9.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.087 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 52.1 mt-10 -150.5 107.11 3.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.033 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.6 mm -77.78 125.11 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.6 m80 -104.81 -30.12 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.135 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.538 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 18.6 t -156.54 152.01 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.441 . . . . 0.0 110.957 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -146.58 150.8 36.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.992 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.95 -172.01 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.681 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LYS . 61.5 t 47.49 77.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.381 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 157' ' ' TYR . 67.8 mt -101.28 172.29 7.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.183 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.8 mp0 -136.94 114.18 10.78 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.88 -91.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 134' ' ' GLU . 31.7 t -119.18 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -122.15 170.31 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.237 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 176' ' ' ILE . 62.5 mt -145.8 125.17 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.462 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.88 131.66 55.22 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.81 112.92 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.571 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' VAL . 75.7 tt0 -50.25 -27.24 5.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.723 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.39 166.15 11.57 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.35 164.95 11.03 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.022 1.815 . . . . 0.0 111.37 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.562 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 75.02 16.79 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.47 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.9 m-85 77.0 26.52 0.75 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.091 0.245 . . . . 0.0 111.278 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -107.57 166.32 10.76 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.927 0.394 . . . . 0.0 110.533 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 96.6 170.65 34.41 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -67.3 146.38 54.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 2.5 mp0 -94.23 148.33 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.456 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -112.61 131.21 55.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.953 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' O ' ' SD ' ' A' ' 59' ' ' MET . 58.1 tp -149.01 99.23 2.94 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.048 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 153' ' ' ASP . 0.5 OUTLIER -151.9 153.22 33.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.634 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.741 ' H ' HD23 ' A' ' 152' ' ' LEU . 8.1 t70 76.63 164.15 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.405 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.54 -77.81 0.05 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -161.85 67.77 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.208 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -172.79 132.96 0.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.158 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.415 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.9 m-85 -133.85 109.37 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.434 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -106.03 -26.13 11.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -120.14 153.82 55.62 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.5 Cg_endo -58.91 -15.19 25.92 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.478 2.119 . . . . 0.0 113.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -103.05 -3.98 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.037 0.446 . . . . 0.0 110.491 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -28.27 66.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.464 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -106.16 22.79 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.1 70.54 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.523 -0.599 . . . . 0.0 114.014 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.44 140.45 41.73 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.19 0.995 . . . . 0.0 109.723 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.46 21.23 0.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 170.49 154.33 0.19 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.388 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.548 ' O ' HG12 ' A' ' 170' ' ' VAL . 41.1 Cg_endo -68.51 -35.0 18.58 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.489 2.126 . . . . 0.0 111.596 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -51.25 83.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.814 HG22 ' N ' ' A' ' 171' ' ' GLN . 1.4 p -102.54 -97.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.465 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.814 ' N ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 161.89 -143.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.096 0.872 . . . . 0.0 109.345 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 3.7 p -90.95 -156.0 0.42 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -169.51 -177.96 2.93 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.31 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -159.97 132.27 6.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 2.8 ptm180 -51.95 136.09 29.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.519 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -68.81 135.68 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.825 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.14 158.77 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.484 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m 45.96 -166.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 110.349 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' THR . 5.5 mtpm? -108.64 -48.01 3.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 3' ' ' LYS . 80.9 p 50.04 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.984 0.421 . . . . 0.0 110.502 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.3 -40.55 2.57 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.4 p -138.59 127.93 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.737 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 38.9 tttt -162.05 152.44 17.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.519 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -145.66 144.69 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.552 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.8 m -131.61 140.47 49.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 110.387 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -121.07 116.21 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.478 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 68.0 m-85 -94.15 137.68 33.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -58.51 -48.21 81.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.5 m-20 -107.14 -172.81 2.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.158 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -178.95 7.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.88 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 50.55 21.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.502 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.7 m-85 68.41 39.45 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' ARG . 80.8 mt-30 -117.15 -167.45 1.31 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.04 0.447 . . . . 0.0 110.621 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 73.22 -26.74 0.83 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.058 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.3 ttm-85 158.87 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.457 0.74 . . . . 0.0 109.661 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -172.33 152.17 2.69 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.783 ' O ' HG23 ' A' ' 9' ' ' THR . 68.2 t80 -129.49 133.26 47.18 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.8 p-10 -118.0 125.43 50.36 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 t -161.32 139.0 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -126.49 30.72 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 26' ' ' ASP . 3.9 t -147.13 142.29 27.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.775 0.322 . . . . 0.0 110.573 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' CYS . 54.4 p-10 -38.79 157.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.4 m -158.05 163.73 37.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.001 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.63 2.93 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.64 105.19 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.09 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.443 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -94.0 10.63 32.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.969 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.2 t60 -57.35 -25.43 59.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.599 . . . . 0.0 109.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -31.54 72.78 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.505 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.9 -18.33 40.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 12.4 tp -141.0 135.68 31.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 110.411 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -93.85 -10.37 34.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.583 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 23.7 ttm180 -157.53 146.2 19.48 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.7 m -110.78 104.2 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.074 0.464 . . . . 0.0 111.088 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.75 ' O ' ' O ' ' A' ' 39' ' ' SER . 8.1 m120 -130.38 158.22 40.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.1 p 35.79 128.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.63 0 O-C-N 124.426 1.079 . . . . 0.0 111.825 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.8 mt -140.73 146.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-O 121.785 0.803 . . . . 0.0 112.08 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -156.18 99.73 1.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.447 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.67 141.41 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.311 0.577 . . . . 0.0 110.873 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -111.88 53.78 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.31 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.73 -93.9 0.1 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.29 -137.21 3.26 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.7 m -77.72 163.04 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.737 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 31.7 m95 -153.97 155.15 35.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HB1' ' HE1' ' A' ' 59' ' ' MET . . . -115.03 119.11 35.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.2 m -116.45 131.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.503 . . . . 0.0 110.85 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CZ ' ' CE ' ' A' ' 59' ' ' MET . 87.4 m-85 -103.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.702 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -37.53 -35.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.915 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -116.81 148.37 41.93 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.9 Cg_endo -67.94 162.61 39.04 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.755 2.303 . . . . 0.0 111.411 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 4.4 m-80 82.58 -5.11 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.287 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 15.4 m-85 85.59 57.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 176.67 9.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.24 -162.6 44.25 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -63.44 137.32 58.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.504 ' HE1' ' HB1' ' A' ' 48' ' ' ALA . 1.8 tpt -112.24 130.01 56.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.128 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 61' ' ' ILE . 21.0 t80 -136.15 139.73 43.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.701 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -103.04 91.77 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.36 111.28 8.21 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 123.219 0.325 . . . . 0.0 110.183 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.93 160.61 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.167 1.912 . . . . 0.0 113.089 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.46 122.4 4.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.037 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.07 -174.68 40.21 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.9 mt-10 -111.37 158.53 18.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.186 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 34.0 m-85 -151.81 85.7 4.73 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.934 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 33.9 Cg_exo -57.43 -14.67 16.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.787 2.324 . . . . 0.0 112.598 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.2 mt-10 -151.3 162.25 41.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 23.6 p90 -65.48 -53.12 47.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.5 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.624 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.5 pt20 -40.44 -14.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.102 0.477 . . . . 0.0 112.051 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -74.13 -2.31 24.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.276 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -119.85 23.65 10.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.3 mmt 90.37 24.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.445 1.091 . . . . 0.0 112.059 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.61 54.34 0.24 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.787 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 49.8 mt -87.01 12.8 10.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 49.0 t30 91.15 137.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.932 0.77 . . . . 0.0 110.004 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.7 p-10 -39.37 -96.08 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.658 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.645 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 8.5 tpp85 29.43 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.431 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -138.7 128.12 24.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.055 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.6 p -110.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.8 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.4 p -46.31 -178.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.506 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.9 p -152.05 155.81 38.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.459 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -118.82 128.1 54.15 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.84 128.4 36.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.539 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.29 129.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.87 159.24 15.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.825 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mt -78.5 148.95 74.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.531 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.03 153.22 75.6 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 p -157.0 171.77 19.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.516 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.41 -72.28 1.72 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -75.91 34.29 1.24 Allowed Glycine 0 C--O 1.225 -0.424 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.2 pt20 34.22 -109.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 42.1 t80 -155.37 113.44 3.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.195 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 2.9 tppm? -156.2 137.31 13.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.85 145.51 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.003 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 45.4 mt-30 -121.65 130.94 53.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.146 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.719 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.09 130.09 74.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.387 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 45.4 m-85 -110.92 129.83 55.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.751 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -62.58 -25.57 68.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -123.93 145.02 49.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.613 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.99 179.15 4.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 55.84 30.82 16.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 15.8 m-85 54.21 80.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.033 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.5 m -160.39 161.27 33.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.19 25.41 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -67.65 136.71 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.674 0.274 . . . . 0.0 110.778 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.0 ttp -121.63 128.21 51.68 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.622 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 43.4 m-85 -122.84 137.22 54.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.7 127.17 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.602 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' THR . 11.6 t -148.76 129.64 14.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.5 p -93.63 38.18 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.3 179.66 6.95 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -85.02 160.47 20.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 41.6 t -134.98 125.34 17.12 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' OG ' ' A' ' 172' ' ' SER . 64.7 Cg_endo -80.25 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.938 1.759 . . . . 0.0 111.287 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.6 m -116.5 110.15 18.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -68.49 -42.44 83.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.079 0.466 . . . . 0.0 111.003 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.7 ttt -67.43 -17.9 64.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.727 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -81.87 -42.54 19.44 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.462 -0.774 . . . . 0.0 111.723 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.652 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -94.24 -30.61 14.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.762 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.64 1.15 13.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.691 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 54.55 13.43 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.791 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.4 mmt -77.53 131.15 37.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -105.14 -29.14 10.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 74.1 mt-10 -151.11 109.08 3.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.187 0.518 . . . . 0.0 110.585 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.6 mm -74.6 125.71 34.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.821 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -106.87 -32.9 7.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.803 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.6 t -152.29 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 111.054 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.36 131.8 14.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.75 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -111.33 -169.04 1.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.234 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.492 ' C ' HD22 ' A' ' 133' ' ' LEU . 44.4 t 52.61 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.674 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.492 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -110.26 164.24 12.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 136' ' ' VAL . 5.9 mp0 -138.34 110.41 7.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.831 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.52 -86.33 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 134' ' ' GLU . 11.6 t -125.74 155.95 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.734 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.4 t-105 -142.67 170.58 15.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 73.5 mt -145.87 125.37 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.401 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -111.01 131.43 55.05 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.61 110.97 22.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.513 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 70.3 tt0 -49.9 -23.48 1.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.909 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.69 160.57 37.85 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.438 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 65.6 Cg_endo -77.79 168.01 22.99 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.54 2.16 . . . . 0.0 111.788 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.5 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 5.7 m120 70.08 17.61 7.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.5 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.7 m-85 76.23 24.55 1.11 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.653 0.263 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 96.0 mtm-85 -105.98 162.73 13.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 100.09 164.21 28.77 Favored Glycine 0 N--CA 1.461 0.365 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 18.7 ptt-85 -60.51 138.24 58.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.308 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.555 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 3.7 mp0 -88.12 150.97 23.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.366 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -117.94 134.92 54.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.347 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.2 tt -152.17 107.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.096 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 151' ' ' LEU . 50.1 tp -131.22 139.78 49.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.263 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -65.93 115.32 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -169.46 179.31 3.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.193 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -134.39 4.67 3.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.378 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.51 150.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.271 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.466 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.6 m-85 -125.89 106.74 9.87 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -105.56 -21.36 13.22 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -124.45 153.07 69.24 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.587 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 22.9 Cg_exo -52.89 -30.52 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.514 1.476 . . . . 0.0 113.523 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.4 mp -89.23 -4.72 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 111.033 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -57.04 -27.44 61.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.162 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.587 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -108.66 21.21 17.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.752 0.31 . . . . 0.0 110.451 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.53 60.64 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.645 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -111.42 136.03 51.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.817 0.809 . . . . 0.0 109.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.39 22.12 0.13 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 169.53 155.18 0.18 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.046 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 69.3 Cg_endo -77.39 4.2 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.651 2.234 . . . . 0.0 112.141 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.14 72.71 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.022 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.4 t -100.83 -147.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.922 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -159.91 -132.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.796 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 m -92.27 -155.01 0.4 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.6 -177.48 2.37 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.033 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.67 132.22 7.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.92 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -51.37 132.2 29.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.429 0.633 . . . . 0.0 110.956 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.1 mt -66.57 133.89 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -138.16 159.31 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.967 0.413 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.517 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 4' ' ' THR . 4.3 m 59.43 128.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 70.34 -30.16 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 2' ' ' SER . 22.5 p -110.35 113.66 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.931 0.396 . . . . 0.0 110.518 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 4' ' ' THR . . . 57.12 158.06 0.01 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 11.2 p -81.65 157.6 24.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.381 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.691 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.4 tttt -159.67 150.57 19.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.9 tt -144.88 141.61 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.362 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 m -127.49 139.02 53.07 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.83 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.72 115.7 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -96.28 138.73 33.45 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.079 0.466 . . . . 0.0 110.474 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -61.4 -51.09 70.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.851 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HA ' HD22 ' A' ' 38' ' ' ASN . 83.3 m-20 -97.29 -175.32 3.19 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.253 0.549 . . . . 0.0 110.219 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.97 -175.29 5.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.619 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 46.7 23.12 0.22 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.01 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.5 m-85 59.78 44.6 13.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.332 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -116.41 162.05 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.13 0.491 . . . . 0.0 110.495 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.95 -150.87 31.2 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.554 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 170.64 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.18 155.11 6.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.406 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.0 t80 -134.74 134.53 41.09 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 51.8 p-10 -102.08 151.73 21.82 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.524 0.202 . . . . 0.0 110.49 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.8 124.6 2.24 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.673 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.06 12.99 9.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 t -150.54 146.96 26.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.669 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -38.63 157.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.678 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 18.3 t -157.69 164.61 36.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.145 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.34 -56.96 2.75 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -153.3 110.95 3.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.33 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.0 p90 -100.55 8.47 43.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.067 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.1 t60 -59.35 -28.76 67.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.527 0.68 . . . . 0.0 110.168 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.0 p -60.69 -28.32 68.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.375 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -89.89 -12.97 37.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.539 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -143.33 138.24 29.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.975 0.417 . . . . 0.0 109.969 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.6 m -100.43 -9.49 22.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 34' ' ' LEU . 51.3 ttm-85 -153.74 141.11 19.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.469 . . . . 0.0 110.45 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.1 m -111.52 106.15 14.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.76 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' O ' ' C ' ' A' ' 39' ' ' SER . 41.1 m-20 -117.91 -155.68 0.61 Allowed 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' ASN . 12.7 p -19.59 138.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.741 0.65 . . . . 0.0 112.476 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 8.8 mt -142.69 147.19 21.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.963 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.63 101.14 1.98 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.921 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.08 142.17 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' SER . 94.8 mt-10 -111.22 52.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.47 0.1 OUTLIER Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.753 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.86 -140.07 3.91 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.8 m -77.9 165.18 24.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 110.859 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.691 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.0 m95 -154.87 155.76 34.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.956 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.75 121.52 41.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.533 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -117.14 132.53 66.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.516 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' GLU . 52.4 m-85 -103.59 110.8 22.99 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.317 0.386 . . . . 0.0 110.897 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' TYR . 80.1 tt0 -35.37 -37.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.137 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 52' ' ' ARG . 19.0 mtp180 -119.02 150.69 49.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.438 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 52.6 Cg_endo -68.12 161.49 44.19 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.684 2.256 . . . . 0.0 111.567 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.5 m120 83.64 -7.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.991 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.5 m-85 85.53 58.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.5 0.5 . . . . 0.0 111.254 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.25 179.76 7.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.135 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.07 -69.77 1.57 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.371 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.571 ' CE2' HD13 ' A' ' 76' ' ' LEU . 0.6 OUTLIER 169.2 121.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -110.93 136.99 49.12 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.331 0.586 . . . . 0.0 111.929 -178.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -116.43 159.62 21.74 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.23 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.85 91.19 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -71.56 110.33 7.36 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.95 161.01 21.03 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.099 1.866 . . . . 0.0 113.851 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -47.24 119.78 2.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.912 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.13 -176.26 41.49 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -109.15 157.74 18.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.835 0.35 . . . . 0.0 110.159 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 48.4 m-85 -147.81 91.99 4.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 41.3 Cg_endo -66.69 -11.38 31.66 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.234 1.956 . . . . 0.0 113.269 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.6 mt-10 -151.35 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 36.3 p90 -63.9 -53.05 56.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -44.98 -9.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.0 tpt180 -75.09 -3.98 35.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.1 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.73 24.07 10.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.7 mmt 86.84 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.438 1.086 . . . . 0.0 111.212 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.24 48.2 0.2 Allowed Glycine 0 N--CA 1.473 1.155 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.16 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 58' ' ' TYR . 18.3 mt -71.66 13.36 0.27 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 119.073 -0.489 . . . . 0.0 111.078 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.6 t30 107.63 164.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.779 1.299 . . . . 0.0 109.363 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -94.92 62.03 2.58 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.35 115.62 11.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.26 128.66 21.19 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.4 p -110.28 -163.5 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 3.4 t -45.42 -178.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.34 0.591 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.595 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 10.7 p -151.82 155.5 38.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.558 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -121.7 129.97 53.12 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.72 126.87 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.296 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.6 t -122.77 131.08 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.52 ' O ' HG21 ' A' ' 136' ' ' VAL . 38.0 m80 -100.13 157.75 16.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.768 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -84.27 153.37 62.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.03 157.84 46.44 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.517 2.144 . . . . 0.0 112.146 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.402 ' H ' ' H ' ' A' ' 91' ' ' GLY . 4.9 m -175.58 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.958 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -67.73 -49.19 51.15 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.639 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.498 ' H ' ' CD ' ' A' ' 134' ' ' GLU . . . -111.24 54.49 0.54 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLY . 6.5 pt20 33.67 -109.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.763 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 26.1 t80 -158.05 114.16 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 110.295 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -153.79 132.56 12.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -135.87 145.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 37.4 mt-30 -122.66 131.0 53.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.504 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 118' ' ' ILE . 11.8 mt -119.58 130.57 73.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.998 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 46.8 m-85 -112.1 128.88 56.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.883 0.373 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.98 -28.23 68.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -120.37 148.36 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.991 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.47 -169.07 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t0 43.63 30.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 53.97 83.26 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.5 m -160.57 163.72 32.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 0.0 110.753 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.66 -152.09 22.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.709 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -71.76 136.59 47.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 0.0 110.429 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 39.1 ttp -120.5 124.62 45.84 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.781 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 48.8 m-85 -116.0 133.6 55.85 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.13 0.491 . . . . 0.0 110.473 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -122.16 121.61 37.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 111' ' ' THR . 6.9 t -147.41 126.94 13.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -93.92 41.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -141.66 -178.46 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.566 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.8 p-10 -84.96 157.69 20.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.513 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.0 m -134.91 121.06 14.52 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.165 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 60.5 Cg_endo -77.95 -56.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.05 1.833 . . . . 0.0 110.936 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.4 m -116.73 112.8 21.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -68.82 -45.05 81.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.403 0.621 . . . . 0.0 110.634 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.465 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -65.71 -21.65 66.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.299 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -73.97 -47.38 37.74 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.275 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.479 ' CD ' ' CE2' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -98.1 -24.8 15.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.479 ' CE2' ' CD ' ' A' ' 121' ' ' GLN . 37.1 m-85 -112.53 2.91 16.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.121 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.6 m-70 51.3 10.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.891 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 122' ' ' PHE . 3.4 mmt -75.72 133.02 40.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -106.27 -30.56 9.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.787 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 29.7 mt-10 -150.58 108.76 3.75 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.089 0.471 . . . . 0.0 111.153 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.37 125.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.586 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.5 m80 -106.31 -32.13 8.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.941 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 17.0 m -154.97 150.28 27.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.116 0.484 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.14 153.63 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.759 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.9 mtpt -131.46 -177.33 4.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.561 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.552 ' C ' HD22 ' A' ' 133' ' ' LEU . 13.8 t 54.04 98.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.552 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.5 mm? -111.21 164.44 12.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.566 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -138.92 111.64 7.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.218 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.56 -87.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.3 t -121.95 157.05 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -143.73 168.21 20.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.16 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.9 mt -144.91 122.84 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.186 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.534 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -109.62 131.72 54.8 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 32.9 m-85 -109.51 112.03 23.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.119 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -50.56 -23.79 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.5 mp -117.38 164.95 17.02 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 94.3 Cg_endo -82.94 167.95 14.06 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.38 2.054 . . . . 0.0 112.194 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.493 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.5 m-80 77.65 15.75 1.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.098 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.493 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.37 29.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.694 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 96.8 mtt180 -135.57 128.43 31.24 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.1 171.98 21.63 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.38 108.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.455 ' CG ' ' CE1' ' A' ' 140' ' ' TYR . 71.6 mt-30 -75.44 147.72 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.963 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.59 164.54 12.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.38 146.78 41.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.64 HD22 ' N ' ' A' ' 152' ' ' LEU . 3.4 mm? -64.3 151.49 43.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.467 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -127.18 -145.7 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.016 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -73.6 -107.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.737 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -56.95 -161.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 9.9 pm0 -78.84 -118.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.741 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 5.2 m-85 -150.42 107.15 3.53 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.013 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 129' ' ' SER . 4.2 ptp180 -102.18 -25.58 13.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.077 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.46 50.04 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.03 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.557 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 21.4 Cg_endo -62.8 -17.29 58.59 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.856 2.371 . . . . 0.0 113.235 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.2 mp -101.36 -4.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.171 0.51 . . . . 0.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.45 -28.59 67.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.767 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -104.97 22.94 14.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.189 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.37 28.72 67.34 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.938 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.596 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -110.88 139.58 46.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.024 0.912 . . . . 0.0 109.795 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.08 22.3 0.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.01 152.72 0.26 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.728 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.78 5.45 4.36 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.746 2.297 . . . . 0.0 111.542 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.5 70.23 5.92 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -98.91 -153.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.868 ' H ' HG12 ' A' ' 170' ' ' VAL . 78.3 mm-40 -152.74 -132.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.705 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -94.22 -155.1 0.44 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -171.17 -176.01 1.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.21 0.528 . . . . 0.0 111.22 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.443 HH21 HG22 ' A' ' 177' ' ' VAL . 9.7 ptm180 -158.96 132.32 7.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.936 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 ptt-85 -52.99 134.48 37.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 138' ' ' ILE . 15.5 mt -67.92 133.71 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.466 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.443 HG22 HH21 ' A' ' 174' ' ' ARG . 34.5 m -139.03 156.6 28.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.452 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.7 tp10 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.356 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.52 ' OG ' HG22 ' A' ' 4' ' ' THR . 6.6 p -79.48 176.58 9.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 2' ' ' SER . 17.3 ptmt -34.54 -45.84 0.25 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.52 HG22 ' OG ' ' A' ' 2' ' ' SER . 10.9 t -62.09 -173.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.22 80.18 0.05 OUTLIER Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.417 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.1 p -84.39 159.35 20.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.786 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.2 tttt -160.26 151.8 19.71 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.008 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -147.23 141.67 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 97.7 m -123.95 138.21 54.5 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.718 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -118.77 115.78 25.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.2 m-85 -94.87 138.31 32.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.231 0.539 . . . . 0.0 110.986 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 7.7 tm-20 -60.44 -49.96 75.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.946 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 45.3 m-20 -99.33 -176.02 3.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.241 0.543 . . . . 0.0 109.773 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -83.19 -176.84 6.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 46.32 24.3 0.27 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.807 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.483 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 62.75 41.53 8.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.176 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.41 173.63 6.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.26 -155.99 53.51 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.682 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -54.65 174.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -169.34 149.92 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 59.4 t80 -132.75 133.15 43.09 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 40.2 p-10 -119.87 132.5 55.58 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.569 0.223 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 140.97 30.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -125.0 15.88 8.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.669 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 26' ' ' ASP . 11.2 m -148.94 145.8 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 43.0 t0 -37.29 155.72 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.542 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 m -155.95 162.03 40.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.98 -56.53 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.802 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -154.18 110.75 3.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.411 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.5 p90 -101.42 9.79 41.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.0 t60 -59.76 -28.57 67.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.694 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.4 p -61.16 -29.12 69.6 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.433 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -88.76 -12.56 41.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.663 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -142.21 136.65 30.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -96.84 -10.73 25.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.702 0.287 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.539 ' NH2' ' OD1' ' A' ' 13' ' ' ASP . 59.9 ttp180 -157.05 145.71 19.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.471 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -110.65 104.35 13.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.733 ' O ' ' O ' ' A' ' 39' ' ' SER . 8.4 m120 -128.57 155.9 44.19 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.733 ' O ' ' O ' ' A' ' 38' ' ' ASN . 24.4 p 35.73 130.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.642 1.21 . . . . 0.0 112.568 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.4 mt -142.15 146.29 22.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.93 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.7 ptpt -154.41 102.55 2.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.008 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.33 149.08 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.291 0.567 . . . . 0.0 110.552 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.31 50.21 1.41 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.682 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.21 -95.48 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.112 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.56 -140.36 4.04 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -80.93 166.54 20.76 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.433 -0.451 . . . . 0.0 110.89 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.786 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.4 m95 -154.71 156.65 36.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.19 120.97 40.7 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.62 132.28 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -104.35 110.16 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -37.59 -34.49 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -115.91 148.41 41.24 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.883 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.1 Cg_endo -68.54 159.77 52.1 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.465 2.11 . . . . 0.0 111.915 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.3 m-80 85.17 -5.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.835 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 11.7 m-85 85.99 60.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.649 0.593 . . . . 0.0 111.001 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.63 177.72 9.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 81.62 -163.31 44.16 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.88 122.2 17.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.4 mpt? -98.3 136.69 38.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.249 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 25.9 t80 -139.74 142.49 36.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.863 HD11 HD12 ' A' ' 151' ' ' LEU . 2.5 mp -102.91 91.37 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.06 111.72 11.76 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.67 162.29 19.01 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.143 1.895 . . . . 0.0 112.661 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.41 117.36 2.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.024 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.34 41.01 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.5 mt-10 -101.2 153.58 19.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 24.2 m-85 -146.5 86.21 6.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.92 -18.47 16.69 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.857 2.371 . . . . 0.0 112.906 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -152.41 162.47 41.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.654 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 6.1 p90 -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -41.21 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.1 mmt180 -75.77 -5.49 46.04 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -117.61 25.27 10.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 119.698 -0.191 . . . . 0.0 111.362 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.4 mmt 89.79 23.59 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.455 1.097 . . . . 0.0 111.636 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.41 59.11 0.23 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.294 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 38.8 mt -94.69 13.92 22.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 33.8 t-20 91.91 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.227 0.954 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.64 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 35.8 p-10 -37.85 -95.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.425 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.64 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.1 tpt180 30.11 93.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.358 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -139.51 128.03 22.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.64 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.0 p -111.04 -162.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.135 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.1 p -45.25 -179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.653 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.521 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 18.6 p -149.04 148.76 30.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.26 126.33 55.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.09 124.25 20.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.151 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 48' ' ' ALA . 67.9 t -120.21 129.0 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.897 0.379 . . . . 0.0 110.444 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 136' ' ' VAL . 49.6 m80 -97.5 160.31 14.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.16 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.15 149.95 70.49 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.648 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.23 150.93 77.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.32 2.013 . . . . 0.0 112.124 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -155.27 169.65 23.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.15 -70.28 1.85 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -74.39 30.71 0.99 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' A' ' 91' ' ' GLY . 4.7 pt20 34.82 -106.19 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.665 0.269 . . . . 0.0 111.169 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.743 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.1 t80 -157.94 113.31 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -153.56 134.01 13.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.021 0.438 . . . . 0.0 111.354 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.59 145.74 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 28.0 mt-30 -124.32 129.76 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.233 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 108' ' ' MET . 10.4 mt -118.7 132.83 67.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.03 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.15 133.89 55.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.258 0.552 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -30.16 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.72 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -119.61 148.65 43.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.225 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.07 174.55 15.67 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.4 t0 57.77 30.76 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.002 0.43 . . . . 0.0 110.441 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 156' ' ' GLU . 5.4 m-85 55.87 82.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -160.12 161.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.556 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.03 -150.99 22.55 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.11 136.04 39.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.654 0.264 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.8 tmm? -122.1 133.38 54.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 59.0 m-85 -123.68 137.71 54.66 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.239 0.542 . . . . 0.0 110.618 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.3 125.28 44.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 111' ' ' THR . 5.1 t -147.9 128.25 13.93 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.705 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -90.29 41.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -146.65 -178.14 6.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.6 p-10 -86.36 162.16 18.33 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.651 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 84.5 m -138.79 122.81 11.32 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.01 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.188 1.925 . . . . 0.0 111.678 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -121.09 109.28 14.83 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.1 tt -64.28 -38.09 81.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.625 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 24.0 ttt -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.56 -44.32 17.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.604 -0.685 . . . . 0.0 111.678 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 1.7 pt20 -90.93 -32.88 15.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.372 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.734 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 23.5 m-85 -115.79 8.84 14.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 49.11 11.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.206 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.5 mtt -79.72 138.05 37.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.465 0.65 . . . . 0.0 110.057 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.518 ' NH2' ' OE2' ' A' ' 126' ' ' GLU . 4.8 ptm180 -109.99 -26.41 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.366 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 75.8 mt-10 -149.84 107.31 3.64 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.321 0.582 . . . . 0.0 111.904 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 118' ' ' ILE . 9.6 mm -76.0 122.71 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.442 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.7 m80 -102.91 -31.9 10.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.119 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 p -155.93 151.35 26.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.801 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -148.67 131.82 16.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.2 -176.4 3.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 133' ' ' LEU . 27.8 t 55.69 98.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.04 167.02 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.067 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.0 mp0 -142.09 111.73 6.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.974 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.92 -89.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.7 t -119.92 150.99 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.145 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -140.07 170.42 15.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.0 mt -145.14 123.61 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.392 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -112.17 132.84 54.66 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 40.1 m-85 -110.46 112.24 24.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 78.3 tt0 -51.54 -21.99 2.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.3 mp -118.16 165.32 16.63 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.29 167.45 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.016 1.81 . . . . 0.0 112.186 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.2 m-20 78.99 14.82 1.1 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.969 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 75.24 28.44 1.01 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.154 0.284 . . . . 0.0 111.371 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 82.0 mtp180 -133.28 126.83 32.33 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.19 174.54 22.17 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.549 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 77.8 mtm180 -53.07 115.99 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.329 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 49.2 mt-30 -85.52 138.16 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.698 ' C ' HD13 ' A' ' 151' ' ' LEU . 59.4 m-85 -114.0 128.89 56.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.866 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -140.63 87.66 2.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.681 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.0 mt -132.32 116.6 17.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.988 -0.445 . . . . 0.0 110.244 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.64 87.6 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.103 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -114.27 -160.52 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.939 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.62 93.09 4.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 104' ' ' PHE . 33.7 tt0 58.76 161.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.295 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -118.76 107.99 14.33 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -105.73 -24.1 12.59 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.811 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -121.26 153.3 58.29 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.551 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -58.83 -14.91 24.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.539 2.159 . . . . 0.0 113.453 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -103.06 -2.9 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.118 0.485 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.36 -26.43 66.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.412 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.39 23.07 15.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.408 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.03 69.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.719 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.02 139.38 43.98 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.257 1.028 . . . . 0.0 109.397 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.4 22.11 0.34 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 170.62 156.27 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.303 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.831 ' O ' HG23 ' A' ' 170' ' ' VAL . 42.1 Cg_endo -68.9 -35.89 14.46 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.674 2.249 . . . . 0.0 111.435 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.65 77.1 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.6 t -94.11 -102.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.345 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.711 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER 162.65 -144.64 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 O-C-N 123.792 0.682 . . . . 0.0 109.718 177.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 1.9 p -91.02 -157.9 0.52 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.568 0.223 . . . . 0.0 111.225 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -169.78 -177.54 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.218 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -158.21 131.82 7.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.235 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 ptm180 -52.3 133.03 34.7 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.714 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.457 HG12 HD12 ' A' ' 138' ' ' ILE . 12.8 mt -63.44 134.08 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.48 137.05 53.74 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.056 0.455 . . . . 0.0 110.577 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.388 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.5 p 40.44 -152.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.767 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -149.06 7.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.353 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 p -62.42 168.18 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.02 35.11 1.72 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 p -132.2 120.01 21.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.844 0.354 . . . . 0.0 110.614 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.57 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.1 tttt -161.71 153.09 18.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.862 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.6 tt -146.71 144.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.808 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.7 m -135.12 141.28 45.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -121.05 115.9 24.01 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 81.5 m-85 -95.28 139.52 31.47 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.259 0.552 . . . . 0.0 111.181 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 8.1 tm-20 -63.46 -49.42 73.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.115 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.8 m-20 -98.84 -177.46 3.65 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -81.87 -178.67 7.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 48.57 22.23 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.516 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.5 m-85 60.15 46.41 10.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.196 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -114.23 167.36 10.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -143.35 31.53 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.499 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -65.58 162.49 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.408 -0.896 . . . . 0.0 109.149 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.57 156.99 8.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.971 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.512 ' O ' HG23 ' A' ' 9' ' ' THR . 27.6 t80 -131.07 133.65 45.88 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.6 p-10 -123.79 124.5 42.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.75 143.56 24.57 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.242 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -123.63 28.71 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.388 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.0 t -145.73 142.32 28.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -40.02 157.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.505 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.6 m -159.2 165.05 34.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.87 -54.79 3.6 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.994 0.426 . . . . 0.0 111.01 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -156.51 106.96 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.255 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -94.36 8.14 42.98 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.0 t60 -58.51 -30.93 67.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.3 p -58.02 -29.46 65.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.301 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.72 -16.85 31.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.608 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.559 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -140.02 137.17 34.42 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 109.954 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -100.61 -7.77 23.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.242 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 78' ' ' ASP . 57.6 ttm-85 -153.58 142.76 21.41 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.443 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.0 m -112.44 102.79 10.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.0 m120 -127.69 153.73 46.14 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 17.1 p 37.38 126.23 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.333 1.064 . . . . 0.0 112.562 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.2 mt -138.93 147.24 25.04 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.463 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.38 100.88 2.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.366 0.603 . . . . 0.0 109.921 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 42' ' ' VAL . 6.7 m -70.2 141.45 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.11 47.59 0.95 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.57 -98.65 0.14 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.42 -137.34 3.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -77.87 166.78 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.62 ' N ' HG22 ' A' ' 46' ' ' THR . 38.6 m95 -156.56 156.8 34.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.546 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.44 118.91 33.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.757 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.38 133.01 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 111.297 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.608 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 31.4 m-85 -107.54 110.57 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.773 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -39.1 -32.77 0.1 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.075 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -116.79 147.72 40.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.733 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -68.71 156.33 65.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.33 2.02 . . . . 0.0 111.585 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 5.4 m120 86.11 -2.93 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.038 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-85 85.07 59.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.596 0.358 . . . . 0.0 111.785 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.49 176.85 9.5 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.42 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.23 -164.39 47.73 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -59.49 137.39 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.608 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 10.7 tpt -123.78 126.08 45.86 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -140.91 152.79 45.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.737 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.63 99.04 7.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.562 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -71.0 110.63 7.62 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.09 163.82 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.148 1.899 . . . . 0.0 113.255 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.2 123.42 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.914 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.28 -173.64 40.28 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.6 mt-10 -111.46 156.35 21.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.956 0.408 . . . . 0.0 109.904 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.585 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.5 m-85 -147.27 81.12 8.94 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.485 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 36.5 Cg_exo -55.43 -14.0 8.72 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.054 2.503 . . . . 0.0 112.661 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -151.47 163.41 39.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.338 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 10.9 p90 -65.4 -51.01 63.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.405 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.2 mt-30 -43.62 -10.6 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' TYR . 39.2 mmt180 -76.3 -0.55 22.86 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.02 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -123.81 22.6 8.9 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 122.929 0.143 . . . . 0.0 111.019 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 8.7 mmt 91.86 18.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.578 1.151 . . . . 0.0 111.709 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.26 62.16 0.24 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.9 mt -90.91 17.19 8.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.461 0.304 . . . . 0.0 111.27 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 67.0 t30 107.28 155.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.798 1.311 . . . . 0.0 109.639 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 54.0 p-10 -87.54 73.49 9.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.126 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -145.86 118.91 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -147.15 130.12 16.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 110.398 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.0 p -108.01 -164.75 0.99 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' SER . 61.5 m -49.44 -174.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.862 ' SG ' HG21 ' A' ' 8' ' ' ILE . 12.9 p -153.58 156.38 37.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -118.99 129.52 55.19 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.37 133.54 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.629 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.82 134.07 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.582 ' O ' HG21 ' A' ' 136' ' ' VAL . 37.4 m80 -101.15 162.13 13.11 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.916 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -91.79 159.45 38.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.662 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.55 149.77 62.38 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.045 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' GLY . 17.8 p -172.53 -9.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.149 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.33 7.27 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.526 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 90' ' ' SER . . . -174.49 -69.06 0.05 OUTLIER Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.412 ' CG ' ' H ' ' A' ' 94' ' ' TYR . 1.2 pt20 170.36 -103.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.262 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.731 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 10.8 t80 -156.88 115.73 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -154.05 131.86 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.26 0.552 . . . . 0.0 110.605 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -138.94 147.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.337 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 38.0 mt-30 -124.44 129.1 50.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.461 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 7.3 mt -119.61 131.71 71.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -111.52 123.76 50.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.115 0.483 . . . . 0.0 110.52 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.51 -19.04 22.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.625 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -131.89 143.58 50.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 110.582 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.85 -178.91 0.78 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.4 t0 52.29 29.44 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.462 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 54.81 80.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.838 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -157.31 164.03 38.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.549 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.46 -157.24 30.03 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -67.7 138.23 56.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.764 0.316 . . . . 0.0 110.636 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 43.4 ttp -118.6 121.33 39.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.488 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.5 m-85 -116.81 132.66 56.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.209 0.528 . . . . 0.0 111.201 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.07 131.33 52.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.826 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -152.84 134.35 14.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -95.54 45.48 1.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -149.24 -177.74 6.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.774 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -86.9 160.28 18.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 64.5 m -137.82 123.34 12.64 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.6 Cg_endo -78.18 -61.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.805 1.67 . . . . 0.0 110.879 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.2 m -111.38 113.16 25.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -70.04 -35.78 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.116 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 25.3 ttt -71.43 -18.53 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.447 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -82.43 -42.44 18.56 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.079 -1.013 . . . . 0.0 111.397 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.528 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.66 -30.19 15.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -177.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 27.7 m-85 -117.73 4.17 12.29 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.9 m-70 55.06 3.63 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.854 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -72.15 131.89 43.42 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.943 0.402 . . . . 0.0 109.921 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -108.4 -24.24 11.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.189 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.4 mt-10 -151.0 108.82 3.68 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.001 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 118' ' ' ILE . 7.8 mm -76.91 125.79 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.8 m80 -105.24 -36.88 7.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.119 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.4 p -153.59 149.62 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.868 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -145.92 156.16 43.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.758 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.5 mtpt -134.06 179.13 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.371 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.553 ' C ' HD22 ' A' ' 133' ' ' LEU . 12.8 t 57.65 99.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -114.42 164.02 14.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.372 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -135.91 111.98 9.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.21 -88.0 0.01 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 87' ' ' HIS . 17.5 t -125.82 144.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.974 0.416 . . . . 0.0 109.996 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.731 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.2 t-105 -130.09 167.85 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 67.5 mt -144.25 124.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -112.42 131.88 55.33 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -110.19 114.21 27.52 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.593 0.558 . . . . 0.0 110.784 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 80.8 tt0 -51.86 -23.65 5.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.507 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.8 mp -118.05 160.9 37.23 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.1 Cg_endo -77.77 167.06 24.51 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.205 1.937 . . . . 0.0 111.763 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.514 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.9 m120 73.2 14.83 4.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.046 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.514 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.2 m-85 77.34 27.84 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.531 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -114.7 170.77 8.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.831 0.348 . . . . 0.0 110.578 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.73 159.57 27.73 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 16.5 ptt180 -64.64 84.7 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.648 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -54.61 -167.5 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.043 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -144.1 162.3 36.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.563 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.701 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -100.0 148.44 24.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 110.194 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.701 ' H ' HD13 ' A' ' 151' ' ' LEU . 1.9 tt -72.78 117.59 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.707 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.594 ' N ' HD23 ' A' ' 152' ' ' LEU . 51.7 p-10 -146.32 164.23 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.982 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.3 tptp 61.34 149.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.455 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.52 120.55 26.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.779 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 64.42 161.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.492 ' OH ' HD21 ' A' ' 152' ' ' LEU . 5.2 m-85 -127.32 108.56 10.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.539 ' CZ ' ' HZ3' ' A' ' 159' ' ' LYS . 48.3 ptt85 -108.34 -22.29 12.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.594 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HZ3' ' CZ ' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -121.59 156.41 58.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.84 0.352 . . . . 0.0 110.736 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.503 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -59.42 -23.06 68.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.214 1.943 . . . . 0.0 113.177 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -94.36 -4.94 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -55.53 -31.77 62.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.298 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 1.0 OUTLIER -103.72 20.82 17.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.713 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.64 27.79 64.5 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.087 -0.577 . . . . 0.0 113.769 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.6 137.41 44.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.805 0.802 . . . . 0.0 110.301 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.25 26.32 0.16 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 166.0 154.54 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.503 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 170' ' ' VAL . 44.0 Cg_endo -71.49 -13.35 30.23 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.047 2.498 . . . . 0.0 111.337 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.65 69.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.582 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.953 HG12 ' H ' ' A' ' 171' ' ' GLN . 4.2 t -101.0 -152.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.953 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.7 tp60 -153.33 -132.04 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.735 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -95.15 -152.99 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.179 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -170.64 -179.44 2.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.09 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.474 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -155.3 130.25 9.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.902 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -52.74 126.39 19.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.943 0.877 . . . . 0.0 110.98 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.445 HG12 HD12 ' A' ' 138' ' ' ILE . 9.3 mt -59.01 128.22 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 174' ' ' ARG . 2.9 m -135.76 144.05 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.198 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 46' ' ' THR . 42.7 tt0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.081 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.1 166.5 25.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.651 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -74.81 119.92 19.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.972 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.6 p -71.21 162.74 28.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.281 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 21.18 31.98 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -134.06 122.02 22.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.745 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.8 tttt -161.28 152.69 18.94 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.983 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 tt -147.2 141.04 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.098 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.3 m -124.8 138.23 54.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.462 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -118.23 116.3 26.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 94.0 m-85 -98.59 139.27 34.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.963 0.411 . . . . 0.0 110.96 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.0 tm-20 -62.03 -51.94 65.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.875 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.92 -177.93 4.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.31 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -82.36 -177.55 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.853 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 46.42 24.82 0.33 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.177 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.8 m-85 62.43 42.71 8.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.257 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.91 172.58 6.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.65 -153.33 51.45 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.845 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -56.89 173.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -169.0 152.53 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.492 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 63.9 t80 -129.23 131.62 47.09 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 37.7 p-10 -120.39 125.36 47.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 0.0 111.24 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.7 t -151.25 142.43 23.21 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.26 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -126.17 24.11 6.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' ASP . 14.3 m -145.99 141.81 28.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.442 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 40.3 t0 -35.73 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 20.8 m -156.85 162.68 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.348 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.75 -55.69 3.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.979 0.419 . . . . 0.0 110.647 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -154.07 110.97 3.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.331 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.3 p90 -100.81 9.27 42.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.963 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.7 t60 -59.07 -28.41 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.515 0.674 . . . . 0.0 110.069 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -60.96 -29.2 69.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.271 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.08 -14.99 37.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -142.34 138.25 31.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -99.98 -8.69 23.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.644 0.259 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 49.2 ttm-85 -154.23 141.5 19.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.824 0.345 . . . . 0.0 110.485 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.4 m -110.92 105.46 14.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.273 0.559 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 45.4 m-20 -117.13 -155.84 0.6 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' ASN . 18.2 p -20.47 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.884 0.74 . . . . 0.0 112.271 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 mt -143.01 146.91 21.14 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.114 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.1 ptpt -154.41 103.97 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.2 t -66.6 148.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.523 0.678 . . . . 0.0 110.555 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.51 50.08 1.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.009 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.77 -95.85 0.1 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.925 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.28 -140.28 4.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 90.0 m -81.05 166.9 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.292 -0.534 . . . . 0.0 110.84 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.745 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.3 m95 -154.47 156.9 37.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.286 0.565 . . . . 0.0 110.742 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.43 120.82 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.1 m -117.47 131.9 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 0.0 110.986 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.7 109.65 21.43 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.723 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 60.2 tt0 -37.06 -36.29 0.12 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -113.69 147.98 38.8 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.5 Cg_endo -68.72 157.09 63.25 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.34 2.026 . . . . 0.0 112.05 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 5.5 m-80 86.03 -2.84 0.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.3 m-85 85.21 61.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.146 0.498 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.57 171.5 14.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.132 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.05 -158.47 34.79 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 4.2 m-85 -69.04 137.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.25 90.14 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 26.3 t80 -98.22 144.64 27.45 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -104.06 92.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.604 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.3 110.23 5.89 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 162.85 19.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.083 1.855 . . . . 0.0 112.759 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.79 117.41 2.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.087 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.78 179.12 41.3 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.51 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -102.24 153.93 19.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 25.1 m-85 -145.93 83.55 8.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.57 -15.72 9.51 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.26 2.64 . . . . 0.0 113.101 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -152.52 161.43 42.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.734 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 13.2 p90 -65.03 -52.36 56.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.334 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 37.2 mt-30 -42.99 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.82 -4.97 46.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.059 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.734 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.85 23.24 11.81 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.618 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.6 mmt 87.41 25.35 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.561 1.163 . . . . 0.0 111.158 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 30.83 50.04 0.2 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.078 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 26.5 mt -75.86 14.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.542 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 14.6 t-20 110.95 162.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.368 1.043 . . . . 0.0 109.27 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -94.4 61.23 2.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -137.61 115.78 11.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.246 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.39 129.16 20.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.6 p -111.58 -162.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.745 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.29 -178.65 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.864 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.588 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.5 p -151.11 153.06 34.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.595 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -118.34 127.86 54.1 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.559 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.49 127.85 33.48 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 48' ' ' ALA . 70.7 t -125.63 132.04 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.735 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.437 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.7 m-70 -100.37 161.56 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 1.2 mt -80.82 150.36 69.12 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.429 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.01 151.23 82.36 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.244 1.963 . . . . 0.0 111.935 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' GLY . 25.7 p -169.3 -17.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.079 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -54.84 -5.61 0.61 Allowed Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.548 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 90' ' ' SER . . . -158.09 -73.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' CG ' ' H ' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 171.54 -100.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.981 0.419 . . . . 0.0 109.919 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.715 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 21.5 t80 -160.88 114.13 2.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.261 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -157.09 132.28 9.04 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.709 0.29 . . . . 0.0 110.676 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.5 tt -135.81 145.0 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.221 0.534 . . . . 0.0 111.296 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 132' ' ' VAL . 11.8 mt-30 -122.23 134.02 54.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.36 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.641 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 mt -121.94 131.52 72.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.216 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -115.98 130.24 56.73 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.211 0.529 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.46 -26.98 65.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.052 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -122.25 147.07 46.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.591 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.46 -168.48 0.41 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 50.7 t0 44.56 29.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.911 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.482 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 12.9 m-85 54.11 79.35 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m -158.56 162.24 37.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.993 0.425 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.99 -171.43 42.69 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -53.89 133.69 42.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.169 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.9 tmm? -121.04 131.98 54.61 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.454 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.7 m-85 -121.46 135.72 55.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.456 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.05 126.24 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 111' ' ' THR . 7.3 t -152.73 128.93 10.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.72 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -95.37 42.68 1.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 111.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.07 -179.46 6.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.508 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.8 p-10 -84.04 156.98 21.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.525 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 65.8 m -134.04 123.02 16.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.907 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' OG ' ' A' ' 172' ' ' SER . 68.3 Cg_endo -77.98 -57.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.8 1.667 . . . . 0.0 110.841 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.8 m -115.89 111.64 20.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -67.4 -41.86 86.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 0.0 111.338 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 9.1 ttp -68.17 -17.12 64.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.344 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -82.47 -42.49 18.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.671 -0.643 . . . . 0.0 111.707 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.525 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.9 -29.96 15.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.111 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.523 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 29.3 m-85 -115.99 4.48 13.77 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.5 m-70 52.48 11.64 0.19 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.234 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -76.85 133.01 39.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -106.98 -28.48 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.71 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 30.3 mt-10 -151.45 109.0 3.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.008 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.9 mm -74.98 125.17 34.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.901 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.0 m80 -107.44 -33.53 7.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.56 -168.12 1.97 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.793 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.609 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.1 OUTLIER 160.99 137.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.082 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -130.16 -169.54 2.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.052 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 97' ' ' GLN . 49.1 t 47.0 87.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 0.0 110.3 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.28 169.8 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.201 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -141.88 113.65 7.9 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.49 -97.44 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -110.54 155.93 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -145.03 168.62 19.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.837 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.47 HD12 HG12 ' A' ' 176' ' ' ILE . 70.5 mt -144.63 123.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.974 0.416 . . . . 0.0 111.576 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.61 129.82 55.56 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -107.5 110.83 22.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.563 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.2 -22.39 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.27 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.55 164.36 16.66 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -84.16 166.9 12.58 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.091 1.86 . . . . 0.0 112.29 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.492 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.1 m120 68.52 21.96 7.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.6 m-85 71.68 66.83 0.15 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -154.44 169.68 23.17 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.931 0.396 . . . . 0.0 110.698 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.93 172.76 39.12 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.982 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.426 ' NE ' ' CD1' ' A' ' 58' ' ' TYR . 79.1 mtp180 -53.9 138.26 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.554 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 15.5 mp0 -99.56 137.5 37.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.033 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -106.83 129.2 54.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.592 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.745 ' C ' HD12 ' A' ' 152' ' ' LEU . 53.5 tp -76.36 144.32 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.745 HD12 ' C ' ' A' ' 151' ' ' LEU . 10.7 mp -128.32 145.98 50.9 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.168 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -136.78 70.99 1.41 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.993 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? 38.29 -126.16 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt 59.2 -105.14 0.23 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.665 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.482 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 18.4 tt0 -178.07 159.49 1.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.426 ' CE2' HD23 ' A' ' 152' ' ' LEU . 5.8 m-85 -129.68 108.21 10.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -109.47 -21.13 12.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -121.24 155.73 58.22 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 121.124 0.488 . . . . 0.0 110.965 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.531 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -60.24 -19.03 55.5 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.259 1.973 . . . . 0.0 113.181 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.686 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.1 mp -97.86 -3.45 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.72 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.5 OUTLIER -60.62 -27.86 68.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.864 -178.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.563 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -107.42 21.25 17.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.28 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.33 70.84 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.331 0.492 . . . . 0.0 114.331 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.563 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.75 138.58 41.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.973 0.886 . . . . 0.0 110.005 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.57 20.86 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.265 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 169.46 156.73 0.18 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.719 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.7 4.48 6.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.006 2.471 . . . . 0.0 111.585 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.55 71.4 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.798 0.333 . . . . 0.0 111.09 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.6 t -99.78 -151.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.888 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -154.61 -130.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.123 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 2.9 p -93.7 -155.48 0.45 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -170.04 -177.27 2.52 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.319 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.72 132.06 6.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.442 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -51.67 134.81 29.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.237 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.2 mt -67.84 135.48 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.658 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.52 156.75 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.152 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 p -139.5 -63.08 0.52 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 110.648 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.56 -45.85 91.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.383 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.8 p -41.54 128.8 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.26 -169.33 42.05 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.0 p -139.14 128.09 23.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 110.393 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.777 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.4 tttt -160.03 152.03 20.41 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.004 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.95 142.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.736 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -125.89 138.99 53.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.642 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -119.33 115.8 24.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.373 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.4 m-85 -94.71 138.73 32.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 110.822 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 8.1 tm-20 -61.06 -49.91 75.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.076 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 65.6 m-20 -99.2 -175.96 3.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.182 0.515 . . . . 0.0 109.667 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -82.73 -176.64 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.829 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 47.53 23.78 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.515 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.9 m-85 63.18 41.46 7.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.117 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -108.19 177.08 4.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.44 -158.56 50.97 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.508 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -54.64 176.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.25 150.15 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 49.8 t80 -127.23 130.97 50.63 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -119.45 124.0 45.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.096 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -150.03 142.3 24.19 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.241 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -125.25 24.01 7.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.951 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.9 t -146.81 141.81 27.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.8 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 25' ' ' CYS . 74.5 m-20 -36.61 156.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.562 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 23.5 t -157.69 164.27 37.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.301 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.47 -56.57 2.98 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.958 0.409 . . . . 0.0 110.861 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 44.7 p-10 -154.24 110.6 3.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.193 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -99.89 10.83 40.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' LEU . 70.5 t60 -59.79 -26.85 66.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.2 p -63.39 -31.31 72.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -85.85 -12.58 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.15 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -142.93 137.62 29.58 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 p -95.49 -11.74 27.01 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' NH2' ' OD1' ' A' ' 13' ' ' ASP . 45.4 ttp180 -158.19 146.07 18.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.217 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.8 m -110.25 104.15 12.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.37 0.605 . . . . 0.0 111.395 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.727 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.7 m120 -128.84 155.6 44.95 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.463 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' O ' ' A' ' 38' ' ' ASN . 11.1 p 36.97 128.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.345 1.069 . . . . 0.0 112.192 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.7 mt -141.46 147.12 22.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.403 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -155.94 102.28 2.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.212 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -67.24 149.78 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-O 121.616 0.722 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -122.89 50.62 1.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.053 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.582 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.53 -96.97 0.11 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.868 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.509 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.92 -141.33 4.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 47' ' ' TRP . 84.9 m -80.84 167.23 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.578 -0.366 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.777 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.8 m95 -154.74 155.65 34.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.611 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 120.79 41.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.48 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.92 131.33 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 110.608 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-85 -102.88 108.23 19.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 79.1 tt0 -36.48 -35.32 0.08 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.07 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.565 HH21 ' HB1' ' A' ' 56' ' ' ALA . 10.5 mtm180 -115.39 147.3 38.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 49.4 Cg_endo -68.45 160.71 48.04 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.324 2.016 . . . . 0.0 111.446 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 83.37 -3.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.293 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.7 m-85 85.42 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' HB1' HH21 ' A' ' 52' ' ' ARG . . . -145.22 168.38 20.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.548 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.34 -156.69 28.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 3.8 m-85 -82.8 114.63 21.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -87.94 98.26 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.332 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.7 m-85 -92.84 146.6 23.51 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -104.39 92.14 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 112.98 16.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.67 162.23 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.02 1.813 . . . . 0.0 112.526 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -51.94 115.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.914 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.12 177.52 42.44 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.8 mt-10 -101.06 153.07 19.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.944 0.402 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 30.6 m-85 -146.05 91.11 5.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 -13.62 40.67 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.056 1.837 . . . . 0.0 113.138 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 91.7 mt-10 -149.41 161.08 42.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.753 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.6 p90 -63.23 -53.97 44.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.99 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.61 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 8.3 pt20 -43.46 -10.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 70' ' ' TYR . 24.0 mmm180 -75.04 -5.6 44.93 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.24 24.39 10.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.05 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.0 mmt 87.97 25.48 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.289 0.993 . . . . 0.0 111.286 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.17 51.47 0.26 Allowed Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 10.4 mt -75.88 13.2 0.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.83 -0.185 . . . . 0.0 110.986 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.2 t30 109.06 169.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.578 1.174 . . . . 0.0 108.743 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -98.96 61.46 1.26 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.901 0.382 . . . . 0.0 110.556 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -139.2 116.9 11.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.304 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.05 129.17 20.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.7 p -111.22 -162.86 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.513 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 81' ' ' SER . 6.3 p -45.51 -179.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.781 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -150.26 151.89 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.431 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -115.52 127.96 55.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.543 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.18 122.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.479 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.08 130.06 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -102.56 162.87 12.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -79.91 150.65 72.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.83 147.11 95.05 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.071 1.848 . . . . 0.0 112.329 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -159.91 174.61 14.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.238 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.75 -44.69 2.54 Favored Glycine 0 CA--C 1.518 0.255 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.89 -80.74 1.33 Allowed Glycine 0 N--CA 1.458 0.131 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.454 ' CG ' ' H ' ' A' ' 94' ' ' TYR . 1.7 pt20 164.97 -104.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 110.046 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 31.0 t80 -159.01 114.16 2.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.519 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' CG ' HG11 ' A' ' 132' ' ' VAL . 17.9 tptm -156.39 132.66 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.451 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -134.53 143.62 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.421 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 34.3 mt-30 -123.74 129.58 51.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.418 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.3 mt -119.15 131.18 72.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.588 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -111.58 129.07 56.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.78 -29.88 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 102' ' ' GLY . 81.4 mttt -112.23 146.91 37.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 101' ' ' LYS . . . -54.3 -163.09 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 38.9 t70 51.72 -96.11 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 103' ' ' ASP . 67.1 m-85 -168.95 71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.993 0.808 . . . . 0.0 109.232 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -156.91 161.73 39.65 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.101 0.477 . . . . 0.0 110.986 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.05 -178.93 33.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.633 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.97 133.78 22.19 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.25 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.0 tmm? -122.33 130.32 53.02 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.815 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.488 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 65.0 m-85 -119.77 135.64 54.77 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.43 117.26 26.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.29 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 111' ' ' THR . 11.7 t -140.95 126.37 18.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.65 38.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.27 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.12 -177.85 5.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.75 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.7 p30 -85.61 159.12 19.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.058 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.1 t -133.3 124.56 18.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -79.06 -53.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.819 1.679 . . . . 0.0 111.272 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -121.14 113.89 20.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.757 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.25 -46.18 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.187 0.518 . . . . 0.0 110.589 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.459 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -64.65 -20.2 66.15 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -73.49 -47.26 42.58 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.673 -0.642 . . . . 0.0 112.433 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.639 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.67 -23.59 14.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.29 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.1 m-85 -111.49 1.56 16.99 Favored 'General case' 0 C--O 1.228 -0.04 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.2 m-70 50.12 11.17 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.862 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.482 ' H ' ' C ' ' A' ' 122' ' ' PHE . 33.8 mtt -77.38 135.2 38.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -106.36 -28.74 10.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.042 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 72.5 mt-10 -152.36 108.6 3.4 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.99 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.36 125.08 33.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.607 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.8 m80 -106.93 -32.46 7.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.242 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 t -152.21 147.76 26.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.16 156.78 44.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 44.5 mtpt -133.71 -171.14 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.166 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.456 ' C ' HD22 ' A' ' 133' ' ' LEU . 25.5 t 47.06 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.3 mm? -110.82 167.48 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -143.17 111.71 6.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.816 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.82 -88.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 134' ' ' GLU . 5.5 t -121.18 155.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.082 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.742 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -143.73 167.81 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.9 mt -144.72 124.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.69 130.77 55.48 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 16.6 m-85 -108.75 111.75 23.67 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.508 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -52.12 -24.7 7.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.7 161.23 27.43 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.342 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.26 164.66 21.7 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.325 2.017 . . . . 0.0 111.489 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.54 15.11 2.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.003 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.7 m-85 78.54 25.91 0.54 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 111.339 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 89.7 mtm180 -109.78 171.26 7.55 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.66 168.56 33.87 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -62.16 134.38 56.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.08 0.467 . . . . 0.0 110.228 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.571 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 54.4 mt-30 -87.27 144.88 26.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -110.79 127.25 55.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.732 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.5 tp -143.39 93.65 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 153' ' ' ASP . 30.9 tp -151.61 142.34 22.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.499 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 7.2 p-10 40.21 95.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.246 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -91.52 91.28 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.235 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -165.16 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 34.9 tt0 -174.01 168.6 4.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.488 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 21.4 m-85 -142.03 108.57 5.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.893 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -99.36 -30.36 12.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.47 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 162' ' ' ASP . 15.4 pttm -118.12 155.42 51.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.47 -17.17 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.148 1.899 . . . . 0.0 113.432 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.22 -3.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.157 0.504 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 1.0 OUTLIER -61.82 -28.34 69.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.582 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -104.68 20.51 18.51 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.09 28.23 66.89 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.134 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.74 137.64 47.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.704 0.752 . . . . 0.0 109.596 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.62 19.68 0.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.563 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 173.12 155.73 0.26 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.481 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.84 4.65 5.5 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.113 2.542 . . . . 0.0 111.709 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.96 69.89 5.2 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -97.71 -153.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.879 ' H ' HG12 ' A' ' 170' ' ' VAL . 71.8 mm-40 -153.83 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.224 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.0 p -93.17 -155.75 0.45 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -170.56 -177.35 2.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.66 132.04 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.862 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 ptt180 -53.05 135.95 36.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 138' ' ' ILE . 14.6 mt -69.28 135.68 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.836 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.6 160.46 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.603 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 29.1 tp10 . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.432 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 44' ' ' GLY . 60.4 p -86.04 165.65 16.49 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -142.12 -1.73 1.2 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -90.73 -92.86 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . -80.46 111.36 3.26 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.6 p -84.93 160.86 20.02 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.767 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 31.9 tttt -160.26 151.89 19.83 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -147.49 142.05 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.997 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.5 m -124.9 138.77 54.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -119.11 116.36 26.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.448 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.6 m-85 -98.78 139.57 34.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.1 tm-20 -62.19 -51.41 67.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.823 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -94.4 -177.46 4.26 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -82.8 -176.79 6.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.874 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 1.6 m120 45.41 25.96 0.26 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.321 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.493 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 63.61 41.44 7.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.57 177.45 4.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.0 110.493 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.81 -158.75 49.66 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.628 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.11 175.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.43 150.79 5.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.473 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 64.6 t80 -129.65 131.88 46.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -120.14 128.79 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.934 0.397 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.9 t -153.7 142.45 20.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.285 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -124.72 24.09 7.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 m -147.83 143.99 27.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.537 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -37.77 156.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -156.94 162.81 39.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.22 -56.12 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.941 0.401 . . . . 0.0 110.629 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -154.22 111.89 3.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.317 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.473 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.6 p90 -101.57 10.16 40.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.998 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' LEU . 42.3 t-80 -59.58 -28.43 67.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.717 0.77 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -60.97 -30.99 70.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.456 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -86.8 -13.65 44.5 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.392 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 31' ' ' HIS . 20.0 tp -142.89 137.22 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 109.985 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -97.78 -10.14 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.296 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HD21 ' A' ' 34' ' ' LEU . 59.3 ttm-85 -155.23 142.79 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.63 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.9 m -110.75 105.82 14.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 110.869 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 59.7 m-20 -118.0 -155.7 0.61 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.493 ' CB ' ' H ' ' A' ' 16' ' ' PHE . 6.3 p -19.68 137.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.992 0.807 . . . . 0.0 112.468 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.7 mt -142.55 146.54 22.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.046 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.62 104.28 2.34 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.953 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -67.24 148.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.38 0.61 . . . . 0.0 110.083 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.01 50.6 1.43 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.708 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.21 -96.17 0.1 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.071 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.25 -140.56 4.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.2 m -80.17 166.34 21.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.466 -0.432 . . . . 0.0 110.954 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.767 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -154.49 155.66 35.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.704 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 120.84 40.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.2 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' A' ' 80' ' ' LEU . 10.0 m -120.37 133.68 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 111.072 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CD1' ' NH1' ' A' ' 84' ' ' ARG . 11.7 m-85 -106.98 112.88 26.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.602 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 44.3 tt0 -37.65 -32.68 0.06 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.169 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -116.57 147.41 39.68 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 120.596 0.236 . . . . 0.0 110.951 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -69.31 161.78 44.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.268 1.979 . . . . 0.0 111.716 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' C ' ' CG ' ' A' ' 55' ' ' PHE . 2.9 m120 81.99 -3.66 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.059 0.849 . . . . 0.0 111.075 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 4.4 m-85 86.02 62.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.235 0.54 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.07 170.2 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.233 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.96 -159.94 34.76 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 6.5 m-85 -69.17 139.53 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -106.37 87.95 2.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.599 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.507 ' C ' HD12 ' A' ' 61' ' ' ILE . 36.0 t80 -92.75 136.0 33.62 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.33 93.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -71.84 110.9 8.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.43 162.83 17.1 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.137 1.891 . . . . 0.0 112.527 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.66 114.85 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.84 176.75 41.67 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.2 mt-10 -100.02 153.25 19.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.049 0.452 . . . . 0.0 110.566 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 26.4 m-85 -146.14 81.57 9.6 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.19 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.17 -12.52 7.75 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.948 2.432 . . . . 0.0 113.071 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' OE1' ' NE2' ' A' ' 71' ' ' GLN . 95.2 mt-10 -152.13 161.35 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.692 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 38.6 p90 -64.21 -54.84 27.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.598 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 11.7 pt20 -43.84 -9.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.4 mmt180 -74.83 -4.92 40.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.79 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.99 25.48 10.32 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 119.778 -0.153 . . . . 0.0 110.742 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.6 mmt 85.48 24.68 0.08 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.439 1.087 . . . . 0.0 111.191 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.56 51.27 0.43 Allowed Glycine 0 N--CA 1.472 1.1 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.8 mt -76.64 13.82 0.92 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.8 t30 111.55 166.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.063 1.477 . . . . 0.0 109.553 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 50.7 p-10 -98.63 63.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -142.69 119.71 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -143.72 129.66 19.49 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.682 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.4 p -110.36 -162.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 84' ' ' ARG . 13.1 p -45.12 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 110.713 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.614 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 19.8 p -147.97 147.91 30.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.799 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.629 ' CG ' HH11 ' A' ' 84' ' ' ARG . 0.0 OUTLIER -111.04 124.78 52.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.69 123.31 17.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.002 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.67 130.86 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -98.51 162.35 13.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 178' ' ' GLU . 1.7 mt -80.21 148.14 66.57 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.845 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.51 155.4 63.53 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.17 1.913 . . . . 0.0 112.054 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 m -171.99 -13.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.078 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.73 -33.41 86.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -139.05 57.36 0.62 Allowed Glycine 0 N--CA 1.464 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 35.2 -105.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.712 0.291 . . . . 0.0 111.301 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.733 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 41.8 t80 -158.29 112.81 2.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -153.56 134.65 14.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.27 0.557 . . . . 0.0 111.111 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -135.9 144.51 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.164 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 30.6 mt-30 -122.83 130.17 52.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.55 132.35 69.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -114.44 132.89 56.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.04 -30.54 70.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.974 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -120.6 150.76 40.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.175 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.13 -176.62 4.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 t0 50.44 28.8 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.715 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 7.3 m-85 55.72 82.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.668 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -159.06 161.31 36.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.54 -149.35 20.53 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -77.12 137.43 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.2 tmm? -123.01 133.87 54.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 111.179 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.9 m-85 -124.71 137.95 54.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.679 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -123.55 123.66 41.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.49 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 111' ' ' THR . 5.6 t -151.59 125.55 9.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.581 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 112' ' ' THR . 1.7 t -92.39 45.31 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.44 . . . . 0.0 111.334 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.35 -179.24 6.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.538 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 18.6 p-10 -86.48 159.25 19.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.84 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 42.4 t -136.17 124.68 15.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.72 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.4 Cg_endo -77.84 -51.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.623 1.549 . . . . 0.0 111.093 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.0 m -121.97 111.39 17.0 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.982 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -68.44 -43.91 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.0 ttt -65.45 -17.66 64.72 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.0 111.032 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -81.87 -43.02 18.77 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.724 -0.61 . . . . 0.0 111.94 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.704 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -95.54 -29.45 14.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.053 -178.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.704 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.03 5.3 14.92 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.678 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.8 m-70 50.78 11.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.919 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 122' ' ' PHE . 36.0 mtt -76.9 135.15 38.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.749 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -107.41 -28.46 9.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.516 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 60.8 mt-10 -151.19 109.04 3.68 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.08 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -74.71 125.14 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.723 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -105.53 -32.19 8.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.8 t -154.04 148.74 26.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.108 0.48 . . . . 0.0 111.267 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -149.8 132.34 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -112.44 -173.08 2.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.243 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t 56.15 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.822 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -94.55 168.03 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.136 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.8 mp0 -142.58 112.14 6.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.69 -88.66 0.01 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.5 t -116.59 156.21 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.733 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.2 t-105 -146.21 167.44 23.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 87.4 mt -144.88 123.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.742 0.306 . . . . 0.0 111.119 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -110.4 131.57 54.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -109.57 111.54 23.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.957 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -51.82 -23.18 4.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.737 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.6 160.4 33.32 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 96.7 Cg_endo -79.47 166.25 22.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.123 1.882 . . . . 0.0 111.46 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.6 m-80 74.84 14.01 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.0 m-85 79.04 25.55 0.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -109.87 171.05 7.68 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.847 0.356 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.23 168.99 36.07 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' NE ' ' CD1' ' A' ' 58' ' ' TYR . 71.2 mtp180 -56.97 142.39 41.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 109.835 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.483 ' OE1' ' CE2' ' A' ' 60' ' ' TYR . 35.1 mt-30 -97.6 137.39 36.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.002 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -104.83 126.22 51.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.404 HD23 ' OH ' ' A' ' 50' ' ' TYR . 33.4 tp -81.11 153.14 27.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.542 0.687 . . . . 0.0 110.218 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -120.21 154.92 34.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.34 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -175.33 -25.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.601 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -72.36 146.91 46.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.82 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 156' ' ' GLU . 68.0 mttm -76.67 99.35 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 13.6 tt0 75.05 148.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.077 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -118.08 111.43 18.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -107.3 -20.26 13.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.701 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -121.56 154.86 59.96 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 15.5 Cg_endo -60.59 -16.09 40.7 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.4 2.067 . . . . 0.0 113.322 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 4.1 mp -100.2 -1.69 9.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -26.08 67.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.671 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.566 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -108.67 21.08 17.75 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.42 26.94 68.8 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.955 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.566 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.93 138.28 43.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.38 1.09 . . . . 0.0 109.721 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.76 21.02 0.21 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 170.86 155.41 0.21 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.675 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.24 6.13 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.087 2.525 . . . . 0.0 111.407 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.8 70.64 8.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 111.056 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.941 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.01 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.941 ' H ' HG12 ' A' ' 170' ' ' VAL . 73.8 mm-40 -155.04 -130.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.357 0.411 . . . . 0.0 109.893 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.594 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.37 -158.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -170.01 -177.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.405 0.622 . . . . 0.0 111.094 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.87 131.76 7.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -52.89 135.3 36.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.652 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.4 mt -64.09 134.49 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.89 135.58 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.501 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . 11.2 tm-20 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.351 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.58 -167.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.523 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 3' ' ' LYS . 19.2 pttp -66.17 -47.57 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.046 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 5' ' ' GLY . 11.1 t -65.86 -44.2 86.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.731 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.547 ' N ' HG23 ' A' ' 4' ' ' THR . . . -92.11 113.58 4.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 73.9 p -84.64 158.17 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.768 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.8 tttt -158.32 150.71 22.01 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.022 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.3 140.31 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.669 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 42.4 m -122.52 137.95 54.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.33 115.85 25.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -95.58 138.13 33.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.235 0.54 . . . . 0.0 111.083 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.27 -49.94 75.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.3 m-20 -99.69 -176.2 3.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.188 0.518 . . . . 0.0 110.148 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.43 -177.2 6.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 47.57 23.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.779 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.2 m-85 63.09 41.11 8.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -108.35 176.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.151 0.5 . . . . 0.0 110.715 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.91 -157.12 52.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.379 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -54.91 174.2 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.137 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.58 151.08 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' THR . 59.6 t80 -135.57 134.14 39.07 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 49.9 p-10 -120.9 140.46 51.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.665 0.269 . . . . 0.0 110.759 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 18.3 t -147.88 141.15 25.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 6' ' ' THR . 7.4 t70 -122.92 14.06 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.8 t -149.66 146.7 27.41 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.812 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 80.3 m-20 -37.54 156.19 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.62 161.22 40.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.35 3.03 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.4 p-10 -153.61 111.0 3.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.466 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.1 p90 -101.28 9.7 41.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.6 t60 -59.98 -26.47 66.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.986 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -63.28 -29.66 70.95 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.505 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -88.45 -12.87 41.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.469 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 31' ' ' HIS . 17.0 tp -143.5 137.7 28.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -99.46 -9.4 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.6 ttm180 -154.75 143.26 20.58 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.3 m -110.65 104.57 13.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.442 0.639 . . . . 0.0 110.887 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.707 ' O ' ' O ' ' A' ' 39' ' ' SER . 70.6 m-20 -129.51 156.78 43.59 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.67 128.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.392 1.091 . . . . 0.0 112.469 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.2 mt -141.44 146.19 23.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.297 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.4 ptpt -154.41 103.6 2.51 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.096 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.72 148.23 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.542 0.686 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -120.9 50.42 1.35 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.81 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.45 -95.3 0.1 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.537 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.46 -140.0 3.98 Favored Glycine 0 N--CA 1.468 0.767 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.2 167.16 18.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.403 -0.469 . . . . 0.0 110.807 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.768 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.7 m95 -155.07 157.25 37.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.604 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.82 121.59 41.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.64 132.74 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.095 0.474 . . . . 0.0 110.881 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -104.56 110.59 22.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.758 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -38.03 -34.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.136 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -116.14 132.99 22.97 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.414 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.2 Cg_exo -55.92 161.91 7.77 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.371 1.38 . . . . 0.0 112.151 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.4 m-20 84.69 -4.61 0.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.076 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.9 m-85 84.88 59.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.533 0.521 . . . . 0.0 110.9 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.04 13.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.021 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 -158.33 35.2 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.472 ' CZ ' ' NE ' ' A' ' 148' ' ' ARG . 4.2 m-30 -66.52 140.7 58.0 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.501 ' N ' ' SD ' ' A' ' 59' ' ' MET . 2.3 mpt? -110.11 87.02 2.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.013 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 36.5 t80 -94.42 135.79 35.44 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.17 91.81 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 111.15 8.84 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 162.36 16.23 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.085 1.857 . . . . 0.0 112.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -51.03 114.57 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.828 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.06 176.71 41.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.4 mt-10 -100.13 153.13 19.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 110.519 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 36.5 m-85 -146.44 91.83 5.31 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.11 -13.26 39.08 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.093 1.862 . . . . 0.0 113.246 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -149.82 161.14 42.85 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.732 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 41.6 p90 -63.49 -54.14 41.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 12.3 pt20 -43.5 -9.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 70' ' ' TYR . 84.5 mmt-85 -75.8 -4.48 40.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.59 25.08 10.67 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.823 -0.171 . . . . 0.0 110.95 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 22.7 mmt 85.39 24.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.465 1.103 . . . . 0.0 111.35 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.54 51.07 0.3 Allowed Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.3 mt -76.19 13.94 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.386 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 55.5 t30 113.39 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.858 1.349 . . . . 0.0 109.493 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -97.35 62.68 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.052 0.453 . . . . 0.0 110.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -141.88 118.53 11.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.987 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.15 128.63 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.9 p -110.63 -162.58 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.138 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.9 p -45.64 -179.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.619 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.495 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.1 p -149.3 149.79 31.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.603 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -115.82 127.85 55.37 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.05 126.49 27.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.277 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 48' ' ' ALA . 73.1 t -125.06 131.84 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.649 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.0 159.13 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.908 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -80.89 148.07 63.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.031 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.8 155.23 69.36 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.084 1.856 . . . . 0.0 111.803 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -173.39 -16.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.78 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.5 -36.81 93.63 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.59 55.32 0.77 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 33.8 -106.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.74 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 38.5 t80 -158.06 113.58 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -154.36 132.04 11.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.438 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.5 tt -134.66 143.9 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.194 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 31.9 mt-30 -121.69 131.74 54.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 118' ' ' ILE . 14.8 mt -120.33 130.99 73.77 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.97 132.93 55.16 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.048 0.451 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 82.8 tt0 -63.69 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.698 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -117.15 148.32 41.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.12 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 178.27 8.56 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.2 t0 54.72 31.25 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.772 0.32 . . . . 0.0 110.5 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 9.7 m-85 55.4 81.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.279 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -159.82 162.52 34.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.79 20.92 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.658 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.39 136.85 39.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.9 tmm? -122.03 131.62 54.08 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.53 137.15 54.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.516 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.73 127.49 47.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.636 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 111' ' ' THR . 5.6 t -149.5 128.64 12.77 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.48 40.47 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.86 -177.96 5.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.063 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -84.66 159.29 20.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.15 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 45.1 t -132.44 119.59 16.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -79.25 -53.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.495 1.463 . . . . 0.0 111.018 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.9 m -119.08 109.94 16.5 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -66.5 -42.58 90.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.355 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 44.1 ttm -66.62 -21.5 66.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.922 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -73.73 -47.48 38.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.241 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.659 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.7 pt20 -101.0 -25.48 14.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 34.9 m-85 -111.47 1.13 16.78 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 51.68 11.38 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.997 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 122' ' ' PHE . 4.8 mmt -77.58 135.57 38.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -109.36 -28.87 8.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.556 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 35.1 mt-10 -150.36 108.01 3.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.383 0.611 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 118' ' ' ILE . 8.7 mm -76.39 122.77 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.864 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.8 m80 -104.39 -31.78 9.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.158 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -151.71 146.48 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 110.681 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -145.46 132.72 20.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -113.03 -176.25 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.575 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' C ' HD22 ' A' ' 133' ' ' LEU . 15.1 t 53.54 90.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -105.6 168.09 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.79 111.88 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.91 -86.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.7 t -122.56 149.15 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.74 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -138.11 169.47 17.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.739 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.446 HD12 HG12 ' A' ' 176' ' ' ILE . 88.3 mt -145.05 123.51 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.679 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.39 130.92 55.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.001 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -110.5 111.92 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.617 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -52.28 -23.34 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.393 0.433 . . . . 0.0 111.159 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.65 162.09 24.29 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.42 165.28 20.93 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.1 1.867 . . . . 0.0 111.488 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.2 m-20 75.44 13.87 2.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.965 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.4 m-85 78.78 25.83 0.5 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -109.84 171.5 7.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.739 0.304 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 94.85 170.29 36.94 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.472 ' NE ' ' CZ ' ' A' ' 58' ' ' TYR . 94.3 mtt180 -57.47 148.79 22.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 6.3 mp0 -110.18 148.21 32.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.162 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -116.58 130.44 56.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.571 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -144.3 98.24 3.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.268 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 153' ' ' ASP . 93.0 mt -142.93 109.28 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 30.1 t0 35.28 -150.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.937 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 59.8 pttt -163.18 33.41 0.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -73.3 35.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.766 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 44.4 tt0 71.81 156.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -125.89 111.61 15.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -107.11 -25.67 11.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -119.22 154.04 53.54 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.559 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.527 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -58.81 -15.66 27.69 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.176 1.917 . . . . 0.0 113.729 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.78 -3.29 9.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.313 0.577 . . . . 0.0 110.477 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.75 -28.29 68.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.478 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -105.8 23.21 14.28 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 120.826 0.346 . . . . 0.0 110.167 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.1 26.45 72.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.946 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.53 139.6 41.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.378 1.089 . . . . 0.0 109.759 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.23 21.25 0.36 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 171.43 154.83 0.22 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.336 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.847 ' O ' HG23 ' A' ' 170' ' ' VAL . 40.1 Cg_endo -68.07 -35.16 20.67 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.641 2.228 . . . . 0.0 111.422 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.92 76.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.801 0.688 . . . . 0.0 110.6 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.4 t -93.84 -98.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.741 ' O ' HD12 ' A' ' 118' ' ' ILE . 5.3 mm-40 158.79 -140.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -92.62 -156.12 0.46 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.931 0.332 . . . . 0.0 111.704 -177.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -170.3 -177.11 2.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.53 131.72 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.258 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.7 ptt180 -52.46 135.33 33.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.61 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 138' ' ' ILE . 15.9 mt -69.6 135.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 178' ' ' GLU . 39.7 t -136.23 156.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.388 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.551 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 31.6 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.451 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 p -100.97 -30.7 11.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.634 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -97.56 -3.97 38.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.632 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.0 p -80.0 42.37 0.55 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.577 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.36 161.04 21.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.544 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 3.7 p -116.26 118.58 33.17 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.801 ' O ' HG13 ' A' ' 42' ' ' VAL . 31.1 tttt -99.64 159.61 14.91 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.846 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -146.5 140.85 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.823 0.344 . . . . 0.0 111.613 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 90.6 m -126.61 138.87 53.5 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 110.554 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -118.23 116.55 27.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 92.9 m-85 -97.1 139.77 32.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 110.879 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.5 tm-20 -61.58 -52.61 63.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.764 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HA ' HD22 ' A' ' 38' ' ' ASN . 99.0 m-20 -95.27 -178.15 4.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -81.89 -178.15 6.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 2.4 m-20 47.17 26.04 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.001 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 62.35 42.48 9.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.414 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -109.79 176.43 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.09 -156.81 52.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.639 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -55.21 174.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.69 148.22 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' THR . 51.4 t80 -130.69 132.73 45.55 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 28.6 t0 -118.4 143.42 46.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.775 0.321 . . . . 0.0 110.53 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -160.46 139.57 10.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 35.3 t70 -121.54 21.82 10.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.49 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.37 148.81 28.58 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.048 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 2.8 t70 -38.08 155.77 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 10.7 t -154.71 160.58 41.45 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.44 -56.66 2.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.022 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.1 p-10 -152.35 108.6 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.9 9.05 43.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -58.47 -27.48 64.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.039 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.8 p -64.26 -29.73 70.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.953 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.17 -11.63 46.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.6 tp -143.72 137.46 28.16 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -98.32 -12.01 21.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.498 ' O ' HD21 ' A' ' 34' ' ' LEU . 17.4 ttm180 -154.46 143.13 20.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.235 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -114.34 108.06 16.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.648 0.737 . . . . 0.0 110.57 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 39' ' ' SER . 56.9 m-20 -117.61 -156.04 0.62 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.608 -1.178 . . . . 0.0 107.979 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.1 p -18.2 138.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.811 0.694 . . . . 0.0 112.748 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.8 mt -141.98 146.49 22.7 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.709 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -156.57 103.26 2.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.68 146.07 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.517 0.675 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -117.47 50.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.483 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.32 -96.56 0.1 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.582 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.14 -142.14 4.63 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 97.0 m -81.85 166.88 19.57 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.187 0.517 . . . . 0.0 110.956 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.632 ' N ' HG22 ' A' ' 46' ' ' THR . 23.5 m95 -155.2 157.59 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.981 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.89 121.2 40.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.281 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.94 132.06 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 52' ' ' ARG . 57.7 m-85 -104.3 111.12 23.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.527 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 50' ' ' TYR . 45.7 tt0 -32.69 -34.15 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.316 0.385 . . . . 0.0 111.216 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HE ' ' HA3' ' A' ' 57' ' ' GLY . 27.3 mtm180 -124.86 158.22 63.51 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' OD1' ' A' ' 54' ' ' ASN . 5.8 Cg_exo -71.18 163.47 39.06 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.391 2.06 . . . . 0.0 112.221 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 0.7 OUTLIER 86.66 -11.24 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.816 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.8 m-85 85.56 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.844 0.715 . . . . 0.0 111.595 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' O ' ' NE ' ' A' ' 52' ' ' ARG . . . -149.82 118.85 6.71 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.243 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.541 ' HA3' ' HE ' ' A' ' 52' ' ' ARG . . . 122.72 127.42 3.29 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 22.24 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.703 0.401 . . . . 0.0 111.402 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.8 mtt -92.04 86.26 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 24.0 t80 -91.18 141.69 28.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.58 93.07 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 111.92 14.26 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.78 164.01 13.98 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.046 1.83 . . . . 0.0 113.203 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -50.92 111.74 0.6 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.24 171.46 39.27 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.28 155.1 16.9 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.99 0.424 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 56.4 m-85 -149.01 84.23 6.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.702 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -54.09 -14.34 6.03 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.894 2.396 . . . . 0.0 112.814 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -155.45 162.88 40.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 7.9 p90 -64.78 -52.35 57.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.499 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 26.4 mt-30 -39.87 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.1 tpm_? -75.79 -5.17 44.54 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.421 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -116.71 25.66 10.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.196 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.7 mmt 88.78 25.18 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.119 0.967 . . . . 0.0 111.632 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 33.35 55.7 0.58 Allowed Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.318 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.8 mt -88.23 11.12 17.31 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 41.5 t30 87.52 139.3 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.66 0.6 . . . . 0.0 109.912 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.641 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 16.0 p-10 -37.88 -95.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.641 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER 27.15 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.55 128.05 20.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.649 ' N ' HD13 ' A' ' 80' ' ' LEU . 6.8 p -110.23 -163.15 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.387 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.5 p -45.81 -179.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 110.761 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 26.5 p -150.8 152.53 33.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.263 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -114.78 127.03 55.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.47 122.08 14.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 48' ' ' ALA . 46.1 t -123.55 130.97 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 136' ' ' VAL . 29.5 m80 -102.73 162.52 12.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.963 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.32 155.85 69.11 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.88 154.14 53.34 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.666 2.244 . . . . 0.0 111.992 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 p -163.11 -19.17 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.785 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.47 49.24 3.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . 155.78 39.85 0.02 OUTLIER Glycine 0 C--O 1.222 -0.595 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.9 pt20 34.59 -106.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 35.8 t80 -158.43 113.26 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 36.0 tptt -154.68 133.57 12.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.19 0.519 . . . . 0.0 111.461 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.0 145.05 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 41.5 mt-30 -123.25 131.42 53.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.526 -1.216 . . . . 0.0 107.942 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.57 HD13 HD11 ' A' ' 118' ' ' ILE . 12.8 mt -119.96 131.9 71.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.036 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -114.1 130.93 56.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 0.0 110.697 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -119.01 147.34 44.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.88 172.02 15.94 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.9 t70 59.75 31.91 21.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.815 0.34 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 54.5 81.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -159.13 163.36 36.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.486 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -151.73 24.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -73.61 135.86 43.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.644 0.259 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 9.3 tmm? -121.83 132.03 54.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.202 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.503 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.0 m-85 -121.52 136.05 54.98 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.74 123.5 41.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.555 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 4.9 t -151.77 126.43 9.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.689 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 t -92.34 43.44 1.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -142.77 -179.34 6.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 11.4 p-10 -85.2 158.92 20.23 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.536 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.6 m -136.59 121.64 12.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.87 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 172' ' ' SER . 69.0 Cg_endo -77.11 -53.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.768 1.645 . . . . 0.0 111.413 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 m -118.58 109.15 15.83 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -66.17 -42.68 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 111.254 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.2 ttt -66.08 -18.45 65.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -82.37 -43.3 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.719 -0.613 . . . . 0.0 111.938 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.84 -31.79 14.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.006 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 28.0 m-85 -115.82 5.8 14.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 51.32 13.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.253 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' C ' ' A' ' 122' ' ' PHE . 2.2 mmt -78.23 133.84 37.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -107.4 -29.55 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.561 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 25.9 mt-10 -150.45 109.14 3.84 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.155 0.502 . . . . 0.0 111.167 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.9 mm -75.03 124.71 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.062 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.3 m80 -104.77 -32.22 8.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.172 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.9 m -154.52 149.28 26.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.05 145.87 32.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.647 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -122.48 -176.91 3.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.668 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' C ' HD12 ' A' ' 133' ' ' LEU . 25.1 t 50.66 92.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.649 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.519 HD21 ' CE2' ' A' ' 157' ' ' TYR . 7.5 mp -107.57 168.57 9.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.121 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.9 mp0 -142.04 112.48 7.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.13 -88.18 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.4 t -119.61 153.72 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.236 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.7 t-105 -141.83 169.32 17.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.767 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.2 mt -144.51 122.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.41 131.87 54.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.026 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -110.87 111.72 23.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.92 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 142' ' ' LEU . 74.8 tt0 -50.38 -21.92 1.64 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -119.53 161.62 36.58 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 0.0 110.377 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.414 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.8 Cg_endo -77.39 168.25 23.19 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.3 m120 73.67 11.95 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 78.76 27.92 0.44 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.329 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -112.87 172.3 7.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.75 172.49 42.48 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.598 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.74 156.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 110.239 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.595 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 13.2 mp0 -121.94 126.83 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -107.57 130.78 54.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 151' ' ' LEU . 4.1 tt -147.34 95.13 2.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.59 116.61 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.915 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.49 138.15 50.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.169 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -158.68 -44.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.404 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -174.74 72.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.558 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.74 -174.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' CE2' HD21 ' A' ' 133' ' ' LEU . 10.9 m-85 -130.65 108.63 10.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.002 0.43 . . . . 0.0 110.851 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -104.8 -25.92 12.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.016 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -119.83 154.79 55.3 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.608 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 13.7 Cg_endo -58.68 -19.7 47.05 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.23 1.953 . . . . 0.0 113.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -99.34 -2.81 9.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.131 0.491 . . . . 0.0 110.704 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.2 -28.16 67.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.547 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.573 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -106.87 21.73 17.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.354 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.57 69.9 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 121.134 -0.555 . . . . 0.0 114.283 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.573 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.92 138.16 42.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.217 1.008 . . . . 0.0 109.765 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.36 20.2 0.16 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 168.99 155.96 0.17 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.845 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.01 7.13 3.0 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.081 2.52 . . . . 0.0 111.502 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.11 70.52 9.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.046 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -99.27 -147.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -160.47 -131.68 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.696 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.01 -157.59 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -169.81 -177.4 2.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.189 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.94 131.28 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.79 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -52.59 135.46 34.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.149 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.465 HG12 HD12 ' A' ' 138' ' ' ILE . 14.3 mt -69.3 134.42 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.6 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 178' ' ' GLU . 43.5 t -137.71 156.55 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.658 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 27.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 4' ' ' THR . 1.5 m -100.49 78.62 2.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.105 0.478 . . . . 0.0 110.563 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 60.73 -4.97 0.11 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.584 ' H ' ' C ' ' A' ' 2' ' ' SER . 3.7 m 39.39 72.64 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.927 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.18 161.61 28.5 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p -84.72 161.08 20.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.242 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.792 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 39.7 tttt -159.75 151.25 19.95 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.11 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 tt -147.1 141.97 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.4 m -124.63 138.52 54.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.47 116.22 25.67 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.93 137.75 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.92 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 7.7 tm-20 -60.66 -48.99 79.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.156 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -99.1 -176.07 3.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 109.917 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.56 -176.72 6.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.282 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 46.8 23.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.883 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 63.48 41.76 7.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.235 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -108.65 174.38 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.604 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.82 -154.97 53.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.66 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -56.26 172.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.94 152.19 5.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -136.22 133.89 37.55 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -121.03 138.2 54.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.698 0.285 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 141.61 25.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.61 16.74 9.58 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.671 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -149.71 146.54 27.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -38.53 156.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.713 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 39.8 t -157.49 163.43 38.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.79 -56.3 3.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.817 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -153.58 112.51 3.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.5 p90 -101.87 8.58 41.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.041 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' LEU . 79.3 t60 -60.33 -27.57 67.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.494 0.664 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.4 p -60.79 -29.37 69.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -89.1 -15.27 34.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.527 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.23 137.65 32.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.954 0.407 . . . . 0.0 110.17 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -99.31 -7.76 25.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 52.5 ttm-85 -156.78 145.75 20.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.865 0.364 . . . . 0.0 110.575 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p -112.26 104.18 12.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.731 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.1 m-20 -129.78 157.55 41.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.731 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 34.24 127.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.581 1.181 . . . . 0.0 112.398 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.6 mt -141.2 146.08 24.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.187 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -154.06 102.96 2.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.25 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -66.89 149.18 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.478 0.656 . . . . 0.0 110.389 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -122.17 50.94 1.4 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.919 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.13 -95.73 0.1 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.967 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.16 -138.59 3.78 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 56.1 m -82.84 166.99 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.593 -0.357 . . . . 0.0 110.745 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.792 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.5 m95 -153.68 155.57 36.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.577 0.703 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.77 122.16 44.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.026 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 60' ' ' TYR . 8.1 m -118.29 132.07 69.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.189 0.518 . . . . 0.0 110.871 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 52' ' ' ARG . 89.3 m-85 -101.5 108.49 20.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.919 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' TYR . 39.6 tt0 -32.21 -37.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.407 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.604 HH21 ' N ' ' A' ' 57' ' ' GLY . 62.0 mtm180 -119.5 148.9 46.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.808 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 39.8 Cg_endo -67.78 163.8 33.93 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.559 2.173 . . . . 0.0 111.901 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 82.56 -3.27 1.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.119 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 81.79 56.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.438 0.461 . . . . 0.0 110.965 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.577 ' HB1' HH21 ' A' ' 52' ' ' ARG . . . -144.68 171.24 14.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.604 ' N ' HH21 ' A' ' 52' ' ' ARG . . . 87.44 -161.65 32.69 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' HD2' ' HH ' ' A' ' 60' ' ' TYR . 3.5 m-30 -63.97 -179.18 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -146.44 126.39 13.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.558 ' HH ' ' HD2' ' A' ' 58' ' ' TYR . 5.6 m-85 -132.14 135.09 46.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -101.34 89.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 110.8 7.05 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.95 161.85 18.37 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.181 1.921 . . . . 0.0 112.519 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.35 117.31 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.247 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.74 179.32 41.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.06 152.97 20.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 18.8 m-85 -145.67 84.6 8.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.65 -17.78 23.87 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.145 2.563 . . . . 0.0 113.028 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -149.88 161.18 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 16.4 p90 -62.68 -49.66 74.24 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.521 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -44.19 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.9 mmt180 -76.38 -5.19 46.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.015 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.673 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -116.66 26.94 9.5 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.469 -0.144 . . . . 0.0 111.249 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 22.0 mmt 88.97 19.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.342 1.027 . . . . 0.0 111.316 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 32.51 59.65 0.4 Allowed Glycine 0 N--CA 1.467 0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.336 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.4 mt -79.75 -67.59 0.75 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -159.93 163.86 33.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 54.7 p-10 -91.42 58.58 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 16.8 tpp180 -138.32 115.9 11.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.79 128.26 21.3 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.644 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.2 p -111.4 -162.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.605 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 m -44.65 179.85 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.322 0.582 . . . . 0.0 110.664 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 17.7 p -148.57 146.69 28.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.733 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -113.11 126.02 55.01 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.66 126.37 27.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.5 t -126.52 132.05 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.553 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -115.1 121.39 42.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.163 0.506 . . . . 0.0 110.253 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.817 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -46.15 163.21 0.23 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.952 -179.44 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.07 163.35 30.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.756 2.304 . . . . 0.0 111.961 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 t -163.97 -25.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.631 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.36 -63.33 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.593 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -84.73 43.96 3.3 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.6 pt20 34.36 -108.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.714 0.292 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.4 t80 -157.77 113.63 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.237 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 110' ' ' GLU . 25.3 tptp -153.95 131.4 11.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.123 0.487 . . . . 0.0 111.424 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.425 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -133.05 141.24 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.354 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 33.8 mt-30 -121.25 130.16 53.53 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' ILE . 8.3 mt -119.34 130.6 73.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.09 129.91 56.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.821 0.343 . . . . 0.0 110.802 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.04 -31.01 70.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.713 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.21 146.26 39.61 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' PHE . . . -47.98 -93.08 0.01 OUTLIER Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 104' ' ' PHE . 38.7 p-10 -38.28 98.58 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' C ' ' O ' ' A' ' 103' ' ' ASP . 23.7 m-85 -8.99 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.216 0.948 . . . . 0.0 112.046 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' ASP . 38.0 m -153.88 163.28 40.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 -151.53 20.14 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.115 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -73.11 135.55 44.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.481 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 44.3 ttp -120.95 124.52 45.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.614 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.5 m-85 -116.23 134.37 54.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 95' ' ' LYS . 1.9 pt-20 -120.96 119.26 32.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.018 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 111' ' ' THR . 6.1 t -148.98 125.11 10.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.78 44.42 1.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.14 -177.33 5.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.583 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.0 p-10 -87.07 155.96 19.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.127 0.489 . . . . 0.0 110.087 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 172' ' ' SER . 53.6 t -133.16 124.25 18.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.75 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.734 1.622 . . . . 0.0 110.789 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.8 m -115.69 112.83 22.66 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.68 -45.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.523 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.3 ttt -66.06 -19.47 65.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.436 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -76.25 -45.82 31.0 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.004 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.5 pt20 -100.74 -25.81 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 35.0 m-85 -110.25 1.71 18.79 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.4 m-70 52.05 9.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.118 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -75.91 133.69 40.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -107.52 -30.01 8.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.492 -178.429 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -149.31 109.28 4.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.87 124.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.792 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.0 m80 -105.79 -30.3 9.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.191 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 102' ' ' GLY . 15.7 t -152.68 147.82 26.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.0 111.196 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -149.22 126.88 11.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.978 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -107.91 -169.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.499 . . . . 0.0 110.468 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t 51.3 89.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.5 HD11 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mm? -104.37 168.5 9.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.092 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -142.02 111.18 6.37 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 34.19 -91.47 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.016 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.0 t -115.28 138.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.7 t-105 -130.23 168.07 17.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 HG12 ' A' ' 176' ' ' ILE . 76.3 mt -144.61 121.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.825 0.345 . . . . 0.0 111.4 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.62 130.4 55.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -107.89 111.22 23.23 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.099 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -51.19 -25.67 5.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.99 160.73 28.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.94 164.87 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.38 2.053 . . . . 0.0 111.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 3.1 m120 74.61 15.97 3.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.32 25.35 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -108.35 168.32 9.4 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 97.87 168.05 32.11 Favored Glycine 0 N--CA 1.462 0.389 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.504 HH11 ' H ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -64.98 137.27 57.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 147' ' ' GLY . 1.4 mp0 -84.21 145.81 28.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -111.54 129.91 55.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.351 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.0 tp -146.32 93.97 2.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.845 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 153' ' ' ASP . 6.0 tp -149.9 145.08 26.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.088 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 152' ' ' LEU . 99.6 m-20 55.88 159.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -156.18 58.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.32 -45.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.346 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -178.85 150.01 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.199 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.5 ' HE2' HD11 ' A' ' 133' ' ' LEU . 3.3 m-85 -122.09 108.33 13.23 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.536 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -108.92 -19.73 13.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -121.23 156.15 57.75 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.687 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.549 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.5 Cg_endo -61.64 -16.39 48.01 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.652 2.235 . . . . 0.0 113.239 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -100.65 -2.85 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.807 0.337 . . . . 0.0 110.779 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -27.46 68.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.549 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.47 21.85 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.389 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.14 26.91 71.19 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.213 -0.517 . . . . 0.0 114.242 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.88 139.21 42.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.847 0.823 . . . . 0.0 109.812 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.22 20.75 0.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.4 153.4 0.25 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.823 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.57 4.38 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 123.023 2.482 . . . . 0.0 111.614 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.33 70.28 4.66 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.929 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.26 -153.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.929 ' H ' HG12 ' A' ' 170' ' ' VAL . 70.8 mm-40 -152.7 -131.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -94.18 -153.67 0.38 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -170.52 -176.25 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -161.08 133.78 6.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.454 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.466 ' CG ' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.95 135.4 42.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.45 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.495 HG12 HD12 ' A' ' 138' ' ' ILE . 13.9 mt -67.56 139.16 21.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.986 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.34 155.72 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.61 179.775 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 4' ' ' THR . 30.3 p -147.76 149.33 32.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.73 0.3 . . . . 0.0 110.271 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 56.94 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 2' ' ' SER . 3.6 p 43.0 26.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.16 43.22 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 4' ' ' THR . 41.5 p -143.38 134.44 25.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.501 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.822 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.2 tttt -160.42 153.24 21.24 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.069 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.39 142.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 122.108 -0.37 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 138.81 53.98 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.964 0.412 . . . . 0.0 110.699 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -119.14 115.01 23.36 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.8 m-85 -94.08 137.96 32.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.14 0.495 . . . . 0.0 110.947 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.22 -49.02 79.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.158 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 39' ' ' SER . 83.1 m-20 -100.97 -174.72 2.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.58 -174.97 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 111.633 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 46.21 23.28 0.19 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.851 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.7 m-85 59.19 44.43 15.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.29 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -115.35 160.67 19.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.355 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.32 -151.4 29.74 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.477 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -56.73 172.36 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -170.56 153.29 4.15 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -135.01 133.81 39.8 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.9 p-10 -120.76 137.63 54.41 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 141.49 25.94 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 8.5 t70 -124.32 15.8 9.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 97.2 m -150.31 147.17 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.35 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 38.1 t0 -37.64 155.55 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.512 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 43.8 t -155.66 161.91 40.69 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.41 -57.62 2.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.62 112.71 4.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -102.17 8.11 40.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.972 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' O ' ' O ' ' A' ' 34' ' ' LEU . 75.0 t60 -59.0 -29.35 67.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.536 0.684 . . . . 0.0 109.91 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.6 p -60.34 -29.76 69.09 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.01 -15.35 36.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.7 tp -140.87 137.2 33.04 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 t -99.67 -9.02 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.36 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.3 ttm180 -154.18 143.13 21.1 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.238 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 4.6 p -110.47 104.6 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.735 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.0 m-20 -129.32 155.85 44.96 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.735 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 36.47 129.6 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.691 1.244 . . . . 0.0 112.218 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.291 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.0 ptpt -155.87 102.84 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.103 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -65.85 151.05 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.402 0.62 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -123.35 51.53 1.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.082 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.27 -96.14 0.1 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.974 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.52 -140.9 4.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 48.8 m -81.43 166.84 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.601 -0.352 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.822 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -154.01 155.39 35.46 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.253 0.549 . . . . 0.0 110.688 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.86 118.33 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 m -115.98 131.43 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.052 0.453 . . . . 0.0 110.73 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.56 111.99 24.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 76.0 tt0 -38.98 -34.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -113.55 147.19 37.01 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.8 Cg_endo -68.01 157.76 60.35 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.733 2.289 . . . . 0.0 111.309 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.8 m120 86.5 -2.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.329 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.6 m-85 85.61 59.14 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.306 0.379 . . . . 0.0 111.261 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . -149.99 178.77 8.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.022 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 60.56 124.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 6.0 m-85 16.34 104.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.074 0.55 . . . . 0.0 112.26 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.7 OUTLIER -99.57 101.86 13.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.341 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.6 m-85 -103.52 149.76 24.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.098 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -107.47 98.78 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -76.65 114.26 37.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.25 163.61 17.35 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.298 1.998 . . . . 0.0 112.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.52 115.24 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.87 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.28 176.31 41.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -100.68 154.67 18.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.159 0.504 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 41.6 m-85 -147.34 86.59 6.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.614 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_exo -57.15 -18.32 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.967 2.444 . . . . 0.0 112.761 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -148.45 161.71 41.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.735 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.6 p90 -65.4 -53.18 46.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 28.8 mt-30 -43.18 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.903 0.382 . . . . 0.0 111.894 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.14 -4.17 40.13 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.735 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.81 23.33 11.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.824 -0.171 . . . . 0.0 110.838 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.4 mmt 89.84 23.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.535 1.147 . . . . 0.0 111.661 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 29.85 54.36 0.2 Allowed Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 17.4 mt -82.63 14.87 2.86 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.953 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER 112.73 163.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 125.263 1.602 . . . . 0.0 109.771 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.4 p30 -94.73 64.99 3.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.675 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 35.9 ttm180 -142.07 118.75 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.76 129.34 20.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 109.784 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.691 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.8 p -110.07 -163.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.0 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.5 m -45.33 -179.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.499 . . . . 0.0 110.879 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.535 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 14.4 p -150.46 152.22 33.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -116.99 128.66 55.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.89 123.24 17.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.118 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.2 t -125.23 133.06 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.495 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.6 m-70 -103.68 161.42 13.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.061 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.784 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -76.84 159.57 78.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.477 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.2 150.73 53.96 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.536 2.157 . . . . 0.0 112.209 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.7 p -155.52 169.34 24.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.467 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 76.28 -71.57 2.01 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -74.98 32.3 1.07 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 91' ' ' GLY . 4.9 pt20 34.16 -106.44 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.27 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 34.4 t80 -156.15 114.17 3.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.343 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.4 tptm -155.62 133.01 10.96 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.148 0.499 . . . . 0.0 111.034 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.9 tt -135.03 145.64 31.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.95 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 28.2 mt-30 -123.57 130.77 53.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.748 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.596 HD13 HD11 ' A' ' 118' ' ' ILE . 8.5 mt -119.98 131.04 73.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.167 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.7 m-85 -111.83 130.01 55.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.964 0.411 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.27 -28.11 68.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.65 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -122.55 148.54 45.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.206 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.24 -171.48 1.25 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 46.33 29.22 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.404 . . . . 0.0 110.464 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 54.67 82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 m -160.32 161.04 33.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.838 0.351 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.85 -153.11 22.21 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -72.58 137.58 46.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 110.641 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 53.0 ttp -122.13 127.11 49.71 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.827 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 54.1 m-85 -118.07 134.97 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 110.65 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.68 116.74 25.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.052 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.22 126.48 24.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.978 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.24 36.38 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.35 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.04 -177.65 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.732 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p30 -85.68 160.13 19.64 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.32 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.2 t -136.03 124.86 15.63 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.669 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 57.4 Cg_endo -78.61 -53.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.208 1.939 . . . . 0.0 110.855 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.3 m -120.26 113.11 19.92 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -67.91 -46.18 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.653 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.48 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 26.9 ttt -64.73 -20.6 66.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.101 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.38 -49.18 35.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 3.9 pt20 -100.16 -23.04 14.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.167 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 33.9 m-85 -111.09 -0.1 16.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.855 0.359 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.1 m-70 52.14 10.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.281 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.438 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.2 mtt -78.58 134.5 37.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -107.3 -27.5 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 48.4 mt-10 -151.19 107.5 3.46 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.075 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 118' ' ' ILE . 8.5 mm -73.67 124.98 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.3 m80 -105.48 -33.43 8.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.035 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 m -152.31 147.46 26.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.986 0.422 . . . . 0.0 110.73 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -145.36 137.46 25.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.776 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -116.07 -173.24 2.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.374 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t 49.21 94.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.41 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 27.1 mt -111.93 168.49 9.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' VAL . 4.3 mp0 -140.62 112.5 7.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.5 -90.77 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 134' ' ' GLU . 10.6 t -117.26 156.29 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.6 t-105 -144.63 169.18 18.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.456 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.7 mt -144.23 123.05 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.47 131.41 55.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -109.17 111.29 22.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -50.11 -21.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.247 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.4 mp -119.37 165.69 16.63 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 86.6 Cg_endo -83.46 167.79 13.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.334 2.023 . . . . 0.0 111.961 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.3 m-20 79.78 14.57 0.94 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.956 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.4 m-85 76.01 28.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.143 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 80.5 mtp180 -136.81 130.21 31.53 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.92 169.14 20.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -51.96 98.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.213 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.616 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 75.5 mt-30 -60.72 133.8 56.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.711 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.4 130.06 56.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.977 0.418 . . . . 0.0 110.822 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 37.3 tp -69.83 134.5 48.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.219 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.31 148.08 45.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.881 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 155' ' ' LYS . 55.1 t0 -121.5 131.56 54.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.125 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -56.84 78.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.465 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 153' ' ' ASP . 49.4 mtpt -145.59 -91.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -174.39 150.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.85 109.6 12.15 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -105.87 -23.21 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.96 157.3 50.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 121.271 0.558 . . . . 0.0 110.784 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.526 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.1 Cg_endo -61.65 -19.38 64.82 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.164 1.909 . . . . 0.0 113.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -98.81 -2.27 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.107 0.479 . . . . 0.0 110.756 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -59.66 -24.87 64.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.153 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.8 OUTLIER -110.36 21.95 16.08 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.54 66.49 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.591 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.27 137.01 46.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.988 0.894 . . . . 0.0 109.437 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.79 21.33 0.16 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 168.1 156.64 0.14 Allowed Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 6.69 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.061 2.507 . . . . 0.0 111.461 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.99 70.87 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.694 0.283 . . . . 0.0 111.35 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -99.03 -150.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.935 ' H ' HG12 ' A' ' 170' ' ' VAL . 16.6 mm-40 -155.99 -132.97 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.356 0 O-C-N 123.14 0.275 . . . . 0.0 110.426 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.3 p -93.4 -155.81 0.46 Allowed 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 122.081 -0.387 . . . . 0.0 111.992 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -171.5 -176.04 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.033 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.433 HH21 HG22 ' A' ' 177' ' ' VAL . 9.1 ptm180 -158.31 133.1 8.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.157 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -51.9 134.37 31.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.235 0.541 . . . . 0.0 110.649 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 138' ' ' ILE . 11.5 mt -68.58 134.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.902 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.433 HG22 HH21 ' A' ' 174' ' ' ARG . 34.7 m -136.15 157.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.255 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 46' ' ' THR . 17.6 tp10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -179.03 -168.34 0.13 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.73 -43.08 97.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.577 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p -113.46 10.65 18.27 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.489 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.9 100.45 2.09 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.2 p -143.03 133.2 24.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.92 0.39 . . . . 0.0 110.534 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -159.22 152.3 22.17 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.096 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -147.49 142.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.816 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 m -125.98 138.97 53.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -119.12 115.75 24.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 84.1 m-85 -95.24 138.23 33.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 6.1 tm-20 -61.24 -49.36 77.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.067 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 99.6 m-20 -98.03 -177.51 3.77 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.103 0.477 . . . . 0.0 109.842 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.7 -176.54 6.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.876 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 46.58 24.43 0.32 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.778 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' H ' ' CB ' ' A' ' 39' ' ' SER . 2.5 m-85 62.07 41.61 10.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.157 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -109.11 172.99 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.114 0.483 . . . . 0.0 110.535 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.77 -155.3 52.82 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.439 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -55.77 175.08 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.8 154.58 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 55.9 t80 -130.76 131.58 44.8 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.7 p-10 -119.66 125.99 50.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.964 0.412 . . . . 0.0 111.197 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -152.79 143.17 22.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.372 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -126.53 24.58 6.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.809 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ASP . 4.4 t -146.79 141.95 27.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.602 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' CYS . 51.7 p-10 -37.16 156.02 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 m -157.95 163.22 38.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.27 -56.63 2.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 38.8 p-10 -152.43 112.26 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -102.19 9.2 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.985 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' O ' ' O ' ' A' ' 34' ' ' LEU . 81.6 t60 -59.66 -28.27 67.11 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.458 0.647 . . . . 0.0 109.964 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -61.27 -30.48 70.5 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.425 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -86.63 -14.06 43.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.97 136.35 30.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.136 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 m -94.86 -10.12 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.495 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 13' ' ' ASP . 58.7 ttp180 -158.7 146.86 18.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.474 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.2 m -110.67 104.61 13.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.416 0.627 . . . . 0.0 111.391 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.741 ' O ' ' O ' ' A' ' 39' ' ' SER . 7.4 m120 -129.33 156.8 43.45 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.348 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.741 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.3 p 35.52 128.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.42 1.105 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.4 mt -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.385 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.2 ptpt -154.67 102.92 2.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.57 150.17 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.448 0.642 . . . . 0.0 110.226 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -123.1 51.68 1.43 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.964 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.06 -96.2 0.1 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.218 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.25 -141.89 4.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 47' ' ' TRP . 83.8 m -79.86 166.34 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.7 m95 -154.65 155.48 34.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.496 0.665 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.36 121.62 42.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.382 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.8 133.54 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.014 0.435 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 52' ' ' ARG . 77.9 m-85 -104.41 109.82 21.83 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 74.0 tt0 -33.55 -33.29 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.644 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 29.9 mtp85 -121.71 151.48 57.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 56.0 Cg_endo -69.92 164.2 35.58 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.764 2.309 . . . . 0.0 112.158 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.6 m120 78.99 -8.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.884 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.9 m-85 81.5 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.5 0.5 . . . . 0.0 110.742 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 52' ' ' ARG . . . -150.01 111.14 4.38 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.874 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 162.45 -66.54 0.24 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' CD1' ' OE1' ' A' ' 51' ' ' GLU . 54.0 m-85 -152.04 178.07 9.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 66.3 mtt -142.09 87.71 2.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.2 t80 -108.96 135.89 49.4 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.782 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.65 91.02 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -70.32 111.86 10.81 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.82 163.51 16.02 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.111 1.874 . . . . 0.0 112.739 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.0 OUTLIER -52.7 116.87 2.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.151 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.64 178.77 42.23 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.528 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.1 mt-10 -101.55 152.4 20.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.002 0.43 . . . . 0.0 110.336 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 22.6 m-85 -144.29 89.52 6.96 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.36 -14.73 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.223 1.948 . . . . 0.0 113.331 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.1 mt-10 -150.26 161.06 43.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.685 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 15.0 p90 -63.26 -50.06 71.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.759 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 30.2 mt-30 -45.0 -9.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.8 mmm180 -75.18 -5.41 44.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.685 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.11 25.98 9.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 75' ' ' GLY . 21.8 mmm 84.93 24.55 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.131 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.4 54.02 0.31 Allowed Glycine 0 N--CA 1.474 1.196 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 30.8 mt -78.98 14.44 1.39 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.148 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 60.0 t30 112.61 164.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.039 1.462 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 52.7 p30 -96.45 65.93 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.57 120.23 10.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.121 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.77 129.73 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.675 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.7 p -111.19 -162.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.578 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.99 -178.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 110.793 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.481 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.8 p -149.75 150.49 32.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -115.99 127.42 54.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 126.39 27.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.309 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.4 t -123.84 131.19 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.704 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.502 ' O ' HG21 ' A' ' 136' ' ' VAL . 25.7 m80 -101.66 161.78 13.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.751 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.06 157.52 71.1 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.24 150.8 53.8 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.31 2.007 . . . . 0.0 112.023 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 91' ' ' GLY . 85.4 p -161.9 -19.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.806 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -92.02 51.72 2.85 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . 153.26 37.61 0.03 OUTLIER Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 35.04 -106.76 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 111.131 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.8 t80 -157.21 113.45 2.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.111 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -154.68 130.99 10.41 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.3 tt -134.26 142.58 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 38.6 mt-30 -123.11 130.59 52.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 8.1 mt -119.49 131.84 70.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.208 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -112.77 131.61 55.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.36 -29.99 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 150.26 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.3 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.5 176.24 14.6 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 55.75 30.58 15.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 6.1 m-85 56.0 83.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -160.58 161.18 32.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.955 0.407 . . . . 0.0 110.569 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.6 -149.36 21.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -77.22 138.59 39.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.671 0.272 . . . . 0.0 110.483 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.3 tmm? -122.23 132.96 54.69 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.055 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 58.1 m-85 -122.1 135.86 54.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -123.11 124.2 42.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.445 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 111' ' ' THR . 11.9 t -147.75 128.57 14.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 p -92.92 38.78 1.03 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.62 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 -177.62 5.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.761 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.4 p-10 -85.51 158.51 20.15 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 172' ' ' SER . 42.7 t -132.8 124.23 18.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.372 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.5 Cg_endo -79.57 -56.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.606 1.537 . . . . 0.0 110.958 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -116.05 113.03 22.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.76 -46.59 74.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-O 121.168 0.509 . . . . 0.0 110.787 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.471 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.1 ttt -65.48 -18.87 65.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.243 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.36 -46.36 33.61 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 121.606 -0.684 . . . . 0.0 111.992 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.45 -24.74 14.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.254 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.3 m-85 -111.28 -0.55 16.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.022 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 52.76 12.13 0.24 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.982 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.414 ' N ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -79.28 133.12 36.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -107.55 -26.94 10.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.545 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.9 mt-10 -150.83 108.27 3.63 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.08 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 118' ' ' ILE . 7.7 mm -74.7 125.97 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.794 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -107.37 -32.27 7.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.332 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.523 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 13.5 t -153.59 147.21 25.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.29 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -146.72 129.18 15.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.735 179.17 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 132' ' ' VAL . 43.9 mtmt -99.83 -157.88 0.63 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.016 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.578 ' O ' ' O ' ' A' ' 131' ' ' LYS . 1.1 m 32.39 110.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.906 0.86 . . . . 0.0 112.058 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 132' ' ' VAL . 3.6 mm? -117.98 166.87 11.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.766 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.2 mp0 -142.75 111.07 6.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.781 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . 35.03 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.603 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -117.25 156.31 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 110.165 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 25.9 t-105 -145.36 168.2 21.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.379 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 91.0 mt -145.39 123.79 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.759 0.314 . . . . 0.0 111.377 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -108.77 130.22 55.38 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.03 110.81 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.83 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 142' ' ' LEU . 76.4 tt0 -49.46 -22.51 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.7 mp -118.47 161.01 37.6 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.432 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 74.1 Cg_endo -77.97 167.44 23.6 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.324 2.016 . . . . 0.0 111.68 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.51 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 1.3 m-20 73.14 14.12 4.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.921 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.2 24.52 0.66 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.636 0.255 . . . . 0.0 111.306 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -108.49 168.96 8.95 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.07 170.43 36.63 Favored Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -55.52 150.32 12.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.148 0.499 . . . . 0.0 109.771 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 7.1 mp0 -108.8 146.7 33.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.665 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -115.46 130.01 56.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 59' ' ' MET . 4.0 tt -150.76 113.42 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.5 tp -150.25 135.71 18.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.232 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 25.2 p30 -86.85 107.86 18.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.543 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -138.38 -116.36 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.565 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -169.3 95.83 0.32 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.48 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 63.61 155.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.467 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.14 108.6 14.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.009 0.433 . . . . 0.0 111.381 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.607 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.2 ptt180 -107.59 -24.69 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.607 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.2 pttm -119.82 154.06 54.98 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 120.84 0.353 . . . . 0.0 110.492 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.537 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.3 Cg_endo -58.42 -16.63 29.97 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.31 2.006 . . . . 0.0 113.5 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.3 mp -100.93 -3.68 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.15 -27.16 68.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.481 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.555 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.7 20.69 18.49 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.642 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.43 28.41 67.8 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.626 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.25 137.67 45.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.792 0.796 . . . . 0.0 109.72 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.11 20.81 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.314 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 171.48 155.47 0.22 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.477 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.64 5.0 5.11 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.952 2.435 . . . . 0.0 111.596 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.59 70.92 6.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.612 0.244 . . . . 0.0 111.153 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -100.93 -147.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -157.73 -132.25 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.611 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -92.21 -154.09 0.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -170.37 -177.07 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.136 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.48 132.45 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.924 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.9 ptm180 -53.92 129.34 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.686 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 138' ' ' ILE . 16.7 mt -59.77 135.41 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.383 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.2 t -133.97 138.74 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.517 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.0 tp10 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.436 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.611 ' H2 ' ' CA ' ' A' ' 5' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 m -58.96 -43.58 91.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.512 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -144.59 -41.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 43.2 p -60.37 -75.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.611 ' CA ' ' H2 ' ' A' ' 1' ' ' GLY . . . 154.09 -50.54 0.48 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p -81.58 163.86 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 110.338 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.722 ' O ' HG13 ' A' ' 42' ' ' VAL . 40.8 tttt -161.45 155.85 22.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.321 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.4 tt -148.58 146.99 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.035 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.6 m -132.97 141.43 48.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -121.71 117.26 26.21 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.5 m-85 -99.68 141.13 32.88 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.047 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.9 tm-20 -64.07 -51.66 63.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.23 -176.39 4.13 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 109.616 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -84.28 -178.17 6.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.466 ' C ' ' CG ' ' A' ' 16' ' ' PHE . 1.6 m120 46.25 24.55 0.28 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER 61.81 44.24 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.214 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -111.21 166.1 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -144.09 31.96 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.608 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -60.97 166.47 3.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.151 -1.025 . . . . 0.0 109.024 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.7 155.94 7.49 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.003 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 58.2 t80 -135.62 135.42 40.21 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 p-10 -104.25 150.12 24.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.615 0.245 . . . . 0.0 110.563 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -162.55 124.94 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.527 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.08 14.35 9.81 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.657 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.8 t -150.66 148.46 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 p30 -39.28 156.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.7 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 48.3 t -158.29 164.29 36.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.65 -56.07 3.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -156.31 109.19 2.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.343 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -92.67 7.53 43.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -58.76 -30.36 67.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.103 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.8 p -64.52 -1.1 1.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.699 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -119.39 -14.84 9.15 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.768 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 15.8 tp -141.33 139.61 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -102.21 -8.38 21.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.852 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.7 ttm180 -153.32 141.87 20.83 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.685 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.9 m -113.02 104.23 12.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.772 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 52.6 m-20 -115.17 -153.76 0.53 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' ASN . 19.1 p -24.94 137.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.61 0.719 . . . . 0.0 112.587 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.0 mt -140.54 147.85 22.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.742 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.8 ptpt -155.89 103.12 2.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.239 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.0 t -66.49 144.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.93 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -115.1 46.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.48 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -164.15 -100.28 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.811 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.544 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.29 -140.15 4.24 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.6 m -78.7 167.27 21.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.437 -0.449 . . . . 0.0 110.851 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.714 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 39.3 m95 -157.11 158.82 37.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.376 0.608 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.98 122.57 43.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.791 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.8 m -119.41 133.02 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.891 0.377 . . . . 0.0 110.671 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 51' ' ' GLU . 92.9 m-85 -106.17 110.57 22.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.928 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 71.4 tt0 -34.87 -36.06 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.37 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.7 mtt-85 -116.61 147.42 39.74 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 45.3 Cg_endo -68.01 156.36 66.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.37 2.047 . . . . 0.0 111.88 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 4.9 m120 86.23 0.41 0.63 Allowed 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.931 0.769 . . . . 0.0 111.216 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 8.9 m-85 82.23 56.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.464 0.478 . . . . 0.0 111.216 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.83 38.31 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.388 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -155.68 22.67 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 17.0 m-85 -74.72 139.11 43.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -103.69 88.98 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.443 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.495 ' C ' HD12 ' A' ' 61' ' ' ILE . 20.6 t80 -92.42 135.42 34.06 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -101.37 94.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -72.46 111.22 10.2 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.15 164.84 19.48 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.078 1.852 . . . . 0.0 112.418 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.06 118.83 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.08 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.48 -180.0 41.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.74 153.24 20.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.004 0.43 . . . . 0.0 110.176 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 4.4 m-85 -142.54 69.79 20.8 Favored Pre-proline 0 C--O 1.221 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.29 -13.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.845 2.363 . . . . 0.0 113.079 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 67' ' ' TYR . 71.2 mt-10 -155.46 163.99 39.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.689 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.1 p90 -65.18 -49.58 69.24 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.063 -179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -42.44 -10.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -80.23 0.78 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.488 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.73 20.9 10.92 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.36 0.124 . . . . 0.0 111.124 178.595 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.8 mmt 92.22 20.33 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.781 1.233 . . . . 0.0 111.716 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.19 59.6 0.27 Allowed Glycine 0 CA--C 1.536 1.358 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.4 mt -89.23 17.14 6.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.423 0.289 . . . . 0.0 111.543 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.6 t30 103.78 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.744 1.278 . . . . 0.0 109.578 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.24 63.74 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -131.54 112.77 12.93 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -146.15 130.34 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.123 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.673 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -108.78 -164.17 0.93 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.034 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' SER . 2.9 m -48.37 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.399 0.619 . . . . 0.0 111.553 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 8' ' ' ILE . 13.5 p -151.41 151.65 32.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.698 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.28 128.28 56.02 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.57 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.87 132.4 53.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.79 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.1 t -129.03 132.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.706 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.44 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.9 m-70 -98.9 162.8 12.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.74 149.92 61.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.08 149.91 82.36 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.126 1.884 . . . . 0.0 112.14 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -156.55 169.45 24.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.284 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 78.72 -73.27 2.29 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -75.93 34.2 1.25 Allowed Glycine 0 C--O 1.226 -0.378 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.5 pt20 33.66 -109.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 111.228 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.725 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 36.7 t80 -153.54 113.1 3.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.2 tptm -153.64 137.29 16.03 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.102 0.477 . . . . 0.0 111.138 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -137.82 145.66 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.087 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 37.2 mt-30 -123.9 129.49 51.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.746 177.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.83 131.42 72.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -111.15 123.38 50.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.011 0.434 . . . . 0.0 110.786 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.01 -19.74 20.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -131.2 144.75 51.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.455 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.49 -170.46 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 44.62 29.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.741 0.305 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 17.4 m-85 54.64 82.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -159.64 164.13 34.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 -158.49 30.04 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.863 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -64.66 135.74 56.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.361 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 45.2 ttp -118.23 122.21 42.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.186 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.58 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 44.9 m-85 -115.85 130.57 56.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.46 120.69 36.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.097 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -149.54 129.75 13.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.412 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -97.09 49.91 1.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.48 -176.63 5.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.351 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.3 p-10 -89.65 160.51 16.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.652 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 58.2 m -138.41 123.02 11.83 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.492 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 58.0 Cg_endo -76.15 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.878 1.719 . . . . 0.0 110.53 178.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.9 m -110.34 114.09 27.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.2 tt -70.05 -37.19 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.958 0.409 . . . . 0.0 110.947 -178.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.5 ttt -70.51 -19.01 62.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.728 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -81.81 -42.3 19.88 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.14 -0.975 . . . . 0.0 111.513 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.669 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 1.0 OUTLIER -93.15 -30.53 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.769 -177.531 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.1 m-85 -116.86 4.23 12.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.813 -178.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.7 m-70 54.19 3.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.0 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.548 ' H ' ' C ' ' A' ' 122' ' ' PHE . 35.8 mtt -72.12 133.09 44.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.112 0.482 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -109.02 -24.65 11.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.192 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.557 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.8 mt-10 -151.78 107.78 3.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 13.8 mm -76.71 126.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.587 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.4 m80 -104.55 -36.5 7.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.169 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.509 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 7.4 t -148.27 143.47 26.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.129 0.49 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.3 t -143.44 134.09 25.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -114.38 -175.99 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.571 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 28.0 t 54.7 93.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.92 165.56 11.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.106 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.4 mp0 -139.4 111.83 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.55 -88.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.6 t -119.13 156.48 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.096 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.725 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.2 t-105 -144.47 166.72 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.643 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.8 mt -144.23 124.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.375 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.888 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 30.8 m-85 -107.4 113.8 27.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.802 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.1 -22.76 1.77 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.647 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.9 mp -121.74 165.36 20.31 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.462 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.0 Cg_endo -81.93 169.91 14.35 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.241 1.961 . . . . 0.0 112.3 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.496 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.3 m-20 77.0 13.67 2.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.783 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.496 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 74.25 30.12 1.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.11 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 93.0 mtt180 -134.68 126.23 28.68 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.4 173.62 20.77 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -52.45 113.66 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.896 0.379 . . . . 0.0 110.499 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' CE2' ' A' ' 60' ' ' TYR . 33.9 mt-30 -82.18 149.48 27.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.53 152.33 39.31 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.857 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tp -110.58 154.42 23.77 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.83 133.73 51.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -121.41 -110.99 0.33 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.428 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.42 153.07 43.76 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.663 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -62.75 129.44 40.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 64.66 158.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.57 111.49 14.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.965 0.412 . . . . 0.0 111.146 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -108.58 -21.48 12.69 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -123.64 154.88 66.8 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.362 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.492 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.0 Cg_endo -58.98 -20.53 53.71 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.481 2.121 . . . . 0.0 113.611 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.24 -5.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 110.654 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.81 -33.18 64.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.331 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.547 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.02 21.97 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.459 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.96 27.64 66.24 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.629 176.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.83 138.2 43.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.802 0.801 . . . . 0.0 110.678 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.31 24.2 0.19 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.1 m 165.19 153.79 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.447 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 170' ' ' VAL . 50.9 Cg_endo -71.18 -18.07 30.85 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.797 2.332 . . . . 0.0 111.509 178.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.41 70.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.302 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.963 HG22 ' H ' ' A' ' 171' ' ' GLN . 8.8 p -104.99 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.963 ' H ' HG22 ' A' ' 170' ' ' VAL . 2.0 tp60 -152.82 -130.86 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.501 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.6 p -94.85 -154.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -171.53 -178.17 2.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.295 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -157.7 132.97 8.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.96 178.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -52.74 126.11 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 110.347 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.491 HD12 ' HB ' ' A' ' 136' ' ' VAL . 10.9 mt -56.59 129.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.823 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.35 135.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.502 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.049 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 79.0 p . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 108.844 -0.798 . . . . 75.04 108.844 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.663 ' O ' HG13 ' A' ' 42' ' ' VAL . 42.7 tttt -107.03 147.91 29.36 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.273 0.358 . . . . 8.2 111.561 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 83' ' ' CYS . 18.5 tt -140.15 136.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.95 -0.389 . . . . 6.76 109.95 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 35.4 m -120.32 138.11 53.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 8.47 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 67.8 m-85 -116.86 116.61 27.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.067 -0.716 . . . . 4.74 109.067 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.602 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 88.6 m-85 -95.96 140.61 30.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.213 0.53 . . . . 9.67 111.144 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HB2' ' CB ' ' A' ' 19' ' ' ARG . 4.3 tm-20 -62.06 -51.86 66.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.851 -0.613 . . . . 46.58 109.841 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.42 -175.95 3.36 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.791 -0.641 . . . . 24.88 109.92 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.67 -179.38 7.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.75 -0.659 . . . . 104.03 110.455 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 49.77 26.11 1.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 66.74 110.61 179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m-85 57.96 44.57 19.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 19.33 110.947 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 15' ' ' ASN . 38.6 mt-30 -114.74 161.49 18.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.974 0.416 . . . . 111.5 110.724 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.26 -146.4 29.06 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.859 -0.61 . . . . 138.46 112.437 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.728 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.1 ttm-85 -57.05 166.25 1.1 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.709 -0.849 . . . . 613.65 108.709 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.24 152.12 4.87 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.78 -0.452 . . . . 325.16 109.78 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 47.4 t80 -130.6 131.9 45.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 18.95 109.596 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -116.21 128.78 55.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 278.02 110.649 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.01 139.21 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 342.02 109.975 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -123.99 22.24 8.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.323 -0.399 . . . . 154.21 111.147 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 150.29 29.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.069 -0.253 . . . . 117.53 110.605 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -39.9 156.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.846 -0.616 . . . . 317.22 111.374 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -157.34 164.21 37.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.625 . . . . 167.98 110.184 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.04 -56.41 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 11.81 110.921 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -151.01 108.79 3.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.579 -0.737 . . . . 348.8 111.295 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.488 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.5 p90 -99.74 5.32 45.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 6.94 110.48 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.3 t60 -58.21 -26.89 63.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.186 0.517 . . . . 9.31 109.966 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.9 p -62.04 -20.94 64.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.956 -0.566 . . . . 32.68 110.265 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.16 -17.33 19.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 13.98 111.266 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.728 HD12 ' HD2' ' A' ' 19' ' ' ARG . 15.7 tp -138.91 135.5 34.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.809 0.338 . . . . 5.79 110.276 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.64 -9.66 26.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.5 -0.318 . . . . 80.89 111.551 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 30.2 ttm-85 -155.11 142.01 19.12 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 110.025 -0.361 . . . . 332.73 110.025 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -108.59 102.32 11.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.332 0.586 . . . . 99.41 110.847 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 39' ' ' SER . 76.4 m-20 -125.57 154.91 41.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.953 -1.499 . . . . 45.58 106.953 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.642 ' O ' ' O ' ' A' ' 38' ' ' ASN . 15.6 p 39.04 128.67 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.497 1.142 . . . . 8.21 112.805 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 13.7 mt -142.02 143.49 26.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.307 -0.86 . . . . 5.81 111.772 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.5 ptpt -154.67 101.79 2.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.722 -0.672 . . . . 8.95 109.571 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 7' ' ' LYS . 1.9 t -65.73 148.03 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 110.033 -0.358 . . . . 131.71 110.033 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.91 57.8 1.04 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.164 -0.68 . . . . 256.75 109.164 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.96 -100.05 0.13 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.544 -0.753 . . . . 10.26 111.338 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -131.43 -142.32 4.99 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.485 -0.646 . . . . 8.86 111.485 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 47' ' ' TRP . 86.6 m -79.98 165.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 8.71 110.601 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.751 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 15.6 m95 -151.79 153.16 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 7.86 111.748 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.42 117.69 33.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.274 -1.009 . . . . 6.12 108.274 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 80' ' ' LEU . 15.4 m -118.03 133.69 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 6.2 110.662 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.42 117.04 33.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 43.74 110.182 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.2 -39.59 0.18 Allowed 'General case' 0 C--N 1.333 -0.111 0 O-C-N 123.553 0.533 . . . . 42.52 110.674 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -116.85 153.32 49.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 698.05 110.866 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 48.1 Cg_endo -71.06 168.02 24.43 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.103 2.535 . . . . 26.34 111.108 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 54' ' ' ASN . 0.6 OUTLIER 79.8 -4.29 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.872 0.732 . . . . 216.76 110.885 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 12.0 m-85 . . . . . 0 N--CA 1.464 0.27 0 O-C-N 123.493 0.495 . . . . 25.54 110.749 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.532 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 13.2 t80 . . . . . 0 N--CA 1.461 0.118 0 N-CA-C 109.587 -0.523 . . . . 999.99 109.587 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -102.26 95.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 11.1 109.811 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD13 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -77.56 109.96 11.2 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.241 -0.436 . . . . 6.8 110.096 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 90.5 Cg_endo -81.98 165.83 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.098 2.532 . . . . 9.35 112.407 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -56.26 112.38 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.182 -0.463 . . . . 16.37 110.119 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.59 175.74 41.54 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.327 -1.109 . . . . 9.23 110.327 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.614 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.4 mt-10 -100.15 157.75 16.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.096 0.474 . . . . 11.75 110.747 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.614 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.4 m-85 -149.93 80.4 7.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.344 -0.843 . . . . 12.89 108.955 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 48.2 Cg_exo -48.79 -22.33 4.53 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.008 2.472 . . . . 28.55 113.284 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.35 163.4 35.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.388 -0.597 . . . . 36.83 109.388 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 26.5 p90 -61.63 -45.2 95.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 22.71 110.74 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG2' ' CE2' ' A' ' 70' ' ' TYR . 7.4 mt-30 -46.0 -13.43 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.217 0.451 . . . . 319.03 112.217 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -75.36 -3.51 34.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.59 -0.277 . . . . 516.27 111.566 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -118.35 26.33 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.404 -0.221 . . . . 7.41 110.404 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.546 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.8 mmt 85.0 23.74 0.09 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.936 0.773 . . . . 49.56 110.955 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.35 50.1 0.25 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.916 -0.473 . . . . 12.4 111.916 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.634 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 16.8 mt -79.89 18.31 0.83 Allowed 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.968 -0.136 . . . . 54.39 110.917 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.634 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 66.3 t30 106.96 159.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.456 1.097 . . . . 154.95 110.155 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -91.72 57.35 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.666 0.604 . . . . 144.44 110.637 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.16 108.84 9.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.811 -0.631 . . . . 657.17 110.276 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -141.03 126.81 19.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.238 -0.585 . . . . 5.23 110.018 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -101.2 -162.54 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.742 -0.663 . . . . 5.2 109.431 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 12.8 p -50.27 -168.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.403 0.621 . . . . 140.35 111.262 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.751 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 28.1 p -154.79 161.79 41.36 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.407 -0.517 . . . . 8.04 110.071 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -122.94 131.84 53.9 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.498 -0.556 . . . . 332.31 109.498 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 123.6 18.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 9.1 110.43 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 48' ' ' ALA . 48.2 t -121.87 129.92 75.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.401 -0.363 . . . . 16.84 110.991 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -101.4 157.62 16.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.935 -0.575 . . . . 126.92 110.265 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.61 150.48 63.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 176.97 110.651 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 C-N-CA 123.007 2.471 . . . . 11.34 112.284 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.621 0.248 . . . . 44.38 110.664 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.703 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.8 t80 -162.49 114.39 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.797 -0.446 . . . . 11.73 109.797 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.486 ' CE ' ' HB2' ' A' ' 110' ' ' GLU . 21.0 tptm -154.83 132.17 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 179.04 110.828 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -133.7 143.1 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 4.92 111.444 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -120.43 131.15 54.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.043 -0.98 . . . . 81.94 109.255 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 108' ' ' MET . 6.7 mt -120.82 134.13 65.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 116.252 -0.431 . . . . 4.03 110.677 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.2 m-85 -115.16 132.66 56.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 7.67 110.976 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.2 -26.7 68.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.637 . . . . 27.19 110.653 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -122.09 144.77 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 146.97 110.584 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -61.44 174.4 6.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.753 -0.939 . . . . 60.39 110.753 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.85 33.6 23.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 414.82 110.536 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 11.7 m-85 53.46 78.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.841 -0.618 . . . . 19.09 110.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -156.39 163.09 39.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 19.13 110.699 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.67 -154.91 27.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.436 -0.665 . . . . 44.38 111.436 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -72.57 132.82 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 35.47 110.906 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 47.8 ttp -116.7 128.37 55.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.82 -0.627 . . . . 161.99 110.492 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 39.1 m-85 -119.25 135.63 54.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 16.12 110.769 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' HB2' ' CE ' ' A' ' 95' ' ' LYS . 8.3 pt-20 -121.55 123.31 41.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.397 -0.82 . . . . 48.3 110.89 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 111' ' ' THR . 11.8 t -148.11 125.83 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.138 -0.483 . . . . 13.7 110.976 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.4 OUTLIER -93.22 38.77 1.04 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.534 0.683 . . . . 113.42 110.719 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.78 -176.47 4.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.597 -0.729 . . . . 67.29 110.352 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -88.1 160.29 17.86 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.891 0.377 . . . . 16.91 110.221 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.59 ' SG ' ' HG2' ' A' ' 121' ' ' GLN . 6.6 t -140.87 122.57 9.29 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.921 -0.582 . . . . 162.84 110.504 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 172' ' ' SER . 56.1 Cg_endo -75.59 -56.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.785 2.324 . . . . 12.34 111.609 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -115.28 109.72 18.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.858 -0.61 . . . . 13.14 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.2 tt -69.37 -40.94 80.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.247 0.546 . . . . 6.62 110.025 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.4 ttt -67.79 -31.9 72.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 78.86 110.855 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.09 -47.2 71.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.207 -0.451 . . . . 342.48 112.155 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.59 ' HG2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -100.87 -29.68 12.1 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.992 0.738 . . . . 251.73 112.992 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 109' ' ' TYR . 17.4 m-85 -104.02 -1.74 27.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.565 -0.454 . . . . 7.65 110.948 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.5 m-70 55.25 7.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 14.8 111.737 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.537 ' SD ' ' CG2' ' A' ' 98' ' ' ILE . 41.7 mtt -77.16 132.88 39.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.988 0.423 . . . . 85.03 110.156 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -102.96 -31.63 10.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.618 -0.719 . . . . 337.58 110.242 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.476 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 57.4 mt-10 -148.67 110.05 4.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 84.76 110.372 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 11.6 mm -74.24 122.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.595 -0.52 . . . . 4.4 109.595 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.6 m80 -103.17 -32.07 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 7.83 110.77 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.476 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 44.3 t -148.18 142.89 26.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.341 -0.39 . . . . 136.38 110.831 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.26 127.21 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 18.11 110.049 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -109.03 -176.79 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.577 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.638 ' C ' HD22 ' A' ' 133' ' ' LEU . 61.8 t 56.86 98.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.0 -0.545 . . . . 239.63 110.742 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.72 161.17 16.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.788 -0.642 . . . . 238.81 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -138.63 111.03 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 385.49 110.169 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.01 -91.88 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.005 -0.838 . . . . 11.62 111.005 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 134' ' ' GLU . 42.8 t -122.83 141.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 110.065 -0.346 . . . . 8.41 110.065 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.703 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 26.6 t-105 -124.51 169.55 11.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 5.14 110.66 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HG12 ' A' ' 176' ' ' ILE . 59.7 mt -145.24 122.21 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.694 -0.684 . . . . 4.68 111.05 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.4 133.91 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.702 -0.481 . . . . 4.24 109.702 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 149' ' ' GLN . 25.0 m-85 -111.08 112.14 23.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 7.07 110.763 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -52.97 -25.27 11.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.159 -0.473 . . . . 28.99 110.277 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.01 160.61 31.68 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.53 . . . . 18.0 109.99 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HG3' ' A' ' 171' ' ' GLN . 58.9 Cg_endo -76.79 169.3 21.98 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.707 2.271 . . . . 11.59 111.552 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 143' ' ' PRO . 8.3 m-80 70.9 19.45 5.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 119.59 111.104 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 174' ' ' ARG . 3.7 m-85 70.92 33.25 2.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.654 -0.248 . . . . 18.4 111.165 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 140' ' ' TYR . 45.4 mtm180 -121.53 174.0 7.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 999.99 110.846 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.92 175.36 42.59 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.895 -0.882 . . . . 20.69 110.895 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -49.03 136.39 14.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 949.07 110.051 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.556 ' HG2' ' CE1' ' A' ' 140' ' ' TYR . 70.0 mt-30 -99.53 122.1 42.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 397.97 109.809 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 71.1 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 40.01 109.925 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.554 ' HE2' HD11 ' A' ' 133' ' ' LEU . 16.0 m-85 . . . . . 0 N--CA 1.46 0.07 0 N-CA-C 110.274 -0.269 . . . . 31.64 110.274 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' HG2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -104.75 -20.52 13.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 708.49 110.768 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 1.5 pttm -124.77 159.76 56.95 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.107 0.479 . . . . 310.53 110.773 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -62.59 -19.84 69.06 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.841 2.361 . . . . 12.19 112.775 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.3 mp -96.25 -6.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.908 0.385 . . . . 26.61 110.443 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -56.77 -30.32 63.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 33.18 110.975 -178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -103.56 23.95 11.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.081 0.467 . . . . 9.22 109.929 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.4 28.73 73.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.851 -0.613 . . . . 11.66 112.904 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.46 137.74 41.87 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.709 0.754 . . . . 10.16 110.082 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.17 18.73 0.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 15.02 110.647 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 169.39 154.17 0.16 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.695 0.283 . . . . 17.04 111.171 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 55.6 Cg_endo -74.8 2.98 5.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.172 2.582 . . . . 20.88 112.037 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.26 75.02 5.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 15.0 110.524 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.863 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -102.74 -147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.894 -0.78 . . . . 80.6 108.894 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.863 ' H ' HG12 ' A' ' 170' ' ' VAL . 15.7 mm-40 -156.67 -133.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.014 -0.365 . . . . 126.0 110.014 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -91.95 -153.02 0.32 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.411 0.148 . . . . 152.78 111.256 -177.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -169.59 -176.14 2.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.064 0.459 . . . . 6.31 110.806 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.55 HH21 HG23 ' A' ' 177' ' ' VAL . 10.2 ptm180 -160.48 130.88 5.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.599 . . . . 13.69 110.353 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.5 ptt180 -53.01 131.52 36.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 467.95 110.879 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 138' ' ' ILE . 30.9 mt -62.5 134.68 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.446 -0.797 . . . . 15.16 109.893 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.55 HG23 HH21 ' A' ' 174' ' ' ARG . 0.1 OUTLIER -135.58 153.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.824 -0.625 . . . . 132.74 110.601 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.026 -0.988 . . . . 408.25 110.757 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 CA--C 1.528 0.098 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.782 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.4 tttt -160.05 151.1 19.23 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.053 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.8 142.14 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.991 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -124.72 138.71 54.27 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 116.16 25.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.83 138.24 34.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.271 0.558 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.7 tm-20 -60.88 -49.94 75.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.01 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.416 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 99.7 m-20 -97.82 -176.94 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 110.141 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -82.08 -176.63 6.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.41 24.26 0.28 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.029 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' H ' ' CB ' ' A' ' 39' ' ' SER . 3.3 m-85 63.76 41.64 6.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.5 179.15 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 110.451 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.38 -159.06 48.15 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -53.39 175.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.05 150.68 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.4 t80 -127.94 131.34 49.33 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -119.8 124.0 45.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.864 0.364 . . . . 0.0 111.151 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.27 142.59 23.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.316 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -125.39 24.39 7.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASP . 10.6 m -146.22 141.71 27.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 25' ' ' CYS . 55.1 p-10 -36.27 156.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.5 m -156.48 162.71 39.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.354 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -55.96 3.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.05 0.452 . . . . 0.0 110.538 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -153.03 111.35 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.2 p90 -101.29 10.56 40.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.963 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.597 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.4 t60 -60.85 -26.07 67.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 109.962 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.7 p -63.2 -30.55 71.68 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.229 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.61 -12.41 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.532 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -144.29 138.33 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 109.986 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 m -99.28 -9.22 23.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.652 0.263 . . . . 0.0 111.464 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 53.2 ttm-85 -156.48 144.89 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.0 m -110.11 103.89 12.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.728 ' O ' ' O ' ' A' ' 39' ' ' SER . 71.5 m-20 -128.7 156.42 43.52 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.728 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.5 p 34.95 129.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.438 1.114 . . . . 0.0 112.399 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -141.76 145.51 24.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.034 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -153.35 102.9 2.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -66.5 148.96 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.52 0.676 . . . . 0.0 110.568 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -122.21 51.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.732 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.548 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.17 -94.64 0.1 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.927 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -139.31 -140.16 3.9 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 47' ' ' TRP . 94.9 m -80.56 166.41 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.366 -0.491 . . . . 0.0 110.824 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.782 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.6 m95 -153.78 156.71 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.336 0.589 . . . . 0.0 110.746 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.99 120.36 38.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.83 132.8 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.017 0.437 . . . . 0.0 110.931 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' GLU . 87.8 m-85 -104.45 111.13 23.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.671 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 50' ' ' TYR . 68.8 tt0 -35.74 -35.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.294 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -116.18 148.12 40.86 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.043 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.8 Cg_endo -68.59 158.61 57.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.459 2.106 . . . . 0.0 111.719 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.5 m-80 85.7 -4.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.841 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 10.9 m-85 . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 121.172 0.51 . . . . 0.0 111.1 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 33.4 t80 . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.36 91.29 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.874 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.7 110.38 5.84 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.422 0.451 . . . . 0.0 110.074 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.78 162.14 18.75 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.269 1.979 . . . . 0.0 112.539 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.19 118.17 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.167 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.47 179.36 41.27 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.539 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.5 mt-10 -101.98 152.55 20.81 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.959 0.409 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 21.8 m-85 -145.75 85.23 7.84 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.5 -18.13 24.35 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.142 2.561 . . . . 0.0 113.137 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.7 mt-10 -150.63 161.73 42.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.724 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -63.11 -51.2 67.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.401 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 18.3 mt-30 -43.28 -10.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.1 mmm180 -75.08 -6.5 49.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.724 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -118.02 27.29 9.09 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.853 -0.158 . . . . 0.0 110.646 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.9 mmt 83.56 24.73 0.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.175 0.922 . . . . 0.0 111.102 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.12 50.39 0.48 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.7 mt -74.45 14.21 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.7 t30 110.21 167.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.538 1.149 . . . . 0.0 109.349 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 54.6 p30 -99.27 60.56 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.034 0.445 . . . . 0.0 110.383 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -137.89 115.72 11.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.057 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.74 128.6 21.82 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -111.81 -162.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 24.3 p -45.25 -179.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.129 0.49 . . . . 0.0 110.504 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.54 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -151.09 153.33 34.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -118.69 128.56 54.62 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.71 126.47 27.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.149 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.2 t -126.54 132.6 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.79 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -99.29 161.88 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.85 148.86 82.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.525 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.293 1.996 . . . . 0.0 112.503 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 120.723 0.297 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 20.5 t80 -155.78 112.4 3.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -149.58 127.91 12.17 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.385 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.2 tt -130.27 136.52 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 53.2 mt-30 -120.04 126.04 49.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 107' ' ' GLN . 5.8 mt -118.37 132.81 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.72 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.691 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 46.3 m-85 -117.5 127.75 54.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.05 0.453 . . . . 0.0 111.523 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.52 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 73.6 tt0 -60.27 -28.02 67.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.859 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 103' ' ' ASP . 51.3 mttm -107.95 141.54 39.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.448 0.642 . . . . 0.0 110.778 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -69.67 37.02 0.37 Allowed Glycine 0 C--N 1.315 -0.597 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.018 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 101' ' ' LYS . 5.6 p-10 -154.27 35.7 0.42 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.479 ' HA ' ' CG ' ' A' ' 99' ' ' PHE . 28.6 m-85 56.31 56.26 5.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.32 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 3.8 m -161.13 170.68 19.92 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.747 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.63 -43.45 2.89 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.835 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 72.1 tp60 -156.86 119.12 3.91 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.517 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 29.4 ttp -116.6 109.15 16.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.232 0.924 . . . . 0.0 110.159 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.607 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 16.8 m-85 -115.54 133.47 56.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -122.9 122.84 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 111' ' ' THR . 5.8 t -152.17 126.24 9.16 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.383 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 t -94.09 44.08 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 111.002 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -141.79 179.52 6.8 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -83.45 155.43 23.42 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.717 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.632 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -131.37 120.71 18.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.939 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.58 -55.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.861 1.707 . . . . 0.0 110.727 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.1 m -118.02 114.36 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -69.31 -43.31 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.5 ttt -67.25 -19.48 65.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.729 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.08 -46.61 41.87 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 4.8 pt20 -99.85 -24.72 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.609 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 28.5 m-85 -114.68 2.48 14.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.6 0.238 . . . . 0.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 50.6 14.02 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.268 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.415 ' N ' ' C ' ' A' ' 122' ' ' PHE . 13.6 mtp -80.24 135.89 36.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -109.32 -25.99 10.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 67.6 mt-10 -150.81 107.06 3.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.014 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 118' ' ' ILE . 8.4 mm -74.58 123.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.681 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 66.1 m80 -105.4 -31.08 9.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.906 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 14.7 m -150.49 145.79 26.22 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.623 ' SG ' HG12 ' A' ' 132' ' ' VAL . 6.5 t -150.56 124.88 9.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.19 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -94.39 53.0 1.63 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.623 HG12 ' SG ' ' A' ' 130' ' ' CYS . 7.5 p -95.92 125.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -147.11 94.95 2.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.325 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 136' ' ' VAL . 14.3 mp0 -144.58 109.78 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.115 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.08 -85.94 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.603 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.7 t -127.12 156.85 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.723 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.4 t-105 -144.82 166.2 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.578 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.3 mt -144.61 123.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.713 0.292 . . . . 0.0 111.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.616 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -108.2 129.07 55.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 23.8 m-85 -108.51 110.8 22.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.34 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.528 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 82.2 tt0 -49.85 -23.27 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.77 160.3 37.21 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.331 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.478 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.4 Cg_endo -78.55 165.25 25.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.387 2.058 . . . . 0.0 111.943 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.695 ' ND2' HH21 ' A' ' 146' ' ' ARG . 1.9 m-80 75.1 13.57 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.2 m-85 79.27 24.6 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.695 HH21 ' ND2' ' A' ' 144' ' ' ASN . 87.7 mtm180 -107.03 169.44 8.55 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.35 170.35 36.2 Favored Glycine 0 N--CA 1.463 0.45 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.536 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.3 ptt180 -61.75 143.27 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.209 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 70.1 mt-30 -97.97 146.79 25.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.536 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 48.0 m-85 . . . . . 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.72 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 N--CA 1.461 0.125 0 CA-C-O 120.789 0.328 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . 13.4 ptm180 -108.27 -21.62 12.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.546 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.44 ' H ' ' HG3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -121.19 156.2 57.6 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.398 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.8 Cg_endo -61.13 -19.0 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.736 2.291 . . . . 0.0 113.847 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -100.8 -1.59 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.355 0.598 . . . . 0.0 110.636 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.09 -29.42 70.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.843 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.571 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -105.0 22.91 14.45 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.79 27.55 70.58 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.871 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.8 138.05 45.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.013 0.906 . . . . 0.0 109.473 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.96 20.63 0.35 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.217 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER 175.42 154.64 0.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.837 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.22 3.14 6.49 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.274 2.649 . . . . 0.0 111.801 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.05 5.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.393 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -95.95 -150.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.9 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -157.18 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.786 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.8 -155.57 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.61 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 52.0 p90 -169.87 -177.07 2.52 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.082 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.93 131.8 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -54.15 129.91 36.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.021 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.557 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.5 mt -61.28 135.87 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.9 152.82 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.261 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.208 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 121.077 0.465 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.77 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.7 tttt -161.25 153.66 20.27 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.277 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.43 142.78 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.714 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 m -126.72 139.96 52.75 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.082 0.468 . . . . 0.0 110.471 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.05 116.73 26.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.297 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.7 m-85 -95.76 138.36 33.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.606 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.46 -49.05 79.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.289 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 82.4 m-20 -100.76 -174.77 2.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.907 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' A' ' 39' ' ' SER . 2.8 mppt? -84.35 -174.96 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.656 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.8 m120 46.21 22.92 0.17 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.88 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.4 m-85 59.17 44.93 15.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.305 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -115.27 161.91 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 110.374 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.36 -151.22 29.47 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.592 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -58.18 173.79 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.46 155.05 5.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -134.61 134.59 41.41 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 30.2 t0 -102.81 154.35 19.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.547 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.43 124.81 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.815 0.34 . . . . 0.0 110.139 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -124.82 11.17 8.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ASP . 8.0 t -150.65 148.25 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.5 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 52.9 p30 -37.54 154.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.79 160.69 40.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.03 -56.82 2.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.5 p-10 -152.98 113.74 4.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -103.41 8.31 38.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 53.4 t60 -59.61 -29.4 67.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.539 0.685 . . . . 0.0 110.024 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.2 p -60.15 -30.52 69.37 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.383 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -87.34 -13.97 42.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.521 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.0 tp -142.2 137.36 30.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 109.943 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -98.16 -9.42 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.268 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.0 ttm-85 -155.66 144.12 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.2 m -110.18 103.67 12.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 110.671 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.736 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.8 m-20 -128.91 155.16 45.72 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.736 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.9 p 36.11 129.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.558 1.17 . . . . 0.0 112.258 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.5 mt -141.55 146.13 23.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.857 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.307 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.5 ptpt -154.46 104.2 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.248 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.71 149.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.39 0.614 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -120.39 47.69 1.73 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.769 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -167.08 -94.84 0.1 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.022 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.536 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.94 -139.81 3.87 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.0 m -79.71 166.66 21.57 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.179 -0.601 . . . . 0.0 110.946 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.77 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -156.0 156.81 35.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.566 0.698 . . . . 0.0 111.039 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.39 119.31 36.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.798 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 5.5 m -117.88 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.232 0.539 . . . . 0.0 111.114 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 30.9 m-85 -93.77 175.31 6.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -100.99 -36.69 8.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -118.96 148.14 44.01 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 38.7 Cg_endo -64.16 157.29 54.43 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.006 1.804 . . . . 0.0 111.915 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.2 m120 84.24 -3.9 1.05 Allowed 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.005 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 16.6 m-85 . . . . . 0 N--CA 1.47 0.525 0 O-C-N 123.616 0.572 . . . . 0.0 111.073 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.475 ' C ' HD12 ' A' ' 61' ' ' ILE . 12.0 t80 . . . . . 0 CA--C 1.52 -0.201 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.22 92.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.438 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -72.22 112.78 15.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.0 162.75 15.71 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.013 1.808 . . . . 0.0 112.456 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.08 115.68 1.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.057 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.11 177.4 41.62 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.8 mt-10 -100.75 153.04 19.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.346 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -144.94 89.41 6.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_endo -63.35 -13.92 38.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.239 1.959 . . . . 0.0 113.419 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 96.7 mt-10 -149.69 161.01 43.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.723 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 34.7 p90 -63.76 -53.69 47.08 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.986 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -43.77 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.9 mmm180 -75.18 -4.38 38.51 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.723 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.29 24.08 10.93 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.883 -0.144 . . . . 0.0 110.976 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 21.1 mmt 87.69 23.96 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.238 1.015 . . . . 0.0 111.064 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.72 50.27 0.42 Allowed Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.2 mt -74.34 13.36 0.59 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.013 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 46.9 t30 109.81 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.94 1.4 . . . . 0.0 109.157 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -96.29 63.0 2.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.443 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.468 ' CA ' ' HE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.9 116.44 11.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.232 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.31 128.06 20.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.1 p -110.3 -162.92 0.82 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.041 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.7 m -45.47 -179.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.6 p -150.29 151.51 33.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.634 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.06 128.73 55.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.551 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 128.04 34.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.304 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.8 t -127.34 132.9 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.79 161.64 13.46 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.07 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -87.94 148.17 42.67 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.493 1.468 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.8 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 120.72 0.295 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.738 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 28.8 t80 -157.29 113.63 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -154.22 133.72 12.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 145.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.131 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.3 mt-30 -123.76 128.17 49.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.563 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.7 mt -118.44 131.93 69.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.16 130.01 56.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.628 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.27 -27.21 65.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.908 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -122.2 149.15 44.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.21 171.34 18.89 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 60.19 29.82 19.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 3.9 m-85 56.01 82.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -158.61 161.6 37.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 0.0 110.26 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.69 -150.95 23.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -74.6 138.87 43.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.5 tmm? -123.55 132.73 53.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.175 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.402 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.3 m-85 -124.11 136.37 54.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -123.96 125.67 44.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -151.27 128.56 11.26 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -93.48 44.45 1.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -144.52 -179.25 6.43 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.6 p30 -86.41 159.96 19.19 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.563 ' O ' ' OG ' ' A' ' 172' ' ' SER . 96.5 m -138.71 123.49 11.77 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.73 -55.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.04 1.827 . . . . 0.0 111.665 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 m -116.59 111.89 20.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -41.72 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.7 ttp -67.94 -16.59 64.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.438 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -83.38 -42.73 16.7 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.595 -0.691 . . . . 0.0 111.39 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.584 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -93.85 -30.61 14.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.903 -177.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 26.1 m-85 -114.8 5.9 15.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.8 m-70 50.9 9.35 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.786 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -76.52 135.36 39.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.868 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -107.35 -27.56 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 49.5 mt-10 -151.03 107.57 3.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.35 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 12.4 mm -75.59 125.4 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 109.779 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.8 m80 -103.75 -31.13 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.283 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.0 p -155.77 151.78 27.69 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.8 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -150.56 131.26 14.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.123 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 51.9 mtmt -112.09 -173.2 2.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.446 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.9 t 55.57 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.679 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.72 167.78 10.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.053 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -139.21 111.38 7.43 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 40.26 -84.82 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.4 t -125.03 154.95 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.745 0.307 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.738 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.8 t-105 -142.12 167.46 22.06 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.594 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.3 mt -145.34 125.72 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.378 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -107.34 112.63 25.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -48.89 -23.15 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.968 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.8 mp -119.26 166.43 14.48 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.2 167.36 12.33 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.093 1.862 . . . . 0.0 111.902 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.81 15.27 1.14 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.078 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.0 m-85 74.02 27.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.635 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 99.5 mtt180 -132.67 126.03 31.67 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.94 174.69 22.87 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -56.08 114.19 1.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -80.93 141.0 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.05 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 . . . . . 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 179.284 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -109.64 -22.02 12.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.271 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -119.53 156.1 53.7 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 121.005 0.431 . . . . 0.0 110.717 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.562 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -60.48 -16.19 40.66 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.746 2.298 . . . . 0.0 113.531 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -101.91 -2.22 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.114 0.483 . . . . 0.0 111.02 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -26.05 67.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.638 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.74 21.87 16.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.459 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.18 67.55 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.788 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.15 138.9 43.63 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.878 0.839 . . . . 0.0 109.994 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.3 22.28 0.23 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 167.08 155.89 0.11 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.229 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 170' ' ' VAL . 45.7 Cg_endo -70.74 -33.62 12.6 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.596 2.197 . . . . 0.0 111.523 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -47.25 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.31 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.892 HG22 ' H ' ' A' ' 171' ' ' GLN . 9.1 p -107.68 -145.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG22 ' A' ' 170' ' ' VAL . 69.3 mm-40 -152.9 -132.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.271 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -95.77 -153.29 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -170.69 -177.04 2.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.485 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.486 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -157.55 133.13 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.061 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.5 ptt-85 -52.43 133.66 35.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.384 0.612 . . . . 0.0 110.616 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 138' ' ' ILE . 18.6 mt -67.29 135.06 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.863 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.486 HG22 HH21 ' A' ' 174' ' ' ARG . 34.2 m -137.35 156.63 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.202 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.486 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 2.7 p . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.829 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.5 tttt -159.99 151.06 19.29 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.948 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.59 141.31 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.887 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -124.32 138.22 54.4 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.144 0.497 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.6 115.95 25.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.3 m-85 -96.4 138.28 34.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.301 0.572 . . . . 0.0 111.152 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.4 tm-20 -60.98 -50.0 75.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.856 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.2 m-20 -97.87 -177.79 3.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.295 0.569 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 15' ' ' ASN . 0.0 OUTLIER -81.7 -177.07 6.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.123 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.638 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 46.67 25.36 0.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.876 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 39' ' ' SER . 1.7 m-85 63.4 40.17 8.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.07 175.11 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.21 -158.33 53.26 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.706 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -53.6 174.91 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -168.46 150.76 5.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -126.5 130.99 51.7 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.9 p-10 -119.36 119.96 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.94 142.69 23.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.176 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -125.81 26.32 6.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.7 m -146.75 141.35 26.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -38.01 157.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.713 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.1 t -159.17 166.57 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.586 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.81 -56.12 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.971 0.415 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -152.15 113.6 4.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.441 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -102.4 8.55 40.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.052 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -60.15 -25.68 65.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.485 0.659 . . . . 0.0 110.066 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.9 p -63.62 -30.37 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -87.02 -13.83 43.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.407 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.8 tp -143.51 137.66 28.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 110.068 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -98.74 -9.74 24.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 ttm-85 -155.66 144.08 20.21 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 7.5 p -110.25 104.39 13.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.771 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 59.2 m-20 -128.96 156.56 43.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.26 128.88 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.44 1.114 . . . . 0.0 112.529 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.7 mt -141.71 146.49 22.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.18 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -154.77 103.29 2.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.204 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.0 t -66.73 148.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.713 0.768 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -123.46 54.54 1.28 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.81 -97.34 0.11 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -133.41 -142.11 4.7 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.23 166.81 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.319 -0.518 . . . . 0.0 110.776 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.829 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -152.98 155.22 36.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.381 0.61 . . . . 0.0 110.783 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.01 120.24 39.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.302 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 80' ' ' LEU . 9.7 m -119.59 133.22 67.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.558 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -107.83 115.49 30.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.064 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 79' ' ' ARG . 59.7 tt0 -37.97 -34.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -115.4 146.78 37.27 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.819 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 44.4 Cg_endo -68.18 160.4 48.98 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.422 2.082 . . . . 0.0 111.495 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.1 m120 83.39 -3.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.29 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 7.6 m-85 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.08 0.466 . . . . 0.0 111.308 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 39.5 t80 . . . . . 0 N--CA 1.462 0.148 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.49 92.24 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.55 110.48 7.05 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.6 163.33 16.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.966 1.777 . . . . 0.0 112.795 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.59 114.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.81 177.52 42.2 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 94.5 mt-10 -101.16 153.03 19.94 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.887 0.375 . . . . 0.0 110.396 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -145.71 90.57 5.89 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.08 -13.72 41.32 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.317 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 93.8 mt-10 -149.07 160.92 42.9 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.7 p90 -63.39 -53.21 56.06 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.322 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -44.62 -9.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.5 mmm180 -75.16 -4.78 40.76 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.834 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.68 24.86 10.8 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.907 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.5 mmt 87.47 23.0 0.05 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 111.085 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 33.13 52.47 0.52 Allowed Glycine 0 N--CA 1.469 0.865 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.1 mt -77.77 13.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.484 -0.294 . . . . 0.0 111.095 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 53.9 t30 109.79 167.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.612 1.195 . . . . 0.0 109.766 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 52.4 p30 -101.98 66.83 1.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLU . 5.5 tpt180 -143.63 77.28 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.585 0.231 . . . . 0.0 110.983 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -102.98 128.21 49.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.346 0.593 . . . . 0.0 109.605 -178.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.678 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -109.38 -163.18 0.85 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.609 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.3 t -44.83 -179.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.174 0.512 . . . . 0.0 110.994 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.536 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.24 155.42 37.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.585 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -121.28 129.89 53.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.96 126.71 28.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.394 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.8 t -123.14 130.19 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.09 162.28 13.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.954 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.897 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -86.51 146.82 42.67 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.688 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 122.427 2.085 . . . . 0.0 112.223 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.666 0.27 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.729 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 15.4 t80 -156.87 113.22 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.2 tptm -153.98 129.29 9.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 111.155 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -133.96 141.57 43.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.9 mt-30 -119.33 128.61 54.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 118' ' ' ILE . 12.5 mt -119.38 131.65 71.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.0 m-85 -111.21 131.22 55.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.98 -31.5 71.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -118.73 152.26 36.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.175 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.0 -169.66 2.22 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.0 t0 45.02 29.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 54.19 80.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 m -158.12 162.55 38.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.52 -149.24 19.7 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.58 138.93 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 110.449 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -120.5 127.85 52.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.526 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -119.44 136.63 54.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.204 0.526 . . . . 0.0 110.868 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.81 126.88 46.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.457 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -147.58 129.21 15.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.42 36.99 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.605 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.96 -177.31 5.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -85.1 158.91 20.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.193 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -132.38 123.79 18.82 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.227 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -78.52 -55.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.512 1.474 . . . . 0.0 110.784 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.2 m -119.11 114.44 22.47 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.13 -45.13 80.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.04 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.0 ttt -65.94 -20.54 66.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.255 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -74.2 -46.84 39.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.15 -24.36 14.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.7 m-85 -110.77 0.92 17.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.4 m-70 52.41 12.13 0.22 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.234 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 122' ' ' PHE . 34.7 mtt -78.97 134.16 36.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -106.22 -27.12 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.222 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.54 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -153.69 109.94 3.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.497 0.665 . . . . 0.0 111.251 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -75.85 125.33 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.748 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.3 m80 -106.79 -31.05 8.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.001 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 7.9 m -152.47 147.03 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.5 t -146.66 133.92 20.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.725 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -114.05 -178.18 3.31 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.618 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 21.5 t 56.46 103.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.99 163.44 15.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.7 mp0 -139.21 112.25 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.694 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.95 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 134' ' ' GLU . 41.8 t -126.6 135.88 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.729 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 t-105 -121.84 169.39 10.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 53.1 mt -145.53 124.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.465 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -110.74 133.73 53.08 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 149' ' ' GLN . 16.9 m-85 -109.73 111.71 23.32 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 123.531 0.519 . . . . 0.0 110.52 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -49.91 -23.38 1.92 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.975 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mp -113.86 166.4 11.46 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.49 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 93.4 Cg_endo -86.47 166.09 9.21 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.216 1.944 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.498 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.5 m-80 69.14 21.26 7.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.454 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.7 m-85 72.19 66.95 0.13 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.703 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -154.63 170.68 20.93 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 122.041 -0.412 . . . . 0.0 110.592 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.38 167.04 29.97 Favored Glycine 0 N--CA 1.464 0.53 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.884 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 149' ' ' GLN . 20.6 ptt180 -68.02 77.57 0.23 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 5.1 pt20 -48.05 175.54 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.443 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.196 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.404 ' O ' ' OG ' ' A' ' 129' ' ' SER . 33.7 ptt180 -107.23 -23.52 12.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.593 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpt -118.18 157.63 48.42 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-O 121.332 0.587 . . . . 0.0 111.044 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.4 Cg_endo -61.24 -19.29 63.14 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.044 1.829 . . . . 0.0 113.451 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -99.52 -0.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.532 . . . . 0.0 110.834 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -62.79 -25.83 68.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.481 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -108.93 21.14 17.6 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-O 120.931 0.395 . . . . 0.0 110.07 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.4 70.46 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.834 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.42 137.63 42.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.524 1.162 . . . . 0.0 109.459 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -72.47 18.37 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.083 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 167.77 157.18 0.14 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.41 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.17 6.17 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.951 2.434 . . . . 0.0 111.617 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.99 69.42 5.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.551 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.0 t -97.04 -153.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.914 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -155.13 -130.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.432 0.457 . . . . 0.0 110.228 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 2.6 p -92.72 -155.73 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -169.75 -177.68 2.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.425 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -162.03 134.33 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.124 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.692 ' O ' HG23 ' A' ' 177' ' ' VAL . 15.0 ptt180 -50.83 133.09 26.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.792 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 136' ' ' VAL . 5.8 mt -59.7 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 175' ' ' ARG . 21.6 t -69.53 140.13 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.072 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.421 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.3 p . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.982 0.42 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.752 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.1 tttt -160.97 149.94 16.58 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.892 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.96 140.47 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.935 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 27.2 m -121.58 137.84 54.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.25 115.49 24.86 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.8 m-85 -95.26 140.0 30.78 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.17 -51.31 69.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.911 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.4 m-20 -98.59 -176.77 3.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.506 ' HB3' HD22 ' A' ' 15' ' ' ASN . 2.9 mppt? -82.04 -176.78 6.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.748 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.59 26.53 0.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.124 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.525 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.7 OUTLIER 62.09 41.0 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -106.58 172.0 7.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.16 -157.57 53.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NH1' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -54.56 175.93 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' CD ' ' A' ' 19' ' ' ARG . 2.7 ppt_? -169.21 149.99 4.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -132.92 133.77 43.68 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.1 p-10 -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.664 0.268 . . . . 0.0 110.798 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.21 37.73 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -124.64 16.56 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' ASP . 7.7 t -148.54 143.4 26.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' CYS . 52.2 p-10 -37.18 158.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.207 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.3 t -157.6 164.17 37.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -96.35 -49.07 5.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -158.57 105.7 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.254 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 1.7 p90 -97.76 12.58 33.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -64.74 -15.59 61.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 110.214 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.1 p -78.6 2.04 20.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.308 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.3 m-85 -120.2 -13.42 8.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 36' ' ' ARG . 20.1 tp -144.76 140.31 28.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 t -100.7 -13.8 18.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' O ' HD21 ' A' ' 34' ' ' LEU . 55.6 ttm-85 -152.61 141.73 21.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' ' CA ' ' A' ' 79' ' ' ARG . 9.0 p -109.34 104.3 13.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.294 0.569 . . . . 0.0 110.981 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.719 ' O ' ' O ' ' A' ' 39' ' ' SER . 86.4 m-20 -128.77 156.45 43.54 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.719 ' O ' ' O ' ' A' ' 38' ' ' ASN . 9.2 p 36.18 129.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.509 1.147 . . . . 0.0 112.341 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.16 146.39 22.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.828 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.16 102.7 2.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.47 148.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.466 0.65 . . . . 0.0 110.906 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.4 50.74 1.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.38 -97.14 0.11 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.39 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.488 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.75 -141.17 4.23 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 47' ' ' TRP . 25.6 m -80.2 164.43 23.28 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.393 -0.475 . . . . 0.0 110.819 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.752 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 35.4 m95 -153.47 156.27 37.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -115.72 120.22 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.552 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -116.82 133.02 64.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.175 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 52' ' ' ARG . 82.5 m-85 -104.49 107.22 18.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.876 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' TYR . 44.7 tt0 -34.02 -32.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.441 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 67.9 mtt180 -127.9 151.27 75.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.154 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -58.65 163.59 10.7 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.222 1.948 . . . . 0.0 113.142 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 55' ' ' PHE . 1.4 m120 57.04 66.94 1.06 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.073 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' A' ' 54' ' ' ASN . 1.4 m-85 . . . . . 0 N--CA 1.469 0.509 0 O-C-N 123.437 0.46 . . . . 0.0 111.764 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.4 mp -104.87 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -72.62 110.84 9.1 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.48 162.92 16.98 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.09 1.86 . . . . 0.0 112.877 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -50.47 115.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.827 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.08 178.03 42.04 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.6 mt-10 -101.19 155.28 18.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 41.7 m-85 -149.04 85.2 6.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.33 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.02 -16.37 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.237 2.624 . . . . 0.0 113.228 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -148.7 161.44 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.7 p90 -65.67 -53.18 44.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 16.5 mt-30 -43.27 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -75.61 -6.38 50.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.291 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -116.1 25.86 10.37 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.513 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.0 mmt 85.1 26.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.376 1.048 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.27 52.46 0.41 Allowed Glycine 0 N--CA 1.468 0.778 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 28.3 mt -78.42 13.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.202 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.4 t30 113.16 168.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.681 1.238 . . . . 0.0 109.165 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -102.03 66.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.232 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.55 ' CA ' ' SG ' ' A' ' 37' ' ' CYS . 14.3 tpt180 -147.9 122.41 9.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.125 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -143.13 128.96 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.689 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.9 p -112.42 -161.29 0.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 2.2 t -44.76 177.79 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.55 ' N ' ' OG ' ' A' ' 82' ' ' SER . 13.8 p -152.18 153.6 34.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.563 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -119.45 129.44 54.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.19 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.53 119.95 9.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.971 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.568 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.5 t -103.82 121.94 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.82 148.55 22.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.038 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.4 146.55 70.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.51 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 N--CA 1.496 1.643 0 C-N-CA 122.299 2.0 . . . . 0.0 112.052 179.357 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.8 0.334 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.719 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 13.9 t80 -158.15 114.08 2.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.406 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 17.9 tptm -154.7 128.57 8.76 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.357 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 tt -133.9 141.42 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.54 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.464 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 14.7 mt-30 -119.22 128.16 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 118' ' ' ILE . 9.3 mt -118.79 131.45 71.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.057 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.407 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 59.1 m-85 -111.14 130.68 55.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -60.84 -31.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.614 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -114.97 151.68 33.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.0 171.52 31.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 40.1 t0 59.52 32.9 21.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.556 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 9.2 m-85 54.3 80.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -158.07 163.66 37.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.64 -147.89 20.82 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.24 139.33 41.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 46.0 ttp -120.81 126.83 51.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.444 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.469 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 52.9 m-85 -117.87 135.87 53.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.93 125.41 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.422 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 6.0 t -152.27 127.97 10.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.71 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.16 39.81 1.08 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.41 178.51 7.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.7 p-10 -82.72 156.41 23.78 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -130.85 121.22 18.85 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.7 Cg_endo -78.24 -53.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.865 1.71 . . . . 0.0 110.593 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.0 m -120.43 113.48 20.4 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.58 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -69.24 -43.53 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.137 0.494 . . . . 0.0 111.162 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.7 ttt -68.09 -19.2 64.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.017 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -76.04 -45.61 33.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 6.9 pt20 -100.38 -26.18 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m-85 -111.93 1.11 16.31 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.738 0.304 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.6 m-70 52.11 15.3 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.455 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 36.5 mtt -81.97 134.44 35.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -106.91 -28.14 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.659 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.551 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 41.9 mt-10 -151.3 108.79 3.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.852 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -74.38 125.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.814 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -106.14 -29.98 9.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.218 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 4.8 m -151.52 146.26 25.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.1 t -153.57 128.82 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.928 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 53.1 mtmt -114.51 -179.44 3.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.854 0.359 . . . . 0.0 110.602 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.447 ' C ' HD22 ' A' ' 133' ' ' LEU . 5.5 t 60.79 64.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 133' ' ' LEU . 3.8 mm? -96.61 100.83 12.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.213 0.53 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 1.2 mp0 -67.0 121.14 14.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.44 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.48 -110.94 0.09 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 176' ' ' ILE . 11.3 t -98.77 142.35 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 110.14 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 32.7 t-105 -131.84 169.33 16.4 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.1 mt -144.94 123.04 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.729 0.3 . . . . 0.0 111.787 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.628 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -107.93 129.52 55.1 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 20.2 m-85 -109.02 111.46 23.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.26 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 142' ' ' LEU . 77.0 tt0 -48.41 -23.66 1.01 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -118.1 160.9 37.31 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 110.277 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.416 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.5 Cg_endo -77.89 167.94 22.96 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.115 1.876 . . . . 0.0 111.83 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 73.07 14.24 4.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.78 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.29 24.54 0.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.636 0.255 . . . . 0.0 111.348 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -108.04 168.96 8.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.26 173.03 38.69 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 -52.5 163.87 0.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 11.7 mp0 -129.47 147.12 51.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.152 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.425 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.038 0.447 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.443 ' O ' ' OG ' ' A' ' 129' ' ' SER . 16.6 ptm180 -105.23 -28.29 11.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.719 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -117.59 154.74 50.82 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.539 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.0 Cg_endo -56.78 -18.64 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.38 2.054 . . . . 0.0 113.595 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -102.52 -2.35 9.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.88 -28.8 70.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -105.06 21.9 16.26 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.43 28.56 71.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.804 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.13 137.48 46.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 118.153 0.977 . . . . 0.0 109.051 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -74.22 17.41 0.19 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.29 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 172.13 156.33 0.24 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.983 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.19 5.91 4.25 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.045 2.497 . . . . 0.0 111.733 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.84 70.59 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 0.0 110.746 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.892 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.2 t -98.71 -147.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -160.14 -132.31 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.517 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.32 -155.31 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -177.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.613 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 26.9 p90 -170.05 -176.01 2.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.448 HH21 HG22 ' A' ' 177' ' ' VAL . 10.1 ptm180 -161.59 133.09 5.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.375 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -54.23 130.45 38.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.827 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 136' ' ' VAL . 12.6 mt -63.48 138.59 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.632 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.448 HG22 HH21 ' A' ' 174' ' ' ARG . 31.0 m -139.36 159.25 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.299 179.66 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.5 tttt -162.29 155.25 20.03 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.106 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.5 tt -149.05 144.38 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.127 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 21' ' ' TYR . 19.0 m -128.04 139.59 52.45 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.185 0.517 . . . . 0.0 110.508 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.36 117.66 28.33 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.989 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 62.9 m-85 -96.89 134.15 40.59 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 110.197 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' A' ' 34' ' ' LEU . 3.1 tm-20 -59.31 -44.83 92.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.439 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 90.6 m-20 -106.73 -173.45 2.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.972 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -83.64 -177.42 6.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 0.0 111.635 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 48.27 19.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.19 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 6.3 m-85 68.02 40.7 2.2 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.138 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 19' ' ' ARG . 6.1 pt20 -122.78 -168.03 1.68 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.972 0.415 . . . . 0.0 111.535 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.28 -24.25 0.46 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.481 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.2 ttm180 162.34 -174.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.294 0.637 . . . . 0.0 110.33 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.93 157.99 6.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 9' ' ' THR . 62.7 t80 -138.84 135.39 34.5 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 91.9 m-20 -100.75 150.44 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -164.05 122.97 1.93 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 178.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -125.38 12.7 8.17 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.614 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.2 m -149.3 145.64 27.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.782 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -38.82 156.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 82' ' ' SER . 2.2 m -157.04 163.26 39.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.279 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.42 -56.74 2.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.5 p-10 -153.56 106.76 2.95 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.463 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -96.34 8.84 42.96 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 65.8 t60 -58.46 -27.46 64.42 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.455 0.645 . . . . 0.0 110.003 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.4 p -62.55 -29.12 70.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' CE1' ' A' ' 21' ' ' TYR . 85.1 m-85 -88.44 -14.8 37.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.923 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 31' ' ' HIS . 13.8 tp -141.64 136.89 31.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 t -95.52 -6.54 40.27 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.9 ttm-85 -160.77 152.03 19.1 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 4.2 p -115.35 103.66 11.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.484 0.659 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.724 ' O ' ' O ' ' A' ' 39' ' ' SER . 80.3 m-20 -129.97 158.66 38.95 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.724 ' O ' ' O ' ' A' ' 38' ' ' ASN . 16.6 p 33.0 125.99 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.319 1.056 . . . . 0.0 112.734 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -139.54 144.68 28.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.355 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -152.21 102.52 2.78 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.939 -0.476 . . . . 0.0 110.211 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.51 150.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.667 0.746 . . . . 0.0 110.547 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -123.61 53.23 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.907 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.29 -93.25 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.582 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.473 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.93 -140.35 3.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 47' ' ' TRP . 85.6 m -81.72 166.86 19.72 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.426 -0.455 . . . . 0.0 110.786 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.3 m95 -155.07 156.3 35.63 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.451 0.643 . . . . 0.0 110.782 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.72 122.84 46.71 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.23 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.5 m -119.41 132.01 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 0.0 110.712 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -103.1 111.36 23.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -37.57 -36.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.177 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -116.16 137.25 23.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.66 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 16.8 Cg_exo -58.88 159.63 20.66 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.269 1.313 . . . . 0.0 112.351 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 m120 86.1 -3.01 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.011 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.1 m-85 . . . . . 0 N--CA 1.469 0.52 0 O-C-N 123.433 0.458 . . . . 0.0 110.819 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 30.6 t80 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.753 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.7 mp -102.02 89.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -68.15 111.43 7.85 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.44 164.26 16.74 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.98 1.786 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -52.86 124.56 14.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.087 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.68 -175.56 40.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.2 mt-10 -107.33 152.89 23.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.217 0.532 . . . . 0.0 110.284 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.6 m-85 -145.6 84.78 8.17 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.3 Cg_exo -58.07 -17.06 29.73 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.984 2.456 . . . . 0.0 112.77 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.8 mt-10 -150.91 162.02 41.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.678 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.3 p90 -61.61 -49.46 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.522 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -42.34 -13.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.2 mmt180 -75.25 -5.19 43.31 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.132 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.678 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.02 26.76 9.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 121.522 -0.071 . . . . 0.0 111.16 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 mmt 88.76 17.72 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.481 1.113 . . . . 0.0 110.935 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 34.24 55.85 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.44 -70.29 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -157.18 158.9 37.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.6 p-10 -85.87 55.95 3.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.796 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 10.8 tpt180 -138.1 115.9 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.49 128.75 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.8 p -110.25 -161.85 0.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.179 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 7.0 t -45.45 -178.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.221 0.534 . . . . 0.0 110.708 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.61 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.4 p -150.01 150.3 31.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.723 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -115.97 126.65 54.13 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -60.61 127.71 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.327 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.3 t -124.53 131.34 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.935 0.398 . . . . 0.0 110.773 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.414 ' O ' HG21 ' A' ' 136' ' ' VAL . 99.4 m-70 -100.18 162.5 12.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.93 150.13 74.71 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 C-N-CA 122.233 1.955 . . . . 0.0 112.124 -179.893 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 t80 -154.29 113.03 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 47.0 tptt -154.59 136.0 14.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.127 0.489 . . . . 0.0 111.034 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.87 145.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.303 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.591 HE21 ' CA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -126.04 132.62 51.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.868 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.529 HD13 HD11 ' A' ' 118' ' ' ILE . 6.3 mt -120.89 132.34 70.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.894 -177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -112.17 126.84 55.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.988 0.423 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.77 -24.03 61.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -125.97 146.76 49.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.214 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -58.81 -168.55 0.2 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 4.5 p-10 42.58 29.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 54.38 81.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -158.15 166.42 32.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.058 0.456 . . . . 0.0 110.528 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 -156.11 29.85 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.614 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -65.23 137.01 57.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.443 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 36.2 ttp -120.56 122.09 39.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.554 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 49.8 m-85 -118.13 133.23 56.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 120.07 35.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 111' ' ' THR . 7.4 t -146.92 127.84 14.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.52 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -95.68 40.96 1.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 111.142 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -141.11 178.38 7.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.526 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.482 ' CG ' HH12 ' A' ' 175' ' ' ARG . 24.6 p-10 -82.76 157.56 23.19 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.533 ' SG ' ' OG ' ' A' ' 172' ' ' SER . 49.7 t -134.4 122.34 15.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 172' ' ' SER . 63.9 Cg_endo -76.43 -57.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.488 1.459 . . . . 0.0 110.862 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.7 m -116.35 115.97 26.86 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.6 tt -70.2 -46.81 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 0.0 110.916 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.464 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.9 ttt -64.59 -20.8 66.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.293 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -72.98 -46.65 51.06 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.897 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.0 pt20 -102.43 -23.39 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.632 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.5 m-85 -111.96 -1.92 15.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.118 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 54.78 11.54 0.47 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.841 0.353 . . . . 0.0 111.018 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.2 mtt -79.77 132.69 36.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.19 -24.89 11.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.722 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 64.9 mt-10 -152.17 108.48 3.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.11 0.481 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 118' ' ' ILE . 8.0 mm -75.16 125.44 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.674 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 76.0 m80 -105.16 -33.81 8.14 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.326 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.1 p -155.38 151.09 27.47 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.656 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -144.77 157.13 44.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.818 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.3 mtpt -135.13 -178.98 5.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.48 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 t 54.7 80.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -98.92 165.89 11.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.5 mp0 -139.96 112.37 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.05 -88.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.1 t -120.01 155.07 22.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 109.998 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.4 t-105 -144.07 169.41 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.618 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 86.9 mt -144.84 123.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.633 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.84 129.69 55.61 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 22.5 m-85 -107.64 111.81 24.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.866 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.445 ' O ' HD12 ' A' ' 142' ' ' LEU . 73.8 tt0 -50.3 -22.29 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.1 mp -118.48 160.09 41.24 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.441 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.1 Cg_endo -77.35 166.4 26.18 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.37 2.047 . . . . 0.0 111.762 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.685 ' ND2' HH21 ' A' ' 146' ' ' ARG . 2.1 m-80 74.13 15.3 3.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.507 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.0 m-85 76.39 25.53 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.608 0.242 . . . . 0.0 111.247 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.685 HH21 ' ND2' ' A' ' 144' ' ' ASN . 88.6 mtm180 -108.55 167.69 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.071 0.462 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.42 168.61 34.24 Favored Glycine 0 N--CA 1.463 0.48 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -59.03 142.28 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 46.2 mt-30 -97.64 147.89 23.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 . . . . . 0 N--CA 1.468 0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.723 0.297 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -105.09 -24.47 12.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -122.53 152.45 61.56 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.57 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.8 Cg_exo -49.9 -35.52 40.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.191 1.928 . . . . 0.0 112.998 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.7 mp -86.66 -3.4 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.607 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -57.26 -29.89 64.2 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.07 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.57 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.1 p90 -105.23 21.27 17.42 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.43 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.18 61.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.574 -0.57 . . . . 0.0 114.24 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.23 137.09 45.95 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.459 1.13 . . . . 0.0 110.572 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.46 21.64 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.684 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 168.99 153.69 0.15 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.684 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.77 5.2 5.03 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.916 2.41 . . . . 0.0 112.044 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.51 71.36 6.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.896 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.912 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.5 t -99.55 -147.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.912 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.4 tp60 -159.31 -131.79 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.39 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.3 -156.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -170.21 -178.02 2.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.298 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.86 133.52 8.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.954 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.482 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.0 ptt-85 -51.91 130.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.68 131.66 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.252 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.24 134.68 60.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.438 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 30.9 tp10 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.513 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.023 0.44 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.711 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 45.5 tttt -159.2 153.29 23.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.122 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -147.15 147.21 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 92.3 m -133.65 141.65 47.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.27 0.557 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -122.61 116.72 24.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.334 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 63.6 m-85 -95.89 137.02 35.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.267 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -45.08 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.3 m-20 -109.36 -173.35 2.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -82.8 -177.81 6.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.95 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.502 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.66 17.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.076 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.476 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 5.3 m-85 73.41 38.84 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.781 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 19' ' ' ARG . 44.1 mt-30 -117.62 -168.45 1.5 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.893 0.378 . . . . 0.0 110.472 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 75.52 -29.01 1.24 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.215 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 19.3 ttt85 158.13 -167.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.729 0.9 . . . . 0.0 109.718 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -170.25 151.38 3.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' THR . 78.0 t80 -129.88 135.0 47.86 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.2 p-10 -102.21 144.29 30.94 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.076 -0.39 . . . . 0.0 110.989 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -166.61 122.74 1.22 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.785 178.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -121.14 20.97 11.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.21 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.35 149.66 29.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -40.9 157.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.471 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.14 160.42 40.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.197 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.99 -55.53 3.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.1 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -155.43 100.62 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.219 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -86.8 9.12 20.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.414 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -59.74 -17.42 34.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.077 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -78.12 -1.15 31.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -117.15 -15.26 10.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 13.2 tp -143.1 139.96 30.67 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -98.28 -7.23 29.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.288 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.0 ttm-85 -159.42 148.27 18.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.9 m -114.52 103.15 10.75 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.718 ' O ' ' O ' ' A' ' 39' ' ' SER . 97.3 m-20 -129.21 156.54 43.78 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.718 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.7 p 35.89 125.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.909 0.861 . . . . 0.0 112.168 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.9 mt -138.5 144.11 30.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.088 0 CA-C-O 121.614 0.721 . . . . 0.0 111.806 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -153.48 99.19 2.31 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.431 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 18.1 m -70.1 138.61 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.523 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -109.81 52.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.21 -99.33 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.165 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.68 -137.17 3.56 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 47' ' ' TRP . 41.3 m -77.23 164.83 25.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 110.884 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.711 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.6 m95 -155.73 157.31 36.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.295 0.569 . . . . 0.0 110.596 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.77 120.37 38.36 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.021 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.45 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.7 m -118.66 132.85 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.245 0.545 . . . . 0.0 111.052 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' ARG . 90.5 m-85 -108.07 112.91 25.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 50' ' ' TYR . 42.2 tt0 -35.75 -32.65 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.715 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -121.0 148.3 48.48 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.313 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.662 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 7.7 Cg_exo -67.16 160.19 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.875 1.717 . . . . 0.0 112.123 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 85.46 -4.8 0.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.887 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 6.2 m-85 . . . . . 0 N--CA 1.467 0.414 0 O-C-N 123.427 0.455 . . . . 0.0 111.055 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 23.0 t80 . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.7 mp -102.09 92.4 2.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -68.94 111.15 7.5 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.7 163.92 16.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.025 1.817 . . . . 0.0 112.946 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -50.06 125.53 12.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.138 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.83 -172.51 38.88 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.0 mt-10 -111.65 155.34 23.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.207 0.527 . . . . 0.0 110.126 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.5 m-85 -147.99 81.09 8.45 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.32 -9.93 14.32 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.294 1.996 . . . . 0.0 112.862 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.3 mt-10 -149.95 161.18 42.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.749 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.0 p90 -64.98 -50.77 65.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.38 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.9 mt-30 -43.98 -10.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 70' ' ' TYR . 25.1 mmm180 -75.4 0.04 18.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.749 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -124.93 24.07 7.69 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 74' ' ' MET . 11.0 mmm 89.77 17.45 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.952 0.782 . . . . 0.0 111.947 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.72 63.09 0.19 Allowed Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.11 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 19.5 mt -93.69 17.61 11.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.959 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 52.3 t-20 111.99 150.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.206 1.566 . . . . 0.0 109.995 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 51.5 p-10 -83.58 69.93 10.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.23 118.9 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.097 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -147.5 132.18 17.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.144 0.497 . . . . 0.0 110.157 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.717 ' N ' HD13 ' A' ' 80' ' ' LEU . 8.9 p -107.68 -163.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.0 p -50.91 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.94 -0.475 . . . . 0.0 110.991 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 8' ' ' ILE . 14.7 p -153.51 155.5 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -117.79 128.18 54.61 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.66 131.58 50.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.78 130.84 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -101.39 162.49 12.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.772 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 88' ' ' LEU . 1.3 mt -87.03 149.17 47.0 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.654 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.494 1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 112.083 179.523 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.727 0.299 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 32.3 t80 -152.93 113.87 4.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -154.59 135.27 13.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.104 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 146.08 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.165 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.3 mt-30 -124.82 129.04 49.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.935 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 118' ' ' ILE . 6.5 mt -119.49 132.43 69.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.368 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 131' ' ' LYS . 39.3 m-85 -112.33 124.74 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.27 -19.9 38.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.778 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -131.09 144.09 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.869 0.366 . . . . 0.0 110.468 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.86 -171.08 0.23 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 2.8 p-10 45.25 29.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.72 0.295 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.537 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 14.3 m-85 54.89 81.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.878 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -158.98 163.61 36.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 110.806 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.57 -156.98 28.42 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -66.62 136.48 55.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 41.8 ttp -117.58 122.54 43.91 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.073 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.582 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.9 m-85 -114.97 129.99 56.83 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 110.991 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.99 121.43 37.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.068 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -151.88 130.99 12.67 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.469 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -97.85 50.79 1.04 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -147.8 -176.44 5.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -89.38 159.7 17.2 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.067 0.461 . . . . 0.0 110.202 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 172' ' ' SER . 45.7 t -137.48 124.81 13.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.754 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.509 ' O ' ' OG ' ' A' ' 172' ' ' SER . 59.4 Cg_endo -78.38 -61.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.662 1.575 . . . . 0.0 110.093 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -112.27 115.01 28.09 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -69.16 -45.28 79.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 28.0 ttt -63.78 -23.69 67.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.685 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.7 -50.27 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.483 -0.761 . . . . 0.0 112.245 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.634 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.3 pt20 -97.56 -23.82 15.83 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.634 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 29.5 m-85 -112.3 0.54 15.75 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.55 0.214 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.6 m-70 54.0 2.52 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.088 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.557 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -70.53 131.92 44.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -106.83 -25.93 11.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.569 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.9 mt-10 -150.87 109.32 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 8.1 mm -76.26 126.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.67 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.9 m80 -106.41 -36.85 6.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.258 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.537 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 10.0 t -148.63 143.73 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.9 t -144.78 140.12 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 99' ' ' PHE . 35.1 mtmm -124.27 -171.95 2.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 36.3 t 54.34 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.516 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -100.38 166.64 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.199 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -137.35 112.84 9.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 37.79 -89.83 0.01 OUTLIER Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.5 t -117.48 152.19 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.5 t-105 -141.2 166.77 23.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 176' ' ' ILE . 78.2 mt -144.02 124.06 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -111.74 129.47 56.11 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -106.34 113.4 26.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -53.83 -25.79 21.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.64 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.94 159.66 32.74 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-O 120.676 0.274 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 164.66 28.07 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.268 1.979 . . . . 0.0 111.383 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 5.3 m-80 75.57 15.99 2.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.2 m-85 76.6 29.75 0.66 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.098 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -116.41 170.49 8.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.912 0.387 . . . . 0.0 110.733 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.31 167.83 38.59 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -47.95 152.0 0.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -113.15 127.8 56.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.648 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.109 0.481 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.673 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.8 ptt180 -108.42 -21.37 12.77 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.0 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.673 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.3 pttm -123.87 154.54 67.48 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.286 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.502 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.9 Cg_endo -59.1 -19.97 51.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.386 2.057 . . . . 0.0 113.368 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.43 -5.98 9.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.923 0.392 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.74 -32.89 63.78 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.44 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.549 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.71 22.32 13.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.798 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 28.79 67.53 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.914 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.3 138.1 44.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.674 0.737 . . . . 0.0 110.124 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.85 24.3 0.23 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER 165.82 154.21 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.496 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 170' ' ' VAL . 56.1 Cg_endo -72.82 -12.01 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.904 2.403 . . . . 0.0 111.398 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.68 69.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.329 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.928 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -101.33 -155.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.928 ' H ' HG12 ' A' ' 170' ' ' VAL . 64.7 mm-40 -149.98 -130.95 0.05 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.4 p -95.28 -155.08 0.45 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -170.84 -178.75 2.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.282 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -156.1 129.95 8.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.479 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -52.65 129.21 28.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.587 0.708 . . . . 0.0 110.684 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -61.66 129.05 24.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.289 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.28 153.28 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.206 179.716 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.81 0.338 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.732 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -156.67 148.53 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.1 tt -144.58 140.67 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.608 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -126.73 138.02 53.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.63 115.75 25.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.6 m-85 -96.41 138.53 33.87 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 110.939 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.4 tm-20 -61.43 -49.81 75.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.903 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -98.18 -177.29 3.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -176.74 6.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.164 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.25 25.11 0.33 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.856 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.1 m-85 60.83 42.72 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.08 166.75 10.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.831 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.27 -153.73 43.45 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.709 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.694 ' NH2' ' H ' ' A' ' 35' ' ' SER . 15.8 ttp180 -58.75 174.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.03 153.91 5.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.408 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.0 t80 -127.05 130.67 50.39 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 44.8 p-10 -118.68 121.73 40.83 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.9 0.381 . . . . 0.0 111.701 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.9 t -150.21 141.57 23.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.095 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -124.46 26.27 7.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.0 m -148.55 144.75 27.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.502 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -38.54 156.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.846 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 25.0 t -156.76 163.05 39.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.145 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.87 -56.63 2.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.561 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.96 111.57 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -101.85 7.67 41.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 82.6 t60 -58.44 -27.18 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -62.63 -29.81 70.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.426 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.02 -15.36 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.574 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.632 HD12 ' HE ' ' A' ' 19' ' ' ARG . 16.5 tp -142.83 137.48 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.07 0.462 . . . . 0.0 110.067 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.694 ' H ' ' NH2' ' A' ' 19' ' ' ARG . 49.9 m -98.9 -9.23 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 56.0 ttm-85 -154.79 143.04 20.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.307 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 5.2 p -109.37 103.62 12.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.732 ' O ' ' O ' ' A' ' 39' ' ' SER . 62.8 m-20 -128.08 156.26 43.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.732 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.9 p 35.05 129.43 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.745 1.259 . . . . 0.0 112.519 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.2 mt -142.55 147.52 20.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.023 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -156.48 100.81 1.98 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.35 139.57 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.292 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -110.13 56.43 0.63 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.268 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.08 -92.84 0.09 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.702 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 -139.11 3.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 47' ' ' TRP . 43.0 m -80.48 164.9 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.732 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 34.0 m95 -152.94 154.12 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.105 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.18 118.76 35.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' HB ' HD21 ' A' ' 80' ' ' LEU . 4.7 m -118.46 132.86 67.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.555 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ARG . 88.2 m-85 -105.59 113.93 27.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 50' ' ' TYR . 79.5 tt0 -30.01 -33.95 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.285 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' TYR . 21.1 mtt180 -127.15 162.67 46.66 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.279 0.362 . . . . 0.0 110.781 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 5.3 Cg_exo -73.9 170.63 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.533 2.155 . . . . 0.0 112.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.7 m120 79.26 -11.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.697 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.1 m-85 . . . . . 0 N--CA 1.465 0.292 0 O-C-N 123.674 0.609 . . . . 0.0 110.43 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.504 ' C ' HD12 ' A' ' 61' ' ' ILE . 29.3 t80 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.55 94.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -69.2 109.57 4.65 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 123.312 0.383 . . . . 0.0 110.048 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.23 160.83 17.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.15 1.9 . . . . 0.0 113.324 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.81 117.8 1.8 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.291 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.47 -179.29 41.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -106.09 155.82 19.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.085 0.469 . . . . 0.0 110.29 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.9 m-85 -146.7 84.53 7.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 32.0 Cg_exo -57.6 -16.87 25.95 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.174 2.583 . . . . 0.0 112.887 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 47.8 mt-10 -149.8 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.706 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.3 p90 -63.59 -51.88 63.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 19.6 mt-30 -43.54 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.1 mmm180 -75.86 -5.58 46.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.706 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.77 23.94 11.37 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.592 -0.067 . . . . 0.0 111.026 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 34.5 mmt 87.41 25.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.45 1.094 . . . . 0.0 110.97 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.11 50.69 0.36 Allowed Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.8 mt -77.45 14.24 1.03 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 118.982 -0.533 . . . . 0.0 111.438 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.9 t30 110.46 164.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.8 1.312 . . . . 0.0 109.252 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.0 p-10 -96.59 64.08 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.493 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 36.5 ttm180 -141.63 117.21 10.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.943 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.74 129.65 20.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.683 ' N ' HD13 ' A' ' 80' ' ' LEU . 53.2 p -112.22 -161.95 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.661 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.9 p -45.99 -178.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.212 0.53 . . . . 0.0 110.642 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 11.8 p -154.3 159.73 41.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.72 131.07 53.49 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.72 127.43 31.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 48' ' ' ALA . 68.9 t -126.43 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -101.29 157.41 16.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.0 157.18 69.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.522 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.492 1.422 0 C-N-CA 122.661 2.241 . . . . 0.0 112.085 179.429 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.73 0.3 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.749 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.3 t80 -159.14 113.3 2.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.197 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 132' ' ' VAL . 16.7 tptm -152.37 133.75 14.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.3 tt -134.88 142.34 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.749 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.2 mt-30 -120.92 129.08 53.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 108' ' ' MET . 13.8 mt -119.13 130.92 73.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.181 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.0 m-85 -111.52 128.1 55.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.837 0.351 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 84.4 tt0 -60.78 -27.65 68.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.918 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -118.33 146.9 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.929 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.74 172.22 20.01 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.01 31.14 19.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.538 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 10.2 m-85 55.14 80.99 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.246 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -160.25 162.61 33.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 -153.01 23.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -70.04 136.16 50.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -121.33 125.51 47.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.4 m-85 -117.11 134.91 54.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.089 0.471 . . . . 0.0 110.657 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -122.16 119.7 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.488 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 111' ' ' THR . 4.5 t -147.0 125.66 12.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -91.06 41.89 1.08 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.019 0.438 . . . . 0.0 111.041 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.07 179.77 6.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 17.1 p-10 -83.95 160.13 21.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.963 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -134.55 121.31 15.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.194 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.13 -53.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.659 1.573 . . . . 0.0 110.873 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -119.71 111.54 18.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -44.33 87.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 0.0 110.875 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.8 ttt -66.99 -21.99 65.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -73.01 -48.33 37.28 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.662 -0.649 . . . . 0.0 112.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.2 pt20 -99.16 -24.86 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.631 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 40.2 m-85 -111.58 2.39 17.33 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.992 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.0 m-70 51.41 11.91 0.13 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.132 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.0 mmt -79.44 135.29 36.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.582 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -110.57 -26.85 9.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.087 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 52.1 mt-10 -150.5 107.11 3.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.033 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.6 mm -77.78 125.11 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.6 m80 -104.81 -30.12 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.135 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.538 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 18.6 t -156.54 152.01 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.441 . . . . 0.0 110.957 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -146.58 150.8 36.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.992 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.411 ' HB2' HE21 ' A' ' 97' ' ' GLN . 46.5 mtpt -131.95 -172.01 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.681 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LYS . 61.5 t 47.49 77.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.381 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 157' ' ' TYR . 67.8 mt -101.28 172.29 7.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.183 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.8 mp0 -136.94 114.18 10.78 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.88 -91.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 134' ' ' GLU . 31.7 t -119.18 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -122.15 170.31 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.237 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 176' ' ' ILE . 62.5 mt -145.8 125.17 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.462 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.88 131.66 55.22 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.81 112.92 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.571 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' VAL . 75.7 tt0 -50.25 -27.24 5.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.723 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.39 166.15 11.57 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.35 164.95 11.03 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.022 1.815 . . . . 0.0 111.37 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.562 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 75.02 16.79 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.47 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.9 m-85 77.0 26.52 0.75 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.091 0.245 . . . . 0.0 111.278 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -107.57 166.32 10.76 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.927 0.394 . . . . 0.0 110.533 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 96.6 170.65 34.41 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -67.3 146.38 54.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 2.5 mp0 -94.23 148.33 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.456 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.953 -179.771 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.415 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.9 m-85 . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -106.03 -26.13 11.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -120.14 153.82 55.62 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.5 Cg_endo -58.91 -15.19 25.92 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.478 2.119 . . . . 0.0 113.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -103.05 -3.98 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.037 0.446 . . . . 0.0 110.491 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -28.27 66.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.464 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -106.16 22.79 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.1 70.54 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.523 -0.599 . . . . 0.0 114.014 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.44 140.45 41.73 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.19 0.995 . . . . 0.0 109.723 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.46 21.23 0.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 170.49 154.33 0.19 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.388 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.548 ' O ' HG12 ' A' ' 170' ' ' VAL . 41.1 Cg_endo -68.51 -35.0 18.58 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.489 2.126 . . . . 0.0 111.596 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -51.25 83.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.814 HG22 ' N ' ' A' ' 171' ' ' GLN . 1.4 p -102.54 -97.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.465 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.814 ' N ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 161.89 -143.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.096 0.872 . . . . 0.0 109.345 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 3.7 p -90.95 -156.0 0.42 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -169.51 -177.96 2.93 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.31 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -159.97 132.27 6.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 2.8 ptm180 -51.95 136.09 29.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.519 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -68.81 135.68 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.825 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.14 158.77 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.484 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.737 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 38.9 tttt -162.05 152.44 17.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.519 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -145.66 144.69 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.552 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.8 m -131.61 140.47 49.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 110.387 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -121.07 116.21 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.478 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 68.0 m-85 -94.15 137.68 33.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -58.51 -48.21 81.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.5 m-20 -107.14 -172.81 2.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.158 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -178.95 7.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.88 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.55 21.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.502 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.7 m-85 68.41 39.45 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' ARG . 34.6 mt-30 -117.15 -167.45 1.31 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.04 0.447 . . . . 0.0 110.621 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 73.22 -26.74 0.83 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.058 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.3 ttm-85 158.87 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.457 0.74 . . . . 0.0 109.661 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -172.33 152.17 2.69 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.783 ' O ' HG23 ' A' ' 9' ' ' THR . 68.2 t80 -129.49 133.26 47.18 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.8 p-10 -118.0 125.43 50.36 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 t -161.32 139.0 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -126.49 30.72 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 26' ' ' ASP . 3.9 t -147.13 142.29 27.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.775 0.322 . . . . 0.0 110.573 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' CYS . 54.4 p-10 -38.79 157.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.4 m -158.05 163.73 37.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.001 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.63 2.93 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.64 105.19 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.09 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.443 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -94.0 10.63 32.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.969 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.2 t60 -57.35 -25.43 59.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.599 . . . . 0.0 109.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -31.54 72.78 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.505 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.9 -18.33 40.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 12.4 tp -141.0 135.68 31.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 110.411 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -93.85 -10.37 34.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.583 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 23.7 ttm180 -157.53 146.2 19.48 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.7 m -110.78 104.2 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.074 0.464 . . . . 0.0 111.088 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.75 ' O ' ' O ' ' A' ' 39' ' ' SER . 96.7 m-20 -130.38 158.22 40.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.1 p 35.79 128.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.63 0 O-C-N 124.426 1.079 . . . . 0.0 111.825 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.8 mt -140.73 146.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-O 121.785 0.803 . . . . 0.0 112.08 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -156.18 99.73 1.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.447 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.67 141.41 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.311 0.577 . . . . 0.0 110.873 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -111.88 53.78 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.31 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.73 -93.9 0.1 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.29 -137.21 3.26 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.7 m -77.72 163.04 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.737 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 31.7 m95 -153.97 155.15 35.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.03 119.11 35.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.2 m -116.45 131.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.503 . . . . 0.0 110.85 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -103.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.702 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -37.53 -35.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.915 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -116.81 148.37 41.93 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.9 Cg_endo -67.94 162.61 39.04 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.755 2.303 . . . . 0.0 111.411 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 4.4 m-80 82.58 -5.11 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.287 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 15.4 m-85 . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 61' ' ' ILE . 21.0 t80 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -103.04 91.77 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.36 111.28 8.21 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 123.219 0.325 . . . . 0.0 110.183 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.93 160.61 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.167 1.912 . . . . 0.0 113.089 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.46 122.4 4.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.037 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.07 -174.68 40.21 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.9 mt-10 -111.37 158.53 18.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.186 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 34.0 m-85 -151.81 85.7 4.73 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.934 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 33.9 Cg_exo -57.43 -14.67 16.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.787 2.324 . . . . 0.0 112.598 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.2 mt-10 -151.3 162.25 41.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 23.6 p90 -65.48 -53.12 47.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.5 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.624 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.5 pt20 -40.44 -14.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.102 0.477 . . . . 0.0 112.051 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -74.13 -2.31 24.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.276 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -119.85 23.65 10.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.3 mmt 90.37 24.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.445 1.091 . . . . 0.0 112.059 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.61 54.34 0.24 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.787 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 49.8 mt -87.01 12.8 10.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 49.0 t30 91.15 137.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.932 0.77 . . . . 0.0 110.004 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.7 p-10 -39.37 -96.08 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.658 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.645 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 8.5 tpp85 29.43 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.431 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -138.7 128.12 24.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.055 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.6 p -110.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.8 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.4 p -46.31 -178.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.506 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.9 p -152.05 155.81 38.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.459 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -118.82 128.1 54.15 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.84 128.4 36.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.539 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.29 129.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.87 159.24 15.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.825 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mt -78.5 148.95 74.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.531 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.496 1.654 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 179.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 42.1 t80 -155.37 113.44 3.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.195 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 2.9 tppm? -156.2 137.31 13.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.439 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.85 145.51 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.003 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mt-30 -121.65 130.94 53.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.146 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.719 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.09 130.09 74.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.387 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 45.4 m-85 -110.92 129.83 55.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.751 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -62.58 -25.57 68.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -123.93 145.02 49.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.613 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.99 179.15 4.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 55.84 30.82 16.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 15.8 m-85 54.21 80.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.033 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.5 m -160.39 161.27 33.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.19 25.41 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -67.65 136.71 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.674 0.274 . . . . 0.0 110.778 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.0 ttp -121.63 128.21 51.68 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.622 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 43.4 m-85 -122.84 137.22 54.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.7 127.17 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.602 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' THR . 11.6 t -148.76 129.64 14.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.5 p -93.63 38.18 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.3 179.66 6.95 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -85.02 160.47 20.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 41.6 t -134.98 125.34 17.12 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' OG ' ' A' ' 172' ' ' SER . 64.7 Cg_endo -80.25 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.938 1.759 . . . . 0.0 111.287 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.6 m -116.5 110.15 18.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -68.49 -42.44 83.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.079 0.466 . . . . 0.0 111.003 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.7 ttt -67.43 -17.9 64.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.727 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -81.87 -42.54 19.44 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.462 -0.774 . . . . 0.0 111.723 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.652 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -94.24 -30.61 14.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.762 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.64 1.15 13.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.691 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 54.55 13.43 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.791 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.4 mmt -77.53 131.15 37.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -105.14 -29.14 10.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 74.1 mt-10 -151.11 109.08 3.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.187 0.518 . . . . 0.0 110.585 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.6 mm -74.6 125.71 34.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.821 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -106.87 -32.9 7.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.803 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.6 t -152.29 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 111.054 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.36 131.8 14.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.75 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HB2' HE21 ' A' ' 97' ' ' GLN . 47.8 mtmt -111.33 -169.04 1.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.234 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.492 ' C ' HD22 ' A' ' 133' ' ' LEU . 44.4 t 52.61 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.674 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.492 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -110.26 164.24 12.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 136' ' ' VAL . 5.9 mp0 -138.34 110.41 7.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.831 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.52 -86.33 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 134' ' ' GLU . 11.6 t -125.74 155.95 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.734 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.4 t-105 -142.67 170.58 15.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 73.5 mt -145.87 125.37 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.401 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -111.01 131.43 55.05 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.61 110.97 22.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.513 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 70.3 tt0 -49.9 -23.48 1.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.909 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.69 160.57 37.85 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.438 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 65.6 Cg_endo -77.79 168.01 22.99 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.54 2.16 . . . . 0.0 111.788 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.601 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 6.7 m-80 70.08 17.61 7.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.5 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.7 m-85 76.23 24.55 1.11 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.653 0.263 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.601 ' NH2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mtm-85 -105.98 162.73 13.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 100.09 164.21 28.77 Favored Glycine 0 N--CA 1.461 0.365 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 18.7 ptt-85 -60.51 138.24 58.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.308 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.555 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 3.7 mp0 -88.12 150.97 23.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.366 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.347 179.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.466 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.6 m-85 . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -105.56 -21.36 13.22 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -124.45 153.07 69.24 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.587 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 22.9 Cg_exo -52.89 -30.52 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.514 1.476 . . . . 0.0 113.523 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.4 mp -89.23 -4.72 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 111.033 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -57.04 -27.44 61.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.162 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.587 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -108.66 21.21 17.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.752 0.31 . . . . 0.0 110.451 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.53 60.64 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.645 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -111.42 136.03 51.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.817 0.809 . . . . 0.0 109.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.39 22.12 0.13 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 169.53 155.18 0.18 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.046 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 69.3 Cg_endo -77.39 4.2 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.651 2.234 . . . . 0.0 112.141 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.14 72.71 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.022 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.4 t -100.83 -147.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.922 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -159.91 -132.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.796 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 m -92.27 -155.01 0.4 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.6 -177.48 2.37 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.033 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.67 132.22 7.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.92 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -51.37 132.2 29.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.429 0.633 . . . . 0.0 110.956 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.1 mt -66.57 133.89 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -138.16 159.31 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.967 0.413 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.517 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 11.2 p . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.691 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.4 tttt -159.67 150.57 19.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.9 tt -144.88 141.61 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.362 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 m -127.49 139.02 53.07 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.83 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.72 115.7 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -96.28 138.73 33.45 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.079 0.466 . . . . 0.0 110.474 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -61.4 -51.09 70.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.851 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HA ' HD22 ' A' ' 38' ' ' ASN . 83.3 m-20 -97.29 -175.32 3.19 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.253 0.549 . . . . 0.0 110.219 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.97 -175.29 5.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.619 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.7 m120 46.7 23.12 0.22 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.01 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.5 m-85 59.78 44.6 13.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.332 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -116.41 162.05 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.13 0.491 . . . . 0.0 110.495 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.95 -150.87 31.2 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.554 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 170.64 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.18 155.11 6.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.406 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.0 t80 -134.74 134.53 41.09 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 51.8 p-10 -102.08 151.73 21.82 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.524 0.202 . . . . 0.0 110.49 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.8 124.6 2.24 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.673 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.06 12.99 9.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 t -150.54 146.96 26.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.669 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -38.63 157.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.678 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 18.3 t -157.69 164.61 36.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.145 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.34 -56.96 2.75 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -153.3 110.95 3.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.33 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.0 p90 -100.55 8.47 43.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.067 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.1 t60 -59.35 -28.76 67.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.527 0.68 . . . . 0.0 110.168 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.0 p -60.69 -28.32 68.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.375 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -89.89 -12.97 37.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.539 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -143.33 138.24 29.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.975 0.417 . . . . 0.0 109.969 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.6 m -100.43 -9.49 22.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 34' ' ' LEU . 51.3 ttm-85 -153.74 141.11 19.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.469 . . . . 0.0 110.45 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.1 m -111.52 106.15 14.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.76 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' O ' ' C ' ' A' ' 39' ' ' SER . 41.1 m-20 -117.91 -155.68 0.61 Allowed 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' ASN . 12.7 p -19.59 138.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.741 0.65 . . . . 0.0 112.476 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 8.8 mt -142.69 147.19 21.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.963 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.63 101.14 1.98 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.921 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.08 142.17 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -111.22 52.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.47 0.1 OUTLIER Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.753 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.86 -140.07 3.91 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.8 m -77.9 165.18 24.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 110.859 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.691 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.0 m95 -154.87 155.76 34.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.956 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.75 121.52 41.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.533 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -117.14 132.53 66.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.516 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' GLU . 52.4 m-85 -103.59 110.8 22.99 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.317 0.386 . . . . 0.0 110.897 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' TYR . 80.1 tt0 -35.37 -37.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.137 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 52' ' ' ARG . 19.0 mtp180 -119.02 150.69 49.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.438 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 52.6 Cg_endo -68.12 161.49 44.19 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.684 2.256 . . . . 0.0 111.567 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.5 m120 83.64 -7.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.991 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.5 m-85 . . . . . 0 N--CA 1.47 0.558 0 O-C-N 123.5 0.5 . . . . 0.0 111.254 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.188 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.85 91.19 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -71.56 110.33 7.36 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.95 161.01 21.03 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.099 1.866 . . . . 0.0 113.851 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -47.24 119.78 2.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.912 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.13 -176.26 41.49 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -109.15 157.74 18.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.835 0.35 . . . . 0.0 110.159 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 48.4 m-85 -147.81 91.99 4.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 41.3 Cg_endo -66.69 -11.38 31.66 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.234 1.956 . . . . 0.0 113.269 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.6 mt-10 -151.35 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 36.3 p90 -63.9 -53.05 56.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -44.98 -9.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.0 tpt180 -75.09 -3.98 35.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.1 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.73 24.07 10.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.7 mmt 86.84 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.438 1.086 . . . . 0.0 111.212 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.24 48.2 0.2 Allowed Glycine 0 N--CA 1.473 1.155 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.16 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 18.3 mt -71.66 13.36 0.27 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 119.073 -0.489 . . . . 0.0 111.078 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.6 t30 107.63 164.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.779 1.299 . . . . 0.0 109.363 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -94.92 62.03 2.58 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.35 115.62 11.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.26 128.66 21.19 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.4 p -110.28 -163.5 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 3.4 t -45.42 -178.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.34 0.591 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.595 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 10.7 p -151.82 155.5 38.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.558 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -121.7 129.97 53.12 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.72 126.87 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.296 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.6 t -122.77 131.08 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.52 ' O ' HG21 ' A' ' 136' ' ' VAL . 38.0 m80 -100.13 157.75 16.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.768 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -84.27 153.37 62.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.49 1.29 0 C-N-CA 122.517 2.144 . . . . 0.0 112.146 178.795 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.763 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 26.1 t80 -158.05 114.16 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 110.295 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -153.79 132.56 12.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -135.87 145.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.1 mt-30 -122.66 131.0 53.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.504 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 118' ' ' ILE . 11.8 mt -119.58 130.57 73.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.998 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 46.8 m-85 -112.1 128.88 56.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.883 0.373 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.98 -28.23 68.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -120.37 148.36 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.991 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.47 -169.07 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t0 43.63 30.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 53.97 83.26 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.5 m -160.57 163.72 32.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 0.0 110.753 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.66 -152.09 22.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.709 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -71.76 136.59 47.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 0.0 110.429 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 39.1 ttp -120.5 124.62 45.84 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.781 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 48.8 m-85 -116.0 133.6 55.85 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.13 0.491 . . . . 0.0 110.473 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -122.16 121.61 37.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 111' ' ' THR . 6.9 t -147.41 126.94 13.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -93.92 41.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -141.66 -178.46 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.566 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.8 p-10 -84.96 157.69 20.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 70.0 m -134.91 121.06 14.52 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.165 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 60.5 Cg_endo -77.95 -56.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.05 1.833 . . . . 0.0 110.936 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.4 m -116.73 112.8 21.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -68.82 -45.05 81.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.403 0.621 . . . . 0.0 110.634 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.465 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -65.71 -21.65 66.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.299 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -73.97 -47.38 37.74 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.275 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.6 pt20 -98.1 -24.8 15.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.1 m-85 -112.53 2.91 16.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.121 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.6 m-70 51.3 10.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.891 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 122' ' ' PHE . 3.4 mmt -75.72 133.02 40.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -106.27 -30.56 9.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.787 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 29.7 mt-10 -150.58 108.76 3.75 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.089 0.471 . . . . 0.0 111.153 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.37 125.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.586 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.5 m80 -106.31 -32.13 8.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.941 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 17.0 m -154.97 150.28 27.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.116 0.484 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.14 153.63 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.759 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.9 mtpt -131.46 -177.33 4.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.561 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.552 ' C ' HD22 ' A' ' 133' ' ' LEU . 13.8 t 54.04 98.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.552 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.5 mm? -111.21 164.44 12.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.566 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -138.92 111.64 7.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.218 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.56 -87.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.3 t -121.95 157.05 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -143.73 168.21 20.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.16 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.9 mt -144.91 122.84 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.186 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.534 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -109.62 131.72 54.8 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 32.9 m-85 -109.51 112.03 23.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.119 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -50.56 -23.79 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.5 mp -117.38 164.95 17.02 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 94.3 Cg_endo -82.94 167.95 14.06 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.38 2.054 . . . . 0.0 112.194 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.493 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.5 m-80 77.65 15.75 1.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.098 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.493 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.37 29.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.694 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 96.8 mtt180 -135.57 128.43 31.24 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.1 171.98 21.63 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.38 108.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.455 ' CG ' ' CE1' ' A' ' 140' ' ' TYR . 71.6 mt-30 -75.44 147.72 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.963 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.613 0.244 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 129' ' ' SER . 4.2 ptp180 -102.18 -25.58 13.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.077 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.46 50.04 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.03 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.557 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 21.4 Cg_endo -62.8 -17.29 58.59 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.856 2.371 . . . . 0.0 113.235 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.2 mp -101.36 -4.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.171 0.51 . . . . 0.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.45 -28.59 67.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.767 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -104.97 22.94 14.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.189 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.37 28.72 67.34 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.938 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.596 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -110.88 139.58 46.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.024 0.912 . . . . 0.0 109.795 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.08 22.3 0.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.01 152.72 0.26 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.728 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.78 5.45 4.36 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.746 2.297 . . . . 0.0 111.542 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.5 70.23 5.92 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -98.91 -153.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.868 ' H ' HG12 ' A' ' 170' ' ' VAL . 78.3 mm-40 -152.74 -132.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.705 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -94.22 -155.1 0.44 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -171.17 -176.01 1.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.21 0.528 . . . . 0.0 111.22 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.443 HH21 HG22 ' A' ' 177' ' ' VAL . 9.7 ptm180 -158.96 132.32 7.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.936 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 ptt-85 -52.99 134.48 37.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 138' ' ' ILE . 15.5 mt -67.92 133.71 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.466 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.443 HG22 HH21 ' A' ' 174' ' ' ARG . 34.5 m -139.03 156.6 28.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.452 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.7 tp10 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.356 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.417 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.1 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.786 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.2 tttt -160.26 151.8 19.71 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.008 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -147.23 141.67 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 97.7 m -123.95 138.21 54.5 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.718 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -118.77 115.78 25.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.2 m-85 -94.87 138.31 32.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.231 0.539 . . . . 0.0 110.986 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 7.7 tm-20 -60.44 -49.96 75.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.946 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 45.3 m-20 -99.33 -176.02 3.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.241 0.543 . . . . 0.0 109.773 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -83.19 -176.84 6.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.32 24.3 0.27 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.807 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.483 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 62.75 41.53 8.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.176 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.41 173.63 6.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.26 -155.99 53.51 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.682 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -54.65 174.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -169.34 149.92 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 59.4 t80 -132.75 133.15 43.09 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 40.2 p-10 -119.87 132.5 55.58 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.569 0.223 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 140.97 30.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -125.0 15.88 8.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.669 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 26' ' ' ASP . 11.2 m -148.94 145.8 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 43.0 t0 -37.29 155.72 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.542 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 m -155.95 162.03 40.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.98 -56.53 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.802 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -154.18 110.75 3.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.411 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.5 p90 -101.42 9.79 41.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.0 t60 -59.76 -28.57 67.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.694 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.4 p -61.16 -29.12 69.6 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.433 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -88.76 -12.56 41.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.663 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -142.21 136.65 30.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -96.84 -10.73 25.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.702 0.287 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.618 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 59.9 ttp180 -157.05 145.71 19.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.471 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -110.65 104.35 13.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.733 ' O ' ' O ' ' A' ' 39' ' ' SER . 95.3 m-20 -128.57 155.9 44.19 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.733 ' O ' ' O ' ' A' ' 38' ' ' ASN . 24.4 p 35.73 130.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.642 1.21 . . . . 0.0 112.568 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.4 mt -142.15 146.29 22.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.93 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.7 ptpt -154.41 102.55 2.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.008 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.33 149.08 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.291 0.567 . . . . 0.0 110.552 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.31 50.21 1.41 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.682 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.21 -95.48 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.112 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.56 -140.36 4.04 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -80.93 166.54 20.76 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.433 -0.451 . . . . 0.0 110.89 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.786 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.4 m95 -154.71 156.65 36.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.19 120.97 40.7 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.62 132.28 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -104.35 110.16 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -37.59 -34.49 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -115.91 148.41 41.24 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.883 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.1 Cg_endo -68.54 159.77 52.1 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.465 2.11 . . . . 0.0 111.915 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.3 m-80 85.17 -5.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.835 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 11.7 m-85 . . . . . 0 N--CA 1.471 0.596 0 O-C-N 123.649 0.593 . . . . 0.0 111.001 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 25.9 t80 . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.786 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.5 mp -102.91 91.37 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.06 111.72 11.76 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.67 162.29 19.01 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.143 1.895 . . . . 0.0 112.661 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.41 117.36 2.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.024 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.34 41.01 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.5 mt-10 -101.2 153.58 19.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 24.2 m-85 -146.5 86.21 6.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.92 -18.47 16.69 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.857 2.371 . . . . 0.0 112.906 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -152.41 162.47 41.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.654 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 6.1 p90 -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -41.21 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.1 mmt180 -75.77 -5.49 46.04 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -117.61 25.27 10.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 119.698 -0.191 . . . . 0.0 111.362 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.4 mmt 89.79 23.59 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.455 1.097 . . . . 0.0 111.636 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.41 59.11 0.23 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.294 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 38.8 mt -94.69 13.92 22.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 91.91 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.227 0.954 . . . . 0.0 110.599 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.64 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 35.8 p-10 -37.85 -95.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.425 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.64 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.1 tpt180 30.11 93.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.358 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -139.51 128.03 22.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.64 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.0 p -111.04 -162.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.135 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.1 p -45.25 -179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.653 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.521 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 18.6 p -149.04 148.76 30.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.26 126.33 55.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.09 124.25 20.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.151 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 48' ' ' ALA . 67.9 t -120.21 129.0 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.897 0.379 . . . . 0.0 110.444 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 136' ' ' VAL . 93.4 m-70 -97.5 160.31 14.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.16 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.15 149.95 70.49 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.648 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.32 2.013 . . . . 0.0 112.124 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.665 0.269 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.743 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.1 t80 -157.94 113.31 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -153.56 134.01 13.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.021 0.438 . . . . 0.0 111.354 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.59 145.74 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.0 mt-30 -124.32 129.76 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.233 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 108' ' ' MET . 10.4 mt -118.7 132.83 67.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.03 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.15 133.89 55.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.258 0.552 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -30.16 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.72 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -119.61 148.65 43.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.225 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.07 174.55 15.67 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.4 t0 57.77 30.76 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.002 0.43 . . . . 0.0 110.441 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 55.87 82.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -160.12 161.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.556 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.03 -150.99 22.55 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.11 136.04 39.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.654 0.264 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.8 tmm? -122.1 133.38 54.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 59.0 m-85 -123.68 137.71 54.66 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.239 0.542 . . . . 0.0 110.618 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.3 125.28 44.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 111' ' ' THR . 5.1 t -147.9 128.25 13.93 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.705 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -90.29 41.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -146.65 -178.14 6.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.6 p-10 -86.36 162.16 18.33 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.584 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 84.5 m -138.79 122.81 11.32 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.416 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.01 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.188 1.925 . . . . 0.0 111.678 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -121.09 109.28 14.83 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.1 tt -64.28 -38.09 81.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.625 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 24.0 ttt -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.56 -44.32 17.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.604 -0.685 . . . . 0.0 111.678 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.584 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -90.93 -32.88 15.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.372 -178.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 23.5 m-85 -115.79 8.84 14.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 49.11 11.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.206 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.5 mtt -79.72 138.05 37.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.465 0.65 . . . . 0.0 110.057 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.518 ' NH2' ' OE2' ' A' ' 126' ' ' GLU . 4.8 ptm180 -109.99 -26.41 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.366 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 75.8 mt-10 -149.84 107.31 3.64 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.321 0.582 . . . . 0.0 111.904 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 118' ' ' ILE . 9.6 mm -76.0 122.71 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.442 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.7 m80 -102.91 -31.9 10.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.119 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 p -155.93 151.35 26.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.801 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -148.67 131.82 16.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.2 -176.4 3.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 133' ' ' LEU . 27.8 t 55.69 98.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.04 167.02 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.067 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.0 mp0 -142.09 111.73 6.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.974 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.92 -89.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.7 t -119.92 150.99 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.145 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -140.07 170.42 15.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.0 mt -145.14 123.61 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.392 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -112.17 132.84 54.66 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.49 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 40.1 m-85 -110.46 112.24 24.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 78.3 tt0 -51.54 -21.99 2.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.3 mp -118.16 165.32 16.63 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.29 167.45 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.016 1.81 . . . . 0.0 112.186 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.99 14.82 1.1 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.969 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 75.24 28.44 1.01 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.154 0.284 . . . . 0.0 111.371 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 82.0 mtp180 -133.28 126.83 32.33 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.19 174.54 22.17 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.549 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 77.8 mtm180 -53.07 115.99 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.329 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 49.2 mt-30 -85.52 138.16 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.516 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -105.73 -24.1 12.59 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.811 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -121.26 153.3 58.29 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.551 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -58.83 -14.91 24.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.539 2.159 . . . . 0.0 113.453 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -103.06 -2.9 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.118 0.485 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.36 -26.43 66.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.412 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.39 23.07 15.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.408 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.03 69.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.719 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.02 139.38 43.98 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.257 1.028 . . . . 0.0 109.397 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.4 22.11 0.34 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 170.62 156.27 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.303 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.831 ' O ' HG23 ' A' ' 170' ' ' VAL . 42.1 Cg_endo -68.9 -35.89 14.46 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.674 2.249 . . . . 0.0 111.435 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.65 77.1 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.6 t -94.11 -102.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.345 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.711 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER 162.65 -144.64 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 O-C-N 123.792 0.682 . . . . 0.0 109.718 177.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 1.9 p -91.02 -157.9 0.52 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.568 0.223 . . . . 0.0 111.225 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -169.78 -177.54 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.218 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -158.21 131.82 7.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.235 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 ptm180 -52.3 133.03 34.7 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.714 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.457 HG12 HD12 ' A' ' 138' ' ' ILE . 12.8 mt -63.44 134.08 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.48 137.05 53.74 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.056 0.455 . . . . 0.0 110.577 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.388 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.844 0.354 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.57 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.1 tttt -161.71 153.09 18.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.862 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.6 tt -146.71 144.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.808 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.7 m -135.12 141.28 45.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -121.05 115.9 24.01 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 81.5 m-85 -95.28 139.52 31.47 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.259 0.552 . . . . 0.0 111.181 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 8.1 tm-20 -63.46 -49.42 73.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.115 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.8 m-20 -98.84 -177.46 3.65 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -81.87 -178.67 7.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 48.57 22.23 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.516 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.5 m-85 60.15 46.41 10.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.196 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.23 167.36 10.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -143.35 31.53 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.499 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -65.58 162.49 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.408 -0.896 . . . . 0.0 109.149 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.57 156.99 8.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.971 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.512 ' O ' HG23 ' A' ' 9' ' ' THR . 27.6 t80 -131.07 133.65 45.88 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.6 p-10 -123.79 124.5 42.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.75 143.56 24.57 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.242 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -123.63 28.71 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.388 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.0 t -145.73 142.32 28.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -40.02 157.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.505 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.6 m -159.2 165.05 34.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.87 -54.79 3.6 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.994 0.426 . . . . 0.0 111.01 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -156.51 106.96 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.255 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -94.36 8.14 42.98 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.0 t60 -58.51 -30.93 67.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.3 p -58.02 -29.46 65.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.301 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.72 -16.85 31.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.608 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.559 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -140.02 137.17 34.42 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 109.954 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -100.61 -7.77 23.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.242 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 78' ' ' ASP . 57.6 ttm-85 -153.58 142.76 21.41 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.443 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.0 m -112.44 102.79 10.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.7 m-20 -127.69 153.73 46.14 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 17.1 p 37.38 126.23 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.333 1.064 . . . . 0.0 112.562 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.2 mt -138.93 147.24 25.04 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.463 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.38 100.88 2.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.366 0.603 . . . . 0.0 109.921 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 42' ' ' VAL . 6.7 m -70.2 141.45 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.11 47.59 0.95 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.57 -98.65 0.14 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.42 -137.34 3.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -77.87 166.78 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.62 ' N ' HG22 ' A' ' 46' ' ' THR . 38.6 m95 -156.56 156.8 34.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.546 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.44 118.91 33.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.757 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.38 133.01 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 111.297 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -107.54 110.57 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.773 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -39.1 -32.77 0.1 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.075 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -116.79 147.72 40.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.733 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -68.71 156.33 65.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.33 2.02 . . . . 0.0 111.585 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 9.2 m-80 86.11 -2.93 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.038 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-85 . . . . . 0 N--CA 1.471 0.615 0 C-N-CA 122.596 0.358 . . . . 0.0 111.785 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.737 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.63 99.04 7.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.562 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -71.0 110.63 7.62 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.09 163.82 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.148 1.899 . . . . 0.0 113.255 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.2 123.42 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.914 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.28 -173.64 40.28 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.585 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.6 mt-10 -111.46 156.35 21.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.956 0.408 . . . . 0.0 109.904 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.585 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.5 m-85 -147.27 81.12 8.94 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.485 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 36.5 Cg_exo -55.43 -14.0 8.72 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.054 2.503 . . . . 0.0 112.661 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -151.47 163.41 39.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.338 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 10.9 p90 -65.4 -51.01 63.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.405 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.2 mt-30 -43.62 -10.6 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' TYR . 39.2 mmt180 -76.3 -0.55 22.86 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.02 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -123.81 22.6 8.9 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 122.929 0.143 . . . . 0.0 111.019 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 8.7 mmt 91.86 18.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.578 1.151 . . . . 0.0 111.709 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.26 62.16 0.24 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.9 mt -90.91 17.19 8.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.461 0.304 . . . . 0.0 111.27 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 67.0 t30 107.28 155.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.798 1.311 . . . . 0.0 109.639 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 54.0 p-10 -87.54 73.49 9.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.126 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -145.86 118.91 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -147.15 130.12 16.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 110.398 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.0 p -108.01 -164.75 0.99 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' SER . 61.5 m -49.44 -174.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.862 ' SG ' HG21 ' A' ' 8' ' ' ILE . 12.9 p -153.58 156.38 37.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -118.99 129.52 55.19 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.525 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.37 133.54 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.629 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.82 134.07 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.582 ' O ' HG21 ' A' ' 136' ' ' VAL . 37.4 m80 -101.15 162.13 13.11 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.916 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -91.79 159.45 38.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.662 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.045 179.372 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.749 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.968 0.413 . . . . 0.0 111.262 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.749 ' H ' HE21 ' A' ' 93' ' ' GLN . 10.8 t80 -156.88 115.73 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -154.05 131.86 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.26 0.552 . . . . 0.0 110.605 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -138.94 147.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.337 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.8 mt-30 -124.44 129.1 50.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.461 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 7.3 mt -119.61 131.71 71.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -111.52 123.76 50.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.115 0.483 . . . . 0.0 110.52 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.51 -19.04 22.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.625 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -131.89 143.58 50.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 110.582 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.85 -178.91 0.78 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.4 t0 52.29 29.44 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.462 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 54.81 80.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.838 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -157.31 164.03 38.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.549 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.46 -157.24 30.03 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -67.7 138.23 56.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.764 0.316 . . . . 0.0 110.636 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 43.4 ttp -118.6 121.33 39.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.488 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.5 m-85 -116.81 132.66 56.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.209 0.528 . . . . 0.0 111.201 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.07 131.33 52.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.826 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -152.84 134.35 14.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -95.54 45.48 1.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -149.24 -177.74 6.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.774 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -86.9 160.28 18.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 64.5 m -137.82 123.34 12.64 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.6 Cg_endo -78.18 -61.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.805 1.67 . . . . 0.0 110.879 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.2 m -111.38 113.16 25.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -70.04 -35.78 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.116 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 25.3 ttt -71.43 -18.53 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.447 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -82.43 -42.44 18.56 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.079 -1.013 . . . . 0.0 111.397 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.528 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.66 -30.19 15.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -177.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 27.7 m-85 -117.73 4.17 12.29 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.9 m-70 55.06 3.63 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.854 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -72.15 131.89 43.42 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.943 0.402 . . . . 0.0 109.921 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -108.4 -24.24 11.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.189 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.4 mt-10 -151.0 108.82 3.68 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.001 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 118' ' ' ILE . 7.8 mm -76.91 125.79 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.8 m80 -105.24 -36.88 7.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.119 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.4 p -153.59 149.62 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.868 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -145.92 156.16 43.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.758 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.5 mtpt -134.06 179.13 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.371 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.553 ' C ' HD22 ' A' ' 133' ' ' LEU . 12.8 t 57.65 99.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -114.42 164.02 14.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.372 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -135.91 111.98 9.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.21 -88.0 0.01 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 87' ' ' HIS . 17.5 t -125.82 144.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.974 0.416 . . . . 0.0 109.996 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.731 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.2 t-105 -130.09 167.85 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 67.5 mt -144.25 124.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -112.42 131.88 55.33 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -110.19 114.21 27.52 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.593 0.558 . . . . 0.0 110.784 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 80.8 tt0 -51.86 -23.65 5.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.507 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.8 mp -118.05 160.9 37.23 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.1 Cg_endo -77.77 167.06 24.51 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.205 1.937 . . . . 0.0 111.763 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.514 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.9 m-80 73.2 14.83 4.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.046 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.514 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.2 m-85 77.34 27.84 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.531 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -114.7 170.77 8.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.831 0.348 . . . . 0.0 110.578 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.73 159.57 27.73 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 16.5 ptt180 -64.64 84.7 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.648 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -54.61 -167.5 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.043 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 N--CA 1.465 0.308 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.563 -179.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.546 0.212 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.539 ' CZ ' ' HZ3' ' A' ' 159' ' ' LYS . 48.3 ptt85 -108.34 -22.29 12.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.594 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HZ3' ' CZ ' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -121.59 156.41 58.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.84 0.352 . . . . 0.0 110.736 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.503 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -59.42 -23.06 68.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.214 1.943 . . . . 0.0 113.177 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -94.36 -4.94 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -55.53 -31.77 62.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.298 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 1.0 OUTLIER -103.72 20.82 17.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.713 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.64 27.79 64.5 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.087 -0.577 . . . . 0.0 113.769 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.6 137.41 44.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.805 0.802 . . . . 0.0 110.301 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.25 26.32 0.16 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 166.0 154.54 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.503 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 170' ' ' VAL . 44.0 Cg_endo -71.49 -13.35 30.23 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.047 2.498 . . . . 0.0 111.337 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.65 69.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.582 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.953 HG12 ' H ' ' A' ' 171' ' ' GLN . 4.2 t -101.0 -152.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.953 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.7 tp60 -153.33 -132.04 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.735 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -95.15 -152.99 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -170.64 -179.44 2.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.09 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.474 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -155.3 130.25 9.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.902 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -52.74 126.39 19.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.943 0.877 . . . . 0.0 110.98 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.445 HG12 HD12 ' A' ' 138' ' ' ILE . 9.3 mt -59.01 128.22 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 174' ' ' ARG . 2.9 m -135.76 144.05 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.198 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 46' ' ' THR . 42.7 tt0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.081 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.467 0.396 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.745 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.8 tttt -161.28 152.69 18.94 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.983 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 tt -147.2 141.04 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.098 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.3 m -124.8 138.23 54.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.462 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -118.23 116.3 26.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 94.0 m-85 -98.59 139.27 34.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.963 0.411 . . . . 0.0 110.96 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.0 tm-20 -62.03 -51.94 65.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.875 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.92 -177.93 4.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.31 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -82.36 -177.55 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.853 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.42 24.82 0.33 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.177 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.8 m-85 62.43 42.71 8.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.257 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.91 172.58 6.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.65 -153.33 51.45 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.845 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -56.89 173.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -169.0 152.53 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.492 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 63.9 t80 -129.23 131.62 47.09 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 37.7 p-10 -120.39 125.36 47.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 0.0 111.24 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.7 t -151.25 142.43 23.21 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.26 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -126.17 24.11 6.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' ASP . 14.3 m -145.99 141.81 28.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.442 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 40.3 t0 -35.73 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 20.8 m -156.85 162.68 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.348 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.75 -55.69 3.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.979 0.419 . . . . 0.0 110.647 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -154.07 110.97 3.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.331 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.3 p90 -100.81 9.27 42.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.963 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.7 t60 -59.07 -28.41 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.515 0.674 . . . . 0.0 110.069 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -60.96 -29.2 69.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.271 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.08 -14.99 37.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -142.34 138.25 31.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -99.98 -8.69 23.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.644 0.259 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 49.2 ttm-85 -154.23 141.5 19.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.824 0.345 . . . . 0.0 110.485 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.4 m -110.92 105.46 14.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.273 0.559 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 45.4 m-20 -117.13 -155.84 0.6 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' ASN . 18.2 p -20.47 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.884 0.74 . . . . 0.0 112.271 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 mt -143.01 146.91 21.14 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.114 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.1 ptpt -154.41 103.97 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.2 t -66.6 148.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.523 0.678 . . . . 0.0 110.555 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.51 50.08 1.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.009 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.77 -95.85 0.1 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.925 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.28 -140.28 4.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 90.0 m -81.05 166.9 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.292 -0.534 . . . . 0.0 110.84 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.745 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.3 m95 -154.47 156.9 37.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.286 0.565 . . . . 0.0 110.742 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.43 120.82 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.1 m -117.47 131.9 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 0.0 110.986 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.7 109.65 21.43 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.723 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -37.06 -36.29 0.12 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -113.69 147.98 38.8 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.5 Cg_endo -68.72 157.09 63.25 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.34 2.026 . . . . 0.0 112.05 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 5.5 m-80 86.03 -2.84 0.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.3 m-85 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 121.146 0.498 . . . . 0.0 111.145 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 26.3 t80 . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -104.06 92.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.604 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.3 110.23 5.89 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 162.85 19.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.083 1.855 . . . . 0.0 112.759 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.79 117.41 2.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.087 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.78 179.12 41.3 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.51 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -102.24 153.93 19.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 25.1 m-85 -145.93 83.55 8.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.57 -15.72 9.51 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.26 2.64 . . . . 0.0 113.101 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -152.52 161.43 42.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.734 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 13.2 p90 -65.03 -52.36 56.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.334 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 37.2 mt-30 -42.99 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.82 -4.97 46.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.059 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.734 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.85 23.24 11.81 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.618 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.6 mmt 87.41 25.35 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.561 1.163 . . . . 0.0 111.158 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 30.83 50.04 0.2 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.078 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 26.5 mt -75.86 14.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.542 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 14.6 t-20 110.95 162.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.368 1.043 . . . . 0.0 109.27 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -94.4 61.23 2.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -137.61 115.78 11.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.246 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.39 129.16 20.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.6 p -111.58 -162.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.745 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.29 -178.65 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.864 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.588 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.5 p -151.11 153.06 34.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.595 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -118.34 127.86 54.1 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.559 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.49 127.85 33.48 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 48' ' ' ALA . 70.7 t -125.63 132.04 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.735 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.437 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.7 m-70 -100.37 161.56 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 1.2 mt -80.82 150.36 69.12 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.429 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 N--CA 1.496 1.619 0 C-N-CA 122.244 1.963 . . . . 0.0 111.935 179.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.692 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.715 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 21.5 t80 -160.88 114.13 2.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.261 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -157.09 132.28 9.04 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.709 0.29 . . . . 0.0 110.676 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.5 tt -135.81 145.0 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.221 0.534 . . . . 0.0 111.296 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 132' ' ' VAL . 11.8 mt-30 -122.23 134.02 54.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.36 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.641 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 mt -121.94 131.52 72.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.216 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -115.98 130.24 56.73 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.211 0.529 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.46 -26.98 65.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.052 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -122.25 147.07 46.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.591 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.46 -168.48 0.41 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 50.7 t0 44.56 29.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.911 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 54.11 79.35 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m -158.56 162.24 37.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.993 0.425 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.99 -171.43 42.69 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -53.89 133.69 42.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.169 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.9 tmm? -121.04 131.98 54.61 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.454 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.7 m-85 -121.46 135.72 55.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.456 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.05 126.24 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 111' ' ' THR . 7.3 t -152.73 128.93 10.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.72 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -95.37 42.68 1.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 111.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.07 -179.46 6.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.508 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.8 p-10 -84.04 156.98 21.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.525 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 65.8 m -134.04 123.02 16.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.907 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' OG ' ' A' ' 172' ' ' SER . 68.3 Cg_endo -77.98 -57.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.8 1.667 . . . . 0.0 110.841 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.8 m -115.89 111.64 20.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -67.4 -41.86 86.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 0.0 111.338 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 9.1 ttp -68.17 -17.12 64.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.344 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -82.47 -42.49 18.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.671 -0.643 . . . . 0.0 111.707 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.525 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.9 -29.96 15.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.111 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.523 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 29.3 m-85 -115.99 4.48 13.77 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.5 m-70 52.48 11.64 0.19 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.234 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -76.85 133.01 39.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -106.98 -28.48 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.71 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 30.3 mt-10 -151.45 109.0 3.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.008 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.9 mm -74.98 125.17 34.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.901 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.0 m80 -107.44 -33.53 7.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.56 -168.12 1.97 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.793 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.609 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.1 OUTLIER 160.99 137.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.082 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -130.16 -169.54 2.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.052 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 97' ' ' GLN . 49.1 t 47.0 87.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 0.0 110.3 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.28 169.8 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.201 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -141.88 113.65 7.9 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.49 -97.44 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -110.54 155.93 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -145.03 168.62 19.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.837 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.47 HD12 HG12 ' A' ' 176' ' ' ILE . 70.5 mt -144.63 123.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.974 0.416 . . . . 0.0 111.576 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.61 129.82 55.56 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -107.5 110.83 22.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.563 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.2 -22.39 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.27 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.55 164.36 16.66 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 90.7 Cg_endo -84.16 166.9 12.58 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.091 1.86 . . . . 0.0 112.29 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 143' ' ' PRO . 1.8 m-80 68.52 21.96 7.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.6 m-85 71.68 66.83 0.15 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -154.44 169.68 23.17 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.931 0.396 . . . . 0.0 110.698 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.93 172.76 39.12 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.982 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -53.9 138.26 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.554 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 15.5 mp0 -99.56 137.5 37.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.033 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.592 -179.69 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -109.47 -21.13 12.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -121.24 155.73 58.22 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 121.124 0.488 . . . . 0.0 110.965 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.531 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -60.24 -19.03 55.5 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.259 1.973 . . . . 0.0 113.181 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.686 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.1 mp -97.86 -3.45 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.72 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.5 OUTLIER -60.62 -27.86 68.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.864 -178.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.563 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -107.42 21.25 17.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.28 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.33 70.84 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.331 0.492 . . . . 0.0 114.331 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.563 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.75 138.58 41.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.973 0.886 . . . . 0.0 110.005 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.57 20.86 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.265 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 169.46 156.73 0.18 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.719 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.7 4.48 6.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.006 2.471 . . . . 0.0 111.585 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.55 71.4 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.798 0.333 . . . . 0.0 111.09 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.6 t -99.78 -151.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.888 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -154.61 -130.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.123 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 2.9 p -93.7 -155.48 0.45 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -170.04 -177.27 2.52 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.319 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.72 132.06 6.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.442 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -51.67 134.81 29.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.237 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.2 mt -67.84 135.48 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.658 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.52 156.75 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.152 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.743 0.306 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.777 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.4 tttt -160.03 152.03 20.41 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.004 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.95 142.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.736 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -125.89 138.99 53.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.642 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -119.33 115.8 24.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.373 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.4 m-85 -94.71 138.73 32.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 110.822 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 8.1 tm-20 -61.06 -49.91 75.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.076 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 65.6 m-20 -99.2 -175.96 3.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.182 0.515 . . . . 0.0 109.667 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -82.73 -176.64 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.829 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.53 23.78 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.515 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.9 m-85 63.18 41.46 7.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.117 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -108.19 177.08 4.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.44 -158.56 50.97 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.508 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -54.64 176.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.25 150.15 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 49.8 t80 -127.23 130.97 50.63 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -119.45 124.0 45.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.096 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -150.03 142.3 24.19 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.241 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -125.25 24.01 7.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.951 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.9 t -146.81 141.81 27.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.8 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 25' ' ' CYS . 74.5 m-20 -36.61 156.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.562 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 23.5 t -157.69 164.27 37.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.301 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.47 -56.57 2.98 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.958 0.409 . . . . 0.0 110.861 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 44.7 p-10 -154.24 110.6 3.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.193 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -99.89 10.83 40.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' LEU . 70.5 t60 -59.79 -26.85 66.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.2 p -63.39 -31.31 72.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -85.85 -12.58 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.15 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -142.93 137.62 29.58 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 p -95.49 -11.74 27.01 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.579 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 45.4 ttp180 -158.19 146.07 18.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.217 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.8 m -110.25 104.15 12.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.37 0.605 . . . . 0.0 111.395 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.727 ' O ' ' O ' ' A' ' 39' ' ' SER . 90.3 m-20 -128.84 155.6 44.95 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.463 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' O ' ' A' ' 38' ' ' ASN . 11.1 p 36.97 128.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.345 1.069 . . . . 0.0 112.192 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.7 mt -141.46 147.12 22.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.403 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -155.94 102.28 2.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.212 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -67.24 149.78 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-O 121.616 0.722 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -122.89 50.62 1.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.053 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.582 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.53 -96.97 0.11 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.868 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.509 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.92 -141.33 4.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 47' ' ' TRP . 84.9 m -80.84 167.23 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.578 -0.366 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.777 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.8 m95 -154.74 155.65 34.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.611 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 120.79 41.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.48 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.92 131.33 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 110.608 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-85 -102.88 108.23 19.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 50' ' ' TYR . 79.1 tt0 -36.48 -35.32 0.08 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.07 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -115.39 147.3 38.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 49.4 Cg_endo -68.45 160.71 48.04 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.324 2.016 . . . . 0.0 111.446 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 83.37 -3.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.293 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.7 m-85 . . . . . 0 N--CA 1.467 0.422 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.7 m-85 . . . . . 0 C--O 1.231 0.117 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -104.39 92.14 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 112.98 16.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.67 162.23 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.02 1.813 . . . . 0.0 112.526 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -51.94 115.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.914 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.12 177.52 42.44 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.523 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.8 mt-10 -101.06 153.07 19.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.944 0.402 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 30.6 m-85 -146.05 91.11 5.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 -13.62 40.67 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.056 1.837 . . . . 0.0 113.138 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 91.7 mt-10 -149.41 161.08 42.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.753 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.6 p90 -63.23 -53.97 44.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.99 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.61 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.9 pt20 -43.46 -10.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 70' ' ' TYR . 24.0 mmm180 -75.04 -5.6 44.93 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.24 24.39 10.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.05 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.0 mmt 87.97 25.48 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.289 0.993 . . . . 0.0 111.286 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.17 51.47 0.26 Allowed Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 10.4 mt -75.88 13.2 0.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.83 -0.185 . . . . 0.0 110.986 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.2 t30 109.06 169.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.578 1.174 . . . . 0.0 108.743 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -98.96 61.46 1.26 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.901 0.382 . . . . 0.0 110.556 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -139.2 116.9 11.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.304 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.05 129.17 20.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.7 p -111.22 -162.86 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.513 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 81' ' ' SER . 6.3 p -45.51 -179.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.781 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -150.26 151.89 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.431 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -115.52 127.96 55.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.543 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.18 122.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.479 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.08 130.06 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -102.56 162.87 12.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -79.91 150.65 72.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 C-N-CA 122.071 1.848 . . . . 0.0 112.329 -179.375 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.705 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.001 0.429 . . . . 0.0 110.046 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 31.0 t80 -159.01 114.16 2.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.519 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.413 ' CG ' HG11 ' A' ' 132' ' ' VAL . 17.9 tptm -156.39 132.66 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.451 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -134.53 143.62 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.421 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -123.74 129.58 51.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.418 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.3 mt -119.15 131.18 72.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.588 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -111.58 129.07 56.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.78 -29.88 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 102' ' ' GLY . 81.4 mttt -112.23 146.91 37.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 101' ' ' LYS . . . -54.3 -163.09 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 38.9 t70 51.72 -96.11 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 103' ' ' ASP . 67.1 m-85 -168.95 71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.993 0.808 . . . . 0.0 109.232 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -156.91 161.73 39.65 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.101 0.477 . . . . 0.0 110.986 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.05 -178.93 33.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.633 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.97 133.78 22.19 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.25 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.0 tmm? -122.33 130.32 53.02 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.815 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.488 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 65.0 m-85 -119.77 135.64 54.77 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.43 117.26 26.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.29 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 111' ' ' THR . 11.7 t -140.95 126.37 18.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.65 38.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.27 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.12 -177.85 5.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.75 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.7 p30 -85.61 159.12 19.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.058 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.1 t -133.3 124.56 18.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -79.06 -53.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.819 1.679 . . . . 0.0 111.272 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -121.14 113.89 20.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.757 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.25 -46.18 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.187 0.518 . . . . 0.0 110.589 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.459 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -64.65 -20.2 66.15 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -73.49 -47.26 42.58 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.673 -0.642 . . . . 0.0 112.433 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.639 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.67 -23.59 14.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.29 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.1 m-85 -111.49 1.56 16.99 Favored 'General case' 0 C--O 1.228 -0.04 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.2 m-70 50.12 11.17 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.862 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.482 ' H ' ' C ' ' A' ' 122' ' ' PHE . 33.8 mtt -77.38 135.2 38.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -106.36 -28.74 10.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.042 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 72.5 mt-10 -152.36 108.6 3.4 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.99 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.36 125.08 33.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.607 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.8 m80 -106.93 -32.46 7.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.242 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 t -152.21 147.76 26.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.16 156.78 44.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 44.5 mtpt -133.71 -171.14 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.166 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.456 ' C ' HD22 ' A' ' 133' ' ' LEU . 25.5 t 47.06 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.3 mm? -110.82 167.48 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -143.17 111.71 6.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.816 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.82 -88.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 134' ' ' GLU . 5.5 t -121.18 155.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.082 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.742 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -143.73 167.81 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.9 mt -144.72 124.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.69 130.77 55.48 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 16.6 m-85 -108.75 111.75 23.67 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.508 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -52.12 -24.7 7.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.7 161.23 27.43 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.342 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.26 164.66 21.7 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.325 2.017 . . . . 0.0 111.489 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.54 15.11 2.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.003 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.7 m-85 78.54 25.91 0.54 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 111.339 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 89.7 mtm180 -109.78 171.26 7.55 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.66 168.56 33.87 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -62.16 134.38 56.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.08 0.467 . . . . 0.0 110.228 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.571 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 54.4 mt-30 -87.27 144.88 26.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.732 -179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -99.36 -30.36 12.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.47 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 162' ' ' ASP . 15.4 pttm -118.12 155.42 51.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.47 -17.17 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.148 1.899 . . . . 0.0 113.432 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.22 -3.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.157 0.504 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 159' ' ' LYS . 1.0 OUTLIER -61.82 -28.34 69.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.582 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -104.68 20.51 18.51 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.09 28.23 66.89 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.134 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.74 137.64 47.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.704 0.752 . . . . 0.0 109.596 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.62 19.68 0.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.563 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 173.12 155.73 0.26 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.481 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.84 4.65 5.5 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.113 2.542 . . . . 0.0 111.709 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.96 69.89 5.2 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -97.71 -153.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.879 ' H ' HG12 ' A' ' 170' ' ' VAL . 71.8 mm-40 -153.83 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.224 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.0 p -93.17 -155.75 0.45 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -170.56 -177.35 2.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.66 132.04 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.862 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 ptt180 -53.05 135.95 36.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 138' ' ' ILE . 14.6 mt -69.28 135.68 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.836 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.6 160.46 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.603 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 29.1 tp10 . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.432 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.6 p . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.767 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 31.9 tttt -160.26 151.89 19.83 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -147.49 142.05 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.997 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.5 m -124.9 138.77 54.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -119.11 116.36 26.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.448 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.6 m-85 -98.78 139.57 34.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.1 tm-20 -62.19 -51.41 67.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.823 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -94.4 -177.46 4.26 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HB3' HD22 ' A' ' 15' ' ' ASN . 41.8 mtmt -82.8 -176.79 6.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.721 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.41 25.96 0.26 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.321 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.493 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 63.61 41.44 7.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.57 177.45 4.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.0 110.493 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.81 -158.75 49.66 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.628 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.11 175.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.43 150.79 5.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.473 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 64.6 t80 -129.65 131.88 46.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -120.14 128.79 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.934 0.397 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.9 t -153.7 142.45 20.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.285 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -124.72 24.09 7.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 m -147.83 143.99 27.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.537 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -37.77 156.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -156.94 162.81 39.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.22 -56.12 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.941 0.401 . . . . 0.0 110.629 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -154.22 111.89 3.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.317 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.473 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.6 p90 -101.57 10.16 40.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.998 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' LEU . 33.2 t60 -59.58 -28.43 67.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.717 0.77 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -60.97 -30.99 70.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.456 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -86.8 -13.65 44.5 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.392 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 31' ' ' HIS . 20.0 tp -142.89 137.22 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 109.985 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -97.78 -10.14 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.296 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HD21 ' A' ' 34' ' ' LEU . 59.3 ttm-85 -155.23 142.79 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.63 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.9 m -110.75 105.82 14.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 110.869 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 59.7 m-20 -118.0 -155.7 0.61 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.493 ' CB ' ' H ' ' A' ' 16' ' ' PHE . 6.3 p -19.68 137.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.992 0.807 . . . . 0.0 112.468 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.7 mt -142.55 146.54 22.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.046 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.62 104.28 2.34 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.953 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -67.24 148.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.38 0.61 . . . . 0.0 110.083 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.01 50.6 1.43 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.708 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.21 -96.17 0.1 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.071 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.511 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.25 -140.56 4.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.2 m -80.17 166.34 21.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.466 -0.432 . . . . 0.0 110.954 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.767 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -154.49 155.66 35.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.704 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 120.84 40.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.2 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' A' ' 80' ' ' LEU . 10.0 m -120.37 133.68 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 111.072 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CD1' ' NH1' ' A' ' 84' ' ' ARG . 11.7 m-85 -106.98 112.88 26.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.602 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -37.65 -32.68 0.06 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.169 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -116.57 147.41 39.68 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 120.596 0.236 . . . . 0.0 110.951 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -69.31 161.78 44.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.268 1.979 . . . . 0.0 111.716 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 3.8 m-80 81.99 -3.66 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.059 0.849 . . . . 0.0 111.075 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 4.4 m-85 . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.235 0.54 . . . . 0.0 111.375 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 36.0 t80 . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.33 93.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -71.84 110.9 8.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.43 162.83 17.1 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.137 1.891 . . . . 0.0 112.527 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.66 114.85 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.84 176.75 41.67 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.2 mt-10 -100.02 153.25 19.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.049 0.452 . . . . 0.0 110.566 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 26.4 m-85 -146.14 81.57 9.6 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.19 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.17 -12.52 7.75 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.948 2.432 . . . . 0.0 113.071 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 95.2 mt-10 -152.13 161.35 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.692 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 38.6 p90 -64.21 -54.84 27.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.598 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.7 pt20 -43.84 -9.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.4 mmt180 -74.83 -4.92 40.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.79 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.99 25.48 10.32 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 119.778 -0.153 . . . . 0.0 110.742 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.6 mmt 85.48 24.68 0.08 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.439 1.087 . . . . 0.0 111.191 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.56 51.27 0.43 Allowed Glycine 0 N--CA 1.472 1.1 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.8 mt -76.64 13.82 0.92 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.8 t30 111.55 166.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.063 1.477 . . . . 0.0 109.553 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 50.7 p-10 -98.63 63.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -142.69 119.71 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -143.72 129.66 19.49 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.682 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.4 p -110.36 -162.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 84' ' ' ARG . 13.1 p -45.12 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 110.713 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.614 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 19.8 p -147.97 147.91 30.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.799 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.629 ' CG ' HH11 ' A' ' 84' ' ' ARG . 0.0 OUTLIER -111.04 124.78 52.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.69 123.31 17.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.002 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.67 130.86 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -98.51 162.35 13.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 178' ' ' GLU . 1.7 mt -80.21 148.14 66.57 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.845 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.493 1.453 0 C-N-CA 122.17 1.913 . . . . 0.0 112.054 179.597 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.712 0.291 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.733 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 41.8 t80 -158.29 112.81 2.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -153.56 134.65 14.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.27 0.557 . . . . 0.0 111.111 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -135.9 144.51 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.164 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -122.83 130.17 52.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.55 132.35 69.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -114.44 132.89 56.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.04 -30.54 70.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.974 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -120.6 150.76 40.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.175 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.13 -176.62 4.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 t0 50.44 28.8 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.715 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 7.3 m-85 55.72 82.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.668 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -159.06 161.31 36.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.54 -149.35 20.53 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -77.12 137.43 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.2 tmm? -123.01 133.87 54.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 111.179 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.9 m-85 -124.71 137.95 54.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.679 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -123.55 123.66 41.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.49 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 111' ' ' THR . 5.6 t -151.59 125.55 9.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.581 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 112' ' ' THR . 1.7 t -92.39 45.31 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.44 . . . . 0.0 111.334 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.35 -179.24 6.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.538 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 18.6 p-10 -86.48 159.25 19.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.84 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 42.4 t -136.17 124.68 15.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.72 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.4 Cg_endo -77.84 -51.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.623 1.549 . . . . 0.0 111.093 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.0 m -121.97 111.39 17.0 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.982 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -68.44 -43.91 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.0 ttt -65.45 -17.66 64.72 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.0 111.032 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -81.87 -43.02 18.77 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.724 -0.61 . . . . 0.0 111.94 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.704 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -95.54 -29.45 14.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.053 -178.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.704 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.03 5.3 14.92 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.678 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.8 m-70 50.78 11.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.919 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 122' ' ' PHE . 36.0 mtt -76.9 135.15 38.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.749 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -107.41 -28.46 9.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.516 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 60.8 mt-10 -151.19 109.04 3.68 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.08 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -74.71 125.14 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.723 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -105.53 -32.19 8.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.8 t -154.04 148.74 26.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.108 0.48 . . . . 0.0 111.267 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -149.8 132.34 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -112.44 -173.08 2.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.243 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t 56.15 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.822 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -94.55 168.03 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.136 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.8 mp0 -142.58 112.14 6.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.69 -88.66 0.01 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.5 t -116.59 156.21 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.733 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.2 t-105 -146.21 167.44 23.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 87.4 mt -144.88 123.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.742 0.306 . . . . 0.0 111.119 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -110.4 131.57 54.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -109.57 111.54 23.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.957 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -51.82 -23.18 4.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.737 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.6 160.4 33.32 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.451 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 96.7 Cg_endo -79.47 166.25 22.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.123 1.882 . . . . 0.0 111.46 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.6 m-80 74.84 14.01 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.0 m-85 79.04 25.55 0.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -109.87 171.05 7.68 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.847 0.356 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.23 168.99 36.07 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -56.97 142.39 41.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 109.835 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 69.5 mt-30 -97.6 137.39 36.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.002 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 -179.579 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -107.3 -20.26 13.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.701 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -121.56 154.86 59.96 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 15.5 Cg_endo -60.59 -16.09 40.7 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.4 2.067 . . . . 0.0 113.322 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 4.1 mp -100.2 -1.69 9.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -26.08 67.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.671 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.566 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -108.67 21.08 17.75 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.42 26.94 68.8 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.955 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.566 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.93 138.28 43.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.38 1.09 . . . . 0.0 109.721 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.76 21.02 0.21 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 170.86 155.41 0.21 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.675 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.24 6.13 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.087 2.525 . . . . 0.0 111.407 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.8 70.64 8.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 111.056 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.941 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.01 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.941 ' H ' HG12 ' A' ' 170' ' ' VAL . 73.8 mm-40 -155.04 -130.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.357 0.411 . . . . 0.0 109.893 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.594 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.37 -158.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -170.01 -177.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.405 0.622 . . . . 0.0 111.094 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.87 131.76 7.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -52.89 135.3 36.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.652 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.4 mt -64.09 134.49 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.89 135.58 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.501 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . 11.2 tm-20 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.351 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 73.9 p . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.768 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.8 tttt -158.32 150.71 22.01 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.022 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.3 140.31 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.669 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 42.4 m -122.52 137.95 54.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.33 115.85 25.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -95.58 138.13 33.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.235 0.54 . . . . 0.0 111.083 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.27 -49.94 75.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.3 m-20 -99.69 -176.2 3.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.188 0.518 . . . . 0.0 110.148 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.43 -177.2 6.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.57 23.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.779 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.2 m-85 63.09 41.11 8.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.35 176.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.151 0.5 . . . . 0.0 110.715 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.91 -157.12 52.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.379 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -54.91 174.2 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.137 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.58 151.08 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' THR . 59.6 t80 -135.57 134.14 39.07 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 49.9 p-10 -120.9 140.46 51.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.665 0.269 . . . . 0.0 110.759 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 18.3 t -147.88 141.15 25.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 6' ' ' THR . 7.4 t70 -122.92 14.06 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.8 t -149.66 146.7 27.41 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.812 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 80.3 m-20 -37.54 156.19 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.62 161.22 40.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.35 3.03 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.4 p-10 -153.61 111.0 3.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.466 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.1 p90 -101.28 9.7 41.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.6 t60 -59.98 -26.47 66.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.986 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -63.28 -29.66 70.95 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.505 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -88.45 -12.87 41.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.469 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 31' ' ' HIS . 17.0 tp -143.5 137.7 28.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -99.46 -9.4 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.6 ttm180 -154.75 143.26 20.58 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.3 m -110.65 104.57 13.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.442 0.639 . . . . 0.0 110.887 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.707 ' O ' ' O ' ' A' ' 39' ' ' SER . 70.6 m-20 -129.51 156.78 43.59 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.67 128.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.392 1.091 . . . . 0.0 112.469 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.2 mt -141.44 146.19 23.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.297 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.4 ptpt -154.41 103.6 2.51 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.096 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.72 148.23 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.542 0.686 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -120.9 50.42 1.35 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.81 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.45 -95.3 0.1 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.537 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.46 -140.0 3.98 Favored Glycine 0 N--CA 1.468 0.767 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.2 167.16 18.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.403 -0.469 . . . . 0.0 110.807 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.768 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.7 m95 -155.07 157.25 37.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.604 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.82 121.59 41.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.64 132.74 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.095 0.474 . . . . 0.0 110.881 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -104.56 110.59 22.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.758 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -38.03 -34.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.136 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -116.14 132.99 22.97 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.414 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.2 Cg_exo -55.92 161.91 7.77 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.371 1.38 . . . . 0.0 112.151 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.8 OUTLIER 84.69 -4.61 0.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.076 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.9 m-85 . . . . . 0 N--CA 1.468 0.448 0 O-C-N 123.533 0.521 . . . . 0.0 110.9 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 36.5 t80 . . . . . 0 C--O 1.232 0.145 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.17 91.81 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 111.15 8.84 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 162.36 16.23 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.085 1.857 . . . . 0.0 112.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -51.03 114.57 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.828 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.06 176.71 41.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.4 mt-10 -100.13 153.13 19.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 110.519 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 36.5 m-85 -146.44 91.83 5.31 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.11 -13.26 39.08 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.093 1.862 . . . . 0.0 113.246 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -149.82 161.14 42.85 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.732 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 41.6 p90 -63.49 -54.14 41.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.4 pt20 -43.5 -9.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 70' ' ' TYR . 84.5 mmt-85 -75.8 -4.48 40.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.732 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.59 25.08 10.67 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.823 -0.171 . . . . 0.0 110.95 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 22.7 mmt 85.39 24.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.465 1.103 . . . . 0.0 111.35 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.54 51.07 0.3 Allowed Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.3 mt -76.19 13.94 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.386 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 10.5 t-20 113.39 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.858 1.349 . . . . 0.0 109.493 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -97.35 62.68 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.052 0.453 . . . . 0.0 110.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -141.88 118.53 11.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.987 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.15 128.63 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.9 p -110.63 -162.58 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.138 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.9 p -45.64 -179.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.619 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.495 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.1 p -149.3 149.79 31.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.603 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -115.82 127.85 55.37 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.05 126.49 27.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.277 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 48' ' ' ALA . 73.1 t -125.06 131.84 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.649 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.0 159.13 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.908 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -80.89 148.07 63.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.031 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 N--CA 1.491 1.344 0 C-N-CA 122.084 1.856 . . . . 0.0 111.803 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.74 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 38.5 t80 -158.06 113.58 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -154.36 132.04 11.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.5 tt -134.66 143.9 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.194 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.69 131.74 54.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 118' ' ' ILE . 14.8 mt -120.33 130.99 73.77 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.97 132.93 55.16 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.048 0.451 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 82.8 tt0 -63.69 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.698 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -117.15 148.32 41.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.12 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 178.27 8.56 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.2 t0 54.72 31.25 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.772 0.32 . . . . 0.0 110.5 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 55.4 81.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.279 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -159.82 162.52 34.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.79 20.92 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.658 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.39 136.85 39.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.9 tmm? -122.03 131.62 54.08 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.53 137.15 54.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.516 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.73 127.49 47.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.636 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 111' ' ' THR . 5.6 t -149.5 128.64 12.77 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.48 40.47 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.86 -177.96 5.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.063 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -84.66 159.29 20.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.15 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 45.1 t -132.44 119.59 16.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -79.25 -53.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.495 1.463 . . . . 0.0 111.018 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.9 m -119.08 109.94 16.5 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -66.5 -42.58 90.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.355 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 44.1 ttm -66.62 -21.5 66.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.922 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -73.73 -47.48 38.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.241 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.659 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.7 pt20 -101.0 -25.48 14.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 34.9 m-85 -111.47 1.13 16.78 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 51.68 11.38 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.997 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 122' ' ' PHE . 4.8 mmt -77.58 135.57 38.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -109.36 -28.87 8.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.556 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 35.1 mt-10 -150.36 108.01 3.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.383 0.611 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 118' ' ' ILE . 8.7 mm -76.39 122.77 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.864 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.8 m80 -104.39 -31.78 9.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.158 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -151.71 146.48 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 110.681 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -145.46 132.72 20.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -113.03 -176.25 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.575 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.412 ' C ' HD22 ' A' ' 133' ' ' LEU . 15.1 t 53.54 90.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -105.6 168.09 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.79 111.88 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.91 -86.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.7 t -122.56 149.15 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.74 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -138.11 169.47 17.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.739 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.446 HD12 HG12 ' A' ' 176' ' ' ILE . 88.3 mt -145.05 123.51 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.679 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.39 130.92 55.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.001 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -110.5 111.92 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.617 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -52.28 -23.34 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.393 0.433 . . . . 0.0 111.159 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.65 162.09 24.29 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.42 165.28 20.93 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.1 1.867 . . . . 0.0 111.488 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.44 13.87 2.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.965 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.4 m-85 78.78 25.83 0.5 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -109.84 171.5 7.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.739 0.304 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 94.85 170.29 36.94 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -57.47 148.79 22.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 6.3 mp0 -110.18 148.21 32.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.162 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.571 179.769 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -107.11 -25.67 11.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -119.22 154.04 53.54 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.559 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.527 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -58.81 -15.66 27.69 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.176 1.917 . . . . 0.0 113.729 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.78 -3.29 9.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.313 0.577 . . . . 0.0 110.477 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.75 -28.29 68.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.478 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -105.8 23.21 14.28 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 120.826 0.346 . . . . 0.0 110.167 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.1 26.45 72.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.946 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.53 139.6 41.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.378 1.089 . . . . 0.0 109.759 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.23 21.25 0.36 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 171.43 154.83 0.22 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.336 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.847 ' O ' HG23 ' A' ' 170' ' ' VAL . 40.1 Cg_endo -68.07 -35.16 20.67 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.641 2.228 . . . . 0.0 111.422 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.92 76.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.801 0.688 . . . . 0.0 110.6 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.4 t -93.84 -98.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.741 ' O ' HD12 ' A' ' 118' ' ' ILE . 5.3 mm-40 158.79 -140.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -92.62 -156.12 0.46 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.931 0.332 . . . . 0.0 111.704 -177.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -170.3 -177.11 2.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.53 131.72 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.258 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.7 ptt180 -52.46 135.33 33.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.61 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 138' ' ' ILE . 15.9 mt -69.6 135.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 178' ' ' GLU . 39.7 t -136.23 156.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.388 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.551 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 31.6 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.451 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.544 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 3.7 p . . . . . 0 C--O 1.215 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.801 ' O ' HG13 ' A' ' 42' ' ' VAL . 31.1 tttt -99.64 159.61 14.91 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.846 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -146.5 140.85 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.823 0.344 . . . . 0.0 111.613 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 90.6 m -126.61 138.87 53.5 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 110.554 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -118.23 116.55 27.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 92.9 m-85 -97.1 139.77 32.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 110.879 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.418 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.5 tm-20 -61.58 -52.61 63.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.764 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HA ' HD22 ' A' ' 38' ' ' ASN . 99.0 m-20 -95.27 -178.15 4.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -81.89 -178.15 6.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 47.17 26.04 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.001 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 62.35 42.48 9.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.414 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -109.79 176.43 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.09 -156.81 52.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.639 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -55.21 174.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.69 148.22 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' THR . 51.4 t80 -130.69 132.73 45.55 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 28.6 t0 -118.4 143.42 46.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.775 0.321 . . . . 0.0 110.53 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -160.46 139.57 10.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 35.3 t70 -121.54 21.82 10.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.49 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.37 148.81 28.58 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.048 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 2.8 t70 -38.08 155.77 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 10.7 t -154.71 160.58 41.45 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.44 -56.66 2.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.022 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.1 p-10 -152.35 108.6 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.9 9.05 43.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -58.47 -27.48 64.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.039 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.8 p -64.26 -29.73 70.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.953 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.17 -11.63 46.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.6 tp -143.72 137.46 28.16 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -98.32 -12.01 21.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.498 ' O ' HD21 ' A' ' 34' ' ' LEU . 17.4 ttm180 -154.46 143.13 20.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.235 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -114.34 108.06 16.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.648 0.737 . . . . 0.0 110.57 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 39' ' ' SER . 56.9 m-20 -117.61 -156.04 0.62 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.608 -1.178 . . . . 0.0 107.979 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.1 p -18.2 138.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.811 0.694 . . . . 0.0 112.748 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.8 mt -141.98 146.49 22.7 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.709 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -156.57 103.26 2.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.68 146.07 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.517 0.675 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -117.47 50.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.483 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.32 -96.56 0.1 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.582 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.14 -142.14 4.63 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 97.0 m -81.85 166.88 19.57 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.187 0.517 . . . . 0.0 110.956 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.632 ' N ' HG22 ' A' ' 46' ' ' THR . 23.5 m95 -155.2 157.59 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.981 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.89 121.2 40.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.281 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.94 132.06 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 52' ' ' ARG . 57.7 m-85 -104.3 111.12 23.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.527 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 50' ' ' TYR . 45.7 tt0 -32.69 -34.15 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.316 0.385 . . . . 0.0 111.216 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 50' ' ' TYR . 27.3 mtm180 -124.86 158.22 63.51 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 5.8 Cg_exo -71.18 163.47 39.06 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.391 2.06 . . . . 0.0 112.221 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.643 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER 86.66 -11.24 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.816 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 54' ' ' ASN . 9.8 m-85 . . . . . 0 N--CA 1.465 0.307 0 O-C-N 123.844 0.715 . . . . 0.0 111.595 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 24.0 t80 . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.58 93.07 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 111.92 14.26 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.78 164.01 13.98 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.046 1.83 . . . . 0.0 113.203 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -50.92 111.74 0.6 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.24 171.46 39.27 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.28 155.1 16.9 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.99 0.424 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 56.4 m-85 -149.01 84.23 6.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.702 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -54.09 -14.34 6.03 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.894 2.396 . . . . 0.0 112.814 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -155.45 162.88 40.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 7.9 p90 -64.78 -52.35 57.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.499 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 26.4 mt-30 -39.87 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.1 tpm_? -75.79 -5.17 44.54 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.421 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -116.71 25.66 10.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.196 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.7 mmt 88.78 25.18 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.119 0.967 . . . . 0.0 111.632 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 33.35 55.7 0.58 Allowed Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.318 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.8 mt -88.23 11.12 17.31 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 41.5 t30 87.52 139.3 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.66 0.6 . . . . 0.0 109.912 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.641 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 16.0 p-10 -37.88 -95.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.641 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER 27.15 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.55 128.05 20.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.649 ' N ' HD13 ' A' ' 80' ' ' LEU . 6.8 p -110.23 -163.15 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.387 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.5 p -45.81 -179.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 110.761 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 26.5 p -150.8 152.53 33.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.263 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -114.78 127.03 55.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.47 122.08 14.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 48' ' ' ALA . 46.1 t -123.55 130.97 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 136' ' ' VAL . 29.5 m80 -102.73 162.52 12.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.963 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.32 155.85 69.11 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 N--CA 1.494 1.546 0 C-N-CA 122.666 2.244 . . . . 0.0 111.992 179.367 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 35.8 t80 -158.43 113.26 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 36.0 tptt -154.68 133.57 12.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.19 0.519 . . . . 0.0 111.461 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.0 145.05 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.9 mt-30 -123.25 131.42 53.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.526 -1.216 . . . . 0.0 107.942 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.57 HD13 HD11 ' A' ' 118' ' ' ILE . 12.8 mt -119.96 131.9 71.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.036 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -114.1 130.93 56.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 0.0 110.697 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -119.01 147.34 44.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.88 172.02 15.94 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.9 t70 59.75 31.91 21.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.815 0.34 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 54.5 81.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -159.13 163.36 36.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.486 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -151.73 24.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -73.61 135.86 43.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.644 0.259 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 9.3 tmm? -121.83 132.03 54.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.202 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.503 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.0 m-85 -121.52 136.05 54.98 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.74 123.5 41.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.555 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 4.9 t -151.77 126.43 9.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.689 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 t -92.34 43.44 1.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -142.77 -179.34 6.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 11.4 p-10 -85.2 158.92 20.23 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.536 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.6 m -136.59 121.64 12.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.87 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 172' ' ' SER . 69.0 Cg_endo -77.11 -53.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.768 1.645 . . . . 0.0 111.413 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 m -118.58 109.15 15.83 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -66.17 -42.68 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 111.254 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.2 ttt -66.08 -18.45 65.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -82.37 -43.3 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.719 -0.613 . . . . 0.0 111.938 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.84 -31.79 14.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.006 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 28.0 m-85 -115.82 5.8 14.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 51.32 13.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.253 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' C ' ' A' ' 122' ' ' PHE . 2.2 mmt -78.23 133.84 37.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -107.4 -29.55 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.561 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 25.9 mt-10 -150.45 109.14 3.84 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.155 0.502 . . . . 0.0 111.167 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.9 mm -75.03 124.71 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.062 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.3 m80 -104.77 -32.22 8.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.172 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.9 m -154.52 149.28 26.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.05 145.87 32.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.647 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HB2' HE21 ' A' ' 97' ' ' GLN . 50.9 mtpt -122.48 -176.91 3.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.668 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' C ' HD12 ' A' ' 133' ' ' LEU . 25.1 t 50.66 92.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.649 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.519 HD21 ' CE2' ' A' ' 157' ' ' TYR . 7.5 mp -107.57 168.57 9.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.121 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.9 mp0 -142.04 112.48 7.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.13 -88.18 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.4 t -119.61 153.72 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.236 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.7 t-105 -141.83 169.32 17.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.767 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.2 mt -144.51 122.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.41 131.87 54.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -110.87 111.72 23.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.92 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 142' ' ' LEU . 74.8 tt0 -50.38 -21.92 1.64 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -119.53 161.62 36.58 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 0.0 110.377 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.8 Cg_endo -77.39 168.25 23.19 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.1 m-80 73.67 11.95 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 78.76 27.92 0.44 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.329 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -112.87 172.3 7.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.75 172.49 42.48 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.598 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.74 156.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 110.239 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.595 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 13.2 mp0 -121.94 126.83 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.384 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.519 ' CE2' HD21 ' A' ' 133' ' ' LEU . 10.9 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.002 0.43 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -104.8 -25.92 12.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.016 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -119.83 154.79 55.3 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.608 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 13.7 Cg_endo -58.68 -19.7 47.05 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.23 1.953 . . . . 0.0 113.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -99.34 -2.81 9.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.131 0.491 . . . . 0.0 110.704 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.2 -28.16 67.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.547 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.573 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -106.87 21.73 17.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.354 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.57 69.9 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 121.134 -0.555 . . . . 0.0 114.283 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.573 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.92 138.16 42.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.217 1.008 . . . . 0.0 109.765 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.36 20.2 0.16 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 168.99 155.96 0.17 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.845 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.01 7.13 3.0 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.081 2.52 . . . . 0.0 111.502 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.11 70.52 9.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.046 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -99.27 -147.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -160.47 -131.68 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.696 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.01 -157.59 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -169.81 -177.4 2.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.189 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.94 131.28 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.79 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -52.59 135.46 34.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.149 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.465 HG12 HD12 ' A' ' 138' ' ' ILE . 14.3 mt -69.3 134.42 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.6 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 178' ' ' GLU . 43.5 t -137.71 156.55 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.658 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 27.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.882 0.372 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.792 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 39.7 tttt -159.75 151.25 19.95 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.11 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 tt -147.1 141.97 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.4 m -124.63 138.52 54.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.47 116.22 25.67 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.93 137.75 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.92 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 7.7 tm-20 -60.66 -48.99 79.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.156 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -99.1 -176.07 3.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 109.917 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.56 -176.72 6.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.282 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.483 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.8 23.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.883 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 63.48 41.76 7.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.235 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.65 174.38 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.604 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.82 -154.97 53.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.66 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -56.26 172.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.94 152.19 5.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -136.22 133.89 37.55 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -121.03 138.2 54.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.698 0.285 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 141.61 25.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.61 16.74 9.58 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.671 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -149.71 146.54 27.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -38.53 156.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.713 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 39.8 t -157.49 163.43 38.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.79 -56.3 3.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.817 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -153.58 112.51 3.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.5 p90 -101.87 8.58 41.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.041 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' LEU . 79.3 t60 -60.33 -27.57 67.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.494 0.664 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.4 p -60.79 -29.37 69.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -89.1 -15.27 34.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.527 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.23 137.65 32.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.954 0.407 . . . . 0.0 110.17 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -99.31 -7.76 25.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 52.5 ttm-85 -156.78 145.75 20.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.865 0.364 . . . . 0.0 110.575 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p -112.26 104.18 12.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.731 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.1 m-20 -129.78 157.55 41.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.731 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 34.24 127.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.581 1.181 . . . . 0.0 112.398 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.6 mt -141.2 146.08 24.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.187 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -154.06 102.96 2.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.25 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -66.89 149.18 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.478 0.656 . . . . 0.0 110.389 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -122.17 50.94 1.4 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.919 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.13 -95.73 0.1 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.967 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.16 -138.59 3.78 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 56.1 m -82.84 166.99 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.593 -0.357 . . . . 0.0 110.745 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.792 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.5 m95 -153.68 155.57 36.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.577 0.703 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.77 122.16 44.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.026 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 60' ' ' TYR . 8.1 m -118.29 132.07 69.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.189 0.518 . . . . 0.0 110.871 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 52' ' ' ARG . 89.3 m-85 -101.5 108.49 20.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.919 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' TYR . 39.6 tt0 -32.21 -37.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.407 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.0 mtm180 -119.5 148.9 46.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.808 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 39.8 Cg_endo -67.78 163.8 33.93 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.559 2.173 . . . . 0.0 111.901 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 82.56 -3.27 1.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.119 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 . . . . . 0 N--CA 1.467 0.423 0 O-C-N 123.438 0.461 . . . . 0.0 110.965 179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.495 ' CE1' HD13 ' A' ' 76' ' ' LEU . 5.6 m-85 . . . . . 0 N--CA 1.462 0.146 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -101.34 89.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 110.8 7.05 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.95 161.85 18.37 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.181 1.921 . . . . 0.0 112.519 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -52.35 117.31 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.247 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.74 179.32 41.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.06 152.97 20.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 18.8 m-85 -145.67 84.6 8.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.65 -17.78 23.87 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.145 2.563 . . . . 0.0 113.028 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -149.88 161.18 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 16.4 p90 -62.68 -49.66 74.24 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.521 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -44.19 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.9 mmt180 -76.38 -5.19 46.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.015 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.673 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -116.66 26.94 9.5 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.469 -0.144 . . . . 0.0 111.249 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 22.0 mmt 88.97 19.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.342 1.027 . . . . 0.0 111.316 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 32.51 59.65 0.4 Allowed Glycine 0 N--CA 1.467 0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.336 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.4 mt -79.75 -67.59 0.75 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -159.93 163.86 33.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.422 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 54.7 p-10 -91.42 58.58 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 16.8 tpp180 -138.32 115.9 11.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.79 128.26 21.3 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.644 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.2 p -111.4 -162.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.605 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 m -44.65 179.85 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.322 0.582 . . . . 0.0 110.664 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 17.7 p -148.57 146.69 28.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.733 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -113.11 126.02 55.01 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.55 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.66 126.37 27.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.5 t -126.52 132.05 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.553 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -115.1 121.39 42.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.163 0.506 . . . . 0.0 110.253 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.817 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -46.15 163.21 0.23 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.952 -179.44 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.756 2.304 . . . . 0.0 111.961 179.634 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.714 0.292 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.4 t80 -157.77 113.63 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.237 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 110' ' ' GLU . 25.3 tptp -153.95 131.4 11.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.123 0.487 . . . . 0.0 111.424 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.425 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -133.05 141.24 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.354 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.25 130.16 53.53 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' ILE . 8.3 mt -119.34 130.6 73.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.09 129.91 56.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.821 0.343 . . . . 0.0 110.802 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.04 -31.01 70.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.713 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.21 146.26 39.61 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' PHE . . . -47.98 -93.08 0.01 OUTLIER Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 104' ' ' PHE . 38.7 p-10 -38.28 98.58 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.526 ' C ' ' O ' ' A' ' 103' ' ' ASP . 23.7 m-85 -8.99 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.216 0.948 . . . . 0.0 112.046 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' ASP . 38.0 m -153.88 163.28 40.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 -151.53 20.14 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.115 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -73.11 135.55 44.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.481 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 44.3 ttp -120.95 124.52 45.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.614 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.5 m-85 -116.23 134.37 54.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 95' ' ' LYS . 1.9 pt-20 -120.96 119.26 32.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.018 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 111' ' ' THR . 6.1 t -148.98 125.11 10.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.78 44.42 1.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.14 -177.33 5.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.583 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.0 p-10 -87.07 155.96 19.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.127 0.489 . . . . 0.0 110.087 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 172' ' ' SER . 53.6 t -133.16 124.25 18.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.75 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.734 1.622 . . . . 0.0 110.789 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.8 m -115.69 112.83 22.66 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.68 -45.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.523 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.3 ttt -66.06 -19.47 65.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.436 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -76.25 -45.82 31.0 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.004 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.5 pt20 -100.74 -25.81 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 35.0 m-85 -110.25 1.71 18.79 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.4 m-70 52.05 9.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.118 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -75.91 133.69 40.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -107.52 -30.01 8.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.492 -178.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -149.31 109.28 4.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.87 124.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.792 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.0 m80 -105.79 -30.3 9.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.191 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 102' ' ' GLY . 15.7 t -152.68 147.82 26.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.0 111.196 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -149.22 126.88 11.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.978 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -107.91 -169.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.499 . . . . 0.0 110.468 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t 51.3 89.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.5 HD11 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mm? -104.37 168.5 9.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.092 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -142.02 111.18 6.37 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 34.19 -91.47 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.016 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.0 t -115.28 138.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.7 t-105 -130.23 168.07 17.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 HG12 ' A' ' 176' ' ' ILE . 76.3 mt -144.61 121.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.825 0.345 . . . . 0.0 111.4 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.62 130.4 55.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -107.89 111.22 23.23 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.099 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -51.19 -25.67 5.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.99 160.73 28.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 92.2 Cg_endo -79.94 164.87 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.38 2.053 . . . . 0.0 111.583 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.7 ' ND2' HH21 ' A' ' 146' ' ' ARG . 3.2 m-80 74.61 15.97 3.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.32 25.35 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.7 HH21 ' ND2' ' A' ' 144' ' ' ASN . 90.4 mtm180 -108.35 168.32 9.4 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 97.87 168.05 32.11 Favored Glycine 0 N--CA 1.462 0.389 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.504 HH11 ' H ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -64.98 137.27 57.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 147' ' ' GLY . 1.4 mp0 -84.21 145.81 28.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 N--CA 1.468 0.469 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.351 179.32 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.5 ' HE2' HD11 ' A' ' 133' ' ' LEU . 3.3 m-85 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.889 0.376 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -108.92 -19.73 13.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -121.23 156.15 57.75 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.687 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.549 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.5 Cg_endo -61.64 -16.39 48.01 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.652 2.235 . . . . 0.0 113.239 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -100.65 -2.85 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.807 0.337 . . . . 0.0 110.779 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -27.46 68.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.549 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.47 21.85 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.389 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.14 26.91 71.19 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.213 -0.517 . . . . 0.0 114.242 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.88 139.21 42.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.847 0.823 . . . . 0.0 109.812 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.22 20.75 0.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.4 153.4 0.25 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.823 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.57 4.38 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 123.023 2.482 . . . . 0.0 111.614 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.33 70.28 4.66 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.929 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.26 -153.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.929 ' H ' HG12 ' A' ' 170' ' ' VAL . 70.8 mm-40 -152.7 -131.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -94.18 -153.67 0.38 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -170.52 -176.25 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -161.08 133.78 6.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.454 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.466 ' CG ' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.95 135.4 42.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.45 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.495 HG12 HD12 ' A' ' 138' ' ' ILE . 13.9 mt -67.56 139.16 21.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.986 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.34 155.72 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.61 179.775 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 41.5 p . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.822 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.2 tttt -160.42 153.24 21.24 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.069 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.39 142.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 122.108 -0.37 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 138.81 53.98 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.964 0.412 . . . . 0.0 110.699 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -119.14 115.01 23.36 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.8 m-85 -94.08 137.96 32.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.14 0.495 . . . . 0.0 110.947 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.22 -49.02 79.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.158 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 39' ' ' SER . 83.1 m-20 -100.97 -174.72 2.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.58 -174.97 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 111.633 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.21 23.28 0.19 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.851 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.7 m-85 59.19 44.43 15.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.29 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -115.35 160.67 19.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.355 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.32 -151.4 29.74 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.477 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -56.73 172.36 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -170.56 153.29 4.15 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -135.01 133.81 39.8 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.9 p-10 -120.76 137.63 54.41 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 141.49 25.94 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 8.5 t70 -124.32 15.8 9.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 97.2 m -150.31 147.17 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.35 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 38.1 t0 -37.64 155.55 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.512 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.564 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 43.8 t -155.66 161.91 40.69 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.41 -57.62 2.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.62 112.71 4.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -102.17 8.11 40.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.972 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.594 ' O ' ' O ' ' A' ' 34' ' ' LEU . 75.0 t60 -59.0 -29.35 67.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.536 0.684 . . . . 0.0 109.91 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.6 p -60.34 -29.76 69.09 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.01 -15.35 36.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.7 tp -140.87 137.2 33.04 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 t -99.67 -9.02 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.36 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.3 ttm180 -154.18 143.13 21.1 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.238 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 4.6 p -110.47 104.6 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.735 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.0 m-20 -129.32 155.85 44.96 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.735 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 36.47 129.6 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.691 1.244 . . . . 0.0 112.218 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.291 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.0 ptpt -155.87 102.84 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.103 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -65.85 151.05 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.402 0.62 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -123.35 51.53 1.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.082 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.27 -96.14 0.1 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.974 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.52 -140.9 4.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 48.8 m -81.43 166.84 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.601 -0.352 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.822 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -154.01 155.39 35.46 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.253 0.549 . . . . 0.0 110.688 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.86 118.33 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 m -115.98 131.43 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.052 0.453 . . . . 0.0 110.73 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.56 111.99 24.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' OE2' ' OD1' ' A' ' 77' ' ' ASN . 76.0 tt0 -38.98 -34.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -113.55 147.19 37.01 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.8 Cg_endo -68.01 157.76 60.35 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.733 2.289 . . . . 0.0 111.309 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.8 m120 86.5 -2.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.329 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.6 m-85 . . . . . 0 N--CA 1.471 0.615 0 O-C-N 123.306 0.379 . . . . 0.0 111.261 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.6 m-85 . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.207 0.527 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -107.47 98.78 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -76.65 114.26 37.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.25 163.61 17.35 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.298 1.998 . . . . 0.0 112.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.52 115.24 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.87 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.28 176.31 41.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -100.68 154.67 18.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.159 0.504 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.489 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 41.6 m-85 -147.34 86.59 6.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.614 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_exo -57.15 -18.32 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.967 2.444 . . . . 0.0 112.761 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -148.45 161.71 41.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.735 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.6 p90 -65.4 -53.18 46.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.445 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 28.8 mt-30 -43.18 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.903 0.382 . . . . 0.0 111.894 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.14 -4.17 40.13 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.735 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.81 23.33 11.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.824 -0.171 . . . . 0.0 110.838 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.4 mmt 89.84 23.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.535 1.147 . . . . 0.0 111.661 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 29.85 54.36 0.2 Allowed Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 17.4 mt -82.63 14.87 2.86 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.953 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER 112.73 163.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 125.263 1.602 . . . . 0.0 109.771 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.4 p30 -94.73 64.99 3.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.675 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 35.9 ttm180 -142.07 118.75 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.76 129.34 20.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 109.784 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.691 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.8 p -110.07 -163.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.0 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.5 m -45.33 -179.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.499 . . . . 0.0 110.879 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.535 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 14.4 p -150.46 152.22 33.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -116.99 128.66 55.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.89 123.24 17.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.118 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.2 t -125.23 133.06 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.495 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.6 m-70 -103.68 161.42 13.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.061 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.784 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -76.84 159.57 78.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.477 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.311 -1.398 0 C-N-CA 122.536 2.157 . . . . 0.0 112.209 179.342 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 34.4 t80 -156.15 114.17 3.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.343 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.4 tptm -155.62 133.01 10.96 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.148 0.499 . . . . 0.0 111.034 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.9 tt -135.03 145.64 31.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.95 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -123.57 130.77 53.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.748 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.596 HD13 HD11 ' A' ' 118' ' ' ILE . 8.5 mt -119.98 131.04 73.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.167 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.7 m-85 -111.83 130.01 55.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.964 0.411 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.27 -28.11 68.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.65 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -122.55 148.54 45.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.206 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.24 -171.48 1.25 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 46.33 29.22 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.404 . . . . 0.0 110.464 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 54.67 82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 m -160.32 161.04 33.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.838 0.351 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.85 -153.11 22.21 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -72.58 137.58 46.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 110.641 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 53.0 ttp -122.13 127.11 49.71 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.827 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 54.1 m-85 -118.07 134.97 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 110.65 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.68 116.74 25.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.052 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.22 126.48 24.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.978 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.24 36.38 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.35 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.04 -177.65 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.732 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p30 -85.68 160.13 19.64 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.32 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.2 t -136.03 124.86 15.63 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.669 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 57.4 Cg_endo -78.61 -53.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.208 1.939 . . . . 0.0 110.855 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.3 m -120.26 113.11 19.92 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -67.91 -46.18 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.653 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.48 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 26.9 ttt -64.73 -20.6 66.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.101 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.38 -49.18 35.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.649 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 3.9 pt20 -100.16 -23.04 14.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.167 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 33.9 m-85 -111.09 -0.1 16.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.855 0.359 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.1 m-70 52.14 10.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.281 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.438 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.2 mtt -78.58 134.5 37.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -107.3 -27.5 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 48.4 mt-10 -151.19 107.5 3.46 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.075 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 118' ' ' ILE . 8.5 mm -73.67 124.98 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.3 m80 -105.48 -33.43 8.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.035 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 m -152.31 147.46 26.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.986 0.422 . . . . 0.0 110.73 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -145.36 137.46 25.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.776 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -116.07 -173.24 2.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.374 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t 49.21 94.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.41 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 27.1 mt -111.93 168.49 9.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' VAL . 4.3 mp0 -140.62 112.5 7.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.5 -90.77 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 134' ' ' GLU . 10.6 t -117.26 156.29 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.6 t-105 -144.63 169.18 18.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.456 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.7 mt -144.23 123.05 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.47 131.41 55.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -109.17 111.29 22.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -50.11 -21.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.247 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.4 mp -119.37 165.69 16.63 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 86.6 Cg_endo -83.46 167.79 13.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.334 2.023 . . . . 0.0 111.961 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.8 OUTLIER 79.78 14.57 0.94 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.956 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.4 m-85 76.01 28.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.143 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 80.5 mtp180 -136.81 130.21 31.53 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.92 169.14 20.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -51.96 98.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.213 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.616 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 75.5 mt-30 -60.72 133.8 56.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.711 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 120.977 0.418 . . . . 0.0 110.822 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -105.87 -23.21 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.472 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.96 157.3 50.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 121.271 0.558 . . . . 0.0 110.784 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.526 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.1 Cg_endo -61.65 -19.38 64.82 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.164 1.909 . . . . 0.0 113.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -98.81 -2.27 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.107 0.479 . . . . 0.0 110.756 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -59.66 -24.87 64.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.153 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.8 OUTLIER -110.36 21.95 16.08 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.54 66.49 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.591 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.27 137.01 46.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.988 0.894 . . . . 0.0 109.437 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.79 21.33 0.16 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 168.1 156.64 0.14 Allowed Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 6.69 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.061 2.507 . . . . 0.0 111.461 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.99 70.87 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.694 0.283 . . . . 0.0 111.35 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -99.03 -150.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.935 ' H ' HG12 ' A' ' 170' ' ' VAL . 16.6 mm-40 -155.99 -132.97 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.356 0 O-C-N 123.14 0.275 . . . . 0.0 110.426 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.3 p -93.4 -155.81 0.46 Allowed 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 122.081 -0.387 . . . . 0.0 111.992 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -171.5 -176.04 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.033 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.433 HH21 HG22 ' A' ' 177' ' ' VAL . 9.1 ptm180 -158.31 133.1 8.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.157 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -51.9 134.37 31.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.235 0.541 . . . . 0.0 110.649 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 138' ' ' ILE . 11.5 mt -68.58 134.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.902 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.433 HG22 HH21 ' A' ' 174' ' ' ARG . 34.7 m -136.15 157.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.255 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 46' ' ' THR . 17.6 tp10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.92 0.39 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -159.22 152.3 22.17 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.096 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -147.49 142.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.816 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 m -125.98 138.97 53.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -119.12 115.75 24.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 84.1 m-85 -95.24 138.23 33.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.49 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.1 tm-20 -61.24 -49.36 77.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.067 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 99.6 m-20 -98.03 -177.51 3.77 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.103 0.477 . . . . 0.0 109.842 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.7 -176.54 6.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.876 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.58 24.43 0.32 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.778 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.481 ' H ' ' CB ' ' A' ' 39' ' ' SER . 2.5 m-85 62.07 41.61 10.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.157 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -109.11 172.99 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.114 0.483 . . . . 0.0 110.535 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.77 -155.3 52.82 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.439 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -55.77 175.08 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.8 154.58 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 55.9 t80 -130.76 131.58 44.8 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.7 p-10 -119.66 125.99 50.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.964 0.412 . . . . 0.0 111.197 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -152.79 143.17 22.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.372 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -126.53 24.58 6.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.809 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ASP . 4.4 t -146.79 141.95 27.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.602 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' CYS . 51.7 p-10 -37.16 156.02 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 m -157.95 163.22 38.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.27 -56.63 2.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 38.8 p-10 -152.43 112.26 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -102.19 9.2 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.985 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.598 ' O ' ' O ' ' A' ' 34' ' ' LEU . 81.6 t60 -59.66 -28.27 67.11 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.458 0.647 . . . . 0.0 109.964 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -61.27 -30.48 70.5 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.425 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -86.63 -14.06 43.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.97 136.35 30.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.136 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 m -94.86 -10.12 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.495 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.607 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 58.7 ttp180 -158.7 146.86 18.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.474 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.2 m -110.67 104.61 13.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.416 0.627 . . . . 0.0 111.391 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.741 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.8 m-20 -129.33 156.8 43.45 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.348 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.741 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.3 p 35.52 128.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.42 1.105 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.4 mt -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.385 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.2 ptpt -154.67 102.92 2.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.57 150.17 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.448 0.642 . . . . 0.0 110.226 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -123.1 51.68 1.43 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.964 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.06 -96.2 0.1 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.218 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.25 -141.89 4.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 47' ' ' TRP . 83.8 m -79.86 166.34 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.7 m95 -154.65 155.48 34.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.496 0.665 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.36 121.62 42.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.382 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.8 133.54 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.014 0.435 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 52' ' ' ARG . 77.9 m-85 -104.41 109.82 21.83 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 50' ' ' TYR . 74.0 tt0 -33.55 -33.29 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.644 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 29.9 mtp85 -121.71 151.48 57.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 56.0 Cg_endo -69.92 164.2 35.58 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.764 2.309 . . . . 0.0 112.158 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 4.6 m-80 78.99 -8.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.884 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.9 m-85 . . . . . 0 N--CA 1.463 0.213 0 O-C-N 123.5 0.5 . . . . 0.0 110.742 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.2 t80 . . . . . 0 N--CA 1.465 0.275 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.782 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.65 91.02 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -70.32 111.86 10.81 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.82 163.51 16.02 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.111 1.874 . . . . 0.0 112.739 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -52.7 116.87 2.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.151 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.64 178.77 42.23 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.528 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.1 mt-10 -101.55 152.4 20.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.002 0.43 . . . . 0.0 110.336 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 22.6 m-85 -144.29 89.52 6.96 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.36 -14.73 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.223 1.948 . . . . 0.0 113.331 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.1 mt-10 -150.26 161.06 43.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.685 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 15.0 p90 -63.26 -50.06 71.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.759 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 30.2 mt-30 -45.0 -9.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.8 mmm180 -75.18 -5.41 44.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.685 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.11 25.98 9.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 75' ' ' GLY . 21.8 mmm 84.93 24.55 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.131 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.4 54.02 0.31 Allowed Glycine 0 N--CA 1.474 1.196 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 30.8 mt -78.98 14.44 1.39 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.148 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 60.0 t30 112.61 164.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.039 1.462 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 52.7 p30 -96.45 65.93 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.57 120.23 10.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.121 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.77 129.73 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.675 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.7 p -111.19 -162.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.578 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.99 -178.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 110.793 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.481 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.8 p -149.75 150.49 32.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -115.99 127.42 54.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.545 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 126.39 27.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.309 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.4 t -123.84 131.19 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.704 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.502 ' O ' HG21 ' A' ' 136' ' ' VAL . 25.7 m80 -101.66 161.78 13.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.751 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.06 157.52 71.1 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 C-N-CA 122.31 2.007 . . . . 0.0 112.023 179.189 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 . . . . . 0 N--CA 1.465 0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.8 t80 -157.21 113.45 2.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.111 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -154.68 130.99 10.41 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.3 tt -134.26 142.58 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.0 mt-30 -123.11 130.59 52.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 8.1 mt -119.49 131.84 70.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.208 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -112.77 131.61 55.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.36 -29.99 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 150.26 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.3 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.5 176.24 14.6 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 55.75 30.58 15.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 6.1 m-85 56.0 83.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -160.58 161.18 32.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.955 0.407 . . . . 0.0 110.569 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.6 -149.36 21.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -77.22 138.59 39.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.671 0.272 . . . . 0.0 110.483 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.3 tmm? -122.23 132.96 54.69 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.055 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 58.1 m-85 -122.1 135.86 54.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -123.11 124.2 42.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.445 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 111' ' ' THR . 11.9 t -147.75 128.57 14.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 p -92.92 38.78 1.03 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.62 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 -177.62 5.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.761 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.4 p-10 -85.51 158.51 20.15 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 172' ' ' SER . 42.7 t -132.8 124.23 18.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.372 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.5 Cg_endo -79.57 -56.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.606 1.537 . . . . 0.0 110.958 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -116.05 113.03 22.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.76 -46.59 74.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-O 121.168 0.509 . . . . 0.0 110.787 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.471 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.1 ttt -65.48 -18.87 65.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.243 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.36 -46.36 33.61 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 121.606 -0.684 . . . . 0.0 111.992 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.45 -24.74 14.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.254 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.3 m-85 -111.28 -0.55 16.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.022 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 52.76 12.13 0.24 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.982 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.414 ' N ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -79.28 133.12 36.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -107.55 -26.94 10.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.545 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.9 mt-10 -150.83 108.27 3.63 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.08 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 118' ' ' ILE . 7.7 mm -74.7 125.97 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.794 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -107.37 -32.27 7.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.332 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.523 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 13.5 t -153.59 147.21 25.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.29 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -146.72 129.18 15.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.735 179.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 132' ' ' VAL . 43.9 mtmt -99.83 -157.88 0.63 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.016 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.578 ' O ' ' O ' ' A' ' 131' ' ' LYS . 1.1 m 32.39 110.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.906 0.86 . . . . 0.0 112.058 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 132' ' ' VAL . 3.6 mm? -117.98 166.87 11.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.766 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.2 mp0 -142.75 111.07 6.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.781 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . 35.03 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.603 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -117.25 156.31 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 110.165 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 25.9 t-105 -145.36 168.2 21.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.379 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 91.0 mt -145.39 123.79 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.759 0.314 . . . . 0.0 111.377 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -108.77 130.22 55.38 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.03 110.81 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.83 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 142' ' ' LEU . 76.4 tt0 -49.46 -22.51 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.7 mp -118.47 161.01 37.6 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.432 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 74.1 Cg_endo -77.97 167.44 23.6 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.324 2.016 . . . . 0.0 111.68 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 73.14 14.12 4.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.921 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.2 24.52 0.66 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.636 0.255 . . . . 0.0 111.306 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -108.49 168.96 8.95 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.07 170.43 36.63 Favored Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -55.52 150.32 12.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.148 0.499 . . . . 0.0 109.771 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 7.1 mp0 -108.8 146.7 33.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.665 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 179.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 . . . . . 0 N--CA 1.463 0.202 0 CA-C-O 121.009 0.433 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.607 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.2 ptt180 -107.59 -24.69 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.607 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.2 pttm -119.82 154.06 54.98 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 120.84 0.353 . . . . 0.0 110.492 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.537 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.3 Cg_endo -58.42 -16.63 29.97 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.31 2.006 . . . . 0.0 113.5 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.3 mp -100.93 -3.68 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.15 -27.16 68.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.481 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.555 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.7 20.69 18.49 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.642 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.43 28.41 67.8 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.626 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.25 137.67 45.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.792 0.796 . . . . 0.0 109.72 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.11 20.81 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.314 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 171.48 155.47 0.22 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.477 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.64 5.0 5.11 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.952 2.435 . . . . 0.0 111.596 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.59 70.92 6.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.612 0.244 . . . . 0.0 111.153 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -100.93 -147.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -157.73 -132.25 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.611 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -92.21 -154.09 0.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -170.37 -177.07 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.136 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.48 132.45 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.924 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.9 ptm180 -53.92 129.34 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.686 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 138' ' ' ILE . 16.7 mt -59.77 135.41 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.383 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.2 t -133.97 138.74 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.517 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.0 tp10 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.436 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.959 0.409 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.722 ' O ' HG13 ' A' ' 42' ' ' VAL . 40.8 tttt -161.45 155.85 22.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.321 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.4 tt -148.58 146.99 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.035 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.6 m -132.97 141.43 48.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -121.71 117.26 26.21 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.5 m-85 -99.68 141.13 32.88 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.047 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.9 tm-20 -64.07 -51.66 63.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.23 -176.39 4.13 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 109.616 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HB3' HD22 ' A' ' 15' ' ' ASN . 42.1 mtmt -84.28 -178.17 6.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.805 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.713 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 46.25 24.55 0.28 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.128 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER 61.81 44.24 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.214 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -111.21 166.1 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -144.09 31.96 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.608 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -60.97 166.47 3.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.151 -1.025 . . . . 0.0 109.024 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.7 155.94 7.49 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.003 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 58.2 t80 -135.62 135.42 40.21 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 p-10 -104.25 150.12 24.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.615 0.245 . . . . 0.0 110.563 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -162.55 124.94 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.527 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.08 14.35 9.81 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.657 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.8 t -150.66 148.46 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 p30 -39.28 156.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.7 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 48.3 t -158.29 164.29 36.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.65 -56.07 3.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -156.31 109.19 2.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.343 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -92.67 7.53 43.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -58.76 -30.36 67.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.103 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.8 p -64.52 -1.1 1.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.699 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -119.39 -14.84 9.15 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.768 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 15.8 tp -141.33 139.61 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -102.21 -8.38 21.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.852 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.7 ttm180 -153.32 141.87 20.83 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.685 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.9 m -113.02 104.23 12.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.772 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 52.6 m-20 -115.17 -153.76 0.53 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' ASN . 19.1 p -24.94 137.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.61 0.719 . . . . 0.0 112.587 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.0 mt -140.54 147.85 22.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.742 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.8 ptpt -155.89 103.12 2.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.239 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.0 t -66.49 144.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.93 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -115.1 46.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.48 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -164.15 -100.28 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.811 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.544 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.29 -140.15 4.24 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.6 m -78.7 167.27 21.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.437 -0.449 . . . . 0.0 110.851 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.714 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 39.3 m95 -157.11 158.82 37.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.376 0.608 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.98 122.57 43.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.791 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.8 m -119.41 133.02 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.891 0.377 . . . . 0.0 110.671 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 51' ' ' GLU . 92.9 m-85 -106.17 110.57 22.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.928 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 50' ' ' TYR . 71.4 tt0 -34.87 -36.06 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.37 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.7 mtt-85 -116.61 147.42 39.74 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 45.3 Cg_endo -68.01 156.36 66.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.37 2.047 . . . . 0.0 111.88 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 7.8 m-80 86.23 0.41 0.63 Allowed 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.931 0.769 . . . . 0.0 111.216 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 8.9 m-85 . . . . . 0 N--CA 1.468 0.447 0 O-C-N 123.464 0.478 . . . . 0.0 111.216 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.6 t80 . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -101.37 94.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -72.46 111.22 10.2 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.15 164.84 19.48 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.078 1.852 . . . . 0.0 112.418 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -55.06 118.83 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.08 179.458 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.48 -180.0 41.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.74 153.24 20.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.004 0.43 . . . . 0.0 110.176 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 4.4 m-85 -142.54 69.79 20.8 Favored Pre-proline 0 C--O 1.221 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.29 -13.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.845 2.363 . . . . 0.0 113.079 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 67' ' ' TYR . 71.2 mt-10 -155.46 163.99 39.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.689 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.1 p90 -65.18 -49.58 69.24 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.063 -179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -42.44 -10.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -80.23 0.78 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.488 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.73 20.9 10.92 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.36 0.124 . . . . 0.0 111.124 178.595 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.8 mmt 92.22 20.33 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.781 1.233 . . . . 0.0 111.716 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.19 59.6 0.27 Allowed Glycine 0 CA--C 1.536 1.358 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.4 mt -89.23 17.14 6.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.423 0.289 . . . . 0.0 111.543 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.6 t30 103.78 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.744 1.278 . . . . 0.0 109.578 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.24 63.74 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -131.54 112.77 12.93 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -146.15 130.34 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.123 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.673 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -108.78 -164.17 0.93 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.034 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' SER . 2.9 m -48.37 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.399 0.619 . . . . 0.0 111.553 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 8' ' ' ILE . 13.5 p -151.41 151.65 32.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.698 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.28 128.28 56.02 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.57 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.87 132.4 53.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.79 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.1 t -129.03 132.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.706 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.44 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.9 m-70 -98.9 162.8 12.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.74 149.92 61.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.494 1.551 0 C-N-CA 122.126 1.884 . . . . 0.0 112.14 179.836 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.725 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 36.7 t80 -153.54 113.1 3.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.2 tptm -153.64 137.29 16.03 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.102 0.477 . . . . 0.0 111.138 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -137.82 145.66 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.087 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.4 mt-30 -123.9 129.49 51.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.746 177.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.83 131.42 72.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -111.15 123.38 50.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.011 0.434 . . . . 0.0 110.786 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.01 -19.74 20.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -131.2 144.75 51.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.455 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.49 -170.46 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 44.62 29.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.741 0.305 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 17.4 m-85 54.64 82.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -159.64 164.13 34.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 -158.49 30.04 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.863 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -64.66 135.74 56.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.361 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 45.2 ttp -118.23 122.21 42.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.186 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.58 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 44.9 m-85 -115.85 130.57 56.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.46 120.69 36.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.097 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -149.54 129.75 13.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.412 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -97.09 49.91 1.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.48 -176.63 5.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.351 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.3 p-10 -89.65 160.51 16.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 58.2 m -138.41 123.02 11.83 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.492 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 58.0 Cg_endo -76.15 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.878 1.719 . . . . 0.0 110.53 178.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.9 m -110.34 114.09 27.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.2 tt -70.05 -37.19 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.958 0.409 . . . . 0.0 110.947 -178.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.5 ttt -70.51 -19.01 62.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.728 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -81.81 -42.3 19.88 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.14 -0.975 . . . . 0.0 111.513 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.15 -30.53 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.769 -177.531 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.58 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 32.1 m-85 -116.86 4.23 12.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.813 -178.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.7 m-70 54.19 3.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.0 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.548 ' H ' ' C ' ' A' ' 122' ' ' PHE . 35.8 mtt -72.12 133.09 44.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.112 0.482 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -109.02 -24.65 11.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.192 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.557 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.8 mt-10 -151.78 107.78 3.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 13.8 mm -76.71 126.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.587 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.4 m80 -104.55 -36.5 7.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.169 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.509 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 7.4 t -148.27 143.47 26.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.129 0.49 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.3 t -143.44 134.09 25.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HB2' HE21 ' A' ' 97' ' ' GLN . 47.8 mtpt -114.38 -175.99 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.571 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 28.0 t 54.7 93.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.92 165.56 11.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.106 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.4 mp0 -139.4 111.83 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.55 -88.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.6 t -119.13 156.48 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.096 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.725 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.2 t-105 -144.47 166.72 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.643 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.8 mt -144.23 124.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.375 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 30.8 m-85 -107.4 113.8 27.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.802 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.1 -22.76 1.77 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.647 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.9 mp -121.74 165.36 20.31 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.462 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.0 Cg_endo -81.93 169.91 14.35 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.241 1.961 . . . . 0.0 112.3 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.496 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 77.0 13.67 2.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.783 179.759 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.496 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 74.25 30.12 1.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.11 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 93.0 mtt180 -134.68 126.23 28.68 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.4 173.62 20.77 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -52.45 113.66 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.896 0.379 . . . . 0.0 110.499 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -82.18 149.48 27.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.466 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.857 179.404 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.965 0.412 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -108.58 -21.48 12.69 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -123.64 154.88 66.8 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.362 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.492 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.0 Cg_endo -58.98 -20.53 53.71 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.481 2.121 . . . . 0.0 113.611 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.24 -5.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 110.654 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.81 -33.18 64.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.331 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.547 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.02 21.97 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.459 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.96 27.64 66.24 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.629 176.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.83 138.2 43.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.802 0.801 . . . . 0.0 110.678 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.31 24.2 0.19 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.1 m 165.19 153.79 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.447 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 170' ' ' VAL . 50.9 Cg_endo -71.18 -18.07 30.85 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.797 2.332 . . . . 0.0 111.509 178.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.41 70.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.302 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.963 HG22 ' H ' ' A' ' 171' ' ' GLN . 8.8 p -104.99 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.963 ' H ' HG22 ' A' ' 170' ' ' VAL . 2.0 tp60 -152.82 -130.86 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.501 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.6 p -94.85 -154.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -171.53 -178.17 2.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.295 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -157.7 132.97 8.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.96 178.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -52.74 126.11 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 110.347 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.491 HD12 ' HB ' ' A' ' 136' ' ' VAL . 10.9 mt -56.59 129.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.823 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.35 135.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.502 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.049 179.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.53 -1.428 . . . . 999.99 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.616 ' O ' HG22 ' A' ' 4' ' ' THR . 47.3 p -95.17 -118.01 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.075 -0.343 . . . . 999.99 110.075 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 34.05 29.67 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.787 0.679 . . . . 999.99 112.797 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 2' ' ' SER . 2.9 t 161.39 -20.3 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.055 0.761 . . . . 999.99 113.055 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.15 107.5 2.31 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.36 -0.924 . . . . 127.44 111.212 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.575 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 79.0 p -95.28 115.26 27.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.844 -0.798 . . . . 75.04 108.844 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.663 ' O ' HG13 ' A' ' 42' ' ' VAL . 42.7 tttt -107.03 147.91 29.36 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.273 0.358 . . . . 8.2 111.561 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 83' ' ' CYS . 18.5 tt -140.15 136.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.95 -0.389 . . . . 6.76 109.95 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 35.4 m -120.32 138.11 53.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 8.47 110.638 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ARG . 67.8 m-85 -116.86 116.61 27.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.067 -0.716 . . . . 4.74 109.067 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.602 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 88.6 m-85 -95.96 140.61 30.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.213 0.53 . . . . 9.67 111.144 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.58 ' HB2' ' CB ' ' A' ' 19' ' ' ARG . 4.3 tm-20 -62.06 -51.86 66.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.851 -0.613 . . . . 46.58 109.841 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -97.42 -175.95 3.36 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.791 -0.641 . . . . 24.88 109.92 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.67 -179.38 7.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.75 -0.659 . . . . 104.03 110.455 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 49.77 26.11 1.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 66.74 110.61 179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.602 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m-85 57.96 44.57 19.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.737 -0.665 . . . . 19.33 110.947 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 15' ' ' ASN . 38.6 mt-30 -114.74 161.49 18.09 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.974 0.416 . . . . 111.5 110.724 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.26 -146.4 29.06 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.859 -0.61 . . . . 138.46 112.437 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.728 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.1 ttm-85 -57.05 166.25 1.1 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.709 -0.849 . . . . 613.65 108.709 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -169.24 152.12 4.87 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.78 -0.452 . . . . 325.16 109.78 178.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.488 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 47.4 t80 -130.6 131.9 45.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 18.95 109.596 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -116.21 128.78 55.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 278.02 110.649 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.01 139.21 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 342.02 109.975 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -123.99 22.24 8.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.323 -0.399 . . . . 154.21 111.147 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -152.11 150.29 29.74 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.069 -0.253 . . . . 117.53 110.605 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.9 p-10 -39.9 156.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.846 -0.616 . . . . 317.22 111.374 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -157.34 164.21 37.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.824 -0.625 . . . . 167.98 110.184 179.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.04 -56.41 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.992 0.425 . . . . 11.81 110.921 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -151.01 108.79 3.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.579 -0.737 . . . . 348.8 111.295 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.488 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.5 p90 -99.74 5.32 45.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.102 -0.499 . . . . 6.94 110.48 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.3 t60 -58.21 -26.89 63.37 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.186 0.517 . . . . 9.31 109.966 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.9 p -62.04 -20.94 64.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.956 -0.566 . . . . 32.68 110.265 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.16 -17.33 19.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.071 -0.513 . . . . 13.98 111.266 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.728 HD12 ' HD2' ' A' ' 19' ' ' ARG . 15.7 tp -138.91 135.5 34.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.809 0.338 . . . . 5.79 110.276 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.8 m -97.64 -9.66 26.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.5 -0.318 . . . . 80.89 111.551 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 30.2 ttm-85 -155.11 142.01 19.12 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 110.025 -0.361 . . . . 332.73 110.025 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.421 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -108.59 102.32 11.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.332 0.586 . . . . 99.41 110.847 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 39' ' ' SER . 76.4 m-20 -125.57 154.91 41.5 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.953 -1.499 . . . . 45.58 106.953 178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.642 ' O ' ' O ' ' A' ' 38' ' ' ASN . 15.6 p 39.04 128.67 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.497 1.142 . . . . 8.21 112.805 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 13.7 mt -142.02 143.49 26.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.307 -0.86 . . . . 5.81 111.772 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.5 ptpt -154.67 101.79 2.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.722 -0.672 . . . . 8.95 109.571 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 7' ' ' LYS . 1.9 t -65.73 148.03 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 110.033 -0.358 . . . . 131.71 110.033 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -121.91 57.8 1.04 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.164 -0.68 . . . . 256.75 109.164 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.96 -100.05 0.13 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 115.544 -0.753 . . . . 10.26 111.338 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -131.43 -142.32 4.99 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.485 -0.646 . . . . 8.86 111.485 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.575 HG22 ' N ' ' A' ' 47' ' ' TRP . 86.6 m -79.98 165.09 22.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 8.71 110.601 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.751 ' CZ3' ' SG ' ' A' ' 83' ' ' CYS . 15.6 m95 -151.79 153.16 33.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.695 . . . . 7.86 111.748 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -112.42 117.69 33.11 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.274 -1.009 . . . . 6.12 108.274 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 80' ' ' LEU . 15.4 m -118.03 133.69 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 6.2 110.662 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -107.42 117.04 33.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.736 -0.666 . . . . 43.74 110.182 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.2 -39.59 0.18 Allowed 'General case' 0 C--N 1.333 -0.111 0 O-C-N 123.553 0.533 . . . . 42.52 110.674 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HE ' ' CA ' ' A' ' 57' ' ' GLY . 25.5 mtm180 -116.85 153.32 49.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.986 -0.552 . . . . 698.05 110.866 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 48.1 Cg_endo -71.06 168.02 24.43 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 123.103 2.535 . . . . 26.34 111.108 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 54' ' ' ASN . 0.6 OUTLIER 79.8 -4.29 1.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.872 0.732 . . . . 216.76 110.885 -179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 12.0 m-85 84.61 51.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.493 0.495 . . . . 25.54 110.749 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.23 167.33 22.32 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.326 -0.397 . . . . 61.34 110.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' CA ' ' HE ' ' A' ' 52' ' ' ARG . . . 89.61 -158.44 27.4 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.132 -0.787 . . . . 118.16 111.132 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -66.94 138.07 57.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.792 0.33 . . . . 436.64 110.299 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.565 ' O ' ' HB2' ' A' ' 149' ' ' GLN . 62.6 mtt -104.08 109.16 20.84 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.974 -0.557 . . . . 614.82 109.818 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.532 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 13.2 t80 -115.15 133.07 56.36 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.587 -0.523 . . . . 999.99 109.587 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -102.26 95.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 11.1 109.811 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD13 HG21 ' A' ' 40' ' ' ILE . 1.2 mt -77.56 109.96 11.2 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.241 -0.436 . . . . 6.8 110.096 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 61' ' ' ILE . 90.5 Cg_endo -81.98 165.83 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.098 2.532 . . . . 9.35 112.407 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -56.26 112.38 1.22 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.182 -0.463 . . . . 16.37 110.119 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.59 175.74 41.54 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.327 -1.109 . . . . 9.23 110.327 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.614 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.4 mt-10 -100.15 157.75 16.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.096 0.474 . . . . 11.75 110.747 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.614 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.4 m-85 -149.93 80.4 7.36 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.344 -0.843 . . . . 12.89 108.955 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 48.2 Cg_exo -48.79 -22.33 4.53 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.008 2.472 . . . . 28.55 113.284 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -146.35 163.4 35.68 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.388 -0.597 . . . . 36.83 109.388 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 26.5 p90 -61.63 -45.2 95.1 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.246 -0.434 . . . . 22.71 110.74 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG2' ' CE2' ' A' ' 70' ' ' TYR . 7.4 mt-30 -46.0 -13.43 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.217 0.451 . . . . 319.03 112.217 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . 0.2 OUTLIER -75.36 -3.51 34.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.59 -0.277 . . . . 516.27 111.566 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -118.35 26.33 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 110.404 -0.221 . . . . 7.41 110.404 179.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.546 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.8 mmt 85.0 23.74 0.09 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.936 0.773 . . . . 49.56 110.955 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.35 50.1 0.25 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.916 -0.473 . . . . 12.4 111.916 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.634 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 16.8 mt -79.89 18.31 0.83 Allowed 'General case' 0 CA--C 1.517 -0.298 0 O-C-N 122.968 -0.136 . . . . 54.39 110.917 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.634 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 66.3 t30 106.96 159.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.456 1.097 . . . . 154.95 110.155 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -91.72 57.35 3.2 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.666 0.604 . . . . 144.44 110.637 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -133.16 108.84 9.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.811 -0.631 . . . . 657.17 110.276 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.729 HD11 ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -141.03 126.81 19.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.238 -0.585 . . . . 5.23 110.018 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -101.2 -162.54 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.742 -0.663 . . . . 5.2 109.431 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.497 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 12.8 p -50.27 -168.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.403 0.621 . . . . 140.35 111.262 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.751 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 28.1 p -154.79 161.79 41.36 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.407 -0.517 . . . . 8.04 110.071 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -122.94 131.84 53.9 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.498 -0.556 . . . . 332.31 109.498 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 123.6 18.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 9.1 110.43 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 48' ' ' ALA . 48.2 t -121.87 129.92 75.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.401 -0.363 . . . . 16.84 110.991 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -101.4 157.62 16.66 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.935 -0.575 . . . . 126.92 110.265 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.61 150.48 63.03 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 176.97 110.651 -179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.14 156.23 55.8 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 123.007 2.471 . . . . 11.34 112.284 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.8 p -170.85 -15.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 193.91 111.592 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.75 -40.69 93.89 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 120.99 -0.624 . . . . 192.01 111.552 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -122.49 54.46 0.7 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.949 -0.86 . . . . 176.66 110.949 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 92' ' ' GLY . 3.7 pt20 34.43 -102.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.621 0.248 . . . . 44.38 110.664 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.703 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.8 t80 -162.49 114.39 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.797 -0.446 . . . . 11.73 109.797 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' CE ' ' HB2' ' A' ' 110' ' ' GLU . 21.0 tptm -154.83 132.17 11.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 179.04 110.828 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -133.7 143.1 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.968 -0.56 . . . . 4.92 111.444 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -120.43 131.15 54.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.043 -0.98 . . . . 81.94 109.255 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 108' ' ' MET . 6.7 mt -120.82 134.13 65.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 116.252 -0.431 . . . . 4.03 110.677 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.497 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.2 m-85 -115.16 132.66 56.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.962 -0.563 . . . . 7.67 110.976 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.2 -26.7 68.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.637 . . . . 27.19 110.653 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -122.09 144.77 48.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 146.97 110.584 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' HA2' ' HB2' ' A' ' 129' ' ' SER . . . -61.44 174.4 6.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.753 -0.939 . . . . 60.39 110.753 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.1 t0 56.85 33.6 23.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 414.82 110.536 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.476 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 11.7 m-85 53.46 78.89 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.841 -0.618 . . . . 19.09 110.835 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.5 m -156.39 163.09 39.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.216 -0.447 . . . . 19.13 110.699 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.67 -154.91 27.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.436 -0.665 . . . . 44.38 111.436 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -72.57 132.82 44.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 35.47 110.906 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 47.8 ttp -116.7 128.37 55.27 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.82 -0.627 . . . . 161.99 110.492 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 39.1 m-85 -119.25 135.63 54.6 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 16.12 110.769 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' HB2' ' CE ' ' A' ' 95' ' ' LYS . 8.3 pt-20 -121.55 123.31 41.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.397 -0.82 . . . . 48.3 110.89 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 111' ' ' THR . 11.8 t -148.11 125.83 11.85 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.138 -0.483 . . . . 13.7 110.976 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.4 OUTLIER -93.22 38.77 1.04 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.534 0.683 . . . . 113.42 110.719 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.78 -176.47 4.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.597 -0.729 . . . . 67.29 110.352 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -88.1 160.29 17.86 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.891 0.377 . . . . 16.91 110.221 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.59 ' SG ' ' HG2' ' A' ' 121' ' ' GLN . 6.6 t -140.87 122.57 9.29 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.921 -0.582 . . . . 162.84 110.504 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 172' ' ' SER . 56.1 Cg_endo -75.59 -56.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.785 2.324 . . . . 12.34 111.609 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.0 m -115.28 109.72 18.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.858 -0.61 . . . . 13.14 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.2 tt -69.37 -40.94 80.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.247 0.546 . . . . 6.62 110.025 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.4 ttt -67.79 -31.9 72.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 78.86 110.855 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -67.09 -47.2 71.93 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.207 -0.451 . . . . 342.48 112.155 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.59 ' HG2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -100.87 -29.68 12.1 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.992 0.738 . . . . 251.73 112.992 -177.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.685 ' CE1' ' HB3' ' A' ' 109' ' ' TYR . 17.4 m-85 -104.02 -1.74 27.03 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 120.565 -0.454 . . . . 7.65 110.948 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.5 m-70 55.25 7.51 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.337 -0.392 . . . . 14.8 111.737 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.537 ' SD ' ' CG2' ' A' ' 98' ' ' ILE . 41.7 mtt -77.16 132.88 39.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.988 0.423 . . . . 85.03 110.156 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -102.96 -31.63 10.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.618 -0.719 . . . . 337.58 110.242 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.476 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 57.4 mt-10 -148.67 110.05 4.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.062 -0.517 . . . . 84.76 110.372 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.477 HD12 ' SD ' ' A' ' 124' ' ' MET . 11.6 mm -74.24 122.14 26.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.595 -0.52 . . . . 4.4 109.595 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.6 m80 -103.17 -32.07 9.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 7.83 110.77 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.476 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 44.3 t -148.18 142.89 26.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.341 -0.39 . . . . 136.38 110.831 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.26 127.21 16.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 18.11 110.049 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -109.03 -176.79 3.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 73.4 110.577 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.638 ' C ' HD22 ' A' ' 133' ' ' LEU . 61.8 t 56.86 98.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.0 -0.545 . . . . 239.63 110.742 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.72 161.17 16.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.788 -0.642 . . . . 238.81 110.36 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.7 OUTLIER -138.63 111.03 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.043 -0.526 . . . . 385.49 110.169 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.01 -91.88 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.005 -0.838 . . . . 11.62 111.005 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 134' ' ' GLU . 42.8 t -122.83 141.57 42.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 110.065 -0.346 . . . . 8.41 110.065 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.703 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 26.6 t-105 -124.51 169.55 11.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 5.14 110.66 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.557 HD12 HG12 ' A' ' 176' ' ' ILE . 59.7 mt -145.24 122.21 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.694 -0.684 . . . . 4.68 111.05 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.4 133.91 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.702 -0.481 . . . . 4.24 109.702 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CE1' ' HG2' ' A' ' 149' ' ' GLN . 25.0 m-85 -111.08 112.14 23.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.14 -0.482 . . . . 7.07 110.763 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -52.97 -25.27 11.46 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.159 -0.473 . . . . 28.99 110.277 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.01 160.61 31.68 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.035 -0.53 . . . . 18.0 109.99 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HG3' ' A' ' 171' ' ' GLN . 58.9 Cg_endo -76.79 169.3 21.98 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.707 2.271 . . . . 11.59 111.552 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 143' ' ' PRO . 8.3 m-80 70.9 19.45 5.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 119.59 111.104 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 174' ' ' ARG . 3.7 m-85 70.92 33.25 2.19 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.654 -0.248 . . . . 18.4 111.165 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 140' ' ' TYR . 45.4 mtm180 -121.53 174.0 7.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 999.99 110.846 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.92 175.36 42.59 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.895 -0.882 . . . . 20.69 110.895 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -49.03 136.39 14.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.051 -0.351 . . . . 949.07 110.051 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' A' ' 59' ' ' MET . 70.0 mt-30 -99.53 122.1 42.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 397.97 109.809 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 139' ' ' PHE . 71.1 m-85 -98.34 129.99 45.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 40.01 109.925 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 151' ' ' LEU . 0.9 OUTLIER -149.41 96.86 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.672 -0.695 . . . . 291.8 109.641 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 162' ' ' ASP . 29.2 tp -121.71 140.72 51.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.356 -0.384 . . . . 999.99 110.057 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -83.44 109.82 17.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 999.99 110.568 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -167.44 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.906 -0.588 . . . . 999.99 110.263 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -126.05 0.75 7.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 999.99 111.373 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 177.97 159.3 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.771 -0.372 . . . . 235.22 110.96 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.554 ' HE2' HD11 ' A' ' 133' ' ' LEU . 16.0 m-85 -128.54 112.17 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.05 -0.523 . . . . 31.64 110.274 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.407 ' HG2' ' HG2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -104.75 -20.52 13.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 708.49 110.768 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 1.5 pttm -124.77 159.76 56.95 Favored Pre-proline 0 C--N 1.333 -0.139 0 CA-C-O 121.107 0.479 . . . . 310.53 110.773 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 168' ' ' PRO . 19.3 Cg_endo -62.59 -19.84 69.06 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.841 2.361 . . . . 12.19 112.775 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.3 mp -96.25 -6.28 9.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.908 0.385 . . . . 26.61 110.443 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.48 ' O ' HD23 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -56.77 -30.32 63.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.933 -0.576 . . . . 33.18 110.975 -178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -103.56 23.95 11.85 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.081 0.467 . . . . 9.22 109.929 179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.4 28.73 73.1 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.851 -0.613 . . . . 11.66 112.904 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.46 137.74 41.87 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.709 0.754 . . . . 10.16 110.082 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.17 18.73 0.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.775 -0.648 . . . . 15.02 110.647 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 169.39 154.17 0.16 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.695 0.283 . . . . 17.04 111.171 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.547 ' HB3' ' HB3' ' A' ' 160' ' ' PRO . 55.6 Cg_endo -74.8 2.98 5.91 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 123.172 2.582 . . . . 20.88 112.037 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.26 75.02 5.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 15.0 110.524 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.863 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -102.74 -147.71 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.894 -0.78 . . . . 80.6 108.894 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.863 ' H ' HG12 ' A' ' 170' ' ' VAL . 15.7 mm-40 -156.67 -133.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.014 -0.365 . . . . 126.0 110.014 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -91.95 -153.02 0.32 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.411 0.148 . . . . 152.78 111.256 -177.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -169.59 -176.14 2.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.064 0.459 . . . . 6.31 110.806 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.55 HH21 HG23 ' A' ' 177' ' ' VAL . 10.2 ptm180 -160.48 130.88 5.34 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.881 -0.599 . . . . 13.69 110.353 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.5 ptt180 -53.01 131.52 36.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.092 -0.504 . . . . 467.95 110.879 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.557 HG12 HD12 ' A' ' 138' ' ' ILE . 30.9 mt -62.5 134.68 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.446 -0.797 . . . . 15.16 109.893 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.55 HG23 HH21 ' A' ' 174' ' ' ARG . 0.1 OUTLIER -135.58 153.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.824 -0.625 . . . . 132.74 110.601 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.026 -0.988 . . . . 408.25 110.757 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -88.02 172.34 9.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.733 0.301 . . . . 0.0 110.595 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -129.91 41.79 3.37 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.6 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -142.58 -59.88 0.44 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.541 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.65 117.68 5.87 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.8 p -83.0 158.61 22.45 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.782 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.4 tttt -160.05 151.1 19.23 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.053 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.8 142.14 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.991 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -124.72 138.71 54.27 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.09 116.16 25.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.83 138.24 34.68 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.271 0.558 . . . . 0.0 111.219 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.469 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.7 tm-20 -60.88 -49.94 75.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.01 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.416 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 99.7 m-20 -97.82 -176.94 3.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.165 0.507 . . . . 0.0 110.141 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -82.08 -176.63 6.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.41 24.26 0.28 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.029 179.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' H ' ' CB ' ' A' ' 39' ' ' SER . 3.3 m-85 63.76 41.64 6.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -108.5 179.15 4.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.056 0.455 . . . . 0.0 110.451 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.38 -159.06 48.15 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -53.39 175.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.05 150.68 4.54 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.4 t80 -127.94 131.34 49.33 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -119.8 124.0 45.06 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.864 0.364 . . . . 0.0 111.151 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.4 t -151.27 142.59 23.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.316 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -125.39 24.39 7.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 26' ' ' ASP . 10.6 m -146.22 141.71 27.67 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 25' ' ' CYS . 55.1 p-10 -36.27 156.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.5 m -156.48 162.71 39.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.354 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -55.96 3.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.05 0.452 . . . . 0.0 110.538 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -153.03 111.35 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.353 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.427 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.2 p90 -101.29 10.56 40.55 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.963 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.597 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.4 t60 -60.85 -26.07 67.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.487 0.661 . . . . 0.0 109.962 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.7 p -63.2 -30.55 71.68 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.229 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -87.61 -12.41 45.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.532 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -144.29 138.33 27.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.004 0.431 . . . . 0.0 109.986 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.1 m -99.28 -9.22 23.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.652 0.263 . . . . 0.0 111.464 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 53.2 ttm-85 -156.48 144.89 19.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.0 m -110.11 103.89 12.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.244 0.545 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.728 ' O ' ' O ' ' A' ' 39' ' ' SER . 71.5 m-20 -128.7 156.42 43.52 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.728 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.5 p 34.95 129.2 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.438 1.114 . . . . 0.0 112.399 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -141.76 145.51 24.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.208 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.034 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -153.35 102.9 2.63 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.084 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -66.5 148.96 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.52 0.676 . . . . 0.0 110.568 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -122.21 51.23 1.38 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.732 179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.548 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.17 -94.64 0.1 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.927 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -139.31 -140.16 3.9 Favored Glycine 0 N--CA 1.466 0.664 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 47' ' ' TRP . 94.9 m -80.56 166.41 21.17 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.366 -0.491 . . . . 0.0 110.824 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.782 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.6 m95 -153.78 156.71 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.336 0.589 . . . . 0.0 110.746 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.99 120.36 38.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.7 m -118.83 132.8 67.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.017 0.437 . . . . 0.0 110.931 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' GLU . 87.8 m-85 -104.45 111.13 23.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.671 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 68.8 tt0 -35.74 -35.48 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.294 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.494 HH21 ' CB ' ' A' ' 56' ' ' ALA . 10.3 mtm180 -116.18 148.12 40.86 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.043 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.8 Cg_endo -68.59 158.61 57.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.459 2.106 . . . . 0.0 111.719 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.5 m-80 85.7 -4.9 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.841 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 10.9 m-85 85.64 62.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.172 0.51 . . . . 0.0 111.1 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' CB ' HH21 ' A' ' 52' ' ' ARG . . . -145.32 168.3 20.79 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.34 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.46 -157.11 28.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 21.1 m-85 -70.8 141.71 51.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.097 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 61.9 mtt -106.86 87.55 2.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.549 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.622 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 33.4 t80 -92.56 136.17 33.45 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.36 91.29 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.874 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.7 110.38 5.84 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.422 0.451 . . . . 0.0 110.074 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.78 162.14 18.75 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.269 1.979 . . . . 0.0 112.539 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.19 118.17 3.32 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.167 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.47 179.36 41.27 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.539 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.5 mt-10 -101.98 152.55 20.81 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 120.959 0.409 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.539 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 21.8 m-85 -145.75 85.23 7.84 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -56.5 -18.13 24.35 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 123.142 2.561 . . . . 0.0 113.137 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.7 mt-10 -150.63 161.73 42.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.724 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 18.9 p90 -63.11 -51.2 67.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.073 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.401 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 18.3 mt-30 -43.28 -10.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.1 mmm180 -75.08 -6.5 49.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.966 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.724 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -118.02 27.29 9.09 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.853 -0.158 . . . . 0.0 110.646 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.9 mmt 83.56 24.73 0.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.175 0.922 . . . . 0.0 111.102 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 33.12 50.39 0.48 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.7 mt -74.45 14.21 0.49 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.7 t30 110.21 167.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 124.538 1.149 . . . . 0.0 109.349 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 54.6 p30 -99.27 60.56 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.034 0.445 . . . . 0.0 110.383 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -137.89 115.72 11.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.057 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.74 128.6 21.82 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -111.81 -162.45 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.824 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 24.3 p -45.25 -179.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.129 0.49 . . . . 0.0 110.504 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.54 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -151.09 153.33 34.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -118.69 128.56 54.62 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.71 126.47 27.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.149 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.2 t -126.54 132.6 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.79 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -99.29 161.88 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.296 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -75.85 148.86 82.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.525 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.78 153.26 73.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.293 1.996 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.3 p -173.27 -13.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.249 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.66 -39.71 95.5 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -130.33 53.03 0.81 Allowed Glycine 0 N--CA 1.465 0.609 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.3 pt20 35.46 -107.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.723 0.297 . . . . 0.0 110.628 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 20.5 t80 -155.78 112.4 3.16 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -149.58 127.91 12.17 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.385 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.2 tt -130.27 136.52 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.503 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 53.2 mt-30 -120.04 126.04 49.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 107' ' ' GLN . 5.8 mt -118.37 132.81 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.72 -177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.691 ' HA ' ' O ' ' A' ' 107' ' ' GLN . 46.3 m-85 -117.5 127.75 54.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.05 0.453 . . . . 0.0 111.523 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.52 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 73.6 tt0 -60.27 -28.02 67.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.859 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 103' ' ' ASP . 51.3 mttm -107.95 141.54 39.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.448 0.642 . . . . 0.0 110.778 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 158' ' ' ARG . . . -69.67 37.02 0.37 Allowed Glycine 0 C--N 1.315 -0.597 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.018 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 101' ' ' LYS . 5.6 p-10 -154.27 35.7 0.42 Allowed 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.479 ' HA ' ' CG ' ' A' ' 99' ' ' PHE . 28.6 m-85 56.31 56.26 5.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.32 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.419 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 3.8 m -161.13 170.68 19.92 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.747 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.63 -43.45 2.89 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.835 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 99' ' ' PHE . 72.1 tp60 -156.86 119.12 3.91 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-O 119.155 -0.45 . . . . 0.0 111.517 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 29.4 ttp -116.6 109.15 16.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.232 0.924 . . . . 0.0 110.159 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.607 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 16.8 m-85 -115.54 133.47 56.0 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -122.9 122.84 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.454 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 111' ' ' THR . 5.8 t -152.17 126.24 9.16 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.383 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 t -94.09 44.08 1.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 111.002 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -141.79 179.52 6.8 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -83.45 155.43 23.42 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.717 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.632 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -131.37 120.71 18.1 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.939 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.58 -55.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.861 1.707 . . . . 0.0 110.727 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.1 m -118.02 114.36 23.03 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -69.31 -43.31 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 27.5 ttt -67.25 -19.48 65.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.729 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.08 -46.61 41.87 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 4.8 pt20 -99.85 -24.72 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.609 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 28.5 m-85 -114.68 2.48 14.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.6 0.238 . . . . 0.0 111.501 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 50.6 14.02 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.529 -0.469 . . . . 0.0 111.268 178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.415 ' N ' ' C ' ' A' ' 122' ' ' PHE . 13.6 mtp -80.24 135.89 36.34 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -109.32 -25.99 10.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 67.6 mt-10 -150.81 107.06 3.46 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.107 0.479 . . . . 0.0 111.014 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.448 HD11 HD13 ' A' ' 118' ' ' ILE . 8.4 mm -74.58 123.62 30.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.681 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 66.1 m80 -105.4 -31.08 9.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.906 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 14.7 m -150.49 145.79 26.22 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.623 ' SG ' HG12 ' A' ' 132' ' ' VAL . 6.5 t -150.56 124.88 9.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.19 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -94.39 53.0 1.63 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.623 HG12 ' SG ' ' A' ' 130' ' ' CYS . 7.5 p -95.92 125.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -147.11 94.95 2.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.325 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 136' ' ' VAL . 14.3 mp0 -144.58 109.78 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.115 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.08 -85.94 0.01 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.603 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.7 t -127.12 156.85 38.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.723 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.4 t-105 -144.82 166.2 25.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.578 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.3 mt -144.61 123.13 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.713 0.292 . . . . 0.0 111.313 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.616 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -108.2 129.07 55.2 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 23.8 m-85 -108.51 110.8 22.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.34 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.528 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 82.2 tt0 -49.85 -23.27 1.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.77 160.3 37.21 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-O 120.73 0.3 . . . . 0.0 110.331 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.478 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.4 Cg_endo -78.55 165.25 25.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.387 2.058 . . . . 0.0 111.943 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.695 ' ND2' HH21 ' A' ' 146' ' ' ARG . 1.9 m-80 75.1 13.57 3.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.063 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.2 m-85 79.27 24.6 0.48 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.695 HH21 ' ND2' ' A' ' 144' ' ' ASN . 87.7 mtm180 -107.03 169.44 8.55 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.722 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.35 170.35 36.2 Favored Glycine 0 N--CA 1.463 0.45 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.536 ' NE ' ' OH ' ' A' ' 150' ' ' TYR . 30.3 ptt180 -61.75 143.27 56.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 0.0 110.209 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.622 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 70.1 mt-30 -97.97 146.79 25.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.806 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.536 ' OH ' ' NE ' ' A' ' 148' ' ' ARG . 48.0 m-85 -119.03 134.89 54.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.72 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.3 tt -149.14 100.81 3.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.204 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 10.4 tp -141.02 132.46 26.85 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.901 0.382 . . . . 0.0 110.061 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 21.7 t0 -83.47 -143.94 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 1.7 ttpm? 67.49 103.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 154' ' ' LYS . 68.2 mttm 42.87 -166.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.552 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.653 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 2.5 pm0 -86.59 -138.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 15.1 m-85 -137.93 109.28 6.9 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.789 0.328 . . . . 0.0 110.291 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.442 ' O ' ' OG ' ' A' ' 129' ' ' SER . 13.4 ptm180 -108.27 -21.62 12.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.546 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.44 ' H ' ' HG3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -121.19 156.2 57.6 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.398 -179.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.543 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.8 Cg_endo -61.13 -19.0 61.5 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.736 2.291 . . . . 0.0 113.847 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -100.8 -1.59 9.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.355 0.598 . . . . 0.0 110.636 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.09 -29.42 70.3 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.843 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.571 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -105.0 22.91 14.45 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.79 27.55 70.58 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.871 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.8 138.05 45.75 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.013 0.906 . . . . 0.0 109.473 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.96 20.63 0.35 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.217 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.8 OUTLIER 175.42 154.64 0.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.837 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.22 3.14 6.49 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 123.274 2.649 . . . . 0.0 111.801 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.05 5.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.393 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.9 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -95.95 -150.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.9 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -157.18 -133.2 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.786 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.8 -155.57 0.42 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -177.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.61 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 52.0 p90 -169.87 -177.07 2.52 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.082 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -159.93 131.8 6.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.236 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -54.15 129.91 36.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.021 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.557 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.5 mt -61.28 135.87 25.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.288 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.9 152.82 26.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.997 0.427 . . . . 0.0 110.261 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--O 1.219 -0.542 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.208 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 2.2 m 160.4 -100.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.767 0.318 . . . . 0.0 110.277 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 59.53 175.67 0.08 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.723 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 74.98 161.87 0.25 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.996 0.427 . . . . 0.0 110.444 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.68 -36.62 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p -81.47 156.63 25.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 110.695 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.77 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.7 tttt -161.25 153.66 20.27 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.277 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.4 tt -147.43 142.78 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.714 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 m -126.72 139.96 52.75 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.082 0.468 . . . . 0.0 110.471 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -120.05 116.73 26.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.297 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.7 m-85 -95.76 138.36 33.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.152 0.501 . . . . 0.0 110.606 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.46 -49.05 79.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.289 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.424 ' O ' ' OG ' ' A' ' 39' ' ' SER . 82.4 m-20 -100.76 -174.77 2.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.907 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HA ' ' HG ' ' A' ' 39' ' ' SER . 2.8 mppt? -84.35 -174.96 5.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.656 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.8 m120 46.21 22.92 0.17 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.88 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.4 m-85 59.17 44.93 15.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.305 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -115.27 161.91 17.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 110.374 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.36 -151.22 29.47 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.592 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -58.18 173.79 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -169.46 155.05 5.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -134.61 134.59 41.41 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 30.2 t0 -102.81 154.35 19.27 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.547 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.43 124.81 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.815 0.34 . . . . 0.0 110.139 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -124.82 11.17 8.38 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.787 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.415 ' O ' ' C ' ' A' ' 26' ' ' ASP . 8.0 t -150.65 148.25 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.5 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 52.9 p30 -37.54 154.92 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -155.79 160.69 40.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.03 -56.82 2.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.881 0.372 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.5 p-10 -152.98 113.74 4.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -103.41 8.31 38.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 53.4 t60 -59.61 -29.4 67.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.539 0.685 . . . . 0.0 110.024 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.2 p -60.15 -30.52 69.37 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.383 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -87.34 -13.97 42.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.521 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.0 tp -142.2 137.36 30.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 109.943 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.9 m -98.16 -9.42 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.268 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.0 ttm-85 -155.66 144.12 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.385 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.2 m -110.18 103.67 12.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.358 0.599 . . . . 0.0 110.671 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.736 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.8 m-20 -128.91 155.16 45.72 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.736 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.9 p 36.11 129.14 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 122.558 1.17 . . . . 0.0 112.258 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.5 mt -141.55 146.13 23.64 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.857 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.307 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.5 ptpt -154.46 104.2 2.55 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.248 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.71 149.06 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-O 121.39 0.614 . . . . 0.0 110.129 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -120.39 47.69 1.73 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.769 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -167.08 -94.84 0.1 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.022 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.536 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.94 -139.81 3.87 Favored Glycine 0 N--CA 1.467 0.762 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.0 m -79.71 166.66 21.57 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.179 -0.601 . . . . 0.0 110.946 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.77 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -156.0 156.81 35.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.566 0.698 . . . . 0.0 111.039 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -114.39 119.31 36.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.798 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 5.5 m -117.88 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.232 0.539 . . . . 0.0 111.114 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 30.9 m-85 -93.77 175.31 6.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -100.99 -36.69 8.93 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -118.96 148.14 44.01 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 38.7 Cg_endo -64.16 157.29 54.43 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.006 1.804 . . . . 0.0 111.915 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.433 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.2 m120 84.24 -3.9 1.05 Allowed 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.005 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 16.6 m-85 85.76 62.87 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.616 0.572 . . . . 0.0 111.073 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.63 168.49 21.17 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.672 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.49 -159.56 33.6 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -65.19 155.5 34.79 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.2 mtp -130.7 140.13 50.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.177 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.475 ' C ' HD12 ' A' ' 61' ' ' ILE . 12.0 t80 -146.18 145.04 30.31 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.3 mp -103.22 92.87 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.438 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -72.22 112.78 15.94 Favored Pre-proline 0 CA--C 1.547 0.849 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.0 162.75 15.71 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.013 1.808 . . . . 0.0 112.456 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.08 115.68 1.82 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.057 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.11 177.4 41.62 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.8 mt-10 -100.75 153.04 19.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.346 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -144.94 89.41 6.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_endo -63.35 -13.92 38.96 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.239 1.959 . . . . 0.0 113.419 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 96.7 mt-10 -149.69 161.01 43.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.723 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 34.7 p90 -63.76 -53.69 47.08 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.986 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -43.77 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.9 mmm180 -75.18 -4.38 38.51 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.726 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.723 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.29 24.08 10.93 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 116.883 -0.144 . . . . 0.0 110.976 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 21.1 mmt 87.69 23.96 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.238 1.015 . . . . 0.0 111.064 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.72 50.27 0.42 Allowed Glycine 0 N--CA 1.471 0.969 0 N-CA-C 111.971 -0.452 . . . . 0.0 111.971 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.562 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.2 mt -74.34 13.36 0.59 Allowed 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.013 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 46.9 t30 109.81 165.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 124.94 1.4 . . . . 0.0 109.157 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -96.29 63.0 2.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.443 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.468 ' CA ' ' HE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.9 116.44 11.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.232 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.616 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.31 128.06 20.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.616 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.1 p -110.3 -162.92 0.82 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.041 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.7 m -45.47 -179.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.488 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.6 p -150.29 151.51 33.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.634 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.06 128.73 55.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.551 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 128.04 34.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.304 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 48' ' ' ALA . 78.8 t -127.34 132.9 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.876 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -100.79 161.64 13.46 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.07 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -87.94 148.17 42.67 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.57 156.72 64.93 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.349 2.033 . . . . 0.0 111.994 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.9 t -170.74 -17.45 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.905 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.16 -49.83 50.23 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.416 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -113.33 53.51 0.59 Allowed Glycine 0 N--CA 1.467 0.75 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.7 pt20 33.45 -106.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.72 0.295 . . . . 0.0 110.916 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.738 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 28.8 t80 -157.29 113.63 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -154.22 133.72 12.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 145.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.131 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.3 mt-30 -123.76 128.17 49.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.563 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.7 mt -118.44 131.93 69.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.513 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -113.16 130.01 56.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.145 0.498 . . . . 0.0 110.628 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -59.27 -27.21 65.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.908 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -122.2 149.15 44.05 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.21 171.34 18.89 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 60.19 29.82 19.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 3.9 m-85 56.01 82.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -158.61 161.6 37.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.989 0.423 . . . . 0.0 110.26 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.69 -150.95 23.64 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -74.6 138.87 43.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.419 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.5 tmm? -123.55 132.73 53.98 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.175 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.402 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.3 m-85 -124.11 136.37 54.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -123.96 125.67 44.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.7 t -151.27 128.56 11.26 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.8 t -93.48 44.45 1.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -144.52 -179.25 6.43 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.6 p30 -86.41 159.96 19.19 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.563 ' O ' ' OG ' ' A' ' 172' ' ' SER . 96.5 m -138.71 123.49 11.77 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.73 -55.06 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.04 1.827 . . . . 0.0 111.665 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 m -116.59 111.89 20.53 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -41.72 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.81 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 7.7 ttp -67.94 -16.59 64.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.438 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -83.38 -42.73 16.7 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.595 -0.691 . . . . 0.0 111.39 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.584 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.3 OUTLIER -93.85 -30.61 14.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.903 -177.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.584 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 26.1 m-85 -114.8 5.9 15.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.8 m-70 50.9 9.35 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.786 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.512 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -76.52 135.36 39.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.868 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -107.35 -27.56 10.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.679 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 49.5 mt-10 -151.03 107.57 3.5 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.35 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 12.4 mm -75.59 125.4 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.106 0.479 . . . . 0.0 109.779 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.8 m80 -103.75 -31.13 9.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.283 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.0 p -155.77 151.78 27.69 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.8 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -150.56 131.26 14.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.123 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.412 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 51.9 mtmt -112.09 -173.2 2.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.446 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 40.9 t 55.57 80.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.679 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.72 167.78 10.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.053 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -139.21 111.38 7.43 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.925 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 40.26 -84.82 0.01 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.4 t -125.03 154.95 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.745 0.307 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.738 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.8 t-105 -142.12 167.46 22.06 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.594 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.3 mt -145.34 125.72 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.378 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.23 131.65 55.37 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -107.34 112.63 25.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -48.89 -23.15 1.0 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.968 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.8 mp -119.26 166.43 14.48 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -84.2 167.36 12.33 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.093 1.862 . . . . 0.0 111.902 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.81 15.27 1.14 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.078 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.0 m-85 74.02 27.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.635 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 99.5 mtt180 -132.67 126.03 31.67 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.94 174.69 22.87 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -56.08 114.19 1.84 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -80.93 141.0 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.05 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -112.69 129.93 56.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.025 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.3 tp -146.18 101.49 3.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 153' ' ' ASP . 49.1 tp -130.43 152.76 49.47 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 152' ' ' LEU . 57.8 t0 -35.68 104.17 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.148 0.499 . . . . 0.0 110.789 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 139.82 58.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.944 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -174.51 -56.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.008 0.432 . . . . 0.0 110.268 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -172.49 137.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -123.73 108.22 12.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.936 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -109.64 -22.02 12.15 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.271 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 ptpt -119.53 156.1 53.7 Favored Pre-proline 0 N--CA 1.47 0.548 0 CA-C-O 121.005 0.431 . . . . 0.0 110.717 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.562 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -60.48 -16.19 40.66 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.746 2.298 . . . . 0.0 113.531 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -101.91 -2.22 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.114 0.483 . . . . 0.0 111.02 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -26.05 67.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.638 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.74 21.87 16.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.459 -179.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.8 28.18 67.55 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.788 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.554 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.15 138.9 43.63 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.878 0.839 . . . . 0.0 109.994 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.3 22.28 0.23 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 167.08 155.89 0.11 Allowed Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.229 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 170' ' ' VAL . 45.7 Cg_endo -70.74 -33.62 12.6 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.596 2.197 . . . . 0.0 111.523 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -47.25 75.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.31 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.892 HG22 ' H ' ' A' ' 171' ' ' GLN . 9.1 p -107.68 -145.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG22 ' A' ' 170' ' ' VAL . 69.3 mm-40 -152.9 -132.09 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.271 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -95.77 -153.29 0.4 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -170.69 -177.04 2.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.485 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.486 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -157.55 133.13 9.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.061 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.49 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.5 ptt-85 -52.43 133.66 35.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.384 0.612 . . . . 0.0 110.616 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.406 HD11 HG13 ' A' ' 138' ' ' ILE . 18.6 mt -67.29 135.06 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.863 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.486 HG22 HH21 ' A' ' 174' ' ' ARG . 34.2 m -137.35 156.63 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.202 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.396 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 4' ' ' THR . 73.6 m -156.04 161.42 40.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt 63.61 -25.7 0.07 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.233 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.614 ' H ' ' C ' ' A' ' 2' ' ' SER . 28.0 p 40.2 87.71 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.817 0.342 . . . . 0.0 110.776 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.56 -153.03 7.64 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.486 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 2.7 p -83.16 156.77 23.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.829 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.5 tttt -159.99 151.06 19.29 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.948 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.59 141.31 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.887 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.7 m -124.32 138.22 54.4 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.144 0.497 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.6 115.95 25.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.191 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.3 m-85 -96.4 138.28 34.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.301 0.572 . . . . 0.0 111.152 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.411 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.4 tm-20 -60.98 -50.0 75.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.856 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.2 m-20 -97.87 -177.79 3.88 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.295 0.569 . . . . 0.0 109.967 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HB3' HD22 ' A' ' 15' ' ' ASN . 0.0 OUTLIER -81.7 -177.07 6.4 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.123 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.638 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.8 OUTLIER 46.67 25.36 0.42 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.876 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.528 ' H ' ' CB ' ' A' ' 39' ' ' SER . 1.7 m-85 63.4 40.17 8.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.506 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.07 175.11 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.13 0.49 . . . . 0.0 110.634 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.21 -158.33 53.26 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.706 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.2 ttm-85 -53.6 174.91 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -168.46 150.76 5.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -126.5 130.99 51.7 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.9 p-10 -119.36 119.96 35.51 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.94 142.69 23.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.176 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -125.81 26.32 6.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.893 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.7 m -146.75 141.35 26.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -38.01 157.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.713 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.1 t -159.17 166.57 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.496 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.586 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.81 -56.12 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.971 0.415 . . . . 0.0 110.684 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -152.15 113.6 4.32 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.441 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -102.4 8.55 40.13 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.052 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -60.15 -25.68 65.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.485 0.659 . . . . 0.0 110.066 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.9 p -63.62 -30.37 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -87.02 -13.83 43.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.407 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.8 tp -143.51 137.66 28.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 110.068 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -98.74 -9.74 24.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.277 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 ttm-85 -155.66 144.08 20.21 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.485 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 7.5 p -110.25 104.39 13.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.771 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 59.2 m-20 -128.96 156.56 43.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.26 128.88 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.44 1.114 . . . . 0.0 112.529 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.485 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.7 mt -141.71 146.49 22.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.18 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -154.77 103.29 2.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.204 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.0 t -66.73 148.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 121.713 0.768 . . . . 0.0 110.368 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -123.46 54.54 1.28 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.849 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.81 -97.34 0.11 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.256 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -133.41 -142.11 4.7 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.622 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.23 166.81 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.319 -0.518 . . . . 0.0 110.776 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.829 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -152.98 155.22 36.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.381 0.61 . . . . 0.0 110.783 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.01 120.24 39.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.302 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 80' ' ' LEU . 9.7 m -119.59 133.22 67.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.962 0.41 . . . . 0.0 110.558 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -107.83 115.49 30.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.064 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 59.7 tt0 -37.97 -34.52 0.12 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.203 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -115.4 146.78 37.27 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.819 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 44.4 Cg_endo -68.18 160.4 48.98 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.422 2.082 . . . . 0.0 111.495 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.1 m120 83.39 -3.74 1.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.29 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 7.6 m-85 85.66 60.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.08 0.466 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.05 171.52 14.76 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.51 -161.9 34.24 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 15.3 m-85 -68.77 138.01 54.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.411 ' CE ' ' HB1' ' A' ' 48' ' ' ALA . 3.9 tpt -102.45 124.27 47.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.361 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 39.5 t80 -131.5 136.87 48.25 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.49 92.24 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.55 110.48 7.05 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.6 163.33 16.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.966 1.777 . . . . 0.0 112.795 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.59 114.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.925 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.81 177.52 42.2 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 94.5 mt-10 -101.16 153.03 19.94 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.887 0.375 . . . . 0.0 110.396 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 33.8 m-85 -145.71 90.57 5.89 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.08 -13.72 41.32 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.317 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 93.8 mt-10 -149.07 160.92 42.9 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.7 p90 -63.39 -53.21 56.06 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.322 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.6 pt20 -44.62 -9.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 23.5 mmm180 -75.16 -4.78 40.76 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.834 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.68 24.86 10.8 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.801 -0.181 . . . . 0.0 110.907 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.5 mmt 87.47 23.0 0.05 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 111.085 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 33.13 52.47 0.52 Allowed Glycine 0 N--CA 1.469 0.865 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.1 mt -77.77 13.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.484 -0.294 . . . . 0.0 111.095 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 53.9 t30 109.79 167.2 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.612 1.195 . . . . 0.0 109.766 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 52.4 p30 -101.98 66.83 1.05 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' GLU . 5.5 tpt180 -143.63 77.28 1.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.585 0.231 . . . . 0.0 110.983 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.678 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -102.98 128.21 49.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.346 0.593 . . . . 0.0 109.605 -178.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.678 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.3 p -109.38 -163.18 0.85 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.609 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.3 t -44.83 -179.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.174 0.512 . . . . 0.0 110.994 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.536 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.8 p -152.24 155.42 37.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.585 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -121.28 129.89 53.37 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.96 126.71 28.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.394 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 48' ' ' ALA . 58.8 t -123.14 130.19 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.895 0.378 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.09 162.28 13.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.954 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.897 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER -86.51 146.82 42.67 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.688 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.27 159.37 53.52 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.427 2.085 . . . . 0.0 112.223 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.9 p -171.2 -18.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.009 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.64 -48.68 60.72 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.531 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -113.03 51.49 0.7 Allowed Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.3 pt20 33.96 -105.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.666 0.27 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.729 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 15.4 t80 -156.87 113.22 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.2 tptm -153.98 129.29 9.77 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.98 0.419 . . . . 0.0 111.155 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -133.96 141.57 43.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.9 mt-30 -119.33 128.61 54.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.59 HD13 HD11 ' A' ' 118' ' ' ILE . 12.5 mt -119.38 131.65 71.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.722 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.0 m-85 -111.21 131.22 55.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.051 0.453 . . . . 0.0 110.533 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.98 -31.5 71.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.747 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -118.73 152.26 36.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.175 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.0 -169.66 2.22 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.0 t0 45.02 29.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.527 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 17.0 m-85 54.19 80.72 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.6 m -158.12 162.55 38.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.52 -149.24 19.7 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.58 138.93 39.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 110.449 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -120.5 127.85 52.59 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.526 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.1 m-85 -119.44 136.63 54.22 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.204 0.526 . . . . 0.0 110.868 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.81 126.88 46.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.457 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 111' ' ' THR . 11.0 t -147.58 129.21 15.08 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.42 36.99 0.99 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.605 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.96 -177.31 5.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -85.1 158.91 20.29 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.193 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 43.3 t -132.38 123.79 18.82 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.227 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 172' ' ' SER . 74.5 Cg_endo -78.52 -55.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.512 1.474 . . . . 0.0 110.784 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.2 m -119.11 114.44 22.47 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.13 -45.13 80.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.209 0.528 . . . . 0.0 111.04 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.0 ttt -65.94 -20.54 66.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.255 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -74.2 -46.84 39.42 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.15 -24.36 14.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.7 m-85 -110.77 0.92 17.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.764 0.316 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.4 m-70 52.41 12.13 0.22 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.234 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.407 ' H ' ' C ' ' A' ' 122' ' ' PHE . 34.7 mtt -78.97 134.16 36.84 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -106.22 -27.12 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.222 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.54 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -153.69 109.94 3.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.497 0.665 . . . . 0.0 111.251 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -75.85 125.33 35.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.748 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.54 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.3 m80 -106.79 -31.05 8.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.001 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 7.9 m -152.47 147.03 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.043 0.449 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.5 t -146.66 133.92 20.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.725 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -114.05 -178.18 3.31 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.618 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 21.5 t 56.46 103.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.663 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.99 163.44 15.13 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.012 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.7 mp0 -139.21 112.25 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.694 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.95 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 134' ' ' GLU . 41.8 t -126.6 135.88 62.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.729 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 t-105 -121.84 169.39 10.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 53.1 mt -145.53 124.38 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.465 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.58 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -110.74 133.73 53.08 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' CZ ' ' OE1' ' A' ' 149' ' ' GLN . 16.9 m-85 -109.73 111.71 23.32 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 123.531 0.519 . . . . 0.0 110.52 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -49.91 -23.38 1.92 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.975 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mp -113.86 166.4 11.46 Favored Pre-proline 0 N--CA 1.468 0.434 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.49 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 93.4 Cg_endo -86.47 166.09 9.21 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.216 1.944 . . . . 0.0 112.044 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.498 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 1.5 m-80 69.14 21.26 7.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.454 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.498 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.7 m-85 72.19 66.95 0.13 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.703 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -154.63 170.68 20.93 Favored 'General case' 0 C--O 1.221 -0.417 0 O-C-N 122.041 -0.412 . . . . 0.0 110.592 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 99.38 167.04 29.97 Favored Glycine 0 N--CA 1.464 0.53 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.884 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.403 ' O ' ' O ' ' A' ' 149' ' ' GLN . 20.6 ptt180 -68.02 77.57 0.23 Allowed 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 60' ' ' TYR . 5.1 pt20 -48.05 175.54 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.443 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -138.83 146.33 41.13 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.196 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.53 ' C ' HD22 ' A' ' 152' ' ' LEU . 2.4 tt -147.76 93.67 2.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.092 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 151' ' ' LEU . 4.3 mm? -112.24 150.77 30.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.825 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -128.84 56.56 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.654 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.503 ' CE ' ' OD1' ' A' ' 162' ' ' ASP . 36.5 ttpt -91.85 -91.89 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -172.06 94.61 0.15 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.072 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.527 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 56.8 tt0 63.61 163.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.075 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.39 107.73 10.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.715 0.293 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.404 ' O ' ' OG ' ' A' ' 129' ' ' SER . 33.7 ptt180 -107.23 -23.52 12.23 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.593 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 3.1 ptpt -118.18 157.63 48.42 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-O 121.332 0.587 . . . . 0.0 111.044 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.4 Cg_endo -61.24 -19.29 63.14 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.044 1.829 . . . . 0.0 113.451 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -99.52 -0.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.218 0.532 . . . . 0.0 110.834 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.503 ' OD1' ' CE ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -62.79 -25.83 68.43 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.481 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.7 OUTLIER -108.93 21.14 17.6 Favored 'General case' 0 C--N 1.335 -0.031 0 CA-C-O 120.931 0.395 . . . . 0.0 110.07 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.05 28.4 70.46 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.57 -0.572 . . . . 0.0 113.834 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -104.42 137.63 42.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.524 1.162 . . . . 0.0 109.459 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -72.47 18.37 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.083 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 167.77 157.18 0.14 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.41 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.17 6.17 3.17 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.951 2.434 . . . . 0.0 111.617 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.99 69.42 5.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.551 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.0 t -97.04 -153.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.914 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -155.13 -130.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.432 0.457 . . . . 0.0 110.228 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 116' ' ' PRO . 2.6 p -92.72 -155.73 0.44 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -169.75 -177.68 2.75 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.425 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -162.03 134.33 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.124 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.692 ' O ' HG23 ' A' ' 177' ' ' VAL . 15.0 ptt180 -50.83 133.09 26.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.792 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' A' ' 136' ' ' VAL . 5.8 mt -59.7 70.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 175' ' ' ARG . 21.6 t -69.53 140.13 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.072 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.421 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.43 ' HG ' ' C ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -165.02 165.61 19.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.85 0.357 . . . . 0.0 110.51 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -137.89 -23.83 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.635 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 5' ' ' GLY . 15.4 t -88.7 -36.44 16.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.619 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' N ' HG23 ' A' ' 4' ' ' THR . . . 99.48 137.23 9.71 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.3 p -142.42 132.82 24.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.982 0.42 . . . . 0.0 110.409 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.752 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.1 tttt -160.97 149.94 16.58 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.892 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.96 140.47 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.935 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 27.2 m -121.58 137.84 54.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.841 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -118.25 115.49 24.86 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.8 m-85 -95.26 140.0 30.78 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -61.17 -51.31 69.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.911 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.444 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.4 m-20 -98.59 -176.77 3.47 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.506 ' HB3' HD22 ' A' ' 15' ' ' ASN . 2.9 mppt? -82.04 -176.78 6.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.928 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.748 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.59 26.53 0.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.124 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.525 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.7 OUTLIER 62.09 41.0 11.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -106.58 172.0 7.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.986 0.422 . . . . 0.0 110.753 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.16 -157.57 53.52 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' NH1' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -54.56 175.93 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.419 ' H ' ' CD ' ' A' ' 19' ' ' ARG . 2.7 ppt_? -169.21 149.99 4.28 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' THR . 68.2 t80 -132.92 133.77 43.68 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.1 p-10 -119.58 129.9 54.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.664 0.268 . . . . 0.0 110.798 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.2 140.21 37.73 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -124.64 16.56 8.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' ASP . 7.7 t -148.54 143.4 26.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' CYS . 52.2 p-10 -37.18 158.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.207 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 42.3 t -157.6 164.17 37.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.862 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -96.35 -49.07 5.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.95 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -158.57 105.7 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.254 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 1.7 p90 -97.76 12.58 33.35 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.894 0.378 . . . . 0.0 110.37 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -64.74 -15.59 61.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.06 0.457 . . . . 0.0 110.214 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.1 p -78.6 2.04 20.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.308 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 79.3 m-85 -120.2 -13.42 8.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.01 0.433 . . . . 0.0 110.732 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.544 HD21 ' O ' ' A' ' 36' ' ' ARG . 20.1 tp -144.76 140.31 28.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 t -100.7 -13.8 18.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.24 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' O ' HD21 ' A' ' 34' ' ' LEU . 55.6 ttm-85 -152.61 141.73 21.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' SG ' ' CA ' ' A' ' 79' ' ' ARG . 9.0 p -109.34 104.3 13.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.294 0.569 . . . . 0.0 110.981 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.719 ' O ' ' O ' ' A' ' 39' ' ' SER . 86.4 m-20 -128.77 156.45 43.54 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.719 ' O ' ' O ' ' A' ' 38' ' ' ASN . 9.2 p 36.18 129.45 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.509 1.147 . . . . 0.0 112.341 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.16 146.39 22.65 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.828 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.16 102.7 2.32 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.47 148.45 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-O 121.466 0.65 . . . . 0.0 110.906 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -122.4 50.74 1.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.569 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.38 -97.14 0.11 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.39 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.488 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.75 -141.17 4.23 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 47' ' ' TRP . 25.6 m -80.2 164.43 23.28 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.393 -0.475 . . . . 0.0 110.819 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.752 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 35.4 m95 -153.47 156.27 37.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.336 0.589 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 86' ' ' VAL . . . -115.72 120.22 38.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.552 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -116.82 133.02 64.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.169 0.509 . . . . 0.0 111.175 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' O ' ' N ' ' A' ' 52' ' ' ARG . 82.5 m-85 -104.49 107.22 18.04 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.876 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' TYR . 44.7 tt0 -34.02 -32.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.441 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 67.9 mtt180 -127.9 151.27 75.44 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.154 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -58.65 163.59 10.7 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 122.222 1.948 . . . . 0.0 113.142 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 55' ' ' PHE . 1.4 m120 57.04 66.94 1.06 Allowed 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.073 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' C ' ' O ' ' A' ' 54' ' ' ASN . 1.4 m-85 22.54 66.27 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.437 0.46 . . . . 0.0 111.764 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.45 161.32 39.99 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.717 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.63 -164.27 43.1 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.542 ' CE2' ' NE ' ' A' ' 148' ' ' ARG . 18.0 m-85 -66.5 138.01 57.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.1 mtm -127.25 131.71 50.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.667 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -138.22 159.48 41.94 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.766 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.4 mp -104.87 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.18 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.431 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -72.62 110.84 9.1 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.48 162.92 16.98 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.09 1.86 . . . . 0.0 112.877 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -50.47 115.28 1.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.827 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.08 178.03 42.04 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.6 mt-10 -101.19 155.28 18.1 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 41.7 m-85 -149.04 85.2 6.03 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.33 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.02 -16.37 26.5 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 123.237 2.624 . . . . 0.0 113.228 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -148.7 161.44 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.714 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.7 p90 -65.67 -53.18 44.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.114 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 16.5 mt-30 -43.27 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -75.61 -6.38 50.09 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.291 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.714 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -116.1 25.86 10.37 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.715 -0.221 . . . . 0.0 110.513 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.0 mmt 85.1 26.36 0.07 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 124.376 1.048 . . . . 0.0 111.511 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.27 52.46 0.41 Allowed Glycine 0 N--CA 1.468 0.778 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 28.3 mt -78.42 13.48 1.55 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 119.178 -0.439 . . . . 0.0 111.202 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.4 t30 113.16 168.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.681 1.238 . . . . 0.0 109.165 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -102.03 66.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.232 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.55 ' CA ' ' SG ' ' A' ' 37' ' ' CYS . 14.3 tpt180 -147.9 122.41 9.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.125 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -143.13 128.96 19.42 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.689 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.9 p -112.42 -161.29 0.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 2.2 t -44.76 177.79 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.385 0.612 . . . . 0.0 110.649 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.55 ' N ' ' OG ' ' A' ' 82' ' ' SER . 13.8 p -152.18 153.6 34.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.563 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -119.45 129.44 54.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.19 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.53 119.95 9.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.971 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.568 ' CG2' ' HB2' ' A' ' 48' ' ' ALA . 48.5 t -103.82 121.94 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.839 0.352 . . . . 0.0 110.92 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.82 148.55 22.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.038 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mt -78.4 146.55 70.41 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.51 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.47 151.8 70.77 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.299 2.0 . . . . 0.0 112.052 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.8 t -169.94 -18.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.998 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.44 -33.79 87.4 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -137.76 56.16 0.67 Allowed Glycine 0 N--CA 1.465 0.611 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 92' ' ' GLY . 4.3 pt20 34.28 -101.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.8 0.334 . . . . 0.0 110.857 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.719 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 13.9 t80 -158.15 114.08 2.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.028 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.406 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 17.9 tptm -154.7 128.57 8.76 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.357 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 tt -133.9 141.42 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.54 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.464 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 14.7 mt-30 -119.22 128.16 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 118' ' ' ILE . 9.3 mt -118.79 131.45 71.55 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.057 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.407 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 59.1 m-85 -111.14 130.68 55.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.114 0.483 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -60.84 -31.96 71.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.614 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -114.97 151.68 33.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.295 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.0 171.52 31.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 103' ' ' ASP . 40.1 t0 59.52 32.9 21.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.556 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CE1' ' CG ' ' A' ' 131' ' ' LYS . 9.2 m-85 54.3 80.9 0.11 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -158.07 163.66 37.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.64 -147.89 20.82 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.24 139.33 41.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 46.0 ttp -120.81 126.83 51.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.444 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.469 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 52.9 m-85 -117.87 135.87 53.82 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.857 0.36 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.93 125.41 44.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.422 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 6.0 t -152.27 127.97 10.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.71 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.42 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.16 39.81 1.08 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.959 0.409 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -140.41 178.51 7.26 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.773 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.7 p-10 -82.72 156.41 23.78 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.623 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.2 m -130.85 121.22 18.85 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.979 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.7 Cg_endo -78.24 -53.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.289 0 C-N-CA 121.865 1.71 . . . . 0.0 110.593 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.0 m -120.43 113.48 20.4 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.58 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -69.24 -43.53 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.137 0.494 . . . . 0.0 111.162 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.435 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.7 ttt -68.09 -19.2 64.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.017 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -76.04 -45.61 33.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.623 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 6.9 pt20 -100.38 -26.18 13.97 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 30.6 m-85 -111.93 1.11 16.31 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.738 0.304 . . . . 0.0 111.545 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.6 m-70 52.11 15.3 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.455 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 36.5 mtt -81.97 134.44 35.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -106.91 -28.14 10.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.659 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.551 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 41.9 mt-10 -151.3 108.79 3.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.852 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.415 HD11 HD13 ' A' ' 118' ' ' ILE . 9.0 mm -74.38 125.39 33.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.814 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.551 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -106.14 -29.98 9.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.218 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 4.8 m -151.52 146.26 25.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.725 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 6.1 t -153.57 128.82 9.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.928 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.509 ' CG ' ' CE1' ' A' ' 104' ' ' PHE . 53.1 mtmt -114.51 -179.44 3.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.854 0.359 . . . . 0.0 110.602 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.447 ' C ' HD22 ' A' ' 133' ' ' LEU . 5.5 t 60.79 64.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 133' ' ' LEU . 3.8 mm? -96.61 100.83 12.38 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.213 0.53 . . . . 0.0 110.547 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 1.2 mp0 -67.0 121.14 14.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.44 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.48 -110.94 0.09 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 176' ' ' ILE . 11.3 t -98.77 142.35 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.886 0.374 . . . . 0.0 110.14 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.719 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 32.7 t-105 -131.84 169.33 16.4 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.778 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.1 mt -144.94 123.04 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.729 0.3 . . . . 0.0 111.787 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.628 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -107.93 129.52 55.1 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.44 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 20.2 m-85 -109.02 111.46 23.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.26 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 142' ' ' LEU . 77.0 tt0 -48.41 -23.66 1.01 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.333 -178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -118.1 160.9 37.31 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-O 120.778 0.323 . . . . 0.0 110.277 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.416 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.5 Cg_endo -77.89 167.94 22.96 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.115 1.876 . . . . 0.0 111.83 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 73.07 14.24 4.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.78 179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.29 24.54 0.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.636 0.255 . . . . 0.0 111.348 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -108.04 168.96 8.92 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 94.26 173.03 38.69 Favored Glycine 0 N--CA 1.464 0.513 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.542 ' NE ' ' CE2' ' A' ' 58' ' ' TYR . 81.4 mtt85 -52.5 163.87 0.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 11.7 mp0 -129.47 147.12 51.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.893 0.378 . . . . 0.0 110.152 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -121.22 132.66 54.95 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.425 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.56 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.8 tt -145.16 101.58 3.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 27.0 mt -136.8 151.19 48.89 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 28.7 t0 -67.08 -143.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.425 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.51 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 71.1 tttt 74.33 -33.46 0.25 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.942 0.401 . . . . 0.0 110.565 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 153' ' ' ASP . 52.0 mtmt 53.53 18.81 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' O ' ' CD1' ' A' ' 157' ' ' TYR . 80.6 tt0 -148.61 135.97 20.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.426 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 22.4 m-85 -135.67 112.48 10.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.038 0.447 . . . . 0.0 110.896 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.443 ' O ' ' OG ' ' A' ' 129' ' ' SER . 16.6 ptm180 -105.23 -28.29 11.03 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.719 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -117.59 154.74 50.82 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-O 120.8 0.333 . . . . 0.0 110.265 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.539 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.0 Cg_endo -56.78 -18.64 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.38 2.054 . . . . 0.0 113.595 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.456 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -102.52 -2.35 9.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.528 . . . . 0.0 110.508 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.88 -28.8 70.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.431 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -105.06 21.9 16.26 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 70.43 28.56 71.04 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.804 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.13 137.48 46.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 118.153 0.977 . . . . 0.0 109.051 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -74.22 17.41 0.19 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.29 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.6 OUTLIER 172.13 156.33 0.24 Allowed Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.983 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.19 5.91 4.25 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 123.045 2.497 . . . . 0.0 111.733 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.84 70.59 7.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.97 0.414 . . . . 0.0 110.746 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.892 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.2 t -98.71 -147.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.892 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.5 tp60 -160.14 -132.31 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.517 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.502 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -91.32 -155.31 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -177.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.613 ' CZ ' ' SG ' ' A' ' 115' ' ' CYS . 26.9 p90 -170.05 -176.01 2.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.056 0.455 . . . . 0.0 111.315 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.448 HH21 HG22 ' A' ' 177' ' ' VAL . 10.1 ptm180 -161.59 133.09 5.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.375 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -54.23 130.45 38.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.827 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.406 HD12 ' HB ' ' A' ' 136' ' ' VAL . 12.6 mt -63.48 138.59 22.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.632 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.448 HG22 HH21 ' A' ' 174' ' ' ARG . 31.0 m -139.36 159.25 28.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.299 179.66 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' THR . 5.1 p 45.21 69.7 0.42 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.687 0.28 . . . . 0.0 110.529 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt 66.19 -57.25 0.36 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.526 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 3.9 t -97.75 -132.8 0.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.512 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.526 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . 177.88 -91.38 0.08 OUTLIER Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.8 p -82.11 161.09 22.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 34.5 tttt -162.29 155.25 20.03 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.106 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.5 tt -149.05 144.38 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.127 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 21' ' ' TYR . 19.0 m -128.04 139.59 52.45 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 121.185 0.517 . . . . 0.0 110.508 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -120.36 117.66 28.33 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.989 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 62.9 m-85 -96.89 134.15 40.59 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.368 0.604 . . . . 0.0 110.197 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' A' ' 34' ' ' LEU . 3.1 tm-20 -59.31 -44.83 92.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.439 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 90.6 m-20 -106.73 -173.45 2.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.972 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -83.64 -177.42 6.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.56 0.695 . . . . 0.0 111.635 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.509 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 48.27 19.21 0.2 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.19 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 6.3 m-85 68.02 40.7 2.2 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.138 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' C ' ' H ' ' A' ' 19' ' ' ARG . 6.1 pt20 -122.78 -168.03 1.68 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.972 0.415 . . . . 0.0 111.535 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.28 -24.25 0.46 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.481 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 17' ' ' GLN . 4.2 ttm180 162.34 -174.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.294 0.637 . . . . 0.0 110.33 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.93 157.99 6.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 9' ' ' THR . 62.7 t80 -138.84 135.39 34.5 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 91.9 m-20 -100.75 150.44 22.78 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.612 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -164.05 122.97 1.93 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 178.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -125.38 12.7 8.17 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.614 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.2 m -149.3 145.64 27.15 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.782 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -38.82 156.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' OG ' ' A' ' 82' ' ' SER . 2.2 m -157.04 163.26 39.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.279 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.42 -56.74 2.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.891 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.5 p-10 -153.56 106.76 2.95 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.463 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -96.34 8.84 42.96 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' LEU . 65.8 t60 -58.46 -27.46 64.42 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.455 0.645 . . . . 0.0 110.003 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 48.4 p -62.55 -29.12 70.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' CE1' ' A' ' 21' ' ' TYR . 85.1 m-85 -88.44 -14.8 37.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.923 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' O ' ' O ' ' A' ' 31' ' ' HIS . 13.8 tp -141.64 136.89 31.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 t -95.52 -6.54 40.27 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 53.9 ttm-85 -160.77 152.03 19.1 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 4.2 p -115.35 103.66 11.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.484 0.659 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.724 ' O ' ' O ' ' A' ' 39' ' ' SER . 80.3 m-20 -129.97 158.66 38.95 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.724 ' O ' ' O ' ' A' ' 38' ' ' ASN . 16.6 p 33.0 125.99 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.319 1.056 . . . . 0.0 112.734 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.57 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.2 mt -139.54 144.68 28.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.242 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.355 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -152.21 102.52 2.78 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 121.939 -0.476 . . . . 0.0 110.211 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.51 150.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.667 0.746 . . . . 0.0 110.547 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -123.61 53.23 1.37 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.907 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -173.29 -93.25 0.09 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.582 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.93 -140.35 3.95 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 47' ' ' TRP . 85.6 m -81.72 166.86 19.72 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.426 -0.455 . . . . 0.0 110.786 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.3 m95 -155.07 156.3 35.63 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.451 0.643 . . . . 0.0 110.782 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.72 122.84 46.71 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.23 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.5 m -119.41 132.01 70.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 0.0 110.712 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -103.1 111.36 23.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 42.6 tt0 -37.57 -36.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.177 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.54 HH21 ' H ' ' A' ' 57' ' ' GLY . 73.3 mtm180 -116.16 137.25 23.31 Favored Pre-proline 0 N--CA 1.466 0.345 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.66 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 16.8 Cg_exo -58.88 159.63 20.66 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.269 1.313 . . . . 0.0 112.351 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 3.0 m120 86.1 -3.01 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.011 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.425 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.1 m-85 84.0 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.433 0.458 . . . . 0.0 110.819 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.45 24.68 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.358 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.54 ' H ' HH21 ' A' ' 52' ' ' ARG . . . 87.55 -156.77 28.24 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 6.7 m-85 -71.14 144.0 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.856 0.36 . . . . 0.0 110.06 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.2 mtt -111.42 88.21 2.74 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.599 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 30.6 t80 -92.43 136.5 33.16 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.753 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.7 mp -102.02 89.71 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -68.15 111.43 7.85 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.44 164.26 16.74 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.98 1.786 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.1 OUTLIER -52.86 124.56 14.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.087 179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.68 -175.56 40.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.2 mt-10 -107.33 152.89 23.54 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.217 0.532 . . . . 0.0 110.284 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.57 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 10.6 m-85 -145.6 84.78 8.17 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.3 Cg_exo -58.07 -17.06 29.73 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.984 2.456 . . . . 0.0 112.77 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 94.8 mt-10 -150.91 162.02 41.59 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.678 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 24.3 p90 -61.61 -49.46 76.5 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.522 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -42.34 -13.07 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.2 mmt180 -75.25 -5.19 43.31 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.132 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.678 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.02 26.76 9.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 121.522 -0.071 . . . . 0.0 111.16 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.6 mmt 88.76 17.72 0.05 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.481 1.113 . . . . 0.0 110.935 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 34.24 55.85 0.72 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.44 -70.29 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -157.18 158.9 37.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.6 p-10 -85.87 55.95 3.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.796 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 10.8 tpt180 -138.1 115.9 11.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.49 128.75 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 5.8 p -110.25 -161.85 0.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.179 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 7.0 t -45.45 -178.09 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.221 0.534 . . . . 0.0 110.708 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.61 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.4 p -150.01 150.3 31.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.723 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -115.97 126.65 54.13 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -60.61 127.71 33.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.327 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 48' ' ' ALA . 76.3 t -124.53 131.34 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 120.935 0.398 . . . . 0.0 110.773 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.414 ' O ' HG21 ' A' ' 136' ' ' VAL . 99.4 m-70 -100.18 162.5 12.93 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.162 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -78.93 150.13 74.71 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.18 151.89 80.56 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.233 1.955 . . . . 0.0 112.124 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.9 t -157.24 172.46 18.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.431 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.23 -72.07 1.69 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.03 34.14 1.27 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.6 pt20 34.73 -109.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.716 0.293 . . . . 0.0 111.056 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.6 t80 -154.29 113.03 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.444 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 47.0 tptt -154.59 136.0 14.16 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.127 0.489 . . . . 0.0 111.034 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.87 145.44 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.303 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.591 HE21 ' CA ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -126.04 132.62 51.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.868 177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.529 HD13 HD11 ' A' ' 118' ' ' ILE . 6.3 mt -120.89 132.34 70.63 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.894 -177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -112.17 126.84 55.63 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.988 0.423 . . . . 0.0 110.45 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -58.77 -24.03 61.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.94 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -125.97 146.76 49.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.813 0.34 . . . . 0.0 110.214 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' OD1' ' A' ' 103' ' ' ASP . . . -58.81 -168.55 0.2 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 4.5 p-10 42.58 29.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.879 0.371 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.401 ' CZ ' ' CD ' ' A' ' 156' ' ' GLU . 21.8 m-85 54.38 81.85 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -158.15 166.42 32.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.058 0.456 . . . . 0.0 110.528 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.73 -156.11 29.85 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.614 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -65.23 137.01 57.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 109.947 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.443 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 36.2 ttp -120.56 122.09 39.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.457 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.554 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 49.8 m-85 -118.13 133.23 56.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.48 120.07 35.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.583 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 111' ' ' THR . 7.4 t -146.92 127.84 14.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 121.075 -0.25 . . . . 0.0 110.52 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -95.68 40.96 1.1 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 111.142 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -141.11 178.38 7.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.526 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.482 ' CG ' HH12 ' A' ' 175' ' ' ARG . 24.6 p-10 -82.76 157.56 23.19 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.533 ' SG ' ' OG ' ' A' ' 172' ' ' SER . 49.7 t -134.4 122.34 15.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.201 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 172' ' ' SER . 63.9 Cg_endo -76.43 -57.48 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.488 1.459 . . . . 0.0 110.862 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.7 m -116.35 115.97 26.86 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.6 tt -70.2 -46.81 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.198 0.523 . . . . 0.0 110.916 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.464 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.9 ttt -64.59 -20.8 66.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.293 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -72.98 -46.65 51.06 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.897 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.632 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.0 pt20 -102.43 -23.39 13.94 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.632 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 32.5 m-85 -111.96 -1.92 15.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.118 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 54.78 11.54 0.47 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.841 0.353 . . . . 0.0 111.018 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.2 mtt -79.77 132.69 36.22 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -107.19 -24.89 11.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.722 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 64.9 mt-10 -152.17 108.48 3.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.11 0.481 . . . . 0.0 110.597 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.433 HD11 HD13 ' A' ' 118' ' ' ILE . 8.0 mm -75.16 125.44 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.674 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 76.0 m80 -105.16 -33.81 8.14 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.326 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.1 p -155.38 151.09 27.47 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.656 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -144.77 157.13 44.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.818 -179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.454 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.3 mtpt -135.13 -178.98 5.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.48 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 t 54.7 80.23 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.199 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.845 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -98.92 165.89 11.55 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.5 mp0 -139.96 112.37 7.79 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 38.05 -88.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.1 t -120.01 155.07 22.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 109.998 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.4 t-105 -144.07 169.41 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.618 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.475 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 86.9 mt -144.84 123.66 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 120.757 0.313 . . . . 0.0 111.262 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.633 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.84 129.69 55.61 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 177.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.412 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 22.5 m-85 -107.64 111.81 24.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.866 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.445 ' O ' HD12 ' A' ' 142' ' ' LEU . 73.8 tt0 -50.3 -22.29 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.735 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.1 mp -118.48 160.09 41.24 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.441 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.1 Cg_endo -77.35 166.4 26.18 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.37 2.047 . . . . 0.0 111.762 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.685 ' ND2' HH21 ' A' ' 146' ' ' ARG . 2.1 m-80 74.13 15.3 3.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.676 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.507 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.0 m-85 76.39 25.53 0.98 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.608 0.242 . . . . 0.0 111.247 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.685 HH21 ' ND2' ' A' ' 144' ' ' ASN . 88.6 mtm180 -108.55 167.69 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.071 0.462 . . . . 0.0 110.582 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.42 168.61 34.24 Favored Glycine 0 N--CA 1.463 0.48 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -59.03 142.28 51.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 46.2 mt-30 -97.64 147.89 23.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.585 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -118.62 137.46 53.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -153.54 105.46 2.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.456 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.561 HD13 ' N ' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -151.05 116.53 5.4 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.561 ' N ' HD13 ' A' ' 152' ' ' LEU . 91.2 m-20 54.33 164.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -137.95 8.65 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.9 -53.12 43.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.068 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.401 ' CD ' ' CZ ' ' A' ' 104' ' ' PHE . 16.0 tt0 -177.94 166.28 2.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.234 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -133.79 107.3 7.81 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.697 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -105.09 -24.47 12.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -122.53 152.45 61.56 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 120.914 0.388 . . . . 0.0 110.759 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.57 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.8 Cg_exo -49.9 -35.52 40.6 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.191 1.928 . . . . 0.0 112.998 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.7 mp -86.66 -3.4 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.963 0.411 . . . . 0.0 111.607 -176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -57.26 -29.89 64.2 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.07 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.57 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.1 p90 -105.23 21.27 17.42 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.43 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.18 61.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.574 -0.57 . . . . 0.0 114.24 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.23 137.09 45.95 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 118.459 1.13 . . . . 0.0 110.572 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.46 21.64 0.14 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.684 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 168.99 153.69 0.15 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.684 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -76.77 5.2 5.03 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.916 2.41 . . . . 0.0 112.044 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.51 71.36 6.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.896 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.912 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.5 t -99.55 -147.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.912 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.4 tp60 -159.31 -131.79 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.39 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.3 -156.39 0.46 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -170.21 -178.02 2.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.298 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.86 133.52 8.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.954 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.482 HH12 ' CG ' ' A' ' 114' ' ' ASP . 35.0 ptt-85 -51.91 130.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt -61.68 131.66 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.252 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.24 134.68 60.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.438 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.492 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 30.9 tp10 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.513 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.0 p -75.21 166.09 24.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HG3' ' H ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -74.9 -57.12 4.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.438 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 81.5 p -147.47 144.1 28.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.487 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.12 121.15 18.04 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.7 p -80.81 164.3 22.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.023 0.44 . . . . 0.0 110.109 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.711 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 45.5 tttt -159.2 153.29 23.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.122 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.761 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -147.15 147.21 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 92.3 m -133.65 141.65 47.7 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.27 0.557 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -122.61 116.72 24.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.334 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 63.6 m-85 -95.89 137.02 35.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.267 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.06 -45.08 91.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.3 m-20 -109.36 -173.35 2.24 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -82.8 -177.81 6.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.95 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.502 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.66 17.26 0.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.076 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.476 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 5.3 m-85 73.41 38.84 0.62 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.781 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 19' ' ' ARG . 44.1 mt-30 -117.62 -168.45 1.5 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.893 0.378 . . . . 0.0 110.472 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 75.52 -29.01 1.24 Allowed Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.215 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 19.3 ttt85 158.13 -167.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.729 0.9 . . . . 0.0 109.718 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.7 OUTLIER -170.25 151.38 3.84 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' THR . 78.0 t80 -129.88 135.0 47.86 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.2 p-10 -102.21 144.29 30.94 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.076 -0.39 . . . . 0.0 110.989 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -166.61 122.74 1.22 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.785 178.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -121.14 20.97 11.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.21 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.35 149.66 29.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -40.9 157.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.471 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.14 160.42 40.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.197 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -93.99 -55.53 3.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.1 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 43.0 p-10 -155.43 100.62 2.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.219 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -86.8 9.12 20.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.414 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -59.74 -17.42 34.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.077 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -78.12 -1.15 31.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -117.15 -15.26 10.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.694 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 13.2 tp -143.1 139.96 30.67 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -98.28 -7.23 29.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.288 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 55.0 ttm-85 -159.42 148.27 18.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.9 m -114.52 103.15 10.75 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.505 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.718 ' O ' ' O ' ' A' ' 39' ' ' SER . 97.3 m-20 -129.21 156.54 43.78 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.718 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.7 p 35.89 125.15 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.909 0.861 . . . . 0.0 112.168 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.628 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.9 mt -138.5 144.11 30.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.088 0 CA-C-O 121.614 0.721 . . . . 0.0 111.806 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -153.48 99.19 2.31 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.431 ' O ' ' NE2' ' A' ' 64' ' ' GLN . 18.1 m -70.1 138.61 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.523 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -109.81 52.74 0.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.429 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.21 -99.33 0.14 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.165 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.68 -137.17 3.56 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 47' ' ' TRP . 41.3 m -77.23 164.83 25.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.04 0.447 . . . . 0.0 110.884 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.711 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.6 m95 -155.73 157.31 36.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.295 0.569 . . . . 0.0 110.596 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' HB1' ' CE ' ' A' ' 59' ' ' MET . . . -116.77 120.37 38.36 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.7 m -118.66 132.85 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 121.245 0.545 . . . . 0.0 111.052 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' ARG . 90.5 m-85 -108.07 112.91 25.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.571 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 50' ' ' TYR . 42.2 tt0 -35.75 -32.65 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.715 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -121.0 148.3 48.48 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.313 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.662 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 7.7 Cg_exo -67.16 160.19 48.61 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.875 1.717 . . . . 0.0 112.123 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 0.3 OUTLIER 85.46 -4.8 0.87 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.887 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 6.2 m-85 84.6 58.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.427 0.455 . . . . 0.0 111.055 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.85 168.55 19.95 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.518 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 148' ' ' ARG . . . 85.04 -163.73 38.17 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -64.17 131.11 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.6 ' CE ' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -105.74 127.75 53.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.467 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 23.0 t80 -134.75 140.1 45.67 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.541 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.7 mp -102.09 92.4 2.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -68.94 111.15 7.5 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.7 163.92 16.22 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.025 1.817 . . . . 0.0 112.946 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -50.06 125.53 12.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.138 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.83 -172.51 38.88 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.0 mt-10 -111.65 155.34 23.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.207 0.527 . . . . 0.0 110.126 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 15.5 m-85 -147.99 81.09 8.45 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.32 -9.93 14.32 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.294 1.996 . . . . 0.0 112.862 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.3 mt-10 -149.95 161.18 42.81 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.749 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.0 p90 -64.98 -50.77 65.06 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.38 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.9 mt-30 -43.98 -10.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 70' ' ' TYR . 25.1 mmm180 -75.4 0.04 18.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.749 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -124.93 24.07 7.69 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 74' ' ' MET . 11.0 mmm 89.77 17.45 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.952 0.782 . . . . 0.0 111.947 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.72 63.09 0.19 Allowed Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.11 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 19.5 mt -93.69 17.61 11.56 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.959 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 52.3 t-20 111.99 150.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 125.206 1.566 . . . . 0.0 109.995 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 51.5 p-10 -83.58 69.93 10.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -144.23 118.9 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.097 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.717 HD13 ' N ' ' A' ' 81' ' ' SER . 0.3 OUTLIER -147.5 132.18 17.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.144 0.497 . . . . 0.0 110.157 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.717 ' N ' HD13 ' A' ' 80' ' ' LEU . 8.9 p -107.68 -163.97 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.0 p -50.91 -172.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.94 -0.475 . . . . 0.0 110.991 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 8' ' ' ILE . 14.7 p -153.51 155.5 36.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.686 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -117.79 128.18 54.61 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -57.66 131.58 50.67 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.5 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.3 t -124.78 130.84 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -101.39 162.49 12.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.772 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' N ' HD23 ' A' ' 88' ' ' LEU . 1.3 mt -87.03 149.17 47.0 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.654 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.48 155.13 71.54 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 112.083 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.427 ' H ' ' H ' ' A' ' 91' ' ' GLY . 3.2 p -170.05 -4.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.988 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -74.16 -56.38 5.26 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.437 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -115.92 59.24 0.44 Allowed Glycine 0 N--CA 1.464 0.567 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 33.73 -109.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.727 0.299 . . . . 0.0 111.247 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 32.3 t80 -152.93 113.87 4.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.001 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -154.59 135.27 13.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 121.16 0.505 . . . . 0.0 111.104 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -136.63 146.08 29.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.165 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.515 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.3 mt-30 -124.82 129.04 49.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.935 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 118' ' ' ILE . 6.5 mt -119.49 132.43 69.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.368 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 131' ' ' LYS . 39.3 m-85 -112.33 124.74 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.041 0.448 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.27 -19.9 38.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.778 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -131.09 144.09 51.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.869 0.366 . . . . 0.0 110.468 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.86 -171.08 0.23 Allowed Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 102' ' ' GLY . 2.8 p-10 45.25 29.6 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.72 0.295 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.537 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 14.3 m-85 54.89 81.65 0.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.878 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -158.98 163.61 36.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.961 0.41 . . . . 0.0 110.806 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.57 -156.98 28.42 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -66.62 136.48 55.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 41.8 ttp -117.58 122.54 43.91 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.073 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.582 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.9 m-85 -114.97 129.99 56.83 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.151 0.5 . . . . 0.0 110.991 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -120.99 121.43 37.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.068 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.4 t -151.88 130.99 12.67 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.469 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -97.85 50.79 1.04 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -147.8 -176.44 5.27 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.493 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.7 p30 -89.38 159.7 17.2 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.067 0.461 . . . . 0.0 110.202 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 172' ' ' SER . 45.7 t -137.48 124.81 13.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.754 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.509 ' O ' ' OG ' ' A' ' 172' ' ' SER . 59.4 Cg_endo -78.38 -61.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.662 1.575 . . . . 0.0 110.093 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -112.27 115.01 28.09 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.0 tt -69.16 -45.28 79.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.228 0.537 . . . . 0.0 110.722 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 28.0 ttt -63.78 -23.69 67.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.685 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -69.7 -50.27 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 121.483 -0.761 . . . . 0.0 112.245 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.634 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.3 pt20 -97.56 -23.82 15.83 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.634 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 29.5 m-85 -112.3 0.54 15.75 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.55 0.214 . . . . 0.0 111.283 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.6 m-70 54.0 2.52 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.088 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.557 ' H ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -70.53 131.92 44.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -106.83 -25.93 11.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.569 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.9 mt-10 -150.87 109.32 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 8.1 mm -76.26 126.05 36.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.67 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.9 m80 -106.41 -36.85 6.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.258 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.537 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 10.0 t -148.63 143.73 26.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.016 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.9 t -144.78 140.12 28.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.151 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 99' ' ' PHE . 35.1 mtmm -124.27 -171.95 2.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.551 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 36.3 t 54.34 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.516 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.852 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -100.38 166.64 10.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.199 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -137.35 112.84 9.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' N ' ' OE1' ' A' ' 134' ' ' GLU . . . 37.79 -89.83 0.01 OUTLIER Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.5 t -117.48 152.19 19.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 36.5 t-105 -141.2 166.77 23.87 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 176' ' ' ILE . 78.2 mt -144.02 124.06 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.226 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.61 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -111.74 129.47 56.11 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -106.34 113.4 26.9 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.886 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -53.83 -25.79 21.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.64 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 mp -111.94 159.66 32.74 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-O 120.676 0.274 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.59 164.66 28.07 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.268 1.979 . . . . 0.0 111.383 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 5.3 m-80 75.57 15.99 2.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.2 m-85 76.6 29.75 0.66 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.098 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -116.41 170.49 8.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.912 0.387 . . . . 0.0 110.733 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.31 167.83 38.59 Favored Glycine 0 N--CA 1.465 0.615 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' NH2' ' O ' ' A' ' 57' ' ' GLY . 80.2 ttt180 -47.95 152.0 0.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -113.15 127.8 56.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.648 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -97.2 144.69 26.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.0 tt -163.95 105.21 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 151' ' ' LEU . 42.9 tp -126.71 134.56 50.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.843 0.354 . . . . 0.0 110.327 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.74 88.76 6.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.194 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 155' ' ' LYS . 14.0 tptp -124.8 -145.91 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.03 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' H ' ' CG ' ' A' ' 154' ' ' LYS . 99.1 mttt -142.82 -9.1 0.81 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.481 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -175.26 162.36 2.94 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.676 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -129.11 109.31 11.08 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.109 0.481 . . . . 0.0 110.656 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.673 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.8 ptt180 -108.42 -21.37 12.77 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.0 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.673 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.3 pttm -123.87 154.54 67.48 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.286 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.502 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 17.9 Cg_endo -59.1 -19.97 51.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.386 2.057 . . . . 0.0 113.368 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.43 -5.98 9.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.923 0.392 . . . . 0.0 110.591 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -55.74 -32.89 63.78 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.44 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.549 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.71 22.32 13.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.798 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.2 28.79 67.53 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.914 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.3 138.1 44.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 117.674 0.737 . . . . 0.0 110.124 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.85 24.3 0.23 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.187 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 166' ' ' ALA . 1.0 OUTLIER 165.82 154.21 0.08 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.496 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 170' ' ' VAL . 56.1 Cg_endo -72.82 -12.01 26.11 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.904 2.403 . . . . 0.0 111.398 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.68 69.92 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.329 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.928 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -101.33 -155.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.928 ' H ' HG12 ' A' ' 170' ' ' VAL . 64.7 mm-40 -149.98 -130.95 0.05 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.349 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.4 p -95.28 -155.08 0.45 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -170.84 -178.75 2.63 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.282 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -156.1 129.95 8.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.479 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -52.65 129.21 28.73 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.587 0.708 . . . . 0.0 110.684 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -61.66 129.05 24.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.289 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.28 153.28 21.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.516 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.206 179.716 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -142.76 -74.3 0.28 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.913 0.387 . . . . 0.0 110.468 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 20.6 ptmt -84.78 50.93 2.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.4 p -138.3 -49.07 0.54 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.46 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.31 9.4 Favored Glycine 0 N--CA 1.464 0.555 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.8 p -83.63 158.62 21.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 110.273 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.732 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -156.67 148.53 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.1 tt -144.58 140.67 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.608 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -126.73 138.02 53.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.018 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -117.63 115.75 25.71 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.6 m-85 -96.41 138.53 33.87 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.351 0.596 . . . . 0.0 110.939 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.4 tm-20 -61.43 -49.81 75.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.903 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -98.18 -177.29 3.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 109.996 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.17 -176.74 6.32 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.164 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.25 25.11 0.33 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.856 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.1 m-85 60.83 42.72 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.271 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.08 166.75 10.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.881 0.372 . . . . 0.0 110.831 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.27 -153.73 43.45 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.709 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.694 ' NH2' ' H ' ' A' ' 35' ' ' SER . 15.8 ttp180 -58.75 174.42 0.34 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.03 153.91 5.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.408 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 57.0 t80 -127.05 130.67 50.39 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 44.8 p-10 -118.68 121.73 40.83 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.9 0.381 . . . . 0.0 111.701 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.9 t -150.21 141.57 23.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.095 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -124.46 26.27 7.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.0 m -148.55 144.75 27.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.502 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.7 p30 -38.54 156.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.846 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.563 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 25.0 t -156.76 163.05 39.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.145 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.87 -56.63 2.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 110.561 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -151.96 111.57 3.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -101.85 7.67 41.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.961 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 82.6 t60 -58.44 -27.18 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 70.8 p -62.63 -29.81 70.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.426 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.02 -15.36 38.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.574 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.632 HD12 ' HE ' ' A' ' 19' ' ' ARG . 16.5 tp -142.83 137.48 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.07 0.462 . . . . 0.0 110.067 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.694 ' H ' ' NH2' ' A' ' 19' ' ' ARG . 49.9 m -98.9 -9.23 24.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 56.0 ttm-85 -154.79 143.04 20.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.307 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 5.2 p -109.37 103.62 12.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.432 . . . . 0.0 111.1 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.732 ' O ' ' O ' ' A' ' 39' ' ' SER . 62.8 m-20 -128.08 156.26 43.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.732 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.9 p 35.05 129.43 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.745 1.259 . . . . 0.0 112.519 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.2 mt -142.55 147.52 20.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.056 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.023 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.3 ptpt -156.48 100.81 1.98 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.842 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.35 139.57 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.292 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -110.13 56.43 0.63 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.268 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.08 -92.84 0.09 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.702 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 -139.11 3.69 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 47' ' ' TRP . 43.0 m -80.48 164.9 22.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.809 0.338 . . . . 0.0 110.777 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.732 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 34.0 m95 -152.94 154.12 34.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.105 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.18 118.76 35.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' HB ' HD21 ' A' ' 80' ' ' LEU . 4.7 m -118.46 132.86 67.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.26 0.552 . . . . 0.0 110.555 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 52' ' ' ARG . 88.2 m-85 -105.59 113.93 27.79 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 79.5 tt0 -30.01 -33.95 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.72 0.638 . . . . 0.0 111.285 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 50' ' ' TYR . 21.1 mtt180 -127.15 162.67 46.66 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.279 0.362 . . . . 0.0 110.781 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 5.3 Cg_exo -73.9 170.63 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.533 2.155 . . . . 0.0 112.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 1.7 m120 79.26 -11.09 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.697 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.1 m-85 83.43 51.08 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.674 0.609 . . . . 0.0 110.43 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.84 114.94 5.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.614 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 58' ' ' TYR . . . 133.08 113.23 1.41 Allowed Glycine 0 N--CA 1.472 1.061 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.572 ' O ' ' O ' ' A' ' 57' ' ' GLY . 28.2 m-85 41.52 -178.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.133 0.492 . . . . 0.0 110.69 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.493 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 3.7 mtm -154.28 113.15 3.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.504 ' C ' HD12 ' A' ' 61' ' ' ILE . 29.3 t80 -130.1 131.41 45.71 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.762 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.55 94.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -69.2 109.57 4.65 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 123.312 0.383 . . . . 0.0 110.048 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.23 160.83 17.72 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.15 1.9 . . . . 0.0 113.324 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -46.81 117.8 1.8 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.291 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 168.47 -179.29 41.56 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -106.09 155.82 19.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.085 0.469 . . . . 0.0 110.29 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 17.9 m-85 -146.7 84.53 7.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.337 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 32.0 Cg_exo -57.6 -16.87 25.95 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 123.174 2.583 . . . . 0.0 112.887 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 47.8 mt-10 -149.8 161.82 41.5 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.706 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.3 p90 -63.59 -51.88 63.36 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.758 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 19.6 mt-30 -43.54 -10.35 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.1 mmm180 -75.86 -5.58 46.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.706 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.77 23.94 11.37 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.592 -0.067 . . . . 0.0 111.026 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 34.5 mmt 87.41 25.58 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 O-C-N 124.45 1.094 . . . . 0.0 110.97 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 32.11 50.69 0.36 Allowed Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.176 -0.37 . . . . 0.0 112.176 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.563 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 33.8 mt -77.45 14.24 1.03 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 118.982 -0.533 . . . . 0.0 111.438 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.9 t30 110.46 164.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.8 1.312 . . . . 0.0 109.252 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 51.0 p-10 -96.59 64.08 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.493 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 36.5 ttm180 -141.63 117.21 10.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.943 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.74 129.65 20.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.683 ' N ' HD13 ' A' ' 80' ' ' LEU . 53.2 p -112.22 -161.95 0.78 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.661 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.9 p -45.99 -178.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.212 0.53 . . . . 0.0 110.642 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 11.8 p -154.3 159.73 41.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.461 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.72 131.07 53.49 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.72 127.43 31.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.263 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 48' ' ' ALA . 68.9 t -126.43 133.47 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.843 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -101.29 157.41 16.8 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.027 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.0 157.18 69.13 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.522 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.46 156.04 40.89 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.661 2.241 . . . . 0.0 112.085 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 91' ' ' GLY . 4.7 p -173.14 -18.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.946 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -63.21 -34.11 89.07 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -130.58 58.14 0.71 Allowed Glycine 0 N--CA 1.468 0.805 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.6 pt20 33.42 -107.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.73 0.3 . . . . 0.0 110.835 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.749 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.3 t80 -159.14 113.3 2.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.197 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 132' ' ' VAL . 16.7 tptm -152.37 133.75 14.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 111.082 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.3 tt -134.88 142.34 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.749 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.2 mt-30 -120.92 129.08 53.32 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 108' ' ' MET . 13.8 mt -119.13 130.92 73.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.744 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.181 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 55.0 m-85 -111.52 128.1 55.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.837 0.351 . . . . 0.0 110.618 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 84.4 tt0 -60.78 -27.65 68.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.918 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -118.33 146.9 44.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.929 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.74 172.22 20.01 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.1 t70 61.01 31.14 19.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.931 0.396 . . . . 0.0 110.557 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.538 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 10.2 m-85 55.14 80.99 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.246 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.9 m -160.25 162.61 33.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 -153.01 23.5 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -70.04 136.16 50.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 45.5 ttp -121.33 125.51 47.18 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 55.4 m-85 -117.11 134.91 54.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.089 0.471 . . . . 0.0 110.657 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -122.16 119.7 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.488 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 111' ' ' THR . 4.5 t -147.0 125.66 12.55 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.635 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.6 t -91.06 41.89 1.08 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.019 0.438 . . . . 0.0 111.041 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.07 179.77 6.7 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 17.1 p-10 -83.95 160.13 21.12 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.963 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 40.9 t -134.55 121.31 15.06 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.194 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.429 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.13 -53.39 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.659 1.573 . . . . 0.0 110.873 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -119.71 111.54 18.15 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.659 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.4 tt -67.36 -44.33 87.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.362 0.601 . . . . 0.0 110.875 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.447 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.8 ttt -66.99 -21.99 65.93 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.182 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -73.01 -48.33 37.28 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.662 -0.649 . . . . 0.0 112.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.2 pt20 -99.16 -24.86 14.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.631 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 40.2 m-85 -111.58 2.39 17.33 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.992 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.0 m-70 51.41 11.91 0.13 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.132 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.44 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.0 mmt -79.44 135.29 36.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.582 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -110.57 -26.85 9.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.087 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 52.1 mt-10 -150.5 107.11 3.51 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.033 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.6 mm -77.78 125.11 37.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.6 m80 -104.81 -30.12 10.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.135 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.538 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 18.6 t -156.54 152.01 26.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.025 0.441 . . . . 0.0 110.957 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -146.58 150.8 36.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.992 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.411 ' HB2' HE21 ' A' ' 97' ' ' GLN . 46.5 mtpt -131.95 -172.01 2.77 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.681 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 95' ' ' LYS . 61.5 t 47.49 77.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.381 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 157' ' ' TYR . 67.8 mt -101.28 172.29 7.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.183 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.8 mp0 -136.94 114.18 10.78 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.718 0.294 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.88 -91.33 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 134' ' ' GLU . 31.7 t -119.18 137.61 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -122.15 170.31 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.237 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 HG12 ' A' ' 176' ' ' ILE . 62.5 mt -145.8 125.17 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.462 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.88 131.66 55.22 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.81 112.92 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.571 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' VAL . 75.7 tt0 -50.25 -27.24 5.71 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.723 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.39 166.15 11.57 Favored Pre-proline 0 N--CA 1.469 0.502 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -85.35 164.95 11.03 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.022 1.815 . . . . 0.0 111.37 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.562 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 75.02 16.79 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.47 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.9 m-85 77.0 26.52 0.75 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.091 0.245 . . . . 0.0 111.278 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -107.57 166.32 10.76 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 120.927 0.394 . . . . 0.0 110.533 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 96.6 170.65 34.41 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -67.3 146.38 54.18 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.525 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 2.5 mp0 -94.23 148.33 22.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.456 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -112.61 131.21 55.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.953 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' O ' ' SD ' ' A' ' 59' ' ' MET . 58.1 tp -149.01 99.23 2.94 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.048 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 153' ' ' ASP . 0.5 OUTLIER -151.9 153.22 33.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.634 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.741 ' H ' HD23 ' A' ' 152' ' ' LEU . 8.1 t70 76.63 164.15 0.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.405 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.54 -77.81 0.05 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -161.85 67.77 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.208 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -172.79 132.96 0.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.158 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.415 ' O ' ' OG ' ' A' ' 129' ' ' SER . 8.9 m-85 -133.85 109.37 9.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.898 0.38 . . . . 0.0 111.434 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -106.03 -26.13 11.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.874 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -120.14 153.82 55.62 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.269 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.559 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.5 Cg_endo -58.91 -15.19 25.92 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.478 2.119 . . . . 0.0 113.54 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -103.05 -3.98 9.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.037 0.446 . . . . 0.0 110.491 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -28.27 66.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.464 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.5 OUTLIER -106.16 22.79 15.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.568 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.28 28.1 70.54 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.523 -0.599 . . . . 0.0 114.014 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.44 140.45 41.73 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.19 0.995 . . . . 0.0 109.723 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.46 21.23 0.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.243 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 170.49 154.33 0.19 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.388 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.548 ' O ' HG12 ' A' ' 170' ' ' VAL . 41.1 Cg_endo -68.51 -35.0 18.58 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.489 2.126 . . . . 0.0 111.596 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -51.25 83.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.609 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.814 HG22 ' N ' ' A' ' 171' ' ' GLN . 1.4 p -102.54 -97.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.465 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.814 ' N ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 161.89 -143.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 124.096 0.872 . . . . 0.0 109.345 178.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.434 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 3.7 p -90.95 -156.0 0.42 Allowed 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -169.51 -177.96 2.93 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.31 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -159.97 132.27 6.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 2.8 ptm180 -51.95 136.09 29.39 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.519 HG12 HD12 ' A' ' 138' ' ' ILE . 14.0 mt -68.81 135.68 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.825 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.14 158.77 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 110.407 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.484 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m 45.96 -166.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 110.349 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' THR . 5.5 mtpm? -108.64 -48.01 3.39 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.859 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 3' ' ' LYS . 80.9 p 50.04 176.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.984 0.421 . . . . 0.0 110.502 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.3 -40.55 2.57 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.4 p -138.59 127.93 24.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.737 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 38.9 tttt -162.05 152.44 17.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.677 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.519 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.6 tt -145.66 144.69 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.552 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.8 m -131.61 140.47 49.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 110.387 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -121.07 116.21 24.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.478 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 68.0 m-85 -94.15 137.68 33.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -58.51 -48.21 81.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.531 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 39' ' ' SER . 92.5 m-20 -107.14 -172.81 2.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.158 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -178.95 7.26 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.88 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.7 OUTLIER 50.55 21.98 0.98 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.502 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.494 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 4.7 m-85 68.41 39.45 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.752 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.489 ' C ' ' H ' ' A' ' 19' ' ' ARG . 34.6 mt-30 -117.15 -167.45 1.31 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.04 0.447 . . . . 0.0 110.621 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 19' ' ' ARG . . . 73.22 -26.74 0.83 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.058 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.3 ttm-85 158.87 -164.55 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.457 0.74 . . . . 0.0 109.661 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 0.8 OUTLIER -172.33 152.17 2.69 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.783 ' O ' HG23 ' A' ' 9' ' ' THR . 68.2 t80 -129.49 133.26 47.18 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.8 p-10 -118.0 125.43 50.36 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.787 0.327 . . . . 0.0 110.899 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 31.1 t -161.32 139.0 9.14 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -126.49 30.72 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 26' ' ' ASP . 3.9 t -147.13 142.29 27.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.775 0.322 . . . . 0.0 110.573 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 25' ' ' CYS . 54.4 p-10 -38.79 157.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.4 m -158.05 163.73 37.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.001 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.63 2.93 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -154.64 105.19 2.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.09 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.443 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 1.7 p90 -94.0 10.63 32.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.969 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.2 t60 -57.35 -25.43 59.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.357 0.599 . . . . 0.0 109.845 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.7 p -64.32 -31.54 72.78 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.505 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.9 -18.33 40.56 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.97 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 31' ' ' HIS . 12.4 tp -141.0 135.68 31.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.053 0.454 . . . . 0.0 110.411 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.0 m -93.85 -10.37 34.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.583 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 23.7 ttm180 -157.53 146.2 19.48 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 1.7 m -110.78 104.2 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.074 0.464 . . . . 0.0 111.088 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.75 ' O ' ' O ' ' A' ' 39' ' ' SER . 96.7 m-20 -130.38 158.22 40.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 38' ' ' ASN . 6.1 p 35.79 128.05 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.63 0 O-C-N 124.426 1.079 . . . . 0.0 111.825 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 22.8 mt -140.73 146.38 24.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-O 121.785 0.803 . . . . 0.0 112.08 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -156.18 99.73 1.96 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.447 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -69.67 141.41 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.311 0.577 . . . . 0.0 110.873 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -111.88 53.78 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.31 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.73 -93.9 0.1 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.18 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.29 -137.21 3.26 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 47' ' ' TRP . 63.7 m -77.72 163.04 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.737 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 31.7 m95 -153.97 155.15 35.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.952 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.504 ' HB1' ' HE1' ' A' ' 59' ' ' MET . . . -115.03 119.11 35.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.2 m -116.45 131.96 67.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.503 . . . . 0.0 110.85 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CZ ' ' CE ' ' A' ' 59' ' ' MET . 87.4 m-85 -103.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.702 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -37.53 -35.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.915 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -116.81 148.37 41.93 Favored Pre-proline 0 C--O 1.233 0.197 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 47.9 Cg_endo -67.94 162.61 39.04 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.755 2.303 . . . . 0.0 111.411 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 4.4 m-80 82.58 -5.11 1.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.287 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CB ' ' O ' ' A' ' 54' ' ' ASN . 15.4 m-85 85.59 57.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 111.353 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 176.67 9.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.644 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.24 -162.6 44.25 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -63.44 137.32 58.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.504 ' HE1' ' HB1' ' A' ' 48' ' ' ALA . 1.8 tpt -112.24 130.01 56.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.128 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 61' ' ' ILE . 21.0 t80 -136.15 139.73 43.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.701 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.9 mp -103.04 91.77 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.36 111.28 8.21 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 123.219 0.325 . . . . 0.0 110.183 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.93 160.61 15.92 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.167 1.912 . . . . 0.0 113.089 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.46 122.4 4.69 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.037 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.07 -174.68 40.21 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.9 mt-10 -111.37 158.53 18.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 110.186 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 34.0 m-85 -151.81 85.7 4.73 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.934 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 33.9 Cg_exo -57.43 -14.67 16.92 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.787 2.324 . . . . 0.0 112.598 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.2 mt-10 -151.3 162.25 41.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.674 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 23.6 p90 -65.48 -53.12 47.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.5 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.624 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.5 pt20 -40.44 -14.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.102 0.477 . . . . 0.0 112.051 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -74.13 -2.31 24.02 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.276 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -119.85 23.65 10.97 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.889 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.3 mmt 90.37 24.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.445 1.091 . . . . 0.0 112.059 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.61 54.34 0.24 Allowed Glycine 0 N--CA 1.472 1.096 0 CA-C-N 116.316 -0.402 . . . . 0.0 112.787 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 49.8 mt -87.01 12.8 10.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 49.0 t30 91.15 137.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.171 0 O-C-N 123.932 0.77 . . . . 0.0 110.004 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 31.7 p-10 -39.37 -96.08 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.658 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.645 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 8.5 tpp85 29.43 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.431 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -138.7 128.12 24.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.055 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.6 p -110.66 -162.76 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.8 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.511 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.4 p -46.31 -178.06 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.506 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 13.9 p -152.05 155.81 38.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.459 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -118.82 128.1 54.15 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.84 128.4 36.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.539 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.4 t -119.29 129.0 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -99.87 159.24 15.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.825 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mt -78.5 148.95 74.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.531 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.03 153.22 75.6 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.461 2.107 . . . . 0.0 112.262 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 p -157.0 171.77 19.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.516 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.41 -72.28 1.72 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -75.91 34.29 1.24 Allowed Glycine 0 C--O 1.225 -0.424 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.2 pt20 34.22 -109.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 42.1 t80 -155.37 113.44 3.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.195 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 2.9 tppm? -156.2 137.31 13.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.439 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.85 145.51 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.003 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mt-30 -121.65 130.94 53.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.146 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.719 HD13 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.09 130.09 74.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.564 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.387 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 45.4 m-85 -110.92 129.83 55.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.751 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -62.58 -25.57 68.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -123.93 145.02 49.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.613 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.99 179.15 4.37 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.1 t0 55.84 30.82 16.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.838 0.352 . . . . 0.0 110.534 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 15.8 m-85 54.21 80.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.033 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.5 m -160.39 161.27 33.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.458 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.25 -158.19 25.41 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -67.65 136.71 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.674 0.274 . . . . 0.0 110.778 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.0 ttp -121.63 128.21 51.68 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.622 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.568 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 43.4 m-85 -122.84 137.22 54.99 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.224 0.535 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.7 127.17 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.602 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 111' ' ' THR . 11.6 t -148.76 129.64 14.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.689 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.5 p -93.63 38.18 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.416 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.3 179.66 6.95 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 12.4 p-10 -85.02 160.47 20.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.204 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 41.6 t -134.98 125.34 17.12 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.989 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' O ' ' OG ' ' A' ' 172' ' ' SER . 64.7 Cg_endo -80.25 -56.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.938 1.759 . . . . 0.0 111.287 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.6 m -116.5 110.15 18.22 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -68.49 -42.44 83.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.079 0.466 . . . . 0.0 111.003 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.7 ttt -67.43 -17.9 64.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.727 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -81.87 -42.54 19.44 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.462 -0.774 . . . . 0.0 111.723 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.652 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -94.24 -30.61 14.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.762 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.64 1.15 13.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.691 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.8 m-70 54.55 13.43 0.67 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.791 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.4 mmt -77.53 131.15 37.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -105.14 -29.14 10.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.757 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 74.1 mt-10 -151.11 109.08 3.7 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.187 0.518 . . . . 0.0 110.585 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.6 mm -74.6 125.71 34.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.821 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -106.87 -32.9 7.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.803 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.6 t -152.29 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.92 0.39 . . . . 0.0 111.054 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -150.36 131.8 14.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.75 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' HB2' HE21 ' A' ' 97' ' ' GLN . 47.8 mtmt -111.33 -169.04 1.38 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.234 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.492 ' C ' HD22 ' A' ' 133' ' ' LEU . 44.4 t 52.61 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.674 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.492 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -110.26 164.24 12.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.397 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 136' ' ' VAL . 5.9 mp0 -138.34 110.41 7.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.831 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.52 -86.33 0.01 OUTLIER Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 134' ' ' GLU . 11.6 t -125.74 155.95 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.734 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.4 t-105 -142.67 170.58 15.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 73.5 mt -145.87 125.37 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.401 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.665 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -111.01 131.43 55.05 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.61 110.97 22.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.513 ' OE2' ' NH2' ' A' ' 148' ' ' ARG . 70.3 tt0 -49.9 -23.48 1.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.909 -179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.69 160.57 37.85 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.805 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.438 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 65.6 Cg_endo -77.79 168.01 22.99 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.54 2.16 . . . . 0.0 111.788 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.601 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 6.7 m-80 70.08 17.61 7.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.5 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.7 m-85 76.23 24.55 1.11 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.653 0.263 . . . . 0.0 111.013 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.601 ' NH2' ' ND2' ' A' ' 144' ' ' ASN . 96.0 mtm-85 -105.98 162.73 13.34 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 100.09 164.21 28.77 Favored Glycine 0 N--CA 1.461 0.365 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' NH2' ' OE2' ' A' ' 141' ' ' GLU . 18.7 ptt-85 -60.51 138.24 58.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.749 0.309 . . . . 0.0 110.308 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.555 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 3.7 mp0 -88.12 150.97 23.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.366 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -117.94 134.92 54.48 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.347 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' C ' HD23 ' A' ' 151' ' ' LEU . 3.2 tt -152.17 107.33 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.096 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 151' ' ' LEU . 50.1 tp -131.22 139.78 49.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.263 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -65.93 115.32 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.47 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -169.46 179.31 3.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.193 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -134.39 4.67 3.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.378 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -168.51 150.2 4.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.271 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.466 ' O ' ' OG ' ' A' ' 129' ' ' SER . 11.6 m-85 -125.89 106.74 9.87 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.964 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 36.3 ptt-85 -105.56 -21.36 13.22 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.615 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -124.45 153.07 69.24 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 110.904 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.587 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 22.9 Cg_exo -52.89 -30.52 48.26 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.514 1.476 . . . . 0.0 113.523 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 161' ' ' ILE . 4.4 mp -89.23 -4.72 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 111.033 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -57.04 -27.44 61.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.162 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.587 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 1.0 OUTLIER -108.66 21.21 17.57 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.752 0.31 . . . . 0.0 110.451 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.56 31.53 60.64 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.645 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -111.42 136.03 51.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.817 0.809 . . . . 0.0 109.642 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.39 22.12 0.13 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 169.53 155.18 0.18 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.046 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.412 ' CB ' ' O ' ' A' ' 127' ' ' ILE . 69.3 Cg_endo -77.39 4.2 6.12 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.651 2.234 . . . . 0.0 112.141 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.14 72.71 4.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.022 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.922 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.4 t -100.83 -147.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.922 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -159.91 -132.54 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.796 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.2 m -92.27 -155.01 0.4 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -170.6 -177.48 2.37 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.033 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -158.67 132.22 7.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.92 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -51.37 132.2 29.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.429 0.633 . . . . 0.0 110.956 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.1 mt -66.57 133.89 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.608 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -138.16 159.31 32.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.967 0.413 . . . . 0.0 110.733 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.517 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 4' ' ' THR . 4.3 m 59.43 128.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 70.34 -30.16 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.824 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 2' ' ' SER . 22.5 p -110.35 113.66 26.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.931 0.396 . . . . 0.0 110.518 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 4' ' ' THR . . . 57.12 158.06 0.01 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.422 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 11.2 p -81.65 157.6 24.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.901 0.381 . . . . 0.0 110.513 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.691 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.4 tttt -159.67 150.57 19.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.459 HG21 ' SG ' ' A' ' 83' ' ' CYS . 14.9 tt -144.88 141.61 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.362 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.4 m -127.49 139.02 53.07 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.83 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.72 115.7 25.03 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -96.28 138.73 33.45 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.079 0.466 . . . . 0.0 110.474 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -61.4 -51.09 70.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.851 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' HA ' HD22 ' A' ' 38' ' ' ASN . 83.3 m-20 -97.29 -175.32 3.19 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.253 0.549 . . . . 0.0 110.219 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.97 -175.29 5.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.619 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.7 m120 46.7 23.12 0.22 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.01 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' A' ' 41' ' ' LYS . 1.5 m-85 59.78 44.6 13.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.332 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -116.41 162.05 18.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.13 0.491 . . . . 0.0 110.495 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.95 -150.87 31.2 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.554 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.28 170.64 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -169.18 155.11 6.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.406 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 82.0 t80 -134.74 134.53 41.09 Favored 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 51.8 p-10 -102.08 151.73 21.82 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.524 0.202 . . . . 0.0 110.49 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -163.8 124.6 2.24 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.673 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -124.06 12.99 9.03 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.2 t -150.54 146.96 26.91 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.669 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -38.63 157.07 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.678 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.584 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 18.3 t -157.69 164.61 36.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.145 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.584 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.34 -56.96 2.75 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -153.3 110.95 3.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.33 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.0 p90 -100.55 8.47 43.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.067 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.57 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.1 t60 -59.35 -28.76 67.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.527 0.68 . . . . 0.0 110.168 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.0 p -60.69 -28.32 68.54 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.375 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -89.89 -12.97 37.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.539 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -143.33 138.24 29.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.975 0.417 . . . . 0.0 109.969 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.6 m -100.43 -9.49 22.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 0.0 111.1 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 34' ' ' LEU . 51.3 ttm-85 -153.74 141.11 19.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.086 0.469 . . . . 0.0 110.45 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.1 m -111.52 106.15 14.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.76 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' O ' ' C ' ' A' ' 39' ' ' SER . 41.1 m-20 -117.91 -155.68 0.61 Allowed 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' ASN . 12.7 p -19.59 138.16 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.741 0.65 . . . . 0.0 112.476 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 8.8 mt -142.69 147.19 21.14 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.775 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.963 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.63 101.14 1.98 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.921 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 m -69.08 142.17 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' SER . 94.8 mt-10 -111.22 52.13 0.75 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.313 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.47 0.1 OUTLIER Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.753 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.86 -140.07 3.91 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.586 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.8 m -77.9 165.18 24.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 110.859 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.691 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.0 m95 -154.87 155.76 34.93 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.303 0.573 . . . . 0.0 110.956 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.75 121.52 41.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.533 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.0 m -117.14 132.53 66.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.516 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' GLU . 52.4 m-85 -103.59 110.8 22.99 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.317 0.386 . . . . 0.0 110.897 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' TYR . 80.1 tt0 -35.37 -37.94 0.09 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.137 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 52' ' ' ARG . 19.0 mtp180 -119.02 150.69 49.25 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.438 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 52.6 Cg_endo -68.12 161.49 44.19 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.684 2.256 . . . . 0.0 111.567 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.499 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.5 m120 83.64 -7.48 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.991 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.5 m-85 85.53 58.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.5 0.5 . . . . 0.0 111.254 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.25 179.76 7.67 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.135 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.07 -69.77 1.57 Allowed Glycine 0 N--CA 1.466 0.666 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.371 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.571 ' CE2' HD13 ' A' ' 76' ' ' LEU . 0.6 OUTLIER 169.2 121.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -110.93 136.99 49.12 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.331 0.586 . . . . 0.0 111.929 -178.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -116.43 159.62 21.74 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.73 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.85 91.19 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -71.56 110.33 7.36 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.95 161.01 21.03 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.099 1.866 . . . . 0.0 113.851 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.527 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.9 OUTLIER -47.24 119.78 2.81 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.912 179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.13 -176.26 41.49 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.0 mt-10 -109.15 157.74 18.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.835 0.35 . . . . 0.0 110.159 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 48.4 m-85 -147.81 91.99 4.81 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 41.3 Cg_endo -66.69 -11.38 31.66 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.234 1.956 . . . . 0.0 113.269 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 93.6 mt-10 -151.35 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 36.3 p90 -63.9 -53.05 56.52 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -44.98 -9.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.0 tpt180 -75.09 -3.98 35.85 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.1 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.697 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -119.73 24.07 10.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.7 mmt 86.84 27.24 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.438 1.086 . . . . 0.0 111.212 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.24 48.2 0.2 Allowed Glycine 0 N--CA 1.473 1.155 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.16 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 58' ' ' TYR . 18.3 mt -71.66 13.36 0.27 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 119.073 -0.489 . . . . 0.0 111.078 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 63.6 t30 107.63 164.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.779 1.299 . . . . 0.0 109.363 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -94.92 62.03 2.58 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.676 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -138.35 115.62 11.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.143 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -141.26 128.66 21.19 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.4 p -110.28 -163.5 0.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.564 ' OG ' ' N ' ' A' ' 83' ' ' CYS . 3.4 t -45.42 -178.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.34 0.591 . . . . 0.0 110.979 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.595 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 10.7 p -151.82 155.5 38.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.558 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -121.7 129.97 53.12 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.72 126.87 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.296 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.6 t -122.77 131.08 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.52 ' O ' HG21 ' A' ' 136' ' ' VAL . 38.0 m80 -100.13 157.75 16.34 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.768 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.672 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -84.27 153.37 62.5 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.03 157.84 46.44 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.517 2.144 . . . . 0.0 112.146 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.402 ' H ' ' H ' ' A' ' 91' ' ' GLY . 4.9 m -175.58 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.958 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -67.73 -49.19 51.15 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.639 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.498 ' H ' ' CD ' ' A' ' 134' ' ' GLU . . . -111.24 54.49 0.54 Allowed Glycine 0 N--CA 1.468 0.821 0 N-CA-C 110.784 -0.927 . . . . 0.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLY . 6.5 pt20 33.67 -109.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.613 0.244 . . . . 0.0 110.573 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.763 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 26.1 t80 -158.05 114.16 2.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.799 0.333 . . . . 0.0 110.295 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -153.79 132.56 12.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.116 0.484 . . . . 0.0 111.089 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -135.87 145.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.1 mt-30 -122.66 131.0 53.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.504 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.615 HD13 HD11 ' A' ' 118' ' ' ILE . 11.8 mt -119.58 130.57 73.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.998 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.418 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 46.8 m-85 -112.1 128.88 56.34 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.883 0.373 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -60.98 -28.23 68.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -120.37 148.36 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.991 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.47 -169.07 0.88 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t0 43.63 30.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 53.97 83.26 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.794 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.5 m -160.57 163.72 32.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.866 0.365 . . . . 0.0 110.753 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.66 -152.09 22.26 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.709 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -71.76 136.59 47.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.692 0.282 . . . . 0.0 110.429 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 39.1 ttp -120.5 124.62 45.84 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.781 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 48.8 m-85 -116.0 133.6 55.85 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.13 0.491 . . . . 0.0 110.473 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -122.16 121.61 37.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.407 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 111' ' ' THR . 6.9 t -147.41 126.94 13.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.691 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.437 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.7 t -93.92 41.24 1.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -141.66 -178.46 5.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.566 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.8 p-10 -84.96 157.69 20.73 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 70.0 m -134.91 121.06 14.52 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.165 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 60.5 Cg_endo -77.95 -56.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.05 1.833 . . . . 0.0 110.936 178.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.4 m -116.73 112.8 21.7 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -68.82 -45.05 81.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.403 0.621 . . . . 0.0 110.634 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.465 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -65.71 -21.65 66.55 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.299 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -73.97 -47.38 37.74 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.148 -0.621 . . . . 0.0 112.275 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.6 pt20 -98.1 -24.8 15.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 37.1 m-85 -112.53 2.91 16.48 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.121 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.6 m-70 51.3 10.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.891 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.468 ' H ' ' C ' ' A' ' 122' ' ' PHE . 3.4 mmt -75.72 133.02 40.87 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -106.27 -30.56 9.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.787 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 29.7 mt-10 -150.58 108.76 3.75 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.089 0.471 . . . . 0.0 111.153 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.3 mm -74.37 125.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.586 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.5 m80 -106.31 -32.13 8.3 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.941 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 158' ' ' ARG . 17.0 m -154.97 150.28 27.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.116 0.484 . . . . 0.0 111.036 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.14 153.63 42.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.759 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.9 mtpt -131.46 -177.33 4.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.561 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.552 ' C ' HD22 ' A' ' 133' ' ' LEU . 13.8 t 54.04 98.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.329 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.552 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.5 mm? -111.21 164.44 12.87 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.566 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.581 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.4 OUTLIER -138.92 111.64 7.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.218 179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.56 -87.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 134' ' ' GLU . 7.3 t -121.95 157.05 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -143.73 168.21 20.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.16 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.9 mt -144.91 122.84 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.186 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.534 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -109.62 131.72 54.8 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.455 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 32.9 m-85 -109.51 112.03 23.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.119 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -50.56 -23.79 2.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.639 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.5 mp -117.38 164.95 17.02 Favored Pre-proline 0 N--CA 1.465 0.276 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.489 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 94.3 Cg_endo -82.94 167.95 14.06 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.38 2.054 . . . . 0.0 112.194 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.493 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 3.5 m-80 77.65 15.75 1.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.098 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.493 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.8 m-85 74.37 29.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.694 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 96.8 mtt180 -135.57 128.43 31.24 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 154.1 171.98 21.63 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.38 108.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.382 . . . . 0.0 110.248 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.455 ' CG ' ' CE1' ' A' ' 140' ' ' TYR . 71.6 mt-30 -75.44 147.72 39.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.963 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -110.59 164.54 12.62 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 19.9 tp -115.38 146.78 41.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.64 HD22 ' N ' ' A' ' 152' ' ' LEU . 3.4 mm? -64.3 151.49 43.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.467 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -127.18 -145.7 0.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.016 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -73.6 -107.94 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.737 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -56.95 -161.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 156' ' ' GLU . 9.9 pm0 -78.84 -118.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.741 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 5.2 m-85 -150.42 107.15 3.53 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.013 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 129' ' ' SER . 4.2 ptp180 -102.18 -25.58 13.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 110.077 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.4 159.46 50.04 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.03 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.557 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 21.4 Cg_endo -62.8 -17.29 58.59 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.856 2.371 . . . . 0.0 113.235 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.2 mp -101.36 -4.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.171 0.51 . . . . 0.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.45 -28.59 67.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.767 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -104.97 22.94 14.38 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.189 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.37 28.72 67.34 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 119.576 -0.569 . . . . 0.0 113.938 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.596 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -110.88 139.58 46.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.024 0.912 . . . . 0.0 109.795 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.08 22.3 0.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.382 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 174.01 152.72 0.26 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.728 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.78 5.45 4.36 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.746 2.297 . . . . 0.0 111.542 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.5 70.23 5.92 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.076 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.868 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -98.91 -153.5 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.868 ' H ' HG12 ' A' ' 170' ' ' VAL . 78.3 mm-40 -152.74 -132.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.705 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -94.22 -155.1 0.44 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -171.17 -176.01 1.82 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.21 0.528 . . . . 0.0 111.22 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.443 HH21 HG22 ' A' ' 177' ' ' VAL . 9.7 ptm180 -158.96 132.32 7.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.936 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 ptt-85 -52.99 134.48 37.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.879 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.419 HG12 HD12 ' A' ' 138' ' ' ILE . 15.5 mt -67.92 133.71 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.466 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.443 HG22 HH21 ' A' ' 174' ' ' ARG . 34.5 m -139.03 156.6 28.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.452 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.7 tp10 . . . . . 0 C--O 1.219 -0.522 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.356 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.52 ' OG ' HG22 ' A' ' 4' ' ' THR . 6.6 p -79.48 176.58 9.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 2' ' ' SER . 17.3 ptmt -34.54 -45.84 0.25 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.028 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.52 HG22 ' OG ' ' A' ' 2' ' ' SER . 10.9 t -62.09 -173.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.422 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.22 80.18 0.05 OUTLIER Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.417 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.1 p -84.39 159.35 20.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.85 0.357 . . . . 0.0 110.237 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.786 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 33.2 tttt -160.26 151.8 19.71 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.008 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -147.23 141.67 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.052 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 97.7 m -123.95 138.21 54.5 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.718 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -118.77 115.78 25.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.483 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 85.2 m-85 -94.87 138.31 32.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.231 0.539 . . . . 0.0 110.986 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 7.7 tm-20 -60.44 -49.96 75.5 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.946 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 45.3 m-20 -99.33 -176.02 3.18 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.241 0.543 . . . . 0.0 109.773 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -83.19 -176.84 6.53 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.32 24.3 0.27 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.807 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.483 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 62.75 41.53 8.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.176 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.41 173.63 6.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.001 0.429 . . . . 0.0 110.593 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.26 -155.99 53.51 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.682 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -54.65 174.56 0.06 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -169.34 149.92 4.17 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 59.4 t80 -132.75 133.15 43.09 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 40.2 p-10 -119.87 132.5 55.58 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.569 0.223 . . . . 0.0 110.879 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.19 140.97 30.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -125.0 15.88 8.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.669 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' O ' ' C ' ' A' ' 26' ' ' ASP . 11.2 m -148.94 145.8 27.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 43.0 t0 -37.29 155.72 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.542 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 m -155.95 162.03 40.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.98 -56.53 2.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.882 0.372 . . . . 0.0 110.802 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -154.18 110.75 3.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.411 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.439 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.5 p90 -101.42 9.79 41.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.058 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.588 ' O ' ' O ' ' A' ' 34' ' ' LEU . 78.0 t60 -59.76 -28.57 67.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.556 0.694 . . . . 0.0 110.177 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.4 p -61.16 -29.12 69.6 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.433 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -88.76 -12.56 41.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.663 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.9 tp -142.21 136.65 30.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -96.84 -10.73 25.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.702 0.287 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.618 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 59.9 ttp180 -157.05 145.71 19.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.471 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.3 m -110.65 104.35 13.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.205 0.526 . . . . 0.0 111.415 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.733 ' O ' ' O ' ' A' ' 39' ' ' SER . 95.3 m-20 -128.57 155.9 44.19 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.733 ' O ' ' O ' ' A' ' 38' ' ' ASN . 24.4 p 35.73 130.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.642 1.21 . . . . 0.0 112.568 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.4 mt -142.15 146.29 22.77 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.93 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.7 ptpt -154.41 102.55 2.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.008 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.33 149.08 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 121.291 0.567 . . . . 0.0 110.552 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.31 50.21 1.41 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.682 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.21 -95.48 0.1 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.112 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.533 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.56 -140.36 4.04 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -80.93 166.54 20.76 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.433 -0.451 . . . . 0.0 110.89 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.786 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.4 m95 -154.71 156.65 36.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.19 120.97 40.7 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.62 132.28 67.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -104.35 110.16 22.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -37.59 -34.49 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.18 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -115.91 148.41 41.24 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.883 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.1 Cg_endo -68.54 159.77 52.1 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.465 2.11 . . . . 0.0 111.915 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 6.3 m-80 85.17 -5.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.835 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.469 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 11.7 m-85 85.99 60.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.649 0.593 . . . . 0.0 111.001 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.63 177.72 9.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.328 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' SD ' ' A' ' 59' ' ' MET . . . 81.62 -163.31 44.16 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -67.88 122.2 17.65 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.4 mpt? -98.3 136.69 38.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.249 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 25.9 t80 -139.74 142.49 36.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.863 HD11 HD12 ' A' ' 151' ' ' LEU . 2.5 mp -102.91 91.37 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.06 111.72 11.76 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.67 162.29 19.01 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.143 1.895 . . . . 0.0 112.661 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.41 117.36 2.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.024 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.15 178.34 41.01 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.5 mt-10 -101.2 153.58 19.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 24.2 m-85 -146.5 86.21 6.94 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -54.92 -18.47 16.69 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.857 2.371 . . . . 0.0 112.906 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -152.41 162.47 41.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.654 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 6.1 p90 -63.2 -50.93 68.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -41.21 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.1 mmt180 -75.77 -5.49 46.04 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.654 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -117.61 25.27 10.52 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 119.698 -0.191 . . . . 0.0 111.362 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.4 mmt 89.79 23.59 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.455 1.097 . . . . 0.0 111.636 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 30.41 59.11 0.23 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 116.661 -0.245 . . . . 0.0 113.294 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 38.8 mt -94.69 13.92 22.82 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 78' ' ' ASP . 0.5 OUTLIER 91.91 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.227 0.954 . . . . 0.0 110.599 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.64 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 35.8 p-10 -37.85 -95.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.425 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.64 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 6.1 tpt180 30.11 93.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.755 0.312 . . . . 0.0 111.358 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.64 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -139.51 128.03 22.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.64 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.0 p -111.04 -162.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.135 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 81' ' ' SER . 11.1 p -45.25 -179.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 0.0 110.653 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.521 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 18.6 p -149.04 148.76 30.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -113.26 126.33 55.29 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.09 124.25 20.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.151 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 48' ' ' ALA . 67.9 t -120.21 129.0 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.897 0.379 . . . . 0.0 110.444 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 136' ' ' VAL . 93.4 m-70 -97.5 160.31 14.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.16 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.15 149.95 70.49 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.648 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.23 150.93 77.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.32 2.013 . . . . 0.0 112.124 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.3 p -155.27 169.65 23.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 75.15 -70.28 1.85 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -74.39 30.71 0.99 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' A' ' 91' ' ' GLY . 4.7 pt20 34.82 -106.19 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.665 0.269 . . . . 0.0 111.169 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.743 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 45.1 t80 -157.94 113.31 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -153.56 134.01 13.56 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.021 0.438 . . . . 0.0 111.354 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -135.59 145.74 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.523 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.0 mt-30 -124.32 129.76 51.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.233 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 108' ' ' MET . 10.4 mt -118.7 132.83 67.44 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.03 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.15 133.89 55.64 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.258 0.552 . . . . 0.0 110.541 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -30.16 71.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.72 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -119.61 148.65 43.08 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.225 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.07 174.55 15.67 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.4 t0 57.77 30.76 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.002 0.43 . . . . 0.0 110.441 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 156' ' ' GLU . 5.4 m-85 55.87 82.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.8 m -160.12 161.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.928 0.394 . . . . 0.0 110.556 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.03 -150.99 22.55 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -76.11 136.04 39.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.654 0.264 . . . . 0.0 110.422 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.531 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.8 tmm? -122.1 133.38 54.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.41 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 59.0 m-85 -123.68 137.71 54.66 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.239 0.542 . . . . 0.0 110.618 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.3 125.28 44.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 111' ' ' THR . 5.1 t -147.9 128.25 13.93 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.705 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 112' ' ' THR . 0.8 OUTLIER -90.29 41.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.681 -179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -146.65 -178.14 6.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.6 p-10 -86.36 162.16 18.33 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.312 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.584 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 84.5 m -138.79 122.81 11.32 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.364 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' O ' ' OG ' ' A' ' 172' ' ' SER . 70.3 Cg_endo -78.01 -50.98 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.188 1.925 . . . . 0.0 111.678 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -121.09 109.28 14.83 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.1 tt -64.28 -38.09 81.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.625 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 24.0 ttt -69.37 -18.93 63.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.56 -44.32 17.48 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.604 -0.685 . . . . 0.0 111.678 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.584 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.5 OUTLIER -90.93 -32.88 15.82 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.372 -178.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.583 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 23.5 m-85 -115.79 8.84 14.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 49.11 11.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.206 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.477 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.5 mtt -79.72 138.05 37.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.465 0.65 . . . . 0.0 110.057 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.518 ' NH2' ' OE2' ' A' ' 126' ' ' GLU . 4.8 ptm180 -109.99 -26.41 9.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.366 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 75.8 mt-10 -149.84 107.31 3.64 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.321 0.582 . . . . 0.0 111.904 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 HD13 ' A' ' 118' ' ' ILE . 9.6 mm -76.0 122.71 30.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.442 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.7 m80 -102.91 -31.9 10.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.119 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.0 p -155.93 151.35 26.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.939 0.4 . . . . 0.0 110.801 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -148.67 131.82 16.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.691 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.2 -176.4 3.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.451 ' C ' HD22 ' A' ' 133' ' ' LEU . 27.8 t 55.69 98.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -113.04 167.02 10.87 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.067 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.0 mp0 -142.09 111.73 6.67 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.974 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.92 -89.06 0.01 OUTLIER Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.414 -0.675 . . . . 0.0 111.414 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 134' ' ' GLU . 6.7 t -119.92 150.99 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.825 0.345 . . . . 0.0 110.145 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 33.2 t-105 -140.07 170.42 15.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 79.0 mt -145.14 123.61 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.392 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -112.17 132.84 54.66 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 40.1 m-85 -110.46 112.24 24.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.549 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 78.3 tt0 -51.54 -21.99 2.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.826 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.3 mp -118.16 165.32 16.63 Favored Pre-proline 0 N--CA 1.464 0.264 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.29 167.45 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.016 1.81 . . . . 0.0 112.186 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.504 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 78.99 14.82 1.1 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.969 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 4.6 m-85 75.24 28.44 1.01 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.154 0.284 . . . . 0.0 111.371 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 82.0 mtp180 -133.28 126.83 32.33 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.19 174.54 22.17 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.549 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 77.8 mtm180 -53.07 115.99 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.329 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 49.2 mt-30 -85.52 138.16 32.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.698 ' C ' HD13 ' A' ' 151' ' ' LEU . 59.4 m-85 -114.0 128.89 56.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.866 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -140.63 87.66 2.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.681 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.0 mt -132.32 116.6 17.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.988 -0.445 . . . . 0.0 110.244 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -77.64 87.6 3.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.103 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -114.27 -160.52 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.939 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.62 93.09 4.23 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 104' ' ' PHE . 33.7 tt0 58.76 161.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.295 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -118.76 107.99 14.33 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.823 0.344 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -105.73 -24.1 12.59 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.811 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -121.26 153.3 58.29 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 120.992 0.425 . . . . 0.0 110.508 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.551 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 19.3 Cg_endo -58.83 -14.91 24.19 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.539 2.159 . . . . 0.0 113.453 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -103.06 -2.9 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.118 0.485 . . . . 0.0 110.477 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.36 -26.43 66.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.412 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.39 23.07 15.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.408 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.25 29.03 69.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.719 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.552 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.02 139.38 43.98 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.257 1.028 . . . . 0.0 109.397 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -78.4 22.11 0.34 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 170.62 156.27 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.303 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.831 ' O ' HG23 ' A' ' 170' ' ' VAL . 42.1 Cg_endo -68.9 -35.89 14.46 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.674 2.249 . . . . 0.0 111.435 178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.65 77.1 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.6 t -94.11 -102.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.345 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.711 ' O ' HD12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER 162.65 -144.64 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 O-C-N 123.792 0.682 . . . . 0.0 109.718 177.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 171' ' ' GLN . 1.9 p -91.02 -157.9 0.52 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.568 0.223 . . . . 0.0 111.225 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -169.78 -177.54 2.69 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.218 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -158.21 131.82 7.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.235 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 ptm180 -52.3 133.03 34.7 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.714 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.457 HG12 HD12 ' A' ' 138' ' ' ILE . 12.8 mt -63.44 134.08 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.589 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.48 137.05 53.74 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-O 121.056 0.455 . . . . 0.0 110.577 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.388 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.5 p 40.44 -152.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 110.767 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -149.06 7.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.353 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 p -62.42 168.18 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -143.02 35.11 1.72 Allowed Glycine 0 N--CA 1.465 0.606 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 p -132.2 120.01 21.65 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.844 0.354 . . . . 0.0 110.614 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.57 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 40.1 tttt -161.71 153.09 18.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.613 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.862 HG21 ' SG ' ' A' ' 83' ' ' CYS . 15.6 tt -146.71 144.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.808 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.7 m -135.12 141.28 45.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 120.923 0.392 . . . . 0.0 110.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -121.05 115.9 24.01 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 81.5 m-85 -95.28 139.52 31.47 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.259 0.552 . . . . 0.0 111.181 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 8.1 tm-20 -63.46 -49.42 73.73 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.115 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' O ' ' OG ' ' A' ' 39' ' ' SER . 95.8 m-20 -98.84 -177.46 3.65 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -81.87 -178.67 7.09 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.018 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 48.57 22.23 0.48 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.516 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.5 m-85 60.15 46.41 10.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.196 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -114.23 167.36 10.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 0.0 110.859 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.42 -143.35 31.53 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.499 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -65.58 162.49 18.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.408 -0.896 . . . . 0.0 109.149 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.57 156.99 8.38 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 120.636 -0.425 . . . . 0.0 109.971 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.512 ' O ' HG23 ' A' ' 9' ' ' THR . 27.6 t80 -131.07 133.65 45.88 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.6 p-10 -123.79 124.5 42.83 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.786 0.327 . . . . 0.0 111.019 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.75 143.56 24.57 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.242 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -123.63 28.71 6.85 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.388 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.0 t -145.73 142.32 28.84 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.851 0.358 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -40.02 157.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.505 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.6 m -159.2 165.05 34.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.87 -54.79 3.6 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.994 0.426 . . . . 0.0 111.01 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -156.51 106.96 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.255 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -94.36 8.14 42.98 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.0 t60 -58.51 -30.93 67.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.509 0.671 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.3 p -58.02 -29.46 65.33 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.301 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -88.72 -16.85 31.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.608 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.559 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -140.02 137.17 34.42 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 109.954 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.0 m -100.61 -7.77 23.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.242 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 78' ' ' ASP . 57.6 ttm-85 -153.58 142.76 21.41 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.443 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.0 m -112.44 102.79 10.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.284 0.564 . . . . 0.0 110.969 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.712 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.7 m-20 -127.69 153.73 46.14 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.712 ' O ' ' O ' ' A' ' 38' ' ' ASN . 17.1 p 37.38 126.23 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.333 1.064 . . . . 0.0 112.562 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 16.2 mt -138.93 147.24 25.04 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.463 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -156.38 100.88 2.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.366 0.603 . . . . 0.0 109.921 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 42' ' ' VAL . 6.7 m -70.2 141.45 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.163 -179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -110.11 47.59 0.95 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.57 -98.65 0.14 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.42 -137.34 3.65 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.62 HG22 ' N ' ' A' ' 47' ' ' TRP . 93.2 m -77.87 166.78 22.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.903 0.382 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.62 ' N ' HG22 ' A' ' 46' ' ' THR . 38.6 m95 -156.56 156.8 34.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.546 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.44 118.91 33.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.757 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -117.38 133.01 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.079 0.466 . . . . 0.0 111.297 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.608 ' CE2' ' SD ' ' A' ' 59' ' ' MET . 31.4 m-85 -107.54 110.57 22.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.773 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -39.1 -32.77 0.1 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.075 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -116.79 147.72 40.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.733 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -68.71 156.33 65.83 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.33 2.02 . . . . 0.0 111.585 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 9.2 m-80 86.11 -2.93 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.038 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-85 85.07 59.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.596 0.358 . . . . 0.0 111.785 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.49 176.85 9.5 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.42 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.23 -164.39 47.73 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -59.49 137.39 58.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.608 ' SD ' ' CE2' ' A' ' 50' ' ' TYR . 10.7 tpt -123.78 126.08 45.86 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.7 OUTLIER -140.91 152.79 45.31 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.737 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.2 mp -104.63 99.04 7.63 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.562 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.0 OUTLIER -71.0 110.63 7.62 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.09 163.82 17.66 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.148 1.899 . . . . 0.0 113.255 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -50.2 123.42 8.38 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.914 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 164.28 -173.64 40.28 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.6 mt-10 -111.46 156.35 21.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.956 0.408 . . . . 0.0 109.904 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.585 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 10.5 m-85 -147.27 81.12 8.94 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.485 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 36.5 Cg_exo -55.43 -14.0 8.72 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.054 2.503 . . . . 0.0 112.661 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -151.47 163.41 39.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.338 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.703 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 10.9 p90 -65.4 -51.01 63.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.405 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 29.2 mt-30 -43.62 -10.6 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' TYR . 39.2 mmt180 -76.3 -0.55 22.86 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.02 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -123.81 22.6 8.9 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 122.929 0.143 . . . . 0.0 111.019 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 8.7 mmt 91.86 18.59 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.578 1.151 . . . . 0.0 111.709 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.26 62.16 0.24 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 31.9 mt -90.91 17.19 8.15 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.461 0.304 . . . . 0.0 111.27 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 67.0 t30 107.28 155.77 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 O-C-N 124.798 1.311 . . . . 0.0 109.639 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 54.0 p-10 -87.54 73.49 9.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.126 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 -145.86 118.91 8.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -147.15 130.12 16.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.053 0.454 . . . . 0.0 110.398 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.0 p -108.01 -164.75 0.99 Allowed 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.851 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' SER . 61.5 m -49.44 -174.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.596 -0.69 . . . . 0.0 111.505 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.862 ' SG ' HG21 ' A' ' 8' ' ' ILE . 12.9 p -153.58 156.38 37.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.221 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -118.99 129.52 55.19 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.525 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.37 133.54 56.19 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.629 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -129.82 134.07 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.734 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.582 ' O ' HG21 ' A' ' 136' ' ' VAL . 37.4 m80 -101.15 162.13 13.11 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.31 -0.405 . . . . 0.0 109.916 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -91.79 159.45 38.23 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.662 -179.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.55 149.77 62.38 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.045 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' GLY . 17.8 p -172.53 -9.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.149 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.33 7.27 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.526 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 90' ' ' SER . . . -174.49 -69.06 0.05 OUTLIER Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.749 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 170.36 -103.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.262 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.749 ' H ' HE21 ' A' ' 93' ' ' GLN . 10.8 t80 -156.88 115.73 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.601 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -154.05 131.86 11.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.26 0.552 . . . . 0.0 110.605 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -138.94 147.6 24.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.337 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.8 mt-30 -124.44 129.1 50.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.461 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 7.3 mt -119.61 131.71 71.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.145 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -111.52 123.76 50.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.115 0.483 . . . . 0.0 110.52 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.51 -19.04 22.2 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.625 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -131.89 143.58 50.25 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.829 0.347 . . . . 0.0 110.582 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.85 -178.91 0.78 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.4 t0 52.29 29.44 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.462 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 54.81 80.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.838 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -157.31 164.03 38.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.549 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.46 -157.24 30.03 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -67.7 138.23 56.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.764 0.316 . . . . 0.0 110.636 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 43.4 ttp -118.6 121.33 39.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.488 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.575 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 37.5 m-85 -116.81 132.66 56.64 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.209 0.528 . . . . 0.0 111.201 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.07 131.33 52.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.826 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.0 t -152.84 134.35 14.45 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -95.54 45.48 1.09 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.596 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -149.24 -177.74 6.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.774 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -86.9 160.28 18.76 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 64.5 m -137.82 123.34 12.64 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.6 Cg_endo -78.18 -61.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 121.805 1.67 . . . . 0.0 110.879 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.2 m -111.38 113.16 25.43 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.3 tt -70.04 -35.78 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.989 0.423 . . . . 0.0 111.116 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 25.3 ttt -71.43 -18.53 62.32 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.447 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -82.43 -42.44 18.56 Favored 'General case' 0 C--N 1.314 -0.948 0 O-C-N 121.079 -1.013 . . . . 0.0 111.397 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.528 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.66 -30.19 15.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.982 -177.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 27.7 m-85 -117.73 4.17 12.29 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.9 m-70 55.06 3.63 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.854 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.531 ' H ' ' C ' ' A' ' 122' ' ' PHE . 31.4 mtt -72.15 131.89 43.42 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.943 0.402 . . . . 0.0 109.921 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -108.4 -24.24 11.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.189 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.542 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.4 mt-10 -151.0 108.82 3.68 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.001 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.413 HD11 HD13 ' A' ' 118' ' ' ILE . 7.8 mm -76.91 125.79 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 74.8 m80 -105.24 -36.88 7.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.119 -178.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.4 p -153.59 149.62 27.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.868 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -145.92 156.16 43.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.758 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 47.5 mtpt -134.06 179.13 6.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.371 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.553 ' C ' HD22 ' A' ' 133' ' ' LEU . 12.8 t 57.65 99.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.606 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.553 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.4 mm? -114.42 164.02 14.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.372 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -135.91 111.98 9.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.889 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 41.21 -88.0 0.01 OUTLIER Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.582 HG21 ' O ' ' A' ' 87' ' ' HIS . 17.5 t -125.82 144.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.974 0.416 . . . . 0.0 109.996 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.731 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.2 t-105 -130.09 167.85 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.825 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 67.5 mt -144.25 124.93 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -112.42 131.88 55.33 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -110.19 114.21 27.52 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.593 0.558 . . . . 0.0 110.784 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.498 ' OE1' ' NE ' ' A' ' 148' ' ' ARG . 80.8 tt0 -51.86 -23.65 5.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.507 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.8 mp -118.05 160.9 37.23 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.728 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.1 Cg_endo -77.77 167.06 24.51 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.205 1.937 . . . . 0.0 111.763 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.514 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 2.9 m-80 73.2 14.83 4.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.046 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.514 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 2.2 m-85 77.34 27.84 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.531 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -114.7 170.77 8.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.831 0.348 . . . . 0.0 110.578 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 100.73 159.57 27.73 Favored Glycine 0 N--CA 1.465 0.573 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' NE ' ' OE1' ' A' ' 141' ' ' GLU . 16.5 ptt180 -64.64 84.7 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.648 ' CD ' ' H ' ' A' ' 149' ' ' GLN . 0.4 OUTLIER -54.61 -167.5 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.043 -179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -144.1 162.3 36.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.563 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.701 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -100.0 148.44 24.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.102 0.477 . . . . 0.0 110.194 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.701 ' H ' HD13 ' A' ' 151' ' ' LEU . 1.9 tt -72.78 117.59 14.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.707 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.594 ' N ' HD23 ' A' ' 152' ' ' LEU . 51.7 p-10 -146.32 164.23 33.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.982 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.3 tptp 61.34 149.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.455 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.52 120.55 26.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.779 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 64.42 161.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.239 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.492 ' OH ' HD21 ' A' ' 152' ' ' LEU . 5.2 m-85 -127.32 108.56 10.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.539 ' CZ ' ' HZ3' ' A' ' 159' ' ' LYS . 48.3 ptt85 -108.34 -22.29 12.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.594 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.539 ' HZ3' ' CZ ' ' A' ' 158' ' ' ARG . 0.1 OUTLIER -121.59 156.41 58.54 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.84 0.352 . . . . 0.0 110.736 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.503 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -59.42 -23.06 68.84 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.214 1.943 . . . . 0.0 113.177 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.4 mp -94.36 -4.94 10.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -55.53 -31.77 62.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.298 -178.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 1.0 OUTLIER -103.72 20.82 17.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.713 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 74.64 27.79 64.5 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.087 -0.577 . . . . 0.0 113.769 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.6 137.41 44.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.805 0.802 . . . . 0.0 110.301 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.25 26.32 0.16 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.162 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.0 OUTLIER 166.0 154.54 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.503 179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.55 ' O ' HG23 ' A' ' 170' ' ' VAL . 44.0 Cg_endo -71.49 -13.35 30.23 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 123.047 2.498 . . . . 0.0 111.337 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.65 69.45 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.582 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.953 HG12 ' H ' ' A' ' 171' ' ' GLN . 4.2 t -101.0 -152.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.953 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.7 tp60 -153.33 -132.04 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.735 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -95.15 -152.99 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -170.64 -179.44 2.92 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.09 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.474 HH21 HG22 ' A' ' 177' ' ' VAL . 9.5 ptm180 -155.3 130.25 9.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.902 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -52.74 126.39 19.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.943 0.877 . . . . 0.0 110.98 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.445 HG12 HD12 ' A' ' 138' ' ' ILE . 9.3 mt -59.01 128.22 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.713 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 174' ' ' ARG . 2.9 m -135.76 144.05 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.198 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 46' ' ' THR . 42.7 tt0 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.081 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.1 166.5 25.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.651 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -74.81 119.92 19.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.972 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.6 p -71.21 162.74 28.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.281 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 21.18 31.98 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 p -134.06 122.02 22.36 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.745 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.8 tttt -161.28 152.69 18.94 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.983 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 tt -147.2 141.04 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.098 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.3 m -124.8 138.23 54.28 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.462 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -118.23 116.3 26.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 94.0 m-85 -98.59 139.27 34.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 120.963 0.411 . . . . 0.0 110.96 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.0 tm-20 -62.03 -51.94 65.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.875 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.92 -177.93 4.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.2 0.524 . . . . 0.0 110.31 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -82.36 -177.55 6.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.853 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.42 24.82 0.33 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.177 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 1.8 m-85 62.43 42.71 8.64 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.257 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -109.91 172.58 6.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.988 0.423 . . . . 0.0 110.84 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.65 -153.33 51.45 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.845 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -56.89 173.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -169.0 152.53 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.492 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 63.9 t80 -129.23 131.62 47.09 Favored 'General case' 0 C--O 1.22 -0.481 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 37.7 p-10 -120.39 125.36 47.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.94 0.4 . . . . 0.0 111.24 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 40.7 t -151.25 142.43 23.21 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.26 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -126.17 24.11 6.94 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.419 ' O ' ' O ' ' A' ' 26' ' ' ASP . 14.3 m -145.99 141.81 28.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.442 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 40.3 t0 -35.73 155.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.844 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 20.8 m -156.85 162.68 39.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.348 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.75 -55.69 3.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.979 0.419 . . . . 0.0 110.647 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -154.07 110.97 3.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.331 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.3 p90 -100.81 9.27 42.57 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.963 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.575 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.7 t60 -59.07 -28.41 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.515 0.674 . . . . 0.0 110.069 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -60.96 -29.2 69.51 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.271 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -88.08 -14.99 37.48 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.7 tp -142.34 138.25 31.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.003 0.43 . . . . 0.0 110.222 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.5 t -99.98 -8.69 23.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.644 0.259 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 49.2 ttm-85 -154.23 141.5 19.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.824 0.345 . . . . 0.0 110.485 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.4 m -110.92 105.46 14.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.273 0.559 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 45.4 m-20 -117.13 -155.84 0.6 Allowed 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' ASN . 18.2 p -20.47 139.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.884 0.74 . . . . 0.0 112.271 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.2 mt -143.01 146.91 21.14 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.114 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.1 ptpt -154.41 103.97 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.2 t -66.6 148.31 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.523 0.678 . . . . 0.0 110.555 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -120.51 50.08 1.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.009 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.77 -95.85 0.1 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.925 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.28 -140.28 4.04 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 90.0 m -81.05 166.9 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 122.292 -0.534 . . . . 0.0 110.84 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.745 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 36.3 m95 -154.47 156.9 37.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.286 0.565 . . . . 0.0 110.742 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.43 120.82 40.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 80' ' ' LEU . 6.1 m -117.47 131.9 68.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 0.0 110.986 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -103.7 109.65 21.43 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.723 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 60.2 tt0 -37.06 -36.29 0.12 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -113.69 147.98 38.8 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 56.5 Cg_endo -68.72 157.09 63.25 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.34 2.026 . . . . 0.0 112.05 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 5.5 m-80 86.03 -2.84 0.76 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.3 m-85 85.21 61.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.146 0.498 . . . . 0.0 111.145 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.57 171.5 14.6 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.132 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.05 -158.47 34.79 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 4.2 m-85 -69.04 137.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.3 mtt -111.25 90.14 3.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.524 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 26.3 t80 -98.22 144.64 27.45 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -104.06 92.96 2.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.604 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.3 110.23 5.89 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -81.32 162.85 19.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.083 1.855 . . . . 0.0 112.759 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -52.79 117.41 2.91 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.087 179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.78 179.12 41.3 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.51 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -102.24 153.93 19.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 25.1 m-85 -145.93 83.55 8.64 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.398 -0.594 . . . . 0.0 109.398 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -54.57 -15.72 9.51 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.26 2.64 . . . . 0.0 113.101 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -152.52 161.43 42.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.734 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 13.2 p90 -65.03 -52.36 56.39 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.334 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 37.2 mt-30 -42.99 -10.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.82 -4.97 46.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.059 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.734 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -117.85 23.24 11.81 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.618 179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.6 mmt 87.41 25.35 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.561 1.163 . . . . 0.0 111.158 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 30.83 50.04 0.2 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.078 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 26.5 mt -75.86 14.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.542 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 14.6 t-20 110.95 162.81 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.368 1.043 . . . . 0.0 109.27 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -94.4 61.23 2.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -137.61 115.78 11.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.246 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.39 129.16 20.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.652 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.6 p -111.58 -162.6 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.745 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.29 -178.65 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.302 0.572 . . . . 0.0 110.864 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.588 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.5 p -151.11 153.06 34.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.595 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -118.34 127.86 54.1 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.559 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.49 127.85 33.48 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 48' ' ' ALA . 70.7 t -125.63 132.04 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.735 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.437 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.7 m-70 -100.37 161.56 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.308 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 88' ' ' LEU . 1.2 mt -80.82 150.36 69.12 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.429 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.01 151.23 82.36 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.244 1.963 . . . . 0.0 111.935 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 92' ' ' GLY . 25.7 p -169.3 -17.31 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.079 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -54.84 -5.61 0.61 Allowed Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.548 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 90' ' ' SER . . . -158.09 -73.22 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.692 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 171.54 -100.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.981 0.419 . . . . 0.0 109.919 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.715 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 21.5 t80 -160.88 114.13 2.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.261 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -157.09 132.28 9.04 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.709 0.29 . . . . 0.0 110.676 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.414 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.5 tt -135.81 145.0 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.221 0.534 . . . . 0.0 111.296 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 132' ' ' VAL . 11.8 mt-30 -122.23 134.02 54.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.36 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.641 HD13 HD11 ' A' ' 118' ' ' ILE . 17.5 mt -121.94 131.52 72.95 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.216 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -115.98 130.24 56.73 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.211 0.529 . . . . 0.0 110.457 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -59.46 -26.98 65.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.052 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -122.25 147.07 46.67 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.591 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.46 -168.48 0.41 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 103' ' ' ASP . 50.7 t0 44.56 29.79 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.911 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.482 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 12.9 m-85 54.11 79.35 0.14 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m -158.56 162.24 37.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.993 0.425 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.99 -171.43 42.69 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.0 tp60 -53.89 133.69 42.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.169 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 7.9 tmm? -121.04 131.98 54.61 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.454 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.7 m-85 -121.46 135.72 55.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.456 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -124.05 126.24 45.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.457 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 111' ' ' THR . 7.3 t -152.73 128.93 10.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.72 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 112' ' ' THR . 1.7 t -95.37 42.68 1.09 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 111.464 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.07 -179.46 6.25 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.508 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.8 p-10 -84.04 156.98 21.96 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.525 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 65.8 m -134.04 123.02 16.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.907 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.474 ' O ' ' OG ' ' A' ' 172' ' ' SER . 68.3 Cg_endo -77.98 -57.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.8 1.667 . . . . 0.0 110.841 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.8 m -115.89 111.64 20.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.664 HD12 ' O ' ' A' ' 171' ' ' GLN . 5.1 tt -67.4 -41.86 86.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 0.0 111.338 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 9.1 ttp -68.17 -17.12 64.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.344 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -82.47 -42.49 18.43 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.671 -0.643 . . . . 0.0 111.707 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.525 ' OE1' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.9 -29.96 15.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.111 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.523 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 29.3 m-85 -115.99 4.48 13.77 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.5 m-70 52.48 11.64 0.19 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.234 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.419 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -76.85 133.01 39.47 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -106.98 -28.48 10.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.71 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 30.3 mt-10 -151.45 109.0 3.62 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.008 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 127' ' ' ILE . 7.9 mm -74.98 125.17 34.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.901 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.56 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.0 m80 -107.44 -33.53 7.33 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.126 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -131.56 -168.12 1.97 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.793 -178.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.609 ' N ' ' OG ' ' A' ' 129' ' ' SER . 0.1 OUTLIER 160.99 137.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.082 178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -130.16 -169.54 2.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.052 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG21 ' OE1' ' A' ' 97' ' ' GLN . 49.1 t 47.0 87.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.135 0.493 . . . . 0.0 110.3 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.2 mt -106.28 169.8 8.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.201 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -141.88 113.65 7.9 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.49 -97.44 0.01 OUTLIER Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -110.54 155.93 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.715 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -145.03 168.62 19.86 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.837 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.47 HD12 HG12 ' A' ' 176' ' ' ILE . 70.5 mt -144.63 123.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.974 0.416 . . . . 0.0 111.576 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.61 129.82 55.56 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -107.5 110.83 22.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.563 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -50.2 -22.39 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.27 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.55 164.36 16.66 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.498 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 90.7 Cg_endo -84.16 166.9 12.58 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.091 1.86 . . . . 0.0 112.29 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.498 ' ND2' ' C ' ' A' ' 143' ' ' PRO . 1.8 m-80 68.52 21.96 7.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.326 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 1.6 m-85 71.68 66.83 0.15 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.856 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -154.44 169.68 23.17 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 120.931 0.396 . . . . 0.0 110.698 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 93.93 172.76 39.12 Favored Glycine 0 N--CA 1.462 0.388 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.982 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.426 ' NE ' ' CD1' ' A' ' 58' ' ' TYR . 79.1 mtp180 -53.9 138.26 36.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.554 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 15.5 mp0 -99.56 137.5 37.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.033 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -106.83 129.2 54.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.592 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.745 ' C ' HD12 ' A' ' 152' ' ' LEU . 53.5 tp -76.36 144.32 40.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 0.0 110.367 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.745 HD12 ' C ' ' A' ' 151' ' ' LEU . 10.7 mp -128.32 145.98 50.9 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.168 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -136.78 70.99 1.41 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.993 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? 38.29 -126.16 0.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt 59.2 -105.14 0.23 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.665 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.482 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 18.4 tt0 -178.07 159.49 1.32 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.426 ' CE2' HD23 ' A' ' 152' ' ' LEU . 5.8 m-85 -129.68 108.21 10.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.836 0.35 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -109.47 -21.13 12.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -121.24 155.73 58.22 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 121.124 0.488 . . . . 0.0 110.965 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.531 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.4 Cg_endo -60.24 -19.03 55.5 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.259 1.973 . . . . 0.0 113.181 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.686 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.1 mp -97.86 -3.45 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.353 . . . . 0.0 110.72 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.5 OUTLIER -60.62 -27.86 68.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.864 -178.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.563 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -107.42 21.25 17.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.28 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.33 70.84 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 114.331 0.492 . . . . 0.0 114.331 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.563 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.75 138.58 41.71 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.973 0.886 . . . . 0.0 110.005 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.57 20.86 0.16 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.265 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 169.46 156.73 0.18 Allowed Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.719 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.7 4.48 6.0 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.006 2.471 . . . . 0.0 111.585 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.55 71.4 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.798 0.333 . . . . 0.0 111.09 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.888 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.6 t -99.78 -151.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.888 ' H ' HG12 ' A' ' 170' ' ' VAL . 79.0 mm-40 -154.61 -130.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.123 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 2.9 p -93.7 -155.48 0.45 Allowed 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -170.04 -177.27 2.52 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.319 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -159.72 132.06 6.5 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.442 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -51.67 134.81 29.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.237 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 138' ' ' ILE . 15.2 mt -67.84 135.48 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.658 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.52 156.75 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.484 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.152 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 p -139.5 -63.08 0.52 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 110.648 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.56 -45.85 91.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.383 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.8 p -41.54 128.8 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.524 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.26 -169.33 42.05 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.0 p -139.14 128.09 23.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 110.393 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.777 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.4 tttt -160.03 152.03 20.41 Favored 'General case' 0 C--O 1.207 -1.143 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.004 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.95 142.7 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.736 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.8 m -125.89 138.99 53.82 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.975 0.417 . . . . 0.0 110.642 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -119.33 115.8 24.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.373 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 83.4 m-85 -94.71 138.73 32.18 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.095 0.474 . . . . 0.0 110.822 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' OE1' ' NH2' ' A' ' 36' ' ' ARG . 8.1 tm-20 -61.06 -49.91 75.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.076 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 65.6 m-20 -99.2 -175.96 3.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.182 0.515 . . . . 0.0 109.667 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -82.73 -176.64 6.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.829 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.53 23.78 0.43 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.515 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 2.9 m-85 63.18 41.46 7.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.117 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -108.19 177.08 4.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 0.0 110.411 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.44 -158.56 50.97 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.508 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -54.64 176.39 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.25 150.15 4.29 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 49.8 t80 -127.23 130.97 50.63 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -119.45 124.0 45.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.748 0.309 . . . . 0.0 111.096 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.1 t -150.03 142.3 24.19 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.241 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -125.25 24.01 7.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.951 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 26' ' ' ASP . 8.9 t -146.81 141.81 27.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.8 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' O ' ' O ' ' A' ' 25' ' ' CYS . 74.5 m-20 -36.61 156.52 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.562 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 23.5 t -157.69 164.27 37.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.301 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.47 -56.57 2.98 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.958 0.409 . . . . 0.0 110.861 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 44.7 p-10 -154.24 110.6 3.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.193 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -99.89 10.83 40.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' LEU . 70.5 t60 -59.79 -26.85 66.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.2 p -63.39 -31.31 72.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.734 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -85.85 -12.58 50.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.15 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.6 tp -142.93 137.62 29.58 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.006 0.431 . . . . 0.0 110.386 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 p -95.49 -11.74 27.01 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.579 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 45.4 ttp180 -158.19 146.07 18.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.217 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 2.8 m -110.25 104.15 12.92 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.37 0.605 . . . . 0.0 111.395 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.727 ' O ' ' O ' ' A' ' 39' ' ' SER . 90.3 m-20 -128.84 155.6 44.95 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.463 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' O ' ' A' ' 38' ' ' ASN . 11.1 p 36.97 128.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.345 1.069 . . . . 0.0 112.192 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 27.7 mt -141.46 147.12 22.45 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.403 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -155.94 102.28 2.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.212 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -67.24 149.78 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-O 121.616 0.722 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -122.89 50.62 1.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.053 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.582 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.53 -96.97 0.11 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.868 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.509 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.92 -141.33 4.39 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.627 HG22 ' N ' ' A' ' 47' ' ' TRP . 84.9 m -80.84 167.23 20.15 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.578 -0.366 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.777 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.8 m95 -154.74 155.65 34.93 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.611 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.91 120.79 41.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.48 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -116.92 131.33 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 110.608 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-85 -102.88 108.23 19.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 79.1 tt0 -36.48 -35.32 0.08 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.07 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.565 HH21 ' HB1' ' A' ' 56' ' ' ALA . 10.5 mtm180 -115.39 147.3 38.38 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.798 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 49.4 Cg_endo -68.45 160.71 48.04 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.324 2.016 . . . . 0.0 111.446 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 83.37 -3.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.293 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 13.7 m-85 85.42 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' HB1' HH21 ' A' ' 52' ' ' ARG . . . -145.22 168.38 20.54 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.548 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.34 -156.69 28.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.531 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 3.8 m-85 -82.8 114.63 21.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -87.94 98.26 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.332 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.7 m-85 -92.84 146.6 23.51 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 61' ' ' ILE . 3.9 mp -104.39 92.14 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.419 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 112.98 16.87 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.67 162.23 16.54 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.02 1.813 . . . . 0.0 112.526 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -51.94 115.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.914 179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.12 177.52 42.44 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.523 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.8 mt-10 -101.06 153.07 19.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.944 0.402 . . . . 0.0 110.289 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 30.6 m-85 -146.05 91.11 5.61 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.3 -13.62 40.67 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.056 1.837 . . . . 0.0 113.138 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 91.7 mt-10 -149.41 161.08 42.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.753 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 37.6 p90 -63.23 -53.97 44.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.99 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.61 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 2.9 pt20 -43.46 -10.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 70' ' ' TYR . 24.0 mmm180 -75.04 -5.6 44.93 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.767 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.24 24.39 10.99 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.05 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 20.0 mmt 87.97 25.48 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.289 0.993 . . . . 0.0 111.286 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 31.17 51.47 0.26 Allowed Glycine 0 N--CA 1.473 1.143 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 10.4 mt -75.88 13.2 0.89 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.83 -0.185 . . . . 0.0 110.986 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.577 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.2 t30 109.06 169.5 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 124.578 1.174 . . . . 0.0 108.743 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -98.96 61.46 1.26 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.901 0.382 . . . . 0.0 110.556 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -139.2 116.9 11.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.304 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.05 129.17 20.91 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.7 p -111.22 -162.86 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.513 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 81' ' ' SER . 6.3 p -45.51 -179.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.153 0.501 . . . . 0.0 110.781 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.544 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 15.1 p -150.26 151.89 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.431 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -115.52 127.96 55.65 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.543 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.18 122.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.479 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.08 130.06 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.138 0.494 . . . . 0.0 110.725 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -102.56 162.87 12.58 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -79.91 150.65 72.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 -179.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.83 147.11 95.05 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.071 1.848 . . . . 0.0 112.329 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.6 p -159.91 174.61 14.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.238 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.75 -44.69 2.54 Favored Glycine 0 CA--C 1.518 0.255 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -106.89 -80.74 1.33 Allowed Glycine 0 N--CA 1.458 0.131 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.705 HE21 ' H ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 164.97 -104.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.001 0.429 . . . . 0.0 110.046 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 31.0 t80 -159.01 114.16 2.51 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.519 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' CG ' HG11 ' A' ' 132' ' ' VAL . 17.9 tptm -156.39 132.66 9.96 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.046 0.451 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.417 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.8 tt -134.53 143.62 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.421 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -123.74 129.58 51.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.418 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.3 mt -119.15 131.18 72.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.588 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -111.58 129.07 56.19 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.008 0.433 . . . . 0.0 110.328 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.78 -29.88 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 102' ' ' GLY . 81.4 mttt -112.23 146.91 37.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.856 0.36 . . . . 0.0 110.425 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 101' ' ' LYS . . . -54.3 -163.09 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 38.9 t70 51.72 -96.11 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.69 ' CG ' ' O ' ' A' ' 103' ' ' ASP . 67.1 m-85 -168.95 71.35 0.08 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.993 0.808 . . . . 0.0 109.232 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 m -156.91 161.73 39.65 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 121.101 0.477 . . . . 0.0 110.986 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.05 -178.93 33.61 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.633 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -49.97 133.78 22.19 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.867 -0.666 . . . . 0.0 110.25 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.0 tmm? -122.33 130.32 53.02 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.815 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.488 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 65.0 m-85 -119.77 135.64 54.77 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.43 117.26 26.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.29 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 111' ' ' THR . 11.7 t -140.95 126.37 18.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.65 38.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.27 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.12 -177.85 5.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.75 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 11.7 p30 -85.61 159.12 19.93 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.058 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 42.1 t -133.3 124.56 18.33 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 172' ' ' SER . 60.8 Cg_endo -79.06 -53.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.819 1.679 . . . . 0.0 111.272 177.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 m -121.14 113.89 20.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.757 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.25 -46.18 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 121.187 0.518 . . . . 0.0 110.589 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.459 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.4 ttt -64.65 -20.2 66.15 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.364 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -73.49 -47.26 42.58 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.673 -0.642 . . . . 0.0 112.433 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.639 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.67 -23.59 14.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.29 -176.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.639 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.1 m-85 -111.49 1.56 16.99 Favored 'General case' 0 C--O 1.228 -0.04 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.2 m-70 50.12 11.17 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.862 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.482 ' H ' ' C ' ' A' ' 122' ' ' PHE . 33.8 mtt -77.38 135.2 38.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -106.36 -28.74 10.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.042 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 72.5 mt-10 -152.36 108.6 3.4 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.99 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.4 mm -74.36 125.08 33.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.607 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 71.8 m80 -106.93 -32.46 7.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.242 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.6 t -152.21 147.76 26.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.035 0.445 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.16 156.78 44.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.704 179.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 44.5 mtpt -133.71 -171.14 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.166 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.456 ' C ' HD22 ' A' ' 133' ' ' LEU . 25.5 t 47.06 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.3 mm? -110.82 167.48 10.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -143.17 111.71 6.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.816 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.82 -88.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 134' ' ' GLU . 5.5 t -121.18 155.75 24.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.082 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.742 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 31.4 t-105 -143.73 167.81 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.9 mt -144.72 124.04 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.788 0.328 . . . . 0.0 111.542 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.69 130.77 55.48 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.402 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 16.6 m-85 -108.75 111.75 23.67 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.508 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -52.12 -24.7 7.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 mp -112.7 161.23 27.43 Favored Pre-proline 0 N--CA 1.468 0.45 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.342 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.26 164.66 21.7 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.325 2.017 . . . . 0.0 111.489 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.54 15.11 2.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.003 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.7 m-85 78.54 25.91 0.54 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.492 0.187 . . . . 0.0 111.339 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.5 ' NH2' ' OD1' ' A' ' 144' ' ' ASN . 89.7 mtm180 -109.78 171.26 7.55 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 96.66 168.56 33.87 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -62.16 134.38 56.49 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.08 0.467 . . . . 0.0 110.228 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.571 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 54.4 mt-30 -87.27 144.88 26.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -110.79 127.25 55.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.732 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 55.5 tp -143.39 93.65 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 153' ' ' ASP . 30.9 tp -151.61 142.34 22.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.499 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 7.2 p-10 40.21 95.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.246 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -91.52 91.28 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.235 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -165.16 -47.28 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 34.9 tt0 -174.01 168.6 4.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.488 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 156' ' ' GLU . 21.4 m-85 -142.03 108.57 5.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.893 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -99.36 -30.36 12.26 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.47 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 162' ' ' ASP . 15.4 pttm -118.12 155.42 51.42 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.791 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.552 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 11.2 Cg_endo -57.47 -17.17 26.4 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.148 1.899 . . . . 0.0 113.432 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.22 -3.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.157 0.504 . . . . 0.0 110.327 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 1.0 OUTLIER -61.82 -28.34 69.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.458 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.582 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.4 OUTLIER -104.68 20.51 18.51 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.09 28.23 66.89 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.134 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.582 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -109.74 137.64 47.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.704 0.752 . . . . 0.0 109.596 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.62 19.68 0.36 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.563 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 173.12 155.73 0.26 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.481 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.84 4.65 5.5 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.113 2.542 . . . . 0.0 111.709 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.96 69.89 5.2 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.879 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.5 t -97.71 -153.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.879 ' H ' HG12 ' A' ' 170' ' ' VAL . 71.8 mm-40 -153.83 -131.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.224 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 4.0 p -93.17 -155.75 0.45 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -170.56 -177.35 2.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.065 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.66 132.04 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.862 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 36.3 ptt180 -53.05 135.95 36.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 138' ' ' ILE . 14.6 mt -69.28 135.68 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.836 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.6 160.46 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.603 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 29.1 tp10 . . . . . 0 C--O 1.218 -0.601 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.432 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 44' ' ' GLY . 60.4 p -86.04 165.65 16.49 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.679 0.276 . . . . 0.0 110.376 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -142.12 -1.73 1.2 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.452 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.502 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -90.73 -92.86 0.13 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.502 ' N ' ' OG1' ' A' ' 4' ' ' THR . . . -80.46 111.36 3.26 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' CZ2' ' A' ' 47' ' ' TRP . 7.6 p -84.93 160.86 20.02 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.767 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 31.9 tttt -160.26 151.89 19.83 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.041 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.8 tt -147.49 142.05 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.997 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 93.5 m -124.9 138.77 54.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.534 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -119.11 116.36 26.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.448 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.6 m-85 -98.78 139.57 34.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.076 0.465 . . . . 0.0 110.654 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.1 tm-20 -62.19 -51.41 67.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.823 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -94.4 -177.46 4.26 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HB3' HD22 ' A' ' 15' ' ' ASN . 41.8 mtmt -82.8 -176.79 6.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.721 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 45.41 25.96 0.26 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.321 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.493 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.3 OUTLIER 63.61 41.44 7.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.57 177.45 4.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.949 0.404 . . . . 0.0 110.493 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.81 -158.75 49.66 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.628 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.11 175.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.43 150.79 5.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.473 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 64.6 t80 -129.65 131.88 46.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -120.14 128.79 53.76 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.934 0.397 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.9 t -153.7 142.45 20.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.285 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.7 p-10 -124.72 24.09 7.83 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 m -147.83 143.99 27.85 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.537 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -37.77 156.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.778 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -156.94 162.81 39.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.17 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.22 -56.12 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.941 0.401 . . . . 0.0 110.629 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -154.22 111.89 3.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.317 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.473 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.6 p90 -101.57 10.16 40.52 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.998 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' LEU . 33.2 t60 -59.58 -28.43 67.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.717 0.77 . . . . 0.0 109.994 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -60.97 -30.99 70.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.456 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -86.8 -13.65 44.5 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.392 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 31' ' ' HIS . 20.0 tp -142.89 137.22 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.022 0.439 . . . . 0.0 109.985 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -97.78 -10.14 25.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.296 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.522 ' O ' HD21 ' A' ' 34' ' ' LEU . 59.3 ttm-85 -155.23 142.79 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.022 0.439 . . . . 0.0 110.63 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.9 m -110.75 105.82 14.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 110.869 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 59.7 m-20 -118.0 -155.7 0.61 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.493 ' CB ' ' H ' ' A' ' 16' ' ' PHE . 6.3 p -19.68 137.62 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.992 0.807 . . . . 0.0 112.468 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.7 mt -142.55 146.54 22.05 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.782 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.046 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -155.62 104.28 2.34 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.953 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.704 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -67.24 148.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.38 0.61 . . . . 0.0 110.083 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -122.01 50.6 1.43 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.708 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -168.21 -96.17 0.1 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.071 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -138.25 -140.56 4.03 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.2 m -80.17 166.34 21.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.466 -0.432 . . . . 0.0 110.954 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.767 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 33.7 m95 -154.49 155.66 35.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.704 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.76 120.84 40.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.2 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' A' ' 80' ' ' LEU . 10.0 m -120.37 133.68 66.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 111.072 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CD1' ' NH1' ' A' ' 84' ' ' ARG . 11.7 m-85 -106.98 112.88 26.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.602 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 44.3 tt0 -37.65 -32.68 0.06 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.169 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -116.57 147.41 39.68 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-O 120.596 0.236 . . . . 0.0 110.951 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 55.9 Cg_endo -69.31 161.78 44.49 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.268 1.979 . . . . 0.0 111.716 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 3.8 m-80 81.99 -3.66 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.059 0.849 . . . . 0.0 111.075 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 4.4 m-85 86.02 62.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.235 0.54 . . . . 0.0 111.375 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.07 170.2 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.233 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.96 -159.94 34.76 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 6.5 m-85 -69.17 139.53 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -106.37 87.95 2.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.599 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.624 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 36.0 t80 -92.75 136.0 33.62 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -102.33 93.1 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.1 mt -71.84 110.9 8.72 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -82.43 162.83 17.1 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.137 1.891 . . . . 0.0 112.527 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.66 114.85 1.38 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.146 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.84 176.75 41.67 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 96.2 mt-10 -100.02 153.25 19.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.049 0.452 . . . . 0.0 110.566 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.525 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 26.4 m-85 -146.14 81.57 9.6 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.19 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.17 -12.52 7.75 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.948 2.432 . . . . 0.0 113.071 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' A' ' 71' ' ' GLN . 95.2 mt-10 -152.13 161.35 42.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.692 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 38.6 p90 -64.21 -54.84 27.27 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.598 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.7 pt20 -43.84 -9.22 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 70' ' ' TYR . 31.4 mmt180 -74.83 -4.92 40.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.79 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.692 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.99 25.48 10.32 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 119.778 -0.153 . . . . 0.0 110.742 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 23.6 mmt 85.48 24.68 0.08 Allowed 'General case' 0 N--CA 1.478 0.95 0 O-C-N 124.439 1.087 . . . . 0.0 111.191 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . . . 32.56 51.27 0.43 Allowed Glycine 0 N--CA 1.472 1.1 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.8 mt -76.64 13.82 0.92 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.963 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 62.8 t30 111.55 166.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 O-C-N 125.063 1.477 . . . . 0.0 109.553 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' A' ' 36' ' ' ARG . 50.7 p-10 -98.63 63.61 1.46 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.211 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -142.69 119.71 11.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -143.72 129.66 19.49 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.682 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.4 p -110.36 -162.86 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.095 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.575 ' C ' HH21 ' A' ' 84' ' ' ARG . 13.1 p -45.12 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.128 0.489 . . . . 0.0 110.713 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.614 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 19.8 p -147.97 147.91 30.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.799 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.629 ' CG ' HH11 ' A' ' 84' ' ' ARG . 0.0 OUTLIER -111.04 124.78 52.85 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.69 123.31 17.57 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.002 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.67 130.86 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -98.51 162.35 13.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.177 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 178' ' ' GLU . 1.7 mt -80.21 148.14 66.57 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.845 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.51 155.4 63.53 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.17 1.913 . . . . 0.0 112.054 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 m -171.99 -13.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.078 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.73 -33.41 86.73 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -139.05 57.36 0.62 Allowed Glycine 0 N--CA 1.464 0.56 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 35.2 -105.2 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.712 0.291 . . . . 0.0 111.301 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.733 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 41.8 t80 -158.29 112.81 2.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -153.56 134.65 14.0 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.27 0.557 . . . . 0.0 111.111 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.5 tt -135.9 144.51 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.164 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.51 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -122.83 130.17 52.56 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' MET . 8.1 mt -119.55 132.35 69.57 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.803 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.003 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -114.44 132.89 56.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.969 0.414 . . . . 0.0 110.575 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.04 -30.54 70.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.974 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -120.6 150.76 40.39 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.175 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.13 -176.62 4.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 t0 50.44 28.8 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.715 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 7.3 m-85 55.72 82.13 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.668 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 m -159.06 161.31 36.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.077 0.465 . . . . 0.0 110.459 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.54 -149.35 20.53 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -77.12 137.43 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.241 . . . . 0.0 110.38 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.2 tmm? -123.01 133.87 54.34 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 111.179 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 55.9 m-85 -124.71 137.95 54.32 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.679 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -123.55 123.66 41.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.49 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 111' ' ' THR . 5.6 t -151.59 125.55 9.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.581 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 112' ' ' THR . 1.7 t -92.39 45.31 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.025 0.44 . . . . 0.0 111.334 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.35 -179.24 6.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.538 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 18.6 p-10 -86.48 159.25 19.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.84 178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.599 ' SG ' ' OE1' ' A' ' 121' ' ' GLN . 42.4 t -136.17 124.68 15.34 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.72 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' O ' ' CB ' ' A' ' 172' ' ' SER . 67.4 Cg_endo -77.84 -51.41 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.623 1.549 . . . . 0.0 111.093 177.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.0 m -121.97 111.39 17.0 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.982 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.7 tt -68.44 -43.91 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.15 0.5 . . . . 0.0 110.953 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.452 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.0 ttt -65.45 -17.66 64.72 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.539 0.685 . . . . 0.0 111.032 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -81.87 -43.02 18.77 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 121.724 -0.61 . . . . 0.0 111.94 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.704 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -95.54 -29.45 14.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.053 -178.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.704 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 24.8 m-85 -115.03 5.3 14.92 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.678 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.8 m-70 50.78 11.07 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.919 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.478 ' H ' ' C ' ' A' ' 122' ' ' PHE . 36.0 mtt -76.9 135.15 38.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.749 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -107.41 -28.46 9.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.516 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 60.8 mt-10 -151.19 109.04 3.68 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.08 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.5 mm -74.71 125.14 33.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.723 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.9 m80 -105.53 -32.19 8.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.143 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 12.8 t -154.04 148.74 26.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.108 0.48 . . . . 0.0 111.267 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -149.8 132.34 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.861 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -112.44 -173.08 2.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.243 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.9 t 56.15 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.536 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.822 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -94.55 168.03 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.136 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.8 mp0 -142.58 112.14 6.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 35.69 -88.66 0.01 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 134' ' ' GLU . 4.5 t -116.59 156.21 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.733 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.2 t-105 -146.21 167.44 23.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.279 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 87.4 mt -144.88 123.22 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 120.742 0.306 . . . . 0.0 111.119 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -110.4 131.57 54.93 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -109.57 111.54 23.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.957 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -51.82 -23.18 4.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.737 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.9 mp -114.6 160.4 33.32 Favored Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 96.7 Cg_endo -79.47 166.25 22.29 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.123 1.882 . . . . 0.0 111.46 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.6 m-80 74.84 14.01 3.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 3.0 m-85 79.04 25.55 0.47 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -109.87 171.05 7.68 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 120.847 0.356 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.23 168.99 36.07 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' NE ' ' CD1' ' A' ' 58' ' ' TYR . 71.2 mtp180 -56.97 142.39 41.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.266 -0.467 . . . . 0.0 109.835 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.624 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 69.5 mt-30 -97.6 137.39 36.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.002 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -104.83 126.22 51.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.404 HD23 ' OH ' ' A' ' 50' ' ' TYR . 33.4 tp -81.11 153.14 27.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.542 0.687 . . . . 0.0 110.218 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.81 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -120.21 154.92 34.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.34 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -175.33 -25.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.601 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -72.36 146.91 46.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.82 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 156' ' ' GLU . 68.0 mttm -76.67 99.35 5.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.625 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 155' ' ' LYS . 13.6 tt0 75.05 148.84 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.077 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -118.08 111.43 18.88 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -107.3 -20.26 13.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.701 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -121.56 154.86 59.96 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.545 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 15.5 Cg_endo -60.59 -16.09 40.7 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.4 2.067 . . . . 0.0 113.322 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 161' ' ' ILE . 4.1 mp -100.2 -1.69 9.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.957 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -26.08 67.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.671 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.566 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -108.67 21.08 17.75 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.42 26.94 68.8 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.955 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.566 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.93 138.28 43.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.38 1.09 . . . . 0.0 109.721 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -76.76 21.02 0.21 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.497 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 170.86 155.41 0.21 Allowed Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.675 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.24 6.13 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.087 2.525 . . . . 0.0 111.407 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.8 70.64 8.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.723 0.297 . . . . 0.0 111.056 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.941 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.01 -151.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.941 ' H ' HG12 ' A' ' 170' ' ' VAL . 73.8 mm-40 -155.04 -130.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.357 0.411 . . . . 0.0 109.893 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.594 ' OG ' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.37 -158.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -170.01 -177.8 2.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.405 0.622 . . . . 0.0 111.094 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.87 131.76 7.07 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -52.89 135.3 36.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.652 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.429 HD12 ' HB ' ' A' ' 136' ' ' VAL . 14.4 mt -64.09 134.49 28.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.723 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.89 135.58 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.501 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . 11.2 tm-20 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.351 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.58 -167.15 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.523 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 3' ' ' LYS . 19.2 pttp -66.17 -47.57 73.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.046 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.547 HG23 ' N ' ' A' ' 5' ' ' GLY . 11.1 t -65.86 -44.2 86.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.731 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.547 ' N ' HG23 ' A' ' 4' ' ' THR . . . -92.11 113.58 4.41 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 73.9 p -84.64 158.17 20.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.768 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 37.8 tttt -158.32 150.71 22.01 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.022 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.2 tt -146.3 140.31 20.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.669 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 42.4 m -122.52 137.95 54.72 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.811 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -118.33 115.85 25.55 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.7 m-85 -95.58 138.13 33.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.235 0.54 . . . . 0.0 111.083 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -60.27 -49.94 75.6 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.861 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.3 m-20 -99.69 -176.2 3.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.188 0.518 . . . . 0.0 110.148 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -82.43 -177.2 6.58 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.482 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 47.57 23.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.779 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.2 m-85 63.09 41.11 8.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -108.35 176.42 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.151 0.5 . . . . 0.0 110.715 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.91 -157.12 52.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.379 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -54.91 174.2 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.731 -0.735 . . . . 0.0 109.137 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.58 151.08 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' THR . 59.6 t80 -135.57 134.14 39.07 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 49.9 p-10 -120.9 140.46 51.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.665 0.269 . . . . 0.0 110.759 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 25' ' ' CYS . 18.3 t -147.88 141.15 25.16 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 6' ' ' THR . 7.4 t70 -122.92 14.06 9.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.8 t -149.66 146.7 27.41 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.812 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 80.3 m-20 -37.54 156.19 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -155.62 161.22 40.85 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.81 -56.35 3.03 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 39.4 p-10 -153.61 111.0 3.48 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.466 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.1 p90 -101.28 9.7 41.46 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.935 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' LEU . 84.6 t60 -59.98 -26.47 66.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.539 0.685 . . . . 0.0 109.986 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.5 p -63.28 -29.66 70.95 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.505 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -88.45 -12.87 41.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.469 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 31' ' ' HIS . 17.0 tp -143.5 137.7 28.69 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.8 m -99.46 -9.4 23.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.6 ttm180 -154.75 143.26 20.58 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.3 m -110.65 104.57 13.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.442 0.639 . . . . 0.0 110.887 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.707 ' O ' ' O ' ' A' ' 39' ' ' SER . 70.6 m-20 -129.51 156.78 43.59 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.707 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.1 p 35.67 128.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.392 1.091 . . . . 0.0 112.469 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 25.2 mt -141.44 146.19 23.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.297 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.4 ptpt -154.41 103.6 2.51 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.096 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.9 t -66.72 148.23 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 121.542 0.686 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -120.9 50.42 1.35 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.81 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.45 -95.3 0.1 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.537 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.46 -140.0 3.98 Favored Glycine 0 N--CA 1.468 0.767 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.617 HG22 ' N ' ' A' ' 47' ' ' TRP . 99.8 m -82.2 167.16 18.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.403 -0.469 . . . . 0.0 110.807 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.768 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 37.7 m95 -155.07 157.25 37.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.604 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.82 121.59 41.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.64 132.74 67.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.095 0.474 . . . . 0.0 110.881 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -104.56 110.59 22.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.758 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -38.03 -34.6 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.136 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -116.14 132.99 22.97 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.414 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 20.2 Cg_exo -55.92 161.91 7.77 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.371 1.38 . . . . 0.0 112.151 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.8 OUTLIER 84.69 -4.61 0.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.076 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 12.9 m-85 84.88 59.95 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.533 0.521 . . . . 0.0 110.9 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.68 172.04 13.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.021 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 -158.33 35.2 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.472 ' CZ ' ' NE ' ' A' ' 148' ' ' ARG . 4.2 m-30 -66.52 140.7 58.0 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.501 ' N ' ' SD ' ' A' ' 59' ' ' MET . 2.3 mpt? -110.11 87.02 2.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.013 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.55 ' CD1' ' NE2' ' A' ' 149' ' ' GLN . 36.5 t80 -94.42 135.79 35.44 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.17 91.81 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.94 111.15 8.84 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.8 162.36 16.23 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.085 1.857 . . . . 0.0 112.725 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -51.03 114.57 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.828 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.06 176.71 41.8 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.4 mt-10 -100.13 153.13 19.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.902 0.382 . . . . 0.0 110.519 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 36.5 m-85 -146.44 91.83 5.31 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.11 -13.26 39.08 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.093 1.862 . . . . 0.0 113.246 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -149.82 161.14 42.85 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.732 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 41.6 p90 -63.49 -54.14 41.09 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.609 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 1.4 pt20 -43.5 -9.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 70' ' ' TYR . 84.5 mmt-85 -75.8 -4.48 40.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.534 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.732 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -117.59 25.08 10.67 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.823 -0.171 . . . . 0.0 110.95 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.411 ' O ' ' C ' ' A' ' 75' ' ' GLY . 22.7 mmt 85.39 24.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.465 1.103 . . . . 0.0 111.35 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.54 51.07 0.3 Allowed Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.3 mt -76.19 13.94 0.82 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.386 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 10.5 t-20 113.39 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.858 1.349 . . . . 0.0 109.493 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.4 p-10 -97.35 62.68 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.052 0.453 . . . . 0.0 110.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -141.88 118.53 11.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.987 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.653 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.15 128.63 20.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.9 p -110.63 -162.58 0.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.138 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.9 p -45.64 -179.05 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.619 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.495 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.1 p -149.3 149.79 31.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.603 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -115.82 127.85 55.37 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -63.05 126.49 27.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.277 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 48' ' ' ALA . 73.1 t -125.06 131.84 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.649 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -99.0 159.13 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.908 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -80.89 148.07 63.72 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.031 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.8 155.23 69.36 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.084 1.856 . . . . 0.0 111.803 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -173.39 -16.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.78 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.5 -36.81 93.63 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.59 55.32 0.77 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 33.8 -106.52 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.74 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 38.5 t80 -158.06 113.58 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -154.36 132.04 11.44 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.849 0.357 . . . . 0.0 110.871 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.438 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.5 tt -134.66 143.9 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.194 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.69 131.74 54.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 118' ' ' ILE . 14.8 mt -120.33 130.99 73.77 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -112.97 132.93 55.16 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.048 0.451 . . . . 0.0 110.816 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' O ' ' ND1' ' A' ' 128' ' ' HIS . 82.8 tt0 -63.69 -31.01 72.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.698 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -117.15 148.32 41.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.12 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.47 178.27 8.56 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.2 t0 54.72 31.25 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.772 0.32 . . . . 0.0 110.5 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 156' ' ' GLU . 9.7 m-85 55.4 81.46 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.279 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -159.82 162.52 34.75 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.29 -149.79 20.92 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.658 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.39 136.85 39.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.602 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.9 tmm? -122.03 131.62 54.08 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.014 0.435 . . . . 0.0 111.076 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -122.53 137.15 54.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.516 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.73 127.49 47.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.636 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 111' ' ' THR . 5.6 t -149.5 128.64 12.77 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.48 40.47 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.595 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.86 -177.96 5.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.063 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -84.66 159.29 20.59 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.15 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 45.1 t -132.44 119.59 16.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.463 ' O ' ' OG ' ' A' ' 172' ' ' SER . 73.1 Cg_endo -79.25 -53.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.495 1.463 . . . . 0.0 111.018 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.9 m -119.08 109.94 16.5 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.741 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.7 tt -66.5 -42.58 90.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.355 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 44.1 ttm -66.62 -21.5 66.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.922 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -73.73 -47.48 38.97 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.241 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.659 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 5.7 pt20 -101.0 -25.48 14.05 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.659 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 34.9 m-85 -111.47 1.13 16.78 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.085 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 51.68 11.38 0.13 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.997 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 122' ' ' PHE . 4.8 mmt -77.58 135.57 38.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -109.36 -28.87 8.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.556 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 35.1 mt-10 -150.36 108.01 3.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.383 0.611 . . . . 0.0 111.485 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 118' ' ' ILE . 8.7 mm -76.39 122.77 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.864 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.8 m80 -104.39 -31.78 9.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.158 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -151.71 146.48 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 110.681 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -145.46 132.72 20.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -113.03 -176.25 2.85 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.575 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' C ' HD22 ' A' ' 133' ' ' LEU . 15.1 t 53.54 90.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.583 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.865 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -105.6 168.09 9.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.79 111.88 7.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.91 -86.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 134' ' ' GLU . 17.7 t -122.56 149.15 26.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.74 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 28.3 t-105 -138.11 169.47 17.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.739 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.446 HD12 HG12 ' A' ' 176' ' ' ILE . 88.3 mt -145.05 123.51 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.902 0.382 . . . . 0.0 111.225 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.679 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -109.39 130.92 55.48 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.001 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -110.5 111.92 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.617 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -52.28 -23.34 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.393 0.433 . . . . 0.0 111.159 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.3 mp -113.65 162.09 24.29 Favored Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.42 165.28 20.93 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.1 1.867 . . . . 0.0 111.488 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 0.7 OUTLIER 75.44 13.87 2.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.965 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.4 m-85 78.78 25.83 0.5 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -109.84 171.5 7.41 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.739 0.304 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.463 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 94.85 170.29 36.94 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.472 ' NE ' ' CZ ' ' A' ' 58' ' ' TYR . 94.3 mtt180 -57.47 148.79 22.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 6.3 mp0 -110.18 148.21 32.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.885 0.374 . . . . 0.0 110.162 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -116.58 130.44 56.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.571 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -144.3 98.24 3.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.268 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 153' ' ' ASP . 93.0 mt -142.93 109.28 5.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.295 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 154' ' ' LYS . 30.1 t0 35.28 -150.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.937 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.533 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 59.8 pttt -163.18 33.41 0.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.909 0.385 . . . . 0.0 110.47 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -73.3 35.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.766 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' A' ' 104' ' ' PHE . 44.4 tt0 71.81 156.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -125.89 111.61 15.01 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.053 0.454 . . . . 0.0 110.978 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -107.11 -25.67 11.46 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.241 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -119.22 154.04 53.54 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.559 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.527 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 14.6 Cg_endo -58.81 -15.66 27.69 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.176 1.917 . . . . 0.0 113.729 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -103.78 -3.29 9.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.313 0.577 . . . . 0.0 110.477 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.75 -28.29 68.59 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.478 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.5 OUTLIER -105.8 23.21 14.28 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 120.826 0.346 . . . . 0.0 110.167 -179.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.1 26.45 72.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.946 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.53 139.6 41.81 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.378 1.089 . . . . 0.0 109.759 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.23 21.25 0.36 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.7 OUTLIER 171.43 154.83 0.22 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.336 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.847 ' O ' HG23 ' A' ' 170' ' ' VAL . 40.1 Cg_endo -68.07 -35.16 20.67 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.641 2.228 . . . . 0.0 111.422 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -49.92 76.58 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.26 0 O-C-N 123.801 0.688 . . . . 0.0 110.6 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 168' ' ' PRO . 60.4 t -93.84 -98.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.741 ' O ' HD12 ' A' ' 118' ' ' ILE . 5.3 mm-40 158.79 -140.9 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.914 0.759 . . . . 0.0 109.298 177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -92.62 -156.12 0.46 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.931 0.332 . . . . 0.0 111.704 -177.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -170.3 -177.11 2.38 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.075 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -158.53 131.72 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.258 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 37.7 ptt180 -52.46 135.33 33.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.61 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.446 HG12 HD12 ' A' ' 138' ' ' ILE . 15.9 mt -69.6 135.58 27.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.458 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 178' ' ' GLU . 39.7 t -136.23 156.27 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.388 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.551 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 31.6 tp10 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.451 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 p -100.97 -30.7 11.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.634 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -97.56 -3.97 38.65 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.632 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.0 p -80.0 42.37 0.55 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.577 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.36 161.04 21.69 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.544 ' O ' ' CZ2' ' A' ' 47' ' ' TRP . 3.7 p -116.26 118.58 33.17 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.801 ' O ' HG13 ' A' ' 42' ' ' VAL . 31.1 tttt -99.64 159.61 14.91 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-O 120.902 0.382 . . . . 0.0 110.846 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' N ' ' CG ' ' A' ' 7' ' ' LYS . 17.4 tt -146.5 140.85 20.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.823 0.344 . . . . 0.0 111.613 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 90.6 m -126.61 138.87 53.5 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-O 120.99 0.424 . . . . 0.0 110.554 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -118.23 116.55 27.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 92.9 m-85 -97.1 139.77 32.61 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.138 0.494 . . . . 0.0 110.879 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.418 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.5 tm-20 -61.58 -52.61 63.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.764 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HA ' HD22 ' A' ' 38' ' ' ASN . 99.0 m-20 -95.27 -178.15 4.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.331 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -81.89 -178.15 6.87 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.951 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 47.17 26.04 0.61 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.001 179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' H ' ' CB ' ' A' ' 39' ' ' SER . 0.4 OUTLIER 62.35 42.48 9.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.414 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -109.79 176.43 5.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.986 0.422 . . . . 0.0 110.576 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.09 -156.81 52.76 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.639 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 ttm-85 -55.21 174.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -168.69 148.22 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' THR . 51.4 t80 -130.69 132.73 45.55 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 23' ' ' CYS . 28.6 t0 -118.4 143.42 46.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.775 0.321 . . . . 0.0 110.53 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -160.46 139.57 10.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 35.3 t70 -121.54 21.82 10.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.49 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.37 148.81 28.58 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.048 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 2.8 t70 -38.08 155.77 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.643 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 10.7 t -154.71 160.58 41.45 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -93.44 -56.66 2.85 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.022 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 41.1 p-10 -152.35 108.6 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.086 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -99.9 9.05 43.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.563 ' O ' ' O ' ' A' ' 34' ' ' LEU . 80.7 t60 -58.47 -27.48 64.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.039 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.8 p -64.26 -29.73 70.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.953 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.17 -11.63 46.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.667 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.6 tp -143.72 137.46 28.16 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -98.32 -12.01 21.96 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.98 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.498 ' O ' HD21 ' A' ' 34' ' ' LEU . 17.4 ttm180 -154.46 143.13 20.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.235 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.664 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -114.34 108.06 16.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.648 0.737 . . . . 0.0 110.57 -179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 39' ' ' SER . 56.9 m-20 -117.61 -156.04 0.62 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.608 -1.178 . . . . 0.0 107.979 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.1 p -18.2 138.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.811 0.694 . . . . 0.0 112.748 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.8 mt -141.98 146.49 22.7 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.709 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -156.57 103.26 2.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.3 t -66.68 146.07 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-O 121.517 0.675 . . . . 0.0 110.136 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -117.47 50.28 1.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.483 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.57 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.32 -96.56 0.1 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.582 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.14 -142.14 4.63 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 -178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.632 HG22 ' N ' ' A' ' 47' ' ' TRP . 97.0 m -81.85 166.88 19.57 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.187 0.517 . . . . 0.0 110.956 -178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.632 ' N ' HG22 ' A' ' 46' ' ' THR . 23.5 m95 -155.2 157.59 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.981 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.89 121.2 40.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.281 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.94 132.06 67.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' O ' ' N ' ' A' ' 52' ' ' ARG . 57.7 m-85 -104.3 111.12 23.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.527 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 50' ' ' TYR . 45.7 tt0 -32.69 -34.15 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 O-C-N 123.316 0.385 . . . . 0.0 111.216 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HE ' ' HA3' ' A' ' 57' ' ' GLY . 27.3 mtm180 -124.86 158.22 63.51 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.643 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 5.8 Cg_exo -71.18 163.47 39.06 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.391 2.06 . . . . 0.0 112.221 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.701 HD21 ' CB ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER 86.66 -11.24 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.816 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 54' ' ' ASN . 9.8 m-85 85.56 51.35 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.844 0.715 . . . . 0.0 111.595 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.701 ' CB ' HD21 ' A' ' 54' ' ' ASN . . . -149.82 118.85 6.71 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.243 177.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.541 ' HA3' ' HE ' ' A' ' 52' ' ' ARG . . . 122.72 127.42 3.29 Favored Glycine 0 N--CA 1.475 1.237 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 57' ' ' GLY . 0.3 OUTLIER 22.24 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.703 0.401 . . . . 0.0 111.402 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.8 mtt -92.04 86.26 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.595 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 24.0 t80 -91.18 141.69 28.53 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.757 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -102.58 93.07 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.9 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 111.92 14.26 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.78 164.01 13.98 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.046 1.83 . . . . 0.0 113.203 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.2 OUTLIER -50.92 111.74 0.6 Allowed 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.24 171.46 39.27 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.28 155.1 16.9 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.99 0.424 . . . . 0.0 110.389 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 56.4 m-85 -149.01 84.23 6.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.702 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -54.09 -14.34 6.03 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.894 2.396 . . . . 0.0 112.814 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -155.45 162.88 40.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 7.9 p90 -64.78 -52.35 57.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.499 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 26.4 mt-30 -39.87 -14.82 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 2.1 tpm_? -75.79 -5.17 44.54 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.421 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -116.71 25.66 10.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.816 -0.175 . . . . 0.0 111.196 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 19.7 mmt 88.78 25.18 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.119 0.967 . . . . 0.0 111.632 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 33.35 55.7 0.58 Allowed Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.318 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 34.8 mt -88.23 11.12 17.31 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 41.5 t30 87.52 139.3 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.66 0.6 . . . . 0.0 109.912 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.641 ' CG ' ' H ' ' A' ' 79' ' ' ARG . 16.0 p-10 -37.88 -95.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.641 ' H ' ' CG ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER 27.15 94.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 179.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.664 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -141.55 128.05 20.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.649 ' N ' HD13 ' A' ' 80' ' ' LEU . 6.8 p -110.23 -163.15 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.387 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.5 p -45.81 -179.06 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.394 0.616 . . . . 0.0 110.761 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 26.5 p -150.8 152.53 33.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.263 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -114.78 127.03 55.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.47 122.08 14.29 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 48' ' ' ALA . 46.1 t -123.55 130.97 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.392 . . . . 0.0 110.987 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 136' ' ' VAL . 29.5 m80 -102.73 162.52 12.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.963 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.32 155.85 69.11 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.618 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.88 154.14 53.34 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.666 2.244 . . . . 0.0 111.992 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 p -163.11 -19.17 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.785 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.47 49.24 3.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . 155.78 39.85 0.02 OUTLIER Glycine 0 C--O 1.222 -0.595 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.9 pt20 34.59 -106.98 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 35.8 t80 -158.43 113.26 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 36.0 tptt -154.68 133.57 12.26 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.19 0.519 . . . . 0.0 111.461 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.406 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.7 tt -136.0 145.05 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.253 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 12.9 mt-30 -123.25 131.42 53.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.526 -1.216 . . . . 0.0 107.942 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.57 HD13 HD11 ' A' ' 118' ' ' ILE . 12.8 mt -119.96 131.9 71.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.036 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -114.1 130.93 56.56 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 0.0 110.697 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -61.73 -29.19 69.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -119.01 147.34 44.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.211 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.88 172.02 15.94 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.9 t70 59.75 31.91 21.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.815 0.34 . . . . 0.0 110.526 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 54.5 81.54 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.139 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -159.13 163.36 36.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.486 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -151.73 24.6 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -73.61 135.86 43.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.644 0.259 . . . . 0.0 110.512 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 9.3 tmm? -121.83 132.03 54.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.202 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.503 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 61.0 m-85 -121.52 136.05 54.98 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.625 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -122.74 123.5 41.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.555 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 111' ' ' THR . 4.9 t -151.77 126.43 9.55 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.689 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 t -92.34 43.44 1.13 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.832 0.349 . . . . 0.0 111.405 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -142.77 -179.34 6.28 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.611 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 11.4 p-10 -85.2 158.92 20.23 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.536 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 69.6 m -136.59 121.64 12.97 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.87 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 172' ' ' SER . 69.0 Cg_endo -77.11 -53.41 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.768 1.645 . . . . 0.0 111.413 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.0 m -118.58 109.15 15.83 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.9 tt -66.17 -42.68 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 111.254 -178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.2 ttt -66.08 -18.45 65.35 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -82.37 -43.3 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.719 -0.613 . . . . 0.0 111.938 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -92.84 -31.79 14.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.006 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 121' ' ' GLN . 28.0 m-85 -115.82 5.8 14.19 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 119' ' ' MET . 5.4 m-70 51.32 13.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.253 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.408 ' N ' ' C ' ' A' ' 122' ' ' PHE . 2.2 mmt -78.23 133.84 37.66 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -107.4 -29.55 9.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.561 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.555 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 25.9 mt-10 -150.45 109.14 3.84 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.155 0.502 . . . . 0.0 111.167 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.9 mm -75.03 124.71 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.062 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 70.3 m80 -104.77 -32.22 8.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.172 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.9 m -154.52 149.28 26.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.93 0.395 . . . . 0.0 110.85 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -144.05 145.87 32.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.647 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' HB2' HE21 ' A' ' 97' ' ' GLN . 50.9 mtpt -122.48 -176.91 3.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.668 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' C ' HD12 ' A' ' 133' ' ' LEU . 25.1 t 50.66 92.16 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.649 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.519 HD21 ' CE2' ' A' ' 157' ' ' TYR . 7.5 mp -107.57 168.57 9.15 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.121 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 136' ' ' VAL . 2.9 mp0 -142.04 112.48 7.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.135 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 36.13 -88.18 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 134' ' ' GLU . 8.4 t -119.61 153.72 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 110.236 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 35.7 t-105 -141.83 169.32 17.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.767 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 77.2 mt -144.51 122.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.805 0.336 . . . . 0.0 111.213 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.655 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -109.41 131.87 54.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -110.87 111.72 23.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.92 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 142' ' ' LEU . 74.8 tt0 -50.38 -21.92 1.64 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.018 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 141' ' ' GLU . 7.0 mp -119.53 161.62 36.58 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 0.0 110.377 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 73.8 Cg_endo -77.39 168.25 23.19 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 145' ' ' TYR . 2.1 m-80 73.67 11.95 4.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.862 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.6 m-85 78.76 27.92 0.44 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.329 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -112.87 172.3 7.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.75 172.49 42.48 Favored Glycine 0 N--CA 1.463 0.493 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.598 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -45.74 156.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 110.239 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.595 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 13.2 mp0 -121.94 126.83 49.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -107.57 130.78 54.84 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.384 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.555 ' C ' HD23 ' A' ' 151' ' ' LEU . 4.1 tt -147.34 95.13 2.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.13 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 58.2 tp -150.59 116.61 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.915 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.49 138.15 50.96 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.169 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -158.68 -44.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.404 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -174.74 72.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.558 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 54.74 -174.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.234 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' CE2' HD21 ' A' ' 133' ' ' LEU . 10.9 m-85 -130.65 108.63 10.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.002 0.43 . . . . 0.0 110.851 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -104.8 -25.92 12.45 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.016 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -119.83 154.79 55.3 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.608 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.536 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 13.7 Cg_endo -58.68 -19.7 47.05 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.23 1.953 . . . . 0.0 113.452 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.6 mp -99.34 -2.81 9.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.131 0.491 . . . . 0.0 110.704 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -60.2 -28.16 67.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.547 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.573 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.7 OUTLIER -106.87 21.73 17.07 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.777 0.323 . . . . 0.0 110.354 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.57 69.9 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 121.134 -0.555 . . . . 0.0 114.283 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.573 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -105.92 138.16 42.58 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.217 1.008 . . . . 0.0 109.765 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.36 20.2 0.16 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.5 OUTLIER 168.99 155.96 0.17 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.845 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -75.01 7.13 3.0 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.081 2.52 . . . . 0.0 111.502 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.11 70.52 9.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.777 0.322 . . . . 0.0 111.046 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -99.27 -147.56 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -160.47 -131.68 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.696 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -92.01 -157.59 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -169.81 -177.4 2.64 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.189 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -158.94 131.28 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.79 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -52.59 135.46 34.42 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.149 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.465 HG12 HD12 ' A' ' 138' ' ' ILE . 14.3 mt -69.3 134.42 30.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.6 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 178' ' ' GLU . 43.5 t -137.71 156.55 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.658 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 27.0 tp10 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.538 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 4' ' ' THR . 1.5 m -100.49 78.62 2.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.105 0.478 . . . . 0.0 110.563 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.2 mttt 60.73 -4.97 0.11 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.584 ' H ' ' C ' ' A' ' 2' ' ' SER . 3.7 m 39.39 72.64 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.927 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.18 161.61 28.5 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p -84.72 161.08 20.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 0.0 110.242 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.792 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 39.7 tttt -159.75 151.25 19.95 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.11 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.7 tt -147.1 141.97 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.4 m -124.63 138.52 54.3 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.798 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -119.47 116.22 25.67 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.3 m-85 -96.93 137.75 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.92 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' OE1' ' OD1' ' A' ' 13' ' ' ASP . 7.7 tm-20 -60.66 -48.99 79.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.156 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' O ' ' OG ' ' A' ' 39' ' ' SER . 99.5 m-20 -99.1 -176.07 3.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.19 0.519 . . . . 0.0 109.917 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.56 -176.72 6.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.282 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.483 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.0 OUTLIER 46.8 23.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.883 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.464 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 3.4 m-85 63.48 41.76 7.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.235 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -108.65 174.38 5.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.604 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.82 -154.97 53.16 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.66 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -56.26 172.98 0.18 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -168.94 152.19 5.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -136.22 133.89 37.55 Favored 'General case' 0 C--O 1.219 -0.535 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -121.03 138.2 54.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.698 0.285 . . . . 0.0 110.816 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.94 141.61 25.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.61 16.74 9.58 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.671 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -149.71 146.54 27.28 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.86 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -38.53 156.49 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.713 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.548 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 39.8 t -157.49 163.43 38.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.286 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.79 -56.3 3.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.817 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -153.58 112.51 3.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.691 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.404 ' O ' ' CD2' ' A' ' 30' ' ' PHE . 2.5 p90 -101.87 8.58 41.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.041 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' LEU . 79.3 t60 -60.33 -27.57 67.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.494 0.664 . . . . 0.0 109.993 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 66.4 p -60.79 -29.37 69.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -89.1 -15.27 34.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.527 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.23 137.65 32.73 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.954 0.407 . . . . 0.0 110.17 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 t -99.31 -7.76 25.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' H ' ' HG ' ' A' ' 34' ' ' LEU . 52.5 ttm-85 -156.78 145.75 20.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.865 0.364 . . . . 0.0 110.575 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 6.8 p -112.26 104.18 12.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.399 0.618 . . . . 0.0 111.036 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.731 ' O ' ' O ' ' A' ' 39' ' ' SER . 74.1 m-20 -129.78 157.55 41.88 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.731 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 34.24 127.83 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.581 1.181 . . . . 0.0 112.398 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 26.6 mt -141.2 146.08 24.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.187 -179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 6.8 ptpt -154.06 102.96 2.52 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.25 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 7' ' ' LYS . 4.4 t -66.89 149.18 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.478 0.656 . . . . 0.0 110.389 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -122.17 50.94 1.4 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.919 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.572 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -169.13 -95.73 0.1 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.967 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -137.16 -138.59 3.78 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 56.1 m -82.84 166.99 18.5 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.593 -0.357 . . . . 0.0 110.745 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.792 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.5 m95 -153.68 155.57 36.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.577 0.703 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -115.77 122.16 44.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.026 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 60' ' ' TYR . 8.1 m -118.29 132.07 69.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.189 0.518 . . . . 0.0 110.871 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 52' ' ' ARG . 89.3 m-85 -101.5 108.49 20.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.919 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' TYR . 39.6 tt0 -32.21 -37.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.407 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.604 HH21 ' N ' ' A' ' 57' ' ' GLY . 62.0 mtm180 -119.5 148.9 46.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.808 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 39.8 Cg_endo -67.78 163.8 33.93 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.559 2.173 . . . . 0.0 111.901 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' PRO . 2.1 m120 82.56 -3.27 1.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.119 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 81.79 56.42 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.438 0.461 . . . . 0.0 110.965 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.577 ' HB1' HH21 ' A' ' 52' ' ' ARG . . . -144.68 171.24 14.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.604 ' N ' HH21 ' A' ' 52' ' ' ARG . . . 87.44 -161.65 32.69 Favored Glycine 0 CA--C 1.519 0.307 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.558 ' HD2' ' HH ' ' A' ' 60' ' ' TYR . 3.5 m-30 -63.97 -179.18 0.38 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -146.44 126.39 13.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.858 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.558 ' HH ' ' HD2' ' A' ' 58' ' ' TYR . 5.6 m-85 -132.14 135.09 46.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.1 mp -101.34 89.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 110.8 7.05 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.95 161.85 18.37 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.181 1.921 . . . . 0.0 112.519 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -52.35 117.31 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.247 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 170.74 179.32 41.96 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.06 152.97 20.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.547 ' CD1' ' C ' ' A' ' 66' ' ' GLU . 18.8 m-85 -145.67 84.6 8.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.65 -17.78 23.87 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 123.145 2.563 . . . . 0.0 113.028 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -149.88 161.18 42.78 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.673 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 16.4 p90 -62.68 -49.66 74.24 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.521 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -44.19 -10.72 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' TYR . 35.9 mmt180 -76.38 -5.19 46.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.015 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.673 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -116.66 26.94 9.5 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 122.469 -0.144 . . . . 0.0 111.249 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 22.0 mmt 88.97 19.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.342 1.027 . . . . 0.0 111.316 -179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 32.51 59.65 0.4 Allowed Glycine 0 N--CA 1.467 0.721 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.336 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.495 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.4 mt -79.75 -67.59 0.75 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -159.93 163.86 33.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.422 ' C ' ' SG ' ' A' ' 37' ' ' CYS . 54.7 p-10 -91.42 58.58 3.64 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 16.8 tpp180 -138.32 115.9 11.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.644 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -140.79 128.26 21.3 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.644 ' N ' HD13 ' A' ' 80' ' ' LEU . 3.2 p -111.4 -162.04 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.605 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' ' O ' ' A' ' 81' ' ' SER . 12.3 m -44.65 179.85 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.322 0.582 . . . . 0.0 110.664 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' CZ3' ' A' ' 47' ' ' TRP . 17.7 p -148.57 146.69 28.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.733 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -113.11 126.02 55.01 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.55 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.66 126.37 27.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.5 t -126.52 132.05 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.553 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -115.1 121.39 42.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.163 0.506 . . . . 0.0 110.253 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.817 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -46.15 163.21 0.23 Allowed Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.952 -179.44 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.07 163.35 30.85 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.756 2.304 . . . . 0.0 111.961 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.5 t -163.97 -25.49 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.631 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.36 -63.33 2.97 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.593 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . -84.73 43.96 3.3 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 92' ' ' GLY . 5.6 pt20 34.36 -108.96 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.714 0.292 . . . . 0.0 111.128 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.724 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.4 t80 -157.77 113.63 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.237 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' NZ ' ' CB ' ' A' ' 110' ' ' GLU . 25.3 tptp -153.95 131.4 11.32 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.123 0.487 . . . . 0.0 111.424 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.425 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.4 tt -133.05 141.24 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.354 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.506 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 9.5 mt-30 -121.25 130.16 53.53 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 118' ' ' ILE . 8.3 mt -119.34 130.6 73.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.09 129.91 56.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.821 0.343 . . . . 0.0 110.802 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -61.04 -31.01 70.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.713 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -113.21 146.26 39.61 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 104' ' ' PHE . . . -47.98 -93.08 0.01 OUTLIER Glycine 0 C--O 1.226 -0.384 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 104' ' ' PHE . 38.7 p-10 -38.28 98.58 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' C ' ' O ' ' A' ' 103' ' ' ASP . 23.7 m-85 -8.99 77.14 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.216 0.948 . . . . 0.0 112.046 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' ASP . 38.0 m -153.88 163.28 40.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.461 0.648 . . . . 0.0 111.253 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.79 -151.53 20.14 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.115 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -73.11 135.55 44.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.249 . . . . 0.0 110.481 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 44.3 ttp -120.95 124.52 45.11 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.614 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.52 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 54.5 m-85 -116.23 134.37 54.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 120.888 0.375 . . . . 0.0 110.755 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' CB ' ' NZ ' ' A' ' 95' ' ' LYS . 1.9 pt-20 -120.96 119.26 32.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.018 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 111' ' ' THR . 6.1 t -148.98 125.11 10.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 94' ' ' TYR . 2.3 t -94.78 44.42 1.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.14 -177.33 5.3 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.583 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 114' ' ' ASP . 10.0 p-10 -87.07 155.96 19.93 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.127 0.489 . . . . 0.0 110.087 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 172' ' ' SER . 53.6 t -133.16 124.25 18.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.064 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.502 ' O ' ' OG ' ' A' ' 172' ' ' SER . 74.0 Cg_endo -79.75 -58.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.734 1.622 . . . . 0.0 110.789 177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 57.8 m -115.69 112.83 22.66 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -68.68 -45.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.197 0.523 . . . . 0.0 110.908 -178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.47 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 28.3 ttt -66.06 -19.47 65.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.436 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -76.25 -45.82 31.0 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.004 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.644 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 2.5 pt20 -100.74 -25.81 14.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 35.0 m-85 -110.25 1.71 18.79 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.938 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.4 m-70 52.05 9.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.118 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.475 ' H ' ' C ' ' A' ' 122' ' ' PHE . 2.7 mmt -75.91 133.69 40.46 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.421 ' O ' ' CD ' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -107.52 -30.01 8.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.492 -178.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 0.6 OUTLIER -149.31 109.28 4.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 -179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.87 124.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.792 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.541 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 69.0 m80 -105.79 -30.3 9.49 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.191 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 102' ' ' GLY . 15.7 t -152.68 147.82 26.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.0 111.196 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.4 t -149.22 126.88 11.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.978 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -107.91 -169.95 1.6 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.499 . . . . 0.0 110.468 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.4 t 51.3 89.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.5 HD11 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mm? -104.37 168.5 9.06 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.092 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.1 mp0 -142.02 111.18 6.37 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 34.19 -91.47 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.016 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.473 ' N ' ' O ' ' A' ' 134' ' ' GLU . 23.0 t -115.28 138.85 44.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.724 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 40.7 t-105 -130.23 168.07 17.43 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 HG12 ' A' ' 176' ' ' ILE . 76.3 mt -144.61 121.91 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.825 0.345 . . . . 0.0 111.4 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.611 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -108.62 130.4 55.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -107.89 111.22 23.23 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.099 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -51.19 -25.67 5.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.99 160.73 28.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 92.2 Cg_endo -79.94 164.87 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.38 2.053 . . . . 0.0 111.583 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.7 ' ND2' HH21 ' A' ' 146' ' ' ARG . 3.2 m-80 74.61 15.97 3.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.195 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.32 25.35 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.7 HH21 ' ND2' ' A' ' 144' ' ' ASN . 90.4 mtm180 -108.35 168.32 9.4 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.886 0.374 . . . . 0.0 110.557 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 149' ' ' GLN . . . 97.87 168.05 32.11 Favored Glycine 0 N--CA 1.462 0.389 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.504 HH11 ' H ' ' A' ' 148' ' ' ARG . 0.1 OUTLIER -64.98 137.27 57.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 110.079 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 147' ' ' GLY . 1.4 mp0 -84.21 145.81 28.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.243 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -111.54 129.91 55.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.351 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.0 tp -146.32 93.97 2.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.845 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 153' ' ' ASP . 6.0 tp -149.9 145.08 26.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.088 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 152' ' ' LEU . 99.6 m-20 55.88 159.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.618 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -156.18 58.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.601 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.32 -45.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.346 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -178.85 150.01 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.199 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.5 ' HE2' HD11 ' A' ' 133' ' ' LEU . 3.3 m-85 -122.09 108.33 13.23 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.536 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -108.92 -19.73 13.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -121.23 156.15 57.75 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-O 120.95 0.405 . . . . 0.0 110.687 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.549 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.5 Cg_endo -61.64 -16.39 48.01 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.652 2.235 . . . . 0.0 113.239 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.9 mp -100.65 -2.85 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.807 0.337 . . . . 0.0 110.779 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -27.46 68.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.814 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.549 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.6 OUTLIER -106.47 21.85 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.389 -179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.14 26.91 71.19 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.213 -0.517 . . . . 0.0 114.242 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -107.88 139.21 42.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 117.847 0.823 . . . . 0.0 109.812 177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.22 20.75 0.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.4 153.4 0.25 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.823 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.57 4.38 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 123.023 2.482 . . . . 0.0 111.614 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.33 70.28 4.66 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.986 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.929 HG12 ' H ' ' A' ' 171' ' ' GLN . 2.9 t -99.26 -153.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.929 ' H ' HG12 ' A' ' 170' ' ' VAL . 70.8 mm-40 -152.7 -131.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -94.18 -153.67 0.38 Allowed 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -170.52 -176.25 2.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.329 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -161.08 133.78 6.19 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.454 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.466 ' CG ' ' CE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -53.95 135.4 42.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.45 -178.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.495 HG12 HD12 ' A' ' 138' ' ' ILE . 13.9 mt -67.56 139.16 21.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.986 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.34 155.72 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.725 0.298 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.61 179.775 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 4' ' ' THR . 30.3 p -147.76 149.33 32.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.73 0.3 . . . . 0.0 110.271 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.5 mttm 56.94 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 2' ' ' SER . 3.6 p 43.0 26.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.719 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.16 43.22 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 4' ' ' THR . 41.5 p -143.38 134.44 25.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.501 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.822 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 36.2 tttt -160.42 153.24 21.24 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.069 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.8 tt -147.39 142.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 122.108 -0.37 . . . . 0.0 110.643 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 138.81 53.98 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 120.964 0.412 . . . . 0.0 110.699 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -119.14 115.01 23.36 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 87.8 m-85 -94.08 137.96 32.69 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.14 0.495 . . . . 0.0 110.947 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -60.22 -49.02 79.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.158 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' O ' ' OG ' ' A' ' 39' ' ' SER . 83.1 m-20 -100.97 -174.72 2.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.879 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.58 -174.97 5.57 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.517 0.675 . . . . 0.0 111.633 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.21 23.28 0.19 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.851 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 68' ' ' PRO . 1.7 m-85 59.19 44.43 15.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.29 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -115.35 160.67 19.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.355 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.32 -151.4 29.74 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.477 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -56.73 172.36 0.26 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -170.56 153.29 4.15 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -135.01 133.81 39.8 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 35.9 p-10 -120.76 137.63 54.41 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.776 0.322 . . . . 0.0 110.776 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -147.49 141.49 25.94 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 8.5 t70 -124.32 15.8 9.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.431 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 97.2 m -150.31 147.17 27.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.35 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 27' ' ' CYS . 38.1 t0 -37.64 155.55 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.512 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.564 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 43.8 t -155.66 161.91 40.69 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.41 -57.62 2.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.067 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.62 112.71 4.28 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.178 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -102.17 8.11 40.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.972 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.594 ' O ' ' O ' ' A' ' 34' ' ' LEU . 75.0 t60 -59.0 -29.35 67.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.536 0.684 . . . . 0.0 109.91 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 65.6 p -60.34 -29.76 69.09 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.01 -15.35 36.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' HIS . 16.7 tp -140.87 137.2 33.04 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 t -99.67 -9.02 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.36 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' O ' HD21 ' A' ' 34' ' ' LEU . 14.3 ttm180 -154.18 143.13 21.1 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.238 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 79' ' ' ARG . 4.6 p -110.47 104.6 13.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.602 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.735 ' O ' ' O ' ' A' ' 39' ' ' SER . 73.0 m-20 -129.32 155.85 44.96 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.735 ' O ' ' O ' ' A' ' 38' ' ' ASN . 13.2 p 36.47 129.6 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 O-C-N 124.691 1.244 . . . . 0.0 112.218 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.6 mt -142.1 147.32 21.6 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.947 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.291 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.0 ptpt -155.87 102.84 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.103 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.8 t -65.85 151.05 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 CA-C-O 121.402 0.62 . . . . 0.0 110.286 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -123.35 51.53 1.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.082 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.27 -96.14 0.1 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.974 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.52 -140.9 4.35 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 47' ' ' TRP . 48.8 m -81.43 166.84 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.601 -0.352 . . . . 0.0 110.453 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.822 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 30.8 m95 -154.01 155.39 35.46 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.253 0.549 . . . . 0.0 110.688 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -113.86 118.33 33.92 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 m -115.98 131.43 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.052 0.453 . . . . 0.0 110.73 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.56 111.99 24.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 76.0 tt0 -38.98 -34.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -113.55 147.19 37.01 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 51.8 Cg_endo -68.01 157.76 60.35 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.733 2.289 . . . . 0.0 111.309 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 2.8 m120 86.5 -2.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.329 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 9.6 m-85 85.61 59.14 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.306 0.379 . . . . 0.0 111.261 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . -149.99 178.77 8.62 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.022 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.489 ' O ' ' C ' ' A' ' 58' ' ' TYR . . . 60.56 124.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.364 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 6.0 m-85 16.34 104.22 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.074 0.55 . . . . 0.0 112.26 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.7 OUTLIER -99.57 101.86 13.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.066 0.46 . . . . 0.0 110.341 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CD2' ' NE2' ' A' ' 149' ' ' GLN . 8.6 m-85 -103.52 149.76 24.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.098 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -107.47 98.78 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.892 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER -76.65 114.26 37.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.25 163.61 17.35 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.298 1.998 . . . . 0.0 112.705 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.52 115.24 1.84 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.87 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.28 176.31 41.7 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 97.7 mt-10 -100.68 154.67 18.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.159 0.504 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.489 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 41.6 m-85 -147.34 86.59 6.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.614 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 16' ' ' PHE . 31.6 Cg_exo -57.15 -18.32 28.98 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.967 2.444 . . . . 0.0 112.761 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -148.45 161.71 41.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.735 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 8.6 p90 -65.4 -53.18 46.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.445 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 28.8 mt-30 -43.18 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.903 0.382 . . . . 0.0 111.894 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -76.14 -4.17 40.13 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.735 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.81 23.33 11.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.824 -0.171 . . . . 0.0 110.838 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 24.4 mmt 89.84 23.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.535 1.147 . . . . 0.0 111.661 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 29.85 54.36 0.2 Allowed Glycine 0 N--CA 1.473 1.144 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 17.4 mt -82.63 14.87 2.86 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.953 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER 112.73 163.38 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 125.263 1.602 . . . . 0.0 109.771 -178.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 53.4 p30 -94.73 64.99 3.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.675 178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' SG ' ' A' ' 37' ' ' CYS . 35.9 ttm180 -142.07 118.75 11.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.416 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.76 129.34 20.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 109.784 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.691 ' N ' HD13 ' A' ' 80' ' ' LEU . 2.8 p -110.07 -163.14 0.84 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.0 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 81' ' ' SER . 14.5 m -45.33 -179.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.147 0.499 . . . . 0.0 110.879 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.535 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 14.4 p -150.46 152.22 33.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -116.99 128.66 55.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -61.89 123.24 17.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.118 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 48' ' ' ALA . 54.2 t -125.23 133.06 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.495 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.6 m-70 -103.68 161.42 13.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.061 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.784 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -76.84 159.57 78.56 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.477 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.2 150.73 53.96 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.536 2.157 . . . . 0.0 112.209 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.7 p -155.52 169.34 24.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.467 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 76.28 -71.57 2.01 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -74.98 32.3 1.07 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.475 ' H ' ' C ' ' A' ' 91' ' ' GLY . 4.9 pt20 34.16 -106.44 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.745 0.307 . . . . 0.0 111.27 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.735 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 34.4 t80 -156.15 114.17 3.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.343 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.4 tptm -155.62 133.01 10.96 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 121.148 0.499 . . . . 0.0 111.034 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.431 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 1.9 tt -135.03 145.64 31.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.95 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.519 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 8.7 mt-30 -123.57 130.77 53.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.748 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.596 HD13 HD11 ' A' ' 118' ' ' ILE . 8.5 mt -119.98 131.04 73.46 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.167 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CZ ' ' SD ' ' A' ' 108' ' ' MET . 48.7 m-85 -111.83 130.01 55.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.964 0.411 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.27 -28.11 68.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.65 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -122.55 148.54 45.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.206 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.24 -171.48 1.25 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.3 t0 46.33 29.22 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.404 . . . . 0.0 110.464 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 54.67 82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.7 m -160.32 161.04 33.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.838 0.351 . . . . 0.0 110.378 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.85 -153.11 22.21 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.512 -0.635 . . . . 0.0 111.512 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -72.58 137.58 46.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.717 0.294 . . . . 0.0 110.641 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 53.0 ttp -122.13 127.11 49.71 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.827 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 122' ' ' PHE . 54.1 m-85 -118.07 134.97 54.49 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 110.65 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -121.68 116.74 25.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.052 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.22 126.48 24.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.31 0.576 . . . . 0.0 110.978 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.24 36.38 1.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.35 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -145.04 -177.65 5.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.732 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 10.9 p30 -85.68 160.13 19.64 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.32 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' O ' ' OG ' ' A' ' 172' ' ' SER . 43.2 t -136.03 124.86 15.63 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.669 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' O ' ' OG ' ' A' ' 172' ' ' SER . 57.4 Cg_endo -78.61 -53.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.208 1.939 . . . . 0.0 110.855 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.3 m -120.26 113.11 19.92 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -67.91 -46.18 82.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.653 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.48 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 26.9 ttt -64.73 -20.6 66.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.101 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -72.38 -49.18 35.9 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.649 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 3.9 pt20 -100.16 -23.04 14.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.167 -176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 33.9 m-85 -111.09 -0.1 16.71 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.855 0.359 . . . . 0.0 111.097 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 119' ' ' MET . 4.1 m-70 52.14 10.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.281 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.438 ' H ' ' C ' ' A' ' 122' ' ' PHE . 1.2 mtt -78.58 134.5 37.21 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -107.3 -27.5 10.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.758 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 48.4 mt-10 -151.19 107.5 3.46 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.075 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.411 HD11 HD13 ' A' ' 118' ' ' ILE . 8.5 mm -73.67 124.98 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.757 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 72.3 m80 -105.48 -33.43 8.13 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.035 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.5 m -152.31 147.46 26.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.986 0.422 . . . . 0.0 110.73 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.519 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -145.36 137.46 25.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.776 179.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -116.07 -173.24 2.32 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.374 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.0 t 49.21 94.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.547 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.41 ' C ' ' OE1' ' A' ' 134' ' ' GLU . 27.1 mt -111.93 168.49 9.54 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' VAL . 4.3 mp0 -140.62 112.5 7.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.289 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 37.5 -90.77 0.01 OUTLIER Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 134' ' ' GLU . 10.6 t -117.26 156.29 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.176 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.735 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 29.6 t-105 -144.63 169.18 18.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.456 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 80.7 mt -144.23 123.05 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.383 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -111.47 131.41 55.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -109.17 111.29 22.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.268 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -50.11 -21.33 1.25 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.247 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.4 mp -119.37 165.69 16.63 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 86.6 Cg_endo -83.46 167.79 13.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.334 2.023 . . . . 0.0 111.961 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.8 OUTLIER 79.78 14.57 0.94 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.956 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.488 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 5.4 m-85 76.01 28.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.143 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 80.5 mtp180 -136.81 130.21 31.53 Favored 'General case' 0 C--O 1.212 -0.901 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 156.92 169.14 20.5 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -51.96 98.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.816 0.341 . . . . 0.0 110.213 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.616 ' NE2' ' CD2' ' A' ' 60' ' ' TYR . 75.5 mt-30 -60.72 133.8 56.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.711 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -112.4 130.06 56.1 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.977 0.418 . . . . 0.0 110.822 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 37.3 tp -69.83 134.5 48.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.219 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.5 mp -122.31 148.08 45.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.881 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 155' ' ' LYS . 55.1 t0 -121.5 131.56 54.22 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.125 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -56.84 78.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.465 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 153' ' ' ASP . 49.4 mtpt -145.59 -91.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.414 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -174.39 150.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.375 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -126.85 109.6 12.15 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.399 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -105.87 -23.21 12.74 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.472 ' NZ ' ' CB ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.96 157.3 50.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-O 121.271 0.558 . . . . 0.0 110.784 -179.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.526 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 18.1 Cg_endo -61.65 -19.38 64.82 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.164 1.909 . . . . 0.0 113.129 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -98.81 -2.27 9.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.107 0.479 . . . . 0.0 110.756 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 159' ' ' LYS . 0.4 OUTLIER -59.66 -24.87 64.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.153 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 160' ' ' PRO . 0.8 OUTLIER -110.36 21.95 16.08 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 71.53 30.54 66.49 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.591 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.27 137.01 46.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.988 0.894 . . . . 0.0 109.437 179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -75.79 21.33 0.16 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.4 OUTLIER 168.1 156.64 0.14 Allowed Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.084 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.08 6.69 3.69 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 123.061 2.507 . . . . 0.0 111.461 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.99 70.87 7.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.694 0.283 . . . . 0.0 111.35 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.935 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.1 t -99.03 -150.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.935 ' H ' HG12 ' A' ' 170' ' ' VAL . 16.6 mm-40 -155.99 -132.97 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.356 0 O-C-N 123.14 0.275 . . . . 0.0 110.426 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.3 p -93.4 -155.81 0.46 Allowed 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 122.081 -0.387 . . . . 0.0 111.992 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -171.5 -176.04 1.74 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.033 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.433 HH21 HG22 ' A' ' 177' ' ' VAL . 9.1 ptm180 -158.31 133.1 8.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.157 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -51.9 134.37 31.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.235 0.541 . . . . 0.0 110.649 -179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 138' ' ' ILE . 11.5 mt -68.58 134.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.902 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.433 HG22 HH21 ' A' ' 174' ' ' ARG . 34.7 m -136.15 157.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.255 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.432 ' OE1' ' OG1' ' A' ' 46' ' ' THR . 17.6 tp10 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.197 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 p -179.03 -168.34 0.13 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.032 0.444 . . . . 0.0 110.425 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.73 -43.08 97.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.577 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.0 p -113.46 10.65 18.27 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.489 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.9 100.45 2.09 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.2 p -143.03 133.2 24.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.92 0.39 . . . . 0.0 110.534 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.793 ' N ' ' HE1' ' A' ' 47' ' ' TRP . 41.2 tttt -159.22 152.3 22.17 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.096 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.2 tt -147.49 142.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.816 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 m -125.98 138.97 53.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.502 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -119.12 115.75 24.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 84.1 m-85 -95.24 138.23 33.22 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.184 0.516 . . . . 0.0 110.915 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.49 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 6.1 tm-20 -61.24 -49.36 77.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.067 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' OD1' ' NH2' ' A' ' 36' ' ' ARG . 99.6 m-20 -98.03 -177.51 3.77 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.103 0.477 . . . . 0.0 109.842 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -81.7 -176.54 6.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.876 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.477 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 1.1 m120 46.58 24.43 0.32 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.778 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' H ' ' CB ' ' A' ' 39' ' ' SER . 2.5 m-85 62.07 41.61 10.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.157 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -109.11 172.99 6.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.114 0.483 . . . . 0.0 110.535 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.77 -155.3 52.82 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.439 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -55.77 175.08 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.459 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -169.8 154.58 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.422 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 55.9 t80 -130.76 131.58 44.8 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 45.7 p-10 -119.66 125.99 50.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.964 0.412 . . . . 0.0 111.197 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 14.0 t -152.79 143.17 22.57 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.372 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -126.53 24.58 6.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.809 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' ASP . 4.4 t -146.79 141.95 27.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.602 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' CYS . 51.7 p-10 -37.16 156.02 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.0 m -157.95 163.22 38.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.27 -56.63 2.98 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.862 0.363 . . . . 0.0 111.093 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 38.8 p-10 -152.43 112.26 3.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.115 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.422 ' CD2' ' CD2' ' A' ' 21' ' ' TYR . 2.7 p90 -102.19 9.2 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.985 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.598 ' O ' ' O ' ' A' ' 34' ' ' LEU . 81.6 t60 -59.66 -28.27 67.11 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.458 0.647 . . . . 0.0 109.964 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.2 p -61.27 -30.48 70.5 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.425 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -86.63 -14.06 43.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 31' ' ' HIS . 15.5 tp -141.97 136.35 30.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.136 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 m -94.86 -10.12 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.495 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.607 ' NE ' ' ND2' ' A' ' 38' ' ' ASN . 58.7 ttp180 -158.7 146.86 18.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.474 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 80' ' ' LEU . 3.2 m -110.67 104.61 13.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.416 0.627 . . . . 0.0 111.391 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.741 ' O ' ' O ' ' A' ' 39' ' ' SER . 81.8 m-20 -129.33 156.8 43.45 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.348 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.741 ' O ' ' O ' ' A' ' 38' ' ' ASN . 12.3 p 35.52 128.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.42 1.105 . . . . 0.0 112.42 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 24.4 mt -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.385 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 7.2 ptpt -154.67 102.92 2.42 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.4 t -66.57 150.17 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-O 121.448 0.642 . . . . 0.0 110.226 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -123.1 51.68 1.43 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.964 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -171.06 -96.2 0.1 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.218 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -136.25 -141.89 4.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 47' ' ' TRP . 83.8 m -79.86 166.34 21.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.0 110.767 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.793 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 32.7 m95 -154.65 155.48 34.74 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.496 0.665 . . . . 0.0 110.789 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 86' ' ' VAL . . . -116.36 121.62 42.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.382 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.8 133.54 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.014 0.435 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 52' ' ' ARG . 77.9 m-85 -104.41 109.82 21.83 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' OE1' ' CD1' ' A' ' 58' ' ' TYR . 74.0 tt0 -33.55 -33.29 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.644 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 29.9 mtp85 -121.71 151.48 57.37 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.493 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' ASN . 56.0 Cg_endo -69.92 164.2 35.58 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.764 2.309 . . . . 0.0 112.158 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 55' ' ' PHE . 4.6 m-80 78.99 -8.13 1.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.884 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' CD2' ' O ' ' A' ' 54' ' ' ASN . 8.9 m-85 81.5 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.5 0.5 . . . . 0.0 110.742 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 52' ' ' ARG . . . -150.01 111.14 4.38 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.874 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 58' ' ' TYR . . . 162.45 -66.54 0.24 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.548 ' CD1' ' OE1' ' A' ' 51' ' ' GLU . 54.0 m-85 -152.04 178.07 9.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.48 ' SD ' ' O ' ' A' ' 151' ' ' LEU . 66.3 mtt -142.09 87.71 2.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.945 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.2 t80 -108.96 135.89 49.4 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.782 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.6 mp -103.65 91.02 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.407 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.2 mt -70.32 111.86 10.81 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.82 163.51 16.02 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.111 1.874 . . . . 0.0 112.739 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' N ' ' OE2' ' A' ' 178' ' ' GLU . 0.3 OUTLIER -52.7 116.87 2.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.151 179.597 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.64 178.77 42.23 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.528 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 98.1 mt-10 -101.55 152.4 20.82 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.002 0.43 . . . . 0.0 110.336 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' ILE . 22.6 m-85 -144.29 89.52 6.96 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.36 -14.73 45.75 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.223 1.948 . . . . 0.0 113.331 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 95.1 mt-10 -150.26 161.06 43.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.685 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 15.0 p90 -63.26 -50.06 71.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.759 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.417 ' CG ' ' CE2' ' A' ' 70' ' ' TYR . 30.2 mt-30 -45.0 -9.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 70' ' ' TYR . 22.8 mmm180 -75.18 -5.41 44.25 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.685 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -118.11 25.98 9.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 75' ' ' GLY . 21.8 mmm 84.93 24.55 0.09 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.131 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 74' ' ' MET . . . 31.4 54.02 0.31 Allowed Glycine 0 N--CA 1.474 1.196 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 30.8 mt -78.98 14.44 1.39 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.148 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 60.0 t30 112.61 164.14 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 O-C-N 125.039 1.462 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 52.7 p30 -96.45 65.93 2.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -144.57 120.23 10.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.121 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -142.77 129.73 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.675 ' N ' HD13 ' A' ' 80' ' ' LEU . 1.7 p -111.19 -162.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.578 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.514 ' O ' ' O ' ' A' ' 81' ' ' SER . 13.0 p -45.99 -178.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 110.793 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.481 ' SG ' ' CE3' ' A' ' 47' ' ' TRP . 15.8 p -149.75 150.49 32.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -115.99 127.42 54.92 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -62.54 126.39 27.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.309 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG21 ' HB2' ' A' ' 48' ' ' ALA . 79.4 t -123.84 131.19 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.704 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.502 ' O ' HG21 ' A' ' 136' ' ' VAL . 25.7 m80 -101.66 161.78 13.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.019 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.751 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -81.06 157.52 71.1 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.739 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.24 150.8 53.8 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.31 2.007 . . . . 0.0 112.023 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 91' ' ' GLY . 85.4 p -161.9 -19.04 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.806 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 90' ' ' SER . . . -92.02 51.72 2.85 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.475 ' O ' ' CG ' ' A' ' 134' ' ' GLU . . . 153.26 37.61 0.03 OUTLIER Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 35.04 -106.76 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.715 0.293 . . . . 0.0 111.131 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.744 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 29.8 t80 -157.21 113.45 2.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.111 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -154.68 130.99 10.41 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.993 0.425 . . . . 0.0 111.077 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' ' CH2' ' A' ' 137' ' ' TRP . 2.3 tt -134.26 142.58 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.85 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.522 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 11.0 mt-30 -123.11 130.59 52.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 HD11 ' A' ' 118' ' ' ILE . 8.1 mt -119.49 131.84 70.97 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.208 -178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -112.77 131.61 55.61 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.117 0.484 . . . . 0.0 110.625 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -60.36 -29.99 69.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.837 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -120.04 150.26 40.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.3 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.5 176.24 14.6 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 55.75 30.58 15.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 110.5 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.523 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 6.1 m-85 56.0 83.0 0.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -160.58 161.18 32.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.955 0.407 . . . . 0.0 110.569 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.6 -149.36 21.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -77.22 138.59 39.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.671 0.272 . . . . 0.0 110.483 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 8.3 tmm? -122.23 132.96 54.69 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.055 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.461 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 58.1 m-85 -122.1 135.86 54.85 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -123.11 124.2 42.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.445 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 111' ' ' THR . 11.9 t -147.75 128.57 14.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.907 0.384 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 p -92.92 38.78 1.03 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.62 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 -177.62 5.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.761 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 14.4 p-10 -85.51 158.51 20.15 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 172' ' ' SER . 42.7 t -132.8 124.23 18.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.372 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' O ' ' OG ' ' A' ' 172' ' ' SER . 66.5 Cg_endo -79.57 -56.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.606 1.537 . . . . 0.0 110.958 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.7 m -116.05 113.03 22.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 171' ' ' GLN . 3.8 tt -69.76 -46.59 74.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-O 121.168 0.509 . . . . 0.0 110.787 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.471 ' N ' ' CG2' ' A' ' 118' ' ' ILE . 27.1 ttt -65.48 -18.87 65.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.243 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -75.36 -46.36 33.61 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 121.606 -0.684 . . . . 0.0 111.992 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' NE2' ' CE2' ' A' ' 122' ' ' PHE . 4.0 pt20 -101.45 -24.74 14.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.254 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.64 ' CE2' ' NE2' ' A' ' 121' ' ' GLN . 31.3 m-85 -111.28 -0.55 16.37 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.728 0.299 . . . . 0.0 111.022 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 119' ' ' MET . 3.7 m-70 52.76 12.13 0.24 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.982 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.414 ' N ' ' C ' ' A' ' 122' ' ' PHE . 32.4 mtt -79.28 133.12 36.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -107.55 -26.94 10.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.545 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 47.9 mt-10 -150.83 108.27 3.63 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.08 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 118' ' ' ILE . 7.7 mm -74.7 125.97 34.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.794 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.5 m80 -107.37 -32.27 7.82 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.332 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.523 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 13.5 t -153.59 147.21 25.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 111.29 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.522 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -146.72 129.18 15.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.735 179.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 132' ' ' VAL . 43.9 mtmt -99.83 -157.88 0.63 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.016 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.578 ' O ' ' O ' ' A' ' 131' ' ' LYS . 1.1 m 32.39 110.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.906 0.86 . . . . 0.0 112.058 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 132' ' ' VAL . 3.6 mm? -117.98 166.87 11.99 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.766 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 136' ' ' VAL . 1.2 mp0 -142.75 111.07 6.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.781 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 134' ' ' GLU . . . 35.03 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.603 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 87' ' ' HIS . 4.9 t -117.25 156.31 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 110.165 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.744 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 25.9 t-105 -145.36 168.2 21.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.379 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 91.0 mt -145.39 123.79 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.759 0.314 . . . . 0.0 111.377 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -108.77 130.22 55.38 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.03 110.81 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.83 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 142' ' ' LEU . 76.4 tt0 -49.46 -22.51 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.517 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 141' ' ' GLU . 6.7 mp -118.47 161.01 37.6 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.432 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 74.1 Cg_endo -77.97 167.44 23.6 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.324 2.016 . . . . 0.0 111.68 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 144' ' ' ASN . 0.7 OUTLIER 73.14 14.12 4.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.921 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 144' ' ' ASN . 2.5 m-85 78.2 24.52 0.66 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.636 0.255 . . . . 0.0 111.306 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 80.6 mtp85 -108.49 168.96 8.95 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 95.07 170.43 36.63 Favored Glycine 0 N--CA 1.462 0.393 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -55.52 150.32 12.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.148 0.499 . . . . 0.0 109.771 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 149' ' ' GLN . 7.1 mp0 -108.8 146.7 33.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.665 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -115.46 130.01 56.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.48 ' O ' ' SD ' ' A' ' 59' ' ' MET . 4.0 tt -150.76 113.42 4.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.64 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.5 tp -150.25 135.71 18.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.232 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 153' ' ' ASP . 25.2 p30 -86.85 107.86 18.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.543 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -138.38 -116.36 0.15 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.565 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -169.3 95.83 0.32 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.48 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 63.61 155.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.467 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -119.14 108.6 14.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.009 0.433 . . . . 0.0 111.381 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.607 ' HE ' ' NZ ' ' A' ' 159' ' ' LYS . 40.2 ptt180 -107.59 -24.69 11.66 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.607 ' NZ ' ' HE ' ' A' ' 158' ' ' ARG . 14.2 pttm -119.82 154.06 54.98 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 120.84 0.353 . . . . 0.0 110.492 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.537 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 12.3 Cg_endo -58.42 -16.63 29.97 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.31 2.006 . . . . 0.0 113.5 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 161' ' ' ILE . 2.3 mp -100.93 -3.68 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.956 0.408 . . . . 0.0 110.37 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -61.15 -27.16 68.2 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.481 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.555 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.6 OUTLIER -107.7 20.69 18.49 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.642 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 72.43 28.41 67.8 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.626 177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.555 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -108.25 137.67 45.84 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.792 0.796 . . . . 0.0 109.72 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.11 20.81 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.314 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 165' ' ' ALA . 0.9 OUTLIER 171.48 155.47 0.22 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.477 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.64 5.0 5.11 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.952 2.435 . . . . 0.0 111.596 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.59 70.92 6.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.612 0.244 . . . . 0.0 111.153 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.908 HG12 ' H ' ' A' ' 171' ' ' GLN . 3.3 t -100.93 -147.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.908 ' H ' HG12 ' A' ' 170' ' ' VAL . 1.6 tp60 -157.73 -132.25 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.611 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 118' ' ' ILE . 1.1 m -92.21 -154.09 0.36 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -170.37 -177.07 2.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.136 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -159.48 132.45 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.924 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 5.9 ptm180 -53.92 129.34 33.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.686 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 138' ' ' ILE . 16.7 mt -59.77 135.41 24.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.383 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.2 t -133.97 138.74 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.517 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 64' ' ' GLN . 25.0 tp10 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.436 179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.611 ' H2 ' ' CA ' ' A' ' 5' ' ' GLY . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.3 m -58.96 -43.58 91.35 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.512 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -144.59 -41.04 0.25 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.652 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 5' ' ' GLY . 43.2 p -60.37 -75.19 0.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.935 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.611 ' CA ' ' H2 ' ' A' ' 1' ' ' GLY . . . 154.09 -50.54 0.48 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p -81.58 163.86 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 110.338 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.722 ' O ' HG13 ' A' ' 42' ' ' VAL . 40.8 tttt -161.45 155.85 22.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.321 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.629 HG21 ' SG ' ' A' ' 83' ' ' CYS . 17.4 tt -148.58 146.99 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.035 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 21' ' ' TYR . 17.6 m -132.97 141.43 48.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.978 0.418 . . . . 0.0 110.119 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -121.71 117.26 26.21 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CG ' ' HA ' ' A' ' 16' ' ' PHE . 86.5 m-85 -99.68 141.13 32.88 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 120.896 0.379 . . . . 0.0 111.047 -179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 4.9 tm-20 -64.07 -51.66 63.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.23 -176.39 4.13 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.203 0.525 . . . . 0.0 109.616 179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HB3' HD22 ' A' ' 15' ' ' ASN . 42.1 mtmt -84.28 -178.17 6.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.805 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.713 HD22 ' N ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 46.25 24.55 0.28 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.128 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' HA ' ' CG ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER 61.81 44.24 8.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.214 179.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -111.21 166.1 11.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.012 0.434 . . . . 0.0 110.919 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.88 -144.09 31.96 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.608 179.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -60.97 166.47 3.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.151 -1.025 . . . . 0.0 109.024 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -168.7 155.94 7.49 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.003 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' HG23 ' A' ' 9' ' ' THR . 58.2 t80 -135.62 135.42 40.21 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 p-10 -104.25 150.12 24.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.615 0.245 . . . . 0.0 110.563 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -162.55 124.94 2.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.949 0.404 . . . . 0.0 110.527 179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -123.08 14.35 9.81 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.657 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.8 t -150.66 148.46 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.713 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.0 p30 -39.28 156.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.7 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 28' ' ' ALA . 48.3 t -158.29 164.29 36.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 27' ' ' CYS . . . -92.65 -56.07 3.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 111.1 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -156.31 109.19 2.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.343 -179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -92.67 7.53 43.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.147 179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -58.76 -30.36 67.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.103 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.8 p -64.52 -1.1 1.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.699 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -119.39 -14.84 9.15 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.768 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 36' ' ' ARG . 15.8 tp -141.33 139.61 33.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.5 m -102.21 -8.38 21.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.852 -179.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.491 ' O ' ' CD2' ' A' ' 34' ' ' LEU . 17.7 ttm180 -153.32 141.87 20.83 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.941 0.4 . . . . 0.0 110.685 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 2.9 m -113.02 104.23 12.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.358 0.599 . . . . 0.0 110.772 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 52.6 m-20 -115.17 -153.76 0.53 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' ASN . 19.1 p -24.94 137.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.61 0.719 . . . . 0.0 112.587 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 6.0 mt -140.54 147.85 22.69 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.008 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.742 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG2' ' CD1' ' A' ' 16' ' ' PHE . 5.8 ptpt -155.89 103.12 2.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.239 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 7' ' ' LYS . 3.0 t -66.49 144.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.93 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -115.1 46.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.48 178.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -164.15 -100.28 0.15 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.811 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.544 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -134.29 -140.15 4.24 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -178.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.631 HG22 ' N ' ' A' ' 47' ' ' TRP . 91.6 m -78.7 167.27 21.46 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.437 -0.449 . . . . 0.0 110.851 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.714 ' HE1' ' N ' ' A' ' 7' ' ' LYS . 39.3 m95 -157.11 158.82 37.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.376 0.608 . . . . 0.0 110.482 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.98 122.57 43.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.791 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' A' ' 80' ' ' LEU . 5.8 m -119.41 133.02 67.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.891 0.377 . . . . 0.0 110.671 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 51' ' ' GLU . 92.9 m-85 -106.17 110.57 22.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.928 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' OE1' ' CD2' ' A' ' 58' ' ' TYR . 71.4 tt0 -34.87 -36.06 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.37 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 50' ' ' TYR . 62.7 mtt-85 -116.61 147.42 39.74 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' ND2' ' A' ' 54' ' ' ASN . 45.3 Cg_endo -68.01 156.36 66.14 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.37 2.047 . . . . 0.0 111.88 178.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 53' ' ' PRO . 7.8 m-80 86.23 0.41 0.63 Allowed 'General case' 0 CA--C 1.528 0.126 0 O-C-N 123.931 0.769 . . . . 0.0 111.216 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CG ' ' C ' ' A' ' 54' ' ' ASN . 8.9 m-85 82.23 56.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.464 0.478 . . . . 0.0 111.216 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.02 160.83 38.31 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.388 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.78 -155.68 22.67 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 17.0 m-85 -74.72 139.11 43.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.941 0.4 . . . . 0.0 110.001 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -103.69 88.98 3.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.443 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.613 ' CE2' ' NE2' ' A' ' 149' ' ' GLN . 20.6 t80 -92.42 135.42 34.06 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 61' ' ' ILE . 2.0 mp -101.37 94.61 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.578 ' CD2' ' CZ ' ' A' ' 67' ' ' TYR . 1.3 mt -72.46 111.22 10.2 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -81.15 164.84 19.48 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.078 1.852 . . . . 0.0 112.418 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -55.06 118.83 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.08 179.458 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 169.48 -180.0 41.66 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 95.9 mt-10 -102.74 153.24 20.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.004 0.43 . . . . 0.0 110.176 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.578 ' CZ ' ' CD2' ' A' ' 62' ' ' LEU . 4.4 m-85 -142.54 69.79 20.8 Favored Pre-proline 0 C--O 1.221 -0.406 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.377 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.29 -13.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.845 2.363 . . . . 0.0 113.079 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 67' ' ' TYR . 71.2 mt-10 -155.46 163.99 39.3 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.689 ' O ' ' CD1' ' A' ' 73' ' ' TRP . 12.1 p90 -65.18 -49.58 69.24 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.063 -179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -42.44 -10.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -80.23 0.78 31.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.488 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.689 ' CD1' ' O ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -121.73 20.9 10.92 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.36 0.124 . . . . 0.0 111.124 178.595 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' TRP . 14.8 mmt 92.22 20.33 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.781 1.233 . . . . 0.0 111.716 -178.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 31.19 59.6 0.27 Allowed Glycine 0 CA--C 1.536 1.358 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 32.4 mt -89.23 17.14 6.3 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.423 0.289 . . . . 0.0 111.543 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 76' ' ' LEU . 64.6 t30 103.78 156.84 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.744 1.278 . . . . 0.0 109.578 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.24 63.74 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.806 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -131.54 112.77 12.93 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 81' ' ' SER . 0.2 OUTLIER -146.15 130.34 17.5 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.123 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.673 ' N ' HD13 ' A' ' 80' ' ' LEU . 4.7 p -108.78 -164.17 0.93 Allowed 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.034 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' SER . 2.9 m -48.37 -173.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.399 0.619 . . . . 0.0 111.553 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.629 ' SG ' HG21 ' A' ' 8' ' ' ILE . 13.5 p -151.41 151.65 32.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.698 -179.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -115.28 128.28 56.02 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.57 ' N ' ' CZ3' ' A' ' 47' ' ' TRP . . . -59.87 132.4 53.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.79 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.1 t -129.03 132.65 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.706 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.44 ' O ' HG21 ' A' ' 136' ' ' VAL . 98.9 m-70 -98.9 162.8 12.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.12 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.74 149.92 61.28 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.08 149.91 82.36 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.126 1.884 . . . . 0.0 112.14 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.2 t -156.55 169.45 24.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.284 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 93' ' ' GLN . . . 78.72 -73.27 2.29 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 93' ' ' GLN . . . -75.93 34.2 1.25 Allowed Glycine 0 C--O 1.226 -0.378 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 91' ' ' GLY . 6.5 pt20 33.66 -109.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.718 0.294 . . . . 0.0 111.228 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.725 ' CZ ' ' CH2' ' A' ' 137' ' ' TRP . 36.7 t80 -153.54 113.1 3.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 15.2 tptm -153.64 137.29 16.03 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.102 0.477 . . . . 0.0 111.138 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 tt -137.82 145.66 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.087 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 130' ' ' CYS . 10.4 mt-30 -123.9 129.49 51.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.746 177.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.83 131.42 72.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -111.15 123.38 50.08 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.011 0.434 . . . . 0.0 110.786 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -57.01 -19.74 20.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.078 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -131.2 144.75 51.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.455 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 128' ' ' HIS . . . -57.49 -170.46 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 -179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 44.62 29.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.741 0.305 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.509 ' CD1' ' OG ' ' A' ' 129' ' ' SER . 17.4 m-85 54.64 82.05 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -159.64 164.13 34.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.644 179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 -158.49 30.04 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.863 179.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -64.66 135.74 56.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.962 0.41 . . . . 0.0 110.361 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' MET . . . . . . . . . . . . . 45.2 ttp -118.23 122.21 42.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.186 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.58 ' CG ' ' CD1' ' A' ' 122' ' ' PHE . 44.9 m-85 -115.85 130.57 56.89 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.142 0.496 . . . . 0.0 111.112 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -120.46 120.69 36.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.097 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -149.54 129.75 13.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.412 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.5 t -97.09 49.91 1.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.012 0.434 . . . . 0.0 110.933 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.48 -176.63 5.38 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.351 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 114' ' ' ASP . 15.3 p-10 -89.65 160.51 16.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 121' ' ' GLN . 58.2 m -138.41 123.02 11.83 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.492 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' O ' ' OG ' ' A' ' 172' ' ' SER . 58.0 Cg_endo -76.15 -61.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.878 1.719 . . . . 0.0 110.53 178.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.9 m -110.34 114.09 27.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 171' ' ' GLN . 4.2 tt -70.05 -37.19 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.958 0.409 . . . . 0.0 110.947 -178.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 123' ' ' HIS . 26.5 ttt -70.51 -19.01 62.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.728 -179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -81.81 -42.3 19.88 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.14 -0.975 . . . . 0.0 111.513 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 115' ' ' CYS . 0.3 OUTLIER -93.15 -30.53 15.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.769 -177.531 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.58 ' CD1' ' CG ' ' A' ' 109' ' ' TYR . 32.1 m-85 -116.86 4.23 12.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.813 -178.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 119' ' ' MET . 2.7 m-70 54.19 3.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.0 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.548 ' H ' ' C ' ' A' ' 122' ' ' PHE . 35.8 mtt -72.12 133.09 44.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.112 0.482 . . . . 0.0 110.09 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -109.02 -24.65 11.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.192 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.557 ' O ' ' CE1' ' A' ' 128' ' ' HIS . 66.8 mt-10 -151.78 107.78 3.4 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.997 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 168' ' ' PRO . 13.8 mm -76.71 126.02 37.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.587 179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 126' ' ' GLU . 73.4 m80 -104.55 -36.5 7.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.169 -178.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.509 ' OG ' ' CD1' ' A' ' 104' ' ' PHE . 7.4 t -148.27 143.47 26.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.129 0.49 . . . . 0.0 110.856 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 97' ' ' GLN . 1.3 t -143.44 134.09 25.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.034 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.425 ' HB2' HE21 ' A' ' 97' ' ' GLN . 47.8 mtpt -114.38 -175.99 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.571 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.486 ' C ' HD22 ' A' ' 133' ' ' LEU . 28.0 t 54.7 93.71 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.672 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.486 HD22 ' C ' ' A' ' 132' ' ' VAL . 4.2 mm? -111.92 165.56 11.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.106 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 136' ' ' VAL . 3.4 mp0 -139.4 111.83 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 39.55 -88.43 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 134' ' ' GLU . 3.6 t -119.13 156.48 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.096 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.725 ' CH2' ' CZ ' ' A' ' 94' ' ' TYR . 30.2 t-105 -144.47 166.72 24.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.643 -179.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.403 ' N ' ' CD1' ' A' ' 137' ' ' TRP . 85.8 mt -144.23 124.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.375 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.614 ' CD2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -111.74 129.57 56.07 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.454 ' CE1' ' CG ' ' A' ' 149' ' ' GLN . 30.8 m-85 -107.4 113.8 27.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.802 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -50.1 -22.76 1.77 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.647 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 146' ' ' ARG . 2.9 mp -121.74 165.36 20.31 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.462 ' N ' ' HG2' ' A' ' 171' ' ' GLN . 73.0 Cg_endo -81.93 169.91 14.35 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.241 1.961 . . . . 0.0 112.3 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.496 ' C ' ' CG ' ' A' ' 145' ' ' TYR . 0.8 OUTLIER 77.0 13.67 2.1 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.783 179.759 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.496 ' CG ' ' C ' ' A' ' 144' ' ' ASN . 3.4 m-85 74.25 30.12 1.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.11 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.488 ' O ' ' CB ' ' A' ' 142' ' ' LEU . 93.0 mtt180 -134.68 126.23 28.68 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.4 173.62 20.77 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 -178.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -52.45 113.66 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.896 0.379 . . . . 0.0 110.499 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.613 ' NE2' ' CE2' ' A' ' 60' ' ' TYR . 74.5 mt-30 -82.18 149.48 27.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.53 152.33 39.31 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.857 179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tp -110.58 154.42 23.77 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.83 133.73 51.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -121.41 -110.99 0.33 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.428 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -66.42 153.07 43.76 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.663 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -62.75 129.44 40.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 64.66 158.8 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.203 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.57 111.49 14.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.965 0.412 . . . . 0.0 111.146 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -108.58 -21.48 12.69 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.945 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 29.7 pttt -123.64 154.88 66.8 Favored Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.362 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.492 ' O ' ' NE1' ' A' ' 163' ' ' TRP . 16.0 Cg_endo -58.98 -20.53 53.71 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.481 2.121 . . . . 0.0 113.611 179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 161' ' ' ILE . 3.5 mp -97.24 -5.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.938 0.399 . . . . 0.0 110.654 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -55.81 -33.18 64.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.331 -178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.547 ' HE1' ' HB3' ' A' ' 165' ' ' ALA . 0.9 OUTLIER -101.02 21.97 12.98 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.999 -179.459 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.96 27.64 66.24 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.629 176.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . . . -106.83 138.2 43.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.802 0.801 . . . . 0.0 110.678 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 167' ' ' SER . . . -77.31 24.2 0.19 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 165' ' ' ALA . 1.1 m 165.19 153.79 0.07 OUTLIER Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.447 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 170' ' ' VAL . 50.9 Cg_endo -71.18 -18.07 30.85 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.797 2.332 . . . . 0.0 111.509 178.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.41 70.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.302 -178.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.963 HG22 ' H ' ' A' ' 171' ' ' GLN . 8.8 p -104.99 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.963 ' H ' HG22 ' A' ' 170' ' ' VAL . 2.0 tp60 -152.82 -130.86 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.501 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 116' ' ' PRO . 3.6 p -94.85 -154.09 0.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -171.53 -178.17 2.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.295 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -157.7 132.97 8.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.96 178.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -52.74 126.11 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.35 0.595 . . . . 0.0 110.347 -179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.491 HD12 ' HB ' ' A' ' 136' ' ' VAL . 10.9 mt -56.59 129.85 18.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.823 -179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.35 135.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.502 179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.049 179.63 . . . . . . . . 0 0 . 1 stop_ save_